{
  "nbformat": 4,
  "nbformat_minor": 0,
  "metadata": {
    "colab": {
      "name": "A2.ipynb",
      "provenance": [],
      "authorship_tag": "ABX9TyMkmSr6YYrnhljR3nH6+7X5",
      "include_colab_link": true
    },
    "kernelspec": {
      "name": "python3",
      "display_name": "Python 3"
    },
    "language_info": {
      "name": "python"
    }
  },
  "cells": [
    {
      "cell_type": "markdown",
      "metadata": {
        "id": "view-in-github",
        "colab_type": "text"
      },
      "source": [
        "<a href=\"https://colab.research.google.com/github/kev457/COMP5349/blob/main/A2.ipynb\" target=\"_parent\"><img src=\"https://colab.research.google.com/assets/colab-badge.svg\" alt=\"Open In Colab\"/></a>"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "HbKD25p24_RU",
        "outputId": "26c1c168-cbc5-45ce-f1db-ce1f30755a73"
      },
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "Looking in indexes: https://pypi.org/simple, https://us-python.pkg.dev/colab-wheels/public/simple/\n",
            "Requirement already satisfied: pyspark in /usr/local/lib/python3.7/dist-packages (3.2.1)\n",
            "Requirement already satisfied: py4j==0.10.9.3 in /usr/local/lib/python3.7/dist-packages (from pyspark) (0.10.9.3)\n"
          ]
        }
      ],
      "source": [
        "!pip install pyspark"
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "from google.colab import drive\n",
        "drive.mount('/content/drive')"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "6W_zr2yW5BdG",
        "outputId": "57de8670-6387-4db4-f185-eacffb16815b"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "Drive already mounted at /content/drive; to attempt to forcibly remount, call drive.mount(\"/content/drive\", force_remount=True).\n"
          ]
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "from pyspark.sql import SparkSession\n",
        "spark = SparkSession \\\n",
        "    .builder \\\n",
        "    .appName(\"COMP5349 A2\") \\\n",
        "    .getOrCreate()"
      ],
      "metadata": {
        "id": "dAd2XEVY5jja"
      },
      "execution_count": null,
      "outputs": []
    },
    {
      "cell_type": "code",
      "source": [
        "test_data = \"/content/drive/MyDrive/comp5349/test.json\"\n",
        "test_init_df = spark.read.json(test_data)\n",
        "train_data = \"/content/drive/MyDrive/comp5349/train_separate_questions.json\"\n",
        "train_init_df = spark.read.json(train_data)\n",
        "all_data = \"/content/drive/MyDrive/comp5349/CUADv1.json\"\n",
        "all_init_df = spark.read.json(all_data)"
      ],
      "metadata": {
        "id": "6yeqAGVD5RKK"
      },
      "execution_count": null,
      "outputs": []
    },
    {
      "cell_type": "code",
      "source": [
        "test_init_df.printSchema()"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "pIdJXWPK5nEn",
        "outputId": "d5da42b4-4eae-4200-94df-9f5ef974854f"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "root\n",
            " |-- data: array (nullable = true)\n",
            " |    |-- element: struct (containsNull = true)\n",
            " |    |    |-- paragraphs: array (nullable = true)\n",
            " |    |    |    |-- element: struct (containsNull = true)\n",
            " |    |    |    |    |-- context: string (nullable = true)\n",
            " |    |    |    |    |-- qas: array (nullable = true)\n",
            " |    |    |    |    |    |-- element: struct (containsNull = true)\n",
            " |    |    |    |    |    |    |-- answers: array (nullable = true)\n",
            " |    |    |    |    |    |    |    |-- element: struct (containsNull = true)\n",
            " |    |    |    |    |    |    |    |    |-- answer_start: long (nullable = true)\n",
            " |    |    |    |    |    |    |    |    |-- text: string (nullable = true)\n",
            " |    |    |    |    |    |    |-- id: string (nullable = true)\n",
            " |    |    |    |    |    |    |-- is_impossible: boolean (nullable = true)\n",
            " |    |    |    |    |    |    |-- question: string (nullable = true)\n",
            " |    |    |-- title: string (nullable = true)\n",
            " |-- version: string (nullable = true)\n",
            "\n"
          ]
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "from pyspark.sql.functions import explode\n",
        "test_data_df= test_init_df.select((explode(\"data\").alias('data')))\n",
        "test_paragraph_df = test_data_df.select(explode(\"data.paragraphs\").alias(\"paragraph\"))\n",
        "qas_context_df = test_paragraph_df.select(explode(\"paragraph.qas\").alias(\"qas\"),\"paragraph.context\")\n",
        "df = qas_context_df.select('qas.id','context','qas.question',explode(\"qas.answers\").alias(\"answers\"),'qas.is_impossible')\n",
        "\n",
        "df.show()"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "2LGWB9t45vaY",
        "outputId": "134b17f8-a214-497b-9376-ba8e4c0de6e1"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "+--------------------+--------------------+--------------------+--------------------+-------------+\n",
            "|                  id|             context|            question|             answers|is_impossible|\n",
            "+--------------------+--------------------+--------------------+--------------------+-------------+\n",
            "|LohaCompanyltd_20...|Exhibit 10.16 SUP...|Highlight the par...|{14, SUPPLY CONTR...|        false|\n",
            "|LohaCompanyltd_20...|Exhibit 10.16 SUP...|Highlight the par...|  {143, The seller:}|        false|\n",
            "|LohaCompanyltd_20...|Exhibit 10.16 SUP...|Highlight the par...|{49, The buyer/En...|        false|\n",
            "|LohaCompanyltd_20...|Exhibit 10.16 SUP...|Highlight the par...|{10985, The Contr...|        false|\n",
            "|LohaCompanyltd_20...|Exhibit 10.16 SUP...|Highlight the par...|{10691, It will b...|        false|\n",
            "|LohaCompanyltd_20...|Exhibit 10.16 SUP...|Highlight the par...|{6665, Within 7 d...|        false|\n",
            "|LohaCompanyltd_20...|Exhibit 10.16 SUP...|Highlight the par...|{3659, To be cove...|        false|\n",
            "|CENTRACKINTERNATI...|1                ...|Highlight the par...|{225, WEB SITE HO...|        false|\n",
            "|CENTRACKINTERNATI...|1                ...|Highlight the par...|{330, Centrack In...|        false|\n",
            "|CENTRACKINTERNATI...|1                ...|Highlight the par...|{14893, I-ON INTE...|        false|\n",
            "|CENTRACKINTERNATI...|1                ...|Highlight the par...|{398, i-on intera...|        false|\n",
            "|CENTRACKINTERNATI...|1                ...|Highlight the par...|{14853, CENTRACK ...|        false|\n",
            "|CENTRACKINTERNATI...|1                ...|Highlight the par...| {378, the Customer}|        false|\n",
            "|CENTRACKINTERNATI...|1                ...|Highlight the par...|         {101, i-on}|        false|\n",
            "|CENTRACKINTERNATI...|1                ...|Highlight the par...|{292, 6th day of ...|        false|\n",
            "|CENTRACKINTERNATI...|1                ...|Highlight the par...|{10363, The term ...|        false|\n",
            "|CENTRACKINTERNATI...|1                ...|Highlight the par...|{10363, The term ...|        false|\n",
            "|CENTRACKINTERNATI...|1                ...|Highlight the par...|{10751, Agreement...|        false|\n",
            "|CENTRACKINTERNATI...|1                ...|Highlight the par...|{10559, This Agre...|        false|\n",
            "|CENTRACKINTERNATI...|1                ...|Highlight the par...|{10751, Agreement...|        false|\n",
            "+--------------------+--------------------+--------------------+--------------------+-------------+\n",
            "only showing top 20 rows\n",
            "\n"
          ]
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "exploded_df  =  df.select('id','context', 'question', \"answers.answer_start\",\"answers.text\",'is_impossible')\n",
        "exploded_df.collect()[100]\n"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "GWYV0yYm5zfO",
        "outputId": "6efba43a-4eea-4345-f10c-76350941a8e9"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "Row(id='PACIRA PHARMACEUTICALS, INC. - A_R STRATEGIC LICENSING, DISTRIBUTION AND MARKETING AGREEMENT __Anti-Assignment', context='Exhibit 10.13\\n\\nConfidential Materials omitted and filed separately with the Securities and Exchange Commission. Asterisks denote omissions.\\n\\nDATED: OCTOBER 15, 2009\\n\\nPACIRA PHARMACEUTICALS, INC.\\n\\nand\\n\\nEKR THERAPEUTICS, INC.        AMENDED AND RESTATED   STRATEGIC LICENSING, DISTRIBUTION AND MARKETING AGREEMENT\\n\\n\\n\\n\\n\\nTHIS AMENDED AND RESTATED STRATEGIC LICENSING, DISTRIBUTION AND MARKETING AGREEMENT (the  \"Agreement\") is made on October 15, 2009 (the \"Agreement Date\") and is effective as of the Effective Date (as defined below), between:   PACIRA PHARMACEUTICALS, INC. (F/K/A SKYEPHARMA, INC.) a company incorporated in the state of California whose principal place of business is 10450 Sciences Center Drive, San Diego, California 92121 USA (\"PPI\"); and   EKR THERAPEUTICS, INC., a company incorporated in the state of Delaware whose principal place of business is 1545 Route 206  South, Third Floor, Bedminster, New Jersey 07921 (\"EKR\").\\n\\nRecitals\\n\\nPPI owns and has all right title and interest in or has acquired exclusive rights to the PPI IP (as defined below), the Trademark (as  defined below) and the Product (as defined below).\\n\\nEKR has, among other things, specialized knowledge and expertise in relation to the marketing and sale of pharmaceutical products.\\n\\nPursuant to that certain Strategic Licensing, Distribution and Marketing Agreement between EKR and PPI dated as of August 10, 2007  (the \"Original Agreement\"), PPI granted and EKR acquired the exclusive right and license to sell, offer to sell, distribute and market the Product in  the Territory (as defined below) in the Field (as defined below).\\n\\nEKR and PPI desire to amend and restate the Original Agreement in its entirety as set forth herein in order to provide for: (i) certain  changes to the financial terms set forth in the Original Agreement, (ii) the transfer of Marketing Authorizations (as defined below) from PPI to      -1-\\n\\n\\n\\n\\n\\nEKR, and EKR\\'s assumption of obligations thereunder, (iii) the transfer of title to certain manufacturing equipment from PPI to EKR and the lease  of such equipment back from EKR to PPI and (iv) certain other changes as are set forth herein; all of the foregoing subject to and in accordance  with the terms and conditions of this Agreement.\\n\\nNOW THEREFORE, in consideration of the following mutual agreements and covenants set forth herein and intending to be legally  bound hereby, PPI and EKR (each, a \"Party\"  and collectively, the \"Parties\")  acknowledge and agree that this Agreement shall amend and  supersede in its entirety the Original Agreement and hereby agree as follows:\\n\\nOperative Provisions\\n\\n\\n\\n\\n\\n   -2-\\n\\n1. Definitions   1.1 As used in this Agreement, the following words and expressions have the following meanings:\\n\\n\"Affiliate\"\\n\\n\\n\\nWith respect to any Party to this Agreement shall mean any company, corporation, firm, individual or other  entity which Controls, is Controlled by or is under common Control with such Party to this Agreement for only  so long as such Control exists;\\n\\n\\n\\n\\n\\n   -3-\\n\\n\"Applicable Laws\"\\n\\n\\n\\nShall mean all laws, rules and regulations regarding the manufacture, packaging, labeling, import, export,  storage, distribution, representation, promotion, marketing and sale of the Products including but not limited to  the Federal Food, Drug and Cosmetic Act of 1938, as amended (\"FD&C Act\") and the Controlled Substances  Act, as amended (21 U.S.C. ยง801 et seq.), or as defined in attendant regulations promulgated under authorities  granted by the FD&C Act, together with any equivalent laws, rules, regulations, codes or guidelines having  effect in any jurisdiction in the Territory;\\n\\n\"Calendar Year\"    Shall mean the period of twelve months commencing on 1st January in any year, and each consecutive period  of twelve months thereafter during the Term;\\n\\n\"cGMP\"    Means Current Good Manufacturing Practices pursuant to 21 CFR Parts 210 and 211, as may be amended from  time to time;\\n\\n\"Commercial Launch\"\\n\\n\\n\\nShall mean the date of the first arm\\'s length sale by EKR to an unaffiliated Third Party customer for commercial  use of Product in a country within the Territory following the grant of Marketing Authorization and any  necessary pricing approval in that country;\\n\\n\"Commercialization  Committee\"   Shall mean the committee to be set up under the terms of Article 5;\\n\\n\\n\\n\\n\\n   -4-\\n\\n\"Competing Product\"\\n\\n\\n\\nMeans any [**] ([**] hours) [**] preparation (other than the Product) available in a country in the Territory  which competes or would compete directly with the Product. For the avoidance of doubt, the definition of  \"Competing Product\" does not include Depobupivacaine or any improvement thereto;\\n\\n\"Confidential Information\"\\n\\n\\n\\nMeans all confidential information, data and materials in whatever form disclosed by or on behalf of one Party  or its Affiliates to the other Party or its Affiliates including, without limitation, the terms of this Agreement,  data, formulae, unpublished patent disclosures, processes, protocols, marketing studies, sales information,  specifications and know-how, (and, in the case of EKR\\'s Confidential Information, EKR\\'s marketing plans and  EKR\\'s sales forecasts), but excluding information which either Party can establish by written documentation:\\n\\n(i) at the time of disclosure, is in the public domain or is public knowledge;\\n\\n(ii) after disclosure, becomes part of the public domain by publication, except by breach of any obligation of  confidentiality by a Party hereto or an Affiliate of such Party;\\n\\n(iii) was already in its possession at the time of its receipt and was not acquired directly or indirectly from the  other Party or its Affiliates; or\\n\\n(iv) received from Third Parties who were lawfully entitled to disclose such information;\\n\\n\\n\\n\\n\\n   -5-\\n\\n\"Control\"\\n\\n\\n\\nMeans in relation to any Party or an Affiliate the possession directly or indirectly, of the power to direct or  cause the direction of the management and policies of such firm, person or entity, by contract or otherwise, or  the ownership either directly or indirectly of 50% or more of the voting securities of such Party;\\n\\n\"Copyrights\"\\n\\n\\n\\nMeans (i) the copyright registrations and applications for registration identified on Schedule III, (ii) works of  authorship whether or not copyrightable and (iii) any other copyrights and works, together with all common law  rights, used or held for use by PPI or any of its Affiliates in connection with the Products in the Territory  (including, but not limited to, any license or other rights of PPI or any of its Affiliates, whether as a licensor,  licensee or otherwise relation to any of the foregoing);\\n\\n\"Current Base Price\"    Means the Product\\'s current (as of the Effective Date) net average selling price of $[**] ([**] mg) and $[**]  ([**] mg);\\n\\n\"DEA\"    Shall mean the United States Drug Enforcement Administration and any successor thereto performing similar  functions;\\n\\n\"Distribution Rights\"   Shall have the meaning set forth in Section 2.1 hereof;\\n\\n\"Domain Name\"    Shall mean Depodur.com and any other domain names owned or licensed by PPI related to the Product set forth  on Schedule IV hereto;\\n\\n\\n\\n\\n\\n   -6-\\n\\n\"EKR Improvement\"   Means any Improvement generated, conceived, reduced to practice or other created during the Term by EKR or  any of its Affiliates.\\n\\nEndo/PPI Unit Sales   Shall have the meaning set forth in Section 3.19 hereof;\\n\\nEndo Product   Means: (i) DepoDur Injectible Liposomal Epidural 10 mg/ml NDC # [**]; and (ii) DepoDur Injectible Liposomal  Epidural 15 mg/1.5 ml NDC # [**];\\n\\n\"Effective Date\"   Means August 10, 2007;\\n\\n\"FDA\"   Means the United States Food and Drug Administration or any successor thereto performing similar functions;\\n\\n\"Field\"   Means the management of post-operative pain following major orthopedic, abdominal or pelvic surgery;\\n\\n\\n\\n\\n\\n   -7-\\n\\n\"Force Majeure\"\\n\\n\\n\\nMeans in relation to either Party, any cause affecting the performance of this Agreement or the Supply  Agreement arising from or attributable to any acts, events, non-happenings, omissions or accidents beyond the  reasonable control of the Party to perform and in particular but without limiting the generality thereof shall  include strikes and labor disturbances, lock-outs, industrial action, civil commotion, riot, invasion, war, threat of  or preparation for war, terrorist activity, fire, explosion, storm, flood, earthquake, subsidence, epidemic or other  natural physical disaster, impossibility of the use of railways, shipping, aircraft, motor transport, or other means  of public or private transport, failure or suspension of utilities, unavailability, shortage or interruption in the  supply of raw material, and political interference with the normal operation of either Party;\\n\\n\"Improvements\"\\n\\n\\n\\nMeans any discovery, development, improvement, know-how or patent relating to the Product generated,  conceived, reduced to practice or otherwise created during the Term by PPI or EKR (or any Affiliate of PPI or  EKR);\\n\\n\"Joint Improvements\"   Means any Improvements generated, conceived, reduced to practice or other created jointly by EKR and PPI or  their Affiliates.\\n\\n\"Known In-Channel  Product Units\"   Shall have the meaning set forth in Section 3.19 hereof;\\n\\n\\n\\n\\n\\n   -8-\\n\\n\"Marketing Authorization\"\\n\\n\\n\\nMeans the new drug application (\"NDA\") and all other necessary regulatory and governmental approvals by a  Regulatory Authority or other governmental body required to market and sell the Product in any country of the  Territory, including, but not limited to, those set forth on Schedule V hereto;\\n\\n\"Marketing Plan\"   Means the plan for the marketing, distribution and sale of the Product in the Territory submitted to the  Commercialization Committee in accordance with Section 5.4;\\n\\n\\n\\n\\n\\n   -9-\\n\\n\"Net Sales\"\\n\\n\\n\\nMeans total gross sales of Product invoiced by EKR, its Affiliates and sub-distributors in arms length sales to  Third Parties, less the following amounts actually incurred, deducted, accrued or allowed:\\n\\n(i) transport, freight and insurance costs which are separately stated;\\n\\n(ii) sales and excise taxes and duties;\\n\\n(iii) normal and customary trade, quantity and cash discounts, rebates and chargebacks;\\n\\n(iv) amounts repaid or credited for properly rejected, returned or recalled goods or resulting from retroactive  price adjustments related to the Product;\\n\\n(v) amounts incurred or resulting from government (or an agency thereof) mandated or managed care or other  rebate programs now existing or implemented hereafter;\\n\\n(vi) any other identifiable amounts included in gross sales of the Product that were or ultimately will be credited  and that are substantially similar to those listed hereinabove; and\\n\\n(vii) any other deductions allowed by GAAP which effectively reduce the net selling price of Product;\\n\\n\"PPI Improvement\"   Means any Improvement generated, conceived, reduced to practice or otherwise created during the Term by  PPI or any of its Affiliates;\\n\\n\\n\\n\\n\\n   -10-\\n\\n\"PPI IP\"   Means the Copyrights, PPI Know-How, PPI Patents and PPI Improvements; and PPI\\'s interest in Joint  Improvements;\\n\\n\"PPI Know-How\"\\n\\n\\n\\nMeans all information, procedures, instructions, techniques, data, technical information, knowledge and  experience (including, without limitation, toxicological, pharmaceutical, clinical, non-clinical and medical data,  health registration data and marketing data), designs, dossiers (including, without limitation, manufacturing  assay and quality control dossiers) manufacturing formulae, processing specifications, sales and marketing  materials and technology relating to the Product;\\n\\n\"PPI Patents\"\\n\\n\\n\\nMeans those patents set out in Schedule I which cover the Products and such other patents as PPI may include  from time to time, including additions, divisions, confirmations, continuations-in-part, substitutions, re-issues,  re-examinations, extensions, registrations, patent terms extensions, supplementary protection certificates and  renewals of any of the above or any other patents owned or licensed by PPI subsequent to the Effective Date  which cover the Products or any Improvements;\\n\\n\\n\\n\\n\\n   -11-\\n\\n\"Product(s)\"\\n\\n\\n\\nMeans: (i) DepoDur Injectible Liposomal Epidural [**] mg/ml [**]; (ii) DepoDur Injectible Liposomal Epidural  [**] mg/[**] ml [**]; (iii) such other presentations and dosages which hereafter receive Marketing  Authorization in any country of the Territory; in each case for epidural administration presented in Vials or  other approved vessels, appropriately packaged and labeled for sale to end users and (iv) any and all  Improvements of the items listed in clauses (i) through (iii).\\n\\n\"Promotional Materials\"   Means promotional, sales, marketing, educational and training materials which are necessary to support the  marketing of the Products;\\n\\n\"Quarter\"   Means a three month period ending on the last day of March, June, September or December in any Calendar  Year;\\n\\n\"Regulatory Authority\"   Means any competent regulatory authority or other governmental body (for example, but not by way of  limitation the FDA and DEA) responsible for granting a Marketing Authorization in the Territory;\\n\\n\"Royalty Cap\"   Shall have the meaning set forth in Section 6.4;\\n\\n\"Supply Agreement\"\\n\\n\\n\\nMeans: (i) with respect to periods between the Effective Date and the Agreement Date, that certain Supply  Agreement entered into by the Parties on the Effective Date and (ii) with respect to periods on or after the  Agreement Date, that certain Amended and Restated Supply Agreement entered into by the Parties on the  Agreement Date (as may be amended from time to time);\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n   -12-\\n\\n\"Term\"   Means the term of this Agreement as set out in Section 15;\\n\\n\"Territory\"   Means each of the countries and territories listed in Schedule VII;\\n\\n\"Third Party\"   Means any company, corporation, firm, individual or other entity but excluding a Party to this Agreement or an  Affiliate;\\n\\n\"Trademarks\"   Means those Trademarks registered or applied for set out in Schedule II;\\n\\n\"Transition Services and  Inventory Agreement\"   Means that certain Transition Services and Inventory Agreement entered into between the Parties on the  Effective Date;\\n\\n\"Vial\"   Means a vial containing the Product supplied to EKR in presentations and dosages and other relevant terms  set out in the Supply Agreement;\\n\\n\"Year\"   Means the period of twelve months commencing on the first Commercial Launch of the Product in the Territory,  and each consecutive period of twelve months thereafter during the Term.  1.2 In this Agreement, unless the context requires otherwise:     (a) the headings are included for convenience only and shall not affect the construction of this Agreement;\\n\\n  (b) references to \"persons\" includes individuals, bodies corporate (wherever incorporated), unincorporated associations and  partnerships;     (c) words denoting the singular shall include the plural and vice versa;     (d) words denoting one gender shall include each gender and all genders; and\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n   -13-\\n\\n  (e) any reference to an enactment or statutory provision is a reference to it as it may have been, or may from time to time be  amended, modified, consolidated or re-enacted.   1.3 The Schedules comprise part of and shall be construed in accordance with the terms of this Agreement. In the event of any inconsistency  between the Schedules and the terms of this Agreement, the terms of this Agreement shall prevail.\\n\\n2. Grant of Rights   2.1 Retention of EKR. Subject to the terms of this Agreement, PPI hereby appoints EKR and EKR agrees to be retained as the exclusive  distributor, and Authorized Distributor of Record, of the Products in the Field in the Territory during the Term to market, distribute,  warehouse and sell the Products. EKR shall have the right to appoint sub-distributors hereunder in each country of the Territory.   2.2 Grant of License and Distribution Rights. PPI hereby grants EKR the exclusive right and license (with the right to sublicense) to use, market, promote, sell, distribute and warehouse the Products (the \"Distribution Rights\") in the Field in the Territory during the Term, as  well as to make or have made the Products anywhere in the world for import or sale in the Field in the Territory in each case, under the PPI  IP provided that PPI retains all rights necessary to manufacture and supply the Products to EKR in accordance with this Agreement and the  Supply Agreement. Such grant by PPI shall include the right of EKR to market the Product in the Territory during the Term as an EKR  product using in addition to the Trademarks, EKR\\'s own trademarks, trade dress, trade names and other proprietary designations in  combination with the Trademarks.   2.3 Grant of Trademark Rights. PPI hereby grants to EKR a royalty free and exclusive license (with the right to sublicense) to use the  Trademarks in the Territory solely in connection with the exercise of the Distribution Rights in the Territory during the Term (and thereafter  as set forth in Section 17.4) and EKR shall market and sell the Products under the Trademarks. For the avoidance of doubt, the term  \"exclusive\" for the\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n   -14-\\n\\n\\n\\npurposes of Sections 2.1, 2.2 and 2.3 means to the exclusion of all others, including PPI and its Affiliates, except to the extent necessary to  enable PPI to perform its specific obligations under this Agreement and the Supply Agreement. Notwithstanding the foregoing, nothing  contained herein shall prohibit PPI from utilizing the Trademarks in the Territory in connection with its business for the sole purpose of signifying that PPI is the manufacturer of the Products for EKR.   2.4 Transfer of Domain Names. On the Effective Date, PPI has transferred the Domain Names to EKR for use in connection with the exercise of  the Distribution Rights. PPI has provided EKR with reasonable assistance as was necessary to effectuate the transfer of the Domain  Names. Upon any termination or expiration of this Agreement, EKR shall promptly transfer the Domain Names back to PPI.   2.5 Condition of Appointment. The acceptance of forecasts and orders for the Products (as provided in the Supply Agreement), and PPI\\'s obligation to supply the Product to EKR shall at all times be conditioned by the Marketing Authorization for the Product being in force in  the country of Territory to which such acceptance and order relates.\\n\\n3. Undertakings of PPI   3.1 Manufacturing Activities. Subject to Section 17.5, PPI shall manufacture and supply, or procure the manufacture and supply of, the Product  in accordance with the terms and conditions of the Supply Agreement.   3.2 Transfer of Transferred NDA. Effective as of the Agreement Date, PPI hereby sells, transfers, conveys and assigns to EKR all right, title  and interest in and to [**] (the \"Transferred NDA\"). Each Party shall, within five (5) business days after the Agreement Date, file with the  FDA a notice letter, substantially in the form attached as Schedule XI(A) or Schedule XI(B) (as applicable), regarding the transfer to EKR of  the Transferred NDA. PPI represents, warrants and covenants that: (i) prior to the Agreement Date, it has provided EKR with complete, up- to-date copies of the Transferred NDA and all material correspondence with Regulatory Authorities in the\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n   -15-\\n\\n\\n\\nTerritory in connection with the Transferred NDA (including, but not limited to, any periodic and annual report submissions, and all  adverse event reports and data) and (ii) on the Agreement Date, EKR shall receive sole ownership of, and good and valid title to, the  Transferred NDA, free and clear of any liens and encumbrances. For the avoidance of doubt, nothing in this Agreement regarding the  appointment of EKR as PPI\\'s distributor of the Products shall be construed to diminish any rights of EKR as holder of the Transferred  NDA. Upon termination of this Agreement for any reason except by EKR pursuant to Section 16.1(a), EKR shall promptly transfer the Transferred NDA and related regulatory documentation to PPI in accordance with Section 17.1(e).   3.3 Maintenance of Transferred NDA. The Parties acknowledge that prior to the Agreement Date, PPI was responsible at its own cost and  expense for maintaining and updating the Transferred NDA, and agree that PPI shall retain all liabilities with respect to the foregoing  obligations to the extent relating to periods prior to the Agreement Date. Commencing as of the Agreement Date, EKR shall, at its own cost  and expense, maintain and update the Transferred NDA and be responsible for all liabilities with respect to the foregoing obligations to the  extent relating to periods after the Agreement Date.\\n\\n3.4 Assistance. PPI shall, at EKR\\'s cost and expense, provide EKR with all assistance, information and guidance, including where appropriate direct access to employees of and consultants to PPI and its Affiliates and shall use reasonable efforts to obtain such assistance and  access from any sub-contractors of PPI and its Affiliates (including for the avoidance of doubt any manufacturers of the Product) which is  reasonably necessary in relation to the conduct of any post-marketing or Phase IV studies to be conducted by EKR in the Territory or  otherwise in connection with the discharge of EKR\\'s obligations under the terms of this Agreement (including, but not limited to, the  maintenance of the Transferred NDA); provided, however, that any such post-marketing or Phase IV studies to be conducted by EKR shall  be at EKR\\'s sole cost and expense. Any labor\\n\\n\\n\\n\\n\\ncosts of PPI employees related to this assistance shall be reimbursed by EKR at a rate of [**] dollars ($[**]) per hour. PPI represents and  warrants that as of the Agreement Date, except for the studies set forth on Schedule X attached hereto (the \"Required Studies\"), no post- marketing or Phase IV studies are required by any applicable Regulatory Authority to be conducted with respect to the Product. EKR shall  be responsible for the conduct of the Required Studies after the Agreement Date, at its own expense, in accordance with the requirements  of the applicable Regulatory Authorities. PPI shall be responsible for all costs and liabilities incurred prior to the Agreement Date with  respect to the Required Studies, and shall indemnify and hold harmless EKR from such costs and liabilities. Promptly after the Agreement  Date, PPI shall provide EKR with copies of all agreements relating to the Required Studies and shall assign such agreements to EKR if and  to the extent (i) such agreements are assignable in accordance with their terms and (ii) requested by EKR.\\n\\n\\n\\n\\n\\n   -16-\\n\\n3.5 Adverse Events. PPI shall at its own cost and expense promptly provide EKR with all information in its possession or otherwise coming to  its attention relating to the occurrence of a serious adverse event or an adverse event (in any jurisdiction throughout the world) in  connection with the Product. PPI shall be responsible, to the extent required by Applicable Laws, to report all charges, complaints or claims  reportable to the FDA relating to the Product, to the extent such charges, complaints or claims are made prior to the Agreement Date. EKR  shall be responsible, to the extent required by Applicable Laws, to report all charges, complaints or claims reportable to the FDA relating to  the Product, to the extent such charges, complaints or claims are made after the Agreement Date.   3.6 Reserved.   3.7 Delivery of Materials. The Parties acknowledge that prior to the Agreement Date, PPI has delivered to EKR (i) all existing PPI produced Promotional Materials (if any) and (ii) any existing market research in its possession related to the Product.\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n   -17-\\n\\n3.8 Customer Orders. PPI shall at its own cost and expense during the Term, promptly forward to EKR any customer orders or inquiries for the Product within the Territory received after the Effective Date and shall inform any customers ordering the Product that EKR is now  distributing the Product and provide such customers with EKR\\'s address and telephone number.   3.9 Payment of Third Party Royalties. During the Term, PPI shall be solely responsible for and pay any royalties or other amounts due to Third Parties related to the Product and shall indemnify and hold EKR harmless from any claims arising from or related thereto.   3.10 Customer Returns. PPI shall at its own cost and expense be responsible for all customer returns of Product sold prior to the Effective Date.   3.11 Governmental Rebates. PPI shall at its own cost and expense be responsible for all discounts, rebates, or promotional allowances/incentive programs deemed to be \"discount[s] or other reduction[s] in price\" for purposes of 42 U.S.C. Section 1320a-7b(b)(3)(A) and may be subject  to the reporting requirements under state and federal Medicaid and Medicare laws for sales of Product prior to the Effective Date. PPI  represents that it is aware of its obligations to report discounts resulting from this Agreement to the appropriate reimbursing agencies and  authorities (including Medicaid and Medicare). PPI is responsible for complying with and agrees to comply with all applicable requirements,  if any, in respect of providing information on such discounts to reimbursing agencies (including Medicaid and Medicare) and other entities  in accordance with Applicable Laws and regulations for sales of Product prior to the Effective Date and for sales of any PPI labeled product  subsequent the Effective Date.   3.12 Chargebacks. PPI shall at its own cost and expense be responsible for all chargebacks for sales of Product prior to the Effective Date.   3.13 Exclusivity. During the Term, PPI and its Affiliates shall not: (i) file for Marketing Authorization with respect to any Competing Product in  any country in the Territory, (ii) manufacture or have manufactured any Competing Product in any country in the Territory, (iii) market or  have marketed any Competing Product in any country in the Territory or (iv) license any Third Party to do any of the foregoing.\\n\\n\\n\\n\\n\\n\\n\\nEKR - Graham May, MD - CMO   PPI - Gary Patou, MD - CMO\\n\\n\\n\\n\\n\\n\\n\\n   -18-\\n\\n3.14 Product Development. PPI shall at its own cost and expense cooperate fully and assist EKR with the preparation of any necessary  submissions to any of the Regulatory Authorities in the Territory for the development and approval or supplemental approval(s) of the  Products, including, but not limited to, by providing access to all PPI Know-How, the drug master file and any other information necessary  for approval or supplemental approval of the Product in any country of the Territory. In addition, PPI shall cooperate fully in participating  in interactions with the appropriate Regulatory Authorities including FDA related to such product development so as to enable EKR to  fully exploit the Distribution Rights granted hereunder. For purpose of this Section, the contact person for each of the parties is set forth  below.\\n\\n3.15 Reserved.   3.16 Recalls and PostMarket Notifications. All costs of safety alerts and all other forms of notifications regarding safety risks associated with the Products in the United States shall be borne by PPI to the extent arising prior to the Agreement Date and by EKR to the extent arising  after the Agreement Date.   3.17 Compliance. During the Term PPI shall at its own cost and expense take all actions necessary to comply with all Applicable Laws and  obtain and maintain all necessary license, permits, records and authorizations PPI is required to obtain and maintain hereunder so as to  enable PPI to perform its obligations hereunder and under the Supply Agreement so as to enable EKR to fully exercise the Distribution  Rights.   3.18 Assignment of ICS Agreement. The Parties acknowledge that effective upon the termination or expiration of the Transition Services and Inventory Agreement, PPI has\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n   -19-\\n\\n\\n\\nassigned to EKR all of PPI\\'s right, title and interest under that certain Commercial Outsourcing Services Agreement between PPI (f/k/a  SkyePharma, Inc.) and Integrated Commercialization Solutions, Inc. (\"ICS\")  dated April 3, 2007 (the \"ICS Agreement\"), and EKR has  assumed all obligations and liabilities under the ICS Agreement arising after the Effective Date. The Parties further acknowledge that as of  the Effective Date, the Parties have entered into an Assignment and Assumption Agreement to further evidence the foregoing assignment  and assumption of the ICS Agreement.   3.19 Product in Channel. All sales of Product conducted by PPI and its distributors and wholesalers (and, to the knowledge of PPI, by Endo Pharmaceuticals and its distributors and wholesalers) during the six month period prior to the Effective Date have been conducted in the  ordinary course upon standard payment terms. PPI has provided EKR: (i) all information regarding sales by Endo Pharmaceuticals during  the six month period prior to the Effective Date and (ii) all information regarding the number of units of Product and Endo Product that were  in the possession or control of PPI or Endo Pharmaceuticals (and their respective distributors or wholesalers) as of the Effective Date (the  \"Known In-Channel Product Units\"). Within 10 days of the end of each month following the Effective Date, PPI shall provide EKR with  copies of: (i) any reports provided by Endo Pharmaceuticals of the number of units of Endo Product sold to hospitals or other customers  during the preceding month by Endo, and (ii) information possessed by PPI of such sales by PPI or any of their respective distributors or  wholesalers (the \"Endo/PPI Unit Sales\").   3.20 Sale and Leaseback of Transferred Equipment.\\n\\n  (a) In consideration of and subject to EKR\\'s payment of the Equipment Purchase Price (as defined below), effective as of the  Agreement Date, PPI hereby sells, transfers, conveys and assigns to EKR all right, title and interest in and to the equipment  described on Schedule XII (the \"Transferred Equipment\"). The\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n   -20-\\n\\n\\n\\nParties shall share equally the responsibility for any and all sales, transfer and conveyance taxes occasioned by the sale of the  Transferred Equipment by PPI to EKR. PPI represents and warrants that: (i) on the Agreement Date, EKR shall receive sole  ownership of, and good and valid title to, the Transferred Equipment, free and clear of any liens and encumbrances, (ii) the  Transferred Equipment as of the Agreement Date is in good operating condition, normal wear and tear excepted and (iii) the  Transferred Equipment constitutes all specialized equipment that is used in the manufacture of Product by PPI as of the Agreement  Date. For purposes of clarity, the Transferred Equipment does not include any standard, non-specialized equipment generally found  in manufacturing facilities or available to manufacturers of products similar to the Product (e.g., refrigerators, freezers, safes,  incubators, stability chambers, clean utilities, supportive utilities, temperature control units and other supportive equipment). On the  Agreement Date, PPI shall execute and deliver to EKR a Bill of Sale with respect to the Transferred Equipment substantially in the  form attached hereto as Exhibit 3.20(a).     (b) EKR will pay PPI [**] Dollars ($[**]) for the Transferred Equipment (the \"Equipment Purchase Price\") as follows:\\n\\n  (i) within five (5) days after the Agreement Date, EKR will pay PPI [**] Dollars ($[**]) of the Equipment Purchase Price in  cash; and\\n\\n  (ii) concurrently with the execution of this Agreement, EKR will issue to PPI a promissory note in principal amount of [**]  Dollars ($[**]), such note to be substantially in the form attached hereto as Exhibit 3.20(b) (the \"Promissory Note\").\\n\\n  (c) Commencing as of the Agreement Date, EKR agrees to lease the Transferred Equipment to PPI through the end of the then-current  calendar quarter and, subject to renewal as provided below, on a calendar quarter-to-calendar quarter\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n   -21-\\n\\n\\n\\nbasis thereafter (the \"Lease Term\"), for use solely in connection with the (i) performance of PPI\\'s obligations under the Supply  Agreement, (ii) the supply of Products to PPI\\'s other licensees and collaborators and (iii) the supply of placebo for PPI\\'s Exparel  product to PPI\\'s other licensees and collaborators. The Lease Term shall automatically renew at the end of each calendar quarter of  the Lease Term. The Lease Term will automatically terminate immediately upon (i) any termination or expiration of this Agreement  and/or the Supply Agreement or (ii) any exercise by EKR of the Step-in Right described in Section 17.5 below.\\n\\n\\n\\n(d) At any time between the Agreement Date and July 1, 2015, EKR shall have the right, exercisable upon sixty (60) days prior written  notice to PPI, to terminate the Lease Term and sell the Transferred Equipment back to PPI, subject to payment by PPI to EKR within  five (5) days of such notice of $[**] in cash, which if exercised shall result in (i) an offset against the unpaid balance of principal and  interest under the Promissory Note pursuant to Section 3.20(f) below; and (ii) the termination of the Step-in Right described in  Section 17.5.\\n\\n\\n\\n(e) At any time after July 1, 2015, PPI shall have the right, exercisable upon sixty (60) days prior written notice to EKR, to terminate the Lease Term and repurchase the Transferred Equipment from EKR, subject to payment by PPI to EKR within five (5) days of such  notice of any principal paid by EKR under the Promissory Note, which if exercised shall result in the termination of the Step-in Right  set forth in Section 17.5.\\n\\n\\n\\n(f) If, upon the expiration or earlier termination of the Lease Term (except as provided in Section 3.20(e) above), the aggregate amount  of repayments and Royalty Offsets (as defined below) earned by EKR pursuant to Section 6.3 below have not equaled or exceeded  the Advanced Royalty Payment (as defined below), then EKR shall have the right, at its option, to offset against the unpaid balance  of principal and interest under the Promissory Note, by an amount equal to the\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n   -22-\\n\\n  then-current balance of the Advanced Royalty Payment that has not yet been recouped by EKR through repayments and Royalty  Offsets pursuant to Section 6.3 below (the \"Remaining Balance\"), in which event PPI\\'s obligations under Section 6.3 below with  respect to repayment of the Advanced Royalty Payment shall be deemed to have been paid in full.\\n\\n  (g) In consideration of the foregoing lease, PPI shall pay EKR [**] lease payments in the amount of $[**]per calendar quarter, with the  first lease payment due on the Agreement Date and each subsequent lease payment due during the Lease Term on the first day of  each calendar quarter thereafter.\\n\\n  (h) PPI shall not, without the prior, written consent of EKR, remove any of the Transferred Equipment from the locations within the  Approved Facilities (as defined in the Supply Agreement) where such Transferred Equipment is installed as of the Agreement Date.\\n\\n\\n\\n(i) During the Lease Term, PPI shall: (i) assume the risk of loss or damage to the Transferred Equipment; (ii) maintain the Transferred Equipment in good operating condition and appearance, ordinary wear and tear excepted; (iii) comply with all requirements  necessary to enforce any warranty rights and to maintain eligibility for any manufacturer maintenance program; (iv) promptly repair  any repairable damage to the Transferred Equipment and (v) maintain property damage and liability insurance and insurance against  loss or damage to the Transferred Equipment as part of PPI\\'s general liability insurance.\\n\\n\\n\\n(j) If any of the Transferred Equipment is lost, stolen, destroyed, damaged beyond repair or in the event of any condemnation,  confiscation, seizure or expropriation of any Transferred Equipment (\"Casualty Transferred Equipment\"), PPI shall promptly (i)  notify EKR of the same, and (ii) pay to EKR an amount equal to the estimated in-place, fair market value of the Casualty Transferred  Equipment as of the date of the loss, as determined by a mutually agreed nationally recognized\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n   -23-\\n\\n\\n\\nappraiser; provided that (i) in the event there are any amounts owed to PPI under the Promissory Note as of the date of such loss,  PPI shall have the right, at its option, to offset against the unpaid balance of principal and interest under the Promissory Note, the  amounts owed to EKR pursuant to this Section 3.20(k), and (ii) in no event shall PPI be required to pay EKR an amount that exceeds  [**] Dollars ($[**]) plus the amounts paid by EKR pursuant to the Promissory Note.\\n\\n\\n\\n(k) Subject to Sections 3.20(d) and (e) and Section 6.3(d) and PPI\\'s right to repurchase the Transferred Equipment thereunder, upon the  expiration or earlier termination of the Lease Term, EKR shall remove the Transferred Equipment from PPI\\'s premises (unless EKR at  its option elects to retain the Transferred Equipment at PPI\\'s premises in connection with EKR\\'s exercise of step-in rights under  Section 17.5). PPI agrees to cooperate with EKR in the removal of the Transferred Equipment, including providing the necessary  access to the Transferred Equipment and the facilities where it is located at times mutually agreed by the Parties, such agreement  not to be unreasonably withheld or delayed by either Party.\\n\\n\\n\\n(l) Upon termination of the Lease Term, unless PPI has repurchased the Transferred Equipment, EKR will, at PPI\\'s request, use  commercially reasonable efforts to (i) supply the Product and (ii) supply placebo for [**], to PPI\\'s other licensees and collaborators  outside the Territory, excluding PPI and any of its Affiliates (the \"Other PPI Customers\"), in each case in accordance with the  commercially reasonable requirements of any existing agreements between PPI and such Other PPI Customers, subject to EKR\\'s  receipt of payment required under such agreements for supplying such Products and/or other products. PPI will use commercially  reasonable efforts to cooperate with EKR so as to enable EKR to supply Product and, if applicable, other products, to such Other  PPI Customers.\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n   -24-\\n\\n4. Undertakings of EKR.   4.1 Marketing Authorizations. EKR shall, as determined in its sole discretion to be commercially reasonable, prepare studies of the markets and sales potential of the Products for countries in the Territory other than the United States and present such studies to the Committee. EKR  shall at its own cost and expense use commercially reasonable efforts to take those steps reasonably necessary in order to obtain and  thereafter maintain Marketing Authorizations (including pricing and reimbursement approvals) for the Product in those countries of the  Territory other than the United States which the Committee determines to present commercially viable opportunities for the Product. EKR  shall provide PPI with a copy of any original certificates of approval/registration in each country in the Territory other than the United  States. EKR shall provide PPI with a copy of any other registration matters received from the appropriate Regulatory Authorities  concerning maintenance, renewal or variations to the original certificates of approval/registration in each country in the Territory. Except as  provided in Section 3.17, EKR shall be solely responsible for, and shall bear all costs associated with, all regulatory activities related to the  development and approval of the Product in the countries of the Territory (including, after the Agreement Date, the United States) and shall  own the Marketing Authorizations for the Product in each other country of the Territory. EKR will comply with all conditions and  requirements attaching to such Marketing Authorizations.   4.2 Liaison with Regulatory Authorities. Pursuant to Section 4.1 above, EKR shall at its own cost and expense liaise with the relevant  Regulatory Authorities in respect of each Marketing Authorization and notify PPI of all material communications relating thereto. The cost  of submitting any data generated by any Phase IV studies conducted by EKR which is required to be filed with the FDA shall be borne by  EKR and the cost of submitting any other data (including data submitted to support the use of the Product for additional indications) shall  also be borne by EKR;\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n   -25-\\n\\n4.3 Submission of Promotional Materials. Pursuant to Section 4.1 above, EKR shall at its own cost and expense submit and obtain the approvals of Regulatory Authorities in the Territory of Promotional Materials as required by Applicable Laws;   4.4 Pre-Launch and Post Launch Activities. Pursuant to Section 4.1 above, EKR shall at its own cost and expense carry out reasonable pre- launch market development and conduct such post-marketing clinical trials (as determined solely by EKR in its reasonable business  judgment) in accordance with the Marketing Plan. Any data resulting from such trials shall be owned by EKR but shall be provided on a  royalty-free license to PPI for use outside of the Territory. PPI shall cooperate with EKR in connection with such pre-launch and post  launch activities as provided in sections 3.3 and 3.14 hereof;   4.5 Launch of Products. Pursuant to Section 4.1 above, EKR shall at its own cost and expense launch and achieve Commercial Launch of the  Products in accordance with the Marketing Plan but no later than 18 months following receipt of Marketing Authorization in each country  in the Territory provided however that EKR shall not be obligated to launch such Product in such country of the Territory where the  approved pricing in such country provides EKR a gross margin of less than [**]% (after payment of Royalties, Additional Royalties and  Cost of Goods) or where the launch of the Product in such country of the Territory as determined by EKR is not commercially reasonable.   4.6 Marketing Activities. EKR shall at its own cost and expense, during the term of this Agreement, promote, market, sell and distribute the Products to customers within the Territory and provided that PPI has supplied EKR with necessary quantities of Product, satisfy the  demand for the Product throughout the Territory. EKR shall be solely responsible for, and shall bear all costs associated with, all marketing  and selling activities related to the Products in the Territory;   4.7 SubDistributors. EKR shall at its own cost and expense maintain, or use reasonable commercial efforts to ensure that sub-distributors maintain, adequate sales and, where\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n   -26-\\n\\n  appropriate, warehouse facilities and employ, or use reasonable commercial efforts to procure that sub-distributors employ, a sufficient  number of experienced, trained and qualified personnel to promote the sale of the Product in the Territory and perform, or procure the  performance of the activities set forth in the Marketing Plan;   4.8 Inventory and Promotional Materials. EKR shall maintain a sufficient inventory of Product and support material to reasonably fulfill the requirements of its customers in the Territory provided that, subject to Section 17.5, PPI shall comply with the Supply Agreement;   4.9 Records. EKR shall maintain adequate records concerning the sale of the Product as required by any applicable Regulatory Authority in the Territory;   4.10 Promotional Materials. EKR shall provide PPI with copies of the Promotional Materials proposed to be used in connection with the sale of  the Products in the United States for approval, solely with respect to Trademark usage, (such approval not to be unreasonably withheld,  conditioned or delayed) to the extent such Promotional Materials include any Trademark. EKR shall submit such Promotional Materials to  PPI at least five (5) business days in advance of its intended use of the same and such Promotional Material shall be deemed to have  received PPI\\'s approval unless PPI Provides EKR with written notice of rejection within said five (5) business day period and EKR shall be  authorized to finalize and use same. For the avoidance of doubt, any Trademark usage set forth on any Promotional Materials in use as of  or prior to the Agreement Date are hereby deemed to be approved by PPI.   4.11 Adverse Events. Each Party shall promptly provide the other Party with all information in its possession or otherwise coming to its  attention relating to the occurrence of a serious adverse event or an adverse event (in any jurisdiction throughout the world) in connection  with the Product, and promptly forward to such other Party information concerning any and all charges, complaints or claims reportable to  any Regulatory Authority relating to the Product that may come to the first Party\\'s attention, and\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n   -27-\\n\\n\\n\\notherwise comply in all respects with the adverse drug event reporting and recall procedures set out or referred to in the Supply Agreement  from time to time. EKR shall be responsible, to the extent required by Applicable Law, to report all charges, complaints or claims reportable  to any Regulatory Authority outside of the United States relating to the Product, as well as any such charges, complaints or claims  reportable to any Regulatory Authority inside the United States to the extent such charges, complaints or claims are made after the  Agreement Date.   4.12 Permits. EKR shall obtain and maintain all necessary licenses, permits, records and authorizations required by Applicable Laws as holder of the Transferred NDA after the Agreement Date and in order to exercise the Distribution Rights and observe and comply with all Applicable  Laws, ordinances, rules and regulations including, but not limited to those of the applicable Regulatory Authorities in the exercise of the  Distribution Rights save insofar as PPI is required to obtain the same as holder of the Marketing Authorizations prior to the Agreement  Date, or under the terms of this Agreement;   4.13 Compliance. EKR shall conduct the promotion and marketing and sale of the Products in accordance with Applicable Laws and with all due  care and diligence.   4.14 Sales and Promotional Activities. In connection with the promotion, marketing and sale of the Product, EKR shall, without limitation:\\n\\n  (a) observe and comply with such storage, stock control and operational practices and procedures as may be legally required  in the Territory and as reasonably specified in writing by PPI from time to time;\\n\\n  (b) from time to time consult with PPI\\'s representatives for the purpose of assessing the state of the market in each country of  the Territory and permit representatives of PPI, on reasonable prior notice, to inspect any premises or documents used in  connection with the marketing, distribution and sale of the Products;\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n   -28-\\n\\n  (c) provide PPI on reasonable prior notice but not more than once in any Calendar Year, copies of its up-to-date price list for  the Product together with full details of standard discounts and any special pricing arrangements entered into or proposed  to be entered into;\\n\\n  (d) market the Product throughout the Territory under the Trademarks and any EKR trademarks and ensure that all marketing  materials for the Product shall display the Trademarks; and\\n\\n  (e) comply with all applicable regulatory and statutory requirements imposed in relation to the Product, including, without  limitation, those imposed by the US Drug Enforcement Agency (\"DEA\") and other equivalent agencies in the Territory.   4.15 Prohibition on Sales Outside the Territory. EKR shall not directly or indirectly market distribute and/or sell the Product outside the Territory, or sell the product to any Third Party that EKR knows intends to sell or distribute the Product outside the Territory. In addition,  the Parties acknowledge that since the Product is a controlled substance, the DEA and other law enforcement agencies will not permit any  sale outside the Territory without relevant clearances and approvals.   4.16 Non-Compete. EKR shall not, during [**], market, distribute or sell a Competing Product in the Territory unless during such time an A/B  rated generic product of the Product(s) is launched in such country of the Territory or in the event this Agreement is terminated or EKR  exercises its rights under Section 17.4 hereof.   4.17 PPI as Exclusive Provider. During the Term, except if PPI is unable to supply Products (including, but not limited to, in connection with EKR\\'s exercise of its rights under Section 17.5 below) or as provided in the Supply Agreement, EKR shall purchase all of its requirements  for the Product from PPI.   4.18 Packaging. During the Term, EKR shall not use in relation to the Product any packaging, labeling and Product inserts, nor any advertising literature that has not been\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n   -29-\\n\\n  approved by PPI in writing with respect to Trademark usage (such approval not to be unreasonably withheld, conditioned or delayed) or  deemed approved pursuant to Section 4.10, to the extent such materials include any Trademark. EKR shall be responsible for insuring that  any packaging, labeling and Product inserts, and advertising literature complies with Applicable Laws.   4.19 Customer Orders. If EKR receives a request from a customer located outside the Territory for supply of the Product outside of the Territory, EKR shall promptly forward such request to PPI.   4.20 Governmental Rebates. Any discounts, rebates, or promotional allowances/incentive programs provided are \"discount[s] or other reduction[s] in price\" for purposes of 42 U.S.C. Section 1320a-7b(b)(3)(A) and may be subject to the reporting requirements under state and  federal Medicaid and Medicare laws. EKR represents that it is aware of its obligations to report discounts resulting from this Agreement to  the appropriate reimbursing agencies and authorities (including Medicaid and Medicare). EKR is responsible for complying with and agrees  to comply with all applicable requirements, if any, in respect of providing information on such discounts to reimbursing agencies (including  Medicaid and Medicare) and other entities in accordance with Applicable Laws and regulations.   4.21 Resale Pricing. In exercising the Distribution Rights, EKR shall determine resale pricing of the Products in its sole discretion.\\n\\n5. Commercialization Committee.   5.1 Establishment of Committee. The Parties have established a Commercialization Committee (\"Committee\")  consisting of 4 individuals  (\"Committee Members\"); 2 of whom were nominated by PPI; and 2 of whom were nominated by EKR. The Committee Members may be  replaced by notice to the other Party and shall be appropriately qualified and experienced in order to make a meaningful contribution to  Committee meetings.\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n   -30-\\n\\n5.2 Purpose. The purpose of the Committee is to provide a forum for the Parties to share information and knowledge on the on-going Commercialization of the Product including, but not limited to, monitoring progress on clinical studies, reviewing clinical trial programs,  discussing the appropriate regulatory strategy for the Products in the Territory, considering proposed marketing and promotional plans,  reviewing competitor activity and discussing any regulatory, technical, quality assurance or safety issues in relation to the Product. The  Committee shall conduct its discussions in good faith with a view to operating to the mutual benefit of the Parties and in furtherance of the  successful development and marketing of the Products.   5.3 Meetings. The Committee shall meet as often as the Committee Members may determine, but in any event not less than 2 times per Calendar  Year. The Committee may invite individuals with special skills to attend such meetings where considered to be relevant and appropriate.  The quorum for Committee meetings shall be 2 Committee Members, comprising 1 Committee Member from each Party.   5.4 Marketing Plan. The Parties acknowledge that EKR has provided the Committee with its Marketing Plans for Calendar Years 2008 and 2009 pursuant to the Original Agreement. EKR shall on or before October 15  2009 and October 15  of each Calendar Year thereafter provide the  Committee with its Marketing Plan for the coming Calendar Year. Each Marketing Plan shall include, without limitation, Net Sales targets  and projections with respect to sales force staffing levels, market research, physician education, marketing expenditure, post-approval  clinical trials and advertising. With regard to pre-marketing clinical trials, the design and conduct shall be subject to the written approval of  PPI, such approval not to be unreasonably withheld or delayed.   5.5 Decision Making. Decisions of the Committee shall be made as follows:\\n\\n  (a) The Committee may make decisions with respect to any subject matter that is subject to the Committee\\'s decision-making  authority. Except as expressly provided in this Agreement, all decisions of the Committee\\n\\nth  th\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n   -31-\\n\\n  shall be made by unanimous vote or written consent, with EKR and PPI each having, collectively, one vote in all decisions.  The Committee shall use commercially reasonable efforts to resolve the matters within its roles and functions or otherwise  referred to it.\\n\\n\\n\\n(b) If, with respect to a matter that is subject to the Committee\\'s decision-making authority, the Committee cannot reach  consensus within 15 days after it has met and attempted to reach such consensus or the Parties cannot reach consensus  on whether the Committee has decision-making authority regarding a matter within 15 days after such matter was first  raised by either Party, the dispute in question shall be referred to the Chief Executive Officer of PPI, on behalf of PPI, or  such other person holding a similar position designated by PPI from time to time, and the Chief Executive Officer of EKR, or  such other person holding a similar position designated by the EKR from time to time (such officers collectively, the  \"Executive Officers\"), for resolution. The Executive Officers shall use reasonable efforts to resolve the matter referred to  them.\\n\\n\\n\\n(c) If the Executive Officers cannot resolve the matter in accordance with Section 5.5(b) within 30 days of the reference of the  matter to them, then EKR shall have the final decision-making authority if the matter relates to the sale or marketing of the  Product in any country of the Territory and PPI shall have the final decision-making authority if the matter relates to the development, manufacture or Trademarks of the Product.\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n   -32-\\n\\n6. Fees, Milestones and Royalties.   6.1 Up-Front Payment. In consideration for work previously undertaken by PPI in respect of the Product, the Parties acknowledge that EKR has  paid a non-refundable, non-creditable up front payment of $[**] to PPI pursuant to the Original Agreement.   6.2 Deferred Milestone Payments. As further consideration for the work previously undertaken by PPI and in consideration for the license and grant of the Distribution Rights to EKR under this Agreement, EKR shall pay to PPI the following milestone payments (the \"Deferred  Milestone Payments\") on the date when due:\\n\\nDeferred Milestone   Due Date $[**] (the \"First Deferred Milestone\")\\n\\n\\n\\nThe Parties acknowledge that EKR has paid  the First Deferred Milestone to PPI prior to  the Agreement Date.\\n\\n$[**] (the \"Second Deferred Milestone\")\\n\\n\\n\\nWithin three (3) days of the Agreement Date,  E K R  s h a l l  p a y  t h e  S e c o n d  D e f e r r e d   Milestone.\\n\\n6.3 Advanced Royalty Payment to PPI.\\n\\n  (a) Within three (3) days of the Agreement Date, EKR shall make an advanced Royalty payment to PPI of $[**] (the \"Advanced  Royalty Payment\"), which will be offset against EKR\\'s payment obligations or otherwise repaid to EKR as set forth below  in this Section 6.3.\\n\\n  (b) Offsets and/or repayment of the Advanced Royalty Payment shall commence on [**] and shall continue, unless sooner  paid, through [**] (the \"Royalty Offset Period\") and such offsets will be taken by EKR (and such repayment will be made  by PPI) as follows:\\n\\n\\n\\n(i) by a reduction in Royalties due under Section 6.4 of this Agreement of $[**] for each [**] mg vial of Product sold  during the Royalty Offset Period and $[**] for each [**] mg Vial of Product sold during the Royalty Offset Period  (collectively the \"Royalty Offset\") which amounts shall be deducted by EKR from any Royalty payments due PPI  and reflected in the quarterly and annual reports required in Section 6.5 of this Agreement;\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n   -33-\\n\\n\\n\\n(ii) by payment to EKR of [**] percent ([**]%) of any purchase price payments, license fees, other access fees or  royalties received by PPI or any of its Affiliates after the Agreement Date in connection with the license (to the  extent permitted hereunder) or transfer of any rights to the Product (and/or any underlying intellectual property  rights) in the Field in the Territory to a Third Party (other than pursuant to any transaction described in Section 6.3 (b)(iii) below), which payment shall be made by PPI to EKR within ten (10) days of PPI\\'s receipt of such payments;  and\\n\\n  (iii) upon any Change of Control (as defined in Section 20.4) of PPI, by repayment to EKR in full of the balance of the  Advanced Royalty Payment not previously used for offsets, which payment shall be made to EKR by PPI within ten  (10) days after the closing date (without any conditions) of any such Change of Control.\\n\\n\\n\\n\\n\\n\\n\\n   -34-\\n\\n\\n\\n(c) Notwithstanding Section 6.3(b), effective July 1, 2013, the balance of the Advanced Royalty Payment that is available for subsequent offsets and/or repayments under Section 6.3(b) above shall be reduced to the lesser of (x) $[**] or (y) the  actual amount of such balance as calculated based upon any payments and offsets deducted to date from the beginning  Advanced Royalty Payment balance of $[**], as outlined in clauses (i) and (ii) of Section 6.3(b) above. As of [**] the  balance of the Advanced Royalty Payment shall have been deemed repaid in full by PPI and no additional offsets to or  repayments of the Royalties shall thereafter be applied for any reason.\\n\\n\\n\\n(d) Notwithstanding anything to the contrary, in the event EKR exercises it right of termination pursuant to Section 16.3(b) of  this Agreement or PPI terminates this Agreement pursuant to Section 16.1(a): (i) EKR will sell the Transferred Equipment  back to PPI, subject to payment by PPI to EKR (within five (5) days of the date of termination) of $[**] in cash and  cancellation of any remaining obligation of EKR under the Promissory Note, (ii) the Advanced Royalty Payment shall be  deemed to have been repaid in full, and EKR shall not have the right to the Royalty Offset between the date of notice of  such termination and the termination date of the Agreement and (iii) EKR shall promptly transfer the Marketing  Authorizations to PPI or its nominee in accordance with Section 17.1(e) below.\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n   -35-\\n\\n  (e) Notwithstanding anything to the contrary, during the Royalty Offset Period, or until such time that the Advanced Royalty  Payment balance has been fully repaid, the combined Royalty and Supply Price (as defined in the Supply Agreement) shall  not exceed [**] percent ([**]%) of the net average selling price of the Product.\\n\\n  (f) For the avoidance of doubt, the Royalty Offset described in clause (i) of Section 6.3(b) shall not be applied against any Additional Royalty due PPI pursuant to Section 6.4.   6.4 Royalties. As further consideration for the license and grant of Distribution Rights and other rights under this Agreement, EKR shall pay to PPI a royalty (\"Royalty\") equal to (a) $[**] for each [**] mg Vial of Product sold during the Term and $[**] for each [**] mg Vial of Product  sold during the Term (the \"Minimum Royalty\")  plus (b) an additional [**]% of any post Effective Date incremental price increase  implemented by EKR over the Current Base Price of $[**] for the [**] mg Vial and $[**] for the [**] mg Vial (the \"Additional Royalty\");  provided, however, that Additional Royalty shall not be payable to the extent that the sum of (i) the Minimum Royalty and Additional  Royalty payable hereunder and (ii) the Supply Price (as defined in the Supply Agreement) shall at any time during the Term exceed [**]  percent ([**]%) of the net average selling price of the Product (the \"Royalty Cap\"); provided, however, that the Royalty Cap shall be [**]  percent ([**]%) of the net average selling price of the Product during certain periods as described in Section 6.3(e) above. EKR shall be  entitled to offset certain amounts from Royalties payable hereunder as set forth in Section 6.3(b) above. Royalties on other presentations and dosages which hereafter receive Marketing Authorization in any country of the Territory shall be negotiated in good faith by the  parties in a manner consistent with the Royalty currently being paid by EKR as of the date of the receipt of Marketing Authorization for  such new presentations and dosages.\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n   -36-\\n\\n6.5 Quarterly Reports and Annual Reports. Within 30 days of the end of each Quarter and within sixty (60) days of the end of each Calendar Year during the Term of this Agreement EKR shall send to PPI a statement setting out in respect of each country in the Territory in which  Product is sold, details of Product sold during the previous Quarter or Calendar Year, as applicable, itemized by presentation form, quantity,  total gross receipts, itemized deductions which are applied to achieve the Net Sales figure, and Net Sales of Product. The statement shall  (where appropriate) show:     (a) the total Net Sales for each country expressed both in local currency and in Dollars and the conversion rate used;\\n\\n  (b) the total number of Vials sold in each country (less properly rejected, returned or recalled Vials) for each of the [**] mg  Product and the [**] mg Product (the \"Unit Sales\");\\n\\n  (c) the applicable Royalty rate multiplied by the Unit Sales for each of the [**]mg and [**] mg Products in that Quarter  (\"Prepayment\") (or in that Calendar Year, as applicable);     (d) any Additional Royalties due in that Quarter (or for such Calendar Year);\\n\\n  (e) the total Royalties payable on those Unit Sales (subject to the Royalty Cap) in accordance with Section 6.4, and any  deductions taken pursuant to Section 6.3.   6.6 Payment. EKR shall pay to PPI, any Minimum Royalties and Additional Royalties due within forty-five (45) days of the end of each Quarter as the case may be subject to reconciliation at the end of each Calendar Year as set forth in Section 6.9.   6.7 Reserved.   6.8 Reserved.   6.9 Reconciliation. Within forty-five (45) days of the end of each Contract Year, there shall be a reconciliation between the sums paid under  Section 6.6 and the Royalties payable under Section 6.4, and any payment due (or in the event of an overpayment by EKR to PPI) such  amounts shall be paid by one Party to the other within thirty (30) days of the resolution of such reconciliation.\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n   -37-\\n\\n6.10 Withholdings. In the event that a Party is required under the laws of a country or other political subdivision of competent jurisdiction to withhold any tax to the tax or revenue authorities in such jurisdiction in connection with any payment to the other Party, such amount shall  be deducted from the payment to be made by such withholding Party; provided that the withholding Party shall take reasonable and lawful  actions to avoid and minimize such withholding and promptly notify the other Party so that the other Party may take lawful actions to avoid  and minimize such withholding. The withholding Party shall promptly furnish the other Party with copies of any tax certificate or other  documentation evidencing such withholding as necessary to satisfy the requirements of the appropriate regulatory authority related to any  application by such other Party for foreign tax credit for such payment. Each Party agrees to reasonably cooperate with the other Party in  claiming exemptions from such deductions or withholdings under any agreement or treaty from time to time in effect.\\n\\n7. Payment, Accounting, Audit Rights.   7.1 Currency. Unless otherwise agreed between the Parties, all payments to be made hereunder shall be made in US Dollars. Net Sales shall be determined in the currency in which the Product was sold and shall, if necessary, be converted into US Dollars using the noon buying rate  as published in the Wall Street Journal for the last day of the Quarter for which such payment is being determined.   7.2 Maintenance of Records. EKR shall maintain and shall procure the maintenance of accurate and up to date records and books of account  showing the quantity, description and value of the Products supplied in each country of the Territory during the previous six (6) Calendar  Years.   7.3 Inspection. EKR shall during business hours, on no less than 14 day\\'s notice from PPI and not more than once in any Calendar Year, make available for inspection the records\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n   -38-\\n\\n\\n\\nand books referred to in Section 7.2. Such inspection shall be undertaken by an independent auditor appointed by PPI and reasonably  acceptable to EKR for the purpose of verifying the accuracy of any statement or report given by EKR to PPI and/or the amount of Royalties  due. Upon completion of such inspection, PPI shall not be entitled to inspect nor shall EKR be required to make available the records and  books for any Calendar Year for which such inspection was previously undertaken.   7.4 Confidentiality. PPI shall procure that any independent auditor appointed under Section 7.4 shall maintain all information and materials  received, directly or indirectly, by it from EKR in strict confidence and shall not use or disclose the same to any Third Party nor to PPI save  for the sole purpose of conducting the audit pursuant to this Section.   7.5 Audit. In the event that an auditor appointed pursuant to this Section concludes that there has been an underpayment or overpayment, PPI shall deliver to EKR a copy of such auditor\\'s report. Any deficit payable by EKR or any excess refundable by PPI shall be payable within 30  days of EKR\\'s receipt of such report. The fees charged by such auditor shall be payable by PPI, provided that if the audit reveals that  payments due to PPI for any Calendar Year have been understated by more than [**]%, the fees charged by such auditor shall be payable  by EKR.   7.6 Interest. Should any amount not be paid by either Party on or before the due date for payment interest on such unpaid amount at the rate of [**]% above the prime lending rate of Citibank, N.A. (or its successor in interest) in effect from time to time and such interest shall be  calculated and payable in respect of the period from the date such amount is due until the date payment in full is received in cleared funds.\\n\\n8. Intellectual Property and Trademarks.   8.1 Limitation of License. Except as set out in this Agreement, all right, title and interest in the PPI IP or Trademarks shall belong to PPI and EKR shall not have any right, title or interest in the PPI IP or Trademarks.\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n   -39-\\n\\n8.2 Trademark Standards. EKR shall use the Trademarks in a manner which conforms to the reasonable directions and standards notified to it  by PPI from time to time and not do anything which could, in the PPI\\'s reasonable opinion, bring the Trademarks or PPI into disrepute or  otherwise damage the goodwill attaching to the Trademarks.   8.3 Maintenance of Trademarks. PPI shall, at its own cost, take all steps required to maintain those registrations for the Trademarks subsisting at the Effective Date, and prosecute any applications subsisting at the Effective Date for registration of the Trademarks through to grant  (including oppositions thereto) in each country of the Territory.   8.4 Additional Trademark Registrations. EKR may request that PPI use reasonable efforts to obtain Trademark registrations in respect of the Trademarks, in classifications which cover the Product, in any countries in the Territory. PPI shall promptly notify EKR if it does not intend  to make or pursue any such Trademark registration in any of the countries in the Territory and EKR shall thereafter be entitled to make  applications for such Trademark registrations in its own name.   8.5 Domain Names. EKR shall have the right during the Term to register domain names in its own name specific to the countries comprised in  the Territory that incorporate the Trademark.   8.6 Improvements. PPI Improvements shall be owned by PPI and be licensed to EKR hereunder. EKR Improvements shall be owned by EKR  and upon termination of this Agreement by PPI pursuant to Section, shall be deemed be licensed to PPI on a worldwide, non-exclusive,  irrevocable basis, at a royalty or for such other consideration as may be mutually agreed upon by the parties in writing. Joint Improvements  shall be owned jointly by the Parties, and PPI\\'s interest therein shall be licensed to EKR hereunder.\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n   -40-\\n\\n9. Representations and Warranties.   9.1 Representations and Warranties of Both Parties. Each Party represents and warrants to the other Party as of the Effective Date, that:\\n\\n  (a) Organization. Such Party is duly organized and validly existing and in good standing of the laws of the jurisdiction of its  incorporation and it has full power and authority and legal right to enter into this Agreement and perform the obligations  under it;\\n\\n  (b) Authorization. Such Party has taken all corporate action such that the execution and delivery of this Agreement and the  consummation of the transaction contemplated hereby has been duly authorized by all necessary actions;\\n\\n  (c) Valid Obligation. This Agreement is a legal and valid obligation of such Party, binding on each of the Parties and  enforceable in accordance with its terms;\\n\\n\\n\\n(d) Execution and Delivery. The execution and entry into and exercise of the respective rights and obligations under this  Agreement including the granting of rights to the other Party pursuant to this Agreement do not, and will not conflict with,  or violate any provision of any agreement or other instrument or document to which it is Party or affect or be in conflict  with or result in the breach of or constitute a default under any such agreement, instrument or document or conflict with  any rights granted by such Party to any Third Party or breach any obligation that such Party has to any Third Party; and\\n\\n\\n\\n(e) Debarment. It is not currently debarred, suspended or otherwise excluded by the United States, under any Federal law,  including, without limitation, the Generic Drug Enforcement Act of 1992, or by any other country in the Territory under any  analogous law, rule or regulation, and does not and will not use in any capacity the services of any person debarred under  applicable law, rule or regulation, in the Territory in the performance of its obligations under this Agreement.\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n   -41-\\n\\n9.2 Representations and Warranties of PPI. PPI hereby represents and warrants to EKR as of the Effective Date that:\\n\\n\\n\\n(a) Ownership; Validity. It is the owner of, or has exclusive rights to, all of the PPI IP and Trademarks in existence on the  Effective Date, and has the exclusive right to grant the Distribution Rights and other rights granted under this Agreement.  All of the PPI Patents in existence on the Effective Date are valid, enforceable, in full force and effect and have been  maintained to date and are not the subject to any interference or opposition procedures. All of the PPI Patents listed in the  Orange Book are properly filed in accordance with Applicable Laws;\\n\\n  (b) Third Party Interests. There are no Third Party interests or rights in the PPI IP or Trademarks that may prevent, encumber or  restrict the exercise by EKR of the Distribution Rights or other rights granted under this Agreement.\\n\\n  (c) Third Party Infringement. No Third Party is infringing or has infringed the intellectual property rights of PPI in any of the  PPI IP or Trademarks;\\n\\n\\n\\n(d) Distribution Rights and other Rights. That neither the Products, the exercise of EKR\\'s Distribution Rights and other rights  granted under this Agreement or the manufacture of the Products as contemplated by this Agreement or the Supply  Agreement do not and will not infringe or conflict with any Third Party intellectual property rights and EKR will not incur  any obligation to any Third Party by the exercise of the rights granted hereunder;\\n\\n  (e) Renewal and Maintenance Fees. All renewal and maintenance fees and all steps necessary for the filing, prosecution and  maintenance of the PPI\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n   -42-\\n\\n  Patents and Trademarks due and payable as of the Effective Date have been paid or taken and there are no actions due  within 180 days of the Effective Date;\\n\\n  (f) Trademarks. The Trademarks are the only trademarks, trade dress or service marks related to the Product that are owned by  PPI or licensed by PPI (with the right to sublicense);\\n\\n  (g) Adverse Events. To its knowledge and belief all information, data and Third Party notices in relation to adverse events  serious adverse events or recalls with respect to the Product and of which PPI is aware have been disclosed by PPI to EKR;\\n\\n\\n\\n(h) Access to Documents. PPI has provided EKR or given EKR access to true, complete and unredacted copies of all (i)  regulatory documentation or (ii) material agreements between PPI and any Third Party including all effective amendments  to any such agreements which in any event (A) affects or may affect EKR\\'s rights under this Agreement or (B) relates to the Product;\\n\\n  (i) No Brokers. Neither PPI nor any office, director or agent of PPI has employed any broker, finder or agent with respect to  this Agreement or the transactions contemplated hereby;\\n\\n  (j) Right to License. PPI has the right to use and license PPI IP and Trademarks free and clear of any material liens, security,  interests, licenses, obligations, transfer agreements, enforceable claims or encumbrances;\\n\\n\\n\\n(k) Litigation. There is no litigation, arbitration, proceeding, governmental investigation, action or claim of any Third Party or  to the knowledge of PPI threatened by or against PPI relating specifically to the PPI IP, or the Trademarks which would  impede, impair, restrict or interfere with the rights granted EKR hereunder or the ability of PPI to perform its obligations  hereunder; and\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n   -43-\\n\\n  (l) Customer Lists. PPI has or prior to the Effective Date will have provided EKR with complete and accurate lists of the names  and addresses of all material customers and suppliers of the Products.\\n\\n\\n\\n(m) Permits. PPI has and shall maintain at all times during the Term all necessary license, permits, records and authorizations  required by Applicable Laws necessary to perform its obligations hereunder and shall observe and comply with all  Applicable Laws, ordinances, rules and regulations including those of the applicable Regulatory Authorities and  governmental entities including but not limited to DEA in the performance of its obligations hereunder.\\n\\n\\n\\n(n) ICS Agreement. All amounts due under the ICS Agreement as of or prior to the Effective Date have been paid in full. PPI is  not in, nor has PPI given or received notice of, any default or claimed, purported or alleged default, or facts that, with notice  or lapse of time, or both, would constitute a default (or give rise to a termination right) on the part of any person in the performance of any obligation to be performed under the ICS Agreement. A true and complete copy of the ICS Agreement,  including any amendments thereto, has been delivered to EKR.\\n\\n10. Liability, Insurance and Indemnities   10.1 Indemnification of EKR. PPI shall be liable for and shall defend, indemnify and hold harmless EKR and its Affiliates and their officers, directors, agents, representatives, consultants and employees (individually an \"EKR Indemnified Party\"  and collectively the \"EKR  Indemnified Parties\") and any of them from and against any and all Claims (as defined below), arising in connection with or relating to:\\n\\n  (a) The development, manufacture, sale and supply of the Product prior to the Effective Date (including Claims arising after the  Effective Date to the extent they are based on events occurring prior to the Effective Date);\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n   -44-\\n\\n\\n\\n(b) The manufacture of the Product by or on behalf of PPI (including, but not limited to, any manufacture of Product or any  other product by EKR for the Other PPI Customers pursuant to Section 3.20(l)) except to the extent that such Claims arise  from (i) the negligence or willful misconduct of EKR or its Affiliates, (ii) the breach by EKR of the terms of this Agreement  or (iii) the manufacture of Product by EKR in accordance with EKR\\'s exercise Step-in Right for supply of Product to EKR or  its Affiliates;     (c) Claims which arise outside the Territory (except to the extent that the Claim has arisen from any act or omission by EKR);\\n\\n  (d) A breach by PPI of any representation, warranty, covenant or agreement contained in this Agreement, the Supply  Agreement or the Transition Services and Inventory Agreement;\\n\\n  (e) PPI\\'s failure to comply with any Applicable Law in connection with the performance of its obligations hereunder or under  the Supply Agreement or the Transition Services and Inventory Agreement, or prior to the Effective Date; and     (f) Any Claims related to Product sold by parties other than EKR prior or subsequent to the Effective Date.\\n\\n  (g) Liabilities arising under the ICS Agreement prior to the Effective Date and subsequent to the Effective Date for Products  sold by parties other than EKR or under the direction of EKR or arising under the Transition Services and Inventory  Agreement.\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n   -45-\\n\\n10.2 Indemnification of PPI. EKR shall be liable for and shall defend, indemnify and hold harmless PPI from and against any and all Claims  arising from (i) EKR\\'s exercise of the Distribution Rights or arising under the Transition Services and Inventory Agreement, (ii) a breach by  EKR of any representation, warranty, covenant or agreement contained in this Agreement, the Supply Agreement or the Transitions  Services and Inventory Agreement, or (iii) EKR\\'s failure to comply with Applicable Laws in connection with its performance of its  obligations hereunder, or (iv) Claims related to the manufacture of Products by EKR or by a Third Party Manufacturer designated by EKR  pursuant to Section 11.5 of the Supply Agreement, except to the extent that such Claims:     (a) relate to any act or circumstance occurring prior to the Effective Date;\\n\\n  (b) relate to Intellectual Property infringement proceedings with Third Parties in connection with the PPI IP and Trademarks  (except to the extent that the Claim has arisen from EKR\\'s use of the PPI IP or Trademarks other than in accordance with  this Agreement);     (c) arise outside the Territory (except to the extent that the Claim has arisen from any act or omission by EKR);     (d) relate to the development or manufacture of the Product by PPI or its Affiliates or its or their agents or sub-contractors;     (e) Arise under the ICS Agreement after the Effective Date for Products sold by EKR.\\n\\n  (f) result from the negligence, willful default or material breach of any representation or warranty given under this Agreement,  the Supply Agreement, or the Transition Services and Inventory Agreement by PPI, its Affiliates or sub-contractors; or     (g) are the responsibility of PPI under Section 10.1 above.\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n   -46-\\n\\n10.3 Conditions to Indemnification. Promptly after receipt by a Party of any Claim or alleged claim or notice of the commencement of any action, administrative or legal proceeding, or investigation as to which the indemnity provided for in this Section 10 may apply, the indemnified  Party shall give written notice to the indemnifying Party of such fact. The indemnifying Party shall have the option to assume the defense  thereof by election in writing within thirty (30) days of receipt of such notice. If the indemnifying Party fails to make such election, the  indemnified Party may assume such defense and the indemnifying Party will be liable for reasonable legal and other expenses subsequently  incurred in connection with such defense. The Parties will co-operate in good faith in the conduct of any defense, provide such reasonable  assistance as may be required to enable any Claim to be properly defended, and the Party with conduct of the action shall provide promptly  to the other Party copies of all proceedings relating to such action.   10.4 Assumption of Defense. Should the indemnifying Party assume conduct of the defense:\\n\\n  (a) the indemnified Party may retain separate legal advisors in the event that it reasonably concludes that it may have defenses  available to it which are additional to, different from or inconsistent with those available to the indemnifying Party, in which  case the indemnifying Party shall not be liable for the indemnified Party\\'s reasonable costs and expenses so incurred; and\\n\\n\\n\\n(b) the indemnifying Party will not, except with the consent of the indemnified Party (such consent not be unreasonably  withheld or delayed), consent to the entry of any judgment or enter into any settlement (other than for the payment of  damages by the indemnifying Party, which includes as an unconditional term a release from the claimant to the indemnified  Party from all liability in respect of all claims).\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n   -47-\\n\\n10.5 Settlement of Claims. The indemnified Party shall not admit liability in respect of, or compromise or settle any such action without the prior  written consent of the indemnifying Party, such consent not to be unreasonably withheld or delayed.   10.6 Insurance. Each Party shall maintain, at its own cost, comprehensive product liability insurance, general commercial liability insurance and business interruption insurance at a level which is reasonable and customary taking into account the nature of the Product but which shall  have combined limits of not less than $[**] per occurrence. Such insurance shall be with a reputable insurance company and where  reasonably possible (taking into account the availability of such insurance) shall be maintained for not less than [**] ([**]) years following  the expiry or termination of this Agreement. During the Term, neither Party shall do or omit to do any act, matter or thing which could  prejudice or render voidable any such insurance. Each Party will provide to the other Party evidence of its insurance and thirty (30) days  prior written notice of any cancellation of its coverage or reduction in coverage from the requirements stated herein.   10.7 Third Party Liability. Each of the Parties shall be liable to the other for legal liability to Third Parties in respect of all claims, actions,  judgments, damages, lawsuits, costs or expenses or professional fees for death or personal injury incurred by such other Party in relation to  or arising out of any breach of this Agreement, the Transition Services and Inventory Agreement or the Supply Agreement by the first  Party or of any gross negligence or willful act of the first Party, or its employees in the course of their employment.   10.8 PPI Liability Limitation. Any and all liability of PPI to EKR howsoever arising in respect of this Agreement, the Transition Services and Inventory Agreement or the Supply Agreement and their performance, in contract tort or otherwise, shall be limited (except for death or  personal injury caused by the negligence of PPI or its employees while acting in the course of their employment) to [**] US Dollars ($[**]);  provided\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n   -48-\\n\\n  however that such limitation shall not apply to the extent that EKR or any EKR Indemnified Party is required to pay in excess of such  amount to a third party in respect of a final judgment or order obtained by the third party or as a result of PPI\\'s breach of Section 7.2.12 of  the Supply Agreement.   10.9 EKR Liability Limitation. Any and all liability of EKR to PPI howsoever arising in respect of this Agreement, the Transition Services and Inventory Agreement or the Supply Agreement and their performance in contract tort or otherwise shall be limited (except for death or  personal injury caused by the negligence of EKR or its employees while acting in the course of their employment, and except in relation to  any specified payment, lump sum, milestone or royalty payment unpaid) to [**] US Dollars ($[**]); provided however that such limitation  shall not apply to the extent that PPI or any PPI Indemnified Party is required to pay in excess of such amount to a third party in respect of a  final judgment or order obtained by the third party.   10.10 Limitation of Damages. Notwithstanding anything contained in this Agreement or the Transition Services and Inventory Agreement or the  Supply Agreement in no circumstance shall either Party be liable to the other in contract, tort (including negligence or breach of statutory  duty) or otherwise howsoever, and whatever the cause thereof, for any special, indirect or consequential loss or damage of any nature  whatsoever except in the cases of fraud or intentional misconduct or in the case of PPI as a result of PPI\\'s breach of Section 7.2.12 of the  Supply Agreement.   10.11 Definition of Claims. In this Section 10, \"Claims\" shall mean any and all claims, actions, demands, losses, damages, costs and reasonable  expenses (including, without limitation, reasonable legal and expert fees) made or brought by Third Parties.\\n\\n11. Confidentiality, Press Releases and Publications   11.1 Confidential Information. PPI and EKR undertake to each other to keep confidential, and to procure that their respective Affiliates, employees, directors, officers, contractors, lawyers and accountants (including those of their Affiliates) keep confidential, Confidential  Information disclosed to it by or belonging to the other Party.\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n   -49-\\n\\n11.2 Third Party Disclosure. Any Confidential Information received from the other Party shall not be disclosed to any Third Party or used for  any purpose other than as provided or specifically envisaged by this Agreement or as required in connection with any securities offering,  financing, merger, acquisition or other corporate transaction involving such Party provided that any Party to whom such disclosure is made  is bound by obligations as to confidentiality that are at least as protective of Confidential Information as those contained herein.   11.3 Duration. The confidentiality and non-use obligations contained in this Agreement shall continue for the duration of this Agreement and  for a period of [**] ([**]) years after termination for any reason of this Agreement.   11.4 Public Announcements. The Parties shall consult with each other, in advance, with regard to the terms of all proposed press releases,  public announcements and other public statements with respect to the transactions contemplated under this Agreement. The Parties  acknowledge that they have issued a joint press release in the form set out in Schedule VI of this Agreement.   11.5 Exceptions to Disclosure of Confidential Information. The Confidential Information may be disclosed by the other Parties to the extent that such disclosure has been ordered by a court of law or directed by a governmental authority, provided that, wherever practicable, the Party  disclosing the Confidential Information has been given sufficient written notice in advance to the other Party to enable it to seek protection  or confidential treatment of such Confidential Information, and may be disclosed only to the extent that such disclosure has been so  ordered or directed.\\n\\n12. Patents   12.1 Maintenance. PPI shall pay all costs and expenses of the filing, prosecution and maintenance of the PPI Patents in each country of the Territory so as to maintain the\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n   -50-\\n\\n  PPI Patents in full force and effect. PPI will consult with EKR with respect to any notice from or correspondence with the USPTO or any  other governmental entity with respect thereto and the development, filing and prosecution of any subdivisions, continuations,  continuations in part or additional applications related to the Product for use in the Field in the Territory.\\n\\n13. Infringement of Third Party Rights  13.1 Notice of Infringement. In the event of a Party becoming aware that the exercise of either Party\\'s rights and obligations pursuant to this  Agreement are infringing or may infringe the rights of a Third Party, it will promptly notify the other Party and provide it with such details  of the Third Party rights and the extent of the infringement as are known to it.   13.2 Infringement of Third Party IP. In the event a claim of infringement of a Third Party\\'s intellectual property rights arising out of the manufacture, use, sale, promotion or distribution of the Products is brought against either Party, PPI shall defend such action at its cost  and expense and take one or more of the following actions simultaneously or sequentially:\\n\\n  (a) Defend the claim and indemnify and hold harmless EKR, its Affiliates, officers, directors, shareholders, employees,  representations, consultants and agents (the \"EKR Infringement Indemnitees\") as set forth in Section 13.3 below.\\n\\n  (b) Obtain for itself as the benefit of EKR the right through license or otherwise to utilize the technology upon which the claim  of infringement was based. Such rights obtained by PPI from a Third Party under this Section 13.2 shall be licensed or  sublicensed to EKR at no additional cost to EKR.   13.3 Infringement Indemnification. Notwithstanding any other provisions of this Agreement, PPI will defend, indemnify and hold harmless the  EKR Infringement\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n   -51-\\n\\n\\n\\nIndemnitees from and against all liabilities, losses, damages, actions, claims and expenses suffered or incurred by the EKR Infringement  Indemnitees (including reasonable attorneys fees, court costs and expert witnesses\\' fees) resulting from any claims by any Third Party that  EKR\\'s exercise during the Term of the rights granted under this Agreement infringes or violates any license, patent, copyright, trademark or  other intellectual property right of that Third Party.\\n\\n14. Infringement of PPI IP  14.1 Notice of Infringement. In the event that either Party becomes aware of any actual or suspected infringement or misuse of the PPI IP or Trademarks in the Territory by a Third Party (\"Third Party Infringement\"), it shall promptly notify the other Party and provide it with all  details thereof in its possession.   14.2 Infringement Action. Within a reasonable time of becoming aware of such Third Party Infringement, the Parties shall consult with each  other and their respective counsel to develop a strategy for addressing the Third Party Infringement. In the event the Parties agree to the  legal action to stop the Third Party Infringement, they shall agree upon legal counsel to prosecute such action and unless the Parties  otherwise agree, PPI shall prosecute the action at its cost and expense. EKR shall provide all such assistance at PPI\\'s cost and expense as  PPI may reasonably require in the prosecution or defense of any such proceedings.   14.3 Awards. Any damages, award or settlement monies actually received by PPI in respect to such infringement and paid in compensation for  sales lost by EKR shall be deemed Net Sales and be paid to EKR, subject to PPI deducting its costs and expenses in pursuing such  infringement from such damages, award or settlement actually received. Any damages, award or settlement monies actually received by PPI  in respect to such infringement and not paid in compensation for sales lost by EKR shall be shared equally by the Parties.\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n   -52-\\n\\n14.4 Non Participation. Should in accordance with Section 14.2, PPI decide not to participate in any such infringement action, EKR may require  PPI to bring the action, subject to reimbursement by EKR for reasonable out-of-pocket expenses incurred by PPI in connection with such  action. The selection of counsel and all other material decisions with respect to such action shall be subject to EKR\\'s prior, written  approval, such approval not to be unreasonably withheld. In addition, EKR shall have the right to discontinue the prosecution of any such  action at any time upon written notice to PPI. Except as provided above in this Section 14.4, PPI shall have control of such action but shall  consult with EKR regarding the conduct of such action and shall not settle such action without the prior written consent of EKR, which  consent shall not be unreasonably withheld, and EKR may, in such instance, retain any award or settlement in its entirety. Notwithstanding  the foregoing, PPI shall offer reasonable assistance to EKR at no charge except for reimbursement of reasonable out of pocket expense  including reasonable attorneys fees.   14.5 Cooperation. Each Party shall keep the other Party reasonably informed and consult with the other Party with regard to any infringement action under this Article 14.\\n\\n15. Term   15.1 This Agreement shall commence on the Effective Date and, subject to earlier termination in accordance with the provisions of Section 16, shall continue in force for a period being the longer of fifteen (15) years from first Commercial Launch of the Product in the Territory or until  the expiration of the last valid claim in the PPI Patents covering the Product in any country of the Territory (the \"Initial Term\"). Thereafter  the term of this Agreement shall automatically renew for consecutive periods of two (2) years each. Notwithstanding the foregoing, this  Agreement can be terminated by EKR at the end of the Initial Term by delivery of written notice to PPI at least one hundred eighty (180)  days prior to the end of the Initial Term or any renewal term. As used herein \"Term\" refers to the Initial Term and any renewal terms.\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n   -53-\\n\\n16. Termination   16.1 Prior Termination by Either Party. Either Party shall be entitled forthwith to terminate this Agreement by notice to the other if:\\n\\n  (a) the other Party commits a material breach of any material obligation under this Agreement or the Supply Agreement, and in  the case of a breach which is capable of remedy fails to remedy it within sixty (60) days of receipt of notice from the first  Party of such breach and of its intention to exercise its rights under this Section; or\\n\\n\\n\\n(b) any representation or warranty made herein or in the Supply Agreement by such other Party proves to be incorrect when  made which has a material adverse effect on the performance of the other Party\\'s obligations hereunder and in the case of a  breach which is capable of remedy fails to remedy it within sixty (60) days of receipt of notice from the first Party of such  breach and of its intention to exercise its rights under this Section; or\\n\\n\\n\\n(c) the entry of a decree or order for relief by a court having jurisdiction in the premises in respect of the other Party in an  involuntary case under the United States Bankruptcy Code, as now constituted or hereafter amended, or any other  applicable foreign, federal or state insolvency or other similar law and the continuance of any such decree or order  unstayed and in effect for a period of sixty (60) consecutive days; or\\n\\n  (d) the filing by the other Party of a petition for relief under the United States Bankruptcy Code, as now constituted or  hereafter amended, or any other applicable foreign, federal or state insolvency law or other similar law; or\\n\\n  (e) the other Party becomes insolvent or takes the benefit of any statute for insolvent debtors or any steps are taken or  proceedings commenced by any person for the dissolution, winding-up or other termination of such other Party\\'s existence  or the liquidation of its assets; or\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n   -54-\\n\\n  (f) a trustee, receiver, receiver-manager or like person is appointed with respect to the business or assets of the other Party; or\\n\\n  (g) the other Party proposes or makes any composition or arrangement or composition with, or any assignment for the benefit  of, its creditors; or\\n\\n  (h) anything analogous to any of the events described in Sections 16.1(c)-(k) - 16.1.6, inclusive, occurs under the laws of any applicable jurisdiction; or     (i) the other Party ceases or threatens to cease to carry on the whole or any material part of its business; or\\n\\n\\n\\n(j) for reasons unrelated to any breach of either Parties\\' duties or obligations under or in connection with this Agreement, the  other Party is prevented from performing any of its material obligations hereunder by any law, governmental or other action  (other than laws of general application) and has not resumed performance in compliance with all Applicable Laws within  one hundred twenty (120) days following the date on which such performance was first provided; or     (k) in accordance with Section 18.2 below.   16.2 Prior Termination by PPI.     (a) Reserved.\\n\\n  (b) PPI may terminate this Agreement with immediate effect in any country of the Territory where EKR is obligated to launch  the Product pursuant to Section 4.5 if within [**] months of the receipt of the Marketing Authorization for such country,  EKR has not made its first Commercial Launch of the Product in that country.\\n\\n  (c) In the event PPI has terminated the Supply Agreement pursuant to Section 10.2 thereof and EKR or its designee is  manufacturing Products pursuant to Section 11.5 of the Supply Agreement, PPI shall have the right to terminate such rights  of manufacture and this Agreement upon thirty (30)\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n   -55-\\n\\n  days prior, written notice to EKR only in the event Royalties and Additional Royalties paid hereunder in any one year  period following the date of such termination are less than $[**], unless the difference between $[**] and the actual  Royalties and Additional Royalties paid by EKR is paid to PPI within thirty (30) days of notice of such termination.   16.3 Prior Termination by EKR.\\n\\n  (a) EKR may terminate this Agreement with immediate effect in any country of the Territory if the Products are withdrawn from  the market in such country of the Territory as a result of regulatory action by FDA or other governmental entities or there  are significant adverse reactions from use of the Products.     (b) EKR may terminate this Agreement for convenience at any time upon [**] ([**]) days prior, written notice to PPI.   16.4 Effect of Termination. The termination or expiration of this Agreement shall not release either of the Parties from any liability which at the  time of termination or expiry has already accrued to the other Party, nor affect in any way the survival of any other right, duty or obligation  of the Parties which is expressly stated elsewhere in this Agreement to survive such termination or expiry.\\n\\n17. Consequences of Termination   17.1 Upon termination of this Agreement for any reason except as set forth in Section 17.4 below (and, if applicable, in respect of that country in  respect of which termination occurs):\\n\\n  (a) the licenses and rights granted and appointments made under Sections 2.1, 2.2 and 2.3 shall terminate and EKR shall (and  shall procure that its Affiliates, sub-distributors and sub-licensees shall) cease all activities licensed or appointed  hereunder, subject to Sections 17.2 and 17.3;\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n   -56-\\n\\n\\n\\n(b) the following provisions of this Agreement shall continue in full force and effect: Article 1 (\"Definitions\"), Section 3.20(k),  Section 3.20(l), Article 9 (\"Representations and Warranties\"), Article 10 (\"Liability, Insurance and Indemnities\") (excluding  Section 10.6 (\"Insurance\")), Article 11 (\"Confidentiality, Press Releases and Publications\"), Article 13 (\"Infringement of  Third Party Rights\"), Section 16.4 (\"Effect of Termination\"), Article 17 (\"Consequences of Termination\"), Article 18 (\"Force  Majeure\"), Article 19 (\"Notices\"), Article 20 (\"Assignment and Change of Control\") and Article 21 (\"General Provisions\");     (c) EKR shall return to PPI all PPI IP in its possession;     (d) EKR shall assign to PPI free of charge any domain name registrations it has registered pursuant to Section 8.5; and\\n\\n  (e) Except in the event of termination of this Agreement by EKR pursuant to Section 16.1(a), EKR shall promptly transfer to PPI  or its nominee, each and every Marketing Authorization (to the extent not held by PPI) relating to the Product, together  with all communications with the relevant Regulatory Authorities, and all notes and record thereof.   17.2 Sale of Remaining Inventory. Where this Agreement has expired or has been terminated for any reason other than by PPI in accordance  with Section 16.1 or EKR in accordance with Section 16.3(b), EKR and its Affiliates and sub-distributors and sales agents shall be entitled  to continue to sell existing stocks of the Product in the Territory for a period of not longer than 12 months following the date of termination,  provided that, EKR continues to make any Royalty payments due to PPI in respect of such sales in accordance with the provisions of this  Agreement.   17.3 Other Rights upon Termination. In the event that this Agreement is terminated by PPI in accordance with Section 16.1 or EKR in accordance with Section 16.3(b), EKR and its Affiliates, sub-distributors and sub-licensees shall be entitled to continue to sell\\n\\n\\n\\n\\n\\n\\n\\n   -57-\\n\\n\\n\\nexisting stocks of the Product in the Territory for so long as PPI deems necessary to ensure that sale of the Product is not disrupted  provided that EKR and its Affiliates shall cease such sale immediately upon notification from PPI and in any event EKR shall not so sell for  a period of longer than three (3) months following the date of termination. Immediately upon notification from PPI, such post termination  sales shall cease.   17.4 Other Remedies of EKR. Notwithstanding anything contained herein to the contrary, in the event that EKR is entitled to exercise its right to terminate this Agreement pursuant to Section 16.1(a), in addition to the right to terminate as provided therein and any other remedies EKR  may have hereunder, PPI shall assist EKR in the transfer of the manufacture of the Products, including the Specifications from PPI to EKR  or EKR\\'s designee. In such event, the Royalty payments payable hereunder shall continue to be paid; provided,  however, that all costs  incurred by EKR in the transfer of manufacturing information from PPI and obtaining FDA approval of the manufacture of the Products by  EKR or EKR\\'s designee, and any other amounts due to EKR, shall be deducted from any royalties payable to PPI. In addition, PPI shall  during the remainder of the Term and for a period of up to [**] ([**]) years thereafter continue to manufacture and supply the Product to  EKR at cost without mark-up until such time that EKR can secure an FDA approved manufacturing facility for the Product. PPI shall provide such advice as necessary for EKR to arrange for an alternative manufacturer and shall provide EKR with access to all relevant PPI  Know-How, and any other information necessary for EKR to transfer such manufacturing to an alternate manufacturer. In addition, (i) PPI  shall transfer to EKR any Marketing Authorizations held by PPI and (ii) the Trademark license granted under Section 2.3 shall continue in  effect following such termination on a perpetual basis and EKR shall be responsible for all costs associated with the maintenance of such  Trademark.\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n   -58-\\n\\n17.5 EKR Step-In Rights.\\n\\n\\n\\n(a) During the Term, in the event EKR has the right to terminate this Agreement under Section 16.1(a) - (i) hereof (the \"Step-in  Right Trigger Event\"), and EKR does not exercise its right to terminate this Agreement under such Section, EKR shall  have the option to exercise step-in rights to manufacture the Product for the remainder of the Term (the \"Step-in Right\") by  providing PPI written notice of such election within ninety (90) days after the Step-in Right Trigger Event (or such longer  period as mutually agreed by the Parties) (the \"Step-in Right Notice\"); provided that in the event such Step-in Right  Trigger Event has been cured prior to EKR\\'s exercise of the Step-in Right, the Step-in Right shall terminate with respect to  such Step-in Right Trigger Event. The Step-in Right Notice shall specify the date which EKR intends to exercise the rights  associated with the Step-in Right.\\n\\n  (b) In the event EKR exercises the Step-in Right, PPI shall, at EKR\\'s cost and expense, cooperate in the exercise of such rights  and EKR shall reimburse PPI for the reasonable costs PPI incurs in assisting EKR in the exercise of such rights within thirty  (30) days of EKR\\'s receipt of invoice.\\n\\n\\n\\n(c) The Step-in Right shall include, without limitation, and to the extent allowable under Applicable Law, PPI\\'s grant to EKR of  such additional license rights, rights of access, rights of observation and rights of management, direction and control, in  each case solely with respect to the manufacture and supply of Product and as reasonably necessary to enable and permit  EKR (or EKR\\'s designee) to ensure that the supply of Product shall continue to be available to EKR under this Agreement  and the Supply Agreement; provided that EKR in exercising the Step-in Right shall not (i) unreasonably interfere with PPI\\'s  other activities at the facilities at which the Product is manufactured, tested, labeled, stored or\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n   -59-\\n\\n\\n\\notherwise handled (\"Product Facilities\") or (ii) require PPI to take any action or fail to take any action that does or could  reasonably be expected to interfere with PPI\\'s other activities at the Product Facilities. The foregoing rights shall apply  with respect to any Product Facility to the extent necessary for EKR to preserve and protect supply of the Product as  contemplated by this Agreement and the Supply Agreement. For the avoidance of doubt, (i) upon termination of the Lease  Term, PPI shall maintain responsibility and control over all other products manufactured by PPI and nothing in this Section  17.5 shall give EKR any rights to direct, manage or control the manufacture of such products (ii) PPI shall maintain  responsibility and control over the facilities where Product is manufactured, tested, labeled, stored or otherwise handled  and nothing in this Section 17.5 shall give EKR general oversight or control of the facilities where Product is manufactured,  tested, labeled, stored or otherwise handled.\\n\\n  (d) In the event EKR exercises the Step-in Right, EKR shall comply with all policies applicable to the facilities where Product is  manufactured, tested, labeled, stored or otherwise handled and all Applicable Laws with respect to the manufacture of the  Product.\\n\\n18. Force Majeure   18.1 Obligation to Perform. Except for payment obligations which shall not be excused or affected by any Force Majeure, neither Party shall be entitled to terminate this Agreement or shall be liable to the other under this Agreement for loss or damages attributable to any Force  Majeure, provided the Party affected shall give prompt notice thereof to the other Party. Subject to Section 18.2, the Party giving such  notice shall be excused from such of its obligations hereunder for so long as it continues to be affected by Force Majeure.\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n   -60-\\n\\n18.2 Duration. If such Force Majeure continues unabated for a period of at least ninety (90) days, the Parties will meet to discuss in good faith  what actions to take or what modifications should be made to this Agreement as a consequence of such Force Majeure in order to alleviate  its consequences on the affected Party. If the affected Party is prevented by reason of any circumstances referred to in this Section of this  Agreement from performing any of its obligations hereunder for a continuous period of six (6) months the other Party may terminate this  Agreement.\\n\\n19. Notices   19.1 Form. Any notice or other document given under this Agreement shall be in writing in the English language and shall be given by hand or  sent by U.S. prepaid first class registered or certified mail, return receipt requested, recognized national overnight courier service, or by fax  transmission to the address of the receiving Party as set out in Section 19.3 below unless a different address or fax number has been  notified to the other in writing for this purpose.   19.2 Delivery. Each such notice or document shall:     (a) if sent by hand, be deemed to have been given when delivered at the relevant address;     (b) if sent by prepaid airmail, be deemed to have been given 7 days after posting; or\\n\\n  (c) if sent by fax transmission be deemed to have been given when transmitted provided that a confirmatory copy of such  facsimile transmission shall have been sent by hand, U.S. prepaid first class registered or certified mail, return receipt  requested, or recognized national overnight courier service within 24 hours of such transmission.\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n   -61-\\n\\n19.3 Notice of Parties. The address for services of notices and other documents on the Parties shall be:\\n\\nTo EKR   To PPI\\n\\nAddress:\\n\\n\\n\\n1545 Route 206 South  Third Floor  Bedminster, NJ 07921\\n\\nAddress:\\n\\n\\n\\n10450 Science Center  Drive, San Diego,  California 92121 USA\\n\\nFax:     Fax:   858 623 0376\\n\\nAttention:   Chairman & CEO   Attention:   President\\n\\nWith a copy to:   With a copy to:\\n\\nLowenstein Sandler  65 Livingston Avenue  Roseland, New Jersey 07068\\n\\nWilmer Cutler Pickering Hale & Dorr LLP  1117 S California Avenue  Palo Alto, CA 94304 USA\\n\\nFax:    973-597-6395   Fax:   650-858-6100  Attention:   Michael J. Lerner   Attention:   Joseph K. Wyatt\\n\\n20. Assignment and Change of Control   20.1 Assignment. Subject to Section 20.2, neither Party shall, nor shall it purport to, assign, license, transfer or change any of its rights or  obligations under this Agreement without the prior written consent of the other, such consent not to be unreasonably withheld  conditioned or delayed; provided, however, that except as provided in Section 20.4 either Party may assign its rights hereunder to an  Affiliate or to any successor by merger, consolidation, sale of stock or other equity interests or the sale of substantially all of the assets of  such Party without the consent of the other Party. For the avoidance of doubt, either Party may grant a security interest with respect to its  rights under this Agreement in connection with a secured financing or similar transaction.   20.2 Sub-Distribution. EKR may appoint sub-distributors under this Agreement provided that EKR:\\n\\n  (a) informs PPI of the identity of any Third Party sub-distributor (other than Affiliate companies) prior to the execution of any  sub-distribution agreement;\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n   -62-\\n\\n  (b) obtain a confidential nondisclosure agreement with the prospective Sub-Distributor in a form acceptable to PPI, which  acceptance shall not be unreasonably withheld or delayed and containing terms at least as stringent as those terms  included in Article 11 of this Agreement;\\n\\n  (c) deliver to the prospective Sub-Distributor a redacted copy of this Agreement (\"Redacted Agreement\") .  Any sub- distribution agreement shall provide that such agreement is subject and subordinate to the rights of PPI under this  Agreement; and\\n\\n  (d) provides PPI with a copy of written sub-distribution agreement as soon as reasonably practicable after the execution  thereof by EKR.   20.3 Responsibility of EKR. Notwithstanding any such sub-distribution agreement, EKR shall remain primarily liable to PPI for its obligations hereunder, and for any act or omission of any sub-distributor.   20.4 Change of Control. Should there be a Change of Control of either Party resulting in the control of such Party by a Third Party which  markets or sells a Competing Product in any part of the Territory, then the rights under this Agreement may not be assigned without the  express consent of the other Party which consent shall not be unreasonably withheld. \"Change of Control\" shall mean (a) the sale, lease,  exchange, license or disposition of all or substantially all of the Party\\'s assets in one transaction or series of related transactions or (b) a  merger or consolidation with an unaffiliated Third Party as a result of which the holders of the Party\\'s issued and outstanding voting  securities immediately before such transaction own or control less than a majority of the voting securities of the continuing or surviving  entity immediately after such transaction. The issuance by either Party of securities in connection with any financing transaction or\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n   -63-\\n\\n\\n\\npublic offering shall not be deemed a Change of Control under this Agreement. Notwithstanding the foregoing, for the purposes of Section  6.3(b)(iii): (i) references to a \"Party\" in the above definition of Change of Control shall be deemed to include PPI as well as any Affiliate of  PPI and (ii) a Change of Control shall also include (in addition to any of the transactions described above in the definition of Change of  Control), any sale of securities of PPI or its Affiliates directly by the holder (the \"Holder\") of such securities (other than to an Affiliate of  such Holder) in which such sale results in a transfer of more than 50% of the outstanding voting stock of PPI or its Affiliates.\\n\\n21. General Provisions   21.1 Relationship of the Parties. Nothing in this agreement is deemed to constitute a partnership, agency, employer-employee or joint venture relationship between the Parties. No Party shall incur any debts or make any commitments for the other, except to the extent, if at all,  specifically provided herein.   21.2 Dispute Resolution. If there is a disagreement between the PPI and EKR on the interpretation of this Agreement or any aspect of the performance by either Party of its obligations under this Agreement, the Parties shall resolve the dispute in accordance with the dispute  resolution procedure set out in Schedule VIII.   21.3 Cooperation. Each of the Parties shall do execute and perform and shall procure to be done executed and performed all such further acts  deeds documents and things as the other Party may reasonably require from time to time to give full effect to the terms of this Agreement.   21.4 Expenses. Each Party shall pay its own costs, charges and expenses incurred in connection with the negotiation, preparation and  completion of this agreement.   21.5 Entire Agreement. This Agreement (together with the Transition Services and Inventory Purchase Agreement and the Supply Agreement)  sets out the entire agreement and understanding between the Parties in respect of the subject matter hereof and thereof. This Agreement  supersedes the Original Agreement and any heads of agreement which shall cease to have any further force or effect. It is agreed that:\\n\\n  (a) no Party has entered into this Agreement in reliance upon any representation, warranty or undertaking of the other Party  which is not expressly set out in this Agreement;\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n   -64-\\n\\n  (b) no Party shall have any remedy in respect of misrepresentation or untrue statement made by the other Party or for any  breach of warranty which is not contained in this Agreement;     (c) this Section shall not exclude any liability for, or remedy in respect of, fraudulent misrepresentation.   21.6 Amendment. No amendment, change or modification of any of the terms, provisions or conditions of this Agreement shall be valid unless it  is in writing and signed by or on behalf of both Parties.   21.7 Waiver. Unless expressly agreed, no waiver of any term, provision or condition of this Agreement shall constitute a general waiver of any provisions of this Agreement, nor shall it affect any rights, obligations or liabilities under or pursuant to this Agreement which have  already accrued up to the date of variation, and the rights and obligations of the Parties under or pursuant to this Agreement shall remain in  full force and effect, except and only to the extent that they are so waived.   21.8 Unenforceability. If and to the extent that any provision of this Agreement is held to be illegal, void or unenforceable, such provision shall  be given no effect and shall be deemed not to be included in this Agreement but without invalidating any of the remaining provisions of  this Agreement.   21.9 Delay. No failure or delay by either Party in exercising any right or remedy provided by law under or pursuant to this Agreement shall  impair such right or remedy or operate or be construed as a waiver or variation of it or preclude its exercise at any subsequent time and no  single or partial exercise of any such right or remedy shall preclude any other or further exercise of it or the exercise of any other right or  remedy.\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n(signature page follows)      -65-\\n\\n21.10 Cumulative Rights. The rights and remedies of each of the Parties under or pursuant to this Agreement are cumulative, may be exercised as often as such Party considers appropriate and are in addition to its rights and remedies under general law.   21.11 Counterparts. This Agreement may be executed in any number of counterparts and by the Parties on separate counterparts, each of which  is an original but all of which together constitute one and the same instrument.   21.12 Reserved.   21.13 Governing Law. This Agreement and the relationship between the Parties shall be governed by, and interpreted in accordance with New  York law without regard to provisions related to conflicts of laws, and, except as provided in Section 21.2 above, the Parties agree to submit  any dispute to the exclusive jurisdiction of the federal and state courts sitting in New York.   21.14 Successors and Assigns. Subject to Section 20.1, this Agreement shall be binding upon and shall inure to the benefit of the Parties hereto  and their respective successors and assigns permitted under this Agreement.   21.15 Systems. Immediately upon the Effective Date, or as soon thereafter as practicable, the Parties shall implement a mutually acceptable operation plan to transfer the processing of chargebacks, federal releases, state releases and customer services from PPI to EKR.\\n\\n\\n\\n\\n\\nAS WITNESS the hands of the Parties or their duly authorized representatives effective as of the Effective Date.\\n\\n   -66-\\n\\nSIGNED for and by behalf of   )   By:  /s/ David Stack  PACIRA PHARMACEUTICALS, INC.         )         David Stack      Print Name\\n\\nSIGNED for and by behalf of   )   By:  /s/ Richard DeSimone  EKR THERAPEUTICS, INC.           Richard DeSimone, CFO      Print Name\\n\\n\\n\\n\\n\\nSCHEDULE I\\n\\nPATENTS\\n\\n   -67-\\n\\n[**] Attorneys\\'  Ref:   Country   Application  date   Application  no.   Patent/  Publication no.   Grant date   Expiry date   Status  [**]   [**]   [**]   [**]   [**]   [**]   [**]   [**]  [**]   [**]   [**]   [**]   [**]   [**]   [**]   [**]  [**]   [**]   [**]   [**]   [**]   [**]   [**]   [**]  [**]   [**]   [**]   [**]   [**]   [**]   [**]   [**]  [**]   [**]   [**]   [**]   [**]   [**]   [**]   [**]\\n\\n[**] Attorneys\\'  Ref:   Country   Application  date   Application  no.   Patent/  Publication no.   Grant date   Expiry date   Status  [**]   [**]   [**]   [**]   [**]   [**]   [**]   [**]  [**]   [**]   [**]   [**]   [**]   [**]   [**]   [**]  [**]   [**]   [**]   [**]   [**]   [**]   [**]   [**]  [**]   [**]   [**]   [**]   [**]   [**]   [**]   [**]\\n\\n[**]\\n\\nAttorneys\\'  Ref:   Country   Application  date   Application  no.\\n\\nPatent/  Publication  no.   Grant date   Expiry date   Status  [**]   [**]   [**]   [**]   [**]   [**]   [**]   [**]  [**]   [**]   [**]   [**]   [**]   [**]   [**]   [**]  [**]   [**]   [**]   [**]         [**]  [**]   [**]             [**]  [**]   [**]   [**]   [**]   [**]   [**]   [**]   [**]  [**]   [**]   [**]   [**]   [**]   [**]   [**]   [**]\\n\\n[**] Attorneys\\'  Ref:   Country   Application  date   Application  no.   Patent/  Publication no.   Grant date   Expiry date   Status  [**]   [**]   [**]   [**]   [**]   [**]   [**]   [**]  [**]   [**]   [**]   [**]   [**]   [**]   [**]   [**]  [**]   [**]   [**]   [**]   [**]   [**]   [**]   [**]  [**]   [**]   [**]   [**]         [**]\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n   -68-\\n\\n[**]\\n\\nAttorneys\\'  Ref:   Country   Application  date   Application  no.\\n\\nPatent/  Publication  no.   Grant date   Expiry date   Status  [**]   [**]   [**]   [**]   [**]     [**]   [**]  [**]   [**]   [**]   [**]   [**]   [**]   [**]   [**]  * Publication date of Application - 13 Apr 06.\\n\\n[**] Attorneys\\'  Ref:   Country   Application  date   Application  no.   Patent/  Publication no.   Grant date   Expiry date   Status  [**]   [**]   [**]   [**]   [**]   [**]   [**]   [**]  [**]   [**]   [**]   [**]   [**]   [**]   [**]   [**]  [**]   [**]   [**]   [**]   [**]   [**]   [**]   [**]  [**]   [**]   [**]   [**]   [**]   [**]   [**]   [**]  [**]   [**]   [**]   [**]   [**]   [**]   [**]   [**]\\n\\n\\n\\n\\n\\nSCHEDULE II   TRADEMARKS\\n\\n[**] - Owner of Record, United States Patent Trademark Office website. Record of Assignment from [**]. to [**] is in process.      -69-\\n\\nFile Date: Serial No.: International Class: First Use: First Use in Commerce: Registration Date: Registration No.: Mark:\\n\\n[**]\\n\\n\\n\\nFile Date: Serial No.: International Class: First Use: First Use in Commerce: Registration Date: Registration No.: Mark:\\n\\n[**]\\n\\n\\n\\nFile Date: Serial No.: International Class: First Use: First Use in Commerce: Registration Date: Registration No.: Mark:\\n\\n[**]\\n\\n\\n\\n*[**] Trademark Application\\n\\nFile Date: Serial No.: International Class: Mark:\\n\\n[**]\\n\\n\\n\\n\\n\\n\\n\\nSCHEDULE III\\n\\nCOPYRIGHTS\\n\\nThere are no recorded copyrights      -70-\\n\\n\\n\\n\\n\\nSCHEDULE IV\\n\\nDOMAIN NAMES\\n\\nDepoDur.com      -71-\\n\\n\\n\\n\\n\\nSCHEDULE V\\n\\nMARKETING AUTHORIZATIONS\\n\\nUnited States Food and Drug Administration New Drug Application: [**]      -72-\\n\\n\\n\\n\\n\\n\\n\\n\\n\\nNews Release\\n\\nEKR Therapeutics Achieves Key Growth Milestone with the   Acquisition of Rights to DepoDurยฎ, a Novel Extended-Release Opioid   Analgesic for Post Operative Pain\\n\\nCedar Knolls, N.J., August X, 2007 - EKR Therapeutics, Inc., a specialty pharmaceutical company focused on acquiring, developing, and  commercializing proprietary products to enhance patient quality-of-life in the acute care setting, today announced it has acquired exclusive  marketing and distribution rights to DepoDur  for the Americas from San Diego-based Pacira Pharmaceuticals who retains manufacturing rights to  the product.\\n\\nFormerly a business unit of SkyePharma, plc, Pacira Pharmaceuticals is an independent private company focused on developing and   manufacturing controlled-release injectable products based on their DepoFoamโข and Biosphereโข drug delivery platforms.\\n\\nDepoDur, which utilizes the DepoFoam technology, is a sterile injectable suspension of multivesicular liposomes formulated to provide extended  release of morphine sulfate. It is the only extended-release opioid that is approved by the Food and Drug Administration for epidural use. A single  injection of DepoDur into the lumbar epidural space may provide pain relief for up to 48 hours following major surgery without the restrictions and  potential complications associated with an indwelling epidural catheter.\\n\\n\"The product characteristics of DepoDur fit exceptionally well with EKR\\'s acquisition model,\" said Howard Weisman, EKR\\'s Chairman & CEO.  \"DepoDur is patent protected, addresses an important medical need in our market space, and has growth prospects that can be fully exploited through the application of EKR\\'s expertise and strengths in the acute care market.\"\\n\\nMr. Weisman further noted, \"EKR is commencing a number of pre-launch activities, including interacting with opinion leaders, and we expect to  fully deploy our sales force in support of DepoDur early next year.\" He concluded, \"We are very optimistic about EKR\\'s growth prospects in 2008  as we foresee a ramp up in sales for both DepoDur and Gelclairยฎ and anticipate favorable market synergies between these products.\" Gelclair,  which is marketed to acute care facilities and cancer centers, is indicated for the management of pain associated with oral lesions of various  etiologies, including chemotherapy and radiation induced oral mucositis/stomatitis.\\n\\nTong Zhang, Ph.D., Director of Business Development for EKR, added, \"Acquiring the rights to DepoDur exemplifies EKR\\'s strategy of focusing  on building a portfolio of premier products in the acute care space.\"  He further noted, \"Our strict acquisition criteria center on high-margin,  innovative products that offer value to healthcare providers and their patients, thus, representing excellent opportunities for EKR to realize strong  returns on investment.\"      -73-\\n\\n\\n\\n  SCHEDULE VI\\n\\n  PRESS RELEASE\\n\\nยฎ\\n\\n\\n\\n\\n\\n\"Pacira Pharmaceuticals is delighted to have EKR Therapeutics as our marketing and commercialization partner for DepoDur in the Americas,\"  commented Fred Middleton, Pacira\\'s Chairman of the Board. \"This product was clinically developed as a proprietary treatment by Pacira R&D and  it received FDA approval in 2004 for long-acting post surgical pain management, for which it is known to be effective.\"\\n\\nMr. Middleton further noted, \"EKR Therapeutics has demonstrated in the past that they possess the strengths to successfully bringing a focused  marketing and clinician targeting approach to DepoDur to help it reach its full commercial potential. We look forward to working with EKR, as our  partner on the expanded commercial marketing of DepoDur.\"\\n\\nDetailed terms of the transaction were not disclosed. However, EKR did note that in addition to royalty payments on net sales, it has agreed to an  upfront payment amounting to somewhat more than [**] times DepoDur\\'s 2006 U.S. sales. EKR has also agreed to certain milestone payments with the sum of upfront and milestone payments potentially worth up to $20 million.\\n\\nAbout EKR Therapeutics   EKR Therapeutics is a privately held specialty pharmaceutical company that has brought together a highly seasoned team of industry professionals The Company focuses on the acquisition, development and commercialization of proprietary products for the acute care segment of  the healthcare market, including oncology supportive care therapeutics. From its inception in late 2005, EKR has been organized to be a class  leader in commercializing products to address unmet and under-satisfied medical needs or to otherwise enhance the therapeutic value of acute-care  prescription products. EKR\\'s goal is to be the pre-eminent provider of acute-care specialty products, backed by a commitment to excellence in  customer service. For additional information about EKR visit the Company\\'s website at http://www.ekrtx.com.\\n\\nAbout Pacira Pharmaceuticals, Inc.   Pacira Pharmaceuticals, Inc. is a wholly owned subsidiary of Pacira Inc., a Delaware corporation, which is controlled and funded by a group of  financial investors including Sanderling Ventures, HBM Bioventures (Cayman) Ltd, OrbiMed Advisors, and MPM Capital. This business is based  in San Diego, CA, and focuses on formulating, developing and manufacturing controlled-release injectable products based on two proprietary  drug delivery platforms: DepoFoam  and Biosphere . Revenues are generated from two marketed products: DepoCyt  for lymphomatous  meningitis and DepoDur  for the treatment of post-surgical pain. For additional information about Pacira visit the Company\\'s website at  http://www.pacira.com\\n\\n####\\n\\nContact for EKR Therapeutics   Stuart Z. Levine, Ph.D.   Corporate Communications   877-435-2524   s.levine@ekrtx.com      -74-\\n\\nTM TM ยฎ\\n\\nยฎ\\n\\n\\n\\n\\n\\nSCHEDULE VII\\n\\nTHE TERRITORY\\n\\nall countries in North America including the United States, its territories as possessions including Puerto Rico, South America and Central America     -75-\\n\\n\\n\\n\\n\\nSCHEDULE VIII\\n\\nDISPUTE RESOLUTION\\n\\n\\n\\n\\n\\nAppointment of an Expert\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n   -76-\\n\\n1.1 Representatives of the Parties will, within 14 days of receipt of a written request from either Party to the other, convene a meeting of the Committee to discuss in good faith and try to resolve the disagreement without recourse to legal proceedings.   1.2 If resolution does not occur within 7 days after meeting, the matter shall be escalated for determination by the respective Chief Executive  Officer of the Parties who may resolve the matter themselves or jointly appoint a mediator or independent expert to do so.   1.3 Nothing in this Agreement restricts either Party\\'s freedom to seek urgent relief to preserve a legal right or remedy, or to protect a proprietary, trade secret or other right.\\n\\n1.4.1 In the event that the Chief Executive Officers are unable to resolve the dispute and the dispute has a monetary value of cost of [**] dollars ($[**]) or more, the dispute shall be submitted to the federal or state courts located in the State of California, which shall have exclusive  jurisdiction over such dispute.   1.4.2 In the event that the Chief Executive Officers are unable to resolve the dispute and the dispute has a monetary value of cost of less than  [**] dollars ($[**]), and the Parties do not agree on the appointment of an expert to resolve the dispute, or mediation has failed to resolve  the dispute, one Party shall serve on the other a written Referral Notice requesting that the matter be referred to an expert for resolution,  and the following procedure shall be followed.\\n\\n  1.4.1 The dispute shall be determined by a single independent impartial expert who shall be agreed between the Parties or, in the  absence of agreement between the Parties within 30 days of the service of a Referral Notice, be appointed by the American  Arbitration Association or any successor thereto, or such other competent body agreed by the Parties.\\n\\n  1.4.2 30 days after the appointment of the expert pursuant to paragraph 1.4.1 both Parties shall exchange simultaneously statements of  case in no more than 10,000 words, in total, and each side shall simultaneously send a copy of its statement of case to the expert.\\n\\n  1.4.3 Each Party may, within 30 days of the date of exchange of statement of case pursuant to paragraph 1.4.2, serve a reply to the  other side\\'s statement of case in no more than 10,000 words. A copy of any such reply shall be simultaneously sent to the expert.\\n\\n  1.4.4 Subject to paragraph 1.4.6, there shall be no oral hearing. The expert shall issue his decision in writing to both Parties within 30  days of the date of service of the last reply pursuant to paragraph 1.4.3 above or, in the absence of receipt of any replies, within  60 days of the date of exchange pursuant to paragraph 1.4.2.\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n   -77-\\n\\n  1.4.5 The seat of the dispute resolution shall be the normal place of residence of the expert.\\n\\n  1.4.6 The expert shall not have power to alter, amend or add to the provisions of this Agreement, except that the expert shall have the  power to decide all procedural matters relating to the dispute, and may call for a one day hearing if desirable and appropriate.\\n\\n  1.4.7 The expert shall have the power to request copies of any documents in the possession and/or control of the Parties which may  be relevant to the dispute. The Parties shall forthwith provide to the expert and the other Party copies of any documents so  requested by the expert.\\n\\n  1.4.8 The decision of the expert shall be final and binding upon both Parties except in the case of manifest error. The Parties hereby  exclude any rights of application or appeal to any court, to the extent that they may validly so agree, and in particular in  connection with any question of law arising in the course of the reference out of the award.\\n\\n  1.4.9 The expert shall determine the proportions in which the Parties shall pay the costs of the expert\\'s procedure. The expert shall  have the authority to order that all or a part of the legal or other costs of a Party shall be paid by the other Party.\\n\\n  1.4.10 All documents and information disclosed in the course of the expert proceedings and the decision and award of the expert shall  be kept strictly confidential by the recipient and shall not be used by the recipient for any purpose except for the purposes of the  proceedings and/or the enforcement of the expert\\'s decision and award.\\n\\n\\n\\n\\n\\nSCHEDULE IX\\n\\nSALES FORECAST\\n\\n\\n\\nWhile we continue to work on our marketing plan and forecast, based on the current run rate of approximately [**] to [**] units per month, you  can expect that our plan will call for the following forecast:\\n\\n   -78-\\n\\nDate: July 25, 2007   From: [**], EKR Therapeutics, Inc.   To: [**], Pacira   Re: DepoDur Unit Sales Forecast, as of July 25, 2007\\n\\nPeriod\\n\\nUnit  Sales  Forecast  August 1 - December 31, 2007     [**]  January 1 - December 31, 2008     [**]  January 1 - December 31, 2009     [**]\\n\\n\\n\\n\\n\\nSCHEDULE X\\n\\nPHASE IV STUDIES\\n\\nA DepoDur study in pediatric patients. Pacira has requested a waiver and is awaiting a response from the FDA      -79-\\n\\n\\n\\n\\n\\nSCHEDULE XI\\n\\nNDA TRANSFER LETTERS\\n\\nA. Transfer Letter to be Filed by PPI\\n\\n[PACIRA PHARMACEUTICALS, INC. LETTERHEAD]\\n\\n , 2009\\n\\nVIA OVERNIGHT MAIL\\n\\n[NAME AND ADDRESS OF APPROPRIATE FDA CONTACT TO BE PROVIDED]\\n\\nGeneral Correspondence: Transfer of NDA Ownership\\n\\nDear  :\\n\\nEffective  , 2009, pursuant to 21 CFR 314.72, DepoDur  NDA [**] is hereby transferred from Pacira Pharmaceuticals, Inc. to EKR Therapeutics, Inc.,  1545 Route 206 South, Third Floor, Bedminster, New Jersey 07921 (Regulatory Contact:  , telephone  ).\\n\\nAs a condition of this transfer of ownership, Pacira will provide to EKR Therapeutics all available information pertaining to the above-referenced  NDA to be kept under 21 CFR 314.70, including all previous correspondence to and from the Agency. A signed 356h form is attached\\n\\nIf you have any questions or require any additional information, please do not hesitate to contact me at  .\\n\\nSincerely,\\n\\nPACIRA PHARMACEUTICALS, INC.      -80-\\n\\nRe: DepoDurยฎ NDA [**]\\n\\nยฎ\\n\\n\\n\\n\\n\\nB. Transfer Letter to be Filed by EKR\\n\\n[EKR THERAPEUTICS, INC. LETTERHEAD]\\n\\n , 2009\\n\\nVIA OVERNIGHT MAIL\\n\\n[NAME AND ADDRESS OF APPROPRIATE FDA CONTACT TO BE PROVIDED]\\n\\nDepoDurยฎ   General Correspondence: Transfer of NDA Ownership\\n\\nDear  :\\n\\nPursuant to 21 CFR 314.72 the above-mentioned NDA has been transferred from Pacira Pharmaceuticals, Inc. to EKR Therapeutics, Inc.  effective  , 2009. EKR has received a complete copy of the approved application, including all supplements and records that are required to be kept  under 21 CFR 314.81. EKR agrees to abide by all agreements, promises and conditions made by the former owner, which are contained in the  application. EKR will advise the FDA about any changes in the conditions in the approved application as required by 21 CFR 314.70, or in the next  annual report, if appropriate. EKR will consider the date of transfer to be the new date for annual reporting purposes. A new signed 356h form is  attached.\\n\\nPlease contact me by phone at  , by email at   or by fax at  , if you have any questions or if you require additional information.\\n\\n   -81-\\n\\nRE: NDA No. [**]\\n\\nSincerely,\\n\\n[Name / Title]\\n\\n\\n\\n\\n\\nSCHEDULE XII\\n\\nTRANSFERRED EQUIPMENT\\n\\nDepoDur processing equipment:\\n\\n1. ST-01 ([**], [**] rated to [**], equipped with agitator used in preparation of [**] prior to [**])\\n\\n2. ST-02 ([**], [**] rated to [**], equipped with agitator used in preparation of [**] [**] prior to [**])\\n\\n3. ST-03 ([**], [**] rated to [**], equipped with agitator used in preparation of [**] prior to [**])\\n\\n4. ST-04 ([**], [**] rated to [**], equipped with agitator used in preparation of [**] [**] prior to [**])\\n\\n5. ST-22 ([**], [**] rated to [**], [**])\\n\\n6. EV-01 ([**], [**] rated to [**], equipped with [**] used to produce [**] [**])\\n\\n7. EV-02 ([**], [**] rated to [**], equipped with [**] and [**] [**] used to produce [**])\\n\\n8. FV-01 ([**], [**] rated to [**], used [**] during [**])\\n\\n9. [**] skid, including [**] lobe pumps, [**] manifold system, and [**] flometers\\n\\n10. Interconnective valves and piping between vessels\\n\\n11. Pressure gauges, temperature probes, other small instrumentation for in-process measurements.\\n\\n12. HMI / PLC / automation      -82-\\n\\n\\n\\n\\n\\nExhibit 3.20(a)   Form of Bill of Sale\\n\\nBILL OF SALE\\n\\nTHIS BILL OF SALE, dated October  , 2009 (this \"Bill of Sale\"), is made by Pacira Pharmaceuticals, Inc. (\"Seller\"), in favor of EKR  Therapeutics, Inc. (\"Purchaser\").\\n\\nWHEREAS, Purchaser and Seller have entered into that certain Amended and Restated Strategic Licensing, Distribution and Marketing  Agreement, dated as of the date hereof (the \"Agreement\"), providing, among other things, for the sale of the Transferred Equipment (as defined  therein) by Seller to Purchaser.\\n\\nNOW, THEREFORE, for good and valuable consideration, the receipt of which is hereby acknowledged, Seller and Purchaser agree as  follows:\\n\\n1. Definitions. Capitalized terms used in this Bill of Sale and not otherwise defined in this Bill of Sale shall have the respective meanings assigned  to them in the Agreement.\\n\\n2. Conveyance. In accordance with the terms of the Agreement, Seller hereby sells, transfers, conveys and assigns to Purchaser all right, title and  interest in and to the Transferred Equipment. A list of the Transferred Equipment is set forth on Schedule A to this Bill of Sale.\\n\\n3. Further Assurances. At any time and from time to time after the date of this Bill of Sale, Seller, at the Purchaser\\'s request and subject to  reimbursement by Purchaser of any out-of-pocket expenses, will do, execute, acknowledge and deliver, or will cause to be done, executed,  acknowledged and delivered, any and all further acts, conveyances, transfers, assignments and assurances as may be reasonably required by  Purchaser to further evidence and effectuate the sale, transfer, conveyance and assignment to the Purchaser of the Transferred Equipment.\\n\\n4. Relationship With Agreement. The provisions of this Bill of Sale are subject, in all respects, to the terms and conditions of the Agreement and  all of the representations, warranties, covenants and agreements contained in the Agreement. Nothing contained in this Bill of Sale shall be  deemed to modify, limit or amend any such rights and obligations of the parties hereto under the Agreement. In the event of any conflict or  inconsistency between this Bill of Sale and the Agreement, the Agreement shall govern.\\n\\n5. Successors and Assigns. This Bill of Sale shall be binding upon and inure to the benefit of and be enforceable by Seller and Purchaser and their  respective successors and assigns.\\n\\n6. Governing Law. This Bill of Sale shall be governed by, and construed in accordance with, the laws of the State of New York, without regard to  the conflicts of law principles thereof.\\n\\n7. Counterparts; Facsimile Signature Pages. This Bill of Sale may be executed by each of Seller and Purchaser in separate counterparts, each of  which when so executed and delivered shall be deemed to be an original and which together shall constitute one and the same instrument. Any  signed counterpart of this Bill of Sale which is delivered by facsimile or other printable electronic transmission shall be deemed to be executed and  delivered for all purposes.\\n\\n[Signature Page Follows]      -83-\\n\\n\\n\\n\\n\\nIN WITNESS WHEREOF, Seller has executed and delivered this Bill of Sale on the date first above written.\\n\\nAcknowledged and Agreed to as   of the date first above written.\\n\\n   -84-\\n\\nPacira Pharmaceuticals, Inc.\\n\\nBy:     Print Name:     Title:\\n\\nEKR Therapeutics, Inc.\\n\\nBy:     Print Name:     Title:\\n\\n\\n\\n\\n\\nSchedule A to Bill of Sale   Transferred Equipment\\n\\nDepoDur processing equipment:\\n\\n1. ST-01 ([**], [**] rated to [**], equipped with agitator used in preparation of [**] prior to [**])\\n\\n2. ST-02 ([**], [**] rated to [**], equipped with agitator used in preparation of [**] [**] prior to [**])\\n\\n3. ST-03 ([**], [**] rated to [**], equipped with agitator used in preparation of [**] prior to [**])\\n\\n4. ST-04 ([**], [**] rated to [**], equipped with agitator used in preparation of [**] [**] prior to [**])\\n\\n5. ST-22 ([**] [**], [**] rated to [**], [**] [**])\\n\\n6. EV-01 ([**], [**] rated to [**], equipped with [**] used to produce [**] [**])\\n\\n7. EV-02 ([**], [**] rated to [**], equipped with [**] and [**] [**] used to produce [**])\\n\\n8. FV-01 ([**], [**] rated to [**], used [**] during [**])\\n\\n9. [**] skid, including [**] lobe pumps, [**] manifold system, and [**] flometers\\n\\n10. Interconnective valves and piping between vessels\\n\\n11. Pressure gauges, temperature probes, other small instrumentation for in-process measurements.\\n\\n12. HMI / PLC / automation      -85-\\n\\n\\n\\n\\n\\nExhibit 3.20(b)   Form of Promissory Note\\n\\nPROMISSORY NOTE\\n\\nFOR VALUE RECEIVED, EKR Therapeutics, Inc. (\"Maker\"), having an address at 1545 Route 206 South, Third Floor, Bedminster,  New Jersey 07921, hereby promises to pay to Pacira Pharmaceuticals, Inc. (\"Payee\"), having an address at 10450 Sciences Center Drive, San Diego,  California 92121, the principal sum of NINE HUNDRED THOUSAND DOLLARS ($900,000.00), plus interest computed at the rate of FIVE PERCENT (5%) per annum, in accordance with the terms and conditions set forth in this Promissory Note (this \"Note\").\\n\\n1. Payments. On the fifth anniversary of the date of this Note, all principal and interest (calculated according to Paragraph 3 below)  accrued on this Note and not sooner paid in accordance with the terms hereof shall be payable in full (the \"Payment\").\\n\\n2. Place of Payment. The entire amount due hereunder shall be payable to Payee at the address set forth above, or at such other place  as Payee may designate in writing to Maker at the address set forth above.\\n\\n3. Interest Calculation: Interest shall be calculated on the basis of a 360 day year based on the number of days elapsed.\\n\\n4. Optional Prepayment. Maker may, at its option, prepay the entire amount due hereunder in whole at any time or in part from time to  time without penalty or premium. At the option of Maker, prepayments pursuant to this Paragraph 4 shall (a) be applied to the outstanding  principal balance in reverse order of maturity or (b) reduce the Payment installments set forth above for the balance of the term of this Note. In the  event that Maker elects to reduce the Payment installments, Maker agrees to provide to Payee written notice of its election to do so at least thirty  (30) days prior to making any prepayment and to execute and deliver to Payee an amendment to this Note setting forth a revised payment  schedule.\\n\\n5. Defaults. At the option of Payee, the entire amount due hereunder shall immediately become due and payable on any of the  following events of default:   (a) Maker fails to make Payment as provided for in this Note and such failure to make Payment continues for thirty (30) days after  Maker\\'s receipt of written notice from Payee that such Payment is due;   (b) Maker makes a general assignment for the benefit of creditors;      -86-\\n\\n$900,000   October  , 2009\\n\\n\\n\\n\\n\\n(c) A receiver is appointed for the assets of Maker upon request by any Person(s) other than Maker, or Maker makes a formal  request for appointment of a receiver; or   (d) Any proceeding is brought by Maker in any court or under supervision of any court-appointed officer under any federal or  state bankruptcy, reorganization, rearrangement, insolvency or debt readjustment law, or if any such proceedings are instituted against  Maker and Maker fails to obtain dismissal of such proceeding within ninety (90) days after the same has been instituted.\\n\\n6. Agreement. This Note is made pursuant to that certain Amended and Restated Strategic Licensing, Distribution and Marketing  Agreement dated as of October  , 2009 by and between Maker and Payee (the \"Agreement\")  and is subject to the terms thereof. This Note is  subject to offset as expressly provided for in the Agreement.\\n\\n7. Nonnegotiability, Nontransferability. This Note shall be nonnegotiable. Further, this Note may not be transferred by either party  except to a permitted transferee under the Agreement.\\n\\n8. Governing Law. This Note shall be governed by and construed in accordance with the laws of the State of New York, excluding any  conflict-of-laws rule or principle that may refer the governance, construction or interpretation of this Note to the laws of another State.\\n\\nIN WITNESS WHEREOF, the Maker has executed this promissory note as of  .\\n\\n   -87-\\n\\n    , Maker', question='Highlight the parts (if any) of this contract related to \"Anti-Assignment\" that should be reviewed by a lawyer. Details: Is consent or notice required of a party if the contract is assigned to a third party?', answer_start=112442, text='Should there be a Change of Control of either Party resulting in the control of such Party by a Third Party which  markets or sells a Competing Product in any part of the Territory, then the rights under this Agreement may not be assigned without the  express consent of the other Party which consent shall not be unreasonably withheld.', is_impossible=False)"
            ]
          },
          "metadata": {},
          "execution_count": 109
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "exploded_df.show()"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "J9O4vcPKWFrf",
        "outputId": "f09be10f-ef11-4605-fee6-ef604fc1ceec"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "+--------------------+--------------------+--------------------+------------+--------------------+-------------+\n",
            "|                  id|             context|            question|answer_start|                text|is_impossible|\n",
            "+--------------------+--------------------+--------------------+------------+--------------------+-------------+\n",
            "|LohaCompanyltd_20...|Exhibit 10.16 SUP...|Highlight the par...|          14|     SUPPLY CONTRACT|        false|\n",
            "|LohaCompanyltd_20...|Exhibit 10.16 SUP...|Highlight the par...|         143|         The seller:|        false|\n",
            "|LohaCompanyltd_20...|Exhibit 10.16 SUP...|Highlight the par...|          49|The buyer/End-Use...|        false|\n",
            "|LohaCompanyltd_20...|Exhibit 10.16 SUP...|Highlight the par...|       10985|The Contract is v...|        false|\n",
            "|LohaCompanyltd_20...|Exhibit 10.16 SUP...|Highlight the par...|       10691|It will be govern...|        false|\n",
            "|LohaCompanyltd_20...|Exhibit 10.16 SUP...|Highlight the par...|        6665|Within 7 days aft...|        false|\n",
            "|LohaCompanyltd_20...|Exhibit 10.16 SUP...|Highlight the par...|        3659|To be covered by ...|        false|\n",
            "|CENTRACKINTERNATI...|1                ...|Highlight the par...|         225|WEB SITE HOSTING ...|        false|\n",
            "|CENTRACKINTERNATI...|1                ...|Highlight the par...|         330|Centrack Internat...|        false|\n",
            "|CENTRACKINTERNATI...|1                ...|Highlight the par...|       14893|I-ON INTERACTIVE,...|        false|\n",
            "|CENTRACKINTERNATI...|1                ...|Highlight the par...|         398|    i-on interactive|        false|\n",
            "|CENTRACKINTERNATI...|1                ...|Highlight the par...|       14853|CENTRACK INTERNAT...|        false|\n",
            "|CENTRACKINTERNATI...|1                ...|Highlight the par...|         378|        the Customer|        false|\n",
            "|CENTRACKINTERNATI...|1                ...|Highlight the par...|         101|                i-on|        false|\n",
            "|CENTRACKINTERNATI...|1                ...|Highlight the par...|         292|6th day of April,...|        false|\n",
            "|CENTRACKINTERNATI...|1                ...|Highlight the par...|       10363|The term of this ...|        false|\n",
            "|CENTRACKINTERNATI...|1                ...|Highlight the par...|       10363|The term of this ...|        false|\n",
            "|CENTRACKINTERNATI...|1                ...|Highlight the par...|       10751|Agreement, which ...|        false|\n",
            "|CENTRACKINTERNATI...|1                ...|Highlight the par...|       10559|This Agreement sh...|        false|\n",
            "|CENTRACKINTERNATI...|1                ...|Highlight the par...|       10751|Agreement, which ...|        false|\n",
            "+--------------------+--------------------+--------------------+------------+--------------------+-------------+\n",
            "only showing top 20 rows\n",
            "\n"
          ]
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "def extraction(row):\n",
        "  #Get the category name from the id, last element split by '_'\n",
        "  category = row[0].split('_')[-1]\n",
        "\n",
        "  context  = row[1]\n",
        "\n",
        "  question  = row[2]\n",
        "\n",
        "  answer_start = row[3]\n",
        "  answer = row[4]\n",
        "  if answer == None:\n",
        "    answer_start = 0\n",
        "    answer_end = 0\n",
        "  else:\n",
        "    answer_end = answer_start + len(answer)\n",
        "  #contract segment\n",
        "  slide = 4096\n",
        "  stride = 2048\n",
        "  context_len = len(context)\n",
        "  if context_len%stride==0:\n",
        "    seq_len = context_len/stride\n",
        "  else:\n",
        "    seq_len = context_len//stride + 1\n",
        "  seq = []\n",
        "  for i in range(seq_len):\n",
        "    #(context[0:4096],0)(context[2048:6144],2048)..\n",
        "    seq.append([context[i*stride:i*stride+slide],i*stride])\n",
        "\n",
        "  \n",
        "\n",
        "\n",
        "  is_impossible = row[5]\n",
        "\n",
        "  return(category, question, answer, answer_start, answer_end, is_impossible,seq)\n",
        "\n",
        "extracted_df = exploded_df.rdd.map(extraction)"
      ],
      "metadata": {
        "id": "L6qozep87bTH"
      },
      "execution_count": null,
      "outputs": []
    },
    {
      "cell_type": "code",
      "source": [
        "extracted_df.take(5)"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "6FU3bChW7dZs",
        "outputId": "78436c65-d9c4-4035-9010-c840ebb17cbe"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "[('Document Name',\n",
              "  'Highlight the parts (if any) of this contract related to \"Document Name\" that should be reviewed by a lawyer. Details: The name of the contract',\n",
              "  'SUPPLY CONTRACT',\n",
              "  14,\n",
              "  29,\n",
              "  False,\n",
              "  [['Exhibit 10.16 SUPPLY CONTRACT Contract No: Date: The buyer/End-User: Shenzhen LOHAS Supply Chain Management Co., Ltd. ADD: Tel No. : Fax No. : The seller: ADD: The Contract is concluded and signed by the Buyer and Seller on , in Hong Kong. 1. General provisions 1.1 This is a framework agreement, the terms and conditions are applied to all purchase orders which signed by this agreement (hereinafter referred to as the \"order\"). 1.2 If the provisions of the agreement are inconsistent with the order, the order shall prevail. Not stated in order content will be subject to the provisions of agreement. Any modification, supplementary, give up should been written records, only to be valid by buyers and sellers authorized representative signature and confirmation, otherwise will be deemed invalid. 2. The agreement and order 2.1 During the validity term of this agreement, The buyer entrust SHENZHEN YICHANGTAI IMPORT AND EXPORT TRADE CO., LTD or SHENZHEN LEHEYUAN TRADING CO, LTD (hereinafter referred to as the \"entrusted party\" or \"YICHANGTAI\" or \"LEHEYUAN\"), to purchase the products specified in this agreement from the seller in the form of orders. 2.2 The seller shall be confirmed within three working days after receipt of order. If the seller finds order is not acceptable or need to modify, should note entrusted party in two working days after receipt of the order, If the seller did not confirm orders in time or notice not accept orders or modifications, the seller is deemed to have been accepted the order. The orders become effective once the seller accepts, any party shall not unilaterally cancel the order before the two sides agreed . 2.3 If the seller puts forward amendments or not accept orders, the seller shall be in the form of a written notice to entrusted party, entrusted party accept the modified by written consent, the modified orders to be taken effect. 2.4 Seller\\'s note, only the buyer entrust the entrusted party issued orders, the product delivery and payment has the force of law.\\n\\n1\\n\\nSource: LOHA CO. LTD., F-1, 12/9/2019\\n\\n\\n\\n\\n\\n3. GOODS AND COUNTRY OF ORIGIN: 4. Specific order: The products quantity, unit price, specifications, delivery time and transportation, specific content shall be subject to the purchase order issued by entrusted party which is commissioned the buyer. 5. PACKING: To be packed in new strong wooden case(s) /carton(s), suitable for long distance transportation and for the change of climate, well protected against rough handling, moisture, rain, corrosion, shocks, rust, and freezing. The seller shall be liable for any damage and loss of the commodity, expenses incurred on account of improper packing, and any damage attributable to inadequate or improper protective measures taken by the seller in regard to the packing. One full set of technical All wooden material of shipping package must be treated as the requirements of Entry-Exit Inspection and Quarantine Bureau of China, by the agent whom is certified by the government where the goods is exported. And the goods must be marked with the IPPC stamps, which are certified by the government agent of Botanical-Inspection and Quarantine Bureau. 6. SHIPPING MARK: The Sellers shall mark on each package with fadeless paint the package number, gross weight, net weight, measurements and the wordings: \"KEEP AWAY FROM MOISTURE\",\"HANDLE WITH CARE\" \"THIS SIDE UP\" etc. and the shipping mark on each package with fadeless paint. 7. DATE OF SHIPMENT: According to specific order by YICHANGTAI or LEHEYUAN. 8. PORT OF SHIPMENT:\\n\\n2\\n\\nSource: LOHA CO. LTD., F-1, 12/9/2019\\n\\n\\n\\n\\n\\n9. PORT OF DESTINATION: SHENZHEN, GUANGDONG, CHINA 10. INSURANCE: To be covered by the Seller for 110% invoice value against All Risks and War Risk. 11. PAYMENT: Under Letter of Credit or T/T: Under the Letter of Credit: The Buyer shall open an irrevocable letter of credit with the bank within 30 days after signing the contract, in favor of the Seller, for 100% value of the total contract value. The letter of credit should state that partial shipments are allowed. The Buyer\\'s agent agrees to pay fo',\n",
              "    0],\n",
              "   [' F-1, 12/9/2019\\n\\n\\n\\n\\n\\n3. GOODS AND COUNTRY OF ORIGIN: 4. Specific order: The products quantity, unit price, specifications, delivery time and transportation, specific content shall be subject to the purchase order issued by entrusted party which is commissioned the buyer. 5. PACKING: To be packed in new strong wooden case(s) /carton(s), suitable for long distance transportation and for the change of climate, well protected against rough handling, moisture, rain, corrosion, shocks, rust, and freezing. The seller shall be liable for any damage and loss of the commodity, expenses incurred on account of improper packing, and any damage attributable to inadequate or improper protective measures taken by the seller in regard to the packing. One full set of technical All wooden material of shipping package must be treated as the requirements of Entry-Exit Inspection and Quarantine Bureau of China, by the agent whom is certified by the government where the goods is exported. And the goods must be marked with the IPPC stamps, which are certified by the government agent of Botanical-Inspection and Quarantine Bureau. 6. SHIPPING MARK: The Sellers shall mark on each package with fadeless paint the package number, gross weight, net weight, measurements and the wordings: \"KEEP AWAY FROM MOISTURE\",\"HANDLE WITH CARE\" \"THIS SIDE UP\" etc. and the shipping mark on each package with fadeless paint. 7. DATE OF SHIPMENT: According to specific order by YICHANGTAI or LEHEYUAN. 8. PORT OF SHIPMENT:\\n\\n2\\n\\nSource: LOHA CO. LTD., F-1, 12/9/2019\\n\\n\\n\\n\\n\\n9. PORT OF DESTINATION: SHENZHEN, GUANGDONG, CHINA 10. INSURANCE: To be covered by the Seller for 110% invoice value against All Risks and War Risk. 11. PAYMENT: Under Letter of Credit or T/T: Under the Letter of Credit: The Buyer shall open an irrevocable letter of credit with the bank within 30 days after signing the contract, in favor of the Seller, for 100% value of the total contract value. The letter of credit should state that partial shipments are allowed. The Buyer\\'s agent agrees to pay for the goods in accordance with the actual amount of the goods shipped. 80% of the system value being shipped will be paid against the documents stipulated in Clause 12.1. The remaining 20% of the system value being shipped will be paid against the documents stipulated in Clause 12.2. The Letter of Credit shall be valid until 90 days after the latest shipment is effected. Under the T/T The trustee of the buyer remitted the goods to the seller by telegraphic transfer in batches as agreed upon after signing each order. 12. DOCUMENTS: 12.1 (1) Invoice in 5 originals indicating contract number and Shipping Mark (in case of more than one shipping mark, the invoice shall be issued separately). (2) One certificate of origin of the goods. (3) Four original copies of the packing list. (4) Certificate of Quality and Quantity in 1 original issued by the agriculture products base. (5) One copy of insurance coverage (6) Copy of cable/letter to the transportation department of Buyer advising of particulars as to shipment immediately after shipment is made.\\n\\n3\\n\\nSource: LOHA CO. LTD., F-1, 12/9/2019\\n\\n\\n\\n\\n\\n12.2 (1) Invoice in 3 originals indicating contract number and L/C number. (2) Final acceptance certificate signed by the Buyer and the Seller. 13. SHIPMENT: CIP The seller shall contract on usual terms at his own expenses for the carriage of the goods to the agreed point at the named place of destination and bear all risks and expenses until the goods have been delivered to the port of destination. The Sellers shall ship the goods within the shipment time from the port of shipment to the port of destination. Transshipment is allowed. Partial Shipment is allowed. In case the goods are to be dispatched by parcel post/sea-freight, the Sellers shall, 3 days before the time of delivery, inform the Buyers by cable/letter of the estimated date of delivery, Contract No., commodity, invoiced value, etc. The sellers shall, immediately after dispatch of the goods, advise the Buyers by cable/letter of the Contract No., commodity, invoiced v',\n",
              "    2048],\n",
              "   [\"r the goods in accordance with the actual amount of the goods shipped. 80% of the system value being shipped will be paid against the documents stipulated in Clause 12.1. The remaining 20% of the system value being shipped will be paid against the documents stipulated in Clause 12.2. The Letter of Credit shall be valid until 90 days after the latest shipment is effected. Under the T/T The trustee of the buyer remitted the goods to the seller by telegraphic transfer in batches as agreed upon after signing each order. 12. DOCUMENTS: 12.1 (1) Invoice in 5 originals indicating contract number and Shipping Mark (in case of more than one shipping mark, the invoice shall be issued separately). (2) One certificate of origin of the goods. (3) Four original copies of the packing list. (4) Certificate of Quality and Quantity in 1 original issued by the agriculture products base. (5) One copy of insurance coverage (6) Copy of cable/letter to the transportation department of Buyer advising of particulars as to shipment immediately after shipment is made.\\n\\n3\\n\\nSource: LOHA CO. LTD., F-1, 12/9/2019\\n\\n\\n\\n\\n\\n12.2 (1) Invoice in 3 originals indicating contract number and L/C number. (2) Final acceptance certificate signed by the Buyer and the Seller. 13. SHIPMENT: CIP The seller shall contract on usual terms at his own expenses for the carriage of the goods to the agreed point at the named place of destination and bear all risks and expenses until the goods have been delivered to the port of destination. The Sellers shall ship the goods within the shipment time from the port of shipment to the port of destination. Transshipment is allowed. Partial Shipment is allowed. In case the goods are to be dispatched by parcel post/sea-freight, the Sellers shall, 3 days before the time of delivery, inform the Buyers by cable/letter of the estimated date of delivery, Contract No., commodity, invoiced value, etc. The sellers shall, immediately after dispatch of the goods, advise the Buyers by cable/letter of the Contract No., commodity, invoiced value and date of dispatch for the Buyers. 14. SHIPPING ADVICE: The seller shall within 72 hours after the shipment of the goods, advise the shipping department of buyer by fax or E-mail of Contract No., goods name, quantity, value, number of packages, gross weight, measurements and the estimated arrival time of the goods at the destination. 15. GUARANTEE OF QUALITY: The Sellers guarantee that the commodity hereof is complies in all respects with the quality and specification stipulated in this Contract. 16. CLAIMS: Within 7 days after the arrival of the goods at destination, should the quality, specification, or quantity be found not in conformity with the stipulations of the Contract except those claims for which the insurance company or the owners of the vessel are liable, the Buyers, on the strength of the Inspection Certificate issued by the China Commodity Inspection Bureau, have the right to claim for replacement with new goods, or for compensation, and all the expenses (such as inspection charges, freight for returning the goods and for sending the replacement, insurance premium, storage and loading and unloading charges etc.) shall be borne by the Sellers. The Certificate so issued shall be accepted as the base of a claim. The Sellers, in accordance with the Buyers' claim, shall be responsible for the immediate elimination of the defect(s), complete or partial replacement of the commodity or shall devaluate the commodity according to the state of defect(s). Where necessary, the Buyers shall be at liberty to eliminate the defect(s) themselves at the Sellers' expenses. If the Sellers fail to answer the Buyers within one weeks after receipt of the aforesaid claim, the claim shall be reckoned as having been accepted by the Sellers.\\n\\n4\\n\\nSource: LOHA CO. LTD., F-1, 12/9/2019\\n\\n\\n\\n\\n\\n17. FORCE MAJEURE: The Sellers shall not be held responsible for the delay in shipment or non-delivery, of the goods due to Force Majeure, which might occur during the process of manufacturing or in the course of loading or transit. Th\",\n",
              "    4096],\n",
              "   [\"alue and date of dispatch for the Buyers. 14. SHIPPING ADVICE: The seller shall within 72 hours after the shipment of the goods, advise the shipping department of buyer by fax or E-mail of Contract No., goods name, quantity, value, number of packages, gross weight, measurements and the estimated arrival time of the goods at the destination. 15. GUARANTEE OF QUALITY: The Sellers guarantee that the commodity hereof is complies in all respects with the quality and specification stipulated in this Contract. 16. CLAIMS: Within 7 days after the arrival of the goods at destination, should the quality, specification, or quantity be found not in conformity with the stipulations of the Contract except those claims for which the insurance company or the owners of the vessel are liable, the Buyers, on the strength of the Inspection Certificate issued by the China Commodity Inspection Bureau, have the right to claim for replacement with new goods, or for compensation, and all the expenses (such as inspection charges, freight for returning the goods and for sending the replacement, insurance premium, storage and loading and unloading charges etc.) shall be borne by the Sellers. The Certificate so issued shall be accepted as the base of a claim. The Sellers, in accordance with the Buyers' claim, shall be responsible for the immediate elimination of the defect(s), complete or partial replacement of the commodity or shall devaluate the commodity according to the state of defect(s). Where necessary, the Buyers shall be at liberty to eliminate the defect(s) themselves at the Sellers' expenses. If the Sellers fail to answer the Buyers within one weeks after receipt of the aforesaid claim, the claim shall be reckoned as having been accepted by the Sellers.\\n\\n4\\n\\nSource: LOHA CO. LTD., F-1, 12/9/2019\\n\\n\\n\\n\\n\\n17. FORCE MAJEURE: The Sellers shall not be held responsible for the delay in shipment or non-delivery, of the goods due to Force Majeure, which might occur during the process of manufacturing or in the course of loading or transit. The Sellers shall advise the Buyers immediately of the occurrence mentioned above and within fourteen days thereafter, the Sellers shall send by airmail to the Buyers a certificate of the accident issued by the competent government authorities, Chamber of Commerce or registered notary public of the place where the accident occurs as evidence thereof. Under such circumstances the Sellers, however, are still under the obligation to take all necessary measures to hasten the delivery of the goods. In case the accident lasts for more than 10 weeks, the Buyers shall have the right to cancel the Contract. 18. LATE DELIVERY AND PENALTY: Should the Sellers fail to make delivery on time as stipulated in the Contract, with exception of Force Majeure causes specified in Clause 17 of this Contract, the Buyers shall agree to postpone the delivery on condition that the Sellers agree to pay a penalty which shall be deducted by the paying bank from the payment. The penalty, however, shall not exceed 5% of the total value of the goods involved in the late delivery. The rate of penalty is charged at 0.5% for every seven days, odd days less than seven days should be counted as seven days. In case the Sellers fail to make delivery ten weeks later than the time of shipment stipulated in the Contract, the Buyers have the right to cancel the contract and the Sellers, in spite of the cancellation, shall still pay the aforesaid penalty to the Buyers without delay, the seller should refund the money received and pay the 30% of the total goods price of the penalty 19. ARBITRATION: All disputes in connection with this Contract or the execution thereof shall be settled friendly through negotiations. In case no settlement can be reached, the case may then be submitted for arbitration to the Foreign Economic and Trade Arbitration Committee of the China Beijing Council for the Promotion of International Trade in accordance with its Provisional Rules of Procedures by the said Arbitration Committee. The Arbitration shall take place in Beijing and th\",\n",
              "    6144],\n",
              "   [\"e Sellers shall advise the Buyers immediately of the occurrence mentioned above and within fourteen days thereafter, the Sellers shall send by airmail to the Buyers a certificate of the accident issued by the competent government authorities, Chamber of Commerce or registered notary public of the place where the accident occurs as evidence thereof. Under such circumstances the Sellers, however, are still under the obligation to take all necessary measures to hasten the delivery of the goods. In case the accident lasts for more than 10 weeks, the Buyers shall have the right to cancel the Contract. 18. LATE DELIVERY AND PENALTY: Should the Sellers fail to make delivery on time as stipulated in the Contract, with exception of Force Majeure causes specified in Clause 17 of this Contract, the Buyers shall agree to postpone the delivery on condition that the Sellers agree to pay a penalty which shall be deducted by the paying bank from the payment. The penalty, however, shall not exceed 5% of the total value of the goods involved in the late delivery. The rate of penalty is charged at 0.5% for every seven days, odd days less than seven days should be counted as seven days. In case the Sellers fail to make delivery ten weeks later than the time of shipment stipulated in the Contract, the Buyers have the right to cancel the contract and the Sellers, in spite of the cancellation, shall still pay the aforesaid penalty to the Buyers without delay, the seller should refund the money received and pay the 30% of the total goods price of the penalty 19. ARBITRATION: All disputes in connection with this Contract or the execution thereof shall be settled friendly through negotiations. In case no settlement can be reached, the case may then be submitted for arbitration to the Foreign Economic and Trade Arbitration Committee of the China Beijing Council for the Promotion of International Trade in accordance with its Provisional Rules of Procedures by the said Arbitration Committee. The Arbitration shall take place in Beijing and the decision of the Arbitration Committee shall be final and binding upon both parties; neither party shall seek recourse to a law court nor other authorities to appeal for revision of the decision. Arbitration fee shall be borne by the losing party. 20. This final price is the confidential information. Dissemination, distribution or duplication of this price is strictly prohibited.\\n\\n5\\n\\nSource: LOHA CO. LTD., F-1, 12/9/2019\\n\\n\\n\\n\\n\\n21. Law application It will be governed by the law of the People's Republic of China ,otherwise it is governed by United Nations Convention on Contract for the International Sale of Goods. 22. <<Incoterms 2000>> The terms in the contract are based on (INCOTERMS 2000) of the International Chamber of Commerce. 23. The Contract is valid for 5 years, beginning from and ended on . This Contract is made out in three originals in both Chinese and English, each language being legally of the equal effect. Conflicts between these two languages arising there from, if any, shall be subject to Chinese version. One copy for the Sellers, two copies for the Buyers. The Contract becomes effective after signed by both parties. THE BUYER: THE SELLER: SIGNATURE: SIGNATURE: 6\\n\\nSource: LOHA CO. LTD., F-1, 12/9/2019\",\n",
              "    8192],\n",
              "   [\"e decision of the Arbitration Committee shall be final and binding upon both parties; neither party shall seek recourse to a law court nor other authorities to appeal for revision of the decision. Arbitration fee shall be borne by the losing party. 20. This final price is the confidential information. Dissemination, distribution or duplication of this price is strictly prohibited.\\n\\n5\\n\\nSource: LOHA CO. LTD., F-1, 12/9/2019\\n\\n\\n\\n\\n\\n21. Law application It will be governed by the law of the People's Republic of China ,otherwise it is governed by United Nations Convention on Contract for the International Sale of Goods. 22. <<Incoterms 2000>> The terms in the contract are based on (INCOTERMS 2000) of the International Chamber of Commerce. 23. The Contract is valid for 5 years, beginning from and ended on . This Contract is made out in three originals in both Chinese and English, each language being legally of the equal effect. Conflicts between these two languages arising there from, if any, shall be subject to Chinese version. One copy for the Sellers, two copies for the Buyers. The Contract becomes effective after signed by both parties. THE BUYER: THE SELLER: SIGNATURE: SIGNATURE: 6\\n\\nSource: LOHA CO. LTD., F-1, 12/9/2019\",\n",
              "    10240]]),\n",
              " ('Parties',\n",
              "  'Highlight the parts (if any) of this contract related to \"Parties\" that should be reviewed by a lawyer. Details: The two or more parties who signed the contract',\n",
              "  'The seller:',\n",
              "  143,\n",
              "  154,\n",
              "  False,\n",
              "  [['Exhibit 10.16 SUPPLY CONTRACT Contract No: Date: The buyer/End-User: Shenzhen LOHAS Supply Chain Management Co., Ltd. ADD: Tel No. : Fax No. : The seller: ADD: The Contract is concluded and signed by the Buyer and Seller on , in Hong Kong. 1. General provisions 1.1 This is a framework agreement, the terms and conditions are applied to all purchase orders which signed by this agreement (hereinafter referred to as the \"order\"). 1.2 If the provisions of the agreement are inconsistent with the order, the order shall prevail. Not stated in order content will be subject to the provisions of agreement. Any modification, supplementary, give up should been written records, only to be valid by buyers and sellers authorized representative signature and confirmation, otherwise will be deemed invalid. 2. The agreement and order 2.1 During the validity term of this agreement, The buyer entrust SHENZHEN YICHANGTAI IMPORT AND EXPORT TRADE CO., LTD or SHENZHEN LEHEYUAN TRADING CO, LTD (hereinafter referred to as the \"entrusted party\" or \"YICHANGTAI\" or \"LEHEYUAN\"), to purchase the products specified in this agreement from the seller in the form of orders. 2.2 The seller shall be confirmed within three working days after receipt of order. If the seller finds order is not acceptable or need to modify, should note entrusted party in two working days after receipt of the order, If the seller did not confirm orders in time or notice not accept orders or modifications, the seller is deemed to have been accepted the order. The orders become effective once the seller accepts, any party shall not unilaterally cancel the order before the two sides agreed . 2.3 If the seller puts forward amendments or not accept orders, the seller shall be in the form of a written notice to entrusted party, entrusted party accept the modified by written consent, the modified orders to be taken effect. 2.4 Seller\\'s note, only the buyer entrust the entrusted party issued orders, the product delivery and payment has the force of law.\\n\\n1\\n\\nSource: LOHA CO. LTD., F-1, 12/9/2019\\n\\n\\n\\n\\n\\n3. GOODS AND COUNTRY OF ORIGIN: 4. Specific order: The products quantity, unit price, specifications, delivery time and transportation, specific content shall be subject to the purchase order issued by entrusted party which is commissioned the buyer. 5. PACKING: To be packed in new strong wooden case(s) /carton(s), suitable for long distance transportation and for the change of climate, well protected against rough handling, moisture, rain, corrosion, shocks, rust, and freezing. The seller shall be liable for any damage and loss of the commodity, expenses incurred on account of improper packing, and any damage attributable to inadequate or improper protective measures taken by the seller in regard to the packing. One full set of technical All wooden material of shipping package must be treated as the requirements of Entry-Exit Inspection and Quarantine Bureau of China, by the agent whom is certified by the government where the goods is exported. And the goods must be marked with the IPPC stamps, which are certified by the government agent of Botanical-Inspection and Quarantine Bureau. 6. SHIPPING MARK: The Sellers shall mark on each package with fadeless paint the package number, gross weight, net weight, measurements and the wordings: \"KEEP AWAY FROM MOISTURE\",\"HANDLE WITH CARE\" \"THIS SIDE UP\" etc. and the shipping mark on each package with fadeless paint. 7. DATE OF SHIPMENT: According to specific order by YICHANGTAI or LEHEYUAN. 8. PORT OF SHIPMENT:\\n\\n2\\n\\nSource: LOHA CO. LTD., F-1, 12/9/2019\\n\\n\\n\\n\\n\\n9. PORT OF DESTINATION: SHENZHEN, GUANGDONG, CHINA 10. INSURANCE: To be covered by the Seller for 110% invoice value against All Risks and War Risk. 11. PAYMENT: Under Letter of Credit or T/T: Under the Letter of Credit: The Buyer shall open an irrevocable letter of credit with the bank within 30 days after signing the contract, in favor of the Seller, for 100% value of the total contract value. The letter of credit should state that partial shipments are allowed. The Buyer\\'s agent agrees to pay fo',\n",
              "    0],\n",
              "   [' F-1, 12/9/2019\\n\\n\\n\\n\\n\\n3. GOODS AND COUNTRY OF ORIGIN: 4. Specific order: The products quantity, unit price, specifications, delivery time and transportation, specific content shall be subject to the purchase order issued by entrusted party which is commissioned the buyer. 5. PACKING: To be packed in new strong wooden case(s) /carton(s), suitable for long distance transportation and for the change of climate, well protected against rough handling, moisture, rain, corrosion, shocks, rust, and freezing. The seller shall be liable for any damage and loss of the commodity, expenses incurred on account of improper packing, and any damage attributable to inadequate or improper protective measures taken by the seller in regard to the packing. One full set of technical All wooden material of shipping package must be treated as the requirements of Entry-Exit Inspection and Quarantine Bureau of China, by the agent whom is certified by the government where the goods is exported. And the goods must be marked with the IPPC stamps, which are certified by the government agent of Botanical-Inspection and Quarantine Bureau. 6. SHIPPING MARK: The Sellers shall mark on each package with fadeless paint the package number, gross weight, net weight, measurements and the wordings: \"KEEP AWAY FROM MOISTURE\",\"HANDLE WITH CARE\" \"THIS SIDE UP\" etc. and the shipping mark on each package with fadeless paint. 7. DATE OF SHIPMENT: According to specific order by YICHANGTAI or LEHEYUAN. 8. PORT OF SHIPMENT:\\n\\n2\\n\\nSource: LOHA CO. LTD., F-1, 12/9/2019\\n\\n\\n\\n\\n\\n9. PORT OF DESTINATION: SHENZHEN, GUANGDONG, CHINA 10. INSURANCE: To be covered by the Seller for 110% invoice value against All Risks and War Risk. 11. PAYMENT: Under Letter of Credit or T/T: Under the Letter of Credit: The Buyer shall open an irrevocable letter of credit with the bank within 30 days after signing the contract, in favor of the Seller, for 100% value of the total contract value. The letter of credit should state that partial shipments are allowed. The Buyer\\'s agent agrees to pay for the goods in accordance with the actual amount of the goods shipped. 80% of the system value being shipped will be paid against the documents stipulated in Clause 12.1. The remaining 20% of the system value being shipped will be paid against the documents stipulated in Clause 12.2. The Letter of Credit shall be valid until 90 days after the latest shipment is effected. Under the T/T The trustee of the buyer remitted the goods to the seller by telegraphic transfer in batches as agreed upon after signing each order. 12. DOCUMENTS: 12.1 (1) Invoice in 5 originals indicating contract number and Shipping Mark (in case of more than one shipping mark, the invoice shall be issued separately). (2) One certificate of origin of the goods. (3) Four original copies of the packing list. (4) Certificate of Quality and Quantity in 1 original issued by the agriculture products base. (5) One copy of insurance coverage (6) Copy of cable/letter to the transportation department of Buyer advising of particulars as to shipment immediately after shipment is made.\\n\\n3\\n\\nSource: LOHA CO. LTD., F-1, 12/9/2019\\n\\n\\n\\n\\n\\n12.2 (1) Invoice in 3 originals indicating contract number and L/C number. (2) Final acceptance certificate signed by the Buyer and the Seller. 13. SHIPMENT: CIP The seller shall contract on usual terms at his own expenses for the carriage of the goods to the agreed point at the named place of destination and bear all risks and expenses until the goods have been delivered to the port of destination. The Sellers shall ship the goods within the shipment time from the port of shipment to the port of destination. Transshipment is allowed. Partial Shipment is allowed. In case the goods are to be dispatched by parcel post/sea-freight, the Sellers shall, 3 days before the time of delivery, inform the Buyers by cable/letter of the estimated date of delivery, Contract No., commodity, invoiced value, etc. The sellers shall, immediately after dispatch of the goods, advise the Buyers by cable/letter of the Contract No., commodity, invoiced v',\n",
              "    2048],\n",
              "   [\"r the goods in accordance with the actual amount of the goods shipped. 80% of the system value being shipped will be paid against the documents stipulated in Clause 12.1. The remaining 20% of the system value being shipped will be paid against the documents stipulated in Clause 12.2. The Letter of Credit shall be valid until 90 days after the latest shipment is effected. Under the T/T The trustee of the buyer remitted the goods to the seller by telegraphic transfer in batches as agreed upon after signing each order. 12. DOCUMENTS: 12.1 (1) Invoice in 5 originals indicating contract number and Shipping Mark (in case of more than one shipping mark, the invoice shall be issued separately). (2) One certificate of origin of the goods. (3) Four original copies of the packing list. (4) Certificate of Quality and Quantity in 1 original issued by the agriculture products base. (5) One copy of insurance coverage (6) Copy of cable/letter to the transportation department of Buyer advising of particulars as to shipment immediately after shipment is made.\\n\\n3\\n\\nSource: LOHA CO. LTD., F-1, 12/9/2019\\n\\n\\n\\n\\n\\n12.2 (1) Invoice in 3 originals indicating contract number and L/C number. (2) Final acceptance certificate signed by the Buyer and the Seller. 13. SHIPMENT: CIP The seller shall contract on usual terms at his own expenses for the carriage of the goods to the agreed point at the named place of destination and bear all risks and expenses until the goods have been delivered to the port of destination. The Sellers shall ship the goods within the shipment time from the port of shipment to the port of destination. Transshipment is allowed. Partial Shipment is allowed. In case the goods are to be dispatched by parcel post/sea-freight, the Sellers shall, 3 days before the time of delivery, inform the Buyers by cable/letter of the estimated date of delivery, Contract No., commodity, invoiced value, etc. The sellers shall, immediately after dispatch of the goods, advise the Buyers by cable/letter of the Contract No., commodity, invoiced value and date of dispatch for the Buyers. 14. SHIPPING ADVICE: The seller shall within 72 hours after the shipment of the goods, advise the shipping department of buyer by fax or E-mail of Contract No., goods name, quantity, value, number of packages, gross weight, measurements and the estimated arrival time of the goods at the destination. 15. GUARANTEE OF QUALITY: The Sellers guarantee that the commodity hereof is complies in all respects with the quality and specification stipulated in this Contract. 16. CLAIMS: Within 7 days after the arrival of the goods at destination, should the quality, specification, or quantity be found not in conformity with the stipulations of the Contract except those claims for which the insurance company or the owners of the vessel are liable, the Buyers, on the strength of the Inspection Certificate issued by the China Commodity Inspection Bureau, have the right to claim for replacement with new goods, or for compensation, and all the expenses (such as inspection charges, freight for returning the goods and for sending the replacement, insurance premium, storage and loading and unloading charges etc.) shall be borne by the Sellers. The Certificate so issued shall be accepted as the base of a claim. The Sellers, in accordance with the Buyers' claim, shall be responsible for the immediate elimination of the defect(s), complete or partial replacement of the commodity or shall devaluate the commodity according to the state of defect(s). Where necessary, the Buyers shall be at liberty to eliminate the defect(s) themselves at the Sellers' expenses. If the Sellers fail to answer the Buyers within one weeks after receipt of the aforesaid claim, the claim shall be reckoned as having been accepted by the Sellers.\\n\\n4\\n\\nSource: LOHA CO. LTD., F-1, 12/9/2019\\n\\n\\n\\n\\n\\n17. FORCE MAJEURE: The Sellers shall not be held responsible for the delay in shipment or non-delivery, of the goods due to Force Majeure, which might occur during the process of manufacturing or in the course of loading or transit. Th\",\n",
              "    4096],\n",
              "   [\"alue and date of dispatch for the Buyers. 14. SHIPPING ADVICE: The seller shall within 72 hours after the shipment of the goods, advise the shipping department of buyer by fax or E-mail of Contract No., goods name, quantity, value, number of packages, gross weight, measurements and the estimated arrival time of the goods at the destination. 15. GUARANTEE OF QUALITY: The Sellers guarantee that the commodity hereof is complies in all respects with the quality and specification stipulated in this Contract. 16. CLAIMS: Within 7 days after the arrival of the goods at destination, should the quality, specification, or quantity be found not in conformity with the stipulations of the Contract except those claims for which the insurance company or the owners of the vessel are liable, the Buyers, on the strength of the Inspection Certificate issued by the China Commodity Inspection Bureau, have the right to claim for replacement with new goods, or for compensation, and all the expenses (such as inspection charges, freight for returning the goods and for sending the replacement, insurance premium, storage and loading and unloading charges etc.) shall be borne by the Sellers. The Certificate so issued shall be accepted as the base of a claim. The Sellers, in accordance with the Buyers' claim, shall be responsible for the immediate elimination of the defect(s), complete or partial replacement of the commodity or shall devaluate the commodity according to the state of defect(s). Where necessary, the Buyers shall be at liberty to eliminate the defect(s) themselves at the Sellers' expenses. If the Sellers fail to answer the Buyers within one weeks after receipt of the aforesaid claim, the claim shall be reckoned as having been accepted by the Sellers.\\n\\n4\\n\\nSource: LOHA CO. LTD., F-1, 12/9/2019\\n\\n\\n\\n\\n\\n17. FORCE MAJEURE: The Sellers shall not be held responsible for the delay in shipment or non-delivery, of the goods due to Force Majeure, which might occur during the process of manufacturing or in the course of loading or transit. The Sellers shall advise the Buyers immediately of the occurrence mentioned above and within fourteen days thereafter, the Sellers shall send by airmail to the Buyers a certificate of the accident issued by the competent government authorities, Chamber of Commerce or registered notary public of the place where the accident occurs as evidence thereof. Under such circumstances the Sellers, however, are still under the obligation to take all necessary measures to hasten the delivery of the goods. In case the accident lasts for more than 10 weeks, the Buyers shall have the right to cancel the Contract. 18. LATE DELIVERY AND PENALTY: Should the Sellers fail to make delivery on time as stipulated in the Contract, with exception of Force Majeure causes specified in Clause 17 of this Contract, the Buyers shall agree to postpone the delivery on condition that the Sellers agree to pay a penalty which shall be deducted by the paying bank from the payment. The penalty, however, shall not exceed 5% of the total value of the goods involved in the late delivery. The rate of penalty is charged at 0.5% for every seven days, odd days less than seven days should be counted as seven days. In case the Sellers fail to make delivery ten weeks later than the time of shipment stipulated in the Contract, the Buyers have the right to cancel the contract and the Sellers, in spite of the cancellation, shall still pay the aforesaid penalty to the Buyers without delay, the seller should refund the money received and pay the 30% of the total goods price of the penalty 19. ARBITRATION: All disputes in connection with this Contract or the execution thereof shall be settled friendly through negotiations. In case no settlement can be reached, the case may then be submitted for arbitration to the Foreign Economic and Trade Arbitration Committee of the China Beijing Council for the Promotion of International Trade in accordance with its Provisional Rules of Procedures by the said Arbitration Committee. The Arbitration shall take place in Beijing and th\",\n",
              "    6144],\n",
              "   [\"e Sellers shall advise the Buyers immediately of the occurrence mentioned above and within fourteen days thereafter, the Sellers shall send by airmail to the Buyers a certificate of the accident issued by the competent government authorities, Chamber of Commerce or registered notary public of the place where the accident occurs as evidence thereof. Under such circumstances the Sellers, however, are still under the obligation to take all necessary measures to hasten the delivery of the goods. In case the accident lasts for more than 10 weeks, the Buyers shall have the right to cancel the Contract. 18. LATE DELIVERY AND PENALTY: Should the Sellers fail to make delivery on time as stipulated in the Contract, with exception of Force Majeure causes specified in Clause 17 of this Contract, the Buyers shall agree to postpone the delivery on condition that the Sellers agree to pay a penalty which shall be deducted by the paying bank from the payment. The penalty, however, shall not exceed 5% of the total value of the goods involved in the late delivery. The rate of penalty is charged at 0.5% for every seven days, odd days less than seven days should be counted as seven days. In case the Sellers fail to make delivery ten weeks later than the time of shipment stipulated in the Contract, the Buyers have the right to cancel the contract and the Sellers, in spite of the cancellation, shall still pay the aforesaid penalty to the Buyers without delay, the seller should refund the money received and pay the 30% of the total goods price of the penalty 19. ARBITRATION: All disputes in connection with this Contract or the execution thereof shall be settled friendly through negotiations. In case no settlement can be reached, the case may then be submitted for arbitration to the Foreign Economic and Trade Arbitration Committee of the China Beijing Council for the Promotion of International Trade in accordance with its Provisional Rules of Procedures by the said Arbitration Committee. The Arbitration shall take place in Beijing and the decision of the Arbitration Committee shall be final and binding upon both parties; neither party shall seek recourse to a law court nor other authorities to appeal for revision of the decision. Arbitration fee shall be borne by the losing party. 20. This final price is the confidential information. Dissemination, distribution or duplication of this price is strictly prohibited.\\n\\n5\\n\\nSource: LOHA CO. LTD., F-1, 12/9/2019\\n\\n\\n\\n\\n\\n21. Law application It will be governed by the law of the People's Republic of China ,otherwise it is governed by United Nations Convention on Contract for the International Sale of Goods. 22. <<Incoterms 2000>> The terms in the contract are based on (INCOTERMS 2000) of the International Chamber of Commerce. 23. The Contract is valid for 5 years, beginning from and ended on . This Contract is made out in three originals in both Chinese and English, each language being legally of the equal effect. Conflicts between these two languages arising there from, if any, shall be subject to Chinese version. One copy for the Sellers, two copies for the Buyers. The Contract becomes effective after signed by both parties. THE BUYER: THE SELLER: SIGNATURE: SIGNATURE: 6\\n\\nSource: LOHA CO. LTD., F-1, 12/9/2019\",\n",
              "    8192],\n",
              "   [\"e decision of the Arbitration Committee shall be final and binding upon both parties; neither party shall seek recourse to a law court nor other authorities to appeal for revision of the decision. Arbitration fee shall be borne by the losing party. 20. This final price is the confidential information. Dissemination, distribution or duplication of this price is strictly prohibited.\\n\\n5\\n\\nSource: LOHA CO. LTD., F-1, 12/9/2019\\n\\n\\n\\n\\n\\n21. Law application It will be governed by the law of the People's Republic of China ,otherwise it is governed by United Nations Convention on Contract for the International Sale of Goods. 22. <<Incoterms 2000>> The terms in the contract are based on (INCOTERMS 2000) of the International Chamber of Commerce. 23. The Contract is valid for 5 years, beginning from and ended on . This Contract is made out in three originals in both Chinese and English, each language being legally of the equal effect. Conflicts between these two languages arising there from, if any, shall be subject to Chinese version. One copy for the Sellers, two copies for the Buyers. The Contract becomes effective after signed by both parties. THE BUYER: THE SELLER: SIGNATURE: SIGNATURE: 6\\n\\nSource: LOHA CO. LTD., F-1, 12/9/2019\",\n",
              "    10240]]),\n",
              " ('Parties',\n",
              "  'Highlight the parts (if any) of this contract related to \"Parties\" that should be reviewed by a lawyer. Details: The two or more parties who signed the contract',\n",
              "  'The buyer/End-User: Shenzhen LOHAS Supply Chain Management Co., Ltd.',\n",
              "  49,\n",
              "  117,\n",
              "  False,\n",
              "  [['Exhibit 10.16 SUPPLY CONTRACT Contract No: Date: The buyer/End-User: Shenzhen LOHAS Supply Chain Management Co., Ltd. ADD: Tel No. : Fax No. : The seller: ADD: The Contract is concluded and signed by the Buyer and Seller on , in Hong Kong. 1. General provisions 1.1 This is a framework agreement, the terms and conditions are applied to all purchase orders which signed by this agreement (hereinafter referred to as the \"order\"). 1.2 If the provisions of the agreement are inconsistent with the order, the order shall prevail. Not stated in order content will be subject to the provisions of agreement. Any modification, supplementary, give up should been written records, only to be valid by buyers and sellers authorized representative signature and confirmation, otherwise will be deemed invalid. 2. The agreement and order 2.1 During the validity term of this agreement, The buyer entrust SHENZHEN YICHANGTAI IMPORT AND EXPORT TRADE CO., LTD or SHENZHEN LEHEYUAN TRADING CO, LTD (hereinafter referred to as the \"entrusted party\" or \"YICHANGTAI\" or \"LEHEYUAN\"), to purchase the products specified in this agreement from the seller in the form of orders. 2.2 The seller shall be confirmed within three working days after receipt of order. If the seller finds order is not acceptable or need to modify, should note entrusted party in two working days after receipt of the order, If the seller did not confirm orders in time or notice not accept orders or modifications, the seller is deemed to have been accepted the order. The orders become effective once the seller accepts, any party shall not unilaterally cancel the order before the two sides agreed . 2.3 If the seller puts forward amendments or not accept orders, the seller shall be in the form of a written notice to entrusted party, entrusted party accept the modified by written consent, the modified orders to be taken effect. 2.4 Seller\\'s note, only the buyer entrust the entrusted party issued orders, the product delivery and payment has the force of law.\\n\\n1\\n\\nSource: LOHA CO. LTD., F-1, 12/9/2019\\n\\n\\n\\n\\n\\n3. GOODS AND COUNTRY OF ORIGIN: 4. Specific order: The products quantity, unit price, specifications, delivery time and transportation, specific content shall be subject to the purchase order issued by entrusted party which is commissioned the buyer. 5. PACKING: To be packed in new strong wooden case(s) /carton(s), suitable for long distance transportation and for the change of climate, well protected against rough handling, moisture, rain, corrosion, shocks, rust, and freezing. The seller shall be liable for any damage and loss of the commodity, expenses incurred on account of improper packing, and any damage attributable to inadequate or improper protective measures taken by the seller in regard to the packing. One full set of technical All wooden material of shipping package must be treated as the requirements of Entry-Exit Inspection and Quarantine Bureau of China, by the agent whom is certified by the government where the goods is exported. And the goods must be marked with the IPPC stamps, which are certified by the government agent of Botanical-Inspection and Quarantine Bureau. 6. SHIPPING MARK: The Sellers shall mark on each package with fadeless paint the package number, gross weight, net weight, measurements and the wordings: \"KEEP AWAY FROM MOISTURE\",\"HANDLE WITH CARE\" \"THIS SIDE UP\" etc. and the shipping mark on each package with fadeless paint. 7. DATE OF SHIPMENT: According to specific order by YICHANGTAI or LEHEYUAN. 8. PORT OF SHIPMENT:\\n\\n2\\n\\nSource: LOHA CO. LTD., F-1, 12/9/2019\\n\\n\\n\\n\\n\\n9. PORT OF DESTINATION: SHENZHEN, GUANGDONG, CHINA 10. INSURANCE: To be covered by the Seller for 110% invoice value against All Risks and War Risk. 11. PAYMENT: Under Letter of Credit or T/T: Under the Letter of Credit: The Buyer shall open an irrevocable letter of credit with the bank within 30 days after signing the contract, in favor of the Seller, for 100% value of the total contract value. The letter of credit should state that partial shipments are allowed. The Buyer\\'s agent agrees to pay fo',\n",
              "    0],\n",
              "   [' F-1, 12/9/2019\\n\\n\\n\\n\\n\\n3. GOODS AND COUNTRY OF ORIGIN: 4. Specific order: The products quantity, unit price, specifications, delivery time and transportation, specific content shall be subject to the purchase order issued by entrusted party which is commissioned the buyer. 5. PACKING: To be packed in new strong wooden case(s) /carton(s), suitable for long distance transportation and for the change of climate, well protected against rough handling, moisture, rain, corrosion, shocks, rust, and freezing. The seller shall be liable for any damage and loss of the commodity, expenses incurred on account of improper packing, and any damage attributable to inadequate or improper protective measures taken by the seller in regard to the packing. One full set of technical All wooden material of shipping package must be treated as the requirements of Entry-Exit Inspection and Quarantine Bureau of China, by the agent whom is certified by the government where the goods is exported. And the goods must be marked with the IPPC stamps, which are certified by the government agent of Botanical-Inspection and Quarantine Bureau. 6. SHIPPING MARK: The Sellers shall mark on each package with fadeless paint the package number, gross weight, net weight, measurements and the wordings: \"KEEP AWAY FROM MOISTURE\",\"HANDLE WITH CARE\" \"THIS SIDE UP\" etc. and the shipping mark on each package with fadeless paint. 7. DATE OF SHIPMENT: According to specific order by YICHANGTAI or LEHEYUAN. 8. PORT OF SHIPMENT:\\n\\n2\\n\\nSource: LOHA CO. LTD., F-1, 12/9/2019\\n\\n\\n\\n\\n\\n9. PORT OF DESTINATION: SHENZHEN, GUANGDONG, CHINA 10. INSURANCE: To be covered by the Seller for 110% invoice value against All Risks and War Risk. 11. PAYMENT: Under Letter of Credit or T/T: Under the Letter of Credit: The Buyer shall open an irrevocable letter of credit with the bank within 30 days after signing the contract, in favor of the Seller, for 100% value of the total contract value. The letter of credit should state that partial shipments are allowed. The Buyer\\'s agent agrees to pay for the goods in accordance with the actual amount of the goods shipped. 80% of the system value being shipped will be paid against the documents stipulated in Clause 12.1. The remaining 20% of the system value being shipped will be paid against the documents stipulated in Clause 12.2. The Letter of Credit shall be valid until 90 days after the latest shipment is effected. Under the T/T The trustee of the buyer remitted the goods to the seller by telegraphic transfer in batches as agreed upon after signing each order. 12. DOCUMENTS: 12.1 (1) Invoice in 5 originals indicating contract number and Shipping Mark (in case of more than one shipping mark, the invoice shall be issued separately). (2) One certificate of origin of the goods. (3) Four original copies of the packing list. (4) Certificate of Quality and Quantity in 1 original issued by the agriculture products base. (5) One copy of insurance coverage (6) Copy of cable/letter to the transportation department of Buyer advising of particulars as to shipment immediately after shipment is made.\\n\\n3\\n\\nSource: LOHA CO. LTD., F-1, 12/9/2019\\n\\n\\n\\n\\n\\n12.2 (1) Invoice in 3 originals indicating contract number and L/C number. (2) Final acceptance certificate signed by the Buyer and the Seller. 13. SHIPMENT: CIP The seller shall contract on usual terms at his own expenses for the carriage of the goods to the agreed point at the named place of destination and bear all risks and expenses until the goods have been delivered to the port of destination. The Sellers shall ship the goods within the shipment time from the port of shipment to the port of destination. Transshipment is allowed. Partial Shipment is allowed. In case the goods are to be dispatched by parcel post/sea-freight, the Sellers shall, 3 days before the time of delivery, inform the Buyers by cable/letter of the estimated date of delivery, Contract No., commodity, invoiced value, etc. The sellers shall, immediately after dispatch of the goods, advise the Buyers by cable/letter of the Contract No., commodity, invoiced v',\n",
              "    2048],\n",
              "   [\"r the goods in accordance with the actual amount of the goods shipped. 80% of the system value being shipped will be paid against the documents stipulated in Clause 12.1. The remaining 20% of the system value being shipped will be paid against the documents stipulated in Clause 12.2. The Letter of Credit shall be valid until 90 days after the latest shipment is effected. Under the T/T The trustee of the buyer remitted the goods to the seller by telegraphic transfer in batches as agreed upon after signing each order. 12. DOCUMENTS: 12.1 (1) Invoice in 5 originals indicating contract number and Shipping Mark (in case of more than one shipping mark, the invoice shall be issued separately). (2) One certificate of origin of the goods. (3) Four original copies of the packing list. (4) Certificate of Quality and Quantity in 1 original issued by the agriculture products base. (5) One copy of insurance coverage (6) Copy of cable/letter to the transportation department of Buyer advising of particulars as to shipment immediately after shipment is made.\\n\\n3\\n\\nSource: LOHA CO. LTD., F-1, 12/9/2019\\n\\n\\n\\n\\n\\n12.2 (1) Invoice in 3 originals indicating contract number and L/C number. (2) Final acceptance certificate signed by the Buyer and the Seller. 13. SHIPMENT: CIP The seller shall contract on usual terms at his own expenses for the carriage of the goods to the agreed point at the named place of destination and bear all risks and expenses until the goods have been delivered to the port of destination. The Sellers shall ship the goods within the shipment time from the port of shipment to the port of destination. Transshipment is allowed. Partial Shipment is allowed. In case the goods are to be dispatched by parcel post/sea-freight, the Sellers shall, 3 days before the time of delivery, inform the Buyers by cable/letter of the estimated date of delivery, Contract No., commodity, invoiced value, etc. The sellers shall, immediately after dispatch of the goods, advise the Buyers by cable/letter of the Contract No., commodity, invoiced value and date of dispatch for the Buyers. 14. SHIPPING ADVICE: The seller shall within 72 hours after the shipment of the goods, advise the shipping department of buyer by fax or E-mail of Contract No., goods name, quantity, value, number of packages, gross weight, measurements and the estimated arrival time of the goods at the destination. 15. GUARANTEE OF QUALITY: The Sellers guarantee that the commodity hereof is complies in all respects with the quality and specification stipulated in this Contract. 16. CLAIMS: Within 7 days after the arrival of the goods at destination, should the quality, specification, or quantity be found not in conformity with the stipulations of the Contract except those claims for which the insurance company or the owners of the vessel are liable, the Buyers, on the strength of the Inspection Certificate issued by the China Commodity Inspection Bureau, have the right to claim for replacement with new goods, or for compensation, and all the expenses (such as inspection charges, freight for returning the goods and for sending the replacement, insurance premium, storage and loading and unloading charges etc.) shall be borne by the Sellers. The Certificate so issued shall be accepted as the base of a claim. The Sellers, in accordance with the Buyers' claim, shall be responsible for the immediate elimination of the defect(s), complete or partial replacement of the commodity or shall devaluate the commodity according to the state of defect(s). Where necessary, the Buyers shall be at liberty to eliminate the defect(s) themselves at the Sellers' expenses. If the Sellers fail to answer the Buyers within one weeks after receipt of the aforesaid claim, the claim shall be reckoned as having been accepted by the Sellers.\\n\\n4\\n\\nSource: LOHA CO. LTD., F-1, 12/9/2019\\n\\n\\n\\n\\n\\n17. FORCE MAJEURE: The Sellers shall not be held responsible for the delay in shipment or non-delivery, of the goods due to Force Majeure, which might occur during the process of manufacturing or in the course of loading or transit. Th\",\n",
              "    4096],\n",
              "   [\"alue and date of dispatch for the Buyers. 14. SHIPPING ADVICE: The seller shall within 72 hours after the shipment of the goods, advise the shipping department of buyer by fax or E-mail of Contract No., goods name, quantity, value, number of packages, gross weight, measurements and the estimated arrival time of the goods at the destination. 15. GUARANTEE OF QUALITY: The Sellers guarantee that the commodity hereof is complies in all respects with the quality and specification stipulated in this Contract. 16. CLAIMS: Within 7 days after the arrival of the goods at destination, should the quality, specification, or quantity be found not in conformity with the stipulations of the Contract except those claims for which the insurance company or the owners of the vessel are liable, the Buyers, on the strength of the Inspection Certificate issued by the China Commodity Inspection Bureau, have the right to claim for replacement with new goods, or for compensation, and all the expenses (such as inspection charges, freight for returning the goods and for sending the replacement, insurance premium, storage and loading and unloading charges etc.) shall be borne by the Sellers. The Certificate so issued shall be accepted as the base of a claim. The Sellers, in accordance with the Buyers' claim, shall be responsible for the immediate elimination of the defect(s), complete or partial replacement of the commodity or shall devaluate the commodity according to the state of defect(s). Where necessary, the Buyers shall be at liberty to eliminate the defect(s) themselves at the Sellers' expenses. If the Sellers fail to answer the Buyers within one weeks after receipt of the aforesaid claim, the claim shall be reckoned as having been accepted by the Sellers.\\n\\n4\\n\\nSource: LOHA CO. LTD., F-1, 12/9/2019\\n\\n\\n\\n\\n\\n17. FORCE MAJEURE: The Sellers shall not be held responsible for the delay in shipment or non-delivery, of the goods due to Force Majeure, which might occur during the process of manufacturing or in the course of loading or transit. The Sellers shall advise the Buyers immediately of the occurrence mentioned above and within fourteen days thereafter, the Sellers shall send by airmail to the Buyers a certificate of the accident issued by the competent government authorities, Chamber of Commerce or registered notary public of the place where the accident occurs as evidence thereof. Under such circumstances the Sellers, however, are still under the obligation to take all necessary measures to hasten the delivery of the goods. In case the accident lasts for more than 10 weeks, the Buyers shall have the right to cancel the Contract. 18. LATE DELIVERY AND PENALTY: Should the Sellers fail to make delivery on time as stipulated in the Contract, with exception of Force Majeure causes specified in Clause 17 of this Contract, the Buyers shall agree to postpone the delivery on condition that the Sellers agree to pay a penalty which shall be deducted by the paying bank from the payment. The penalty, however, shall not exceed 5% of the total value of the goods involved in the late delivery. The rate of penalty is charged at 0.5% for every seven days, odd days less than seven days should be counted as seven days. In case the Sellers fail to make delivery ten weeks later than the time of shipment stipulated in the Contract, the Buyers have the right to cancel the contract and the Sellers, in spite of the cancellation, shall still pay the aforesaid penalty to the Buyers without delay, the seller should refund the money received and pay the 30% of the total goods price of the penalty 19. ARBITRATION: All disputes in connection with this Contract or the execution thereof shall be settled friendly through negotiations. In case no settlement can be reached, the case may then be submitted for arbitration to the Foreign Economic and Trade Arbitration Committee of the China Beijing Council for the Promotion of International Trade in accordance with its Provisional Rules of Procedures by the said Arbitration Committee. The Arbitration shall take place in Beijing and th\",\n",
              "    6144],\n",
              "   [\"e Sellers shall advise the Buyers immediately of the occurrence mentioned above and within fourteen days thereafter, the Sellers shall send by airmail to the Buyers a certificate of the accident issued by the competent government authorities, Chamber of Commerce or registered notary public of the place where the accident occurs as evidence thereof. Under such circumstances the Sellers, however, are still under the obligation to take all necessary measures to hasten the delivery of the goods. In case the accident lasts for more than 10 weeks, the Buyers shall have the right to cancel the Contract. 18. LATE DELIVERY AND PENALTY: Should the Sellers fail to make delivery on time as stipulated in the Contract, with exception of Force Majeure causes specified in Clause 17 of this Contract, the Buyers shall agree to postpone the delivery on condition that the Sellers agree to pay a penalty which shall be deducted by the paying bank from the payment. The penalty, however, shall not exceed 5% of the total value of the goods involved in the late delivery. The rate of penalty is charged at 0.5% for every seven days, odd days less than seven days should be counted as seven days. In case the Sellers fail to make delivery ten weeks later than the time of shipment stipulated in the Contract, the Buyers have the right to cancel the contract and the Sellers, in spite of the cancellation, shall still pay the aforesaid penalty to the Buyers without delay, the seller should refund the money received and pay the 30% of the total goods price of the penalty 19. ARBITRATION: All disputes in connection with this Contract or the execution thereof shall be settled friendly through negotiations. In case no settlement can be reached, the case may then be submitted for arbitration to the Foreign Economic and Trade Arbitration Committee of the China Beijing Council for the Promotion of International Trade in accordance with its Provisional Rules of Procedures by the said Arbitration Committee. The Arbitration shall take place in Beijing and the decision of the Arbitration Committee shall be final and binding upon both parties; neither party shall seek recourse to a law court nor other authorities to appeal for revision of the decision. Arbitration fee shall be borne by the losing party. 20. This final price is the confidential information. Dissemination, distribution or duplication of this price is strictly prohibited.\\n\\n5\\n\\nSource: LOHA CO. LTD., F-1, 12/9/2019\\n\\n\\n\\n\\n\\n21. Law application It will be governed by the law of the People's Republic of China ,otherwise it is governed by United Nations Convention on Contract for the International Sale of Goods. 22. <<Incoterms 2000>> The terms in the contract are based on (INCOTERMS 2000) of the International Chamber of Commerce. 23. The Contract is valid for 5 years, beginning from and ended on . This Contract is made out in three originals in both Chinese and English, each language being legally of the equal effect. Conflicts between these two languages arising there from, if any, shall be subject to Chinese version. One copy for the Sellers, two copies for the Buyers. The Contract becomes effective after signed by both parties. THE BUYER: THE SELLER: SIGNATURE: SIGNATURE: 6\\n\\nSource: LOHA CO. LTD., F-1, 12/9/2019\",\n",
              "    8192],\n",
              "   [\"e decision of the Arbitration Committee shall be final and binding upon both parties; neither party shall seek recourse to a law court nor other authorities to appeal for revision of the decision. Arbitration fee shall be borne by the losing party. 20. This final price is the confidential information. Dissemination, distribution or duplication of this price is strictly prohibited.\\n\\n5\\n\\nSource: LOHA CO. LTD., F-1, 12/9/2019\\n\\n\\n\\n\\n\\n21. Law application It will be governed by the law of the People's Republic of China ,otherwise it is governed by United Nations Convention on Contract for the International Sale of Goods. 22. <<Incoterms 2000>> The terms in the contract are based on (INCOTERMS 2000) of the International Chamber of Commerce. 23. The Contract is valid for 5 years, beginning from and ended on . This Contract is made out in three originals in both Chinese and English, each language being legally of the equal effect. Conflicts between these two languages arising there from, if any, shall be subject to Chinese version. One copy for the Sellers, two copies for the Buyers. The Contract becomes effective after signed by both parties. THE BUYER: THE SELLER: SIGNATURE: SIGNATURE: 6\\n\\nSource: LOHA CO. LTD., F-1, 12/9/2019\",\n",
              "    10240]]),\n",
              " ('Expiration Date',\n",
              "  'Highlight the parts (if any) of this contract related to \"Expiration Date\" that should be reviewed by a lawyer. Details: On what date will the contract\\'s initial term expire?',\n",
              "  'The Contract is valid for 5 years, beginning from and ended on .',\n",
              "  10985,\n",
              "  11049,\n",
              "  False,\n",
              "  [['Exhibit 10.16 SUPPLY CONTRACT Contract No: Date: The buyer/End-User: Shenzhen LOHAS Supply Chain Management Co., Ltd. ADD: Tel No. : Fax No. : The seller: ADD: The Contract is concluded and signed by the Buyer and Seller on , in Hong Kong. 1. General provisions 1.1 This is a framework agreement, the terms and conditions are applied to all purchase orders which signed by this agreement (hereinafter referred to as the \"order\"). 1.2 If the provisions of the agreement are inconsistent with the order, the order shall prevail. Not stated in order content will be subject to the provisions of agreement. Any modification, supplementary, give up should been written records, only to be valid by buyers and sellers authorized representative signature and confirmation, otherwise will be deemed invalid. 2. The agreement and order 2.1 During the validity term of this agreement, The buyer entrust SHENZHEN YICHANGTAI IMPORT AND EXPORT TRADE CO., LTD or SHENZHEN LEHEYUAN TRADING CO, LTD (hereinafter referred to as the \"entrusted party\" or \"YICHANGTAI\" or \"LEHEYUAN\"), to purchase the products specified in this agreement from the seller in the form of orders. 2.2 The seller shall be confirmed within three working days after receipt of order. If the seller finds order is not acceptable or need to modify, should note entrusted party in two working days after receipt of the order, If the seller did not confirm orders in time or notice not accept orders or modifications, the seller is deemed to have been accepted the order. The orders become effective once the seller accepts, any party shall not unilaterally cancel the order before the two sides agreed . 2.3 If the seller puts forward amendments or not accept orders, the seller shall be in the form of a written notice to entrusted party, entrusted party accept the modified by written consent, the modified orders to be taken effect. 2.4 Seller\\'s note, only the buyer entrust the entrusted party issued orders, the product delivery and payment has the force of law.\\n\\n1\\n\\nSource: LOHA CO. LTD., F-1, 12/9/2019\\n\\n\\n\\n\\n\\n3. GOODS AND COUNTRY OF ORIGIN: 4. Specific order: The products quantity, unit price, specifications, delivery time and transportation, specific content shall be subject to the purchase order issued by entrusted party which is commissioned the buyer. 5. PACKING: To be packed in new strong wooden case(s) /carton(s), suitable for long distance transportation and for the change of climate, well protected against rough handling, moisture, rain, corrosion, shocks, rust, and freezing. The seller shall be liable for any damage and loss of the commodity, expenses incurred on account of improper packing, and any damage attributable to inadequate or improper protective measures taken by the seller in regard to the packing. One full set of technical All wooden material of shipping package must be treated as the requirements of Entry-Exit Inspection and Quarantine Bureau of China, by the agent whom is certified by the government where the goods is exported. And the goods must be marked with the IPPC stamps, which are certified by the government agent of Botanical-Inspection and Quarantine Bureau. 6. SHIPPING MARK: The Sellers shall mark on each package with fadeless paint the package number, gross weight, net weight, measurements and the wordings: \"KEEP AWAY FROM MOISTURE\",\"HANDLE WITH CARE\" \"THIS SIDE UP\" etc. and the shipping mark on each package with fadeless paint. 7. DATE OF SHIPMENT: According to specific order by YICHANGTAI or LEHEYUAN. 8. PORT OF SHIPMENT:\\n\\n2\\n\\nSource: LOHA CO. LTD., F-1, 12/9/2019\\n\\n\\n\\n\\n\\n9. PORT OF DESTINATION: SHENZHEN, GUANGDONG, CHINA 10. INSURANCE: To be covered by the Seller for 110% invoice value against All Risks and War Risk. 11. PAYMENT: Under Letter of Credit or T/T: Under the Letter of Credit: The Buyer shall open an irrevocable letter of credit with the bank within 30 days after signing the contract, in favor of the Seller, for 100% value of the total contract value. The letter of credit should state that partial shipments are allowed. The Buyer\\'s agent agrees to pay fo',\n",
              "    0],\n",
              "   [' F-1, 12/9/2019\\n\\n\\n\\n\\n\\n3. GOODS AND COUNTRY OF ORIGIN: 4. Specific order: The products quantity, unit price, specifications, delivery time and transportation, specific content shall be subject to the purchase order issued by entrusted party which is commissioned the buyer. 5. PACKING: To be packed in new strong wooden case(s) /carton(s), suitable for long distance transportation and for the change of climate, well protected against rough handling, moisture, rain, corrosion, shocks, rust, and freezing. The seller shall be liable for any damage and loss of the commodity, expenses incurred on account of improper packing, and any damage attributable to inadequate or improper protective measures taken by the seller in regard to the packing. One full set of technical All wooden material of shipping package must be treated as the requirements of Entry-Exit Inspection and Quarantine Bureau of China, by the agent whom is certified by the government where the goods is exported. And the goods must be marked with the IPPC stamps, which are certified by the government agent of Botanical-Inspection and Quarantine Bureau. 6. SHIPPING MARK: The Sellers shall mark on each package with fadeless paint the package number, gross weight, net weight, measurements and the wordings: \"KEEP AWAY FROM MOISTURE\",\"HANDLE WITH CARE\" \"THIS SIDE UP\" etc. and the shipping mark on each package with fadeless paint. 7. DATE OF SHIPMENT: According to specific order by YICHANGTAI or LEHEYUAN. 8. PORT OF SHIPMENT:\\n\\n2\\n\\nSource: LOHA CO. LTD., F-1, 12/9/2019\\n\\n\\n\\n\\n\\n9. PORT OF DESTINATION: SHENZHEN, GUANGDONG, CHINA 10. INSURANCE: To be covered by the Seller for 110% invoice value against All Risks and War Risk. 11. PAYMENT: Under Letter of Credit or T/T: Under the Letter of Credit: The Buyer shall open an irrevocable letter of credit with the bank within 30 days after signing the contract, in favor of the Seller, for 100% value of the total contract value. The letter of credit should state that partial shipments are allowed. The Buyer\\'s agent agrees to pay for the goods in accordance with the actual amount of the goods shipped. 80% of the system value being shipped will be paid against the documents stipulated in Clause 12.1. The remaining 20% of the system value being shipped will be paid against the documents stipulated in Clause 12.2. The Letter of Credit shall be valid until 90 days after the latest shipment is effected. Under the T/T The trustee of the buyer remitted the goods to the seller by telegraphic transfer in batches as agreed upon after signing each order. 12. DOCUMENTS: 12.1 (1) Invoice in 5 originals indicating contract number and Shipping Mark (in case of more than one shipping mark, the invoice shall be issued separately). (2) One certificate of origin of the goods. (3) Four original copies of the packing list. (4) Certificate of Quality and Quantity in 1 original issued by the agriculture products base. (5) One copy of insurance coverage (6) Copy of cable/letter to the transportation department of Buyer advising of particulars as to shipment immediately after shipment is made.\\n\\n3\\n\\nSource: LOHA CO. LTD., F-1, 12/9/2019\\n\\n\\n\\n\\n\\n12.2 (1) Invoice in 3 originals indicating contract number and L/C number. (2) Final acceptance certificate signed by the Buyer and the Seller. 13. SHIPMENT: CIP The seller shall contract on usual terms at his own expenses for the carriage of the goods to the agreed point at the named place of destination and bear all risks and expenses until the goods have been delivered to the port of destination. The Sellers shall ship the goods within the shipment time from the port of shipment to the port of destination. Transshipment is allowed. Partial Shipment is allowed. In case the goods are to be dispatched by parcel post/sea-freight, the Sellers shall, 3 days before the time of delivery, inform the Buyers by cable/letter of the estimated date of delivery, Contract No., commodity, invoiced value, etc. The sellers shall, immediately after dispatch of the goods, advise the Buyers by cable/letter of the Contract No., commodity, invoiced v',\n",
              "    2048],\n",
              "   [\"r the goods in accordance with the actual amount of the goods shipped. 80% of the system value being shipped will be paid against the documents stipulated in Clause 12.1. The remaining 20% of the system value being shipped will be paid against the documents stipulated in Clause 12.2. The Letter of Credit shall be valid until 90 days after the latest shipment is effected. Under the T/T The trustee of the buyer remitted the goods to the seller by telegraphic transfer in batches as agreed upon after signing each order. 12. DOCUMENTS: 12.1 (1) Invoice in 5 originals indicating contract number and Shipping Mark (in case of more than one shipping mark, the invoice shall be issued separately). (2) One certificate of origin of the goods. (3) Four original copies of the packing list. (4) Certificate of Quality and Quantity in 1 original issued by the agriculture products base. (5) One copy of insurance coverage (6) Copy of cable/letter to the transportation department of Buyer advising of particulars as to shipment immediately after shipment is made.\\n\\n3\\n\\nSource: LOHA CO. LTD., F-1, 12/9/2019\\n\\n\\n\\n\\n\\n12.2 (1) Invoice in 3 originals indicating contract number and L/C number. (2) Final acceptance certificate signed by the Buyer and the Seller. 13. SHIPMENT: CIP The seller shall contract on usual terms at his own expenses for the carriage of the goods to the agreed point at the named place of destination and bear all risks and expenses until the goods have been delivered to the port of destination. The Sellers shall ship the goods within the shipment time from the port of shipment to the port of destination. Transshipment is allowed. Partial Shipment is allowed. In case the goods are to be dispatched by parcel post/sea-freight, the Sellers shall, 3 days before the time of delivery, inform the Buyers by cable/letter of the estimated date of delivery, Contract No., commodity, invoiced value, etc. The sellers shall, immediately after dispatch of the goods, advise the Buyers by cable/letter of the Contract No., commodity, invoiced value and date of dispatch for the Buyers. 14. SHIPPING ADVICE: The seller shall within 72 hours after the shipment of the goods, advise the shipping department of buyer by fax or E-mail of Contract No., goods name, quantity, value, number of packages, gross weight, measurements and the estimated arrival time of the goods at the destination. 15. GUARANTEE OF QUALITY: The Sellers guarantee that the commodity hereof is complies in all respects with the quality and specification stipulated in this Contract. 16. CLAIMS: Within 7 days after the arrival of the goods at destination, should the quality, specification, or quantity be found not in conformity with the stipulations of the Contract except those claims for which the insurance company or the owners of the vessel are liable, the Buyers, on the strength of the Inspection Certificate issued by the China Commodity Inspection Bureau, have the right to claim for replacement with new goods, or for compensation, and all the expenses (such as inspection charges, freight for returning the goods and for sending the replacement, insurance premium, storage and loading and unloading charges etc.) shall be borne by the Sellers. The Certificate so issued shall be accepted as the base of a claim. The Sellers, in accordance with the Buyers' claim, shall be responsible for the immediate elimination of the defect(s), complete or partial replacement of the commodity or shall devaluate the commodity according to the state of defect(s). Where necessary, the Buyers shall be at liberty to eliminate the defect(s) themselves at the Sellers' expenses. If the Sellers fail to answer the Buyers within one weeks after receipt of the aforesaid claim, the claim shall be reckoned as having been accepted by the Sellers.\\n\\n4\\n\\nSource: LOHA CO. LTD., F-1, 12/9/2019\\n\\n\\n\\n\\n\\n17. FORCE MAJEURE: The Sellers shall not be held responsible for the delay in shipment or non-delivery, of the goods due to Force Majeure, which might occur during the process of manufacturing or in the course of loading or transit. Th\",\n",
              "    4096],\n",
              "   [\"alue and date of dispatch for the Buyers. 14. SHIPPING ADVICE: The seller shall within 72 hours after the shipment of the goods, advise the shipping department of buyer by fax or E-mail of Contract No., goods name, quantity, value, number of packages, gross weight, measurements and the estimated arrival time of the goods at the destination. 15. GUARANTEE OF QUALITY: The Sellers guarantee that the commodity hereof is complies in all respects with the quality and specification stipulated in this Contract. 16. CLAIMS: Within 7 days after the arrival of the goods at destination, should the quality, specification, or quantity be found not in conformity with the stipulations of the Contract except those claims for which the insurance company or the owners of the vessel are liable, the Buyers, on the strength of the Inspection Certificate issued by the China Commodity Inspection Bureau, have the right to claim for replacement with new goods, or for compensation, and all the expenses (such as inspection charges, freight for returning the goods and for sending the replacement, insurance premium, storage and loading and unloading charges etc.) shall be borne by the Sellers. The Certificate so issued shall be accepted as the base of a claim. The Sellers, in accordance with the Buyers' claim, shall be responsible for the immediate elimination of the defect(s), complete or partial replacement of the commodity or shall devaluate the commodity according to the state of defect(s). Where necessary, the Buyers shall be at liberty to eliminate the defect(s) themselves at the Sellers' expenses. If the Sellers fail to answer the Buyers within one weeks after receipt of the aforesaid claim, the claim shall be reckoned as having been accepted by the Sellers.\\n\\n4\\n\\nSource: LOHA CO. LTD., F-1, 12/9/2019\\n\\n\\n\\n\\n\\n17. FORCE MAJEURE: The Sellers shall not be held responsible for the delay in shipment or non-delivery, of the goods due to Force Majeure, which might occur during the process of manufacturing or in the course of loading or transit. The Sellers shall advise the Buyers immediately of the occurrence mentioned above and within fourteen days thereafter, the Sellers shall send by airmail to the Buyers a certificate of the accident issued by the competent government authorities, Chamber of Commerce or registered notary public of the place where the accident occurs as evidence thereof. Under such circumstances the Sellers, however, are still under the obligation to take all necessary measures to hasten the delivery of the goods. In case the accident lasts for more than 10 weeks, the Buyers shall have the right to cancel the Contract. 18. LATE DELIVERY AND PENALTY: Should the Sellers fail to make delivery on time as stipulated in the Contract, with exception of Force Majeure causes specified in Clause 17 of this Contract, the Buyers shall agree to postpone the delivery on condition that the Sellers agree to pay a penalty which shall be deducted by the paying bank from the payment. The penalty, however, shall not exceed 5% of the total value of the goods involved in the late delivery. The rate of penalty is charged at 0.5% for every seven days, odd days less than seven days should be counted as seven days. In case the Sellers fail to make delivery ten weeks later than the time of shipment stipulated in the Contract, the Buyers have the right to cancel the contract and the Sellers, in spite of the cancellation, shall still pay the aforesaid penalty to the Buyers without delay, the seller should refund the money received and pay the 30% of the total goods price of the penalty 19. ARBITRATION: All disputes in connection with this Contract or the execution thereof shall be settled friendly through negotiations. In case no settlement can be reached, the case may then be submitted for arbitration to the Foreign Economic and Trade Arbitration Committee of the China Beijing Council for the Promotion of International Trade in accordance with its Provisional Rules of Procedures by the said Arbitration Committee. The Arbitration shall take place in Beijing and th\",\n",
              "    6144],\n",
              "   [\"e Sellers shall advise the Buyers immediately of the occurrence mentioned above and within fourteen days thereafter, the Sellers shall send by airmail to the Buyers a certificate of the accident issued by the competent government authorities, Chamber of Commerce or registered notary public of the place where the accident occurs as evidence thereof. Under such circumstances the Sellers, however, are still under the obligation to take all necessary measures to hasten the delivery of the goods. In case the accident lasts for more than 10 weeks, the Buyers shall have the right to cancel the Contract. 18. LATE DELIVERY AND PENALTY: Should the Sellers fail to make delivery on time as stipulated in the Contract, with exception of Force Majeure causes specified in Clause 17 of this Contract, the Buyers shall agree to postpone the delivery on condition that the Sellers agree to pay a penalty which shall be deducted by the paying bank from the payment. The penalty, however, shall not exceed 5% of the total value of the goods involved in the late delivery. The rate of penalty is charged at 0.5% for every seven days, odd days less than seven days should be counted as seven days. In case the Sellers fail to make delivery ten weeks later than the time of shipment stipulated in the Contract, the Buyers have the right to cancel the contract and the Sellers, in spite of the cancellation, shall still pay the aforesaid penalty to the Buyers without delay, the seller should refund the money received and pay the 30% of the total goods price of the penalty 19. ARBITRATION: All disputes in connection with this Contract or the execution thereof shall be settled friendly through negotiations. In case no settlement can be reached, the case may then be submitted for arbitration to the Foreign Economic and Trade Arbitration Committee of the China Beijing Council for the Promotion of International Trade in accordance with its Provisional Rules of Procedures by the said Arbitration Committee. The Arbitration shall take place in Beijing and the decision of the Arbitration Committee shall be final and binding upon both parties; neither party shall seek recourse to a law court nor other authorities to appeal for revision of the decision. Arbitration fee shall be borne by the losing party. 20. This final price is the confidential information. Dissemination, distribution or duplication of this price is strictly prohibited.\\n\\n5\\n\\nSource: LOHA CO. LTD., F-1, 12/9/2019\\n\\n\\n\\n\\n\\n21. Law application It will be governed by the law of the People's Republic of China ,otherwise it is governed by United Nations Convention on Contract for the International Sale of Goods. 22. <<Incoterms 2000>> The terms in the contract are based on (INCOTERMS 2000) of the International Chamber of Commerce. 23. The Contract is valid for 5 years, beginning from and ended on . This Contract is made out in three originals in both Chinese and English, each language being legally of the equal effect. Conflicts between these two languages arising there from, if any, shall be subject to Chinese version. One copy for the Sellers, two copies for the Buyers. The Contract becomes effective after signed by both parties. THE BUYER: THE SELLER: SIGNATURE: SIGNATURE: 6\\n\\nSource: LOHA CO. LTD., F-1, 12/9/2019\",\n",
              "    8192],\n",
              "   [\"e decision of the Arbitration Committee shall be final and binding upon both parties; neither party shall seek recourse to a law court nor other authorities to appeal for revision of the decision. Arbitration fee shall be borne by the losing party. 20. This final price is the confidential information. Dissemination, distribution or duplication of this price is strictly prohibited.\\n\\n5\\n\\nSource: LOHA CO. LTD., F-1, 12/9/2019\\n\\n\\n\\n\\n\\n21. Law application It will be governed by the law of the People's Republic of China ,otherwise it is governed by United Nations Convention on Contract for the International Sale of Goods. 22. <<Incoterms 2000>> The terms in the contract are based on (INCOTERMS 2000) of the International Chamber of Commerce. 23. The Contract is valid for 5 years, beginning from and ended on . This Contract is made out in three originals in both Chinese and English, each language being legally of the equal effect. Conflicts between these two languages arising there from, if any, shall be subject to Chinese version. One copy for the Sellers, two copies for the Buyers. The Contract becomes effective after signed by both parties. THE BUYER: THE SELLER: SIGNATURE: SIGNATURE: 6\\n\\nSource: LOHA CO. LTD., F-1, 12/9/2019\",\n",
              "    10240]]),\n",
              " ('Governing Law',\n",
              "  'Highlight the parts (if any) of this contract related to \"Governing Law\" that should be reviewed by a lawyer. Details: Which state/country\\'s law governs the interpretation of the contract?',\n",
              "  \"It will be governed by the law of the People's Republic of China ,otherwise it is governed by United Nations Convention on Contract for the International Sale of Goods.\",\n",
              "  10691,\n",
              "  10859,\n",
              "  False,\n",
              "  [['Exhibit 10.16 SUPPLY CONTRACT Contract No: Date: The buyer/End-User: Shenzhen LOHAS Supply Chain Management Co., Ltd. ADD: Tel No. : Fax No. : The seller: ADD: The Contract is concluded and signed by the Buyer and Seller on , in Hong Kong. 1. General provisions 1.1 This is a framework agreement, the terms and conditions are applied to all purchase orders which signed by this agreement (hereinafter referred to as the \"order\"). 1.2 If the provisions of the agreement are inconsistent with the order, the order shall prevail. Not stated in order content will be subject to the provisions of agreement. Any modification, supplementary, give up should been written records, only to be valid by buyers and sellers authorized representative signature and confirmation, otherwise will be deemed invalid. 2. The agreement and order 2.1 During the validity term of this agreement, The buyer entrust SHENZHEN YICHANGTAI IMPORT AND EXPORT TRADE CO., LTD or SHENZHEN LEHEYUAN TRADING CO, LTD (hereinafter referred to as the \"entrusted party\" or \"YICHANGTAI\" or \"LEHEYUAN\"), to purchase the products specified in this agreement from the seller in the form of orders. 2.2 The seller shall be confirmed within three working days after receipt of order. If the seller finds order is not acceptable or need to modify, should note entrusted party in two working days after receipt of the order, If the seller did not confirm orders in time or notice not accept orders or modifications, the seller is deemed to have been accepted the order. The orders become effective once the seller accepts, any party shall not unilaterally cancel the order before the two sides agreed . 2.3 If the seller puts forward amendments or not accept orders, the seller shall be in the form of a written notice to entrusted party, entrusted party accept the modified by written consent, the modified orders to be taken effect. 2.4 Seller\\'s note, only the buyer entrust the entrusted party issued orders, the product delivery and payment has the force of law.\\n\\n1\\n\\nSource: LOHA CO. LTD., F-1, 12/9/2019\\n\\n\\n\\n\\n\\n3. GOODS AND COUNTRY OF ORIGIN: 4. Specific order: The products quantity, unit price, specifications, delivery time and transportation, specific content shall be subject to the purchase order issued by entrusted party which is commissioned the buyer. 5. PACKING: To be packed in new strong wooden case(s) /carton(s), suitable for long distance transportation and for the change of climate, well protected against rough handling, moisture, rain, corrosion, shocks, rust, and freezing. The seller shall be liable for any damage and loss of the commodity, expenses incurred on account of improper packing, and any damage attributable to inadequate or improper protective measures taken by the seller in regard to the packing. One full set of technical All wooden material of shipping package must be treated as the requirements of Entry-Exit Inspection and Quarantine Bureau of China, by the agent whom is certified by the government where the goods is exported. And the goods must be marked with the IPPC stamps, which are certified by the government agent of Botanical-Inspection and Quarantine Bureau. 6. SHIPPING MARK: The Sellers shall mark on each package with fadeless paint the package number, gross weight, net weight, measurements and the wordings: \"KEEP AWAY FROM MOISTURE\",\"HANDLE WITH CARE\" \"THIS SIDE UP\" etc. and the shipping mark on each package with fadeless paint. 7. DATE OF SHIPMENT: According to specific order by YICHANGTAI or LEHEYUAN. 8. PORT OF SHIPMENT:\\n\\n2\\n\\nSource: LOHA CO. LTD., F-1, 12/9/2019\\n\\n\\n\\n\\n\\n9. PORT OF DESTINATION: SHENZHEN, GUANGDONG, CHINA 10. INSURANCE: To be covered by the Seller for 110% invoice value against All Risks and War Risk. 11. PAYMENT: Under Letter of Credit or T/T: Under the Letter of Credit: The Buyer shall open an irrevocable letter of credit with the bank within 30 days after signing the contract, in favor of the Seller, for 100% value of the total contract value. The letter of credit should state that partial shipments are allowed. The Buyer\\'s agent agrees to pay fo',\n",
              "    0],\n",
              "   [' F-1, 12/9/2019\\n\\n\\n\\n\\n\\n3. GOODS AND COUNTRY OF ORIGIN: 4. Specific order: The products quantity, unit price, specifications, delivery time and transportation, specific content shall be subject to the purchase order issued by entrusted party which is commissioned the buyer. 5. PACKING: To be packed in new strong wooden case(s) /carton(s), suitable for long distance transportation and for the change of climate, well protected against rough handling, moisture, rain, corrosion, shocks, rust, and freezing. The seller shall be liable for any damage and loss of the commodity, expenses incurred on account of improper packing, and any damage attributable to inadequate or improper protective measures taken by the seller in regard to the packing. One full set of technical All wooden material of shipping package must be treated as the requirements of Entry-Exit Inspection and Quarantine Bureau of China, by the agent whom is certified by the government where the goods is exported. And the goods must be marked with the IPPC stamps, which are certified by the government agent of Botanical-Inspection and Quarantine Bureau. 6. SHIPPING MARK: The Sellers shall mark on each package with fadeless paint the package number, gross weight, net weight, measurements and the wordings: \"KEEP AWAY FROM MOISTURE\",\"HANDLE WITH CARE\" \"THIS SIDE UP\" etc. and the shipping mark on each package with fadeless paint. 7. DATE OF SHIPMENT: According to specific order by YICHANGTAI or LEHEYUAN. 8. PORT OF SHIPMENT:\\n\\n2\\n\\nSource: LOHA CO. LTD., F-1, 12/9/2019\\n\\n\\n\\n\\n\\n9. PORT OF DESTINATION: SHENZHEN, GUANGDONG, CHINA 10. INSURANCE: To be covered by the Seller for 110% invoice value against All Risks and War Risk. 11. PAYMENT: Under Letter of Credit or T/T: Under the Letter of Credit: The Buyer shall open an irrevocable letter of credit with the bank within 30 days after signing the contract, in favor of the Seller, for 100% value of the total contract value. The letter of credit should state that partial shipments are allowed. The Buyer\\'s agent agrees to pay for the goods in accordance with the actual amount of the goods shipped. 80% of the system value being shipped will be paid against the documents stipulated in Clause 12.1. The remaining 20% of the system value being shipped will be paid against the documents stipulated in Clause 12.2. The Letter of Credit shall be valid until 90 days after the latest shipment is effected. Under the T/T The trustee of the buyer remitted the goods to the seller by telegraphic transfer in batches as agreed upon after signing each order. 12. DOCUMENTS: 12.1 (1) Invoice in 5 originals indicating contract number and Shipping Mark (in case of more than one shipping mark, the invoice shall be issued separately). (2) One certificate of origin of the goods. (3) Four original copies of the packing list. (4) Certificate of Quality and Quantity in 1 original issued by the agriculture products base. (5) One copy of insurance coverage (6) Copy of cable/letter to the transportation department of Buyer advising of particulars as to shipment immediately after shipment is made.\\n\\n3\\n\\nSource: LOHA CO. LTD., F-1, 12/9/2019\\n\\n\\n\\n\\n\\n12.2 (1) Invoice in 3 originals indicating contract number and L/C number. (2) Final acceptance certificate signed by the Buyer and the Seller. 13. SHIPMENT: CIP The seller shall contract on usual terms at his own expenses for the carriage of the goods to the agreed point at the named place of destination and bear all risks and expenses until the goods have been delivered to the port of destination. The Sellers shall ship the goods within the shipment time from the port of shipment to the port of destination. Transshipment is allowed. Partial Shipment is allowed. In case the goods are to be dispatched by parcel post/sea-freight, the Sellers shall, 3 days before the time of delivery, inform the Buyers by cable/letter of the estimated date of delivery, Contract No., commodity, invoiced value, etc. The sellers shall, immediately after dispatch of the goods, advise the Buyers by cable/letter of the Contract No., commodity, invoiced v',\n",
              "    2048],\n",
              "   [\"r the goods in accordance with the actual amount of the goods shipped. 80% of the system value being shipped will be paid against the documents stipulated in Clause 12.1. The remaining 20% of the system value being shipped will be paid against the documents stipulated in Clause 12.2. The Letter of Credit shall be valid until 90 days after the latest shipment is effected. Under the T/T The trustee of the buyer remitted the goods to the seller by telegraphic transfer in batches as agreed upon after signing each order. 12. DOCUMENTS: 12.1 (1) Invoice in 5 originals indicating contract number and Shipping Mark (in case of more than one shipping mark, the invoice shall be issued separately). (2) One certificate of origin of the goods. (3) Four original copies of the packing list. (4) Certificate of Quality and Quantity in 1 original issued by the agriculture products base. (5) One copy of insurance coverage (6) Copy of cable/letter to the transportation department of Buyer advising of particulars as to shipment immediately after shipment is made.\\n\\n3\\n\\nSource: LOHA CO. LTD., F-1, 12/9/2019\\n\\n\\n\\n\\n\\n12.2 (1) Invoice in 3 originals indicating contract number and L/C number. (2) Final acceptance certificate signed by the Buyer and the Seller. 13. SHIPMENT: CIP The seller shall contract on usual terms at his own expenses for the carriage of the goods to the agreed point at the named place of destination and bear all risks and expenses until the goods have been delivered to the port of destination. The Sellers shall ship the goods within the shipment time from the port of shipment to the port of destination. Transshipment is allowed. Partial Shipment is allowed. In case the goods are to be dispatched by parcel post/sea-freight, the Sellers shall, 3 days before the time of delivery, inform the Buyers by cable/letter of the estimated date of delivery, Contract No., commodity, invoiced value, etc. The sellers shall, immediately after dispatch of the goods, advise the Buyers by cable/letter of the Contract No., commodity, invoiced value and date of dispatch for the Buyers. 14. SHIPPING ADVICE: The seller shall within 72 hours after the shipment of the goods, advise the shipping department of buyer by fax or E-mail of Contract No., goods name, quantity, value, number of packages, gross weight, measurements and the estimated arrival time of the goods at the destination. 15. GUARANTEE OF QUALITY: The Sellers guarantee that the commodity hereof is complies in all respects with the quality and specification stipulated in this Contract. 16. CLAIMS: Within 7 days after the arrival of the goods at destination, should the quality, specification, or quantity be found not in conformity with the stipulations of the Contract except those claims for which the insurance company or the owners of the vessel are liable, the Buyers, on the strength of the Inspection Certificate issued by the China Commodity Inspection Bureau, have the right to claim for replacement with new goods, or for compensation, and all the expenses (such as inspection charges, freight for returning the goods and for sending the replacement, insurance premium, storage and loading and unloading charges etc.) shall be borne by the Sellers. The Certificate so issued shall be accepted as the base of a claim. The Sellers, in accordance with the Buyers' claim, shall be responsible for the immediate elimination of the defect(s), complete or partial replacement of the commodity or shall devaluate the commodity according to the state of defect(s). Where necessary, the Buyers shall be at liberty to eliminate the defect(s) themselves at the Sellers' expenses. If the Sellers fail to answer the Buyers within one weeks after receipt of the aforesaid claim, the claim shall be reckoned as having been accepted by the Sellers.\\n\\n4\\n\\nSource: LOHA CO. LTD., F-1, 12/9/2019\\n\\n\\n\\n\\n\\n17. FORCE MAJEURE: The Sellers shall not be held responsible for the delay in shipment or non-delivery, of the goods due to Force Majeure, which might occur during the process of manufacturing or in the course of loading or transit. Th\",\n",
              "    4096],\n",
              "   [\"alue and date of dispatch for the Buyers. 14. SHIPPING ADVICE: The seller shall within 72 hours after the shipment of the goods, advise the shipping department of buyer by fax or E-mail of Contract No., goods name, quantity, value, number of packages, gross weight, measurements and the estimated arrival time of the goods at the destination. 15. GUARANTEE OF QUALITY: The Sellers guarantee that the commodity hereof is complies in all respects with the quality and specification stipulated in this Contract. 16. CLAIMS: Within 7 days after the arrival of the goods at destination, should the quality, specification, or quantity be found not in conformity with the stipulations of the Contract except those claims for which the insurance company or the owners of the vessel are liable, the Buyers, on the strength of the Inspection Certificate issued by the China Commodity Inspection Bureau, have the right to claim for replacement with new goods, or for compensation, and all the expenses (such as inspection charges, freight for returning the goods and for sending the replacement, insurance premium, storage and loading and unloading charges etc.) shall be borne by the Sellers. The Certificate so issued shall be accepted as the base of a claim. The Sellers, in accordance with the Buyers' claim, shall be responsible for the immediate elimination of the defect(s), complete or partial replacement of the commodity or shall devaluate the commodity according to the state of defect(s). Where necessary, the Buyers shall be at liberty to eliminate the defect(s) themselves at the Sellers' expenses. If the Sellers fail to answer the Buyers within one weeks after receipt of the aforesaid claim, the claim shall be reckoned as having been accepted by the Sellers.\\n\\n4\\n\\nSource: LOHA CO. LTD., F-1, 12/9/2019\\n\\n\\n\\n\\n\\n17. FORCE MAJEURE: The Sellers shall not be held responsible for the delay in shipment or non-delivery, of the goods due to Force Majeure, which might occur during the process of manufacturing or in the course of loading or transit. The Sellers shall advise the Buyers immediately of the occurrence mentioned above and within fourteen days thereafter, the Sellers shall send by airmail to the Buyers a certificate of the accident issued by the competent government authorities, Chamber of Commerce or registered notary public of the place where the accident occurs as evidence thereof. Under such circumstances the Sellers, however, are still under the obligation to take all necessary measures to hasten the delivery of the goods. In case the accident lasts for more than 10 weeks, the Buyers shall have the right to cancel the Contract. 18. LATE DELIVERY AND PENALTY: Should the Sellers fail to make delivery on time as stipulated in the Contract, with exception of Force Majeure causes specified in Clause 17 of this Contract, the Buyers shall agree to postpone the delivery on condition that the Sellers agree to pay a penalty which shall be deducted by the paying bank from the payment. The penalty, however, shall not exceed 5% of the total value of the goods involved in the late delivery. The rate of penalty is charged at 0.5% for every seven days, odd days less than seven days should be counted as seven days. In case the Sellers fail to make delivery ten weeks later than the time of shipment stipulated in the Contract, the Buyers have the right to cancel the contract and the Sellers, in spite of the cancellation, shall still pay the aforesaid penalty to the Buyers without delay, the seller should refund the money received and pay the 30% of the total goods price of the penalty 19. ARBITRATION: All disputes in connection with this Contract or the execution thereof shall be settled friendly through negotiations. In case no settlement can be reached, the case may then be submitted for arbitration to the Foreign Economic and Trade Arbitration Committee of the China Beijing Council for the Promotion of International Trade in accordance with its Provisional Rules of Procedures by the said Arbitration Committee. The Arbitration shall take place in Beijing and th\",\n",
              "    6144],\n",
              "   [\"e Sellers shall advise the Buyers immediately of the occurrence mentioned above and within fourteen days thereafter, the Sellers shall send by airmail to the Buyers a certificate of the accident issued by the competent government authorities, Chamber of Commerce or registered notary public of the place where the accident occurs as evidence thereof. Under such circumstances the Sellers, however, are still under the obligation to take all necessary measures to hasten the delivery of the goods. In case the accident lasts for more than 10 weeks, the Buyers shall have the right to cancel the Contract. 18. LATE DELIVERY AND PENALTY: Should the Sellers fail to make delivery on time as stipulated in the Contract, with exception of Force Majeure causes specified in Clause 17 of this Contract, the Buyers shall agree to postpone the delivery on condition that the Sellers agree to pay a penalty which shall be deducted by the paying bank from the payment. The penalty, however, shall not exceed 5% of the total value of the goods involved in the late delivery. The rate of penalty is charged at 0.5% for every seven days, odd days less than seven days should be counted as seven days. In case the Sellers fail to make delivery ten weeks later than the time of shipment stipulated in the Contract, the Buyers have the right to cancel the contract and the Sellers, in spite of the cancellation, shall still pay the aforesaid penalty to the Buyers without delay, the seller should refund the money received and pay the 30% of the total goods price of the penalty 19. ARBITRATION: All disputes in connection with this Contract or the execution thereof shall be settled friendly through negotiations. In case no settlement can be reached, the case may then be submitted for arbitration to the Foreign Economic and Trade Arbitration Committee of the China Beijing Council for the Promotion of International Trade in accordance with its Provisional Rules of Procedures by the said Arbitration Committee. The Arbitration shall take place in Beijing and the decision of the Arbitration Committee shall be final and binding upon both parties; neither party shall seek recourse to a law court nor other authorities to appeal for revision of the decision. Arbitration fee shall be borne by the losing party. 20. This final price is the confidential information. Dissemination, distribution or duplication of this price is strictly prohibited.\\n\\n5\\n\\nSource: LOHA CO. LTD., F-1, 12/9/2019\\n\\n\\n\\n\\n\\n21. Law application It will be governed by the law of the People's Republic of China ,otherwise it is governed by United Nations Convention on Contract for the International Sale of Goods. 22. <<Incoterms 2000>> The terms in the contract are based on (INCOTERMS 2000) of the International Chamber of Commerce. 23. The Contract is valid for 5 years, beginning from and ended on . This Contract is made out in three originals in both Chinese and English, each language being legally of the equal effect. Conflicts between these two languages arising there from, if any, shall be subject to Chinese version. One copy for the Sellers, two copies for the Buyers. The Contract becomes effective after signed by both parties. THE BUYER: THE SELLER: SIGNATURE: SIGNATURE: 6\\n\\nSource: LOHA CO. LTD., F-1, 12/9/2019\",\n",
              "    8192],\n",
              "   [\"e decision of the Arbitration Committee shall be final and binding upon both parties; neither party shall seek recourse to a law court nor other authorities to appeal for revision of the decision. Arbitration fee shall be borne by the losing party. 20. This final price is the confidential information. Dissemination, distribution or duplication of this price is strictly prohibited.\\n\\n5\\n\\nSource: LOHA CO. LTD., F-1, 12/9/2019\\n\\n\\n\\n\\n\\n21. Law application It will be governed by the law of the People's Republic of China ,otherwise it is governed by United Nations Convention on Contract for the International Sale of Goods. 22. <<Incoterms 2000>> The terms in the contract are based on (INCOTERMS 2000) of the International Chamber of Commerce. 23. The Contract is valid for 5 years, beginning from and ended on . This Contract is made out in three originals in both Chinese and English, each language being legally of the equal effect. Conflicts between these two languages arising there from, if any, shall be subject to Chinese version. One copy for the Sellers, two copies for the Buyers. The Contract becomes effective after signed by both parties. THE BUYER: THE SELLER: SIGNATURE: SIGNATURE: 6\\n\\nSource: LOHA CO. LTD., F-1, 12/9/2019\",\n",
              "    10240]])]"
            ]
          },
          "metadata": {},
          "execution_count": 112
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "def expand(row):\n",
        "  for i in row[6]:\n",
        "    return ((row[0],row[1],row[2],row[3],row[4],row[5]),i)\n",
        "\n",
        "extracted_df1 = extracted_df.map(expand)\n"
      ],
      "metadata": {
        "id": "uGYGia9V7ogF"
      },
      "execution_count": null,
      "outputs": []
    },
    {
      "cell_type": "code",
      "source": [
        "extracted_df1.take(10)"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "-JeAEMsa7qL2",
        "outputId": "6457c648-0056-4718-e87c-2a3b5f549e03"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "[(('Document Name',\n",
              "   'Highlight the parts (if any) of this contract related to \"Document Name\" that should be reviewed by a lawyer. Details: The name of the contract',\n",
              "   'SUPPLY CONTRACT',\n",
              "   14,\n",
              "   29,\n",
              "   False),\n",
              "  ['Exhibit 10.16 SUPPLY CONTRACT Contract No: Date: The buyer/End-User: Shenzhen LOHAS Supply Chain Management Co., Ltd. ADD: Tel No. : Fax No. : The seller: ADD: The Contract is concluded and signed by the Buyer and Seller on , in Hong Kong. 1. General provisions 1.1 This is a framework agreement, the terms and conditions are applied to all purchase orders which signed by this agreement (hereinafter referred to as the \"order\"). 1.2 If the provisions of the agreement are inconsistent with the order, the order shall prevail. Not stated in order content will be subject to the provisions of agreement. Any modification, supplementary, give up should been written records, only to be valid by buyers and sellers authorized representative signature and confirmation, otherwise will be deemed invalid. 2. The agreement and order 2.1 During the validity term of this agreement, The buyer entrust SHENZHEN YICHANGTAI IMPORT AND EXPORT TRADE CO., LTD or SHENZHEN LEHEYUAN TRADING CO, LTD (hereinafter referred to as the \"entrusted party\" or \"YICHANGTAI\" or \"LEHEYUAN\"), to purchase the products specified in this agreement from the seller in the form of orders. 2.2 The seller shall be confirmed within three working days after receipt of order. If the seller finds order is not acceptable or need to modify, should note entrusted party in two working days after receipt of the order, If the seller did not confirm orders in time or notice not accept orders or modifications, the seller is deemed to have been accepted the order. The orders become effective once the seller accepts, any party shall not unilaterally cancel the order before the two sides agreed . 2.3 If the seller puts forward amendments or not accept orders, the seller shall be in the form of a written notice to entrusted party, entrusted party accept the modified by written consent, the modified orders to be taken effect. 2.4 Seller\\'s note, only the buyer entrust the entrusted party issued orders, the product delivery and payment has the force of law.\\n\\n1\\n\\nSource: LOHA CO. LTD., F-1, 12/9/2019\\n\\n\\n\\n\\n\\n3. GOODS AND COUNTRY OF ORIGIN: 4. Specific order: The products quantity, unit price, specifications, delivery time and transportation, specific content shall be subject to the purchase order issued by entrusted party which is commissioned the buyer. 5. PACKING: To be packed in new strong wooden case(s) /carton(s), suitable for long distance transportation and for the change of climate, well protected against rough handling, moisture, rain, corrosion, shocks, rust, and freezing. The seller shall be liable for any damage and loss of the commodity, expenses incurred on account of improper packing, and any damage attributable to inadequate or improper protective measures taken by the seller in regard to the packing. One full set of technical All wooden material of shipping package must be treated as the requirements of Entry-Exit Inspection and Quarantine Bureau of China, by the agent whom is certified by the government where the goods is exported. And the goods must be marked with the IPPC stamps, which are certified by the government agent of Botanical-Inspection and Quarantine Bureau. 6. SHIPPING MARK: The Sellers shall mark on each package with fadeless paint the package number, gross weight, net weight, measurements and the wordings: \"KEEP AWAY FROM MOISTURE\",\"HANDLE WITH CARE\" \"THIS SIDE UP\" etc. and the shipping mark on each package with fadeless paint. 7. DATE OF SHIPMENT: According to specific order by YICHANGTAI or LEHEYUAN. 8. PORT OF SHIPMENT:\\n\\n2\\n\\nSource: LOHA CO. LTD., F-1, 12/9/2019\\n\\n\\n\\n\\n\\n9. PORT OF DESTINATION: SHENZHEN, GUANGDONG, CHINA 10. INSURANCE: To be covered by the Seller for 110% invoice value against All Risks and War Risk. 11. PAYMENT: Under Letter of Credit or T/T: Under the Letter of Credit: The Buyer shall open an irrevocable letter of credit with the bank within 30 days after signing the contract, in favor of the Seller, for 100% value of the total contract value. The letter of credit should state that partial shipments are allowed. The Buyer\\'s agent agrees to pay fo',\n",
              "   0]),\n",
              " (('Parties',\n",
              "   'Highlight the parts (if any) of this contract related to \"Parties\" that should be reviewed by a lawyer. Details: The two or more parties who signed the contract',\n",
              "   'The seller:',\n",
              "   143,\n",
              "   154,\n",
              "   False),\n",
              "  ['Exhibit 10.16 SUPPLY CONTRACT Contract No: Date: The buyer/End-User: Shenzhen LOHAS Supply Chain Management Co., Ltd. ADD: Tel No. : Fax No. : The seller: ADD: The Contract is concluded and signed by the Buyer and Seller on , in Hong Kong. 1. General provisions 1.1 This is a framework agreement, the terms and conditions are applied to all purchase orders which signed by this agreement (hereinafter referred to as the \"order\"). 1.2 If the provisions of the agreement are inconsistent with the order, the order shall prevail. Not stated in order content will be subject to the provisions of agreement. Any modification, supplementary, give up should been written records, only to be valid by buyers and sellers authorized representative signature and confirmation, otherwise will be deemed invalid. 2. The agreement and order 2.1 During the validity term of this agreement, The buyer entrust SHENZHEN YICHANGTAI IMPORT AND EXPORT TRADE CO., LTD or SHENZHEN LEHEYUAN TRADING CO, LTD (hereinafter referred to as the \"entrusted party\" or \"YICHANGTAI\" or \"LEHEYUAN\"), to purchase the products specified in this agreement from the seller in the form of orders. 2.2 The seller shall be confirmed within three working days after receipt of order. If the seller finds order is not acceptable or need to modify, should note entrusted party in two working days after receipt of the order, If the seller did not confirm orders in time or notice not accept orders or modifications, the seller is deemed to have been accepted the order. The orders become effective once the seller accepts, any party shall not unilaterally cancel the order before the two sides agreed . 2.3 If the seller puts forward amendments or not accept orders, the seller shall be in the form of a written notice to entrusted party, entrusted party accept the modified by written consent, the modified orders to be taken effect. 2.4 Seller\\'s note, only the buyer entrust the entrusted party issued orders, the product delivery and payment has the force of law.\\n\\n1\\n\\nSource: LOHA CO. LTD., F-1, 12/9/2019\\n\\n\\n\\n\\n\\n3. GOODS AND COUNTRY OF ORIGIN: 4. Specific order: The products quantity, unit price, specifications, delivery time and transportation, specific content shall be subject to the purchase order issued by entrusted party which is commissioned the buyer. 5. PACKING: To be packed in new strong wooden case(s) /carton(s), suitable for long distance transportation and for the change of climate, well protected against rough handling, moisture, rain, corrosion, shocks, rust, and freezing. The seller shall be liable for any damage and loss of the commodity, expenses incurred on account of improper packing, and any damage attributable to inadequate or improper protective measures taken by the seller in regard to the packing. One full set of technical All wooden material of shipping package must be treated as the requirements of Entry-Exit Inspection and Quarantine Bureau of China, by the agent whom is certified by the government where the goods is exported. And the goods must be marked with the IPPC stamps, which are certified by the government agent of Botanical-Inspection and Quarantine Bureau. 6. SHIPPING MARK: The Sellers shall mark on each package with fadeless paint the package number, gross weight, net weight, measurements and the wordings: \"KEEP AWAY FROM MOISTURE\",\"HANDLE WITH CARE\" \"THIS SIDE UP\" etc. and the shipping mark on each package with fadeless paint. 7. DATE OF SHIPMENT: According to specific order by YICHANGTAI or LEHEYUAN. 8. PORT OF SHIPMENT:\\n\\n2\\n\\nSource: LOHA CO. LTD., F-1, 12/9/2019\\n\\n\\n\\n\\n\\n9. PORT OF DESTINATION: SHENZHEN, GUANGDONG, CHINA 10. INSURANCE: To be covered by the Seller for 110% invoice value against All Risks and War Risk. 11. PAYMENT: Under Letter of Credit or T/T: Under the Letter of Credit: The Buyer shall open an irrevocable letter of credit with the bank within 30 days after signing the contract, in favor of the Seller, for 100% value of the total contract value. The letter of credit should state that partial shipments are allowed. The Buyer\\'s agent agrees to pay fo',\n",
              "   0]),\n",
              " (('Parties',\n",
              "   'Highlight the parts (if any) of this contract related to \"Parties\" that should be reviewed by a lawyer. Details: The two or more parties who signed the contract',\n",
              "   'The buyer/End-User: Shenzhen LOHAS Supply Chain Management Co., Ltd.',\n",
              "   49,\n",
              "   117,\n",
              "   False),\n",
              "  ['Exhibit 10.16 SUPPLY CONTRACT Contract No: Date: The buyer/End-User: Shenzhen LOHAS Supply Chain Management Co., Ltd. ADD: Tel No. : Fax No. : The seller: ADD: The Contract is concluded and signed by the Buyer and Seller on , in Hong Kong. 1. General provisions 1.1 This is a framework agreement, the terms and conditions are applied to all purchase orders which signed by this agreement (hereinafter referred to as the \"order\"). 1.2 If the provisions of the agreement are inconsistent with the order, the order shall prevail. Not stated in order content will be subject to the provisions of agreement. Any modification, supplementary, give up should been written records, only to be valid by buyers and sellers authorized representative signature and confirmation, otherwise will be deemed invalid. 2. The agreement and order 2.1 During the validity term of this agreement, The buyer entrust SHENZHEN YICHANGTAI IMPORT AND EXPORT TRADE CO., LTD or SHENZHEN LEHEYUAN TRADING CO, LTD (hereinafter referred to as the \"entrusted party\" or \"YICHANGTAI\" or \"LEHEYUAN\"), to purchase the products specified in this agreement from the seller in the form of orders. 2.2 The seller shall be confirmed within three working days after receipt of order. If the seller finds order is not acceptable or need to modify, should note entrusted party in two working days after receipt of the order, If the seller did not confirm orders in time or notice not accept orders or modifications, the seller is deemed to have been accepted the order. The orders become effective once the seller accepts, any party shall not unilaterally cancel the order before the two sides agreed . 2.3 If the seller puts forward amendments or not accept orders, the seller shall be in the form of a written notice to entrusted party, entrusted party accept the modified by written consent, the modified orders to be taken effect. 2.4 Seller\\'s note, only the buyer entrust the entrusted party issued orders, the product delivery and payment has the force of law.\\n\\n1\\n\\nSource: LOHA CO. LTD., F-1, 12/9/2019\\n\\n\\n\\n\\n\\n3. GOODS AND COUNTRY OF ORIGIN: 4. Specific order: The products quantity, unit price, specifications, delivery time and transportation, specific content shall be subject to the purchase order issued by entrusted party which is commissioned the buyer. 5. PACKING: To be packed in new strong wooden case(s) /carton(s), suitable for long distance transportation and for the change of climate, well protected against rough handling, moisture, rain, corrosion, shocks, rust, and freezing. The seller shall be liable for any damage and loss of the commodity, expenses incurred on account of improper packing, and any damage attributable to inadequate or improper protective measures taken by the seller in regard to the packing. One full set of technical All wooden material of shipping package must be treated as the requirements of Entry-Exit Inspection and Quarantine Bureau of China, by the agent whom is certified by the government where the goods is exported. And the goods must be marked with the IPPC stamps, which are certified by the government agent of Botanical-Inspection and Quarantine Bureau. 6. SHIPPING MARK: The Sellers shall mark on each package with fadeless paint the package number, gross weight, net weight, measurements and the wordings: \"KEEP AWAY FROM MOISTURE\",\"HANDLE WITH CARE\" \"THIS SIDE UP\" etc. and the shipping mark on each package with fadeless paint. 7. DATE OF SHIPMENT: According to specific order by YICHANGTAI or LEHEYUAN. 8. PORT OF SHIPMENT:\\n\\n2\\n\\nSource: LOHA CO. LTD., F-1, 12/9/2019\\n\\n\\n\\n\\n\\n9. PORT OF DESTINATION: SHENZHEN, GUANGDONG, CHINA 10. INSURANCE: To be covered by the Seller for 110% invoice value against All Risks and War Risk. 11. PAYMENT: Under Letter of Credit or T/T: Under the Letter of Credit: The Buyer shall open an irrevocable letter of credit with the bank within 30 days after signing the contract, in favor of the Seller, for 100% value of the total contract value. The letter of credit should state that partial shipments are allowed. The Buyer\\'s agent agrees to pay fo',\n",
              "   0]),\n",
              " (('Expiration Date',\n",
              "   'Highlight the parts (if any) of this contract related to \"Expiration Date\" that should be reviewed by a lawyer. Details: On what date will the contract\\'s initial term expire?',\n",
              "   'The Contract is valid for 5 years, beginning from and ended on .',\n",
              "   10985,\n",
              "   11049,\n",
              "   False),\n",
              "  ['Exhibit 10.16 SUPPLY CONTRACT Contract No: Date: The buyer/End-User: Shenzhen LOHAS Supply Chain Management Co., Ltd. ADD: Tel No. : Fax No. : The seller: ADD: The Contract is concluded and signed by the Buyer and Seller on , in Hong Kong. 1. General provisions 1.1 This is a framework agreement, the terms and conditions are applied to all purchase orders which signed by this agreement (hereinafter referred to as the \"order\"). 1.2 If the provisions of the agreement are inconsistent with the order, the order shall prevail. Not stated in order content will be subject to the provisions of agreement. Any modification, supplementary, give up should been written records, only to be valid by buyers and sellers authorized representative signature and confirmation, otherwise will be deemed invalid. 2. The agreement and order 2.1 During the validity term of this agreement, The buyer entrust SHENZHEN YICHANGTAI IMPORT AND EXPORT TRADE CO., LTD or SHENZHEN LEHEYUAN TRADING CO, LTD (hereinafter referred to as the \"entrusted party\" or \"YICHANGTAI\" or \"LEHEYUAN\"), to purchase the products specified in this agreement from the seller in the form of orders. 2.2 The seller shall be confirmed within three working days after receipt of order. If the seller finds order is not acceptable or need to modify, should note entrusted party in two working days after receipt of the order, If the seller did not confirm orders in time or notice not accept orders or modifications, the seller is deemed to have been accepted the order. The orders become effective once the seller accepts, any party shall not unilaterally cancel the order before the two sides agreed . 2.3 If the seller puts forward amendments or not accept orders, the seller shall be in the form of a written notice to entrusted party, entrusted party accept the modified by written consent, the modified orders to be taken effect. 2.4 Seller\\'s note, only the buyer entrust the entrusted party issued orders, the product delivery and payment has the force of law.\\n\\n1\\n\\nSource: LOHA CO. LTD., F-1, 12/9/2019\\n\\n\\n\\n\\n\\n3. GOODS AND COUNTRY OF ORIGIN: 4. Specific order: The products quantity, unit price, specifications, delivery time and transportation, specific content shall be subject to the purchase order issued by entrusted party which is commissioned the buyer. 5. PACKING: To be packed in new strong wooden case(s) /carton(s), suitable for long distance transportation and for the change of climate, well protected against rough handling, moisture, rain, corrosion, shocks, rust, and freezing. The seller shall be liable for any damage and loss of the commodity, expenses incurred on account of improper packing, and any damage attributable to inadequate or improper protective measures taken by the seller in regard to the packing. One full set of technical All wooden material of shipping package must be treated as the requirements of Entry-Exit Inspection and Quarantine Bureau of China, by the agent whom is certified by the government where the goods is exported. And the goods must be marked with the IPPC stamps, which are certified by the government agent of Botanical-Inspection and Quarantine Bureau. 6. SHIPPING MARK: The Sellers shall mark on each package with fadeless paint the package number, gross weight, net weight, measurements and the wordings: \"KEEP AWAY FROM MOISTURE\",\"HANDLE WITH CARE\" \"THIS SIDE UP\" etc. and the shipping mark on each package with fadeless paint. 7. DATE OF SHIPMENT: According to specific order by YICHANGTAI or LEHEYUAN. 8. PORT OF SHIPMENT:\\n\\n2\\n\\nSource: LOHA CO. LTD., F-1, 12/9/2019\\n\\n\\n\\n\\n\\n9. PORT OF DESTINATION: SHENZHEN, GUANGDONG, CHINA 10. INSURANCE: To be covered by the Seller for 110% invoice value against All Risks and War Risk. 11. PAYMENT: Under Letter of Credit or T/T: Under the Letter of Credit: The Buyer shall open an irrevocable letter of credit with the bank within 30 days after signing the contract, in favor of the Seller, for 100% value of the total contract value. The letter of credit should state that partial shipments are allowed. The Buyer\\'s agent agrees to pay fo',\n",
              "   0]),\n",
              " (('Governing Law',\n",
              "   'Highlight the parts (if any) of this contract related to \"Governing Law\" that should be reviewed by a lawyer. Details: Which state/country\\'s law governs the interpretation of the contract?',\n",
              "   \"It will be governed by the law of the People's Republic of China ,otherwise it is governed by United Nations Convention on Contract for the International Sale of Goods.\",\n",
              "   10691,\n",
              "   10859,\n",
              "   False),\n",
              "  ['Exhibit 10.16 SUPPLY CONTRACT Contract No: Date: The buyer/End-User: Shenzhen LOHAS Supply Chain Management Co., Ltd. ADD: Tel No. : Fax No. : The seller: ADD: The Contract is concluded and signed by the Buyer and Seller on , in Hong Kong. 1. General provisions 1.1 This is a framework agreement, the terms and conditions are applied to all purchase orders which signed by this agreement (hereinafter referred to as the \"order\"). 1.2 If the provisions of the agreement are inconsistent with the order, the order shall prevail. Not stated in order content will be subject to the provisions of agreement. Any modification, supplementary, give up should been written records, only to be valid by buyers and sellers authorized representative signature and confirmation, otherwise will be deemed invalid. 2. The agreement and order 2.1 During the validity term of this agreement, The buyer entrust SHENZHEN YICHANGTAI IMPORT AND EXPORT TRADE CO., LTD or SHENZHEN LEHEYUAN TRADING CO, LTD (hereinafter referred to as the \"entrusted party\" or \"YICHANGTAI\" or \"LEHEYUAN\"), to purchase the products specified in this agreement from the seller in the form of orders. 2.2 The seller shall be confirmed within three working days after receipt of order. If the seller finds order is not acceptable or need to modify, should note entrusted party in two working days after receipt of the order, If the seller did not confirm orders in time or notice not accept orders or modifications, the seller is deemed to have been accepted the order. The orders become effective once the seller accepts, any party shall not unilaterally cancel the order before the two sides agreed . 2.3 If the seller puts forward amendments or not accept orders, the seller shall be in the form of a written notice to entrusted party, entrusted party accept the modified by written consent, the modified orders to be taken effect. 2.4 Seller\\'s note, only the buyer entrust the entrusted party issued orders, the product delivery and payment has the force of law.\\n\\n1\\n\\nSource: LOHA CO. LTD., F-1, 12/9/2019\\n\\n\\n\\n\\n\\n3. GOODS AND COUNTRY OF ORIGIN: 4. Specific order: The products quantity, unit price, specifications, delivery time and transportation, specific content shall be subject to the purchase order issued by entrusted party which is commissioned the buyer. 5. PACKING: To be packed in new strong wooden case(s) /carton(s), suitable for long distance transportation and for the change of climate, well protected against rough handling, moisture, rain, corrosion, shocks, rust, and freezing. The seller shall be liable for any damage and loss of the commodity, expenses incurred on account of improper packing, and any damage attributable to inadequate or improper protective measures taken by the seller in regard to the packing. One full set of technical All wooden material of shipping package must be treated as the requirements of Entry-Exit Inspection and Quarantine Bureau of China, by the agent whom is certified by the government where the goods is exported. And the goods must be marked with the IPPC stamps, which are certified by the government agent of Botanical-Inspection and Quarantine Bureau. 6. SHIPPING MARK: The Sellers shall mark on each package with fadeless paint the package number, gross weight, net weight, measurements and the wordings: \"KEEP AWAY FROM MOISTURE\",\"HANDLE WITH CARE\" \"THIS SIDE UP\" etc. and the shipping mark on each package with fadeless paint. 7. DATE OF SHIPMENT: According to specific order by YICHANGTAI or LEHEYUAN. 8. PORT OF SHIPMENT:\\n\\n2\\n\\nSource: LOHA CO. LTD., F-1, 12/9/2019\\n\\n\\n\\n\\n\\n9. PORT OF DESTINATION: SHENZHEN, GUANGDONG, CHINA 10. INSURANCE: To be covered by the Seller for 110% invoice value against All Risks and War Risk. 11. PAYMENT: Under Letter of Credit or T/T: Under the Letter of Credit: The Buyer shall open an irrevocable letter of credit with the bank within 30 days after signing the contract, in favor of the Seller, for 100% value of the total contract value. The letter of credit should state that partial shipments are allowed. The Buyer\\'s agent agrees to pay fo',\n",
              "   0]),\n",
              " (('Warranty Duration',\n",
              "   'Highlight the parts (if any) of this contract related to \"Warranty Duration\" that should be reviewed by a lawyer. Details: What is the duration of any\\xa0 warranty against defects or errors in technology, products, or services\\xa0 provided under the contract?',\n",
              "   'Within 7 days after the arrival of the goods at destination, should the quality, specification, or quantity be found not in conformity with the stipulations of the Contract except those claims for which the insurance company or the owners of the vessel are liable, the Buyers, on the strength of the Inspection Certificate issued by the China Commodity Inspection Bureau, have the right to claim for replacement with new goods, or for compensation, and all the expenses (such as inspection charges, freight for returning the goods and for sending the replacement, insurance premium, storage and loading and unloading charges etc.) shall be borne by the Sellers.',\n",
              "   6665,\n",
              "   7326,\n",
              "   False),\n",
              "  ['Exhibit 10.16 SUPPLY CONTRACT Contract No: Date: The buyer/End-User: Shenzhen LOHAS Supply Chain Management Co., Ltd. ADD: Tel No. : Fax No. : The seller: ADD: The Contract is concluded and signed by the Buyer and Seller on , in Hong Kong. 1. General provisions 1.1 This is a framework agreement, the terms and conditions are applied to all purchase orders which signed by this agreement (hereinafter referred to as the \"order\"). 1.2 If the provisions of the agreement are inconsistent with the order, the order shall prevail. Not stated in order content will be subject to the provisions of agreement. Any modification, supplementary, give up should been written records, only to be valid by buyers and sellers authorized representative signature and confirmation, otherwise will be deemed invalid. 2. The agreement and order 2.1 During the validity term of this agreement, The buyer entrust SHENZHEN YICHANGTAI IMPORT AND EXPORT TRADE CO., LTD or SHENZHEN LEHEYUAN TRADING CO, LTD (hereinafter referred to as the \"entrusted party\" or \"YICHANGTAI\" or \"LEHEYUAN\"), to purchase the products specified in this agreement from the seller in the form of orders. 2.2 The seller shall be confirmed within three working days after receipt of order. If the seller finds order is not acceptable or need to modify, should note entrusted party in two working days after receipt of the order, If the seller did not confirm orders in time or notice not accept orders or modifications, the seller is deemed to have been accepted the order. The orders become effective once the seller accepts, any party shall not unilaterally cancel the order before the two sides agreed . 2.3 If the seller puts forward amendments or not accept orders, the seller shall be in the form of a written notice to entrusted party, entrusted party accept the modified by written consent, the modified orders to be taken effect. 2.4 Seller\\'s note, only the buyer entrust the entrusted party issued orders, the product delivery and payment has the force of law.\\n\\n1\\n\\nSource: LOHA CO. LTD., F-1, 12/9/2019\\n\\n\\n\\n\\n\\n3. GOODS AND COUNTRY OF ORIGIN: 4. Specific order: The products quantity, unit price, specifications, delivery time and transportation, specific content shall be subject to the purchase order issued by entrusted party which is commissioned the buyer. 5. PACKING: To be packed in new strong wooden case(s) /carton(s), suitable for long distance transportation and for the change of climate, well protected against rough handling, moisture, rain, corrosion, shocks, rust, and freezing. The seller shall be liable for any damage and loss of the commodity, expenses incurred on account of improper packing, and any damage attributable to inadequate or improper protective measures taken by the seller in regard to the packing. One full set of technical All wooden material of shipping package must be treated as the requirements of Entry-Exit Inspection and Quarantine Bureau of China, by the agent whom is certified by the government where the goods is exported. And the goods must be marked with the IPPC stamps, which are certified by the government agent of Botanical-Inspection and Quarantine Bureau. 6. SHIPPING MARK: The Sellers shall mark on each package with fadeless paint the package number, gross weight, net weight, measurements and the wordings: \"KEEP AWAY FROM MOISTURE\",\"HANDLE WITH CARE\" \"THIS SIDE UP\" etc. and the shipping mark on each package with fadeless paint. 7. DATE OF SHIPMENT: According to specific order by YICHANGTAI or LEHEYUAN. 8. PORT OF SHIPMENT:\\n\\n2\\n\\nSource: LOHA CO. LTD., F-1, 12/9/2019\\n\\n\\n\\n\\n\\n9. PORT OF DESTINATION: SHENZHEN, GUANGDONG, CHINA 10. INSURANCE: To be covered by the Seller for 110% invoice value against All Risks and War Risk. 11. PAYMENT: Under Letter of Credit or T/T: Under the Letter of Credit: The Buyer shall open an irrevocable letter of credit with the bank within 30 days after signing the contract, in favor of the Seller, for 100% value of the total contract value. The letter of credit should state that partial shipments are allowed. The Buyer\\'s agent agrees to pay fo',\n",
              "   0]),\n",
              " (('Insurance',\n",
              "   'Highlight the parts (if any) of this contract related to \"Insurance\" that should be reviewed by a lawyer. Details: Is there a requirement for insurance that must be maintained by one party for the benefit of the counterparty?',\n",
              "   'To be covered by the Seller for 110% invoice value against All Risks and War Risk.',\n",
              "   3659,\n",
              "   3741,\n",
              "   False),\n",
              "  ['Exhibit 10.16 SUPPLY CONTRACT Contract No: Date: The buyer/End-User: Shenzhen LOHAS Supply Chain Management Co., Ltd. ADD: Tel No. : Fax No. : The seller: ADD: The Contract is concluded and signed by the Buyer and Seller on , in Hong Kong. 1. General provisions 1.1 This is a framework agreement, the terms and conditions are applied to all purchase orders which signed by this agreement (hereinafter referred to as the \"order\"). 1.2 If the provisions of the agreement are inconsistent with the order, the order shall prevail. Not stated in order content will be subject to the provisions of agreement. Any modification, supplementary, give up should been written records, only to be valid by buyers and sellers authorized representative signature and confirmation, otherwise will be deemed invalid. 2. The agreement and order 2.1 During the validity term of this agreement, The buyer entrust SHENZHEN YICHANGTAI IMPORT AND EXPORT TRADE CO., LTD or SHENZHEN LEHEYUAN TRADING CO, LTD (hereinafter referred to as the \"entrusted party\" or \"YICHANGTAI\" or \"LEHEYUAN\"), to purchase the products specified in this agreement from the seller in the form of orders. 2.2 The seller shall be confirmed within three working days after receipt of order. If the seller finds order is not acceptable or need to modify, should note entrusted party in two working days after receipt of the order, If the seller did not confirm orders in time or notice not accept orders or modifications, the seller is deemed to have been accepted the order. The orders become effective once the seller accepts, any party shall not unilaterally cancel the order before the two sides agreed . 2.3 If the seller puts forward amendments or not accept orders, the seller shall be in the form of a written notice to entrusted party, entrusted party accept the modified by written consent, the modified orders to be taken effect. 2.4 Seller\\'s note, only the buyer entrust the entrusted party issued orders, the product delivery and payment has the force of law.\\n\\n1\\n\\nSource: LOHA CO. LTD., F-1, 12/9/2019\\n\\n\\n\\n\\n\\n3. GOODS AND COUNTRY OF ORIGIN: 4. Specific order: The products quantity, unit price, specifications, delivery time and transportation, specific content shall be subject to the purchase order issued by entrusted party which is commissioned the buyer. 5. PACKING: To be packed in new strong wooden case(s) /carton(s), suitable for long distance transportation and for the change of climate, well protected against rough handling, moisture, rain, corrosion, shocks, rust, and freezing. The seller shall be liable for any damage and loss of the commodity, expenses incurred on account of improper packing, and any damage attributable to inadequate or improper protective measures taken by the seller in regard to the packing. One full set of technical All wooden material of shipping package must be treated as the requirements of Entry-Exit Inspection and Quarantine Bureau of China, by the agent whom is certified by the government where the goods is exported. And the goods must be marked with the IPPC stamps, which are certified by the government agent of Botanical-Inspection and Quarantine Bureau. 6. SHIPPING MARK: The Sellers shall mark on each package with fadeless paint the package number, gross weight, net weight, measurements and the wordings: \"KEEP AWAY FROM MOISTURE\",\"HANDLE WITH CARE\" \"THIS SIDE UP\" etc. and the shipping mark on each package with fadeless paint. 7. DATE OF SHIPMENT: According to specific order by YICHANGTAI or LEHEYUAN. 8. PORT OF SHIPMENT:\\n\\n2\\n\\nSource: LOHA CO. LTD., F-1, 12/9/2019\\n\\n\\n\\n\\n\\n9. PORT OF DESTINATION: SHENZHEN, GUANGDONG, CHINA 10. INSURANCE: To be covered by the Seller for 110% invoice value against All Risks and War Risk. 11. PAYMENT: Under Letter of Credit or T/T: Under the Letter of Credit: The Buyer shall open an irrevocable letter of credit with the bank within 30 days after signing the contract, in favor of the Seller, for 100% value of the total contract value. The letter of credit should state that partial shipments are allowed. The Buyer\\'s agent agrees to pay fo',\n",
              "   0]),\n",
              " (('Document Name',\n",
              "   'Highlight the parts (if any) of this contract related to \"Document Name\" that should be reviewed by a lawyer. Details: The name of the contract',\n",
              "   'WEB SITE HOSTING AGREEMENT',\n",
              "   225,\n",
              "   251,\n",
              "   False),\n",
              "  ['1                                                                     Exhibit 10.3\\n\\nI-on. (LOGO) www.i-on.com 561.394.9484 o 561.394-9773 fax 1733 avenida del sol, boca raton, florida, 33432\\n\\nWEB SITE HOSTING AGREEMENT\\n\\nThis WEB SITE HOSTING AGREEMENT (\"this Agreement\") is entered into this 6th day of April, 1999 by and between Centrack International, a Florida corporation (\"the Customer\"), and i-on interactive, a Florida corporation (\"i-on\").\\n\\nDEFINITIONS\\n\\nAs used in this Agreement, the term \"Web site\" shall mean a computer system intended to be accessed through the World Wide Web segment of the Internet, including software and content intended to be viewed and/or operated upon by persons accessing the computer system via the Internet. A Web site may exist on a single computer system with other Web sites.\\n\\nThe term \"Hosted Site\" shall mean the Web site of the Customer that is hosted by i-on under the terms and conditions of this Agreement.\\n\\nThe term \"Hosting Computer\" shall mean the computer system and related equipment on which the Hosted Site exists.\\n\\nSERVICES PROVIDED TO THE CUSTOMER\\n\\ni-on will maintain the operation of the Hosted Site continuously, twenty-four (24) hours per day, seven (7) days per week, including holidays, with the exception of reasonable hardware and software maintenance that must be performed on the Hosting Computer and/or the Hosted Site. i-on will use best efforts to schedule and perform such maintenance between the hours of 8pm and 8am Eastern Standard Time on weekdays, or during weekends.\\n\\nUnder this Agreement, i-on will provide the following limited services for the Hosted Site:\\n\\n      1. connectivity to the Internet via a T1 (that may be shared by other             Web sites) to a leading Internet backbone access provider such as             UUNET, and reasonable efforts to maintain such connectivity with the             phone company and the Internet backbone access provider;\\n\\n      2. use of the Hosting Computer (that may be shared by other Web sites)             as described in this Agreement and maintenance required to keep such             Hosting Computer in good working order;\\n\\n      3. physical space for the Hosting Computer at a facility that maintains             proper environmental conditions in the area(s) where the Hosting             Computer is located and maintains reasonable efforts to prevent             unauthorized access to the physical location of the Hosting             Computer;\\n\\n      4. an emergency electrical power backup system for the Hosting             Computer;\\n\\n      5. up to 150 MB of mirrored computer storage on the Hosting Computer;\\n\\n      6. archival backups of such mirrored computer storage on a weekly             basis;    2          7.  off-site storage of such backups at separate facility than the              location of the Hosting Computer;\\n\\n      8.  use of the Microsoft Windows NT Server 4.0 or higher operating              system software for the Hosting Computer and the Hosted Site;\\n\\n      9.  use of the Microsoft Internet Information Service (IIS) 3.0 or              higher Web server software for the Hosted Site (providing support              for the HTTP Web protocol);\\n\\n      10. use of the Microsoft SQL Server 6.5 or higher database server              software for the Hosted Site, within the boundaries of allocated              computer storage, per #5 above;\\n\\n      11. access to the Hosted Site via the ftp protocol to an administrative              account designated by the Customer for the Customer to maintain the              Hosted Site\\'s static content (such as HTML Web pages and computer              graphics);\\n\\n      12. up to 10 mailboxes accessible via the POP3 mail protocol that are              mapped to the Hosted Site\\'s Internet address;\\n\\n      13. up to 1 hour per month of Web site administration services at no              additional charge, limited to:\\n\\n               requests for changes to ftp/e-mail users and passwords;                   requests for e-mail configuration changes;                   modification of mail',\n",
              "   0]),\n",
              " (('Parties',\n",
              "   'Highlight the parts (if any) of this contract related to \"Parties\" that should be reviewed by a lawyer. Details: The two or more parties who signed the contract',\n",
              "   'Centrack International',\n",
              "   330,\n",
              "   352,\n",
              "   False),\n",
              "  ['1                                                                     Exhibit 10.3\\n\\nI-on. (LOGO) www.i-on.com 561.394.9484 o 561.394-9773 fax 1733 avenida del sol, boca raton, florida, 33432\\n\\nWEB SITE HOSTING AGREEMENT\\n\\nThis WEB SITE HOSTING AGREEMENT (\"this Agreement\") is entered into this 6th day of April, 1999 by and between Centrack International, a Florida corporation (\"the Customer\"), and i-on interactive, a Florida corporation (\"i-on\").\\n\\nDEFINITIONS\\n\\nAs used in this Agreement, the term \"Web site\" shall mean a computer system intended to be accessed through the World Wide Web segment of the Internet, including software and content intended to be viewed and/or operated upon by persons accessing the computer system via the Internet. A Web site may exist on a single computer system with other Web sites.\\n\\nThe term \"Hosted Site\" shall mean the Web site of the Customer that is hosted by i-on under the terms and conditions of this Agreement.\\n\\nThe term \"Hosting Computer\" shall mean the computer system and related equipment on which the Hosted Site exists.\\n\\nSERVICES PROVIDED TO THE CUSTOMER\\n\\ni-on will maintain the operation of the Hosted Site continuously, twenty-four (24) hours per day, seven (7) days per week, including holidays, with the exception of reasonable hardware and software maintenance that must be performed on the Hosting Computer and/or the Hosted Site. i-on will use best efforts to schedule and perform such maintenance between the hours of 8pm and 8am Eastern Standard Time on weekdays, or during weekends.\\n\\nUnder this Agreement, i-on will provide the following limited services for the Hosted Site:\\n\\n      1. connectivity to the Internet via a T1 (that may be shared by other             Web sites) to a leading Internet backbone access provider such as             UUNET, and reasonable efforts to maintain such connectivity with the             phone company and the Internet backbone access provider;\\n\\n      2. use of the Hosting Computer (that may be shared by other Web sites)             as described in this Agreement and maintenance required to keep such             Hosting Computer in good working order;\\n\\n      3. physical space for the Hosting Computer at a facility that maintains             proper environmental conditions in the area(s) where the Hosting             Computer is located and maintains reasonable efforts to prevent             unauthorized access to the physical location of the Hosting             Computer;\\n\\n      4. an emergency electrical power backup system for the Hosting             Computer;\\n\\n      5. up to 150 MB of mirrored computer storage on the Hosting Computer;\\n\\n      6. archival backups of such mirrored computer storage on a weekly             basis;    2          7.  off-site storage of such backups at separate facility than the              location of the Hosting Computer;\\n\\n      8.  use of the Microsoft Windows NT Server 4.0 or higher operating              system software for the Hosting Computer and the Hosted Site;\\n\\n      9.  use of the Microsoft Internet Information Service (IIS) 3.0 or              higher Web server software for the Hosted Site (providing support              for the HTTP Web protocol);\\n\\n      10. use of the Microsoft SQL Server 6.5 or higher database server              software for the Hosted Site, within the boundaries of allocated              computer storage, per #5 above;\\n\\n      11. access to the Hosted Site via the ftp protocol to an administrative              account designated by the Customer for the Customer to maintain the              Hosted Site\\'s static content (such as HTML Web pages and computer              graphics);\\n\\n      12. up to 10 mailboxes accessible via the POP3 mail protocol that are              mapped to the Hosted Site\\'s Internet address;\\n\\n      13. up to 1 hour per month of Web site administration services at no              additional charge, limited to:\\n\\n               requests for changes to ftp/e-mail users and passwords;                   requests for e-mail configuration changes;                   modification of mail',\n",
              "   0]),\n",
              " (('Parties',\n",
              "   'Highlight the parts (if any) of this contract related to \"Parties\" that should be reviewed by a lawyer. Details: The two or more parties who signed the contract',\n",
              "   'I-ON INTERACTIVE, INC.',\n",
              "   14893,\n",
              "   14915,\n",
              "   False),\n",
              "  ['1                                                                     Exhibit 10.3\\n\\nI-on. (LOGO) www.i-on.com 561.394.9484 o 561.394-9773 fax 1733 avenida del sol, boca raton, florida, 33432\\n\\nWEB SITE HOSTING AGREEMENT\\n\\nThis WEB SITE HOSTING AGREEMENT (\"this Agreement\") is entered into this 6th day of April, 1999 by and between Centrack International, a Florida corporation (\"the Customer\"), and i-on interactive, a Florida corporation (\"i-on\").\\n\\nDEFINITIONS\\n\\nAs used in this Agreement, the term \"Web site\" shall mean a computer system intended to be accessed through the World Wide Web segment of the Internet, including software and content intended to be viewed and/or operated upon by persons accessing the computer system via the Internet. A Web site may exist on a single computer system with other Web sites.\\n\\nThe term \"Hosted Site\" shall mean the Web site of the Customer that is hosted by i-on under the terms and conditions of this Agreement.\\n\\nThe term \"Hosting Computer\" shall mean the computer system and related equipment on which the Hosted Site exists.\\n\\nSERVICES PROVIDED TO THE CUSTOMER\\n\\ni-on will maintain the operation of the Hosted Site continuously, twenty-four (24) hours per day, seven (7) days per week, including holidays, with the exception of reasonable hardware and software maintenance that must be performed on the Hosting Computer and/or the Hosted Site. i-on will use best efforts to schedule and perform such maintenance between the hours of 8pm and 8am Eastern Standard Time on weekdays, or during weekends.\\n\\nUnder this Agreement, i-on will provide the following limited services for the Hosted Site:\\n\\n      1. connectivity to the Internet via a T1 (that may be shared by other             Web sites) to a leading Internet backbone access provider such as             UUNET, and reasonable efforts to maintain such connectivity with the             phone company and the Internet backbone access provider;\\n\\n      2. use of the Hosting Computer (that may be shared by other Web sites)             as described in this Agreement and maintenance required to keep such             Hosting Computer in good working order;\\n\\n      3. physical space for the Hosting Computer at a facility that maintains             proper environmental conditions in the area(s) where the Hosting             Computer is located and maintains reasonable efforts to prevent             unauthorized access to the physical location of the Hosting             Computer;\\n\\n      4. an emergency electrical power backup system for the Hosting             Computer;\\n\\n      5. up to 150 MB of mirrored computer storage on the Hosting Computer;\\n\\n      6. archival backups of such mirrored computer storage on a weekly             basis;    2          7.  off-site storage of such backups at separate facility than the              location of the Hosting Computer;\\n\\n      8.  use of the Microsoft Windows NT Server 4.0 or higher operating              system software for the Hosting Computer and the Hosted Site;\\n\\n      9.  use of the Microsoft Internet Information Service (IIS) 3.0 or              higher Web server software for the Hosted Site (providing support              for the HTTP Web protocol);\\n\\n      10. use of the Microsoft SQL Server 6.5 or higher database server              software for the Hosted Site, within the boundaries of allocated              computer storage, per #5 above;\\n\\n      11. access to the Hosted Site via the ftp protocol to an administrative              account designated by the Customer for the Customer to maintain the              Hosted Site\\'s static content (such as HTML Web pages and computer              graphics);\\n\\n      12. up to 10 mailboxes accessible via the POP3 mail protocol that are              mapped to the Hosted Site\\'s Internet address;\\n\\n      13. up to 1 hour per month of Web site administration services at no              additional charge, limited to:\\n\\n               requests for changes to ftp/e-mail users and passwords;                   requests for e-mail configuration changes;                   modification of mail',\n",
              "   0])]"
            ]
          },
          "metadata": {},
          "execution_count": 114
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "# step 2\n",
        "\n",
        "def step2(row):\n",
        "  is_impossible = row[0][-1]\n",
        "\n",
        "  if is_impossible == True:\n",
        "    return(row[0][0],'impossible negative'),(row[1][0],row[0][1],row[0][2],0,0)\n",
        "  else:\n",
        "    answer_start = row[0][3]\n",
        "    answer_end = row[0][4]\n",
        "    seq_start = row[1][1]\n",
        "\n",
        "    if answer_start - seq_start >=0 and answer_end - seq_start <=4096:\n",
        "      return(row[0][0],'positive'),(row[1][0],row[0][1],row[0][2],answer_start - seq_start,answer_end - seq_start)\n",
        "    else:\n",
        "      return(row[0][0],'possible negative'),(row[1][0],row[0][1],row[0][2],0,0)\n"
      ],
      "metadata": {
        "id": "jwxTaZn21oeS"
      },
      "execution_count": null,
      "outputs": []
    },
    {
      "cell_type": "code",
      "source": [
        "labelled_df = extracted_df1.map(step2)"
      ],
      "metadata": {
        "id": "bnskrEmg4kN-"
      },
      "execution_count": null,
      "outputs": []
    },
    {
      "cell_type": "code",
      "source": [
        "labelled_df.take(5)"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "UaFfFLPV40Mv",
        "outputId": "b6d4b680-e34a-4da4-f079-79c8bdce7ecf"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "[(('Document Name', 'positive'),\n",
              "  ('Exhibit 10.16 SUPPLY CONTRACT Contract No: Date: The buyer/End-User: Shenzhen LOHAS Supply Chain Management Co., Ltd. ADD: Tel No. : Fax No. : The seller: ADD: The Contract is concluded and signed by the Buyer and Seller on , in Hong Kong. 1. General provisions 1.1 This is a framework agreement, the terms and conditions are applied to all purchase orders which signed by this agreement (hereinafter referred to as the \"order\"). 1.2 If the provisions of the agreement are inconsistent with the order, the order shall prevail. Not stated in order content will be subject to the provisions of agreement. Any modification, supplementary, give up should been written records, only to be valid by buyers and sellers authorized representative signature and confirmation, otherwise will be deemed invalid. 2. The agreement and order 2.1 During the validity term of this agreement, The buyer entrust SHENZHEN YICHANGTAI IMPORT AND EXPORT TRADE CO., LTD or SHENZHEN LEHEYUAN TRADING CO, LTD (hereinafter referred to as the \"entrusted party\" or \"YICHANGTAI\" or \"LEHEYUAN\"), to purchase the products specified in this agreement from the seller in the form of orders. 2.2 The seller shall be confirmed within three working days after receipt of order. If the seller finds order is not acceptable or need to modify, should note entrusted party in two working days after receipt of the order, If the seller did not confirm orders in time or notice not accept orders or modifications, the seller is deemed to have been accepted the order. The orders become effective once the seller accepts, any party shall not unilaterally cancel the order before the two sides agreed . 2.3 If the seller puts forward amendments or not accept orders, the seller shall be in the form of a written notice to entrusted party, entrusted party accept the modified by written consent, the modified orders to be taken effect. 2.4 Seller\\'s note, only the buyer entrust the entrusted party issued orders, the product delivery and payment has the force of law.\\n\\n1\\n\\nSource: LOHA CO. LTD., F-1, 12/9/2019\\n\\n\\n\\n\\n\\n3. GOODS AND COUNTRY OF ORIGIN: 4. Specific order: The products quantity, unit price, specifications, delivery time and transportation, specific content shall be subject to the purchase order issued by entrusted party which is commissioned the buyer. 5. PACKING: To be packed in new strong wooden case(s) /carton(s), suitable for long distance transportation and for the change of climate, well protected against rough handling, moisture, rain, corrosion, shocks, rust, and freezing. The seller shall be liable for any damage and loss of the commodity, expenses incurred on account of improper packing, and any damage attributable to inadequate or improper protective measures taken by the seller in regard to the packing. One full set of technical All wooden material of shipping package must be treated as the requirements of Entry-Exit Inspection and Quarantine Bureau of China, by the agent whom is certified by the government where the goods is exported. And the goods must be marked with the IPPC stamps, which are certified by the government agent of Botanical-Inspection and Quarantine Bureau. 6. SHIPPING MARK: The Sellers shall mark on each package with fadeless paint the package number, gross weight, net weight, measurements and the wordings: \"KEEP AWAY FROM MOISTURE\",\"HANDLE WITH CARE\" \"THIS SIDE UP\" etc. and the shipping mark on each package with fadeless paint. 7. DATE OF SHIPMENT: According to specific order by YICHANGTAI or LEHEYUAN. 8. PORT OF SHIPMENT:\\n\\n2\\n\\nSource: LOHA CO. LTD., F-1, 12/9/2019\\n\\n\\n\\n\\n\\n9. PORT OF DESTINATION: SHENZHEN, GUANGDONG, CHINA 10. INSURANCE: To be covered by the Seller for 110% invoice value against All Risks and War Risk. 11. PAYMENT: Under Letter of Credit or T/T: Under the Letter of Credit: The Buyer shall open an irrevocable letter of credit with the bank within 30 days after signing the contract, in favor of the Seller, for 100% value of the total contract value. The letter of credit should state that partial shipments are allowed. The Buyer\\'s agent agrees to pay fo',\n",
              "   'Highlight the parts (if any) of this contract related to \"Document Name\" that should be reviewed by a lawyer. Details: The name of the contract',\n",
              "   'SUPPLY CONTRACT',\n",
              "   14,\n",
              "   29)),\n",
              " (('Parties', 'positive'),\n",
              "  ('Exhibit 10.16 SUPPLY CONTRACT Contract No: Date: The buyer/End-User: Shenzhen LOHAS Supply Chain Management Co., Ltd. ADD: Tel No. : Fax No. : The seller: ADD: The Contract is concluded and signed by the Buyer and Seller on , in Hong Kong. 1. General provisions 1.1 This is a framework agreement, the terms and conditions are applied to all purchase orders which signed by this agreement (hereinafter referred to as the \"order\"). 1.2 If the provisions of the agreement are inconsistent with the order, the order shall prevail. Not stated in order content will be subject to the provisions of agreement. Any modification, supplementary, give up should been written records, only to be valid by buyers and sellers authorized representative signature and confirmation, otherwise will be deemed invalid. 2. The agreement and order 2.1 During the validity term of this agreement, The buyer entrust SHENZHEN YICHANGTAI IMPORT AND EXPORT TRADE CO., LTD or SHENZHEN LEHEYUAN TRADING CO, LTD (hereinafter referred to as the \"entrusted party\" or \"YICHANGTAI\" or \"LEHEYUAN\"), to purchase the products specified in this agreement from the seller in the form of orders. 2.2 The seller shall be confirmed within three working days after receipt of order. If the seller finds order is not acceptable or need to modify, should note entrusted party in two working days after receipt of the order, If the seller did not confirm orders in time or notice not accept orders or modifications, the seller is deemed to have been accepted the order. The orders become effective once the seller accepts, any party shall not unilaterally cancel the order before the two sides agreed . 2.3 If the seller puts forward amendments or not accept orders, the seller shall be in the form of a written notice to entrusted party, entrusted party accept the modified by written consent, the modified orders to be taken effect. 2.4 Seller\\'s note, only the buyer entrust the entrusted party issued orders, the product delivery and payment has the force of law.\\n\\n1\\n\\nSource: LOHA CO. LTD., F-1, 12/9/2019\\n\\n\\n\\n\\n\\n3. GOODS AND COUNTRY OF ORIGIN: 4. Specific order: The products quantity, unit price, specifications, delivery time and transportation, specific content shall be subject to the purchase order issued by entrusted party which is commissioned the buyer. 5. PACKING: To be packed in new strong wooden case(s) /carton(s), suitable for long distance transportation and for the change of climate, well protected against rough handling, moisture, rain, corrosion, shocks, rust, and freezing. The seller shall be liable for any damage and loss of the commodity, expenses incurred on account of improper packing, and any damage attributable to inadequate or improper protective measures taken by the seller in regard to the packing. One full set of technical All wooden material of shipping package must be treated as the requirements of Entry-Exit Inspection and Quarantine Bureau of China, by the agent whom is certified by the government where the goods is exported. And the goods must be marked with the IPPC stamps, which are certified by the government agent of Botanical-Inspection and Quarantine Bureau. 6. SHIPPING MARK: The Sellers shall mark on each package with fadeless paint the package number, gross weight, net weight, measurements and the wordings: \"KEEP AWAY FROM MOISTURE\",\"HANDLE WITH CARE\" \"THIS SIDE UP\" etc. and the shipping mark on each package with fadeless paint. 7. DATE OF SHIPMENT: According to specific order by YICHANGTAI or LEHEYUAN. 8. PORT OF SHIPMENT:\\n\\n2\\n\\nSource: LOHA CO. LTD., F-1, 12/9/2019\\n\\n\\n\\n\\n\\n9. PORT OF DESTINATION: SHENZHEN, GUANGDONG, CHINA 10. INSURANCE: To be covered by the Seller for 110% invoice value against All Risks and War Risk. 11. PAYMENT: Under Letter of Credit or T/T: Under the Letter of Credit: The Buyer shall open an irrevocable letter of credit with the bank within 30 days after signing the contract, in favor of the Seller, for 100% value of the total contract value. The letter of credit should state that partial shipments are allowed. The Buyer\\'s agent agrees to pay fo',\n",
              "   'Highlight the parts (if any) of this contract related to \"Parties\" that should be reviewed by a lawyer. Details: The two or more parties who signed the contract',\n",
              "   'The seller:',\n",
              "   143,\n",
              "   154)),\n",
              " (('Parties', 'positive'),\n",
              "  ('Exhibit 10.16 SUPPLY CONTRACT Contract No: Date: The buyer/End-User: Shenzhen LOHAS Supply Chain Management Co., Ltd. ADD: Tel No. : Fax No. : The seller: ADD: The Contract is concluded and signed by the Buyer and Seller on , in Hong Kong. 1. General provisions 1.1 This is a framework agreement, the terms and conditions are applied to all purchase orders which signed by this agreement (hereinafter referred to as the \"order\"). 1.2 If the provisions of the agreement are inconsistent with the order, the order shall prevail. Not stated in order content will be subject to the provisions of agreement. Any modification, supplementary, give up should been written records, only to be valid by buyers and sellers authorized representative signature and confirmation, otherwise will be deemed invalid. 2. The agreement and order 2.1 During the validity term of this agreement, The buyer entrust SHENZHEN YICHANGTAI IMPORT AND EXPORT TRADE CO., LTD or SHENZHEN LEHEYUAN TRADING CO, LTD (hereinafter referred to as the \"entrusted party\" or \"YICHANGTAI\" or \"LEHEYUAN\"), to purchase the products specified in this agreement from the seller in the form of orders. 2.2 The seller shall be confirmed within three working days after receipt of order. If the seller finds order is not acceptable or need to modify, should note entrusted party in two working days after receipt of the order, If the seller did not confirm orders in time or notice not accept orders or modifications, the seller is deemed to have been accepted the order. The orders become effective once the seller accepts, any party shall not unilaterally cancel the order before the two sides agreed . 2.3 If the seller puts forward amendments or not accept orders, the seller shall be in the form of a written notice to entrusted party, entrusted party accept the modified by written consent, the modified orders to be taken effect. 2.4 Seller\\'s note, only the buyer entrust the entrusted party issued orders, the product delivery and payment has the force of law.\\n\\n1\\n\\nSource: LOHA CO. LTD., F-1, 12/9/2019\\n\\n\\n\\n\\n\\n3. GOODS AND COUNTRY OF ORIGIN: 4. Specific order: The products quantity, unit price, specifications, delivery time and transportation, specific content shall be subject to the purchase order issued by entrusted party which is commissioned the buyer. 5. PACKING: To be packed in new strong wooden case(s) /carton(s), suitable for long distance transportation and for the change of climate, well protected against rough handling, moisture, rain, corrosion, shocks, rust, and freezing. The seller shall be liable for any damage and loss of the commodity, expenses incurred on account of improper packing, and any damage attributable to inadequate or improper protective measures taken by the seller in regard to the packing. One full set of technical All wooden material of shipping package must be treated as the requirements of Entry-Exit Inspection and Quarantine Bureau of China, by the agent whom is certified by the government where the goods is exported. And the goods must be marked with the IPPC stamps, which are certified by the government agent of Botanical-Inspection and Quarantine Bureau. 6. SHIPPING MARK: The Sellers shall mark on each package with fadeless paint the package number, gross weight, net weight, measurements and the wordings: \"KEEP AWAY FROM MOISTURE\",\"HANDLE WITH CARE\" \"THIS SIDE UP\" etc. and the shipping mark on each package with fadeless paint. 7. DATE OF SHIPMENT: According to specific order by YICHANGTAI or LEHEYUAN. 8. PORT OF SHIPMENT:\\n\\n2\\n\\nSource: LOHA CO. LTD., F-1, 12/9/2019\\n\\n\\n\\n\\n\\n9. PORT OF DESTINATION: SHENZHEN, GUANGDONG, CHINA 10. INSURANCE: To be covered by the Seller for 110% invoice value against All Risks and War Risk. 11. PAYMENT: Under Letter of Credit or T/T: Under the Letter of Credit: The Buyer shall open an irrevocable letter of credit with the bank within 30 days after signing the contract, in favor of the Seller, for 100% value of the total contract value. The letter of credit should state that partial shipments are allowed. The Buyer\\'s agent agrees to pay fo',\n",
              "   'Highlight the parts (if any) of this contract related to \"Parties\" that should be reviewed by a lawyer. Details: The two or more parties who signed the contract',\n",
              "   'The buyer/End-User: Shenzhen LOHAS Supply Chain Management Co., Ltd.',\n",
              "   49,\n",
              "   117)),\n",
              " (('Expiration Date', 'possible negative'),\n",
              "  ('Exhibit 10.16 SUPPLY CONTRACT Contract No: Date: The buyer/End-User: Shenzhen LOHAS Supply Chain Management Co., Ltd. ADD: Tel No. : Fax No. : The seller: ADD: The Contract is concluded and signed by the Buyer and Seller on , in Hong Kong. 1. General provisions 1.1 This is a framework agreement, the terms and conditions are applied to all purchase orders which signed by this agreement (hereinafter referred to as the \"order\"). 1.2 If the provisions of the agreement are inconsistent with the order, the order shall prevail. Not stated in order content will be subject to the provisions of agreement. Any modification, supplementary, give up should been written records, only to be valid by buyers and sellers authorized representative signature and confirmation, otherwise will be deemed invalid. 2. The agreement and order 2.1 During the validity term of this agreement, The buyer entrust SHENZHEN YICHANGTAI IMPORT AND EXPORT TRADE CO., LTD or SHENZHEN LEHEYUAN TRADING CO, LTD (hereinafter referred to as the \"entrusted party\" or \"YICHANGTAI\" or \"LEHEYUAN\"), to purchase the products specified in this agreement from the seller in the form of orders. 2.2 The seller shall be confirmed within three working days after receipt of order. If the seller finds order is not acceptable or need to modify, should note entrusted party in two working days after receipt of the order, If the seller did not confirm orders in time or notice not accept orders or modifications, the seller is deemed to have been accepted the order. The orders become effective once the seller accepts, any party shall not unilaterally cancel the order before the two sides agreed . 2.3 If the seller puts forward amendments or not accept orders, the seller shall be in the form of a written notice to entrusted party, entrusted party accept the modified by written consent, the modified orders to be taken effect. 2.4 Seller\\'s note, only the buyer entrust the entrusted party issued orders, the product delivery and payment has the force of law.\\n\\n1\\n\\nSource: LOHA CO. LTD., F-1, 12/9/2019\\n\\n\\n\\n\\n\\n3. GOODS AND COUNTRY OF ORIGIN: 4. Specific order: The products quantity, unit price, specifications, delivery time and transportation, specific content shall be subject to the purchase order issued by entrusted party which is commissioned the buyer. 5. PACKING: To be packed in new strong wooden case(s) /carton(s), suitable for long distance transportation and for the change of climate, well protected against rough handling, moisture, rain, corrosion, shocks, rust, and freezing. The seller shall be liable for any damage and loss of the commodity, expenses incurred on account of improper packing, and any damage attributable to inadequate or improper protective measures taken by the seller in regard to the packing. One full set of technical All wooden material of shipping package must be treated as the requirements of Entry-Exit Inspection and Quarantine Bureau of China, by the agent whom is certified by the government where the goods is exported. And the goods must be marked with the IPPC stamps, which are certified by the government agent of Botanical-Inspection and Quarantine Bureau. 6. SHIPPING MARK: The Sellers shall mark on each package with fadeless paint the package number, gross weight, net weight, measurements and the wordings: \"KEEP AWAY FROM MOISTURE\",\"HANDLE WITH CARE\" \"THIS SIDE UP\" etc. and the shipping mark on each package with fadeless paint. 7. DATE OF SHIPMENT: According to specific order by YICHANGTAI or LEHEYUAN. 8. PORT OF SHIPMENT:\\n\\n2\\n\\nSource: LOHA CO. LTD., F-1, 12/9/2019\\n\\n\\n\\n\\n\\n9. PORT OF DESTINATION: SHENZHEN, GUANGDONG, CHINA 10. INSURANCE: To be covered by the Seller for 110% invoice value against All Risks and War Risk. 11. PAYMENT: Under Letter of Credit or T/T: Under the Letter of Credit: The Buyer shall open an irrevocable letter of credit with the bank within 30 days after signing the contract, in favor of the Seller, for 100% value of the total contract value. The letter of credit should state that partial shipments are allowed. The Buyer\\'s agent agrees to pay fo',\n",
              "   'Highlight the parts (if any) of this contract related to \"Expiration Date\" that should be reviewed by a lawyer. Details: On what date will the contract\\'s initial term expire?',\n",
              "   'The Contract is valid for 5 years, beginning from and ended on .',\n",
              "   0,\n",
              "   0)),\n",
              " (('Governing Law', 'possible negative'),\n",
              "  ('Exhibit 10.16 SUPPLY CONTRACT Contract No: Date: The buyer/End-User: Shenzhen LOHAS Supply Chain Management Co., Ltd. ADD: Tel No. : Fax No. : The seller: ADD: The Contract is concluded and signed by the Buyer and Seller on , in Hong Kong. 1. General provisions 1.1 This is a framework agreement, the terms and conditions are applied to all purchase orders which signed by this agreement (hereinafter referred to as the \"order\"). 1.2 If the provisions of the agreement are inconsistent with the order, the order shall prevail. Not stated in order content will be subject to the provisions of agreement. Any modification, supplementary, give up should been written records, only to be valid by buyers and sellers authorized representative signature and confirmation, otherwise will be deemed invalid. 2. The agreement and order 2.1 During the validity term of this agreement, The buyer entrust SHENZHEN YICHANGTAI IMPORT AND EXPORT TRADE CO., LTD or SHENZHEN LEHEYUAN TRADING CO, LTD (hereinafter referred to as the \"entrusted party\" or \"YICHANGTAI\" or \"LEHEYUAN\"), to purchase the products specified in this agreement from the seller in the form of orders. 2.2 The seller shall be confirmed within three working days after receipt of order. If the seller finds order is not acceptable or need to modify, should note entrusted party in two working days after receipt of the order, If the seller did not confirm orders in time or notice not accept orders or modifications, the seller is deemed to have been accepted the order. The orders become effective once the seller accepts, any party shall not unilaterally cancel the order before the two sides agreed . 2.3 If the seller puts forward amendments or not accept orders, the seller shall be in the form of a written notice to entrusted party, entrusted party accept the modified by written consent, the modified orders to be taken effect. 2.4 Seller\\'s note, only the buyer entrust the entrusted party issued orders, the product delivery and payment has the force of law.\\n\\n1\\n\\nSource: LOHA CO. LTD., F-1, 12/9/2019\\n\\n\\n\\n\\n\\n3. GOODS AND COUNTRY OF ORIGIN: 4. Specific order: The products quantity, unit price, specifications, delivery time and transportation, specific content shall be subject to the purchase order issued by entrusted party which is commissioned the buyer. 5. PACKING: To be packed in new strong wooden case(s) /carton(s), suitable for long distance transportation and for the change of climate, well protected against rough handling, moisture, rain, corrosion, shocks, rust, and freezing. The seller shall be liable for any damage and loss of the commodity, expenses incurred on account of improper packing, and any damage attributable to inadequate or improper protective measures taken by the seller in regard to the packing. One full set of technical All wooden material of shipping package must be treated as the requirements of Entry-Exit Inspection and Quarantine Bureau of China, by the agent whom is certified by the government where the goods is exported. And the goods must be marked with the IPPC stamps, which are certified by the government agent of Botanical-Inspection and Quarantine Bureau. 6. SHIPPING MARK: The Sellers shall mark on each package with fadeless paint the package number, gross weight, net weight, measurements and the wordings: \"KEEP AWAY FROM MOISTURE\",\"HANDLE WITH CARE\" \"THIS SIDE UP\" etc. and the shipping mark on each package with fadeless paint. 7. DATE OF SHIPMENT: According to specific order by YICHANGTAI or LEHEYUAN. 8. PORT OF SHIPMENT:\\n\\n2\\n\\nSource: LOHA CO. LTD., F-1, 12/9/2019\\n\\n\\n\\n\\n\\n9. PORT OF DESTINATION: SHENZHEN, GUANGDONG, CHINA 10. INSURANCE: To be covered by the Seller for 110% invoice value against All Risks and War Risk. 11. PAYMENT: Under Letter of Credit or T/T: Under the Letter of Credit: The Buyer shall open an irrevocable letter of credit with the bank within 30 days after signing the contract, in favor of the Seller, for 100% value of the total contract value. The letter of credit should state that partial shipments are allowed. The Buyer\\'s agent agrees to pay fo',\n",
              "   'Highlight the parts (if any) of this contract related to \"Governing Law\" that should be reviewed by a lawyer. Details: Which state/country\\'s law governs the interpretation of the contract?',\n",
              "   \"It will be governed by the law of the People's Republic of China ,otherwise it is governed by United Nations Convention on Contract for the International Sale of Goods.\",\n",
              "   0,\n",
              "   0))]"
            ]
          },
          "metadata": {},
          "execution_count": 117
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "\n",
        "# For an impossible question in a contract, the number of impossible negative samples\n",
        "# to keep equals the average number of positive samples of that question in other\n",
        "# contracts that have at least one positive sample for the same question.\n",
        "\n",
        "# For each contract, the number of possible negative samples to keep for each question\n",
        "# equals the number of positive samples of that question in this contract.\n",
        "\n",
        "count = labelled_df.countByKey()\n",
        "\n",
        "def countPos(row):\n",
        "  label = row[0][1]\n",
        "  if label == 'positive':\n",
        "    id = row[0][0]\n",
        "    question = row[1][1]\n",
        "    return((question,id),label)\n",
        "\n",
        "\n",
        "pos_count = labelled_df.map(countPos).filter(lambda x: x is not None).groupByKey().mapValues(list).map(lambda x: (x[0],len(x[1]))).collect()\n",
        "print(pos_count)"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "DZ5LeDsb4_GQ",
        "outputId": "90690f01-df71-4ade-c414-7b58285434b7"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "[(('Highlight the parts (if any) of this contract related to \"Document Name\" that should be reviewed by a lawyer. Details: The name of the contract', 'Document Name'), 84), (('Highlight the parts (if any) of this contract related to \"Insurance\" that should be reviewed by a lawyer. Details: Is there a requirement for insurance that must be maintained by one party for the benefit of the counterparty?', 'Insurance'), 3), (('Highlight the parts (if any) of this contract related to \"Agreement Date\" that should be reviewed by a lawyer. Details: The date of the contract', 'Agreement Date'), 84), (('Highlight the parts (if any) of this contract related to \"Non-Compete\" that should be reviewed by a lawyer. Details: Is there a restriction on the ability of a party to compete with the counterparty or operate in a certain geography or business or technology sector?\\xa0', 'Non-Compete'), 1), (('Highlight the parts (if any) of this contract related to \"License Grant\" that should be reviewed by a lawyer. Details: Does the contract contain a license granted by one party to its counterparty?', 'License Grant'), 23), (('Highlight the parts (if any) of this contract related to \"Irrevocable Or Perpetual License\" that should be reviewed by a lawyer. Details: Does the contract contain a\\xa0 license grant that is irrevocable or perpetual?', 'Irrevocable Or Perpetual License'), 2), (('Highlight the parts (if any) of this contract related to \"Expiration Date\" that should be reviewed by a lawyer. Details: On what date will the contract\\'s initial term expire?', 'Expiration Date'), 19), (('Highlight the parts (if any) of this contract related to \"Covenant Not To Sue\" that should be reviewed by a lawyer. Details: Is a party restricted from contesting the validity of the counterpartyโs ownership of intellectual property or otherwise bringing a claim against the counterparty for matters unrelated to the contract?', 'Covenant Not To Sue'), 3), (('Highlight the parts (if any) of this contract related to \"Non-Transferable License\" that should be reviewed by a lawyer. Details: Does the contract limit the ability of a party to transfer the license being granted to a third party?', 'Non-Transferable License'), 3), (('Highlight the parts (if any) of this contract related to \"Rofr/Rofo/Rofn\" that should be reviewed by a lawyer. Details: Is there a clause granting one party a right of first refusal, right of first offer or right of first negotiation to purchase, license, market, or distribute equity interest, technology, assets, products or services?', 'Rofr/Rofo/Rofn'), 1), (('Highlight the parts (if any) of this contract related to \"Affiliate License-Licensor\" that should be reviewed by a lawyer. Details: Does the contract contain a license grant by affiliates of the licensor or that includes intellectual property of affiliates of the licensor?\\xa0', 'Affiliate License-Licensor'), 1), (('Highlight the parts (if any) of this contract related to \"Affiliate License-Licensee\" that should be reviewed by a lawyer. Details: Does the contract contain a license grant to a licensee (incl. sublicensor) and the affiliates of such licensee/sublicensor?', 'Affiliate License-Licensee'), 3), (('Highlight the parts (if any) of this contract related to \"Post-Termination Services\" that should be reviewed by a lawyer. Details: Is a party subject to obligations after the termination or expiration of a contract, including any post-termination transition, payment, transfer of IP, wind-down, last-buy, or similar commitments?', 'Post-Termination Services'), 3), (('Highlight the parts (if any) of this contract related to \"Governing Law\" that should be reviewed by a lawyer. Details: Which state/country\\'s law governs the interpretation of the contract?', 'Governing Law'), 1), (('Highlight the parts (if any) of this contract related to \"Change Of Control\" that should be reviewed by a lawyer. Details: Does one party have the right to terminate or is consent or notice required of the counterparty if such party undergoes a change of control, such as a merger, stock sale, transfer of all or substantially all of its assets or business, or assignment by operation of law?', 'Change Of Control'), 1), (('Highlight the parts (if any) of this contract related to \"Renewal Term\" that should be reviewed by a lawyer. Details: What is the renewal term after the initial term expires? This includes automatic extensions and unilateral extensions with prior notice.', 'Renewal Term'), 4), (('Highlight the parts (if any) of this contract related to \"Cap On Liability\" that should be reviewed by a lawyer. Details: Does the contract include a cap on liability upon the breach of a partyโs obligation? This includes time limitation for the counterparty to bring claims or maximum amount for recovery.', 'Cap On Liability'), 1), (('Highlight the parts (if any) of this contract related to \"Warranty Duration\" that should be reviewed by a lawyer. Details: What is the duration of any\\xa0 warranty against defects or errors in technology, products, or services\\xa0 provided under the contract?', 'Warranty Duration'), 1), (('Highlight the parts (if any) of this contract related to \"Liquidated Damages\" that should be reviewed by a lawyer. Details: Does the contract contain a clause that would award either party liquidated damages for breach or a fee upon the termination of a contract (termination fee)?', 'Liquidated Damages'), 1), (('Highlight the parts (if any) of this contract related to \"Unlimited/All-You-Can-Eat-License\" that should be reviewed by a lawyer. Details: Is there a clause granting one party an โenterprise,โ โall you can eatโ or unlimited usage license?', 'Unlimited/All-You-Can-Eat-License'), 1), (('Highlight the parts (if any) of this contract related to \"Audit Rights\" that should be reviewed by a lawyer. Details: Does a party have the right to\\xa0 audit the books, records, or physical locations of the counterparty to ensure compliance with the contract?', 'Audit Rights'), 1), (('Highlight the parts (if any) of this contract related to \"Parties\" that should be reviewed by a lawyer. Details: The two or more parties who signed the contract', 'Parties'), 512), (('Highlight the parts (if any) of this contract related to \"Effective Date\" that should be reviewed by a lawyer. Details: The date when the contract is effective\\xa0', 'Effective Date'), 57), (('Highlight the parts (if any) of this contract related to \"Anti-Assignment\" that should be reviewed by a lawyer. Details: Is consent or notice required of a party if the contract is assigned to a third party?', 'Anti-Assignment'), 2), (('Highlight the parts (if any) of this contract related to \"Exclusivity\" that should be reviewed by a lawyer. Details: Is there an exclusive dealing\\xa0 commitment with the counterparty? This includes a commitment to procure all โrequirementsโ from one party of certain technology, goods, or services or a prohibition on licensing or selling technology, goods or services to third parties, or a prohibition on\\xa0 collaborating or working with other parties), whether during the contract or\\xa0 after the contract ends (or both).', 'Exclusivity'), 14), (('Highlight the parts (if any) of this contract related to \"Revenue/Profit Sharing\" that should be reviewed by a lawyer. Details: Is one party required to share revenue or profit with the counterparty for any technology, goods, or\\xa0services?', 'Revenue/Profit Sharing'), 4), (('Highlight the parts (if any) of this contract related to \"Competitive Restriction Exception\" that should be reviewed by a lawyer. Details: This category includes the exceptions or carveouts to Non-Compete, Exclusivity and No-Solicit of Customers above.', 'Competitive Restriction Exception'), 1), (('Highlight the parts (if any) of this contract related to \"Volume Restriction\" that should be reviewed by a lawyer. Details: Is there a fee increase or consent requirement, etc. if one partyโs use of the product/services exceeds certain threshold?', 'Volume Restriction'), 8), (('Highlight the parts (if any) of this contract related to \"Notice Period To Terminate Renewal\" that should be reviewed by a lawyer. Details: What is the notice period required to terminate renewal?', 'Notice Period To Terminate Renewal'), 4), (('Highlight the parts (if any) of this contract related to \"Minimum Commitment\" that should be reviewed by a lawyer. Details: Is there a minimum order size or minimum amount or units per-time period that one party must buy from the counterparty under the contract?', 'Minimum Commitment'), 5), (('Highlight the parts (if any) of this contract related to \"Termination For Convenience\" that should be reviewed by a lawyer. Details: Can a party terminate this\\xa0 contract without cause (solely by giving a notice and allowing a waiting\\xa0 period to expire)?', 'Termination For Convenience'), 1)]\n"
          ]
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "def balanceResult(row):\n",
        "  num_of_positive = count[row[0][0],\"positive\"]\n",
        "  label = row[0][1]\n",
        "  \n",
        "  if label == 'possible negative':\n",
        "    return row[0],row[1][:num_of_positive]\n",
        "  elif label == 'impossible negative':\n",
        "    question = row[1][2]\n",
        "    id = row[0][0]\n",
        "    total = []\n",
        "    for i in pos_count:\n",
        "      if i[0][0] == question and i[0][1]!=id:\n",
        "        total.append(i[1])\n",
        "    average = round(sum(total) / len(total))\n",
        "    return row[0],row[1][:average]\n",
        "  else:\n",
        "    return row\n",
        "\n",
        "\n",
        "\n",
        "\n",
        "\n",
        "group_key_df= labelled_df.groupByKey().mapValues(list).map(balanceResult).filter(lambda x: x is not None)\n",
        "group_key_df.take(10)\n",
        "\n"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "RGZe5AJqY9Xw",
        "outputId": "9625be2e-ec38-48d8-a507-37377a4454e0"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "[(('Document Name', 'positive'),\n",
              "  [('Exhibit 10.16 SUPPLY CONTRACT Contract No: Date: The buyer/End-User: Shenzhen LOHAS Supply Chain Management Co., Ltd. ADD: Tel No. : Fax No. : The seller: ADD: The Contract is concluded and signed by the Buyer and Seller on , in Hong Kong. 1. General provisions 1.1 This is a framework agreement, the terms and conditions are applied to all purchase orders which signed by this agreement (hereinafter referred to as the \"order\"). 1.2 If the provisions of the agreement are inconsistent with the order, the order shall prevail. Not stated in order content will be subject to the provisions of agreement. Any modification, supplementary, give up should been written records, only to be valid by buyers and sellers authorized representative signature and confirmation, otherwise will be deemed invalid. 2. The agreement and order 2.1 During the validity term of this agreement, The buyer entrust SHENZHEN YICHANGTAI IMPORT AND EXPORT TRADE CO., LTD or SHENZHEN LEHEYUAN TRADING CO, LTD (hereinafter referred to as the \"entrusted party\" or \"YICHANGTAI\" or \"LEHEYUAN\"), to purchase the products specified in this agreement from the seller in the form of orders. 2.2 The seller shall be confirmed within three working days after receipt of order. If the seller finds order is not acceptable or need to modify, should note entrusted party in two working days after receipt of the order, If the seller did not confirm orders in time or notice not accept orders or modifications, the seller is deemed to have been accepted the order. The orders become effective once the seller accepts, any party shall not unilaterally cancel the order before the two sides agreed . 2.3 If the seller puts forward amendments or not accept orders, the seller shall be in the form of a written notice to entrusted party, entrusted party accept the modified by written consent, the modified orders to be taken effect. 2.4 Seller\\'s note, only the buyer entrust the entrusted party issued orders, the product delivery and payment has the force of law.\\n\\n1\\n\\nSource: LOHA CO. LTD., F-1, 12/9/2019\\n\\n\\n\\n\\n\\n3. GOODS AND COUNTRY OF ORIGIN: 4. Specific order: The products quantity, unit price, specifications, delivery time and transportation, specific content shall be subject to the purchase order issued by entrusted party which is commissioned the buyer. 5. PACKING: To be packed in new strong wooden case(s) /carton(s), suitable for long distance transportation and for the change of climate, well protected against rough handling, moisture, rain, corrosion, shocks, rust, and freezing. The seller shall be liable for any damage and loss of the commodity, expenses incurred on account of improper packing, and any damage attributable to inadequate or improper protective measures taken by the seller in regard to the packing. One full set of technical All wooden material of shipping package must be treated as the requirements of Entry-Exit Inspection and Quarantine Bureau of China, by the agent whom is certified by the government where the goods is exported. And the goods must be marked with the IPPC stamps, which are certified by the government agent of Botanical-Inspection and Quarantine Bureau. 6. SHIPPING MARK: The Sellers shall mark on each package with fadeless paint the package number, gross weight, net weight, measurements and the wordings: \"KEEP AWAY FROM MOISTURE\",\"HANDLE WITH CARE\" \"THIS SIDE UP\" etc. and the shipping mark on each package with fadeless paint. 7. DATE OF SHIPMENT: According to specific order by YICHANGTAI or LEHEYUAN. 8. PORT OF SHIPMENT:\\n\\n2\\n\\nSource: LOHA CO. LTD., F-1, 12/9/2019\\n\\n\\n\\n\\n\\n9. PORT OF DESTINATION: SHENZHEN, GUANGDONG, CHINA 10. INSURANCE: To be covered by the Seller for 110% invoice value against All Risks and War Risk. 11. PAYMENT: Under Letter of Credit or T/T: Under the Letter of Credit: The Buyer shall open an irrevocable letter of credit with the bank within 30 days after signing the contract, in favor of the Seller, for 100% value of the total contract value. The letter of credit should state that partial shipments are allowed. The Buyer\\'s agent agrees to pay fo',\n",
              "    'Highlight the parts (if any) of this contract related to \"Document Name\" that should be reviewed by a lawyer. Details: The name of the contract',\n",
              "    'SUPPLY CONTRACT',\n",
              "    14,\n",
              "    29),\n",
              "   ('1                                                                     Exhibit 10.3\\n\\nI-on. (LOGO) www.i-on.com 561.394.9484 o 561.394-9773 fax 1733 avenida del sol, boca raton, florida, 33432\\n\\nWEB SITE HOSTING AGREEMENT\\n\\nThis WEB SITE HOSTING AGREEMENT (\"this Agreement\") is entered into this 6th day of April, 1999 by and between Centrack International, a Florida corporation (\"the Customer\"), and i-on interactive, a Florida corporation (\"i-on\").\\n\\nDEFINITIONS\\n\\nAs used in this Agreement, the term \"Web site\" shall mean a computer system intended to be accessed through the World Wide Web segment of the Internet, including software and content intended to be viewed and/or operated upon by persons accessing the computer system via the Internet. A Web site may exist on a single computer system with other Web sites.\\n\\nThe term \"Hosted Site\" shall mean the Web site of the Customer that is hosted by i-on under the terms and conditions of this Agreement.\\n\\nThe term \"Hosting Computer\" shall mean the computer system and related equipment on which the Hosted Site exists.\\n\\nSERVICES PROVIDED TO THE CUSTOMER\\n\\ni-on will maintain the operation of the Hosted Site continuously, twenty-four (24) hours per day, seven (7) days per week, including holidays, with the exception of reasonable hardware and software maintenance that must be performed on the Hosting Computer and/or the Hosted Site. i-on will use best efforts to schedule and perform such maintenance between the hours of 8pm and 8am Eastern Standard Time on weekdays, or during weekends.\\n\\nUnder this Agreement, i-on will provide the following limited services for the Hosted Site:\\n\\n      1. connectivity to the Internet via a T1 (that may be shared by other             Web sites) to a leading Internet backbone access provider such as             UUNET, and reasonable efforts to maintain such connectivity with the             phone company and the Internet backbone access provider;\\n\\n      2. use of the Hosting Computer (that may be shared by other Web sites)             as described in this Agreement and maintenance required to keep such             Hosting Computer in good working order;\\n\\n      3. physical space for the Hosting Computer at a facility that maintains             proper environmental conditions in the area(s) where the Hosting             Computer is located and maintains reasonable efforts to prevent             unauthorized access to the physical location of the Hosting             Computer;\\n\\n      4. an emergency electrical power backup system for the Hosting             Computer;\\n\\n      5. up to 150 MB of mirrored computer storage on the Hosting Computer;\\n\\n      6. archival backups of such mirrored computer storage on a weekly             basis;    2          7.  off-site storage of such backups at separate facility than the              location of the Hosting Computer;\\n\\n      8.  use of the Microsoft Windows NT Server 4.0 or higher operating              system software for the Hosting Computer and the Hosted Site;\\n\\n      9.  use of the Microsoft Internet Information Service (IIS) 3.0 or              higher Web server software for the Hosted Site (providing support              for the HTTP Web protocol);\\n\\n      10. use of the Microsoft SQL Server 6.5 or higher database server              software for the Hosted Site, within the boundaries of allocated              computer storage, per #5 above;\\n\\n      11. access to the Hosted Site via the ftp protocol to an administrative              account designated by the Customer for the Customer to maintain the              Hosted Site\\'s static content (such as HTML Web pages and computer              graphics);\\n\\n      12. up to 10 mailboxes accessible via the POP3 mail protocol that are              mapped to the Hosted Site\\'s Internet address;\\n\\n      13. up to 1 hour per month of Web site administration services at no              additional charge, limited to:\\n\\n               requests for changes to ftp/e-mail users and passwords;                   requests for e-mail configuration changes;                   modification of mail',\n",
              "    'Highlight the parts (if any) of this contract related to \"Document Name\" that should be reviewed by a lawyer. Details: The name of the contract',\n",
              "    'WEB SITE HOSTING AGREEMENT',\n",
              "    225,\n",
              "    251),\n",
              "   ('Exhibit 10.13\\n\\nConfidential Materials omitted and filed separately with the Securities and Exchange Commission. Asterisks denote omissions.\\n\\nDATED: OCTOBER 15, 2009\\n\\nPACIRA PHARMACEUTICALS, INC.\\n\\nand\\n\\nEKR THERAPEUTICS, INC.        AMENDED AND RESTATED   STRATEGIC LICENSING, DISTRIBUTION AND MARKETING AGREEMENT\\n\\n\\n\\n\\n\\nTHIS AMENDED AND RESTATED STRATEGIC LICENSING, DISTRIBUTION AND MARKETING AGREEMENT (the  \"Agreement\") is made on October 15, 2009 (the \"Agreement Date\") and is effective as of the Effective Date (as defined below), between:   PACIRA PHARMACEUTICALS, INC. (F/K/A SKYEPHARMA, INC.) a company incorporated in the state of California whose principal place of business is 10450 Sciences Center Drive, San Diego, California 92121 USA (\"PPI\"); and   EKR THERAPEUTICS, INC., a company incorporated in the state of Delaware whose principal place of business is 1545 Route 206  South, Third Floor, Bedminster, New Jersey 07921 (\"EKR\").\\n\\nRecitals\\n\\nPPI owns and has all right title and interest in or has acquired exclusive rights to the PPI IP (as defined below), the Trademark (as  defined below) and the Product (as defined below).\\n\\nEKR has, among other things, specialized knowledge and expertise in relation to the marketing and sale of pharmaceutical products.\\n\\nPursuant to that certain Strategic Licensing, Distribution and Marketing Agreement between EKR and PPI dated as of August 10, 2007  (the \"Original Agreement\"), PPI granted and EKR acquired the exclusive right and license to sell, offer to sell, distribute and market the Product in  the Territory (as defined below) in the Field (as defined below).\\n\\nEKR and PPI desire to amend and restate the Original Agreement in its entirety as set forth herein in order to provide for: (i) certain  changes to the financial terms set forth in the Original Agreement, (ii) the transfer of Marketing Authorizations (as defined below) from PPI to      -1-\\n\\n\\n\\n\\n\\nEKR, and EKR\\'s assumption of obligations thereunder, (iii) the transfer of title to certain manufacturing equipment from PPI to EKR and the lease  of such equipment back from EKR to PPI and (iv) certain other changes as are set forth herein; all of the foregoing subject to and in accordance  with the terms and conditions of this Agreement.\\n\\nNOW THEREFORE, in consideration of the following mutual agreements and covenants set forth herein and intending to be legally  bound hereby, PPI and EKR (each, a \"Party\"  and collectively, the \"Parties\")  acknowledge and agree that this Agreement shall amend and  supersede in its entirety the Original Agreement and hereby agree as follows:\\n\\nOperative Provisions\\n\\n\\n\\n\\n\\n   -2-\\n\\n1. Definitions   1.1 As used in this Agreement, the following words and expressions have the following meanings:\\n\\n\"Affiliate\"\\n\\n\\n\\nWith respect to any Party to this Agreement shall mean any company, corporation, firm, individual or other  entity which Controls, is Controlled by or is under common Control with such Party to this Agreement for only  so long as such Control exists;\\n\\n\\n\\n\\n\\n   -3-\\n\\n\"Applicable Laws\"\\n\\n\\n\\nShall mean all laws, rules and regulations regarding the manufacture, packaging, labeling, import, export,  storage, distribution, representation, promotion, marketing and sale of the Products including but not limited to  the Federal Food, Drug and Cosmetic Act of 1938, as amended (\"FD&C Act\") and the Controlled Substances  Act, as amended (21 U.S.C. ยง801 et seq.), or as defined in attendant regulations promulgated under authorities  granted by the FD&C Act, together with any equivalent laws, rules, regulations, codes or guidelines having  effect in any jurisdiction in the Territory;\\n\\n\"Calendar Year\"    Shall mean the period of twelve months commencing on 1st January in any year, and each consecutive period  of twelve months thereafter during the Term;\\n\\n\"cGMP\"    Means Current Good Manufacturing Practices pursuant to 21 CFR Parts 210 and 211, as may be amended from  time to time;\\n\\n\"Commercial Launch\"\\n\\n\\n\\nShall mean the date of the first arm\\'s length sale by EKR to an unaffiliated Third Party customer for commercial  use of Pro',\n",
              "    'Highlight the parts (if any) of this contract related to \"Document Name\" that should be reviewed by a lawyer. Details: The name of the contract',\n",
              "    'AMENDED AND RESTATED STRATEGIC LICENSING, DISTRIBUTION AND MARKETING AGREEMENT',\n",
              "    322,\n",
              "    400),\n",
              "   ('ENDORSEMENT\\n\\nContract Number: ENDORSEMENT\\n\\nEffective Date: July 1, 2019\\n\\nThrivent Life Insurance Company has been dissolved. (Thrivent Life Insurance Company was formerly known as Lutheran Brotherhood Variable Insurance Products Company.) All assets and related liabilities of Thrivent Life Insurance Company have been transferred to Thrivent Financial for Lutherans. That includes contracts of insurance, separate accounts, and cash and investment securities. Thrivent Financial for Lutherans now has all obligations under this contract. It is the same as if Thrivent Financial for Lutherans had originally issued the contract. All references to \"Thrivent Life Insurance Company\" are amended to read \"Thrivent Financial for Lutherans.\" All benefits and other terms of this contract remain unchanged except as described below.\\n\\nYou may direct inquiries to:\\n\\nThrivent Financial for Lutherans 4321 N. Ballard Road Appleton, WI 54919-0001 (800) 847-4836\\n\\nThe following amendments apply in lieu of any contract provisions to the contrary.\\n\\nThe following provisions are included as part of this contract:\\n\\nMAINTENANCE OF SOLVENCY. This provision applies only to benefits provided through the General Account. If the solvency of the Society becomes impaired, you may be required to make an extra payment. The Board of Directors will determine the amount of any extra payment. It will be based on each member\\'s fair share of the deficiency. You may make the extra payment by an equivalent reduction in benefits or by a payment in cash. If you do not make the extra payment within 60 days from the date we notify you of your share of the deficiency, the amount will be charged as an indebtedness against the contract with interest compounded at the rate of 5% per year.\\n\\nMEMBERSHIP. The person(s) named as the Insured(s) or the Annuitant(s) is a benefit member of the Society. Rights and privileges of membership are set forth in the Articles of Incorporation and Bylaws of the Society. These rights and privileges are separate from the ownership of this contract.\\n\\nDIVIDENDS. Each year, we will determine our divisible surplus. This contract\\'s share, if any, will be credited as a dividend. Since we do not expect this contract to contribute to divisible surplus, it is not expected that any dividends will be credited.\\n\\nDIVIDEND OPTIONS. If dividends are credited after premiums can no longer be paid under this contract, dividends will be paid in cash. Otherwise, dividends will be applied under the Payment of Premium option unless the Cash option has been chosen in writing.\\n\\nCash. Dividends are paid in cash.\\n\\nPayment of Premium. Dividends are applied as payment of a Net Premium. VB-TL-TFFL (18) page TL-1 @TL18#AA\\n\\nSource: THRIVENT VARIABLE INSURANCE ACCOUNT B, N-6, 7/1/2019\\n\\n\\n\\n\\n\\nContract Number: ENDORSEMENT (continued)\\n\\nThe following provisions of this contract are amended:\\n\\nDEFINITIONS\\n\\nThe DEFINITIONS section of the contract is amended to include the following:\\n\\nService Center. Where this contract is administered. Our Service Center address is 4321 North Ballard Road, Appleton, WI 54919-0001.\\n\\nAnd in the DEFINITIONS section, the definition:\\n\\nWe, Our, Us. Lutheran Brotherhood Variable Insurance Products Company.\\n\\nWhich previously was amended to read:\\n\\nWe, Our, Us. Thrivent Life Insurance Company.\\n\\nIs amended to read:\\n\\nWe, we, Our, our, Us, us, Society. Thrivent Financial for Lutherans.\\n\\nENTIRE CONTRACT\\n\\nIn the ENTIRE CONTRACT section, the first phrase and numbered list are amended to read:\\n\\nThe Entire Contract consists of: 1) This contract including any attached riders, amendments, or endorsements; 2) The Application attached to this contract; and 3) The Articles of Incorporation and Bylaws of the Society and all amendments to them. Benefits will not be reduced or eliminated by any future amendments to our Articles of Incorporation or Bylaws.\\n\\nASSIGNMENT\\n\\nThe ASSIGNMENT section is amended to include the following:\\n\\nYou may transfer ownership of this contract in accordance with our bylaws. Society membership rights and privileges cannot be transferred or assigned. VB-T',\n",
              "    'Highlight the parts (if any) of this contract related to \"Document Name\" that should be reviewed by a lawyer. Details: The name of the contract',\n",
              "    'ENDORSEMENT',\n",
              "    30,\n",
              "    41),\n",
              "   ('Exhibit 10.4   INTELLECTUAL PROPERTY AGREEMENT   This INTELLECTUAL PROPERTY AGREEMENT (this \"Agreement\" or \"IPA\"), effective as of this 30  day of June 2016 (the \"Effective Date\") among THE HERTZ CORPORATION, a Delaware corporation, with an address of 8501 Williams Road, Estero, Florida 33928 (hereinafter \"THC\"); HERTZ SYSTEM, INC., a Delaware corporation, with an address of 8501 Williams Road, Estero, Florida 33928, United States of America (hereinafter \"HSI\") and HERC RENTALS INC., a Delaware corporation, with an address of 27500 Riverview Center Blvd., Bonita Springs, Florida 34134, United States of America (hereinafter \"HERC\") (hereinafter referred to collectively as the \"Parties\" and individually as a \"Party\").   WITNESSETH   WHEREAS, both HSI and HERC are wholly-owned subsidiaries of THC, and THC is an indirect wholly-owned subsidiary of Hertz Global Holdings, Inc., a Delaware corporation (\"HGH\");   WHEREAS, THC is the owner of a unique plan or system (hereinafter the \"Hertz System\") for conducting, inter alia, the business of renting and leasing vehicles with and without drivers (hereinafter the \"Vehicle Rental Business\" or \"VRB\") which it conducts in collaboration with HSI which is the owner of all trademarks for HERTZ and HERTZ-formative trademarks and designs and other trademarks and designs worldwide in connection with the Vehicle Rental Business (the \"VRB Trademarks\") and Other Intellectual Property (as defined herein);   WHEREAS, THC is the owner of a unique plan or system for conducting an equipment rental business (hereinafter the \"Equipment Rental Business\" or \"ERB\" as further defined below) which it conducts through HERC;   WHEREAS, HGH has approved plans to separate the Vehicle Rental Business and the Equipment Rental Business into two independent, publicly traded companies (the \"Separation\") pursuant to, among other agreements, the Separation and Distribution Agreement by and between Hertz Rental Car Holding Company, Inc. (to be renamed \"Hertz Global Holdings, Inc.\" in connection with the Separation, \"New Hertz\") and HGH (to be renamed Herc Holdings Inc. in connection with the Separation) dated as of June 30, 2016 (the \"Distribution Agreement\");   WHEREAS, as a result of the Separation, THC and HSI will become indirect wholly-owned subsidiaries of New Hertz, and HERC will continue to be an indirect wholly-owned subsidiary of HGH;   WHEREAS, THC exercises control with respect to the use, registration and enforcement of all of its company trademarks through its subsidiary HSI. HERC uses certain HERTZ or HERTZ-formative trademarks in connection with the ERB with the\\n\\nth\\n\\n\\n\\n\\n\\n  permission of HSI and THC;   WHEREAS, HSI is the owner of certain foreign HERTZ and HERTZ-formative and other trademarks and logos (the \"HSI (HERTZ) Foreign ERB Trademarks\") used or to be used by HERC with the permission of HSI in connection with the Equipment Rental Business, including the trademark applications and registrations therefor as more fully set forth on Schedule A;   WHEREAS, HSI is the owner of certain United States HERTZ and HERTZ-formative and other trademarks and logos (the \"HSI (HERTZ) US ERB Trademarks\") used by HERC with the permission of HSI in connection with the Equipment Rental Business, including the trademark applications and registrations therefor as more fully set forth on Schedule B;   WHEREAS, HSI is the owner of certain foreign HERC trademarks and logos (the \"HSI HERC Foreign ERB Trademarks\") used by HERC with the permission of HSI in connection with the Equipment Rental Business, including the trademark applications and registrations therefor, as more fully set forth on Schedule C;   WHEREAS, HERC is the owner of certain US HERTZ-formative trademarks (the \"HERC (HERTZ) US ERB Trademarks\") used by HERC with the permission of HSI in connection with the Equipment Rental Business, including the trademark applications and registrations therefore as more fully set forth on Schedule D;   WHEREAS, HERC is the owner of certain US trademarks not derived from the HERTZ trademark (the \"HERC (HERC) US ERB Trademar',\n",
              "    'Highlight the parts (if any) of this contract related to \"Document Name\" that should be reviewed by a lawyer. Details: The name of the contract',\n",
              "    'INTELLECTUAL PROPERTY AGREEMENT',\n",
              "    54,\n",
              "    85),\n",
              "   ('Exhibit 10.4\\n\\nCOOPERATION AGREEMENT\\n\\n(2014 Amendment)\\n\\nThis Cooperation Agreement (2014 Amendment) (this \"Agreement\") is entered into on January 24, 2014 in Beijing by and between:\\n\\n(1) Nanjing Tuniu Technology Co., Ltd., with its registered address at 3-5/F Building No.6, Southeast University Science Park, 6 Changjianghou Street, Xuanwu District, Nanjing and its legal representative being Yu Dunde (\"Party A\");\\n\\n(2) Beijing Tuniu Technology Co., Ltd., with its registered address at R1006 10/F Building No.4, Yard No.1 of Shangdishi Street, Haidian District, Beijing and its legal representative being Yu Dunde (\"Party B\").\\n\\nWHEREAS\\n\\n1. Party A is a company with exclusively domestic capital incorporated under the laws of the People\\'s Republic of China, mainly engaged in the internet-based sale, promotion of tour products, room reservation and conference affairs services.\\n\\n2. Party B is a limited liability company incorporated under the laws of the People\\'s Republic of China, mainly engaged in research and development of computer software technology, technology transfer, technical consultancy and technical services, computer technology training, technical services and business consultancy services in relation to the internet-based sale and promotion of tour products.\\n\\n3. Party A intends to authorize Party B to provide to Party A and its subsidiaries the technical services and business consultancy services in relation to the internet-based sale and promotion of tour products, including but not limited to development, operation, maintenance of internet technology platform as well as consultancy services relating to sale and promotion of tour products or cooperation provided by Party B in other forms as required under this Agreement, and Party B agrees to accept such authorization.\\n\\n4. After an amiable consideration, the Parties unanimously agree that the establishment of a long-term and close cooperation relationship is in the best interests of the Parties and their beneficiaries.\\n\\n5. The Parties have entered into the Cooperation Agreement on September 17, 2008 in respect of the aforementioned cooperative matters (the \"Original Cooperation Agreement\").\\n\\n\\n\\n\\n\\nThe Parties unanimously agree to amend and restate the Original Cooperation Agreement through friendly negotiation and the Original Cooperation Agreement is amended and restated as follows:\\n\\n  1. Business Cooperation\\n\\nParty A and Party B unanimously agree that the proposed cooperation shall be the internet-based sale and promotion of tour products conducted by Party A and its subsidiaries or other value-added business carried out by Party A. Party B shall provide the business consultancy and technical services as well as the technical consultancy as set forth in Article 3 hereinafter to Party A and its subsidiaries to facilitate them to conduct the aforementioned business and supply relevant products and services.\\n\\n  2. Exclusive Cooperation\\n\\n\\n\\n2.1 Party A irrevocably undertakes that Party A will take Party B as its exclusive and sole partner to provide the business consultancy and technical services as well as technical consultancy to Party A and its subsidiaries. Party A shall not establish any same or similar cooperative relationship with any third party in respect of such businesses nor shall it make any same or similar arrangement, unless with the prior written consent of Party B.\\n\\n  2.2 Party A irrevocably undertakes that it will make best efforts to assist and endeavor to achieve the exclusive operation of thecooperative business to the extent permitted by laws.\\n\\n\\n\\n2.3 Party A irrevocably undertakes that, without Party B\\'s consent, Party A shall not conduct any other business or make any commercial arrangement, including without limitation being engaged in or otherwise participating in any commercial activities and businesses independently or together with any other person or entity, nor shall it carry out any activities that may be competitive with or cause adverse effect to Party B\\'s business.\\n\\n  3. Party B\\'s Services\\n\\nParty B undertakes to provide the following tec',\n",
              "    'Highlight the parts (if any) of this contract related to \"Document Name\" that should be reviewed by a lawyer. Details: The name of the contract',\n",
              "    'Cooperation Agreement (2014 Amendment)',\n",
              "    60,\n",
              "    98),\n",
              "   ('EXHIBIT 10.13                  Cyberian Outpost, Inc. has omitted from this Exhibit 10.13 portions of the Agreement for which Cyberian Outpost, Inc. has requested confidential treatment from the Securities and Exchange Commission. The portions of the Agreement for which confidential treatment has been requested are marked with X\\'s in brackets and such confidential portions have been filed separately with the Securities and Exchange Commission.\\n\\n                              PROMOTION AGREEMENT\\n\\nThis Promotion Agreement (the \"Agreement\") is dated as of January 26, 1998 between CNET, Inc. (\"CNET\") and Cyberian Outpost, Inc. (the \"Company\"). Pursuant to this Agreement, CNET will provide various links and other online and television promotions (collectively, the \"Promotions\") to the Company to assist the Company in promoting its products and services and facilitating the sale of products to potential buyers through its Internet site. CNET will be compensated by the Company for providing the Promotions. Accordingly, the parties hereby agree as follows:\\n\\n1.   Background.\\n\\n     1.1  The Company. The Company operates an electronic retailing operation           through its Internet sites located at www.cyberianoutpost.com or           www.outpost.com (together with any successors to such sites, the           \"Company Site\"). Through the Company Site, the Company sells or           facilitates the sale of various products and services, either directly           or as an agent for third party vendors. All products and services           offered for sale through the Company Site are referred to as the           \"Products.\"\\n\\n     1.2  CNET. CNET produces television programs and operates a network of           Internet sites on the world wide web. For purposes of this Agreement,           the \"CNET Sites\" refer to any Internet sites operated by CNET or its           subsidiaries, including without limitation the sites referenced in           Section 2.5 and Exhibit A.\\n\\n2.   CNET\\'s Obligations.\\n\\n     2.1  TV Promotions. CNET will provide the Company one 15 second \"spot\" for           Promotions on its syndicated weekly TV program, TV.COM. Promotions           will run on each weekly episode of TV.COM during the Term; provided           that TV.COM remains on the air throughout such period. Should TV.COM           not be run on the air during a portion of the Term, CNET will run two           download.com banner advertising programs per month during such portion           of the Term in lieu of the foregoing TV.COM Promotions.\\n\\n     2.2  Banner Promotions. CNET will provide advertising banners to the           Company during the Term as described in Exhibit A.\\n\\n     2.3  Retail Promotions.\\n\\n            2.3.1  CNET will provide for various retail Promotions across the CNET                  Sites, which may include text/HTML links, buttons, portals and                  other fixed Promotions that include embedded links to the                  Company Site (the \"Retail Promotions\" and, together with the                  advertising banners contemplated in the preceding paragraph,                  the \"Online Promotions\").\\n\\n          2.3.2  Subject to Section 4 below, CNET will provide the Company with                  a total of at least (a) [XXXXXX] Retail Impressions during                  the first three months of the Term, (b) [XXXXXX] Retail                  Impressions during the second three months of the Term, (c)                  [XXXXXX] Retail Impressions during the third three months                  of the Term, and (d) [XXXXXX] Retail Impressions during                  the fourth three months of the Term. For such purposes, a                  \"Retail Impression\" means the display of one page of a CNET                  Site that contains at least one Retail Promotion. If CNET fails                  to provide the Retail Impressions required by the preceding                  sentence during the Term, then CNET will continue to display                  Retail Impressions in accordance with this Agreement following             ',\n",
              "    'Highlight the parts (if any) of this contract related to \"Document Name\" that should be reviewed by a lawyer. Details: The name of the contract',\n",
              "    'Promotion Agreement',\n",
              "    505,\n",
              "    524),\n",
              "   ('Exhibit 10.1\\n\\nStrategic Alliance Agreement\\n\\nAGREEMENT made as of  , 2013, between Freedom Mortgage Corporation, a New Jersey corporation (\"Freedom Mortgage\"), and Cherry Hill Mortgage Investment Corp., a Maryland corporation (\"Cherry Hill\").\\n\\nWITNESSETH:\\n\\nWHEREAS, Freedom Mortgage is a privately held, national mortgage bank that originates and services mortgage loans secured by liens on one- to four-family properties; and\\n\\nWHEREAS, Cherry Hill is a newly formed affiliate of Freedom Mortgage that intends to elect and qualify as a Real Estate Investment Trust under the Internal Revenue Code of 1986, as amended; and\\n\\nWHEREAS, Cherry Hill will have access to capital, including capital raised through one or more offerings of its securities; and\\n\\nWHEREAS, Cherry Hill will seek to benefit from having a consistent and predictable source of real estate assets from Freedom Mortgage, and Freedom Mortgage will seek to benefit from the liquidity available to Cherry Hill; and\\n\\nWHEREAS, the parties desire to set forth the terms of a strategic alliance that is expected to benefit them both;\\n\\nNOW, THEREFORE, in consideration of the foregoing, and of other good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, the parties here to agree as follows.\\n\\nSection 1. Definitions.\\n\\n(a) The following terms shall have the meanings specified wherever used in this Agreement.\\n\\nAcknowledgement Agreement: The Acknowledgement Agreement to be entered into by Freedom Mortgage, as Issuer, Cherry Hill, as Secured Party, and the Government National Mortgage Association.\\n\\nAction: Any civil, criminal, investigative or administrative claim, demand, action, suit, charge, citation, complaint, notice of violation, proceeding (public or private), litigation, prosecution, arbitration or inquiry by or before any Governmental Entity whether at law, in equity or otherwise.\\n\\nAgreement: This Strategic Alliance Agreement as the same may be amended in accordance with the terms hereof.\\n\\n1\\n\\n\\n\\n\\n\\nAncillary Agreements: The Acknowledgement Agreement, the Purchase Agreement and the Flow Agreement.\\n\\nBase Servicing Fee: As to any Mortgage Loan and any Collection Period, an amount equal to the product of the Base Servicing Fee Rate, the UPB of that Mortgage Loan as of the related Measurement Date and 1/12 or, for the first Collection Period, the number of days in such Collection Period divided by 360; provided, however, that payment of the Base Servicing Fee for any delinquent Mortgage Loan shall be suspended unless and until Freedom Mortgage recovers the amount thereof from payments in respect thereof from the related mortgagor or the amount thereof is otherwise recovered from liquidation of the related property.\\n\\nBase Servicing Fee Rate: As to any Mortgage Loan, the per annum rate specified to be payable to Freedom Mortgage to cover the actual costs of servicing. For example, the Base Servicing Fee Rate for the Mortgage Loans in the initial pool will be eight (8) basis points.\\n\\nBusiness Day: Any day other than a Saturday or Sunday or a day on which banks in New Jersey and New York are authorized or obligated by law to close.\\n\\nClosing: The closing of the initial public offering of the common stock of Cherry Hill.\\n\\nClosing Date: The date of the Closing.\\n\\nCollection Period: The period beginning on the Closing Date and ending on the last day of the calendar month in which the Closing Date occurs and each calendar month thereafter.\\n\\nExcess MSR: As to any Mortgage Loan, the portion of the servicing fee for that Mortgage Loan that exceeds the Base Servicing Fee.\\n\\nFlow Agreement : The Flow and Bulk Purchase Agreement to be entered into between Cherry Hill, as purchaser, and Freedom Mortgage, as seller, substantially in the form of Exhibit B attached hereto.\\n\\nGAAP: Generally accepted accounting principles in the United States as in effect from time to time as set forth in the statements, pronouncements and opinions of the Accounting Principles Board and the American Institute of Certified Public Accountants.\\n\\nGinnie Mae: The Government National Mortgage',\n",
              "    'Highlight the parts (if any) of this contract related to \"Document Name\" that should be reviewed by a lawyer. Details: The name of the contract',\n",
              "    'Strategic Alliance Agreement',\n",
              "    1911,\n",
              "    1939),\n",
              "   ('Exhibit 10.2    SHBV (HONG KONG) LTD.     and     WASTE2ENERGY GROUP HOLDINGS PLC\\n\\n   STRATEGIC ALLIANCE AGREEMENT\\n\\n   1\\n\\n\\n\\n\\n\\n        THIS AGREEMENT IS MADE ON THE 19  DAY OF MAY , 2010     PARTIES     (1) SHBV (HONG KONG) LTD, a company incorporated in Hong Kong whose registered office is at Unit 3208, 32/F Office Tower (\"SHBV\"); and  Convention Plaza, 1 Harbour Rd, Hong Kong     (2) WASTE2ENERGY GROUP HOLDINGS PLC a company incorporated in Isle of Man whose registered office is at Stanley House, Lord Street,  Douglas, Isle of Man 1M1 2BF (\"W2E\"),     each a \"Party\" and together the \"Parties\".     BACKGROUND     (A) SHBV is engaged in the business of design, marketing, manufacture, commissioning and post sales servicing of steam and hot water plant and  possesses certain proprietary products, technologies, formulations, know-how and/or rights within the fields of steam and hot water plant  and equipment, engineering, and process designs (hereinafter, \"SHBV Technologies\").     (B) W2E is a provider of engineered solutions for waste to energy plants (each being an \"Engineered Solution\") utilising W2E proprietary  technology for the destruction of waste through gasification and the conversion of latent energy into thermal energy.     (C) The Parties wish to collaborate together to provide for a world class manufacturing facility for W2E Equipment, for the integration of SHBV  Technologies into the Engineered Solution and to exploit joint sales channels and post sales support, for the mutual benefit of both  Parties.     (D) The Parties wish to cooperate and work together to promote, market and sell their respective products and services in accordance with the  terms of this Agreement.     AGREED PROVISIONS     1. DEFINITIONS AND INTERPRETATION     1.1 In this Agreement, the terms and expressions below shall have the following meanings:     2\\n\\nTH\\n\\n\\n\\n\\n\\n     Affiliates means subsidiaries or other entities that will be mutually agreed in writing.     Agreement means the body of this agreement and its schedules, as each may be amended from time to time in accordance with its  provisions;     Alliance means the strategic alliance between the Parties facilitated under this Agreement;     SHBV Boiler means a boiler that is manufactured and supplied by SHBV from time to time;     SHBV Technologies has the meaning given in Recital A above;     Commencement Date means the date of this Agreement;     Dispute means any dispute, issue or claim arising out of or relating to this Agreement;     Engineered Solution has the meaning given in Recital B above;     Good Industry Practice means the exercise of that degree of skill, diligence, prudence, foresight and practice which would reasonably and  ordinarily be expected from a skilled and experienced person engaged in performing obligations the same as or similar to the obligations  under this Agreement or any part of them (as appropriate to the context in which this expression is used);     Group means, in relation to any company, that company and the following for the time being: (i) its Holding Company, (ii) its Subsidiaries  and (iii) the Subsidiaries of its Holding Company;     Holding Company has the meaning given in $1159 Companies Act 2006;     Intellectual Property Rights means (i) patents, designs, trade marks and trade names (whether registered or unregistered), copyright and  related rights, database rights, know-how and confidential information; (ii) all other intellectual property rights and similar or equivalent  rights anywhere in the world which currently exist or are recognised in the future; and (iii) applications, extensions and renewals in  relation to any such rights;     Manufacturing Agreement has the meaning given in clause 5.1;     Subsidiary has the meaning given to it in $1159 Companies Act 2006;     Supply Agreement means an agreement under which an Engineered Solution is to be delivered to a customer of W2E by W2E or such  other entity established or nominated for that purpose;     Term has the meaning set out in Clause 3.1;     3\\n\\n\\n\\n\\n\\n     Territory shall mean',\n",
              "    'Highlight the parts (if any) of this contract related to \"Document Name\" that should be reviewed by a lawyer. Details: The name of the contract',\n",
              "    'STRATEGIC ALLIANCE AGREEMENT',\n",
              "    86,\n",
              "    114),\n",
              "   ('EXHIBIT 10.2   ENDORSEMENT AGREEMENT ADDENDUM I   This Endorsement Agreement Addendum I (the \"Addendum\") is made and effective November 7, 2017,   BETWEEN:\\n\\n\\n\\nNational Football League Alumni - Northern California Chapter (\"NFLA-NC\"), a charitable corporation organized under the laws of California, having its principal office at 1311 Madison Avenue, Redwood CA 94061; National Football League Alumni, Inc. (\"NFLA\"), a charitable corporation organized under the laws of Florida, having its principal office at 8000 Midlantic Drive, 130 S., Mount Laurel, NJ. 08054.     AND:   Food For Athletes, Inc. a corporation organized under the laws of California / Gridiron BioNutrientsโข, a corporation organized under the laws of Nevada having their principal office(s) at 1147 N Roseburg CT, STE A/B Visalia, CA 93291 (collectively the \"Company\").   RECITALS   The NFLA, NFLA-NC and the Company (collectively the \"Parties\") agree that this Addendum I shall be affixed and be enforceable under the terms of the Endorsement Agreement executed by the Parties on October 30, 2017.   Parties agree to the addition of Gridiron CBD H2O Probioticโข Water to \"Licensed Products\" as follows:   SECTION ONE. DEFINITIONS    As used in this Agreement, the following terms shall be defined as follows:      F. \"Licensed Products\" shall mean BlackMP Living Water, BlackMP Concentrate, Zezel Probiotic Water, Zayin Sports Water, Gridiron CBD H2O Probioticsโข Water, Gridiron MVPโข and Gridiron MVPโข Concentrate using the Pro Football Legends Logo on the Licensed Products\\' affixed labels, hang-tags or packaging. Other products of the Company may be added to the list of Licensed Products during the Contract Period by written amendment to this Agreement. All amendments to this Agreement must be signed by all parties to this Agreement.   Endorsement Agreement Addendum I  Page 1 of 2\\n\\nSource: GRIDIRON BIONUTRIENTS, INC., 8-K, 12/6/2017\\n\\n\\n\\n\\n\\n      SECTION FOUR. REMUNERATION    C. A *donation of $0.05 per Unit sold of Licensed Products within the Contract Territory payable to the **NFL Alumni Northern California Chapter. Donated amounts will be allocated and dispersed to the Northern California Chapter beginning on the first full quarter [three (3) month period] of the Agreement and continue on a quarterly basis thereafter for the term of this Agreement. Where the following per Unit conversion shall apply for the term of this Agreement:\\n\\n a. (1) Bottle of BlackMP LivingWater = 1 Unit\\n\\n b. (1) 4oz bottle of BlackMPConcentrate = 30 Units\\n\\n c. (1) Bottle of Zezel ProbioticWater = 1 Unit\\n\\n d. (1) Bottle of Zayin Sports Water = 1 Unit  e. (1) Bottle Gridiron MVPโข Water= 1 Unit\\n\\n f. (1) Bottle Gridiron CBD H20 Probioticsโข Water = 1 Unit\\n\\n g. (1) 4oz bottle of Gridiron MVPโขConcentrate = 30 Units\\n\\n _____________  * The NFLA-NC will donate 15% of the above described proceeds to the NFLA.  ** The Company will provide to the NFLA-NC upon request the most recent quarterly sales report of the Company\\'s Licensed Products.   The parties have executed this Agreement on November 22nd, 2017.   Food For Athletes, Inc. / Gridiron BioNutrientsโข   By: /s/ Darren Long    Darren Long - CEO     The National Football League Alumni, Inc.   By: /s/ Elvis Gooden    Elvis Gooden - President     NFL Alumni - Northern California Chapter   By: /s/ Eric Price    Eric Price - President     Endorsement Agreement Addendum I  Page 2 of 2\\n\\nSource: GRIDIRON BIONUTRIENTS, INC., 8-K, 12/6/2017',\n",
              "    'Highlight the parts (if any) of this contract related to \"Document Name\" that should be reviewed by a lawyer. Details: The name of the contract',\n",
              "    'ENDORSEMENT AGREEMENT ADDENDUM I',\n",
              "    15,\n",
              "    47),\n",
              "   ('EXHIBIT 10.1\\n\\nCorporate Sponsorship Agreement Between American Diabetes Association and Freeze Tag, Inc. This Agreement (\"Agreement\") is made effective March 22, 2018, by and between Freeze Tag Inc., a Delaware Corporation (\"Company\"), with its principal place of business located at 1720 Bray Central Drive, McKinney, TX 75069 and the American Diabetes Association, Inc. (\"Association\"), an Ohio not-for profit corporation, with its principal place of business located at 2451 Crystal Drive, Suite 900, Arlington, VA 22202. ADA and/or Company may be referred to as a \"Party\" or collectively as the \"Parties.\" 1. Purpose: The purpose of this Agreement is to benefit the Association and advance its not-for-profit mission through a National Sponsorship of Get Fit Don\\'t Sit DayT M. Company desires to assist the Association to carry out its mission and agrees to provide the support described in this Agreement. Company understands that as a not-for-profit charitable organization Association cannot promote or endorse Company\\'s products or services, either explicitly or implicitly. The Association may require that a disclaimer stating that Company\\'s participation in this Agreement does not convey or imply the Association\\'s approval, endorsement, certification, acceptance, or referral of any product or service of Company. 2. Scope: The Association agrees to identify and acknowledge Company as a supporter of the organization and the diabetes cause, as permitted in connection with qualified sponsorship payments and royalties under Section 513(i) and Section 512 of the Internal Revenue Code and Treasury regulations thereunder (\"Code\"). Company agrees not to knowingly take any actions that would jeopardize the tax-exempt status of Association under section 501(c)(3) of the Code. Company agrees to inform its business partners about Association\\'s tax-exempt status. Company agrees to provide its services, as defined in Attachment A, in accordance with all applicable laws and in accordance with standards of decorum and taste so as not to adversely reflect upon the Association or its mission. 3. Term: This Agreement shall commence on March 15, 2018 and will expire on March 14, 2020 unless terminated earlier pursuant to Section 13 of the Agreement (the \"Term\"). 4. Intellectual Property: The Association is the sole and exclusive owner of its name and logos, with or without accompanying words, and has the legal right to enter into this Agreement. In addition, any materials provided by or developed by the Association remain the property of the Association. The Association\\'s names, logos, and various marks, are \"the Association Marks\", as listed in Attachment B. The Association\\'s ownership of the Association Marks is or shall be secured through registration, or under common law, or both. Company\\'s use of the Association Marks does not create ownership rights in the Association Marks for Company. Company shall not, during the period of this Agreement, or any time thereafter, challenge Association\\'s exclusive ownership or registration of Association\\'s Marks, including any and all moral rights. Company is the sole and exclusive owner of its name, logos, and marks (the \"Company Marks\"), which include, without limitation, the names, logos, and marks listed in Attachment B as Company Marks. 1\\n\\nSource: FREEZE TAG, INC., 8-K, 4/11/2018\\n\\n\\n\\n\\n\\n5. License: The Association grants Company a non-exclusive, limited, revocable and conditional license during the term to use the Association Marks, solely to identify Company as a supporter of the Association. Use by Company of the Association Marks is limited to the particular Association Marks as authorized by the Association, which may not be revised or altered in any way, without prior written consent, must be displayed in the same form and colors, and does not extend to any other marks of the Association. Use by Company of the Association Marks on and in conjunction with its product or brand is conditioned upon Company\\'s observance of the specifications for permissible uses of the Association Marks as stated herein a',\n",
              "    'Highlight the parts (if any) of this contract related to \"Document Name\" that should be reviewed by a lawyer. Details: The name of the contract',\n",
              "    'Corporate Sponsorship Agreement',\n",
              "    14,\n",
              "    45),\n",
              "   ('Exhibit 10.1 CERTAIN CONFIDENTIAL PORTIONS OF THIS EXHIBIT WERE OMITTED AND REPLACED WITH \"[***]\". A COMPLETE VERSION OF THIS EXHIBIT HAS BEEN FILED SEPARATELY WITH THE SECRETARY OF THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO AN APPLICATION REQUESTING CONFIDENTIAL TREATMENT PURSUANT TO RULE 24B-2 PROMULGATED UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED. AMENDMENT NO. 2 TO MANUFACTURING AND SUPPLY AGREEMENT THIS AMENDMENT NO. 2 (this \"Amendment\") to the Manufacturing and Supply Agreement dated as of December 8, 2009 (as amended by an amendment agreement dated 31 December 2013) (the \"Existing Agreement\"), by and between Columbia Laboratories, (Bermuda) Ltd., a limited company existing and organised under the laws of Bermuda, having a place of business at Canon\\'s Court, 22 Victoria Street, Hamilton HM12, Bermuda (\"Columbia\"), and Fleet Laboratories Limited, a limited private company existing and organised under the laws of England, having a place of business at 94 Rickmansworth Road, Watford Herts, WD18 7JJ, United Kingdom (\"Fleet\") is entered into on 2018 (the \"Effective Date\"). WHEREAS, Columbia and Fleet entered into the Existing Agreement pursuant to which Fleet has agreed to manufacture and supply to Columbia, and Columbia has agreed to purchase, certain Products; and WHEREAS, Columbia and Fleet wish to amend the Existing Agreement in accordance with the terms of this Amendment. NOW THEREFORE, in consideration of the foregoing and other good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, Columbia and Fleet agree as follows: General Capitalised terms used but not defined in this Amendment shall have the same meanings ascribed to such terms in the Existing Agreement. The following amendments to the Existing Agreement shall have effect on and from the Effective Date.\\n\\n1. The following definitions shall be added to Section 1 of the Existing Agreement:\\n\\n\"\"Ares Agreement\" means the supply agreement entered into between Columbia and Ares Trading S.A. (a subsidiary of Merck Serono S.A.) dated 7 January 2018.\"\\n\\n\"GDP\" means the EU guidelines for current Good Distribution Practice guidelines 2013/C 343/01 as amended.\"\\n\\n2. The definition of \"batch\" in Section 1 of the Existing Agreement shall be deleted in its entirety and replaced with the following:\\n\\n\"\"Batch\" means a quantity of [***] kilograms of material (or such other quantity as the Parties may agree in writing from time to time) produced in a process or series of processes that is expected to be homogeneous within specified limits.\"\\n\\n3. The following shall be added to Section 2.1 of the Existing Agreement (Regulatory Requirements) as a new Section 2.1 (d):\\n\\n\"2.1 (d) Subject to the prior written consent of Columbia (such consent not to be unreasonably withheld, delayed or conditioned), Fleet may subcontract all or part of the activities to be performed by it under this Agreement to any subcontractor provided that the subcontracting of any activities shall not relieve Fleet of, and Fleet shall remain solely liable for, its obligations under this Agreement. Columbia may subcontract all or any part of the activities performed by it under this Agreement to any subcontractor without the consent of Fleet.\"\\n\\n1\\n\\n\\n\\n\\n\\nCERTAIN CONFIDENTIAL PORTIONS OF THIS EXHIBIT WERE OMITTED AND REPLACED WITH \"[***]\". A COMPLETE VERSION OF THIS EXHIBIT HAS BEEN FILED SEPARATELY WITH THE SECRETARY OF THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO AN APPLICATION REQUESTING CONFIDENTIAL TREATMENT PURSUANT TO RULE 24B-2 PROMULGATED UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED. 4. The following new Sections 2.2 (b), 2.2 (c) and 2.2 (d) shall be added to Section 2.2 of the Existing Agreement (Regulatory Requirements):\\n\\n\"2.2 (b) Compliance with Brazilian Regulatory Authorities Regulations. Fleet hereby warrants that the facilities where the Product is manufactured complies in full with the relevant standards stipulated by the Brazil National Health Surveillance Agency (\"ANVISA\") and undertakes to ensure the facilities will continue to do',\n",
              "    'Highlight the parts (if any) of this contract related to \"Document Name\" that should be reviewed by a lawyer. Details: The name of the contract',\n",
              "    'AMENDMENT NO. 2 TO MANUFACTURING AND SUPPLY AGREEMENT',\n",
              "    372,\n",
              "    425),\n",
              "   ('1                                                                    Exhibit 10.16\\n\\n                                                                 CONFIDENTIAL Portions of this Exhibit have been omitted pursuant to a request for confidential treatment. The omitted portions, marked by [****], have been separately filed with the Commission.\\n\\n                           SPONSORSHIP AGREEMENT\\n\\nThis agreement (\"Agreement\") is entered into as of the 23rd day of September, 1997 (\"Effective Date\"), by and between Excite, Inc., a California corporation, located at 555 Broadway, Redwood City, California 94063 (\"Excite\"), and N2K Inc., a Pennsylvania corporation, located at 55 Broad Street, 26th Floor, New York, New York, 10004 (\"Sponsor\").\\n\\n                                 RECITALS\\n\\nA.   Excite maintains a site on the Internet at http://www.excite.com (the      \"Excite Site\") and owns and/or manages related Web Sites worldwide      (collectively, the \"Excite Network\") which, among other things, allow users      to search for and access content and other sites on the Internet.\\n\\nB.   Excite also maintains and/or manages certain Web pages which may be      delivered to users via email, desktop \"channels\" or Internet \"push\"      technologies (collectively, \"Broadcast Pages\") which may incorporate      content supplied to Excite by third parties for the purpose of providing      value to Excite users and providing access to the content, products and/or      services of such third parties.\\n\\nC.   Sponsor is in the business of distributing certain online retail music      merchandise and related content and maintains a Web site at      http://www.musicblvd.com (the \"Sponsor Site\") and other Web sites through      which it makes this merchandise and this content available to its users.\\n\\nD.   Sponsor wishes to be the exclusive retail store music sponsor of the Excite      Site and the Excite Broadcast Pages, to distribute its music-related      content through the Excite Site and the Excite Broadcast Pages and to      promote its online retail music merchandise business to Excite.com users.\\n\\nTherefore, the parties agree as follows:\\n\\n1.       EXCLUSIVITY, TERM AND RIGHT OF FIRST REFUSAL\\n\\n      a)       Sponsor will be the exclusive retail music store sponsor of                   the Excite Site and the Excite Broadcast Pages. Excite will                   not permit the display of advertising banners, promotional                   buttons, promotional links or other promotional materials for                   any retail sale of Music Products on the Excite Site, except                   those Music Products offered by Sponsor, nor advertising by                   any other Retail Music Store. \"Retail Music Store\" shall mean                   any entity which is primarily engaged in the sale of Music                   Products at retail to consumers. \"Music Products\"     2                                                                     CONFIDENTIAL\\n\\n              shall mean pre-recorded music hard goods, digitally                  distributed music (except live and/or cybercast events), music                  books (to the extent this Agreement does not conflict with                  Excite\\'s existing agreement with Amazon.com), music-related                  t-shirts and apparel, and music videos (except live and/or                  cybercast events).\\n\\n              Notwithstanding the foregoing, Excite may make available                  opportunities on the Excite Site to purchase Music Products                  from parties other than Sponsor if such Music Products are not                  available from Sponsor so long as, prior to entering into                  arrangements to make available opportunities to purchase Music                  Products from parties other than Sponsor, Excite notifies                  Sponsor of its interest in the Music Products and gives Sponsor                  thirty (30) days to make the desired Music Products available                  through the Sponsor Site. Excite and Sponsor acknowledge that ',\n",
              "    'Highlight the parts (if any) of this contract related to \"Document Name\" that should be reviewed by a lawyer. Details: The name of the contract',\n",
              "    'SPONSORSHIP AGREEMENT',\n",
              "    371,\n",
              "    392),\n",
              "   ('Exhibit 2.7 FORM OF TRADEMARK LICENSE AGREEMENT THIS TRADEMARK LICENSE AGREEMENT (this \"Agreement\"), made and entered into as of the [ ] day of [ ], 2020 (the \"Effective Date\"), by and between ARCONIC INC., a corporation organized under the laws of Delaware (\"Licensee\") and ARCONIC ROLLED PRODUCTS CORP., a corporation organized under the laws of Delaware (\"Licensor\"). WHEREAS, Licensor and Licensee entered into a Separation and Distribution Agreement having an effective date of the [ ] day of [ ], 2020 (\"Separation and Distribution Agreement\"); unless specifically defined in this Agreement, any capitalized term in this Agreement shall have the meaning set forth in the Separation and Distribution Agreement. WHEREAS, Licensor formerly operated as a business unit of Licensee; WHEREAS, as part of and further to the Separation and Distribution Agreement: (a) Licensor and Licensee are now two separate publicly traded companies; and (b) Licensor was assigned all right, title, and interest to the trademark \"ARMX\" (the \"Licensed Mark\"); WHEREAS, Licensee wishes to license from Licensor the right to the Licensed Mark as hereinafter defined below; WHEREAS, Licensee wishes to obtain from Licensor, subject to the terms and conditions set forth in this Agreement, the right and license to use, have used, manufacture, have manufactured, sell, have sold, advertise, have advertised, import, have imported, export, have exported, offer for sale, and have offered for sale the Licensed Products (later defined) using the Licensed Mark (the \"Licensed Purpose\"); WHEREAS, Licensor is willing to grant such rights, upon the terms and subject to the conditions set forth in this Agreement. NOW, THEREFORE, in consideration of the mutual agreements, provisions and covenants contained in this Agreement, and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties, intending to be legally bound, hereby agree as follows:\\n\\n1\\n\\nSource: ARCONIC ROLLED PRODUCTS CORP, 10-12B, 12/17/2019\\n\\n\\n\\n\\n\\n1. GRANT AND SCOPE OF LICENSE. 1.1 Grant of License. Licensor on behalf of itself and its Affliates hereby grants to Licensee the limited licenses to use and have used the Licensed Mark: (i) for the Licensed Products as set forth on Schedule 2; and (ii) as set forth on Schedule 1, concerning agreements entered into by Licensee prior to the Effective Date (\"Existing Agreements\"). For the avoidance of doubt, Licensor also grants to Licensee and its subsidiaries and affiliates a non-exclusive, worldwide royalty-free license for continued use of the Licensed Mark for the production and sale of inventory containing the Licensed Mark applied to such products during the Transition Period as set forth in section 8.2 of the Separation and Distribution Agreement and in Schedule 2 of this Agreement. Licensee will not, however, use the Licensed Mark except for the production and sale of inventory as provided in this Section 1.1 and in Section 8.2 of the Separation and Distribution Agreement and Schedule 2 of this Agreement. For avoidance of doubt, to the extent that any of the licenses granted by the terms of this Agreement include any right to sublicense, such right to sublicense shall extend to Licensee\\'s subsidiaries and joint venturers. 1.2 Goodwill. Licensee expressly recognizes and acknowledges that its use of the Licensed Mark shall inure solely to the benefit of Licensor, and shall not confer on Licensee any ownership rights to the Licensed Mark. Licensee agrees and covenants that it shall not challenge, contest, or take any actions inconsistent with Licensor\\'s exclusive rights of ownership of the Licensed Mark. 1.3 Trademark Notices. All print and electronic displays of the Licensed Mark by Licensee shall include at Licensor\\'s option, a notice to the effect that the Licensed Mark are owned by Licensor and used by Licensee under license from Licensor. 1.4 Licensee Cooperation. Licensee agrees to reasonably cooperate with Licensor in achieving registration of the Licensed Mark worldwide, and in maintaining and protectin',\n",
              "    'Highlight the parts (if any) of this contract related to \"Document Name\" that should be reviewed by a lawyer. Details: The name of the contract',\n",
              "    'FORM OF TRADEMARK LICENSE AGREEMENT',\n",
              "    12,\n",
              "    47),\n",
              "   ('Exhibit 10.1   COOPERATION AGREEMENT BETWEEN THE CITY OF FORT STOCKTON, TEXAS AND STW RESOURCES HOLDING CORP. REGARDING DEVELOPMENT OF WATER WELL(S) IN THE CAPITAN REEF AQUIFER FORMATION\\n\\nThis AGREEMENT regarding development of water well(s) in the Capitan Reef Aquifer Formation (the \"AGREEMENT\") is entered into by the City of Fort Stockton, Texas, a Texas Type A-General Law city (\"COFS\") and STW Resources Holding Corp., a Nevada corporation (\"STW\"), effective as of the last date of signature on the signature pages below. STW and COFS are sometimes individually referred to as a \"Party\" and collectively referred to as the \"Parties.\"\\n\\nWHEREAS, the City of Fort Stockton, Texas (\"COFS\") owns the surface and groundwater rights to several areas of the Capitan Reef Aquifer Formation; and\\n\\nWHEREAS, COFS has an existing Capitan Reef Aquifer (\"CRA\") water well located at Section 112 on COFS property, which is currently drilled to an approximate depth of 3,500 feet (the \"Existing CRA Well\"), and also owns property at Section 71; and\\n\\nWHEREAS, STW desires to attempt to deepen the Existing CRA Well in order to make it a producing water well and/or drill an alternate well(s) at its own expense, and to lease CRA groundwater rights from Sections 112 and 71 of COFS property; and   WHEREAS, STW and COFS desire to work together for the development of a CRA water supply project within the area that will serve to meet the future needs of COFS and the municipal and industrial needs within the region.\\n\\nTHE PARTIES HEREBY AGREE AS FOLLOWS:\\n\\n1.  Leasing of Property  and Drilling  of Water Well(s). COFS hereby grants, leases and lets unto STW the right to explore for, drill for, produce, utilize, transport, and treat groundwater from the CRA only from beneath the surface of the property more specifically described in Exhibit \"A,\" which is attached hereto and fully incorporated into this AGREEMENT (hereinafter collectively referred to as the \"Property\"). STW is further authorized to drill, deepen, and/or rework at its expense the Existing CRA Well on Section 112 of the Property from its current depth of approximately 3,500 feet to approximately 4,000 feet, so as to determine the following to be verified by a study to be performed by a hydrogeologist mutually agreed upon by both Parties (\"Post-Well Study\"): (a) the gallons per day (\"GPD\") of maximum water capacity of the Existing CRA Well or alternate well, as may be required under Section 5 of the AGREEMENT; and (b) the quality of the water to be obtained from the Existing CRA Well or alternate well. The rights granted to STW under this AGREEMENT also include the right of access to the Property to perform the activities authorized herein.   2.  Acces s and Surface Use. STW agrees to coordinate reasonably with COFS with respect to location of any new wells, roadways, power infrastructure, and other improvements that are to be constructed or used on the Property. COFS shall provide STW rent free site leases for the commercially reasonable amounts of surface area required for CRA pumping and filling stations located on the Property. STW shall pay for or repair all actual damages to roads, fences, or improvements caused by its activities on the Property within sixty (60) days of the occurrence, and will fill and level all pits, mounds, ruts, and shall restore the surface to as near its original condition as is reasonably practicable within ninety (90) days after termination of the provisions of this AGREEMENT related only to the Property. Upon termination of the provisions of this AGREEMENT related to the Property only, STW, or its successors or assigns, shall transfer title of all water conveyance pipelines from the Property to COFS. STW shall administer and provide all necessary and reasonable insurance to insure its activities on the Property in relation to the AGREEMENT and shall list COFS as additional insured.\\n\\n  -1-\\n\\n\\n\\n\\n\\n    3.  Term.  Subject to the other provisions contained herein, this AGREEMENT shall be for a term of thirty (30) years from the Effective Date, which shall automatically rene',\n",
              "    'Highlight the parts (if any) of this contract related to \"Document Name\" that should be reviewed by a lawyer. Details: The name of the contract',\n",
              "    'COOPERATION AGREEMENT',\n",
              "    15,\n",
              "    36),\n",
              "   ('SCHEDULE TO Software License, Customization and Maintenance Agreement    Supplier Name:  Cardlytics, Inc.  Agreement Number:  CW251207\\n\\nSupplier Address:\\n\\n\\n\\n621 North Avenue NE Suite C-30 Atlanta, GA 30308\\n\\nAddendum Number:\\n\\n\\n\\nCW255039\\n\\nSupplier Telephone:  888.798.5802  Addendum Effective Date  March 3, 2011\\n\\nThis Schedule (\"Schedule\") is made as of the effective date set forth above to that Software License, Customization, and Maintenance Agreement, by and between Cardlytics, Inc. (\"Supplier\") and Bank of America, N. A, (\"Bank of America\"), dated November 5, 2010, as amended (\"SLCMA\"). Each capitalized term used but not defined herein shall have the meaning assigned in the SLCMA.\\n\\nWHEREAS, Bank of America and Supplier entered into the SLCMA in order to set forth the terms and conditions pursuant to which Supplier provides certain Software to Bank of America,\\n\\nWHEREAS, the parties desire to add to the SLCMA the Supplier Offer Placement System Software;\\n\\nNOW THEREFORE, in consideration of the promises and accords made herein, and the exchange of such good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, Bank of America and Supplier agree as follows:\\n\\nThe attached Schedule [A] is hereby incorporated into the SLCMA describing the Offer Placement System Software for use by Bank of America.\\n\\nTHE FOREGOING IS UNDERSTOOD AND AGREED TO BY:   Cardlytics, Inc. (\"Supplier\")   Bank of America, N.A. (\"Bank of America\")\\n\\nBy:  /s/ Scott Grimes  By:  /s/ Chandra Torrence\\n\\nName: Scott Grimes  Name: Chandra Torrence\\n\\nTitle:  Chief Executive Officer  Title:  V.P., Sourcing Manager\\n\\nDate:  3/4/11  Date:  3/3/11    1.\\n\\nSource: CARDLYTICS, INC., S-1, 1/12/2018',\n",
              "    'Highlight the parts (if any) of this contract related to \"Document Name\" that should be reviewed by a lawyer. Details: The name of the contract',\n",
              "    'SCHEDULE TO Software License, Customization and Maintenance Agreement',\n",
              "    0,\n",
              "    69),\n",
              "   ('Exhibit 10.5\\n\\nNote: Portions of this exhibit indicated by\"[*]\" are subject to a confidential treatment request, and have been omitted from this exhibit. Complete, unredacted copies of this exhibit have been filed with the Securities and Exchange Commission as part of this Company\\'s confidential treatment request.\\n\\nDistributor Agreement                              ---------------------\\n\\nThis Distributor Agreement (the \"Agreement\") is made effective as of the 31st day of March, 2000 (the \"Effective Date\"), by and between Airspan Networks Incorporated, a company incorporated under the laws of the State of Washington having its principal office at 777 108th Avenue NE, Suite 1895, Bellevue, Washington 98004 (\"Airspan\") and GLS LLC, (\"Distributor\") a limited liability company incorporated under the laws of the State of South Dakota having its principal office at 501 Fourth Street, Sergeant Bluff, IA 51054.\\n\\nWITNESSETH:\\n\\nWHEREAS, Airspan is engaged in the design and manufacture of various telecommunications product lines, including, among others, those product lines more completely described in Schedule I hereto (the product lines described in Schedule I, as from time to time amended in accordance with the provisions of this Agreement, are hereinafter called the \"Airspan Products\") the hardware components thereof are sometimes referred to separately as \"Equipment,\" the software components thereof are sometimes referred to separately as \"Software\" as defined in Section 11.1, and an arrangement of Equipment which, when interfaced with Software, is operable to perform predetermined functions, is referred to as a \"System\");\\n\\nWHEREAS, Distributor is engaged in the promotion of sales of telecommunications products; and\\n\\nWHEREAS, Airspan desires to appoint Distributor as a Distributor for the Airspan Products for the territory described in Schedule II hereto (the \"Territory\").\\n\\nNOW, THEREFORE, in consideration of the mutual promises herein contained, it is hereby agreed as follows:\\n\\n1.   APPOINTMENT.      -----------\\n\\n1.1  Subject to the provisions of this Agreement, Airspan hereby appoints Distributor as an independent, exclusive distributor to assist Airspan in marketing the Airspan Products to customers in the Territory, and Distributor hereby accepts such appointment as of the Effective Date of this Agreement. Distributor\\'s appointment as a distributor of the Airspan Products grants to Distributor only a license to resell the\\n\\n- -------------------------------------------------------------------------------\\n\\nPage 1\\n\\nAirspan Products to Distributor\\'s customers in the Territory, and does not transfer any right, title, or interest in any of the Airspan Software to Distributor.\\n\\n1.2  Distributor\\'s relationship to Airspan is that of an independent contractor, and nothing in this Agreement shall constitute Distributor as the agent or employee of Airspan.  Distributor shall have no authority to accept any order or make any offer (except as herein stated), or execute any instrument or make any commitment on behalf of Airspan.  Specifically, without in any way limiting the generality of the foregoing, Distributor agrees not to make any representation, guarantee, or warranty on Airspan\\'s behalf concerning the Airspan Products, but will refer customers to Airspan\\'s printed literature. Nothing contained in this Agreement is to be construed as a limitation or restriction upon Airspan in the sale or other disposition of any of its products to any person, firm, or corporation inside or outside of the Territory. Airspan will pay no commissions under this Agreement.  Distributor\\'s compensation is to be obtained solely by the difference between the price Distributor pays to Airspan and the price Distributor charges its customers. The parties also acknowledge that this Agreement is not intended to create a joint venture or partnership between Airspan and Distributor.\\n\\n1.3  Distributor will use its best efforts to maintain and support the Airspan Products within the Territory by devoting such attention, time, and effort as may be reasonably necessar',\n",
              "    'Highlight the parts (if any) of this contract related to \"Document Name\" that should be reviewed by a lawyer. Details: The name of the contract',\n",
              "    'Distributor Agreement',\n",
              "    395,\n",
              "    416),\n",
              "   ('EXHIBIT 10.6    TRANSPORTATION CONTRACT  SPECIFIC CONDITIONS\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n   PURPOSE\\n\\n  ECONOMIC CONDITIONS\\n\\n  CONTRACTED CAPACITY\\n\\n\\n\\n   POINTS OF ENTRANCE AND EXIT     MANSOYร - TUMACO\\n\\n\\n\\nDate Bogota D.C. January 30, 2012\\n\\nContract No. VIT-005-2012\\n\\nSENDER SOLANA PETROLEUM EXPLORATION  COLOMBIA LIMITED\\n\\nTAX ID 830.051.027-8\\n\\nSHIPPER ECOPETROL S.A.   TAX ID 899.999.068-1\\n\\nT Y P E  O F   CRUDE  OWN PRODUCTION x  PROPERTY\\n\\nTransportation Service of liquid hydrocarbons through the \"Trasandino\" Pipeline(OTA) and Mansoyรก-Orito (OMO) pipeline.\\n\\nEstimated Value of the Contract Six millions seven hundred forty five thousand dollars of The United States of  America (USD$6.745.000).  Rate \"Mansoyรก-Orito\" Pipeline (OMO) Cero point five one nine two dollars of The Untied States of America (USD$0,5192) per Barrel  Rate \"Trasandino\" Pipeline (OTA) Three dollars eleven forty three cents of dollars of The Untied States of America (USD$3,1143) per Barrel.\\n\\nPRODUCT Daily Average  (Barrels/calendar day)  Monthly average  (Barrels/month)  Crude 10.000 300.000\\n\\nTERM OF EXECUTION From January 30, 2012 until July 29, 2012\\n\\nPoint   #  Type of Point    Name of Point  Distance  (km)\\n\\n1 Point of Entrance  Entrance bridle to the srapers tramp in the PK 35+400 of  OMO 377,3  2 Point of Exit Exit bridle to the main tanks of Tumaco Plant.\\n\\n\\n\\n\\n\\n\\n\\n   SPECIFICATIONS OF PRODUCTS TO BE SHIPPED    PRODUCT CHARACTERISTICS\\n\\n   Quality Specifications of Crude:    Bases on the operating conditions of the \"Trasandino\" Pipeline, ECOPETROL shall only receive daily crude oil from the SENDER up to a maximum  equivalent to 12% of the total light crude received in the day at the Orito Plant.    The indicated Quality Specifications correspond to those which the final mix of crude delivered by the SENDER shall have. In the event in which  the Crude delivered by the SENDER fails to meet the Quality Specification and if the buying of dissolvent is required to make mixes, the SENDER  shall request approval from ECOPETROL before its delivery for transportation by ECOPETROL.    It is the SENDER\\'s responsibility to ensure its possession, control and entitlement to deliver or make deliver on its behalf the crude received by  ECOPETROL at the Entrance Point. The SENDER shall hold ECOPETROL harmless against any claim, action or damages which may result from  suits, claims or administrative, judicial or extrajudicial actions from any third persons alleging ownership or possession on the crude to be shipped.    BONDS\\n\\n   In witness whereof, and accepting the General Conditions and the Specific Conditions this Contract is subscribed in two (2) duplicates of the same  content in the city of Bogotรก on the thirtieth (30th) day of the month of January, 2012.\\n\\n\\n\\nCharacteristics Lower Limit Upper Limit  Temperature   120ยฐF  Viscosity   300 cSt 30ยบC.  Water and sediments (BSW)   0,5 % in volume  Salt   20 PTB  Steam pressure   Eleven (11) psi at 100ยฐF  Gravity in API degrees 18 degrees 50 degrees\\n\\nTYPE OF BOND AMOUNT  Performance Insurance Policy Four thousand forty seven millions of Colombian pesos ($4.047.000.000)\\n\\n  1\\n\\n\\n\\n\\n\\n\\n\\n   All notifications and communications to be delivered to the Parties as a result of the execution of the Contract hereof shall be made to the  addresses indicated as follows:    ECOPETROL\\n\\n  THE SENDER\\n\\n\\n\\n\\n\\nBY THE SENDER: BY ECOPETROL S.A.:  Signature \"/s/ Duncan Nightingale\" Signature \"/s/ Rafael Espinosa Rozo\"          Name: DUNCAN NIGHTINGALE Name: RAFAEL ESPINOSA ROZO  Title: Legal Representative  Pasaporte No. BA386341  Title: Pipelines Manager  C.C. No. 79.432.773 de Bogotรก D.C.          Signature \"/s/ Hugo Rodriguez\"             Name: HUGO RODRIGUEZ     Title: Legal Representative  C.C. No. 3.093.980\\n\\nADDRESS 5.1 Carrera 7 No. 37 - 69 Piso 9 Edificio Teusacรก  TELEPHONE 5.2 2343491 FAX 5.3 2343532 CITY 5.4 Bogotรก D.C.\\n\\nADDRESS 5.5 Calle 113 No. 7 - 80 Piso 17  TELEPHONE 5.6 6585757 FAX 5.7 2139327 CITY 5.8 Bogotรก D.C.\\n\\n  2\\n\\n\\n\\n\\n\\n   TRANSPORTATION CONTRACT  GENERAL CONDITIONS    The Contract hereof executed between ECOPETROL and the SENDER shall be comprised by t',\n",
              "    'Highlight the parts (if any) of this contract related to \"Document Name\" that should be reviewed by a lawyer. Details: The name of the contract',\n",
              "    'TRANSPORTATION CONTRACT  GENERAL CONDITIONS',\n",
              "    3964,\n",
              "    4007),\n",
              "   ('Exhibit 10.1 NON-COMPETITION AGREEMENT AMENDMENT NO. 1   This NON-COMPETITION AGREEMENT AMENDMENT NO. 1 (this \"Amendment\") is entered into as of August 16, 2017, by and between VIVINT SOLAR, INC., a Delaware corporation (together with its successors and permitted assigns, \"Vivint Solar\"), and VIVINT, INC., a Utah corporation (together with its successors and permitted assigns \"Vivint\"). Each of Vivint Solar and Vivint may also be referred to herein individually as a \"Party\", and collectively as the \"Parties\".   RECITALS\\n\\nWHEREAS, Vivint Solar and Vivint are affiliate business entities, under the common control and ownership of 313 Acquisition, LLC, a Delaware limited liability company.\\n\\nWHEREAS, the Parties had entered into a Non-Competition Agreement dated September 30, 2014, by and between the Parties (collectively, the \"Non-Competition Agreement\") to set out certain restrictive covenants of each Party.\\n\\nWHEREAS, the Parties wish to amend the existing obligations under the Non-Competition Agreement.\\n\\nWHEREAS, the Parties also desire to extend the term of the non-solicitation obligations under the Non-Competition Agreement.\\n\\nAGREEMENT\\n\\nNOW, THEREFORE, in consideration of the mutual covenants, agreements and conditions set forth herein, and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Parties agree as follows:\\n\\n1. Definitions. Any capitalized term used but not defined in this Amendment will have the meaning set forth for that term in the Non-Competition Agreement or the Master Framework Agreement, dated September 30, 2016, by and between the Parties (the \"Master Framework Agreement\").\\n\\n2. Non-Competition. Section 2 of the Non-Competition Agreement shall be deleted in its entirety and the other provisions of the Non-Competition Agreement that relate to such Section 2, including, without limitation, Sections 5 and 6, shall be amended hereby to delete the applicable references, and provisions solely applicable to, Section 2, mutatis mutandis.   3. Non-Solicitation. Section 4 of the Non-Competition Agreement is hereby deleted in its entirety and replaced with the following:\\n\\n\"Term. This Agreement will become effective on the Effective Date, and will continue until the expiration of the \"Sales Term\" as that term is defined in the Sales Dealer Agreement dated as of August 16, 2017 between Vivint and Vivint Solar Developer, LLC (the \"Term\").\"   4. Continuation. This Amendment will apply and be effective only with respect to the provisions of the Non- Competition Agreement specifically referred to herein. Except as otherwise set forth in this Amendment, the Non-Competition Agreement will continue in full force and effect in accordance with its terms.\\n\\n1\\n\\n\\n\\n\\n\\n  5. Master Framework Agreement. This Amendment is governed by the Master Framework Agreement, including, without limitation, the provisions of Sections 4 (Confidentiality) and 6 (Miscellaneous) of the Master Framework Agreement.\\n\\n[SIGNATURE PAGES FOLLOW]\\n\\n2\\n\\n\\n\\n\\n\\n  IN WITNESS WHEREOF, the Parties have executed this Non-Competition Agreement Amendment No. 1 as of the date first written above.\\n\\n\\n\\nVIVINT SOLAR:     VIVINT SOLAR, INC., a Delaware corporation     By: /s/ David Bywater Name: David Bywater Title: Chief Executive Officer\\n\\n[SIGNATURE PAGES CONTINUE ON FOLLOWING PAGE]\\n\\n\\n\\n[SIGNATURE PAGE]\\n\\n\\n\\n\\n\\nVIVINT:     VIVINT, INC., a Utah corporation     By: /s/ Alex J. Dunn Name: Alex J. Dunn Title: President\\n\\n[SIGNATURE PAGE]',\n",
              "    'Highlight the parts (if any) of this contract related to \"Document Name\" that should be reviewed by a lawyer. Details: The name of the contract',\n",
              "    'NON-COMPETITION AGREEMENT AMENDMENT NO. 1',\n",
              "    62,\n",
              "    103),\n",
              "   ('Exhibit 4.72\\n\\nConfidential\\n\\n(Translation, for reference only)\\n\\nStrategic Alliance Agreement\\n\\nThis Strategic Alliance Agreement (\"Agreement\") is executed on this 11th day of December, 2015 (\"Execution Date\") by and between ChipMOS TECHNOLOGIES INC., a company incorporated under the laws of Taiwan (\"ChipMOS\"), and Tsinghua Unigroup Ltd. (\"Tsinghua Unigroup\"), a company incorporated under the laws of the People\\'s Republic of China (\"PRC\"). ChipMOS and Tsinghua Unigroup shall collectively be referred to as the \"Parties.\"\\n\\nWHEREAS, Tsinghua Unigroup actively searches for investment targets which are leading companies in upstream, midstream, or downstream semiconductor industries, provides abundant funds to build strategic cooperation, and jointly shares the growing business opportunities of the semiconductor market in Mainland China; ChipMOS is a leading company engaged in the assembly and testing services of LCD drivers and wafer bumping process technologies.\\n\\nWHEREAS, ChipMOS and Tsinghua Unigroup will also, on the Execution Date, enter into the Share Subscription Agreement (\"Share Subscription Agreement\"). ChipMOS agrees, according to the terms and conditions of the Share Subscription Agreement, to increase its capital and issue 299,252,000 common shares through private placement (\"Private Placement Shares\") and the Private Placement Shares will be subscribed to by a company over which Tsinghua Unigroup has de facto control (\"Subscriber\"); Tsinghua Unigroup also agrees that such Private Placement Shares be subscribed to by the Subscriber from ChipMOS (\"Transaction\").\\n\\nWHEREAS, ChipMOS and Tsinghua Unigroup, in order to strengthen their relationship, are going to form a strategic alliance, establish a long-term cooperative relationship, share resources and networks, support each other in the semiconductor industry, and strive for expansion and growth. NOW, THEREFORE, the Parties hereby agree as follows:\\n\\n  Article 1 Strategic Alliance\\n\\n1.1 Content of Strategic Alliance and Expected Benefits After the Closing Date (as defined in the Share Subscription Agreement), Tsinghua Unigroup and ChipMOS shall cooperate, expand, strengthen and stabilize the relationship with the related upstream, midstream, and downstream industries engaged in the assembly and testing services of LCD drivers, microelectromechanical systems (MEMS), the Internet of Things (IoT) and Radio Frequency Integrated Circuits (RFIC) and/or wafer bumping services in Mainland China. Tsinghua Unigroup shall also introduce other potential suppliers, customers and business partners in Mainland China to ChipMOS.   - 1 -\\n\\n\\n\\n\\n\\nConfidential\\n\\n(Translation, for reference only)   1.2 Covenants of Parties\\n\\n(1) Tsinghua Unigroup covenants to follow the Share Subscription Agreement to subscribe for, via the Subscriber, in compliance with the requirements of Taiwan\\'s laws and regulations relating to securities transactions and PRC investment in Taiwan, at the Subscription Price per Share (as defined in the Share Subscription Agreement), 299,252,000 common shares through private placement from ChipMOS, and Tsinghua Unigroup shall comply with, and shall cause the Subscriber to comply with the content of the Share Subscription Agreement, Taiwan\\'s laws and regulations concerning securities transactions and PRC investments in Taiwan so that ChipMOS may make use of the Total Subscription Price (as defined in the Share Subscription Agreement) to replenish operating capital, recruit talents, and upgrade its technologies related to the semiconductor assembly and testing services, to create profits for each of the Parties and its shareholders.\\n\\n(2) ChipMOS covenants that part or all of the Total Subscription Price shall be used:\\n\\n  (a) To strengthen research and development, and technologies, and expand production capacity in Taiwan in order to strengthen itsroots in Taiwan, and increase job opportunities.\\n\\n\\n\\n(b) To increase the capital of ChipMOS TECHNOLOGIES (Shanghai) LTD. (\"ChipMOS Shanghai\"), and replenish the operating capital of ChipMOS Shanghai, in order to expand ChipMOS and its a',\n",
              "    'Highlight the parts (if any) of this contract related to \"Document Name\" that should be reviewed by a lawyer. Details: The name of the contract',\n",
              "    'Strategic Alliance Agreement',\n",
              "    98,\n",
              "    126),\n",
              "   ('Exhibit 10.11    Execution Copy    STRATEGIC ALLIANCE AGREEMENT    This STRATEGIC ALLIANCE AGREEMENT (this \"Agreement\") is made as of December 21, 2006 by and among OXBOW CARBON & MINERALS LLC, a Delaware limited liability company having a principal office address at 1601 Forum Place, Suite 1400, West Palm Beach, Florida 33401 (\"Oxbow\") and GLOBAL ENERGY, INC., an Ohio corporation having a principal office address at 312 Walnut Street, Suite 2650, Cincinnati, Ohio 45202 (\"Global Energy\"). Oxbow and Global each may be referred to from time to time herein as a \"Party\" and collectively as the \"Parties\".    RECITALS    WHEREAS, Oxbow is a world leader in petroleum coke trading, marketing, sales, and shipping; and    WHEREAS, Global Energy is a world leader in petroleum coke gasification, having optimized operations of the leading petroleum coke gasification technology, EGASโข technology, at its Wabash gasification facility in Indiana; and    WHEREAS, Oxbow leases a marine terminal site in Texas City, Texas which it believes to be well-suited for installation of petroleum coke gasification technology, in that gasification would optimize Oxbow\\'s flexibility in the sale and use of petroleum coke currently stored on the site, which could be converted into pipeline SNG or hydrogen, as well as being shipped onward to Oxbow\\'s traditional petroleum coke customers; and    WHEREAS, Global Energy is a leader in the development and permitting of gasification facilities, and currently is the only gasification facility owner/operator with permits to construct new gasification facilities (specifically, its Lima and Westfield Projects); and    WHEREAS, the Parties believe that an alliance as described in this Agreement will prove mutually beneficial;    NOW, THEREFORE, in consideration of the premises and for other good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, the Parties agree as follows:    AGREEMENT    1. Purchase of Shares. Global Energy shall issue and sell to Oxbow, and Oxbow shall purchase from Global Energy, on the Closing Date, Twenty-Five Thousand (25,000) common shares of Global Energy (the \"Shares\"), on the following terms and conditions, and subject to satisfaction of the conditions set forth in Section 6 hereof:    (a) Purchase Price. The purchase price for the Shares shall be Five Million and No/100 Dollars ($5,000,000.00), or $200.00 per Share.      1\\n\\n\\n\\n\\n\\n    (b) Payment. Payment of the Purchase Price shall be made on the Closing Date by wire transfer of immediately available funds to Global Energy, as applicable, at the applicable account designated by Global Energy, as follows:                                           Bank:     PNC Bank, N.A.                               Cincinnati, OH                          ABA No.:     042000398                          Account No.:     40-7690-5189                          Account Name:    Global Energy, Inc.                            (c) Closing. Unless this Agreement shall have been terminated and subject to the satisfaction or waiver of the conditions set forth in Section 6, the closing of the purchase of the Shares (the \"Closing\") shall take place at 11:00 a.m., on December 22, 2006 (such date of closing referred to herein as the \"Closing Date\") at the offices of Oxbow, 1601 Forum Place, Suite 1400, West Palm Beach, Florida 33401, unless another date, time or place is agreed to in writing by the parties hereto. At the Closing, Oxbow shall pay to Global Energy the Purchase Price and Global Energy shall deliver to Oxbow a stock certificate evidencing the issuance to Oxbow of the Shares. The Closing shall be deemed effective as of 12:01 a.m. U.S. Eastern Standard Time, on the Closing Date.    2. Strategic Alliance. The Parties hereby form a strategic alliance having the following key elements:    (a) Preferred Suppliers. Oxbow and Global Energy hereby designate one another as their preferred suppliers of certain goods and services, as follows:    (i) Oxbow shall be the preferred petroleum coke supplier to petroleum coke gasification ',\n",
              "    'Highlight the parts (if any) of this contract related to \"Document Name\" that should be reviewed by a lawyer. Details: The name of the contract',\n",
              "    'STRATEGIC ALLIANCE AGREEMENT',\n",
              "    72,\n",
              "    100),\n",
              "   ('NON COMPETITION AGREEMENT AND RIGHT OF FIRST OFFER\\n\\nTHIS AGREEMENT is dated May 3,2006.\\n\\nBETWEEN:\\n\\nGLAMIS GOLD LTD., a company incorporated under the laws  of the Province of British Columbia, having an office at 310-5190  Neil Road, Reno, Nevada 89502\\n\\n(\"Glam is\")\\n\\nAND:\\n\\nWESTERN COPPER CORPORATION, a company  incorporated under the laws of the Province of British Columbia,  having an office at 2050-1111 West Georgia Street, Vancouver.  B.C. V6E 4M3\\n\\n(\"Western Copper\")\\n\\nWHEREAS:\\n\\n(A) Glamis, Western Copper and Western Silver Corporation (\"Western Silver\") are  parties to an arrangement agreement dated as of February 23, 2006 (the \"Arrangement  Agreement\"), pursuant to which, among other things, Western Copper will acquire certain assets  of Western Silver and Glamis will become the sole shareholder of Western Silver and the  indirect owner, through Western Silver, of certain corporations and mineral properties in Mexico  (the \"Arrangement\"); and\\n\\n(B) It is an obligation under the Arrangement Agreement that Western Copper agree  not to compete with Glamis in certain areas of Mexico and that Glamis grant Western Copper a  right of first offer with respect to the proposed disposition by Glamis of mineral properties or  legal interests therein located in Mexico that Glamis acquired under the Arrangement.\\n\\nNOW THEREFORE TIHS AGREEMENT WITNESSES that in consideration of the mutual  covenants and agreements contained herein and other good and valuable consideration, the  receipt and sufficiency of which is hereby acknowledged, the parties hereto covenant and agree  as follows: (Scheme B. mca)\\n\\n1I629<<7J\\n\\n\\n\\n\\n\\nPART I\\n\\nINTERPRETATION\\n\\nDefinitions\\n\\n1.1 In this Agreement, including the recitals, except as expressly provided or unless  the context otherwise requires,\\n\\n(a) Affiliate means, in respect of a party hereto, a corporation which is the subsidiary  of the party or vice versa or where each of the party and the corporation is controlled by  the same person,\\n\\n(b) Area of Non-Competition means the State of Zacatecas, Mexico and the area  extending 20 kilometers in all directions from the external boundary of each mineral  property owned or controlled by Western Silver or in which Western Silver holds any  legal interest, in Mexico, as at the Effective Date,\\n\\n(c) Business Day means a day which is not a Saturday, Sunday or a civic or statutory  holiday in Reno, Nevada and Vancouver, British Columbia,\\n\\n(d) Closing means the completion of the transactions contemplated by the  Arrangement Agreement,\\n\\n(e) Designated Mineral Property means a mineral property or individual mineral  concession within a mineral property, that is owned or controlled by Western Silver or in  which Western Silver holds any legal interest in Mexico as of the Effective Date,\\n\\n(f) Effective Date means May 3, 200ri or such later date as determined under the  Arrangement Agreement,\\n\\n(g) Mining Activities means any acquisition of mineral rights or any mineral  exploration or development activities, in any manner whatsoever, and\\n\\n(h) Person means an individual, corporation, body corporate, firm, limited liability  company, parmership, syndicate, joint venture, society, association, trust or  unincorporated organization.\\n\\nInterpretation\\n\\n1.2 In this Agreement, except as otherwise expressly provided or unless the context  otherwise requires,\\n\\n(a) the terms \"this Agreement\", \"hereof\\', \"herein\", \"hereunder\" and similar  expressions refer to this Agreement as from time to time supplemented or amended by  one or more agreements entered into pursuant to the applicable provisions of this  Agreement and not to any particular section or other portion,\\n\\n1162967.3\\n\\n\\n\\n\\n\\n- 3 \\'\\n\\n(b) a reference to a Part means a Part of this Agreement and the symbol ยง followed by  a number or some combination of numbers and letters refers to the provision of this  Agreement so designated and the symbol ยง followed by a letter within a provision refers  to a clause within such provision,\\n\\n(c) the headings used in this Agreement are for convenience only and do not form a  part of this Agreement and a',\n",
              "    'Highlight the parts (if any) of this contract related to \"Document Name\" that should be reviewed by a lawyer. Details: The name of the contract',\n",
              "    'NON COMPETITION AGREEMENT AND RIGHT OF FIRST OFFER',\n",
              "    0,\n",
              "    50),\n",
              "   ('EXHIBIT 10.15\\n\\nCO-BRANDING AGREEMENT\\n\\nThis Agreement is made this 21st day of January 2003 by and between Lucent Technologies Inc., a Delaware corporation having a principal place of business at 600 Mountain Avenue, Murray Hill, New Jersey 07974 (\"Lucent\") and mPhase Technologies Inc., a New Jersey corporation located at 587 Connecticut Avenue, Norwalk, Connecticut 068545 (\"mPhase\") (each individually, \"a Party\" and, collectively, \"the Parties\"}.\\n\\nWHEREAS, mPhase wishes to use the Lucent Technologies name and Logo and the slogan TECHNOLOGY BY LUCENT TECHNOLOGIES on printed circuit boards, product packaging and in printed marketing materials (\"Approved Uses\") in connection with its multi-access product (the \"Goods\") and Lucent wishes to permit mPhase to do so.\\n\\nNOW THEREFORE, the Parties, for good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, agree as follows:\\n\\n1.       mPhase may apply only the exact logo shown on Schedule A of this          Agreement (the \"Lucent Co-Branding Logo\"} in Approved Uses for mPhase\\'s          Goods.\\n\\n2.       mPhase agrees to abide by the guidelines appearing on Schedule B of          this Agreement specifying the dimensions, requirements and          specifications, and the review process related to use of the Lucent          Co-Branding Logo. mPhase understands that these guidelines may be          updated from time to time and agrees to abide by those updates as well          as the guidelines provided herein.\\n\\n3.       In the event that mPhase\\'s use of the Lucent Co-Branding Logo, in the          sole judgment of Lucent, may adversely affect Lucent\\'s rights to the          mark shown on Schedule A or the marks and names LUCENT, LUCENT          TECHNOLOGIES or LUCENT INNOVATION RING DESIGN, Lucent may upon written          notification to mPhase, terminate this Agreement.\\n\\n4.       mPhase agrees that it acquires no rights to the Lucent Co-Branding Logo          nor to the marks LUCENT, LUCENT TECHNOLOGIES or LUCENT INNOVATION RING          DESIGN, by its use and that any use of the Lucent Co-Branding Logo by          mPhase inures to the benefit of Lucent.\\n\\n5.       mPhase agrees not to adopt any designation which is confusingly similar          to the Lucent Co-Branding Logo or Lucent\\'s marks LUCENT, LUCENT          TECHNOLOGIES or LUCENT INNOVATION RING DESIGN. Any attempt to do so          shall be a breach of this Agreement and Lucent may terminate this          Agreement without notice in the event of such a breach.\\n\\n6.       This Agreement shall terminate in the event of a significant change in          the management or ownership of mPhase or in the event mPhase is the          subject of any bankruptcy proceedings.\\n\\n7.       Lucent is generally aware of the current quality of mPhase\\'s Goods.          mPhase agrees to maintain the quality of its Goods associated with the          Lucent Co-Branding Logo to a level of quality comparable to the current          quality of their Goods.\\n\\n8.       If Lucent determines that mPhase\\'s Goods are no longer maintained at          the current level of quality, Lucent shall so notify mPhase, in          writing, and Lucent shall have the right to terminate this Agreement.\\n\\n9.       mPhase agrees to allow Lucent to inspect the Approved Uses bearing the          Lucent Co-Branding Logo, to ensure that those uses reviewed and          approved pursuant to the procedure set forth in Schedule B continue to          be in compliance with the terms of this Agreement.\\n\\n10.      In the event that mPhase becomes aware of any unauthorized use of the          Lucent Co-Branding Logo or other Lucent marks by third parties, mPhase          agrees to promptly notify Lucent and to cooperate fully, at Lucent\\'s          expense, in any enforcement of Lucent\\'s rights against such third\\n\\nSource: MPHASE TECHNOLOGIES INC, 10-K, 9/11/2003\\n\\n\\n\\n\\n\\nparties. Nothing contained in this paragraph shall be construed to          require Lucent to enforce any rights against third parties or to          restrict Lucent\\'s rights to licens',\n",
              "    'Highlight the parts (if any) of this contract related to \"Document Name\" that should be reviewed by a lawyer. Details: The name of the contract',\n",
              "    'CO-BRANDING AGREEMENT',\n",
              "    15,\n",
              "    36),\n",
              "   ('Exhibit 10.17\\n\\nINTELLECTUAL PROPERTY AGREEMENT\\n\\nbetween\\n\\nTHE BABCOCK & WILCOX COMPANY\\n\\nand\\n\\nBABCOCK & WILCOX ENTERPRISES, INC.\\n\\ndated as of\\n\\nJune 26, 2015\\n\\n\\n\\n\\n\\nTABLE OF CONTENTS   ARTICLE I   DEFINITIONS     1\\n\\n  Section 1.1   Definitions     1\\n\\n  Section 1.2   Interpretation     4\\n\\nARTICLE II   INTELLECTUAL PROPERTY ASSIGNMENT AND OWNERSHIP     5\\n\\n  Section 2.1   Reserved     5\\n\\n  Section 2.2   Reserved     5\\n\\n  Section 2.3   Assistance by Employees; Inventor Compensation     5\\n\\n  Section 2.4   Ownership     6\\n\\n  Section 2.5   Rights Arising in the Future     6\\n\\n  Section 2.6   Abandonment of Certain Intellectual Property     7\\n\\n  Section 2.7   Reserved     7\\n\\n  Section 2.8   Steam/Its Generation and Use     7\\n\\nARTICLE III   TRADEMARKS     8\\n\\n  Section 3.1   House Marks     8\\n\\n  Section 3.2   Limited License to Use SpinCo House Marks     9\\n\\n  Section 3.3   Removal of Classes from SpinCo Marks    10\\n\\n  Section 3.4   RemainCo Marks    10\\n\\n  Section 3.5   Duty to Avoid Confusion    10\\n\\nARTICLE IV   SHARED LIBRARY MATERIALS    11\\n\\n  Section 4.1   Shared Library Materials    11\\n\\n  Section 4.2   Cross-License of Shared Library Materials    11\\n\\n  Section 4.3   Maintenance of Shared Library Materials    11\\n\\n  Section 4.4   Potential Allocation of Shared Library Materials    12\\n\\n  Section 4.5   Confidentiality and Trade Secret Status of Shared Library Materials    13\\n\\n  Section 4.6   Third Party Materials Contained in the Shared Library Materials    13\\n\\nARTICLE V   INTELLECTUAL PROPERTY LICENSES AND COVENANTS    13\\n\\n  Section 5.1   Cross-License of Shared Know-How    13\\n\\n  Section 5.2   Reserved    14\\n\\n  Section 5.3   Reserved    14    i\\n\\n\\n\\n\\n\\n  Section 5.4   Cross-Licenses of Software    14\\n\\n  Section 5.5   Reserved    15\\n\\n  Section 5.6   Sublicensing; Assignability    15\\n\\n  Section 5.7   Restrictions on Licensor Exploitation of Intellectual Property    16\\n\\n  Section 5.8   Third Party Agreements; Reservation of Rights    16\\n\\n  Section 5.9   Maintenance of Intellectual Property    16\\n\\n  Section 5.10   Covenants    17\\n\\nARTICLE VI   TECHNICAL ASSISTANCE AND TECHNOLOGY TRANSFER    17\\n\\n  Section 6.1   Reserved    17\\n\\n  Section 6.2   Reserved    17\\n\\n  Section 6.3   No Additional Technical Assistance    17\\n\\nARTICLE VII   NO WARRANTIES    18\\n\\nARTICLE VIII   THIRD-PARTY INFRINGEMENT    18\\n\\n  Section 8.1   No Obligation    18\\n\\n  Section 8.2   Notice Regarding Infringement    19\\n\\n  Section 8.3   Suits for Infringement    19\\n\\nARTICLE IX   CONFIDENTIALITY    21\\n\\nARTICLE X   MISCELLANEOUS    22\\n\\n  Section 10.1   Authority    22\\n\\n  Section 10.2   Entire Agreement    22\\n\\n  Section 10.3   Binding Effect; Third-Party Beneficiaries; Assignment    23\\n\\n  Section 10.4   Amendment    23\\n\\n  Section 10.5   Failure or Indulgence Not Waiver; Remedies Cumulative    23\\n\\n  Section 10.6   Notices    23\\n\\n  Section 10.7   Counterparts    23\\n\\n  Section 10.8   Severability    23\\n\\n  Section 10.9   Governing Law    24\\n\\n  Section 10.10   Construction    24\\n\\n  Section 10.11   Performance    24\\n\\nSCHEDULES   Schedule 1.1(e)   SpinCo Core Field; RemainCo Core Field Schedule 1.1(i)   Specific RemainCo Field; Specific SpinCo Field Schedule 1.1(o)   SpinCo House Marks Schedule 1.1(p)   RemainCo House Marks   ii\\n\\n\\n\\n\\n\\nSchedule 2.4(a)   RemainCo Ownership Schedule 2.4(b)   SpinCo Ownership Schedule 2.6   Abandonment of Certain Intellectual Property Schedule 3.1   SpinCo Trademarks Schedule 3.3   Required Actions and Filings Schedule 3.4   RemainCo Trademarks Schedule 4.1   Shared Library Materials Schedule 4.4   Nuclear Design Materials Schedule 5.4(a)   Foundational Software   iii\\n\\n\\n\\n\\n\\nINTELLECTUAL PROPERTY AGREEMENT\\n\\nThis INTELLECTUAL PROPERTY AGREEMENT (this \"Agreement\") is entered into as of June 26, 2015 (the \"Effective Date\"), between The Babcock & Wilcox Company, a Delaware corporation, (\"RemainCo\") and Babcock & Wilcox Enterprises, Inc., a Delaware corporation (\"SpinCo\"). RemainCo and SpinCo are sometimes referred to herein individually as a \"Party,\" and collectively as the \"Parties.\" Capitalized terms used herein and not otherwise defined shall have the meanings ascr',\n",
              "    'Highlight the parts (if any) of this contract related to \"Document Name\" that should be reviewed by a lawyer. Details: The name of the contract',\n",
              "    'INTELLECTUAL PROPERTY AGREEMENT',\n",
              "    3598,\n",
              "    3629),\n",
              "   ('Exhibit 10.22\\n\\nSTRATEGIC ALLIANCE AGREEMENT\\n\\n(Hyatt Ziva Cancun)\\n\\nTHIS STRATEGIC ALLIANCE AGREEMENT (the \"Agreement\") is made and entered into as of December 14, 2016 (the \"Effective Date\"), by and between Hyatt Franchising Latin America, L.L.C., a limited liability company organized and existing under the laws of the State of Delaware (U.S.A.) with its principal place of business located at 71 South Wacker Drive, Chicago, Illinois 60606, U.S.A. (\"Hyatt\"), and Playa Hotels & Resorts, B.V., a private limited liability company organized and existing under the laws of the Netherlands with its registered address at Prins Bernhardplein 200, 1097 JB Amsterdam, the Netherlands (\"Playa\"). Hyatt and Playa are each referred to as a \"Party\" and collectively as the \"Parties.\"\\n\\nR E C I T A L S:\\n\\nWHEREAS, Hyatt and Playa are parties to that certain Master Development Agreement dated as of August 9, 2013 (as amended, the \"Master Development Agreement\") under which Hyatt granted Playa the exclusive (to the extent set forth therein) right, provided that Playa met certain conditions, to develop all-inclusive resorts under either or both of the Hyatt Zivaยฎ or Hyatt Zilaraยฎ brands and other aspects of the proprietary system owned by Hyatt or its affiliates (\"Hyatt All-Inclusive Resorts\") in the countries of Mexico, Costa Rica, the Dominican Republic, Jamaica and Panama, as their boundaries exist as of the Effective Date (the \"Market Area\"); and\\n\\nWHEREAS, simultaneously with signing this Agreement, Hyatt and Playa or its affiliates are terminating the Master Development Agreement and signing amendments to the following franchise agreements (collectively, the \"Existing Franchise Agreements\") covering the following Hyatt All-Inclusive Resorts:\\n\\n  โข   Franchise Agreement dated as of August 9, 2013, amended and restated on January 31, 2014 between Hyatt and Playa Hall JamaicanResort Limited for the operation of the Hyatt Ziva/Zilaraยฎ resort at 1 Ritz-Carlton Drive, Rose Hall, Montego Bay, Jamaica\\n\\n  โข   Franchise Agreement dated as of August 9, 2013, amended and restated on January 31, 2014 between Hyatt and Playa Cabos Baja, S. DeR.L. De C.V. for the operation of the Hyatt Zivaยฎ resort at Paseo de Malecรณn I-5 D, San Josรฉ del Cabo, 23405, Mexico\\n\\n  โข   Franchise Agreement dated as of August 9, 2013, amended and restated on January 31, 2014 between Hyatt and Cameron Del Pacifico S. De R.L. De C.V. for the operation of the Hyatt Zivaยฎ resort at Carretera Barra de Navidad Km. 3.5, Zona Hotelera, 48300, Puerto Vallarta, Jalisco, Mexico\\n\\n  โข   Franchise Agreement dated as of August 9, 2013, amended and restated on January 31, 2014 between Hyatt and Cameron Del Caribe S. De R.L. De C.V. for the operation of the Hyatt Zivaยฎ resort at Blvd. Kukulkan Km 9.5, Zona Hotelera, Punta Cancรบn, 77500, Cancรบn, Quintana Roo, Mexico\\n\\n\\n\\n\\n\\n  โข   Franchise Agreement dated as of August 9, 2013, amended and restated on January 31, 2014 between Hyatt and The Royal Cancun S. De R.L. De C.V. for the operation of the Hyatt Zilaraยฎ resort at Blvd. Kukulkan Km 11.5, Zona Hotelera, 77500 Cancรบn, Quintana Roo, Mexico; and\\n\\nWHEREAS, Hyatt and Playa have agreed to terminate the Master Development Agreement and to enter into this Agreement.\\n\\nNOW, THEREFORE, in consideration of the mutual covenants and agreements contained in this Amendment and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties agree as follows:\\n\\n1. First Offer for Development Opportunities. During the period beginning on the Effective Date and ending on December 31, 2018 (the \"Development Term\"), each Party (the \"Offering Party\") agrees to provide to the other Party (the \"Receiving Party\") a right of first offer with respect to any proposed offer or arrangement, which the Offering Party (or its affiliate) desires to accept, under which the Offering Party or one of its affiliates would acquire the ownership of real property in the Market Area (the \"Development Property\") on which a Hyatt All-Inclusive Resort would operate (a \"Development Opportunity\"',\n",
              "    'Highlight the parts (if any) of this contract related to \"Document Name\" that should be reviewed by a lawyer. Details: The name of the contract',\n",
              "    'STRATEGIC ALLIANCE AGREEMENT',\n",
              "    71,\n",
              "    99),\n",
              "   ('Exhibit 10.1\\n\\nCOOPERATION AGREEMENT\\n\\nThis Cooperation Agreement (\"Agreement\") is entered into as of June 18, 2020, by and between Spรดk Holdings, Inc., a Delaware corporation (the \"Company\"), and White Hat Strategic Partners LP, a Delaware limited partnership, White Hat SP GP LLC, a Delaware limited liability company, White Hat Capital Partners LP, a Delaware limited partnership, and White Hat Capital Partners GP LLC, a Delaware limited liability company (collectively, the \"White Hat Parties\") (each of the Company and the White Hat Parties, a \"Party\" to this Agreement, and collectively, the \"Parties\").\\n\\nRECITALS\\n\\nWHEREAS, the White Hat Parties have voting power or sole dispositive power or otherwise have beneficial ownership of 319,708 shares (the \"Current Position\") of the common stock, par value $0.0001 per share, of the Company (the \"Common Stock\") as of the date of this Agreement; and\\n\\nWHEREAS, as of the date of this Agreement, the Company and the White Hat Parties have determined to come to an agreement with respect to certain matters set forth below; and\\n\\nNOW, THEREFORE, in consideration of the foregoing premises and the mutual covenants and agreements contained herein, and for other good and valuable consideration, the receipt and sufficiency of which are acknowledged, the Parties to this Agreement, intending to be legally bound, agree as follows:\\n\\n1. Board Nominations; Certain Information.\\n\\n(a) Brett Shockley (the \"New Director\") has provided the Company with responses to a Director and Officer Questionnaire customarily used for NASDAQ-listed companies and certain biographical information in compliance with Item 401 of Regulation S-K as promulgated by the Securities and Exchange Commission (the \"SEC\") (collectively, the \"Information\"), has executed all documents required to be executed by directors of the Company, and has cooperated with a background check. (b) Based on the Information, the Nominating and Governance Committee (the \"Nominating Committee\") of the Board of Directors (the \"Board\") of the Company and the Board have determined that the New Director may serve as an \"independent\" director of the Company in accordance with the rules and listing standards of the NASDAQ National Market and applicable rules and regulations of the Securities Exchange Commission (the \"SEC\"). (c) Concurrently with the execution of this Agreement, the Board shall increase the size of the Board by one and appoint the New Director to the Board to fill the resulting vacancy. Concurrently with the execution of this Agreement, the Board shall also appoint the New Director to the Nominating Committee. (d) Concurrently with the execution of this Agreement, the White Hat Parties shall send a letter to the Corporate Secretary and Treasurer of the Company irrevocably withdrawing (i) the nomination letter they previously sent to the Company on May 26, 2020, and, accordingly, (ii) their nomination (the \"Nominations\") of three directors for election to the Board at the Company\\'s 2020 Annual Meeting of Stockholders (including any adjournments or postponements thereof, the \"2020 Annual Meeting\"). (e) The Nominating Committee and the Board shall take all necessary action to nominate Brett Shockley for election to the Board at the 2020 Annual Meeting, and to recommend his election and to support and solicit proxies in the same manner as the other candidates nominated by the Board in the Company\\'s proxy statements for the 2020 Annual Meeting. (f) Nothing in this Agreement shall be deemed to abridge or limit the fiduciary duties of any member of the Board under Delaware law. 2. Representations of the White Hat Parties. The White Hat Parties represent and warrant to the Company as of the date hereof as follows: (a) The White Hat Parties are the beneficial owners of 319,708 shares of Common Stock, such shares of Common Stock constitute all of the Common Stock beneficially owned by the White Hat Parties and the White Hat Parties have no agreements, understandings or undertakings with any third party to share or delegate disposition or voting control o',\n",
              "    'Highlight the parts (if any) of this contract related to \"Document Name\" that should be reviewed by a lawyer. Details: The name of the contract',\n",
              "    'Cooperation Agreement',\n",
              "    42,\n",
              "    63),\n",
              "   ('Exhibit 99.1 JOINT FILING AGREEMENT The undersigned hereby agree that the Schedule 13G/A with respect to the shares of Class A Common Stock, $0.001 par value per share, of The RMR Group Inc., dated as of December 31, 2019, is, and any amendments thereto (including amendments on Schedule 13D) signed by each of the undersigned shall be, filed on behalf of each of us pursuant to and in accordance with the provisions of Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended. January 22, 2020 (Date) ABP TRUST /s/ Adam D. Portnoy (Signature) Adam D. Portnoy, President (Name/Title) ADAM D. PORTNOY /s/ Adam D. Portnoy (Signature) 10',\n",
              "    'Highlight the parts (if any) of this contract related to \"Document Name\" that should be reviewed by a lawyer. Details: The name of the contract',\n",
              "    'JOINT FILING AGREEMENT',\n",
              "    13,\n",
              "    35),\n",
              "   ('EXHIBIT 10.23\\n\\nCOMPLETION AND LIOUDm MAINTENANCE 4GRFFMFST\\n\\nTHIS COMPLEHON AGREEMENT AND UQITDITV MAINTENANCE AGREEMENT ( \\'Agreement\") {5 made and entered into effective as of  June 29, 2006 between PRIMEEVERG\\\\\\'CORPORATION ( Time\"), GUARANTY BANK, FSB (\\'Guaranty\") and PRIME OFFSHORELT.C. T: Offshore\"!\\n\\nPrime is the majority shareholder of Prime Offshore L.L.C. COffshore\"! Offshore and Guaranty are parties to a Credit Agreement dated June 29,  2006, by and between Offshore as Borrower and Guaranty, as Agent and Lender i \"Credit Agreement\\'T wherein Guaranty is loaning certain funds  to Offshore to drill and complete wells and construct, install and operate in-field and flow pipelines, caissons, platforms and production facilities  for wells m South Padre Island Area OCS Blocks 1113, 1059, 1060, 1073 and 1133 and North Padre Island Area OCS Block 998 T\\'Derelopment  Project\").\\n\\n1. Completion Commrtiryr.t\\n\\nEach of the South Padre Island Area OCS Blocks 1113,1059,1060,1073 and 1133 and the North Padre Island Area OCS Block 998 shall be defined  as a \"Project Field.\\'\\'\\n\\nFor purposes ofthis Agreement, Project Completion shall consist oftwo components and be defined as:\\n\\nA) each Project Field in the Development Project having all planned in-field and flow pipelines, caissons, platforms and production facilities  for all the wells in such Project Field, for which Guaranty has loaned funds, installed and operationalsuch that the production from all such  wells can be transported to a readily available sales point for naturalgas. In addition, for each Project Field, Project Completion will include,  but not limited to:\\n\\na) obtaining required permits, easements and governmental approvals;\\n\\nb) executing necessary\" construction contract(s);\\n\\nc) completing tests considered usual and customary\" and required to be conducted with results tn accordance with those necessary\" to  permit operations;\\n\\nd) ensuring that each Project Field is free and clear of all bens other than those in favor of Guaranty and Permitted Liens under the Credit  Agreement and:\\n\\ne) causing all costs of the Development Project to be paid when due; and,\\n\\nB) the 12-inch loop pipeline fromNorth Padre Island Area OCS Block 996 to the pipeline owned by the Williams Companies Inc. having been  constructed and installed in accordance with the plans and specifications in the construction contracts).\\n\\n\\n\\n\\n\\nAs consideration for Guaranty entering into the Credit Agreement to provide such loans for the Development Project and to ensure Project  Completion. Prime absolutely and unconditionally warrants to Guaranty to fund the payment to Offshore of all costs that exzeed the available  commitments under the Credit Agreement, including interest, for Project Completion. In the event Offshore is in Default under Section 7.1(f), (g),  (h) and/or (i) ofthe Credit Agreement, then Prime absolutely and unconditionally warrants to Guaranty\" the assumption of all costs for Project  Completion.\\n\\n2. Licuieitv Maintenance\\n\\nPrime will, during the term of the Credit Agreement, maintain liquidity consisting of unused revolver availability\" under the Credit Agreement dated  December!, 2002, as amended, with Prime et aland Guaranty, and/or unrestricted cash and cash equivalents of $25,000,000. This required liquidity\"  win reduce dollar-for-dollar with any additional shareholder advance s and increase dollar-for-dollar to a maximum of $21,000,000 with any  repayment of shareholder advances. To the extent that shareholder repayment has occurred, Prime agrees to fund additional shareholder loans  equal to the amount repayed by the shareholder, as needed to ensure Project Clomp let ion\\n\\nThis Agreement shall remain in force until each component ofProject Completion is satisfied. Once a component is satisfied, Prime\\'s absolute and  unconditional warranty to Guaranty to fund the payment to Offshore of ad costs that esceed the available commitments under the Credit  Agreement for that conponent, including interest, wid ejpire.\\n\\nPrime understands that a breach ofobligations under this Agreement would result i',\n",
              "    'Highlight the parts (if any) of this contract related to \"Document Name\" that should be reviewed by a lawyer. Details: The name of the contract',\n",
              "    'COMPLEHON AGREEMENT AND UQITDITV MAINTENANCE AGREEMENT',\n",
              "    65,\n",
              "    119),\n",
              "   ('ODM - SUPPLY AGREEMENT BETWEEN: ORGANIC PREPARATIONS INC. 2nd Floor, Transpacific Haus Lini Highway, Port Vila. Vanuatu \"the Manufacturer\" -- AND -- AGAPE ATP INTERNATIONAL HOLDING LIMITED Unit 05, 4F, Energy Plaza No. 92, Granville Road Tsim Sha Tsui East Kowloon, Hong Kong \"the Customer\"\\n\\nSource: AGAPE ATP CORP, 10-K/A, 12/2/2019\\n\\n\\n\\n\\n\\nODM SUPPLY AGREEMENT THIS AGREEMENT is made on the 15t h day of January 2018. BETWEEN: ORGANIC PREPARATIONS INC. 2nd Floor, Transpacific Haus Lini Highway, Port Vila. Vanuatu (\\'the Manufacturer\\') of one part AND: AGAPE ATP INTERNATIONAL HOLDING LIMITED Unit 05, 4F, Energy Plaza No. 92, Granville Road Tsim Sha Tsui East Kowloon, Hong Kong (\\'the Customer\\') of the other part. RECITALS a. The Manufacturer wishes to appoint the Customer to be the sole and exclusive agent for the promotion, sales, marketing distribution and administration of the Products listed in schedule A of this agreement. b. The Manufacturer and the Customer wish to record their agreement under the stipulations of this Agreement. NOW IT IS AGREED as follows:- 1. TERMS OF AGREEMENT 1.1 Commencement This agreement commences upon execution of this document. 1.2 Term This agreement is for a term of ten (10) years. 1.3 Renewal This agreement will be automatically renewed at the end of every ten (10) year term, with each subsequent term of renewal being for a ten (10) year term. A six (6) months notice must be given by either party of their intention to terminate relations due to any reason other than breach of this agreement. ODM Supply Agreement 2 Organic Preparations INC. & Agape ATP International Holding Limited\\n\\nSource: AGAPE ATP CORP, 10-K/A, 12/2/2019\\n\\n\\n\\n\\n\\n2. PROVISION OF DOCUMENTATION 2.1 Provision by the Manufacturer The Manufacturer agrees to supply to the Customer, within a reasonable period of time, all documentation and information relating to the Products and their Manufacture as is required for the registration of the Products in the Territories as listed in Schedule C of this document. The party responsible for documentation fees and costs will be the Customer. 2.2 Provision by the Customer The Customer agrees to supply to the Manufacturer at its own expense, within a reasonable period of time, all documentation and information as is reasonably required by or would be beneficial to the Manufacturer in the performance of its obligations under this agreement. 3. COVENANTS BY THE MANUFACTURER 3.1 Compliance with Local Laws and Regulations The Manufacturer covenants that it is and will remain for the term of this agreement in compliance with any and all Local Laws and Regulations. This includes without limitation laws relating to business practice, workplace relations, safety and taxation. 3.2 Manufacturing standards The Manufacturer covenants that it is and will remain for the term of this agreement in compliance with all International standards in production and manufacturing. 3.3 Packaging The Manufacturer covenants that it is and will remain for the term of this agreement in compliance with any and all packaging laws and regulations in all of the Territories. 3.4 Ability to Perform The Manufacturer covenants that it is willing and able to perform any and all of its obligations under this agreement. 3.5 Intellectual Property 3.5 (a) The Manufacturer covenants that the Products are clear of any Intellectual Property claims by third parties and that the Customer has full rights to sell and market the Products worldwide. The Manufacturer indemnifies the Customer for the same. ODM Supply Agreement 3 Organic Preparations INC. & Agape ATP International Holding Limited\\n\\nSource: AGAPE ATP CORP, 10-K/A, 12/2/2019\\n\\n\\n\\n\\n\\n3.5 (b) The composition of the below individuals is also relevant and related to the Intellectual Property of the Manufacturer. The following names listed as Medical Team members, and any subsequent consultations in that capacity, are considered the Intellectual Property of The Manufacturer: 1. Dr Lily Tomas 2. Dr Bernd Friedlander 3. Mr Markus Eistert 4. Dr Ed Smith 5. Mr Vic Cherikoff 6. Dr Pavel Yutsis 7. ',\n",
              "    'Highlight the parts (if any) of this contract related to \"Document Name\" that should be reviewed by a lawyer. Details: The name of the contract',\n",
              "    'ODM SUPPLY AGREEMENT',\n",
              "    339,\n",
              "    359),\n",
              "   ('Exhibit 10.17    Program Content License Agreement     between     Phoenix Satellite Television Company Limited     and     Beijing Tianying Jiuzhou Network Technology Co., Ltd.     November 24, 2009\\n\\nSource: PHOENIX NEW MEDIA LTD, F-1, 4/21/2011\\n\\n\\n\\n\\n\\n     Program Content License Agreement     This Program Content License Agreement (\"Agreement\") is entered into between the following two parties on November 24, 2009 in Beijing:     Phoenix Satellite Television Company Limited (\"Party A\" or \"Phoenix Satellite TV\"), a foreign enterprise duly established and validly existing  under the laws of Hong Kong     Registered Address: No. 2-6, Dai King Street, Taipo Industrial Estate, Taipo, N. T., H.K.     Authorized Representative: Cui Qiang     and     Beijing Tianying Jiuzhou Network Technology Co., Ltd. (\"Party B\"), a limited liability company duly registered and validly existing under PRC laws     Address: Floor 5 Information Building, No. 12 Zhongguancun South Street, Haidian District, Beijing 100081 China     Legal Representative: Qiao Hai Yan     Party A and Party B are hereinafter referred to individually as a \"Party\" and collectively as \"Parties\".     WHEREAS:     1. Party A owns copyrights and other related rights to the programs listed in Exhibit 1 hereto, as amended from time to time;     2. In accordance with the \"Agreement Between Phoenix Satellite TV and Phoenix New Media Regarding Cooperation in the Fields of Content,  Branding, Promotion and Technology\" dated November 24, 2009 between Phoenix Satellite Television Holdings Limited and Phoenix  Online (Beijing) Information Technology Co., Ltd., Party B has the right to operate the Phoenix Satellite TV Websites (defined below)  and Other Websites (defined below), provide Internet information services such as news, entertainment, and business information, as  well as computer information services through such websites and transfer information from Phoenix Satellite TV to mobile network  clients, and authorize the use of the Phoenix Satellite TV program content by other information network service providers (collectively,  \"Party B Business\"); and     3. Both Parties agree that Party A will provide the program content of Phoenix Satellite TV to Party B, subject to the terms and conditions hereof.     2\\n\\nSource: PHOENIX NEW MEDIA LTD, F-1, 4/21/2011\\n\\n\\n\\n\\n\\n     NOW, THEREFORE, upon amicable consultation based on principles of equality, mutual benefit and complementary advantage, the Parties have  reached this Agreement as follows:     ARTICLE ONE DEFINITION     1.1 Unless otherwise referenced herein, each of the terms used herein shall have the meaning ascribed to it below:     (i) \"Affiliate\", with respect to any Party hereto, shall mean any legal person, non-legal person economic organization, or natural person,  which owns a controlling interest in, or which is controlling, controlled by or under common control with, such Party, directly or  indirectly.     As used in this Agreement, \"control\" means the power of any person to direct or cause the direction of management and policies  of another party on account of such person\\'s ownership of equity interest, voting right, the right to appoint directors, by contract  or otherwise.     (ii) \"Business Day\" shall mean a date on which commercial banks open for business, other than Saturdays, Sundays and public holidays  in mainland China.     (iii) \"Intellectual Property Right\" shall mean authorship right, proprietary trademark right, patent right, business secret ownership right  and other intellectual property right under PRC Law.     (iv) \"Other Websites\" shall mean Internet websites whose domain name are licensed by Party A or its Affiliate to Party B and which are  operated and managed by Party B upon Party A\\'s approval in writing, other than the Phoenix Satellite TV Websites.     (v) \"Phoenix Satellite TV Websites\" shall mean Internet websites which have the domain name of www.ifeng.com, www.phoenixtv.com  or www.phoenixtv.com.cn.     (vi) \"Program Content\", with respect to this Agreement, shall mean all program content',\n",
              "    'Highlight the parts (if any) of this contract related to \"Document Name\" that should be reviewed by a lawyer. Details: The name of the contract',\n",
              "    'Program Content License Agreement',\n",
              "    257,\n",
              "    290),\n",
              "   ('Exhibit D\\n\\nJOINT FILING AGREEMENT OneMain Holdings, Inc.\\n\\nIn accordance with Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended, the undersigned hereby confirm the agreement by and among them to the joint filing on behalf of them of the Statement on Schedule 13D and any and all further amendments thereto, with respect to the securities of the above referenced issuer, and that this Agreement be included as an Exhibit to such filing. This Agreement may be executed in any number of counterparts each of which shall be deemed to be an original and all of which together shall be deemed to constitute one and the same Agreement.\\n\\nIN WITNESS WHEREOF, the undersigned hereby execute this Agreement as of February 20, 2020. UNIFORM INVESTCO LP\\n\\nBy: Uniform InvestCo GP LLC, its General Partner By: Vรคrde Partners, Inc., its Manager\\n\\nBy: /s/ David A. Marple Name: David A. Marple Title: General Counsel\\n\\nUNIFORM INVESTCO GP LLC\\n\\nBy: Vรคrde Partners, Inc., its Manager\\n\\nBy: /s/ David A. Marple Name: David A. Marple Title: General Counsel\\n\\nTHE VรRDE FUND VI-A, L.P.\\n\\nBy: Vรคrde Investment Partners G.P., LLC, its General Partner By: Vรคrde Investment Partners UGP, LLC, its General Partner By: Vรคrde Partners, L.P., its Managing Member By: Vรคrde Partners, Inc., its General Partner\\n\\nBy: /s/ David A. Marple Name: David A. Marple Title: General Counsel\\n\\n\\n\\n\\n\\nVรRDE INVESTMENT PARTNERS, L.P.\\n\\nBy: Vรคrde Investment Partners G.P., LLC, its General Partner By: Vรคrde Investment Partners UGP, LLC, its General Partner By: Vรคrde Partners, L.P., its Managing Member By: Vรคrde Partners, Inc., its General Partner\\n\\nBy: /s/ David A. Marple Name: David A. Marple Title: General Counsel\\n\\nVรRDE INVESTMENT PARTNERS (OFFSHORE) MASTER, L.P.\\n\\nBy: Vรคrde Investment Partners G.P., LLC, its General Partner By: Vรคrde Investment Partners UGP, LLC, its General Partner By: Vรคrde Partners, L.P., its Managing Member By: Vรคrde Partners, Inc., its General Partner\\n\\nBy: /s/ David A. Marple Name: David A. Marple Title: General Counsel\\n\\nVรRDE INVESTMENT PARTNERS G.P., LLC\\n\\nBy: Vรคrde Investment Partners UGP, LLC, its General Partner By: Vรคrde Partners, L.P., its Managing Member By: Vรคrde Partners, Inc., its General Partner\\n\\nBy: /s/ David A. Marple Name: David A. Marple Title: General Counsel\\n\\nVรRDE INVESTMENT PARTNERS UGP, LLC\\n\\nBy: Vรคrde Partners, L.P., its Managing Member By: Vรคrde Partners, Inc., its General Partner\\n\\nBy: /s/ David A. Marple Name: David A. Marple Title: General Counsel\\n\\n\\n\\n\\n\\nTHE VรRDE SKYWAY MASTER FUND, L.P.\\n\\nBy: The Vรคrde Skyway Fund G.P., LLC, its General Partner By: The Vรคrde Skyway Fund UGP, LLC, its General Partner By: Vรคrde Partners, L.P., its Managing Member By: Vรคrde Partners, Inc., its General Partner\\n\\nBy: /s/ David A. Marple Name: David A. Marple Title: General Counsel\\n\\nTHE VรRDE SKYWAY FUND G.P., L.P.\\n\\nBy: The Vรคrde Skyway Fund UGP, LLC, its General Partner By: Vรคrde Partners, L.P., its Managing Member By: Vรคrde Partners, Inc., its General Partner\\n\\nBy: /s/ David A. Marple Name: David A. Marple Title: General Counsel\\n\\nTHE VรRDE SKYWAY FUND UGP, LLC\\n\\nBy: Vรคrde Partners, L.P., its Managing Member By: Vรคrde Partners, Inc., its General Partner\\n\\nBy: /s/ David A. Marple Name: David A. Marple Title: General Counsel\\n\\nTHE VรRDE FUND XII (MASTER), L.P.\\n\\nBy: The Vรคrde Fund XII G.P., L.P., its General Partner By: The Vรคrde Fund XII UGP, LLC, its General Partner By: Vรคrde Partners, L.P., its Managing Member By: Vรคrde Partners, Inc., its General Partner\\n\\nBy: /s/ David A. Marple Name: David A. Marple Title: General Counsel\\n\\n\\n\\n\\n\\nTHE VรRDE FUND XII G.P., L.P.\\n\\nBy: The Vรคrde Fund XII UGP, LLC, its General Partner By: Vรคrde Partners, L.P., its Managing Member By: Vรคrde Partners, Inc., its General Partner\\n\\nBy: /s/ David A. Marple Name: David A. Marple Title: General Counsel\\n\\nTHE VรRDE FUND XII UGP, LLC\\n\\nBy: Vรคrde Partners, L.P., its Managing Member By: Vรคrde Partners, Inc., its General Partner\\n\\nBy: /s/ David A. Marple Name: David A. Marple Title: General Counsel\\n\\nVรRDE CREDIT PARTNERS MASTER, L.P.\\n\\nBy: Vรคrde Credit Partners G.P., LLC, its General Partner By: Vรคrde Cre',\n",
              "    'Highlight the parts (if any) of this contract related to \"Document Name\" that should be reviewed by a lawyer. Details: The name of the contract',\n",
              "    'JOINT FILING AGREEMENT',\n",
              "    11,\n",
              "    33),\n",
              "   ('Exhibit 10.16   ENDORSEMENT AGREEMENT     THIS ENDORSEMENT AGREEMENT (\"Agreement\") by and between GENO AURIEMMA (\"Auriemma\") and BERKSHIRE BANK, a  Massachusetts savings bank with its principal place of business at 24 North Street, Pittsfield, MA 01210 (\"Berkshire\")(Each or both of which shall  hereinafter be referred to as the \"PARTY\" or \"PARTIES,\" respectively).     RECITALS:     Berkshire desires to obtain the right to use the name, likeness, and endorsement services of Auriemma in connection with the advertisement  and promotion of Berkshire\\'s Financial Services (as defined below).     The endorsement by Auriemma of Berkshire is of commercial value.     Berkshire and Auriemma wish to enter into an agreement to cooperate and coordinate the marketing of Auriemma\\'s endorsement with  Berkshire\\'s banking services.     NOW, THEREFORE for and in consideration of the foregoing, and the mutual covenants and agreements set forth herein, the Parties hereby  agree as follows:     1. DEFINITIONS.     The following terms shall be defined in the Agreement as follows:     a) \"CONTRACT PERIOD\" means that period of time commencing upon the full execution of this Agreement by both Parties and  terminating on May 31, 2016 unless sooner terminated under this Agreement.     b) \"SERVICES PERIOD\" means that period of time commencing upon the full execution of this Agreement by both Parties and  terminating on May 31, 2014 unless sooner terminated under this Agreement.     b) \"CONTRACT TERRITORY\" shall be any State in which Berkshire currently, or at any time during the Contract Period, offers  Banking Services.     c) \"FINANCIAL SERVICES\" shall mean banking, lending, financial and wealth management products and services offered by Berkshire  and insurance products and services offered by Berkshire\\'s affiliate Berkshire Insurance Group, Inc.     d) \"AURIEMMA IDENTIFICATION\" shall mean any words, symbols, photographic or graphic representations, statements by  Auriemma or any combination thereof which identify Auriemma such as, for example, Auriemma\\'s name, voice, nickname, likeness, and anything  else that identifies Auriemma. The Auriemma\\n\\nSource: BERKSHIRE HILLS BANCORP INC, 10-Q, 8/9/2012\\n\\n\\n\\n\\n\\n     Identification shall not include any reference to the University of Connecticut, UConn, the use of the University of Connecticut logos or  trademarks, Auriemma\\'s position as head women\\'s basketball coach for the University of Connecticut. If during the Contract Period Berkshire  desires to make reference to University of Connecticut, UConn, or to use of the University of Connecticut logos or trademarks, or to refer to  Auriemma\\'s position as head women\\'s basketball coach for the University of Connecticut, Auriemma agrees to use reasonable efforts to obtain  the necessary consents from the State of Connecticut and the University of Connecticut in order to permit Berkshire to do so, it being understood  by Berkshire that Auriemma makes no representation or warrantees that he will be able to obtain such consents and that the time required to obtain  such consents is wholly outside of the control of Auriemma.     e) \"RIGHTS\" shall mean all of the endorsement rights, services and other rights and benefits granted to Berkshire in this Agreement.     g) \"BERKSHIRE COMPETITOR\" is any person or entity that in any way competes with Berkshire\\'s financial services.     h) \"BERKSHIRE PARTIES\" is Berkshire, and any affiliates of Berkshire, as defined herein. For purposes of this Agreement,  \"AFFILIATES\" means any other person or entity that directly or indirectly through one or more intermediaries, controls, is controlled by or is  under common control with, Berkshire.     i) \"$\" shall mean the lawful currency of the United States of America unless otherwise specified.     2. ENDORSEMENT AND GRANT OF RIGHTS. During the Contract Period:     a) Subject to the terms of Paragraph 6 below, Auriemma will make the appearances and provide to Berkshire during the Services Period  the services, initiatives and programs described in Schedule A attached hereto (the \"End',\n",
              "    'Highlight the parts (if any) of this contract related to \"Document Name\" that should be reviewed by a lawyer. Details: The name of the contract',\n",
              "    'ENDORSEMENT AGREEMENT',\n",
              "    47,\n",
              "    68),\n",
              "   ('EXHIBIT 10.3\\n\\n                             JOINT VENTURE CONTRACT\\n\\n                          CHAPTER 1 GENERAL PROVISIONS\\n\\n        In accordance with the Law of the People\\'s Republic of China on Joint Ventures Using Chinese and Foreign Investment (the \"Joint Venture Law\") and other relevant Chinese laws and regulations, Fengfan Group Limited Liability Company and Valence Technology Inc., in accordance with the principle of equality and mutual benefit and through friendly consultations, agree to jointly invest to establish a joint venture enterprise in Baoding City, Hebei Province of the People\\'s Republic of China.\\n\\n                       CHAPTER 2 PARTIES TO THIS CONTRACT\\n\\nArticle 1      Parties to this Joint Venture Contract\\n\\n1.      Baoding Fengfan Group Limited Liability Company (hereinafter referred to         as Party A), established and existing under the laws of the People\\'s         Republic of China (\"PRC\"), registered with the No. 1306001000338         Business License in China.\\n\\n        Legal address: 8 Fuchang Road, Baoding City, Hebei Province, PRC\\n\\n        Legal Representative of Party A:\\n\\n               Name:  Mengli Chen\\n\\n               Position:  CHAIRMAN AND GENERAL MANAGER\\n\\n               Nationality:  Chinese\\n\\n2.      Valence Technology, Inc., (hereinafter referred to as Party B),         established and existing under the laws of the State of Delaware in the         United States of America (\"USA\").\\n\\n        Registered address: 301 Conestoga Way, Henderson, Nevada 89015, USA\\n\\n        Legal Representative of Party B:\\n\\n               Name:  Stephan B. Godevais\\n\\n               Position:  CHAIRMAN AND CEO\\n\\n               Nationality:  United States of America\\n\\n3.      Each of the Parties hereby represents and warrants to the other Party         that, as of the date hereof and as of the Effective Date:\\n\\n                                     Page 1\\n\\n        (1)    such Party is duly organized, validly existing and in good                standing under the laws of the place of its establishment or                incorporation;\\n\\n        (2)    such Party has all requisite power and approval required to enter                into this Contract and, upon the Effective Date, will have all                requisite power and approval to perform fully each and every one                of its obligations hereunder;\\n\\n        (3)    such Party has taken all internal and corporate actions necessary                to authorize it to enter into this Contract and its                representative whose signature is affixed hereto is fully                authorized to sign this Contract and to bind such Party thereby;\\n\\n        (4)    upon the Effective Date, this Contract shall be legally binding                on such Party;\\n\\n        (5)    neither the signature of this Contract nor the performance of its                obligations hereunder will conflict with, or result in a breach                of, or constitute a default under, any provision of the Articles                of Association (in the case of Party A) or the Certificate of                Incorporation or By-Laws (in the case of Party B) of such Party,                or any law, regulation, rule, authorization or approval of any                government agency or body, or of any contract or agreement, to                which such Party is a party or subject;\\n\\n        (6)    no lawsuit, arbitration, other legal or administrative                proceeding, or governmental investigation is pending, or to the                best of such Party\\'s knowledge threatened, against such Party                that would affect in any way its ability to enter into or perform                this Contract; and\\n\\n        (7)    all documents, statements and information of or derived from any\\n\\n\\n\\n\\n\\n               governmental body of China in the possession of such Party                relating to the transactions contemplated by this Contract which                may have a material adverse effect on such Party\\'s ability to                fully perform its obligations hereunder, ',\n",
              "    'Highlight the parts (if any) of this contract related to \"Document Name\" that should be reviewed by a lawyer. Details: The name of the contract',\n",
              "    'JOINT VENTURE CONTRACT',\n",
              "    43,\n",
              "    65),\n",
              "   ('EXHIBIT 10.2 EXECUTION VERSION NON-COMPETITION AND NON-SOLICITATION AGREEMENT THIS NON-COMPETITION AND NON-SOLICITATION AGREEMENT (this \"Agreement\"), dated as of August 1, 2019 (the \"Effective Date\"), is entered into by Quaker Chemical Corporation (\"Buyer\"), a Pennsylvania corporation, Gulf Houghton Lubricants Ltd., a company incorporated in the Cayman Islands (\"Gulf Houghton\"), Gulf Oil International Limited, a company incorporated in the Cayman Islands (\"Gulf International\"), and GOCL Corporation Limited, a public limited company incorporated in India (\"Gulf Oil\" and, together with Gulf Houghton and Gulf International, the \"Sellers\" and each, a \"Seller\"). In addition, Gulf Oil Lubricants India, Ltd, a public limited company incorporated in India (\"Gulf India\"), is executing this Agreement solely for purposes of Section 1(c) [Confidentiality; Non-competition; Non-solicitation]. BACKGROUND WHEREAS, Gulf Houghton owns 3,074,270.00 of the outstanding ordinary shares (the \"Shares\") in Global Houghton Ltd., an exempted company incorporated under the Laws of the Cayman Islands (the \"Company\"); Gulf International owns approximately 90% of Gulf Houghton; and Gulf Oil is an indirect owner of approximately 10% of Gulf Houghton. WHEREAS, The Company and its subsidiaries are engaged in the business of manufacturing, distributing and/or selling one or more of the following formulated chemical specialty product lines: fire resistant hydraulic fluids, semi-synthetic and specialty metalworking fluids, cleaning fluids, cold-rolling oils, hot-rolling oils, and specialty industrial greases (such business, as conducted by the Company and its Subsidiaries as of the Effective Date, the \"Company Business\"). WHEREAS, Buyer and its subsidiaries are engaged in the business of manufacturing, distributing and/or selling the following formulated chemical specialty product lines or chemical management services (\"CMS\"), (i) rolling lubricants (used by manufacturers of steel in the hot and cold rolling of steel and by manufacturers of aluminum in the hot rolling of aluminum); (ii) corrosion preventives (used by steel and metalworking customers generally to protect metal during manufacture, storage, and shipment); (iii) metal finishing compounds (used to prepare metal surfaces for special treatments such as, but not limited to, galvanizing and tin plating and to prepare metal for further processing); (iv) machining and grinding compounds (typically used by customers in cutting, shaping, and grinding metal parts which require special treatment to enable them to tolerate the manufacturing process, achieve closer tolerance, and improve tool life); (v) forming compounds (used generally to facilitate the drawing and extrusion of metal products); (vi) bio-lubricants (typically used in machinery in the forestry and construction industries); (vii) hydraulic fluids (used generally by steel, metalworking, mining, and other customers to operate hydraulic equipment); (viii) chemical milling maskants for the aerospace industry; (ix) temporary and permanent coatings for metal and concrete products, tubes and pipes and other applications; (x) construction products, such as flexible sealants and protective coatings, for various applications; (xi) various specialty greases used in automobile, industrial and various other applications; (xii) various die casting lubricants and mold release agents; (xiii) various dust suppressants, ground control agents and roofing products used in mining; and (xiv)\\n\\n\\n\\n\\n\\nprograms to provide CMS (such business, as conducted by Buyer and its subsidiaries as of the Effective Date, the \"Existing Business\" and, together with the Company Business, the \"Combined Business\"). WHEREAS, Buyer, Gulf Houghton and other shareholders of the Company are parties to a Share Purchase Agreement dated as of April 4, 2017, under which Buyer is acquiring the Shares (the \"Purchase Agreement\"). Capitalized terms used herein but not otherwise defined herein shall have the meanings given to such terms in the Purchase Agreement. WHEREAS, Sellers, together with the C',\n",
              "    'Highlight the parts (if any) of this contract related to \"Document Name\" that should be reviewed by a lawyer. Details: The name of the contract',\n",
              "    'NON-COMPETITION AND NON-SOLICITATION AGREEMENT',\n",
              "    83,\n",
              "    129),\n",
              "   ('Exhibit 10.8 EXECUTION COPY CERTAIN INFORMATION HAS BEEN EXCLUDED FROM THIS EXHIBIT BECAUSE IT IS NOT MATERIAL AND WOULD LIKELY CAUSE COMPETITIVE HARM TO THE REGISTRANT IF PUBLICLY DISCLOSED. [***] OR [REDACTED] INDICATES THAT INFORMATION HAS BEEN REDACTED. SPONSORSHIP AND SERVICES AGREEMENT This SPONSORSHIP AND SERVICES AGREEMENT (the \"Agreement\") is made and entered into as of the 19t h day of December, 2018, by and among HOF Village, LLC, a Delaware limited liability company (\"HOFV\"), National Football Museum, Inc., d/b/a Pro Football Hall of Fame, an Ohio corporation (\"PFHOF\" and, together with HOFV, the \"HOF Entities\") and Constellation NewEnergy, Inc., a Delaware corporation, on behalf of itself and its retail affiliates and subsidiaries (collectively, \"Constellation\"). HOFV and/or PFHOF, on the one hand, and Constellation, on the other hand, are referred to herein as a \"Party\" and, collectively, as the \"Parties\". WITNESSETH: WHEREAS, Constellation desires to provide to the HOF Entities, and the HOF Entities desire to obtain from Constellation, certain of Constellation\\'s products and services listed and described in Exhibit A (collectively, the \"Products & Services\") for use in connection with the Johnson Controls Hall of Fame Village in Canton, Ohio (the \"Village\"); and WHEREAS, Constellation desires to become a sponsor of the Village and to obtain the rights set forth herein in connection with such sponsorship. NOW, THEREFORE, in consideration of the promises herein contained, the Parties hereto agree as follows: ARTICLE 1\\n\\nSUPPLY OF PRODUCTS & SERVICES 1.1 Sale of Products & Services. (a) The HOF Entities shall consult with Constellation to develop a comprehensive energy strategy with respect to the Products & Services listing in Exhibit A, which reflects sustainable product solutions, competitive market pricing (incorporating completion of the Supplier Component Questionnaire in the form of Exhibit B hereof for the applicable HOF Entity or affiliate), periodic reporting and analytics, regulatory/market intelligence and infrastructure services and equipment.\\n\\nSource: GPAQ ACQUISITION HOLDINGS, INC., S-4/A, 1/23/2020\\n\\n\\n\\n\\n\\n(b) The HOF Entities or their affiliates shall, during the Term (as defined below), purchase from Constellation, and Constellation shall sell to the HOF Entities and/or their affiliates, as applicable, such Products & Services as shall be requested by an HOF Entity or its affiliates, in each case at the applicable Market Prices for such Products & Services and on competitive terms. For purposes of this Section 1.1(b), (i) the \"Market Price\" of any Products & Services shall mean the price for such Products & Services established by Constellation as the competitive market price at which such Products & Services are to be made available to Constellation\\'s customers with a similar anticipated load profile within a specified utility service territory. Constellation shall invoice the applicable HOF Entity or its appropriate affiliate for all Products & Services purchased by such HOF Entity or its appropriate affiliate pursuant to the applicable Second Level Agreement (as defined below). In the event that the purchaser of Products & Services pursuant to this Article 1 is an affiliate of an HOF Entity (but not an HOF Entity), such affiliate shall be subject to Constellation\\'s credit approval of such affiliate as the contracting entity. In the event that such affiliate does not meet Constellation\\'s credit requirements (and in the event that such affiliate still desires to purchase such Products & Services), such affiliate shall provide to Constellation a surety bond reasonably acceptable to Constellation from a provider rated than A- (or an equivalent rating from S&P, Moody\\'s, Fitch or AM Best) or better prior to the purchase of such Products & Services. (c) The Parties agree and acknowledge that neither HOF Entity or any of its respective affiliates shall be subject to any individual minimum purchase requirement (whether in terms of price, quantity or any other criteria) under this Agreement with respec',\n",
              "    'Highlight the parts (if any) of this contract related to \"Document Name\" that should be reviewed by a lawyer. Details: The name of the contract',\n",
              "    'SPONSORSHIP AND SERVICES AGREEMENT',\n",
              "    298,\n",
              "    332),\n",
              "   ('Exhibit 10.2 STRATEGIC ALLIANCE AGREEMENT dated as of August 26, 2015 among Sucampo Pharmaceuticals, Inc., Sucampo Pharma, LLC. and R-Tech Ueno, Ltd.\\n\\n\\n\\n\\n\\nTABLE OF CONTENTS\\n\\nARTICLE I DEFINITIONS AND INTERPRETATION\\n\\nSection 1.01 Definitions 2 Section 1.02 Interpretation 8\\n\\nARTICLE II TRANSACTION\\n\\nSection 2.01 Strategic Alliance 8 Section 2.02 Obligations of Acquiror 9 Section 2.03 Obligations of the Company 11\\n\\nARTICLE III REPRESENTATIONS AND WARRANTIES\\n\\nSection 3.01 Representations and Warranties of the Company 11 Section 3.02 Representations and Warranties of Acquiror 12\\n\\nARTICLE IV COVENANTS OF THE PARTIES\\n\\nSection 4.01 The Company\\'s Obligation 12 Section 4.02 Consummation of the Squeeze-out 15 Section 4.03 Applications and Consents; Governmental Communications and Filings 15 Section 4.04 Further Assurance 15 Section 4.05 Access 15 Section 4.06 Notifications 16 Section 4.07 Confidentiality 16 Section 4.08 Public Announcement 17 Section 4.09 No Lender Liability 17 Section 4.10 Employees of Company 17 Section 4.11 Development Programs and Clinical Trials 18\\n\\nARTICLE V INDEMNIFICATION\\n\\nSection 5.01 Indemnification by the Company 18 Section 5.02 Indemnification by Acquiror 18 Section 5.03 Indemnification Procedure 18 Section 5.04 Limitations 18\\n\\ni\\n\\n\\n\\n\\n\\nARTICLE VI TERMINATION\\n\\nSection 6.01 Termination 19 Section 6.02 Notice of Termination 19 Section 6.03 Effect of Termination 19\\n\\nARTICLE VII GUARANTEE\\n\\nSection 7.01 Guarantee 19\\n\\nARTICLE VIII MISCELLANEOUS\\n\\nSection 8.01 Governing Law 19 Section 8.02 Jurisdiction 19 Section 8.03 Cost and Expenses 20 Section 8.04 Assignment 20 Section 8.05 Amendments and Waivers 20 Section 8.06 Severability 20 Section 8.07 Counterparts 21 Section 8.08 Entire Agreement 21 Section 8.09 Notices 21 Section 8.10 Language 22 Section 8.11 Disclosure Schedules 22 Section 8.12 Fraud 22 Section 8.13 Third-party Beneficiaries 23\\n\\nii\\n\\n\\n\\n\\n\\nSTRATEGIC ALLIANCE AGREEMENT This STRATEGIC ALLIANCE AGREEMENT is made and entered into as of August 26, 2015 (this \"Agreement\"), by and among R-Tech Ueno, Ltd., a corporation organized under Japanese law (the \"Company\"), Sucampo Pharma, LLC., a corporation organized under Japanese law (\"Acquiror\"), and Sucampo Pharmaceuticals, Inc., a corporation organized under Delaware law (\"SPI,\" and, together with the Company and Acquiror, collectively, the \"Parties\"). RECITALS WHEREAS, the Acquiror is a wholly-owned subsidiary of SPI, which operates a biopharmaceutical business focused on the research and development of proprietary drugs; WHEREAS, the Company operates a drug discovery and manufacturing business; WHEREAS, Acquiror and the Company share the objective of creating a combined biopharmaceutical company that can drive considerable growth in global markets, including Japan; WHEREAS, the Company has currently in issuance and outstanding 19,312,300 shares of common stock (the \"Common Stock\") and stock options representing an additional 328,600 shares of Common Stock (the \"Stock Options\", and together with the issued and outstanding Common Stock, the \"Target Securities\"); WHEREAS, pursuant to the terms and subject to the conditions set forth herein, Acquiror has agreed to commence a tender offer bid (such tender offer bid, including any amendments or extensions thereto made in accordance with the terms of this Agreement and applicable Law, including Articles 27-2 through 27-22 of the FIEL, the \"Offer\") to acquire for cash (i) all of the issued and outstanding shares of Common Stock at a price per share of JPY1,900 (the \"Share Offer Price\") and (ii) all of the outstanding Stock Options at the price prescribed in this Agreement; WHEREAS, the Company has agreed, on the terms and subject to the conditions set forth herein, to support the Offer and recommend the holders of Target Securities to tender their shares of Common Stock and Stock Options to the Offer and publicly announce such statement; WHEREAS, Jefferies Finance LLC (\"Jefferies\") has entered into a financing commitment letter, dated as of August 26, 2015, between SPI and Jefferies (the \"Financing Commitment\"), pursuant',\n",
              "    'Highlight the parts (if any) of this contract related to \"Document Name\" that should be reviewed by a lawyer. Details: The name of the contract',\n",
              "    'STRATEGIC ALLIANCE AGREEMENT is',\n",
              "    1922,\n",
              "    1953),\n",
              "   ('Exhibit 1.1\\n\\n                                1,265,000 Shares                    (subject to increase up to 1,454,750 shares                       in the event of an oversubscription)\\n\\n                              AFSALA BANCORP, INC.                             (a Delaware corporation)\\n\\n                                  COMMON STOCK                            ($0.10 Par Value Per Share)\\n\\n                      Subscription Price: $10.00 Per Share\\n\\n                                AGENCY AGREEMENT\\n\\n                                                            ____________, 1996\\n\\nCapital Resources, Inc. 1701 K Street, N.W. Suite 700 Washington, D.C. 20006\\n\\nLadies and Gentlemen:\\n\\n                  AFSALA  Bancorp,  Inc. (the  \"Company\") and Amsterdam  Federal Savings and Loan  Association,  a federally  chartered  mutual  savings and loan association  (\"Association\"),  with its deposit  accounts insured by the Savings Association   Insurance  Fund  (\"SAIF\")  administered  by  the  Federal  Deposit Insurance  Corporation  (\"FDIC\"),  hereby  confirm their  agreement with Capital Resources, Inc. (\"Capital Resources\") as follows:\\n\\n                  SECTION 1. The Offering.  The Association,  in accordance with and pursuant to its plan of conversion  adopted by the Board of Directors of the Association  (the \"Plan\"),  intends to be converted  from a  federally-chartered mutual savings and loan association to a federally-chartered  stock savings bank and will  sell all of its  issued  and  outstanding  stock to the  Company.  The Company  will  offer  and  sell its  common  stock  (the  \"Common  Stock\")  in a subscription  offering  (\"Subscription  Offering\") to (1) tax qualified employee benefit plans of the Association,  (2) depositors of the Association as of March 31, 1995 (\"Eligible Account  Holders\"),  (3) depositors of the Association as of June 30, 1996  (\"Supplemental  Eligible  Account  Holders\"),  (4) certain  other deposit  account  holders  and  borrower  members  of  the  Association  (\"Other Members\") and (5) to its employees,  officers and directors,  pursuant to rights to  subscribe  for shares of Common Stock (the  \"Shares\").  Subject to the prior subscription rights of the above-listed  parties, the Company may offer for sale in a public offering (the \"Public  Offering,\" and when referred to together with the Subscription  Offering,  the \"Subscription and Public Offerings\")  conducted after the Subscription  Offering, the Shares not so subscribed for or ordered in the  Subscription  Offering  to the  general  public  (all such  offerees  being referred to in the aggregate as \"Eligible Offerees\"). Shares may also be sold in the Public Offering by a selling group of  broker-dealers  organized and managed by Capital  Resources.  It is  acknowledged  that the  purchase of Shares in the Subscription  and Public  Offerings  is subject to maximum and minimum  purchase limitations as described in the Plan and that the Company may reject in whole or in part any subscriptions received from subscribers in the Public Offering.\\n\\n                  The  Company  and the  Association  desire to  retain  Capital Resources to assist the Company with its sale of the Shares in the  Subscription and Public  Offerings.  By and  through  this  Agreement,  the  Company  and the Association confirm the retention of Capital Resources to assist the Company and the Association during the Subscription and Public Offerings.\\n\\n                  The  Company  has  filed  with  the  Securities  and  Exchange Commission  (the  \"Commission\")  a registration  statement on Form S-l (File No. 333-6399)  containing an offering  prospectus  relating to the  Subscription and Public  Offerings for the registration of the Shares under the Securities Act of 1933, as amended (the \"1933 Act\"),  and has filed such  amendments  thereto,  if any, and such amended  prospectuses as may have been required to the date hereof (the  \"Registration  Statement\").  The prospectus,  as amended,  included in the Registration   Statement  at  the  time  it  initially  become',\n",
              "    'Highlight the parts (if any) of this contract related to \"Document Name\" that should be reviewed by a lawyer. Details: The name of the contract',\n",
              "    'AGENCY AGREEMENT',\n",
              "    485,\n",
              "    501),\n",
              "   ('Exhibit 10.1 Certain portions of this exhibit have been omitted pursuant to Rule 601(b)(10) of Regulation S-K. The omitted information is (i) not material and (ii) would likely cause competitive harm to the Company if publicly disclosed. Information that has been omitted has been noted in this document with a placeholder identified by the mark \"[***]\". EXECUTION COPY PROMOTION AGREEMENT\\n\\nby and between\\n\\nSIGA TECHNOLOGIES, INC.\\n\\nand\\n\\nMERIDIAN MEDICAL TECHNOLOGIES, INC., a Pfizer company\\n\\nSource: SIGA TECHNOLOGIES INC, 8-K, 6/3/2019\\n\\n\\n\\n\\n\\nTABLE OF CONTENTS PAGE ARTICLE 1 DEFINITIONS 1 ARTICLE 2 GRANT OF RIGHTS 11 2.1 Grant of Rights to MMT 11 2.2 Negative Covenants 11 2.3 Non-Compete Covenant 11 2.4 Retained Rights 12 2.5 No Implied Licenses 12 2.6 [***] 12 ARTICLE 3 GOVERNANCE 12 3.1 Joint Steering Committee 12 3.2 Good Faith 12 3.3 Scope of Governance 13 ARTICLE 4 PROMOTION AND OTHER COMMERCIALIZATION 13 4.1 Promotion in the Territory 13 4.2 Diligence 14 4.3 Customer Contracts 14 4.4 Regulatory Matters 15 4.5 Discontinued Countries 15 ARTICLE 5 FORECASTING AND ORDERING 15 5.1 Product Forecasts 15 5.2 Purchase Orders 15 5.3 Delivery 16 5.4 Supply Limitation 16 5.5 Supply Penalties 16 5.6 Adverse Event Reporting 16 ARTICLE 6 PAYMENTS 16 6.1 Promotion Fee 16 6.2 Payments 17 6.3 Currency 17 6.4 Records 17 6.5 Audits 18 6.6 Blocked Payment and Indemnification 19 6.7 Source of Recovery 19 6.8 Taxes 19 ARTICLE 7 INTELLECTUAL PROPERTY 20 7.1 Ownership of SIGA Intellectual Property 20 7.2 Intellectual Property Maintenance 20 7.3 New Patents and Trademarks 20\\n\\n-i-\\n\\nSource: SIGA TECHNOLOGIES INC, 8-K, 6/3/2019\\n\\n\\n\\n\\n\\nTABLE OF CONTENTS (CONTINUED) PAGE ARTICLE 8 REPRESENTATIONS AND WARRANTIES; COVENANTS 21 8.1 Mutual Representations and Warranties 21 8.2 Additional Representations, Warranties and Covenants of SIGA 22 8.3 Additional Representations and Warranties of MMT 26 8.4 Covenants 27 8.5 No Other Representations or Warranties 29 ARTICLE 9 INDEMNIFICATION 29 9.1 Indemnification by SIGA 29 9.2 Indemnification by MMT 30 9.3 Indemnification Procedures 30 9.4 Insurance 31 9.5 Limitation of Liability 31 ARTICLE 10 CONFIDENTIALITY 31 10.1 Confidentiality 31 10.2 Authorized Disclosure 32 10.3 Technical Publication 33 10.4 Publicity; Terms of Agreement 33 10.5 Prior Confidentiality Agreements 34 10.6 Return of Confidential Information 34 10.7 Unauthorized Use 34 10.8 Exclusive Property 34 ARTICLE 11 TERM AND TERMINATION 35 11.1 Term 35 11.2 Termination for Cause 35 11.3 Termination Upon Certain Changes of Control 36 11.4 Termination for Failure to [***] 36 11.5 Termination for Convenience 36 11.6 Effect of Termination 36 11.7 Survival 36 ARTICLE 12 DISPUTE RESOLUTION 36 12.1 Executive Officer Resolution 36 12.2 Governing Law 37 12.3 Jurisdiction 37 12.4 NO JURY TRIAL 37 ARTICLE 13 MISCELLANEOUS 38 13.1 Entire Agreement; Amendment 38 13.2 Force Majeure 38\\n\\n-ii-\\n\\nSource: SIGA TECHNOLOGIES INC, 8-K, 6/3/2019\\n\\n\\n\\n\\n\\nTABLE OF CONTENTS (CONTINUED) PAGE 13.3 Notices 38 13.4 No Strict Construction; Interpretation; Headings 39 13.5 Assignment 40 13.6 Performance by Affiliates 40 13.7 Further Assurances and Actions 40 13.8 Severability 41 13.9 No Waiver 41 13.10 Relationship of the Parties 41 13.11 English Language 42 13.12 Counterparts 42 13.13 Schedules 42 13.14 Expenses 42\\n\\nExhibit A Permitted Subcontractors Exhibit B Business Plan Exhibit C SIGA Press Release Schedule 1 SIGA Patents Schedule 2 SIGA Trademarks Schedule 3 Safety Reporting Requirements Schedule 8.2(b) Encumbrances\\n\\n-iii-\\n\\nSource: SIGA TECHNOLOGIES INC, 8-K, 6/3/2019\\n\\n\\n\\n\\n\\nPROMOTION AGREEMENT This PROMOTION AGREEMENT  (this \"Agreement\") is entered into as of May 31, 2019 (the \"Effective Date\") by and between SIGA TECHNOLOGIES, INC., a Delaware corporation having an address at 31 East 62nd Street, New York, NY 10065 (\"SIGA\"), and MERIDIAN MEDICAL TECHNOLOGIES, INC., a Pfizer company, and Delaware corporation having an address at 6350 Stevens Forest Road, Suite #301, Columbia, MD 21046 (\"MMT\"). SIGA and MMT are sometimes referred to individually as a \"Party\" and collectively as the \"Part',\n",
              "    'Highlight the parts (if any) of this contract related to \"Document Name\" that should be reviewed by a lawyer. Details: The name of the contract',\n",
              "    'PROMOTION AGREEMENT',\n",
              "    3574,\n",
              "    3593),\n",
              "   ('COOPERATION AGREEMENT     made by and between     HPIL ENERGYTECH Inc.   and   GINARES GROUP AG     January 5, 2015\\n\\n\\n\\n\\n\\n\\n\\n    Table of Contents       1. Term........................................................................................................................................... 2 2. Goals And Objectives................................................................................................................ 2 3. Obligations Of The Parties........................................................................................................ 3 4. Confidentiality........................................................................................................................... 3 5. Relation Of The Parties............................................................................................................. 3 6. Closing....................................................................................................................................... 3 7. Representations, Warranties, And Covenants Of GINARES.................................................... 3 8. Representations, Warranties, And Covenants Of HPIL ET...................................................... 4 9. GINARES\\'s Indemnity.............................................................................................................. 5 10. HPIL ET\\'s Indemnity............................................................................................................... 5 11. Payment Of Expenses................................................................................................................ 5 12. Approval Of Counsel................................................................................................................. 5 13. Notices....................................................................................................................................... 6 14. Additional Undertakings............................................................................................................ 6   15. Compliance With The Foreign Corrupt Practices Act And Export Control And Antiboycott Laws...........................................................................................................................................   7 16. Arbitration.................................................................................................................................. 7 17. Governing Law.......................................................................................................................... 7 18. Binding Effect............................................................................................................................ 7 19. Counterparts............................................................................................................................... 7 20. No Reliance............................................................................................................................... 8 21. Early Termination...................................................................................................................... 8 22. Captions..................................................................................................................................... 8 23. Entire Agreement....................................................................................................................... 8         1\\n\\n\\n\\n\\n\\n    COOPERATION AGREEMENT   THIS COOPERATION AGREEMENT (\"Agreement\") is signed this 5th day of January, 2015 (the \"Closing Date\"), by and between HPIL ENERGYTECH Inc., a Nevada (USA) corporation (hereafter \"HPIL ET\") and GINARES GROUP AG,  a private company domiciled in Switzerland (hereafter \"GINARES\").   R E C I T A L S:   The following is a recital of facts underlying this Agreement:   A. HPIL ET is focused on investing in both private and public companies in the energy business sector. HPIL ET does not restrict its potential candidate target companies to any specific geographical location and thus acquires va',\n",
              "    'Highlight the parts (if any) of this contract related to \"Document Name\" that should be reviewed by a lawyer. Details: The name of the contract',\n",
              "    'COOPERATION AGREEMENT',\n",
              "    3480,\n",
              "    3501),\n",
              "   ('LIMITED POWER OF ATTORNEY\\n\\nKNOW ALL MEN BY THESE PRESENTS, dated as of January 1, 2004, that FEDERATED INVESTMENT MANAGEMENT COMPANY, a statutory trust duly organized under the laws of the State of Delaware (the \"Adviser\"), does hereby nominate, constitute and appoint FEDERATED ADVISORY SERVICES COMPANY, a statutory trust duly organized under the laws of the State of Delaware (\"FASC\"), to act hereunder as the true and lawful agent and attorney-in-fact of the Adviser, acting on behalf of each of the funds or accounts for which Adviser acts as investment adviser or subadviser shown on Schedule 1 attached hereto and incorporated by reference herein (each such fund or account being hereinafter referred to as a \"Fund\" and collectively as the \"Funds\"), for the specific purpose of executing and delivering all such agreements, instruments, contracts, assignments, bond powers, stock powers, transfer instructions, receipts, waivers, consents and other documents, and performing all such acts, as Adviser, or FASC acting as agent for the Adviser pursuant to the Services Agreement dated as of January 1, 2004 between the Adviser and FASC (such agreement, as may be amended, supplemented or otherwise modified from time to time is hereinafter referred to as the \"Services Agreement\"), may deem necessary or reasonably desirable, related to the acquisition, disposition and/or reinvestment of the funds and assets of a Fund in accordance with Adviser\\'s supervision of the investment, sale and reinvestment of the funds and assets of each Fund pursuant to the authority granted to the Adviser as investment adviser or subadviser of each Fund under the Adviser\\'s investment advisory or subadvisory contract for such Fund (such investment advisory or subadvisory contract, as may be amended, supplemented or otherwise modified from time to time is hereinafter referred to as the \"Investment Advisory Contract\").\\n\\nThe Adviser hereby ratifies and confirms as good and effectual, at law or in equity, all that FASC, and its officers and employees, may do by virtue hereof. However, despite the above provisions, nothing herein shall be construed as imposing a duty on FASC to act or assume responsibility for any matters referred to above or other matters even though FASC may have power or authority hereunder to do so. Nothing in this Limited Power of Attorney shall be construed (i) to be an amendment or modifications of, or supplement to, the Investment Advisory Contract, (ii) to amend, modify, limit or denigrate any duties, obligations or liabilities of the Adviser under the terms of the Investment Advisory Contract or (iii) exonerate, relieve or release the Adviser from any losses, obligations, penalties, actions, judgments and suits and other costs, expenses and disbursements of any kind or nature whatsoever which may be imposed on, incurred by or asserted against the Adviser (x) under the terms of the Investment Advisory Contract or (y) at law, or in equity, for the performance of its duties as the investment adviser or subadviser of any of the Funds.\\n\\nThe Adviser hereby agrees to indemnify and save harmless FASC and its trustees, officers and employees (each of the foregoing an \"Indemnified Party\" and collectively the \"Indemnified Parties\") against and from any and all losses, obligations, penalties, actions, judgments and suits and other costs, expenses and disbursements of any kind or nature whatsoever which may be imposed on, incurred by or asserted against an Indemnified Party, other than as a consequence of gross negligence or willful misconduct on the part of an Indemnified Party, arising out of or in connection with this Limited Power of Attorney or any other agreement, instrument or document executed in connection with the exercise of the authority granted to FASC herein to act on behalf of the Adviser, including without limitation the reasonable costs, expenses and disbursements in connection with defending such Indemnified Party against any claim or liability related to the exercise or performance of any of FASC\\'s powers or duties under this Limited',\n",
              "    'Highlight the parts (if any) of this contract related to \"Document Name\" that should be reviewed by a lawyer. Details: The name of the contract',\n",
              "    'LIMITED POWER OF ATTORNEY',\n",
              "    0,\n",
              "    25),\n",
              "   ('CORPORATE SPONSORSHIP AGREEMENT\\n\\nThis agreement (the \"Agreement\") is entered into as of May 18, 2010, (the \"Effective Date\") by and between Phoenix Performance, LLC, 481  Schuylkill Road, Phoenixville, PA 19460 (\"Vendor\") and Torvec Inc.., a New York corporation with its principal place of business located at 1999  Mt Read Blvd, Building 3, Rochester, NY. 14615 (Torvec).\\n\\nRECITALS\\n\\nWHEREAS, the parties desire to enter into an agreement regarding promotional, marketing and sponsorship activities designed to be of  mutual benefit as described herein; and\\n\\nNOW, THEREFORE, for and in consideration of the mutual covenants, rights and obligations set forth in this Agreement, the parties agree  as follows:\\n\\n1. Term\\n\\nThe term of this Agreement (the \"Term\") shall commence on the Effective Date and conclude on October 31, 2010, unless renewed by  agreement or sooner terminated in accordance with this Agreement.\\n\\n2. Termination\\n\\n(a) Either party may terminate this Agreement immediately if the other party (i) files a petition commencing a voluntary case under the  Bankruptcy Code; (ii) makes a general assignment for the benefit of creditors; (iii) admits in writing its inability to pay its debts as they become  due; (iv) seeks, consents to or acquiesces in the appointment of any trustee, receiver or liquidator of it or any part of its property; or (v) has  commenced against it an involuntary case under the Bankruptcy Code or a proceeding under any receivership, composition, readjustment,  liquidation, insolvency, dissolution or like law or statute, which case or proceeding is not dismissed or vacated within sixty (60) days.\\n\\n(b) Upon termination of this Agreement, NEITHER PARTY SHALL BE LIABLE TO THE OTHER FOR ANY CONSEQUENTIAL,  EXEMPLARY, SPECIAL, INCIDENTAL OR PUNITIVE DAMAGES, EVEN IF IT HAS BEEN ADVISED OF THE POSSIBILITY OF SUCH  DAMAGES, WHICH ARE RELATED TO THE AGREEMENT OR ITS BREACH.\\n\\nPreparation, maintenance and running of one (1) T-1 C5 Corvette race vehicle to race in:\\n\\na. 1 round of the World Challenge series in the GTS class (Mosport Double);\\n\\nb. 4 rounds of SCCA National Racing (events to be finalized but at this time expected to be NJMP, Road America, Watkins Glen  Double);\\n\\nc. the SCCA runoffs at Road America.\\n\\n.\\n\\n5. Payment and Other Consideration\\n\\nAs consideration for the benefits it receives under this Agreement, Torvec shall provide the following to Vendor:\\n\\nSee Exhibit A\\n\\nThe schedule set forth in Exhibit A will constitute invoicing for the events. Notwithstanding the above, Torvec may, in its sole  discretion, cancel its participation in any of the above-referenced events by notifying Vendor of such cancellation not later than two weeks  prior to the due date(s) for payment hereunder. All checks shall be made payabe to: Phoenix Performance, LLC and mailed to 481, Schuylkill  Rd, Phoenixville, Pa. 19460.\\n\\n(b) Equipment\\n\\n           3.     Responsibilities and Benefits\\n\\n        Vendor shall be responsible for the following in 2010:\\n\\n  4.  Torvec Benefits\\n\\n     During the Term of this Agreement, Torvec shall be entitled to the following sponsorship benefits:\\n\\n  a)  Primary sponsorship rights to all of Vendor\\'s participation efforts in the above race events.\\n\\n  b)  The right to specify and approve all team sponsorship identification markings, logos, graphics, etc. for vehicle livery, team  equipment and uniforms.\\n\\n  c)  Sole right to disapprove any driver selected by Vendor for any reason. The driver for these events will be John Heinricy.\\n\\n  (a)  Payment Schedule\\n\\n\\n\\n\\n\\nTorvec will provide to Vendor the use of up to 2 Differential units to be used in the T-1 C5 Corvette for testing, evaluation and racing  purposes..\\n\\n6. Grant of License\\n\\nEach party shall have a non-exclusive, royalty free, non-transferable license to use the name, logo, any item used in connection with that  name or logo, and the registered symbols and trademarks of the other party (the \"Trademarks\") only for the purposes set forth in this Agreement.  Neither party will use the other\\'s Trademarks without obtaining the prior approval of the other pa',\n",
              "    'Highlight the parts (if any) of this contract related to \"Document Name\" that should be reviewed by a lawyer. Details: The name of the contract',\n",
              "    'CORPORATE SPONSORSHIP AGREEMENT',\n",
              "    0,\n",
              "    31),\n",
              "   ('EXHIBIT 10.1   ENDORSEMENT AGREEMENT   This Endorsement Agreement (\"Agreement\") made October 30, 2017, between National Football League Alumni - Northern California Chapter (\"NFLA-NC\"), a charitable corporation organized under the laws of California, having its principal office at 1311 Madison Avenue, Redwood CA 94061; National Football League Alumni, Inc. (\"NFLA\"), a charitable corporation organized under the laws of Florida, having its principal office at 8000 Midlantic Drive, 130 S., Mount Laurel, NJ. 08054 and Food For Athletes, Inc. a corporation organized under the laws of California / Gridiron BioNutrientsโข, a corporation organized under the laws of Nevada having their principal office(s) at 1119 West 1st Ave., STE G, Spokane, WA 99201 (collectively the \"Company\").   RECITALS   A. Whereas, NFLA is a nationwide group of former National Football League players, coaches, and other employees whose mission is to serve, assist and inform players and their families. The association offers a variety of medical, financial and social programs to help members lead healthy, productive and connected lives.    B. Whereas, NFLA-NC is a local Chapter of the NFLA and supports the organizations \"Caring for Kids\" initiative through fundraising for youth-related charities.    C. The Company desires to obtain the rights to use the Pro Football Legends Logo of the NFLA in connection with the advertisement and promotion of certain of its products. An image of the Pro Football Legends Logo is depicted in Exhibit A.    D. The NFLA agrees to license such rights to the Company.   In consideration of the matters described above, and of the mutual benefits and obligations set forth in this Agreement, the parties agree as follows:   SECTION ONE. DEFINITIONS   As used in this Agreement, the following terms shall be defined as follows:   A. \"Contract Period\" shall mean that period of time of three (3) years commencing on November 1st, 2017 and concluding November 2nd, 2020, unless terminated sooner or extended as provided in this Agreement.    B. \"Contract Territory\" shall mean worldwide.    C. \"Contract Year\" shall mean each of the consecutive 12-month periods beginning on the effective date of the Agreement of the Contract Period.   1\\n\\nSource: GRIDIRON BIONUTRIENTS, INC., 8-K, 12/6/2017\\n\\n\\n\\n\\n\\n      D. \"Gross Sales\" shall mean total revenues, under generally accepted accounting principles, from sales of the Licensed Products, but does not include any revenue from sales, use or other transaction taxes, duties, handling, graphics, embroidery or shipping.    E. \"Net Sales\" shall mean Gross Sales less Product returns, trade discounts, samples, allowances, value added services, markdowns, customer charge backs and liquidation sales (substantially discounted and out of ordinary distribution channel) of Licensed Products.    F. \"Licensed Products\" shall mean BlackMP Living Water, BlackMP Concentrate, Zezel Probiotic Water, Zayin Sports Water, Gridiron MVPโข and Gridiron MVPโข Concentrate using the Pro Football Legends Logo on the Licensed Products\\' affixed labels, hang-tags or packaging. Other products of the Company may be added to the list of Licensed Products during the Contract Period by written amendment to this Agreement. All amendments to this Agreement must be signed by all parties to this Agreement.    G. \"Products\" shall mean goods manufactured, distributed or otherwise sold by the Company.    H. \"Licensed Marks\" shall mean in connection with the rights and benefits granted to Company hereunder as set forth in General Terms. Company may utilize only the logo and other trademarks listed on Exhibit A (the \"Licensed Marks\") during the Term and within the Territory solely in connection with advertising and promotional materials that identify Company as a sponsor of the Pro Football Legends, provided that NFLA first approves all such uses in writing. Any use of the Licensed Marks will bear the trademark and/or copyright notices required by NFLA to facilitate its trademark protection program and will be a \"work made for hire\" for NFLA. All of Company',\n",
              "    'Highlight the parts (if any) of this contract related to \"Document Name\" that should be reviewed by a lawyer. Details: The name of the contract',\n",
              "    'ENDORSEMENT AGREEMENT',\n",
              "    15,\n",
              "    36),\n",
              "   ('Exhibit 10.2\\n\\nIN ACCORDANCE WITH ITEM 601(b) OF REGULATION S-K, CERTAIN IDENTIFIED INFORMATION (THE \"CONFIDENTIAL INFORMATION\") HAS BEEN EXCLUDED FROM THIS EXHIBIT BECAUSE IT IS BOTH (I) NOT MATERIAL AND (II) WOULD LIKELY CAUSE COMPETITIVE HARM IF PUBLICLY DISCLOSED. THE CONFIDENTIAL INFORMATION IS DENOTED HEREIN BY [*****].\\n\\nZEBRAยฎ PARTNERCONNECT PROGRAM\\n\\nADDENDUM TO\\n\\nZEBRAยฎ PARTNERCONNECT DISTRIBUTOR AGREEMENT\\n\\nTHIS ADDENDUM (\"Addendum\") is made on the 4th day of February 2019 (\"Effective Date\") between the following parties: Zebra Technologies International, LLC, with an office at 3 Overlook Point, Lincolnshire IL 60069 (\"Zebra\");\\n\\nZebra Technologies do Brasil - Comรฉrcio de Produtos de Informรฅtica Ltda., a company incorporated and organized under the laws of Brazil, with offices at Av. Magalhรคes de Castro, 4800, sala 72-A, Cidade Jardim, CEP 05676-120, Sรคo Paulo, sp (\"Zebra Brazil\")\\n\\nXplore Technologies Corporation of America, a company with its principal place of business at 8601 RR 2222, Building 2, Suite #100, Austin, Texas 78730, U.S.A. (\"Xplore\");\\n\\n(collectively \"Zebra\")\\n\\nAND\\n\\nScanSource, Inc., a company incorporated in South Carolina, with its registered office at 6 Logue Court, Greenville, South Carolina 29615 (\"ScanSource\").\\n\\nScanSource Latin America, Inc. a ScanSource Affiliate incorporated in Florida, whose registered business address is 1935 NW 87 Avenue, Miami, Florida 33172 (\"ScanSource Latin America\")\\n\\nScanSource Brazil Distribuidora de Technologias, Ltda., a ScanSource Affiliate incorporated and organized under the laws of Brazil, with offices in the City of Sรคo Josรฉ dos Pinhais, State of Paranรฅ, at Avenida Rui Barbosa, 2529, Modulos 11 and 12, Bairro Jardim Ipรฉ, CEP: 83055-320, enrolled with the Taxpayer Register (CNPJ/MF) under No. 05.607.657/0001-35 (\"ScanSource Brazil\")\\n\\nSCANSOURCE DE MEXICO S. DE R.L. DE C.V., a ScanSource Affiliate incorporated in Mexico, whose registered business address is Calle 4 No. 298, Colonia Franccionamiento Industrial Alce Blanco, Naucalpan de Juarez, Estado de Mรฉxico 53370 (\"ScanSource Mexico\")\\n\\n(Collectively \"Distributor\\')\\n\\n\"Zebra\" and the \"Distributor\" are referred to collectively as \\'Parties\" and individually as a \"Party\".\\n\\nWHEREAS: (A) On February 12, 2014 the Parties entered into an agreement that was renamed, as of April 11, 2016, to: PartnerConnectTM EVM Distribution Agreement, (as amended) (\"Distribution Agreement\"), which relates to Zebra Enterprise Visibility and Mobility (\\'EVM\") products and services, and which, as acknowledged by the Parties by entering into this Amendment, is in full force and effect and valid as when this Amendment is executed;\\n\\n(B) Distributor purchases Products from Zebra under the Distributor Agreement;\\n\\n(C)\\u200b Zebra has recently completed the acquisition of Xplore, which transaction closed on August 14, 2018;\\n\\n(D) Zebra has expanded its products portfolio by adding the product families listed in Exhibit A, that as of the Effective Date hereof are branded Xplore or Motion Computing, thereto (\"Xplore Products\"); (E) Xplore, now a Zebra Affiliate, is the seller of Xplore Products;\\n\\nSource: SCANSOURCE, INC., 10-Q, 5/9/2019\\n\\n\\n\\n\\n\\n(F) Xplore wishes to sell Xplore Products to Distributor and Distributor wishes to purchase such products from Xplore pursuant to the terms and conditions of the Distributor Agreement by entering into this Addendum; and\\n\\n(G) The Parties desire to amend the Distributor Agreement by adding Xplore Products and authorizing Distributor to purchase such products from Xplore for further resale to members of the Zebra PartnerConnect Program in the Market or Territory. THEREFORE, in consideration of the mutual covenants and promises, and subject to the terms and conditions of the Distributor Agreement, the Parties agree as follows:\\n\\n1. Expressions used in this Addendum shall have the same meanings given to them in the Distributor Agreement, unless the context requires otherwise.\\n\\n2. This Addendum automatically incorporates any future amendments to the Distributor Agreement and such amendments will be made part of this Addendum ',\n",
              "    'Highlight the parts (if any) of this contract related to \"Document Name\" that should be reviewed by a lawyer. Details: The name of the contract',\n",
              "    'ADDENDUM TO\\n\\nZEBRAยฎ PARTNERCONNECT DISTRIBUTOR AGREEMENT',\n",
              "    359,\n",
              "    415),\n",
              "   (\"ADDENDUM REQUIRED BY THE DEPARTMENT OF LAW OF THE STATE OF NEW YORK   The following Items are required to be included within the Disclosure Document and shall be deemed to supersede the language in the Disclosure Document itself:   3. LITIGATION   Neither the Franchisor, its Predecessor nor any person listed under Item 2 or an affiliate offering franchises under Franchisor's principal trademark:     (A) has an administrative, criminal or civil action pending against that person alleging: a felony; a violation of a franchise, antitrust or securities law; fraud; embezzlement; fraudulent conversion; misappropriation of property; unfair or deceptive practices; or comparable civil or misdemeanor allegations.\\n\\n  (B) has been convicted of a felony or pleaded nolo contendere to a felony charge or, within the ten year period immediately preceding the application for registration, has been convicted of or pleaded nolo contendere to a misdemeanor charge or has been the subject of a civil action alleging: violation of a franchise; anti-fraud or securities law; fraud; embezzlement; fraudulent conversion or misappropriation of property; unfair or deceptive practices; or comparable allegations.\\n\\n  (C) is subject to a currently effective injunctive or restrictive order or decree relating to the franchise, or under a Federal, State or Canadian franchise, securities, antitrust, trade regulation or trade practice law, resulting from a concluded or pending action or proceeding brought by a public agency; or is subject to any currently effective order of any national securities association or national securities exchange, as defined in the Securities and Exchange Act of 1934, suspending or expelling such person from membership in such association or exchange; or is subject to a currently effective injunctive or restrictive order relating to any other business activity as a result of an action brought by a public agency or department, including, without limitation, actions affecting a license as a real estate broker or sales agent.   4. BANKRUPTCY   Neither the Franchisor, its affiliate, its predecessor, officers, or general partner during the ten year period immediately before the date of the disclosure document: (a) filed as debtor (or had filed against it) a petition to start an action under the U.S. Bankruptcy Code (or any comparable foreign law); (b) obtained a discharge of its debts under the bankruptcy code; or (c) was a principal officer of a company or a general partner in a partnership that either filed as a debtor (or had filed against it) a petition to start an action under the U.S. Bankruptcy Code or that obtained a discharge of its debts under the U.S. Bankruptcy Code during or within one year after the officer or general partner of the Franchisor held this position in the company or partnership.   IN WITNESS WHEREOF, the parties hereto have duly executed, sealed and delivered this Addendum dated this ______ day of ______________, 2015.\\n\\n2\\n\\nSource: SOUPMAN, INC., 8-K, 8/14/2015\\n\\n\\n\\n\\n\\n\\n\\n              ATTEST   KIOSK CONCEPTS, INC.:                 By:       Witness   Name:       Title:                     MASTER FRANCHISEE: THE GRILLED CHEESE TRUCK, INC.                 By:           Name:       Title:               Witness\\n\\n3\\n\\nSource: SOUPMAN, INC., 8-K, 8/14/2015\",\n",
              "    'Highlight the parts (if any) of this contract related to \"Document Name\" that should be reviewed by a lawyer. Details: The name of the contract',\n",
              "    'ADDENDUM REQUIRED BY THE DEPARTMENT OF LAW OF THE STATE OF NEW YORK',\n",
              "    0,\n",
              "    67),\n",
              "   ('VISP WEB SITE BUILDING AND HOSTING AGREEMENT\\n\\nThis Agreement is made on this 12th day of May 2003 by and between YourNetPlus.com, Inc., a New York Corporation; with its principle office located at 501 Route 208, Monroe, NY 10950 (\"Provider\") and Kingdom Connect, Inc., a Corporation with its principle office located at 1045 Stephanie Way, Minden, NV 89423 (\"KCI\").\\n\\nWhereas, Provider is in the business of providing websites and internet connectivity which may be Private Labeled or offered as same service.\\n\\nWhereas KCI wishes to purchase the services of Provider on behalf of KCI\\'s customers.\\n\\nWhereas, Provider agrees to provide VISP setup, maintenance, and technical support services for five thousand (5,000) websites for KCI\\'s customers over the next five years.\\n\\nBe it agreed on this day that the following agreement will govern the relationship between our two companies.\\n\\n1    TERM\\n\\nThis agreement shall be for a term of five years from the date of this document. This agreement shall renew automatically each year thereafter, unless either party serves written notice of its intention not to renew, on the other at least 90 days prior to the expiration of the then current term of this agreement.\\n\\n2    PROVIDER\\'S  REPRESENTATIONS\\n\\nYournetplus, one of the largest private label internet service providers in the United States agrees to allow us to prepay for our customers all set up, development, maintenance, and service fees associated with five thousand VISP websites for the customers of KCI at no charge to the customer (churches). Provider represents that these fees normally are charged to the customer according to the following schedule:\\n\\n$299.00 one time start-up and developmental fee due at contract signing\\n\\n$29.95 monthly maintenance and service fee\\n\\n24/7 \"800\" Number Customer Service / Tech Support $25.00 per month for private labeled service and Free for the first 90 days for generic service.  If the ISP does not have 250 users within the first 90 days we will charge $25.00 each month thereafter.\\n\\n3    PROVIDER\\'S  RESPONSIBILITIES\\n\\nProvider agrees to provide KCI with VISP Private labeled website building and maintenance capabilities. Deliverables shall include: Sales collateral materials including brochures and flyers to help KCI sign customers to the service. A fully staffed back end including; Billing, real time credit card transactions, administrative reports, Customer and technical support, Online Customer Account Maintenance, Private labeled E-Mail Server, Administrative E-Mail Addresses, vacation e-mail, Web based and POP Access, Online Interfaces, a private labeled Internet portal for KCI and include an affiliate program.\\n\\nKCI\\'s Customers will receive an initial VISP web site setup including 5Mbs of storage space, maintenance of the site, technical support, and any services necessary for use of the site for no charge.\\n\\n4    KCI\\'S  RESPONSIBILITIES\\n\\nTo market Private Labeled Service to retail and wholesale clients of KCI.\\n\\nKCI, its officers, directors, employees and any authorized sub-licensee will (I) conduct their business in an honest, professional and ethical manner and (ii) not commit any action or omission to act which could adversely affect PROVIDER, its name, reputation or ability to conduct its business. KCI shall promptly and fully cooperate with Provider to address and resolve all issues, problems, administrative procedures, End User complaints, regulatory investigations or inquiries or any other circumstances arising from KCI\\'s use of Provider\\'s services.\\n\\n5    PROPRIETARY  INFORMATION\\n\\nThe parties understand and agree that the terms and conditions of this Agreement, all documents and invoices and all communications between the parties regarding this Agreement or the Service to be provided as well as such information relevant to any other agreement between the parties (collectively \"Confidential Information\"), are strictly confidential between KCI and Provider. For purposes of this Agreement, \"Confidential Information\" shall mean information in written or other tangible form specifically labeled as such w',\n",
              "    'Highlight the parts (if any) of this contract related to \"Document Name\" that should be reviewed by a lawyer. Details: The name of the contract',\n",
              "    'VISP WEB SITE BUILDING AND HOSTING AGREEMENT',\n",
              "    0,\n",
              "    44),\n",
              "   ('Exhibit A\\n\\nJOINT FILING AGREEMENT\\n\\nPursuant to and in accordance with the Securities Exchange Act of 1934, as amended, and the rules and regulations thereunder (the \"Exchange Act\") the undersigned hereby agree to the joint filing of Clarus IV-A, L.P., Clarus IV-B, L.P., Clarus IV-C, L.P., Clarus IV-D, L.P., Clarus IV GP, L.P., Blackstone Clarus GP L.P., Blackstone Clarus GP L.L.C., Blackstone Holdings II L.P., Blackstone Holdings I/II GP L.L.C., The Blackstone Group Inc., Blackstone Group Management L.L.C. and Stephen A. Schwarzman, on behalf of each of them of any filing required by such party under Section 13 of the Exchange Act or any rule or regulation thereunder (including any amendment, restatement, supplement, and/or exhibit thereto) with respect to securities of Galera Therapeutics, Inc., a Delaware corporation, and further agree to the filing, furnishing, and/or incorporation by reference of this Agreement as an exhibit thereto. Each of them is responsible for the timely filing of such filings and any amendments thereto, and for the completeness and accuracy of the information concerning such person contained therein; but none of them is responsible for the completeness or accuracy of the information concerning the other persons making the filing, unless such person knows or has reason to believe that such information is inaccurate. This Agreement shall remain in full force and effect until revoked by any party hereto in a signed writing provided to each other party hereto, and then only with respect to such revoking party. This Agreement may be executed in any number of counterparts all of which taken together shall constitute one and the same instrument.\\n\\nIN WITNESS WHEREOF, the undersigned hereby execute this Agreement this 14t h day of February 2020. CLARUS IV-A, L.P. By: Clarus IV GP, L.P., its general partner By: Blackstone Clarus GP L.P., its general partner By: Blackstone Clarus GP L.L.C., its general partner\\n\\nBy: /s/ John G. Finley Name: John G. Finley Title: Chief Legal Officer\\n\\nCLARUS IV-B, L.P. By: Clarus IV GP, L.P., its general partner By: Blackstone Clarus GP L.P., its general partner By: Blackstone Clarus GP L.L.C., its general partner\\n\\nBy: /s/ John G. Finley Name: John G. Finley Title: Chief Legal Officer\\n\\nCLARUS IV-C, L.P. By: Clarus IV GP, L.P., its general partner By: Blackstone Clarus GP L.P., its general partner By: Blackstone Clarus GP L.L.C., its general partner\\n\\nBy: /s/ John G. Finley Name: John G. Finley Title: Chief Legal Officer\\n\\n[Galera Therapeutics, Inc. - Joint Filing Agreement]\\n\\n\\n\\n\\n\\nCLARUS IV-D, L.P. By: Clarus IV GP, L.P., its general partner By: Blackstone Clarus GP L.P., its general partner By: Blackstone Clarus GP L.L.C., its general partner\\n\\nBy: /s/ John G. Finley Name: John G. Finley Title: Chief Legal Officer\\n\\nCLARUS IV GP, L.P. By: Blackstone Clarus GP L.P., its general partner By: Blackstone Clarus GP L.L.C., its general partner\\n\\nBy: /s/ John G. Finley Name: John G. Finley Title: Chief Legal Officer\\n\\nBLACKSTONE CLARUS GP L.P. By: Blackstone Clarus GP L.L.C., its general partner\\n\\nBy: /s/ John G. Finley Name: John G. Finley Title: Chief Legal Officer\\n\\nBLACKSTONE CLARUS GP L.L.C.\\n\\nBy: /s/ John G. Finley Name: John G. Finley Title: Chief Legal Officer\\n\\nBLACKSTONE HOLDINGS II L.P. By: Blackstone Holdings I/II GP L.L.C., its general partner\\n\\nBy: /s/ John G. Finley Name: John G. Finley Title: Chief Legal Officer\\n\\nBLACKSTONE HOLDINGS I/II GP L.L.C.\\n\\nBy: /s/ John G. Finley Name: John G. Finley Title: Chief Legal Officer\\n\\nTHE BLACKSTONE GROUP INC.\\n\\nBy: /s/ John G. Finley Name: John G. Finley Title: Chief Legal Officer\\n\\n[Galera Therapeutics, Inc. - Joint Filing Agreement]\\n\\n\\n\\n\\n\\nBLACKSTONE GROUP MANAGEMENT L.L.C.\\n\\nBy: /s/ John G. Finley Name: John G. Finley Title: Chief Legal Officer\\n\\n/s/ Stephen A. Schwarzman Stephen A. Schwarzman\\n\\n[Galera Therapeutics, Inc. - Joint Filing Agreement]',\n",
              "    'Highlight the parts (if any) of this contract related to \"Document Name\" that should be reviewed by a lawyer. Details: The name of the contract',\n",
              "    'JOINT FILING AGREEMENT',\n",
              "    11,\n",
              "    33),\n",
              "   ('Exhibit 4.1\\n\\nEXECUTION VERSION\\n\\nREINSURANCE GROUP OF AMERICA, INCORPORATED\\n\\nRGA CAPITAL TRUST I\\n\\nAMENDED AND RESTATED REMARKETING AGREEMENT\\n\\nFebruary 15, 2011\\n\\nBarclays Capital Inc.  745 Seventh Avenue  New York, NY 10019\\n\\nLadies and Gentlemen:\\n\\nReinsurance Group of America, Incorporated, a Missouri corporation (the \"Company\"), and RGA Capital Trust I, a Delaware statutory business  trust (the \"Trust\"), issued and sold to Lehman Brothers Inc. and Banc of America Securities LLC (the \"Underwriters\") pursuant to the  Underwriting Agreement, dated December 12, 2001 (the \"Underwriting Agreement\"), 4,500,000 Trust Preferred Income Equity Redeemable  Securities (\"PIERS\")1 units (the \"Firm Units\") issued pursuant to a Unit Agreement (the \"Unit Agreement\") dated as of December 18, 2001, as  supplemented September 12, 2008, among the Company, the Trust, The Bank of New York Mellon Trust Company, N.A., as successor unit agent  (in such capacity, the \"Unit Agent\"), as successor warrant agent (in such capacity, the \"Warrant Agent\"), and as successor property trustee (in  such capacity, the \"Property Trustee\"). In addition, the Company and the Trust granted to the Underwriters an option (the \"Option\") to purchase  up to an additional 675,000 Units (the \"Option Units\" and, together with the Firm Units, the \"Units\").\\n\\nEach Unit consists of a preferred security, liquidation preference $50 per security, of the Trust (each, a \"Preferred Security\") and a warrant (each,  a \"Warrant\") of the Company to purchase at any time prior to the close of business on December 15, 2050, shares (the \"Warrant Shares\") of  common stock, par value $0.01 per share, of the Company (\"Common Stock\"), subject to antidilution adjustments. Each Preferred Security  represents an undivided beneficial ownership interest in the assets of the Trust, which assets consist solely of the 5.75% Junior Subordinated  Deferrable Interest Debentures due 2051 of the Company (the \"Debentures\"). Certain payments on the Preferred Securities and Common Securities  (the \"Trust Securities\") are guaranteed (the \"Guarantee\") by the Company pursuant to the Guarantee Agreement (the \"Guarantee Agreement\")  dated as of December 18, 2001, between the Company and The Bank of New York Mellon Trust Company, as successor guarantee trustee (in such  capacity, the \"Guarantee Trustee\").\\n\\nThe Trust was formed on February 9, 2001 pursuant to a trust agreement dated as of February 8, 2001 (the \"Original Trust Agreement\") executed  by the Company, as depositor,\\n\\n\\n\\n1   \"Preferred Income Equity Redeemable SecuritiesSM\" and \"PIERSSM\" are service marks owned by Lehman Brothers Inc.\\n\\n\\n\\n\\n\\n\\n\\nand The Bank of New York (Delaware), as Delaware trustee (in such capacity, the \"Delaware Trustee\"), and a certificate of trust dated as of  February 8, 2001 (the \"Trust Certificate\") filed with the Secretary of State of the State of Delaware. The Trust is governed by, and the Preferred  Securities were issued under, the Original Trust Agreement, as amended and restated by the Amended and Restated Trust Agreement (the  \"Amended and Restated Trust Agreement\" and, together with the Original Trust Agreement, the \"Trust Agreement\")) dated as of December 18,  2001, among the Company, the Property Trustee, the Delaware Trustee and A. Greig Woodring, Jack B. Lay and Todd C. Larson, as the initial  administrative trustees (in such capacities, the \"Administrative Trustees\") which amended and restated the Original Trust Agreement.\\n\\nThe Trust used the proceeds from the sale of the Trust Securities to purchase the Debentures that were issued pursuant to the Indenture (the  \"Original Indenture\"), as supplemented by a Supplemental Indenture (the \"Supplemental Indenture\" and, together with the Original Indenture, as  so supplemented, the \"Indenture\"), in each case, dated as of December 18, 2001 between the Company and The Bank of New York Mellon Trust  Company, N.A., as successor indenture trustee (in such capacity, the \"Indenture Trustee\"). The Trust will, if and to the extent it receives the  proceeds of a payment on the Debentures, di',\n",
              "    'Highlight the parts (if any) of this contract related to \"Document Name\" that should be reviewed by a lawyer. Details: The name of the contract',\n",
              "    'AMENDED AND RESTATED REMARKETING AGREEMENT',\n",
              "    97,\n",
              "    139),\n",
              "   ('Exhibit 10.4\\n\\n                              CO-BRANDING AGREEMENT\\n\\nThis Co-Branding Agreement (this \"Agreement\") dated September 30, 1999 (the \"Effective Date\") is entered into between VerticalNet, Inc., a Pennsylvania corporation having a principal place of business at 700 Dresher Road, Suite 100, Horsham, Pennsylvania, PA 19044 (\"VerticalNet\"), and PaperExchange.com, LLC, a Delaware limited liability company having a principal place of business at 545 Boylston Street, 8th Floor, Boston, MA 02116 (\"PaperExchange\"). In consideration of the mutual covenants herein, and intending to be legally bound hereby, the parties agree as follows:\\n\\n1. DEFINITIONS\\n\\n      1.1. Affiliate shall mean, when used with reference to a party, any individual or entity directly or indirectly controlling, controlled by or under common control with such party. For purposes of this definition, \"control\" means the direct or indirect ownership of at least 50% of the outstanding voting securities of a party, or the right to control the policy decisions of such party.\\n\\n      1.2. Career Center Net Revenue shall have the meaning ascribed thereto in Section 7.1.1  [Co-Branded Career Center].\\n\\n      1.3. Co-Branded Career Center shall mean the \"Career Center\" portion of Pulp and Paper Online located at: http://www.pulpandpaperonline.com/Content/CareerCenter/Home/JobScan_Home.asp (or a successor Site thereto).\\n\\n      1.4. Co-Branded Equipment Listings shall mean the \"Auctions\" portion of Pulp and Paper Online located at: http://www2.pulpandpaperonline.com/content/auctions/home.asp (or a successor Site thereto).\\n\\n      1.5. Co-Branded Sites shall mean the Co-Branded Career Center and the Co-Branded Equipment Listings.\\n\\n      1.6. Co-Branded URLs shall mean the mutually agreed-upon URLs which shall be registered jointly by VerticalNet and PaperExchange and shall route users through to the Co-Branded Sites.\\n\\n      1.7. Confidential Information shall mean all proprietary and confidential information of a party, including, without limitation, trade secrets, technical information, business information, sales information, customer and potential customer lists and identities, product sales plans, sublicense agreements, inventions, developments, discoveries, software, know-how, methods, techniques, formulae, data, processes and other trade secrets and proprietary ideas, whether or not protectable under patent, trademark, copyright or other areas of law, that the other party has access to or receives, but does not include information that (a) is or becomes publicly available through no fault of receiving party; (b) was already known to the receiving party at the time it was disclosed to the receiving party, as evidenced by written records of the receiving party; (c) is independently developed by employees of the receiving party who had no knowledge of or\\n\\n* Confidential Treatment Requested: material has been omitted and filed   separately with the Commission.\\n\\naccess to such information, as evidenced by written records of the receiving party; or (d) is received from a third party who is under no obligation of confidentiality to the disclosing party.\\n\\n      1.8. Equipment Listings Net Revenue shall have the meaning ascribed thereto in Section 7.1.2  [Co-Branded Equipment Listings].\\n\\n      1.9. Initial Term shall mean the Effective Date through the day prior to the fourth anniversary of the Effective Date, unless earlier terminated pursuant to Section 8.\\n\\n      1.10. Intellectual Property shall mean any and all trade secrets, patents, copyrights, trademarks, URLs, trade dress, brand features, know-how and similar rights of any type under the laws of any applicable governmental authority, including, without limitation, all applications and registrations relating to any of the foregoing.\\n\\n      1.11. Intellectual Property Rights shall mean all rights in and to Intellectual Property.\\n\\n      1.12. Link shall mean a link (including, but not limited to, a hyperlink, button or banner) that connects two Sites in a manner so that when a user clicks on the link, the user is tra',\n",
              "    'Highlight the parts (if any) of this contract related to \"Document Name\" that should be reviewed by a lawyer. Details: The name of the contract',\n",
              "    'CO-BRANDING AGREEMENT',\n",
              "    44,\n",
              "    65),\n",
              "   ('1                                                                    EXHIBIT 10.13\\n\\n2\\n\\n                            BIOPURE CORPORATION                                 AGENCY AGREEMENT\\n\\n   This \"Agency\" Agreement is made as of March 29, 1999, by and between Biopure Corporation, a Delaware corporation (the \"Company\") and the Agent named on the signature page hereof (the \"Agent\").\\n\\n   WHEREAS, the Company is preparing to manufacture and sell Oxyglobin(R) brand veterinary products (\"Products\") enumerated on the Company\\'s veterinary products agency price list (Exhibit A)(as such list may be changed by the Company from time to time, the \"Price List\"); and\\n\\n   WHEREAS, the Agent and the Company wish to enter into an arrangement wherein the Agent would promote, sell, and collect payment for, such Products for the Company as a representative (\"Agent\") of the Company within the United States of America to duly licensed veterinarians (the \"Customers\") on the terms provided herein;\\n\\n   NOW, THEREFORE, in consideration of the premises and of the mutual promises and covenants contained herein, the parties hereby agree as follows:\\n\\n                      1. APPOINTMENT AND ACCEPTANCE.\\n\\n   1.1. Appointment. Subject to the terms and conditions of this Agreement, the Company hereby appoints the Agent, and the Agent hereby accepts appointment, as an authorized distributor agent within the Territory, (Territory as outlined in section 1.2), for the promotion, sale and collection of payment for, the Products to Customers. The Company has appointed a limited number of Agents; however, the Company retains the right to itself, and/or appoint others to, promote, sell, and collect payment for, and distribute, the Products to Customers in the Territory.\\n\\n   1.2. Territory. The Territory is defined as that geographical area in which said Agent is represented by a full time field sales representative, and of which assigned Distributor agrees to be responsible for mutually agreed upon quarterly and annual sales objectives as described in the \"Business Plan\". Compensation by the Company to the Agent will be limited to the area stated as follows:\\n\\n   The 48 Continental United States (including DC) plus Alaska    3\\n\\n                                    -2-\\n\\nNo compensation will be earned by the Agent for sales generated from customers in geographical areas not indicated in this section 1.2.\\n\\n   1.3. Business Plan. The Company and the Agent will jointly develop a written business plan for the promotion, distribution and sale of the Products to Customers in the Territory for each year (Nov 1 - Oct 31) during the term of this Agreement (a \"Contract Year\") and, on a nonbinding preliminary basis, for the next succeeding Contract Year (a \"Business Plan\"). Each Business Plan will include, among other things, sales and marketing strategies, advertising and promotion plans, financial projections (including projected sales, expenses and other customary items) and Agent performance criteria (including, but not limited to, market penetration, sales promotion execution, Product availability/accessibility and trade support). In the event of any conflict between this Agreement and a Business Plan, this Agreement will govern. The Business Plan relating to Contract Year ending Oct 31, 1999 will be agreed upon at least thirty (30) days after the Agent Launch Date (as defined below) or at a mutually agreed upon date and location. The Business Plan relating to all Contract Years thereafter will be agreed upon not less than sixty (60) days (or at a mutually agreed upon date and location) prior to the start of the Contract Year to which it relates. The Company and the Agent will negotiate the terms and conditions of each Business Plan in good faith, using their respective best efforts to agree upon such terms and conditions. The parties will review each then-current Business Plan quarterly and update such Business Plan from time to time as may be mutually agreed upon in writing. For purposes of this Agreement, \"Agent Launch Date\" means the date specified by the Company to the A',\n",
              "    'Highlight the parts (if any) of this contract related to \"Document Name\" that should be reviewed by a lawyer. Details: The name of the contract',\n",
              "    'AGENCY AGREEMENT',\n",
              "    167,\n",
              "    183),\n",
              "   ('1                                                                 EXHIBIT 10.17\\n\\n                       [MEDICAL MANAGER LETTERHEAD]\\n\\n              TECHNICAL INFRASTRUCTURE MAINTENANCE AGREEMENT\\n\\nDate:                           March 1, 1998\\n\\nContract No.:                   pr-4544\\n\\n                                 Between\\n\\nClient Name:                    MEDICAL MANAGER MIDWEST, INC.                                 53702 Generations Drive                                 South Bend, IN 46635 Principle Contact:              Tom Liddell\\n\\n                                   And\\n\\nCustomer Name:                  MTS, INC.                                 9931 Corporate Service Drive                                 Louisville, KY 40223 Principle Contact:              Gail Knopf\\n\\nANNUAL FEE.    [ ] Technical Support     Hours Maximum: [*]; If                    Retainer $[*]         support extends beyond [*] hours,                                          Support will be charged at [*] per                                          hour.\\n\\n[*].\\n\\nMEDICAL MANAGER, MIDWEST, INC., hereinafter referred to as \"MMMW\", hereby agrees to provide service with respect to the technical infrastructure and MTS, INC., hereinafter referred to as \"Customer\", agrees to accept such service, subject to the following terms and conditions:\\n\\nTHE ATTACHED TERMS AND CONDITIONS ARE PART OF THIS AGREEMENT. THIS AGREEMENT IS THE SOLE AND EXCLUSIVE AGREEMENT BETWEEN THE PARTIES RELATING TO SERVICES FOR THE ABOVE ITEMS. THE \"Customer\" HAS READ THIS AGREEMENT, UNDERSTANDS IT AND AGREES TO BE BOUND BY IT.\\n\\n                           TERMS AND CONDITIONS\\n\\n1. TECHNICAL INFRASTRUCTURE\\n\\n      (a)      Technical Infrastructure Maintenance Agreement covers                   applicable items that make up the underlying technical                   infrastructure that is required to run an application. This                   would include items such as hardware, operating system,                   network connections, etc.\\n\\n      (b)      Maintenance refers to the services involved in maintenance of                   equipment already purchased.\\n\\n      (c)      This Agreement shall be effective on the date of signed                   acceptance (\"Effective Date\") by MMMW.\\n\\n      (d)      Renewal agreement shall be effective on the \"Effective Date\"                   if it is signed and returned to MMMW by the \"Effective Date.\"\\n\\n      (e)      Renewal agreement not signed and received by MMMW by the                   \"Effective Date\" will suspend all coverage of technical                   infrastructure support between the \"Effective Date\" and the                   actual date of receival of the renewal technical                   infrastructure maintenance agreement. Services provided                   between these two dates are billable.\\n\\n[*] Confidential portions omitted and filed separately with the Securities and     Exchange Commission.\\n\\n2 2.  TERM\\n\\n (a)   MMMW provided Customer with an all inclusive warranty for a period of           12 months commencing on the date of installation to include system           purchased by Customer from MMMW. Upon expiration of that 12 months,           MMMW affords the Customer the opportunity of a continuation of support           on an annual basis as follows: The Initial Term of this Technical           Infrastructure Maintenance Agreement is twelve months, commencing on           the Effective Date. The support agreement will be subject to prior           inspection and acceptance of the hardware for service and to the           Customer\\'s payment of any charges for the inspection and/or the           pre-agreement servicing and repair of the hardware, such estimates to           be approved in advance by Customer.\\n\\n (b)   MMMW shall make two options of hardware support available to Customer:\\n\\n       TECHNICAL SUPPORT RETAINER is a Support Plan that allows the Customer\\n\\n\\n\\n\\n\\n       to pay a Retainer that provides technical Related Support by qualified           Support Analysts and Field Technicians. This Support Plan covers a 12',\n",
              "    'Highlight the parts (if any) of this contract related to \"Document Name\" that should be reviewed by a lawyer. Details: The name of the contract',\n",
              "    'TECHNICAL INFRASTRUCTURE MAINTENANCE AGREEMENT',\n",
              "    148,\n",
              "    194),\n",
              "   (\"Exhibit 10.47   Cooperation Agreement of 50MWp Photovoltaic Grid-connected Power Generation Project in Yangqiao of Fenyi County   Party A: People's Government of Fenyi County Party B: Xinyu Xinwei New Energy Co., Ltd.   Party A welcomes and supports Party B to invest and develop new energy project in Fenyi County, and Party B is willing to invest and build 50MWp photovoltaic grid-connected power generation project in Fenyi County; both parties, in the principle of equality, mutual benefits, win-win cooperation and solid progress, reach the following cooperation agreement as for relevant matters of the project:   I. Party A supports and guarantees the project construction and development of Party B, and will provide the most preferential policies and all- round service in the aspects of preliminary work, construction and grid-connected of the project, and actively coordinate relevant departments and units to help Party B accelerate project construction progress. Party B will give full play to the advantages in funds, talents, technologies, and etc. to accelerate the preliminary work progress of the project, ensure the early commencement of the project and produce benefits upon early completion.   II. As required by Party B building PV grid-connected power station project, Party A accepts the Cooperation Agreement of 50MWp Photovoltaic Grid-connected Power Generation Project in Yangqiao Town of Fenyi County signed by Party B and Yangqiao Town of Fenyi County, and actively coordinates Yangqiao Town to perform relevant responsibilities.   III. In the principle of win-win cooperation, based on 50MWp photovoltaic grid-connected power generation project in Yangqiao Town, Party B will vigorously promote the application of PV products, improve local energy-saving and emission reduction benefits, increase local fiscal levy, enhance villagers' income and increase villagers' employment.   IV. Party B promises that land nature will not be changed for building large-scale PV grid-connected power generation project in the plot; comprehensive development will be carried out according to relevant national stipulations, such commercial crops will be interplanted as agriculture and forestry as well as medicinal materials; local employees will enjoy the priority to be employed; local building materials will be adopted and relevant expenses will be paid on schedule.   V. Party B will register a foreign-funded company in Fenyi County before implementing the project; Party A will offer all the preferential policies to the company as per local investment promotion policies for foreign investment introduction.   Party A: People's Government of Fenyi County (seal) Rao Cheng (signature) June 25, 2014   Party B: Xinyu Xinwei New Energy Co., Ltd. (seal) Xiahou Min (signature) June 25, 2014\",\n",
              "    'Highlight the parts (if any) of this contract related to \"Document Name\" that should be reviewed by a lawyer. Details: The name of the contract',\n",
              "    'Cooperation Agreement',\n",
              "    1312,\n",
              "    1333),\n",
              "   ('1                                                                    EXHIBIT 10.17\\n\\n               PRODUCT DEVELOPMENT AND CO-BRANDING AGREEMENT\\n\\n                         \"SONGS 4 WORSHIP SERIES\"\\n\\n                      EXCLUDING CONFIDENTIAL PORTIONS\\n\\n/1/ Indicates information which has been redacted pursuant to a request for     confidential treatment.\\n\\n2\\n\\n                    INDEX TO THE CONFIDENTIAL PORTIONS\\n\\n      PAGE                      SECTION                     LINE(S)          ----                      -------                     -------                                                             1                          1(c)                    3, 4, and 5           3                          3(a)              4, 5, 10, 11, 12 and 13           4                          4(c)                     2, 4 and 5           4                          4(d)                   2, 3, 4 and 5           5                           5                           2\\n\\n3\\n\\n               PRODUCT DEVELOPMENT AND CO-BRANDING AGREEMENT                             \"SONGS 4 WORSHIP SERIES\"\\n\\n      This Agreement, entered into this the 10th day of January 2000, by and between INTEGRITY INCORPORATED, a Delaware corporation with principal offices at 1000 Cody Road, Mobile, Alabama (\"Integrity\") and TIME LIFE, INC., a Delaware corporation d/b/a Time Life Music, with principal offices located at 2000 Duke Street, Alexandria, Virginia 22314 (\"TL\"). The parties wish to produce a series of recorded compilations and companion song books featuring praise and worship repertoires, which will be co-branded and co-marketed throughout the world. Now, therefore, the parties agree as follows:\\n\\n1.       Product Concept and Creation.\\n\\n      a.       Product description. The product to be created under the                   series trade name \"Songs 4 Worship\" will be a praise and                   worship continuity series, with each volume in the series                   containing approximately 22 songs. Each volume will be                   manufactured in Double CD, Double Cassette, and song book                   formats, with standard double jewel boxes, inlays, booklets                   and j-cards (the \"Product\"). TL and Integrity will jointly                   develop the repertoire, and all repertoire selections are                   subject to master, mechanical and print rights clearance in                   accordance with the financial terms established below. The                   exact songbook format, song selection and number of songbook                   volumes has not yet been determined, and TL has no obligation                   to sell any songbooks produced pursuant to this Agreement.\\n\\n      b.       Branding. The Product will prominently display the \"Songs 4                   Worship\" logo and trademark (or other logo as mutually                   approved) and will also bear the labels of \"Time Life Music\"                   and \"Integrity Music\" in equal proportion on the exterior of                   Product packaging. The \"Integrity Music\" and \"Time Life Music\"                   logos will be used on advertising whenever possible, and it is                   understood that neither logo will be used without the other                   with reference to the Product.\\n\\n      c.       Integrity\\'s responsibilities. Integrity will obtain master                   lease and print agreements with all third party owners of                   masters embodied in the Product at its own expense. Mechanical                   rates will not exceed [**]/1/ percent ([**]/1/%) of the                   then-current statutory rate, and Print licenses will not                   exceed a prorated portion of [**]/1/ percent ([**]/1/%) of the                   retail selling price, Integrity will also manufacture the                   Product and sell to TL its requirements for resale.\\n\\n--------------- /1/ Indicates information which has been redacted pursuant to a request for     confidential treatment.\\n\\n4\\n\\nSource: INTEGRITY MEDIA INC, 10-K405, 3/29/20',\n",
              "    'Highlight the parts (if any) of this contract related to \"Document Name\" that should be reviewed by a lawyer. Details: The name of the contract',\n",
              "    'PRODUCT DEVELOPMENT AND CO-BRANDING AGREEMENT',\n",
              "    991,\n",
              "    1036),\n",
              "   ('Exhibit 10.1\\n\\n\\n\\nOceanic Time Warner Cable and Watchit Media Content and License Agreement\\n\\nEffective Dates: September 1, 2006, August 31, 2007\\n\\nWatchit agrees to provide Oceanic Time Warner Cable the following content:\\n\\n- Watchit Gaming Guides - Lunchtime with Ira segments every week\\n\\nWatchit will provide the content on BetaSp format and reserves the right to modify the content to reflect sponsorship by an advertiser and advertisers.\\n\\nOceanic Time Warner Cable agrees to not edit or modify the above content.\\n\\nOceanic Time Warner Cable will use the content solely on channel 777, the Las Vegas channel.\\n\\nIn the event that Oceanic Time Warner Cable removes the above content and or terminates this agreement prior to December 31, 2006, Oceanic Time Warner Cable agrees to pay a cancellation fee of Five Thousand Dollars ($5,000) per month multiplied by the number of months remain on the agreement.\\n\\nWatchit shall have the exclusive right to sell third party advertising as sponsors of their content and will have the right to brand the content under the Watchit brand and place a \"bug\" on the screen identifying the content with a Watchit trademark.\\n\\nOceanic Time Warner Cable will include the following disclaimer on the Watchit Content: \"The materials shown are for entertainment purposes only and does not provide any guarantees of winning or improving your odds of winning on this program. The rules of the games as shown may not apply to all properties and may change from time to time.\"\\n\\nOcean Time Warner Cable will provide Watchit with data on viewership to both Channel 777 and specifically to the content provided by Watchit.\\n\\nOcean Time Warner Cable will be able to not include any content that it deems inappropriate or distasteful.\\n\\nThis agreement will be in effect until the end of 2006 and will be evaluated at that time.\\n\\nBoth parties agree to discuss use of information gathered form this arrangement before using it in any kind of promotional or public message.\\n\\nAccepted by:\\n\\n            Oceanic Time Warner Cable/Date\\n\\nWatchit Media/Date\\n\\nSource: WATCHIT MEDIA, INC., 8-K, 12/1/2006',\n",
              "    'Highlight the parts (if any) of this contract related to \"Document Name\" that should be reviewed by a lawyer. Details: The name of the contract',\n",
              "    'Media Content and License Agreement',\n",
              "    54,\n",
              "    89),\n",
              "   ('EXHIBIT 10.25                                RESELLER AGREEMENT\\n\\nTHIS AGREEMENT (the \"AGREEMENT\") entered into as of the 19 day of March, 2004 (the \"EFFECTIVE DATE\") provides the terms and conditions under which MediaNet Group Technologies, Inc., a Nevada corporation having an address at 5100 W. Copans Road Suite 710 Margate, FL 33063 USA (\"MEDIANET GROUP TECHNOLOGIES\"), authorizes International Direct Response, Inc., a Pennsylvania Corporation, having an address at 1125 Lancaster Avenue, Berwyn, PA 19312(\"RESELLER\") to be its true and lawful representative and agent for the purpose of reselling licenses of the MediaNet Group Technologies Portals (\"PORTALS\") and other MediaNet Group Technologies products and services in accordance with the terms and conditions contained in this Agreement. This Agreement, together with the other agreements and schedules referenced in it, contains the complete terms and conditions between the parties.\\n\\nMEDIANET GROUP TECHNOLOGIES AND RESELLER AGREE AS FOLLOWS:\\n\\n1.   LICENSE\\n\\nReseller is hereunder licensed to market MediaNet Group Technologies\\' Brand-A-Port portals (\"PORTALS\") and to resell MediaNet Group Technologies products and services for compensation in accordance with the annexed \"RESELLING SCHEDULE.\" Under the terms and conditions as outlined in this Agreement.\\n\\n2.   RESELLING\\n\\nThe Reseller intends to market the Portals to companies and various businesses and individuals (\"BUYERS\") who may include corporations, small businesses, religious organizations, network marketing, franchise, business opportunities, chains, charities, organizations and other companies that would have a use for individual and multiple portals. The purpose of this Agreement is to define the scope of compensation for the marketing of Portals to these potential customers. During the Term of this Agreement, Reseller shall have the right to market Brand-A-Port Portals, both through the existing Brand-A-Port Portal under the License and independently to Buyers for resale, subject to approval by MediaNet Group Technologies.\\n\\n3.   COMPENSATION\\n\\nMediaNet Group Technologies shall pay Reseller a fee in accordance with the annexed Fee Schedule. MediaNet Group Technologies will remit payment as directed by Reseller in the time frames noted on the Compensation Schedule attached hereto.\\n\\n4.   PUBLICITY AND ADVERTISING\\n\\nSubject to Section 7, Reseller and MediaNet Group Technologies agree that broad publicity with respect to the relationship developed by this Agreement, and the advantages of such relationship, will be permitted and actively encouraged and supported by both parties. This publicity initiative will include, but is not limited to, a press releases issued by Reseller and MediaNet Group Technologies, publicizing the strategic alliance between the parties, on site promotion and email campaigns. In this regard, Reseller and MediaNet Group Technologies shall agree on the form, content of the press release prior to its release. MediaNet Group Technologies must approve any advertising prior to issuance and placement.\\n\\n5.   PROPRIETARY RIGHTS\\n\\n5.1 OWNERSHIP. RESELLER understands and agrees that MediaNet Group      Technologies is the exclusive holder of and shall retain, all right, title      and interest in and to the Portal, Content and Engine and the All Pages,      including without limitation all intellectual Property therein site      (EXCLUDING PROPRIETARY PAGES PROVIDED BY RESELLER OR BUYERS).\\n\\nReseller Agreement                                     Initials ______   _______                                        1\\n\\n5.2 INTELLECTUAL PROPERTY. Nothing herein shall grant a party any right,      title or interest in the other party\\'s Intellectual Property, except as      explicitly set forth herein. At no time during or after the Term of this      Agreement shall a party challenge or assist others to challenge the other      party\\'s Intellectual Property or the registration thereof or attempt to      register any trademarks, marks or trade names confusingly similar to those      or the other party.\\n\\n5.3 INTELLECTUAL P',\n",
              "    'Highlight the parts (if any) of this contract related to \"Document Name\" that should be reviewed by a lawyer. Details: The name of the contract',\n",
              "    'RESELLER AGREEMENT',\n",
              "    45,\n",
              "    63),\n",
              "   ('Exhibit 10.2    INTELLECTUAL PROPERTY AGREEMENT        between        SONY ELECTRONICS INC.        and        GSI TECHNOLOGY, INC.        August 28, 2009\\n\\n\\n\\n\\n\\n     TABLE OF CONTENTS\\n\\n   i\\n\\n    Page        1. Definitions 1            1.1 IP Agreement 2    1.2 Asset Purchase Agreement 2    1.3 Effective Date 2    1.4 Licensed Patent(s) 2    1.5 Transferred Patent(s) 3         2. Assignment 3         3. Licenses 3            3.1 Grant by SONY 3    3.2 Grant Back by PURCHASER 4    3.3 No Implied License or Other Assignment 4    3.4 No Sublicense Rights 4         4. Each Party\\'s Sole Right to the Intellectual Property 4         5. Restrictions on Use of SONY Trademarks 5            5.1 No Trademark License 5    5.2 Removal of SONY Trademarks 5    5.3 Packaging 5    5.4 No Affiliation 6    5.5 JTAG / Mask Works 6         6. Payment 6         7. Term and Termination 7            7.1 Term 7    7.2 Termination 7    7.3 Insolvency 7    7.4 Continuing Obligations 8         8. Representations and Warranties 8            8.1 Power and Authority 8    8.2 Essential Patents 8    8.3 Ownership 8    8.4 Validity and Enforceability 8    8.5 Sufficiency 9    8.6 Non-infringement by the Business 9    8.7 Infringement by a Third Party 10    8.8 Intellectual Property Development 10\\n\\n\\n\\n\\n\\n     TABLE OF CONTENTS  (continued)\\n\\n   ii\\n\\n    Page           8.9 Material Intellectual Property Agreements 11    8.10 Royalties 11    8.11 No Loss of Rights 12    8.12 Transferability 12    8.13 No SRAM Product Warranty Issues 12    8.14 Disclaimer 12         9. Miscellaneous 13            9.1 Notices 13    9.2 Expenses 14    9.3 Successors and Assigns 14    9.4 Waiver 15    9.5 Entire Agreement 15    9.6 Amendments and Supplements 15    9.7 Rights of Third Parties 15    9.8 Further Assurances 16    9.9 Applicable Law 16    9.10 Execution in Counterparts 16    9.11 Titles and Headings 16    9.12 Invalid Provisions 16    9.13 Transfer Taxes 17    9.14 Attorneys\\' Fees 17\\n\\n\\n\\n\\n\\n     INTELLECTUAL PROPERTY AGREEMENT     This Intellectual Property Agreement is made and entered into as of August 28, 2009 by and between GSI Technology, Inc., a Delaware  corporation (\"PURCHASER\"), on the one hand, and Sony Electronics Inc. (\"SONY\"), a Delaware corporation, on the other hand. PURCHASER  and SONY are referred to individually as a \"Party\" and collectively as the \"Parties\".     RECITALS     WHEREAS, SONY presently conducts the business of manufacturing, marketing and selling SRAM products (the \"Business\");     WHEREAS, SONY has agreed to sell and PURCHASER has agreed to purchase certain assets, rights and properties of SONY used or  useful in connection with the Business, all on the terms and subject to the conditions set forth in the Asset Purchase Agreement of even date  herewith;     WHEREAS, SONY has or will transfer title to the Transferred Assets to PURCHASER under the Asset Purchase Agreement;     WHEREAS, SONY is the owner of certain intellectual property related to the Business; and     WHEREAS, SONY desires to transfer certain patents to PURCHASER and grant to PURCHASER a license under certain intellectual  property related to the SRAM Products.     NOW, THEREFORE, in consideration of the mutual covenants, representations, warranties and agreements herein contained, the Parties  hereto agree as follows:     1. Definitions     As used in this IP Agreement, all capitalized terms shall have the meaning ascribed to them as set forth in the Asset Purchase  Agreement, except for terms defined herein, including the following terms, which shall have the meanings set forth below:     1\\n\\n\\n\\n\\n\\n     1.1 IP Agreement     The term \"IP Agreement\" means this Intellectual Property Agreement, including all attached Exhibits hereto, and any  amendments or supplements agreed to in writing and signed by SONY and PURCHASER.     1.2 Asset Purchase Agreement     The term \"Asset Purchase Agreement\" means the Asset Purchase Agreement dated August 28, 2009 between SONY and  PURCHASER to which this IP Agreement is attached as Exhibit F.     1.3 Effective Date     The term \"Effective Date\" me',\n",
              "    'Highlight the parts (if any) of this contract related to \"Document Name\" that should be reviewed by a lawyer. Details: The name of the contract',\n",
              "    'Intellectual Property Agreement',\n",
              "    2016,\n",
              "    2047),\n",
              "   ('ENDORSEMENT LICENSING AND CO-BRANDING AGREEMENT   This ENDORSEMENT LICENSING AND CO-BRANDING AGREEMENT is entered into on July 26, 2013 (the \"Effective Date\") by and between Marine MP, LLC (\"Lender\"), for services of Arnold Schwarzenegger (\"Endorser\"), and Fitness Publications, Inc. (\"Fitness\") (collectively, Lender, Endorser, and Fitness are referred to as the \"AS Parties\") and MusclePharm Corporation with its principal place of business in Denver, Colorado and its subsidiaries, (collectively, \"MusclePharm\" or the \"Company\").   RECITALS   WHEREAS, the AS Parties have the rights necessary to license the use of the rights of publicity with respect to name, voice, approved signature, approved photographs, approved images, and approved likenesses of Arnold Schwarzenegger (the \"Name and Appearance Rights\") and the use of the Name and Appearance Rights as trademarks or service marks (the \"Trademarks\"); and   WHEREAS, MusclePharm is engaged in the business of developing and marketing nutritional products for athletes and fitness enthusiasts, and   WHEREAS, MusclePharm from time to time uses consumer, celebrity, and expert endorsements or testimonials to promote MusclePharm Products (as defined in Section 2(b) of this Agreement) in marketing and advertising materials, and   WHEREAS, MusclePharm desires to develop, market, promote and sell in conjunction and in cooperation with the Endorser a unique Arnold Schwarzenegger customized product line approved by the Endorser initially comprised of between four to eight (4 to 8) products, subject to Section 2(b) below), that will be marketed and advertised under the Endorser\\'s name and likeness, all subject to the Endorser\\'s approval, as described in Section 12, (the \"AS Product Line\"); and   WHEREAS, MusclePharm desires to engage Endorser, and Endorser desires to accept the engagement, as more fully described in this Agreement, whereby Endorser will lend his name, reputation, and appearance to (i) endorse and promote MusclePharm and its Products and (ii) to develop the AS Product Line and several related promotional giveaway items that will depict the Endorser\\'s name and likeness solely in conjunction with the MusclePharm logo or images of the AS Product Line on the permitted promotional products (the \"Promotional Products\") set forth on Exhibit A attached hereto, as may be amended in writing by the parties hereto from time to time (collectively, the Promotional Products and the AS Product Line are referred to as the \"Licensed Products\").   NOW, THEREFORE, in consideration of the mutual promises and agreements set forth below, the parties agree as follows:\\n\\n\\n\\nSource: MUSCLEPHARM CORP, 10-K/A, 2/8/2017\\n\\n\\n\\n\\n\\n\\n\\n  1. Term:   (a) This Agreement shall have an Initial Term of three (3) years. The Term shall commence on July 23, 2013 and shall expire on July 22, 2016, unless otherwise terminated earlier pursuant to Section 9 of this Agreement. The period from July 23, 2013 to July 22, 2014 shall be referred to as the \"First Contract Year\". The period from July 23, 2014 to July 22, 2015 shall be referred to as the \"Second Contract Year\". The period from July 23, 2015 to July 22, 2016 shall be referred to as the \"Third Contract Year\".   (b) In the event that MusclePharm shall achieve Net Sales (as defined below) of $20 million (the \"First Renewal Threshold\") in the aggregate during the Third Contract Year, then this Agreement shall automatically be renewed for an additional term of three (3) years (the \"First Additional Term\") on the same terms and conditions for the Initial Term except that: (i) no additional Stock Compensation (as defined below) shall be issued in connection with the renewal Term, (ii) the Cash Compensation for the First Additional Term shall be as set forth in Section 7 and Exhibit \"C\" Section (2) attached hereto, (iii) Endorser shall only be obligated to make two (2) Appearances in each Contract Year during the First Additional Term pursuant to Section 4(a)(ii) below and (iv) the marketing budget to promote the Licensed Products shall be $5.0 million during each Contract Ye',\n",
              "    'Highlight the parts (if any) of this contract related to \"Document Name\" that should be reviewed by a lawyer. Details: The name of the contract',\n",
              "    'ENDORSEMENT LICENSING AND CO-BRANDING AGREEMENT',\n",
              "    55,\n",
              "    102),\n",
              "   ('Exhibit 10.12 Certain identified information has been excluded because it is both not material and would likely cause competitive harm if publicly disclosed.\\n\\nMaster Service Agreement This Master Service Agreement (\"Agreement\"), entered into on May 25th, 2018 by and between CRO Consulting (Pty) Limited, whose Registered Office is at OnQ House 250 Market Street Fairland Johannesburg 2170 South Africa (hereinafter referred to as \"CRO\") and Purinix Pharmaceuticals LLC whose Registered Office is at 1266 East Main Street, Suite 700R, Stamford, CT 06902, USA (hereinafter referred to as \"Client\"). 1.0 Services 1.1. Client requires CRO to carry out Clinical Research Services in South Africa (\"Services\"). CRO will carry out the tasks agreed and summarised in the Addenda to this Master Service Agreement. 1.2. This Agreement forms the basis for a working relationship between Client and CRO. This Agreement will be supplemented, in the form of Project-specific Addenda, as the need arises. The Project-specific Addenda will contain the detailed requirements of each Project for which Services are contracted to CRO by Client and all fees to be paid by Client. 1.3. Client will provide CRO with the documents and information necessary as requested by CRO for the conduct of the Services. 1.4. CRO agrees to perform the specific tasks set forth in the Project-specific Addenda in a professional manner, in strict accordance with the terms and conditions contained herein, relevant professional standards including in accordance with the Protocol and applicable amendments and ICH GCP Guidelines (ICH Harmonised Tripartite Guideline for Good Clinical Practice, May 1996) and all other relevant laws, rules, regulations and guidelines. 1.5. CRO agrees to perform these Services according to CRO\\'s Standard Operating Procedures (SOPs) or other guidelines as provided, which are provided to Client on request. 1.6 CRO may not subcontract any parts of the Services to a third party without the prior written approval of Client, which approval shall not unreasonably be withheld. CRO will remain fully liable for the acts and omissions of its employees and approved subcontractors as if performed by CRO. 1.7 CRO will provide Client with a weekly written report summarizing the Services including all clinical study activity and any other information reasonably requested by Client. 2.0 Payment 2.1 Client will pay CRO for satisfactory performance of Services as agreed in each Project-specific Addendum to this Agreement. Confidential Page 1 of 7 Initials: CL MD Version Jan16_v1\\n\\n\\n\\n\\n\\nCertain identified information has been excluded because it is both not material and would likely cause competitive harm if publicly disclosed. 2.2 Routine telephone calls, mobile calls, faxes and photocopying will be included in the rate provided by CRO. For clarity, there shall be no payment obligations other than as agreed in each Project-specific Addendum. 2.4 CRO will provide a detailed account of all time and tasks, as against project specific task and time addenda, and will be payable within 30 days of receipt of invoice by Client. 2.5. Changes in scope may be incorporated into this Agreement or the Project-specific Addenda upon the written consent of both parties. 2.6. In the event of a conflict between the terms of this Agreement and the Project-specific Addenda the terms of this Agreement shall prevail unless specifically stated in the Project-specific Addenda. 3.0 Period of the Agreement 3.1. This Agreement shall take effect on the date of signature of the Agreement by both parties and shall terminate when all obligations required of both parties hereunder are performed unless either terminated earlier or extended by the parties pursuant to the terms of this Agreement subject to clause 4.0. 4.0 Termination 4.1. Either party may terminate this Agreement on thirty (30) days written notice if the other materially breaches this Agreement; provided, however that the party in breach shall have the right to cure such breach within thirty (30) days after receipt of written notice of the ot',\n",
              "    'Highlight the parts (if any) of this contract related to \"Document Name\" that should be reviewed by a lawyer. Details: The name of the contract',\n",
              "    'Master Service Agreement',\n",
              "    189,\n",
              "    213),\n",
              "   ('Exhibit 10.4 CONSULTING AGREEMENT This Consulting Agreement (\"Agreement\") is made and entered into as of May 1, 2019 (\"Effective Date\") by and between Driven Deliveries, Inc. (\"Company\"), a Nevada corporation, and TruckThat LLC (\"Consultant\"). Company and Consultant shall sometimes be referred to herein singularly as a \"Party\" or collectively as the \"Parties\" to this Agreement. WHEREAS, the Company desires to retain Consultant as an independent contractor to perform consulting services for the Company, and Consultant is willing to perform such services on the terms set forth below. In consideration of the mutual promises contained here, the Parties hereby agree as follows: 1. Services and Compensation. 1.1. Services. Consultant shall perform the following services: - The Consultant will provide the Company services as a Strategic Marketing & Fundraising Consultant. - The Consultant shall be responsible for the strategic planning of business expansion, including Fundraising and Stock Promotion, of the Company and its subsidiaries. - These Services shall include Marketing guidance and support, not limited to: โ Graphics โ Web โ Social โ Brand - These Services will include updates to investor decks, customer sales decks and other marketing material available to the public - The Company will provide the Consultant with the appropriate level of resources and information to perform such duties, and the Consultant shall be reimbursed for fees and expenses approved by the Company. - The Consultant will report directly to the CEO of the and will keep the CEO informed of all matters concerning the Services as requested by the CEO from time to time. - The Consultant acknowledges that he may be required to travel in order to provide the Services. 1.2 Compensation. The Company shall pay Consultant a flat fee consulting rate of $18,000 per month. 1.3 Expenses. The Company shall reimburse Consultant, in accordance with Company policy, for all reasonable expenses incurred by Consultant in performing the Services pursuant to this Agreement, but only if Consultant receives written consent from an authorized agent of the Company prior to incurring such expenses and submits receipts for such expenses to the Company in accordance with the Company\\'s general expense reimbursement policies.\\n\\nTruckThat LLC Consulting Agreement Page 1 of 7\\n\\n\\n\\n\\n\\n2. Confidentiality. 2.1. Definition of Confidential Information. \"Confidential Information\" means any nonpublic information that relates to the actual or anticipated business and/or products, research or development of the Company, its affiliates or subsidiaries, or to the Company\\'s, its affiliates\\' or subsidiaries\\' technical data, trade secrets, or know-how, including, but not limited to, research, product plans, or other information regarding the Company\\'s, its affiliates\\' or subsidiaries\\' products or services and markets therefore, customer lists and customers (including, but not limited to, customers of the Company on whom Consultant called or with whom Consultant became acquainted during the term of this Agreement), software, developments, inventions, processes, formulas, technology, designs, drawings, engineering, hardware configuration information, marketing, finances, and other business information disclosed by the Company, its affiliates or subsidiaries, either directly or indirectly, in writing, orally or by drawings or inspection of premises, parts, equipment, or other property of Company, its affiliates or subsidiaries. Notwithstanding the foregoing, Confidential Information shall not include any such information which Consultant can establish (i) was publicly known or made generally available prior to the time of disclosure to Consultant; (ii) becomes publicly known or made generally available after disclosure to Consultant through no wrongful action or inaction of Consultant; or (iii) is in the rightful possession of Consultant, without confidentiality obligations, at the time of disclosure as shown by Consultant\\'s then-contemporaneous written records. 2.2. Nonuse and Nondisclosure. During an',\n",
              "    'Highlight the parts (if any) of this contract related to \"Document Name\" that should be reviewed by a lawyer. Details: The name of the contract',\n",
              "    'Consulting Agreement',\n",
              "    2323,\n",
              "    2343),\n",
              "   ('EXHIBIT 10.15\\n\\n                      SPONSORSHIP AND DEVELOPMENT AGREEMENT\\n\\n      This Agreement is made as of August 6, 2004 (the \"Effective Date\") by and between TEKNIK DIGITAL ARTS INC., a Nevada corporation with offices at 7377 E. Doubletree Ranch Road, Suite 270, Scottsdale, Arizona 85258 (\"TDA\") and RICK SMITH ENTERPRISES (\"Smith\"), c/o GAYLORD SPORTS MANAGEMENT, 14646 N. Kierland Blvd., Suite 230, Scottsdale, Arizona 85254 Attention: Steve Loy.\\n\\n                                    RECITALS\\n\\n      TDA is in the business of developing and publishing interactive entertainment software products. TDA desires to have Smith assist in the development, endorsement and publicizing of TDA\\'s golf instruction related software products.\\n\\n      THEREFORE, TDA and Smith agree as follows:\\n\\n1.    DEVELOPMENT, PRODUCTION, COMMERCIAL AND PUBLICITY SERVICES\\n\\n      1.1 General. Smith agrees to cooperate, consult with and aid TDA in connection with the development of TDA\\'s \"Golf Instruction Related Product\" (hereinafter defined) and the advertising, marketing and publicity thereof. As used herein, the term \"Golf Instruction Related Product\" shall mean any interactive entertainment software product related to golf instruction which is produced and released during the \"Term\" (hereinafter defined in Section 5.1) and which may be published in multiple versions (e.g., versions for play on handheld mobile devices (including cell phones), for sale in any and all territories.\\n\\n2.    GRANT OF RIGHTS; COOPERATIONS\\n\\n      2.1 Publicity Rights. Smith hereby grants to TDA the following rights (the \"Rights\"):\\n\\n            (a) the right to use and reuse Smith\\'s name, voice, likeness,       facsimile signature, personal statistics, biographical information and any       reproduction or simulation thereof (\"Smith\\'s Likeness\") in TDA\\'s Golf       Instruction Related Products and on packaging for TDA\\'s Golf Instruction       Related Products in any fashion, said grant of rights being limited to the       world (the \"Contract Territory\")\";\\n\\n            (b) the right to use and reuse Smith\\'s Likeness in TDA\\'s general       internal, non-public corporate promotional materials (such as TDA\\'s Annual       Report), corporate advertising and in other forms of publicity;\\n\\n            (c) the right to use and reuse Smith\\'s Likeness in and in connection       with the marketing, advertising, promoting and publicizing of TDA\\'s Golf       Instruction Related Products, by any and all means now known or hereafter       developed;\\n\\n            (d) the exclusive right to use and reuse the results and proceeds of       the in connection with TDA\\'s Golf Instruction Related Products; and\\n\\n            (e) with Smith\\'s prior reasonable approval, the right to license to       third parties any of the foregoing rights but only in connection with or       directly related to the marketing and sale of TDA\\'s Golf Instruction       Related Products.\\n\\nSmith agrees to cooperate in good faith with TDA in connection with TDA\\'s exercise of the Rights in accordance with the terms of this Agreement.\\n\\n      2.2 Limitations of License\\n\\n            (a) The Rights granted in Section 2.1 above will only be used by TDA       in connection with its Golf Instruction Related Products. TDA does not       have the right to use the Rights in any product whatsoever released before       or after the Term.\\n\\n            (b) TDA shall not utilize Smith\\'s Likeness in a manner that would       constitute an endorsement of any product or service other than TDA\\'s Golf       Instruction Related Products.\\n\\n                                       1\\n\\n      2.3 Smith as Featured Swing Instructor. TDA agrees that Smith will be the featured Instructor on all packaging of, and promotional materials related to, TDA\\'s Golf Instruction Related Product.\\n\\n      2.4 No Obligation to Use. Except as set forth in Section 2.3 above, the payment to Smith of the sums required under this Agreement shall fully discharge all obligations of TDA to use Smith\\'s Likeness under this Agreement.\\n\\n      2.5 Approvals. TDA agrees that no us',\n",
              "    'Highlight the parts (if any) of this contract related to \"Document Name\" that should be reviewed by a lawyer. Details: The name of the contract',\n",
              "    'SPONSORSHIP AND DEVELOPMENT AGREEMENT',\n",
              "    37,\n",
              "    74),\n",
              "   ('Exhibit 10.1\\n\\n[*****] Text omitted for confidential treatment. The redacted information has been excluded because it is both (i) not material and (ii) would be competitively harmful if publicly disclosed.\\n\\nGLOBAL MASTER SUPPLY AGREEMENT\\n\\nThis Global Master Supply Agreement (\"Agreement\" or \"Contract\") is between ExxonMobil Chemical Company, a division of Exxon Mobil Corporation (\"Seller\"),on behalf of itself and in the interest of the ExxonMobil affiliates listed on Attachment B (each an \"ExxonMobil Selling Affiliate\" or \"EMCC/A\" or collectively, \"ExxonMobil Selling Affiliates\"), and West Pharmaceutical Services, Inc. (\"Buyer\"), on behalf of itself and the Buyer affiliates listed on Attachment C (each a \"Buyer Affiliate\" or \"West/A\" or collectively, \"Buyer Affiliates\").\\n\\nPRODUCTS, QUANTITY, PRICE\\n\\nIn accordance with the provisions of this Agreement, ExxonMobil Selling Affiliates agree to sell to Buyer Affiliates, and Buyer Affiliates agree to purchase from ExxonMobil Selling Affiliates, the following product(s) (collectively, \"Product\"):\\n\\nProducts Quantity [Metric Tons / Year] Container PackageYear 2019 2020 2021 2022 2023 [*****] [*****] Minimum Maximum [*****] [*****] [*****] [*****] [*****] [*****] [*****] [*****] [*****] [*****] Leased metal crates\\n\\n[*****] [*****] [*****] [*****] [*****] [*****] Leased metal crates [*****] not defined Leased metal crates\\n\\nSubject to this Agreement\\'s terms and conditions, Buyer Affiliates shall purchase and ExxonMobil Selling Affiliates shall sell the yearly minimum amount of Product amounts (in the aggregate) listed above. Buyer or Buyer Affiliates may request to purchase amounts over the Product maximum amounts per year, however, it shall be solely within Seller or any ExxonMobil Selling Affiliate\\'s discretion whether and under which conditions to accommodate Buyer\\'s request.\\n\\nBuyer Affiliates shall issue a purchase order(s), or call off order(s) when purchasing Product from ExxonMobil Selling Affiliates in writing pursuant to this Contract (\"Purchase Order\"). Such Purchase Order(s) shall specify (a) the quantity of Product, and (b) general date of delivery. All Purchase Orders agreed to be filled by an ExxonMobil Selling affiliate shall be deemed to be a separate agreement between the relevant ExxonMobil Selling Affiliate and the relevant Buyer Affiliate, incorporating the terms of this Contract. Notwithstanding anything to the contrary in the attachments ExxonMobil and the ExxonMobil Selling Affiliates shall not unreasonably reject any Purchase Order that otherwise complies with the terms of this Agreement.\\n\\nPurchase Order(s), order acknowledgements and similar form documents evidencing the purchase or sale of Products, including any terms and conditions contained or referenced therein, shall not supersede, add to or amend in any way this Contract. In the event of any conflict between the terms of this Contract and the terms of any Purchase Order, order acknowledgement or similar document the terms of this Contract shall prevail.\\n\\n[*****]\\n\\nPRICING\\n\\nFor calendar years 2019, 2020, 2021, 2022 and 2023, the price of Products sold by Seller/ExxonMobil Selling Affiliates to Buyer/Buyer Affiliates will comprise the Base Price, the crude adjustment and the freight cost depending on Incoterms.\\n\\nSource: WEST PHARMACEUTICAL SERVICES INC, 8-K, 1/16/2020\\n\\n\\n\\n\\n\\nBase price\\n\\nRequested delivery date 1.1.2019 - 28.2.2019: All [*****] grades except [*****]: [*****] $/t [*****]: [*****] $/t [*****]: [*****] $/t\\n\\n1.3.2019 - 31.12.2019: All [*****] grades except [*****]: [*****] $/t [*****]: [*****] $/t [*****]: [*****] $/t\\n\\n1.1.2020 - 31.12.2020: All [*****] grades except [*****]: [*****] $/t [*****]: [*****] $/t [*****]: [*****] $/t\\n\\n1.1.2021 - 31.12.2021: All [*****] grades except [*****]: [*****] $/t [*****]: [*****] $/t [*****]: [*****] $/t\\n\\n1.1.2022 - 31.12.2022: All [*****] grades except [*****]: [*****] $/t [*****]: [*****] $/t [*****]: [*****] $/t\\n\\n1.1.2023 - 31.12.2023: All [*****] grades except [*****]: [*****] $/t [*****]: [*****] $/t [*****]: [*****] $/t\\n\\n[*****]\\n\\nBase prices listed above a',\n",
              "    'Highlight the parts (if any) of this contract related to \"Document Name\" that should be reviewed by a lawyer. Details: The name of the contract',\n",
              "    'GLOBAL MASTER SUPPLY AGREEMENT',\n",
              "    206,\n",
              "    236),\n",
              "   ('CELEBRITY ENDORSEMENT AGREEMENT     THIS AGREEMENT is made as of this March 14, 2012 but effective as of March 1, 2012 (\"Effective Date\") by and between Bizzingo, Inc., a Nevada  corporation with offices at 63 Main Street, Suite 202, Flemington, NJ 08822 (\"Bizzingo\") and Joseph Theismann, an individual whose address is 21495  Ridgetop Circle, Suite 304A, Sterling Virginia 20166 (\"Theismann\") (collectively the \"Parties\").     WITNESSETH:     WHEREAS, Theismann is recognized and widely known throughout the world as a retired, hall of fame professional athlete, and sports celebrity; and     WHEREAS, Theismann\\'s name, by virtue of his ability and experience, has acquired a meaning in the mind of the purchasing public important to the  advertising, promotion, and sale of services and merchandise; and     WHEREAS, Bizzingo has developed a B2B interactive platform which engages in business social media including mobile and Internet applications  (\"Network\"); and     WHEREAS, Bizzingo is desirous of acquiring the rights to utilize Theismann\\'s name in connection with the advertisement, promotion, and sale of the  Network as provided herein and Theismann is willing to grant such right     NOW, THEREFORE, in consideration of the mutual covenants set forth herein and for other good and valuable consideration, it is agreed as  follows:     1. GRANT OF RIGHTS. Subject to the terms and conditions set forth herein, Theismann hereby grants to Bizzingo and its affiliates the unlimited  right and privilege during the Term (as defined herein) and within the Territory to use the Property (as defined herein) in connection with the  advertisement, promotion, and sale of the Network in the Territory whether through film, television, radio, print and Internet media, including the right to use  the Property in or on the Network. It being understood and agreed that Bizzingo shall have the right to exhibit commercials, infomercials, advertisements and  otherwise make use of all Property on a worldwide basis and that Bizzingo and its affiliates shall be the sole owner of all commercials, promotional materials and  other items produced or created hereunder and all related rights worldwide, including, without limitation, copyright, trademark and intellectual property rights,  subject however to the terms and conditions herein. Theismann agrees to cooperate with Bizzzingo\\'s promotional efforts in this regard. In addition, as  reasonably requested by Bizzingo, Theismann agrees to provide Bizzingo with such signatures, photographs and the like in order to fulfill his obligations  hereunder.\\n\\n1\\n\\nSource: BIZZINGO, INC., 8-K, 3/22/2012\\n\\n\\n\\n\\n\\n   Bizzingo agrees that any use of the Property for advertising, promotional or sale purposes will be approved in advance by Theismann. Theismann  agrees that such material, submitted for approval as provided herein may be deemed by Bizzingo to have been approved hereunder if the same is  not disapproved by the Theismann in writing within fourteen (14) days after Theismann\\'s receipt thereof. Theismann agrees that any material  submitted hereunder will not be unreasonably disapproved and, if it is disapproved, that Theismann shall advise Bizzingo in writing of the specific  grounds therefor at the time of disapproval and provide Bizzingo with specific changes or alterations to such materials. Bizzingo thereafter shall  have the right and privileged to use such Property as provided in this Agreement subject to such changes or alterations.     Except as stated herein, no other rights or privileges are granted to Bizzingo by Theismann.     \"Property\" as stated herein shall mean Theismann\\'s name (including \"Joe Theismann\", \"Theismann\" \"J. Theismann\"), nicknames, initials,  autograph, facsimile signature, photograph, image, likeness, voice, video portrayals, biographical data, character, symbols, and/or other  endorsement, and any variations or deviations thereof.     \"Territory\" as stated herein shall mean worldwide.     2. TERM. Unless sooner terminated under the provisions hereof, this Agreement shall commence on the Effect',\n",
              "    'Highlight the parts (if any) of this contract related to \"Document Name\" that should be reviewed by a lawyer. Details: The name of the contract',\n",
              "    'CELEBRITY ENDORSEMENT AGREEMENT',\n",
              "    0,\n",
              "    31),\n",
              "   (\"EXHIBIT D JOINT FILING AGREEMENT MFA FINANCIAL, INC. In accordance with Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended, the undersigned hereby confirm the agreement by and among them to the joint filing on behalf of them of the Statement on Schedule 13D and any and all further amendments thereto, with respect to the securities of the above referenced issuer, and that this Agreement be included as an Exhibit to such filing. This Agreement may be executed in any number of counterparts each of which shall be deemed to be an original and all of which together shall be deemed to constitute one and the same Agreement. IN WITNESS WHEREOF, the undersigned hereby execute this Agreement as of July 6, 2020. ATHENE ANNUITY AND LIFE COMPANY By: Apollo Insurance Solutions Group LP, its investment adviser By: AISG GP Ltd., its general partner By: /s/ Matthew S. O'Mara Matthew S. O'Mara Authorized Signatory ATHENE ANNUITY & LIFE ASSURANCE COMPANY By: Apollo Insurance Solutions Group LP, its investment adviser By: AISG GP Ltd., its general partner By: /s/ Matthew S. O'Mara Matthew S. O'Mara Authorized Signatory ATHENE USA CORPORATION By: Apollo Insurance Solutions Group LP, its investment adviser By: AISG GP Ltd., its general partner By: /s/ Matthew S. O'Mara Matthew S. O'Mara Authorized Signatory\\n\\n\\n\\n\\n\\nATHENE LIFE RE LTD. By: Apollo Insurance Solutions Group LP, its investment adviser By: AISG GP Ltd., its general partner By: /s/ Matthew S. O'Mara Matthew S. O'Mara Authorized Signatory ATHENE HOLDING LTD. By: Apollo Insurance Solutions Group LP, its investment adviser By: AISG GP Ltd., its general partner By: /s/ Matthew S. O'Mara Matthew S. O'Mara Authorized Signatory APOLLO INSURANCE SOLUTIONS GROUP LP By: AISG GP Ltd., its general partner By: /s/ Matthew S. O'Mara Matthew S. O'Mara Authorized Signatory AISG GP LTD. By: /s/ Matthew S. O'Mara Matthew S. O'Mara Authorized Signatory APOLLO LIFE ASSET, L.P. By: Apollo Life Asset GP, LLC, its general partner By: /s/ William B. Kuesel William B. Kuesel Vice President\\n\\n\\n\\n\\n\\nAPOLLO LIFE ASSET GP, LLC By: /s/ William B. Kuesel William B. Kuesel Vice President APOLLO CAPITAL MANAGEMENT, L.P. By: Apollo Capital Management GP, LLC, its general partner By: /s/ William B. Kuesel William B. Kuesel Vice President APOLLO CAPITAL MANAGEMENT GP, LLC By: /s/ William B. Kuesel William B. Kuesel Vice President APOLLO MANAGEMENT HOLDINGS, L.P. By: Apollo Management Holdings GP, LLC, its general partner By: /s/ William B. Kuesel William B. Kuesel Vice President APOLLO MANAGEMENT HOLDINGS GP, LLC By: /s/ William B. Kuesel William B. Kuesel Vice President OMAHA EQUITY AGGREGATOR, L.P. By: AP Omaha Advisors, LLC, its general partner By: Apollo Hybrid Value Advisors, L.P., its sole member By: Apollo Hybrid Value Capital Management, LLC, its general partner By: /s/ Joseph D. Glatt Joseph D. Glatt Vice President\\n\\n\\n\\n\\n\\nAP OMAHA ADVISORS, LLC By: Apollo Hybrid Value Advisors, L.P., its sole member By: Apollo Hybrid Value Capital Management, LLC, its general partner By: /s/ Joseph D. Glatt Joseph D. Glatt Vice President APOLLO HYBRID VALUE ADVISORS, L.P. By: Apollo Hybrid Value Capital Management, LLC, its general partner By: /s/ Joseph D. Glatt Joseph D. Glatt Vice President APOLLO HYBRID VALUE CAPITAL MANAGEMENT, LLC By: /s/ Joseph D. Glatt Joseph D. Glatt Vice President APH HOLDINGS, L.P. By: Apollo Principal Holdings III GP, Ltd., its general partner By: /s/ William B. Kuesel William B. Kuesel Vice President APOLLO PRINCIPAL HOLDINGS III GP, LTD. By: /s/ William B. Kuesel William B. Kuesel Vice President\",\n",
              "    'Highlight the parts (if any) of this contract related to \"Document Name\" that should be reviewed by a lawyer. Details: The name of the contract',\n",
              "    'JOINT FILING AGREEMENT',\n",
              "    10,\n",
              "    32),\n",
              "   ('Exhibit 4.5 SUPPLY AGREEMENT between PROFOUND MEDICAL INC. and PHILIPS MEDICAL SYSTEMS NEDERLAND B.V.\\n\\n\\n\\n\\n\\nTHIS AGREEMENT is made July 31, 2017 BETWEEN: PROFOUND MEDICAL INC., a company incorporated under the laws of the province of Ontario and having its registered address at 2400 Skymark, Unit 6, Mississauga, Ontario L4W 5K5, Canada (hereinafter referred to as \"Customer\") - and - PHILIPS MEDICAL SYSTEMS NEDERLAND B.V., a company incorporated under the laws of the Netherlands with its principal place of business at Veenpluis 4-6 5684 PC Best, the Netherlands (hereinafter referred to as \"Philips\") Customer and Philips hereinafter also collectively referred to as the \"Parties\" and individually as a \"Party\". WHEREAS: A. Pursuant to the Asset and Share Purchase Agreement (the \"Purchase Agreement\") entered into on June 30, 2017 by Customer, Koninklijke Philips NV (\"Philips NV\") N.V. and Customer agreed to execute and deliver (or cause to be executed and delivered) certain ancillary agreements one of which is this Agreement; B. Prior to the consummation of the transactions contemplated by the Purchase Agreement, Philips manufactured the Product in-house and did not outsource the manufacturing to an independent facility, and as a result, Philips has intimate knowledge of the manufacturing process and requirements for the Product; C. Customer originally desired to take over responsibility for the manufacture of the Product immediately upon closing of the transactions contemplated by the Purchase Agreement; D. As Philips historically manufactured the Product in-house, to enable Customer to prepare for and realize the transition of the manufacturing of the Product to Customer\\'s organization, Customer requires the assistance of Philips to continue manufacturing the Product until such time as the manufacturing process can be transitioned to Customer hereunder; E. Until such time as the manufacturing of the Product can be transitioned to Customer in accordance with the terms of this Agreement, Philips agrees to supply, as a contract manufacturer to Customer, on a temporary basis for the Term (as defined herein), the Product, and Customer wishes to buy such Products from Philips under this Agreement;\\n\\n\\n\\n\\n\\nF. Customer acknowledges and agrees that it assumes all obligations and liabilities as the legal manufacturer of the Product as from the Effective Date, on the terms and conditions set out in this Agreement. NOW IT IS HEREBY AGREED as follows: 1. DEFINITIONS The following terms used in this Agreement shall have the meaning set forth below: \"Affiliate\" means, with respect to any Person, any other Person that directly, or indirectly through one or more intermediaries, controls, is controlled by or is under common control with the specified Person. As used in this definition, \"control\", \"controlled by\" and \"under common control with\" means possession, directly or indirectly, of power to direct or cause the direction of management or policies of such Person (whether through ownership of securities or other partnership or ownership interests, as trustee, personal representative or executive or by contract, credit agreement or otherwise), provided that in any event, any Person which owns directly, indirectly or beneficially 50% or more of the securities having voting power for the election of directors or other governing body of a corporation or 50% or more of the partnership interests or other ownership interests of any other Person will be deemed to control such Person. \"Agreement\" means this Supply Agreement including any and all of its Schedules as attached hereto and as may be amended or supplemented from time to time in accordance with the provisions hereof. \"Business Day\" means any day other than a Saturday, Sunday or statutory holiday, in the Province of Ontario or the Netherlands. \"Claim\" means any claim, action, cause of action, demand, lawsuit, arbitration, inquiry, audit, notice of violation, proceeding, litigation, citation, summons, subpoena or investigation of any nature, civil, criminal, administrative, regulatory or other',\n",
              "    'Highlight the parts (if any) of this contract related to \"Document Name\" that should be reviewed by a lawyer. Details: The name of the contract',\n",
              "    'SUPPLY AGREEMENT',\n",
              "    12,\n",
              "    28),\n",
              "   ('OUTSOURCING AGREEMENT\\n\\nBY AND BETWEEN\\n\\nTRI CITY NATIONAL BANK\\n\\nand\\n\\nMARSHALL & ILSLEY CORPORATION acting through its division M&I DATA SERVICES\\n\\nDATED AS OF\\n\\nFebruary 16, 1998\\n\\nTABLE OF CONTENTS\\n\\nPage 1. DEFINITIONS  1.1 Background  1.2 Definitions      1.3 References  1.4 Interpretation   2. TERM    2.1 Initial Term     2.2 Extensions  3. APPOINTMENT  3.1 Performance by M&I Affiliates   3.2 Third Party Services  3.3 Proper Instructions   4. CONVERSION   4.1 Banking Applications  4.2 Development of Conversion Plan  4.3 Conversion Resources  4.4 Conversion Milestones      5. OUTSOURCING OF TRUST SERVICES    6. BANKING APPLICATIONS   6.1 Services to be Rendered    6.2 Banking Application Processing  6.3 Corporate Support Services      6.4 Item Processing Services   6.5 Automated Clearing House Services    6.6 Home Banking and Internet Services   6.7 Retail Delivery Systems    6.8 Visa Check/MasterMoney Card Services      6.9 EFT Services     7. FACILITIES MANAGEMENT  8. FEES    8.1 Fee Structure    8.2 Conversion  8.3 Pricing and Operational Assumptions  8.4 Banking Applications Services   8.5 Corporate Support Services      8.6 Item Processing Services   8.7 Management Services   8.8 Visa Check/MasterMoney Card Services      8.9 EFT Services     8.10 Training and Education    8.11 Excluded Costs  8.12 Disputed Amounts     8.13 Terms of Payment     8.14 Modification of Terms and Pricing   9. PERFORMANCE STANDARDS  9.1 General     9.2 Banking Applications  10. MODIFICATION OR TERMINATION OF SERVICES   10.1 Modifications to Services      10.2 Partial Termination by M&I     10.3 Partial Termination by Customer     10.4 Development of Custom Software\\n\\n\\n\\n\\n\\n11. TERMINATION      11.1 For Convenience      11.2 For Cause  11.3 Following Change in Control of Customer  11.4 Termination Assistance    12. EVENTS OF DEFAULT; REMEDIES     12.1 By M&I     12.2 By Customer     12.3 Remedies   13. DAMAGES     13.1 Direct Damages  13.2 No Consequential Damages  13.3 Equitable Relief     13.4 Limitation of Liability   13.5 Liquidated Damages   14. INSURANCE AND INDEMNITY    14.1 Insurance  14.2 Indemnity  14.3 Indemnification Procedures     15. DISPUTE RESOLUTION    15.1 Representatives of Parties     15.2 Continuity of Performance      16. REPRESENTATIONS AND WARRANTIES  16.1 By M&I     16.2 By Customer     17. CONFIDENTIALITY AND OWNERSHIP   17.1 Customer Data   17.2 M&I Systems     17.3 Confidential Information  17.4 Obligations of the Parties     17.5 Security   18. MANAGEMENT OF PROJECT      18.1 Account Representatives   18.2 Change Control Procedures      18.3 Reporting and Meetings    18.4 Development Projects and Technical Support    19. REGULATORY COMPLIANCE      20. DISASTER RECOVERY     20.1 Disaster Recovery Plan    20.2 Relocation      20.3 Resumption of Services    20.4 Annual Test     21. GENERAL TERMS AND CONDITIONS    21.1 Force Majeure   21.2 Transmission of Data      21.3 Equipment and Network     21.4 Reliance on Data     21.5 Data Backup     21.6 Balancing and Controls    21.7 Use of Services      21.8 Regulatory Assurances     21.9 IRS Filing      21.10 Affiliates     21.11 Future Acquisitions      22. MISCELLANEOUS PROVISIONS   22.1 Governing Law   22.2 Venue and Jurisdiction    22.3 Entire Agreement; Amendments   22.4 Assignment      22.5 Relationship of Parties   22.6 Notices    22.7 Headings   22.8 Counterparts    22.9 Waiver     22.10 Severability   22.11 Attorneys\\' Fees and Costs     22.12 Financial Statements     22.13 Publicity      22.14 Solicitation   22.15 No Third Party Beneficiaries  22.16 Construction   23. SOURCE CODE      23.1 Escrow     23.2 Copy of Source Code  23.3 Cost of Escrow  23.4 Customer\\'s Right to Obtain the Source Code    23.5 Use of Source Code\\n\\nSchedules\\n\\n4.2  Conversion Plan 6.2  Banking Application Services 8.1  Fee Schedule\\n\\nExhibits\\n\\nA    RDS Agreement B    ACH Authorization Agreement C    Attorney-in-Fact Appointment D    Affidavit\\n\\nOUTSOURCING AGREEMENT\\n\\n\\n\\n\\n\\n     This Outsourcing Agreement (\"Agreement\") is made as of the 16th day of February, 1998, by and between Tri City National Ban',\n",
              "    'Highlight the parts (if any) of this contract related to \"Document Name\" that should be reviewed by a lawyer. Details: The name of the contract',\n",
              "    'Outsourcing Agreement',\n",
              "    3978,\n",
              "    3999),\n",
              "   ('Exhibit 10.16\\n\\nEL POLLO LOCOยฎ FRANCHISE DEVELOPMENT AGREEMENT\\n\\nDated: ____________________\\n\\nTerritory: Developer:\\n\\n(Disclosure Document Control No. 032619)\\n\\nTABLE OF CONTENTS 1.DEVELOPMENT RIGHTS IN TERRITORY. 4 2.LIMITATION ON DEVELOPMENT RIGHTS. 5 3.DEVELOPMENT FEE. 9 4.TERM OF DEVELOPMENT AGREEMENT. 10 5.TERRITORY CONFLICTS. 10 6.PROPRIETARY RIGHTS OF EL POLLO LOCO. 11 7.INSURANCE AND INDEMNIFICATION. 11 8.TRANSFER OF RIGHTS. 13 9.ACKNOWLEDGMENT OF SELECTED TERMS AND PROVISIONS OF THE FRANCHISE AGREEMENT. 14 10.TERMINATION BY DEVELOPER; EXPIRATION DATE. 14 11.EVENTS OF DEFAULT. 15 12.EFFECT OF TERMINATION. 16 13.NON-WAIVER. 17 14.INDEPENDENT CONTRACTOR AND INDEMNIFICATION. 17 15.ENTIRE AGREEMENT. 17 16.DISPUTE RESOLUTION 18 17.SEVERABILITY. 19 18.APPLICABLE LAW; CHOICE OF FORUM; WAIVER OF JURY TRIAL. 19 19.DOCUMENT INTERPRETATION. 19 20.COVENANT NOT TO COMPETE. 20 21.NOTICES. 21 22.SECTION HEADINGS. 21 23.ACKNOWLEDGMENTS. 21 24.COUNTERPARTS. 22 Source: EL POLLO LOCO HOLDINGS, INC., 10-K, 3/6/2020\\n\\n\\n\\n\\n\\nEXHIBITS EXHIBIT \"A\" TO DEVELOPMENT AGREEMENT - TERRITORY23 EXHIBIT \"B\" TO DEVELOPMENT AGREEMENT - DEVELOPMENT SCHEDULE24 EXHIBIT \"C\" TO DEVELOPMENT AGREEMENT - EXISTING EL POLLO LOCOยฎ RESTAURANTS IN THE TERRITORY 25\\n\\nEL POLLO LOCOยฎ FRANCHISE DEVELOPMENT AGREEMENT (Non-exclusive/Exclusive)\\n\\nTHIS FRANCHISE DEVELOPMENT AGREEMENT (\"Agreement\") dated for identification purposes only as of _____________________, is made and entered into by and between EL POLLO LOCO, INC., a Delaware corporation, with its principal place of business at 3535 Harbor Blvd, Suite 100, Costa Mesa, California 92626 (referred to herein as \"El Pollo Loco\" or \"Franchisor\") and __________________an individual, with its principal place of business at _____________________________________ (\"Developer\").\\n\\nRecitals.\\n\\nA.Franchisor owns certain proprietary and other property rights and interests in and to the \"El Pollo Locoยฎ\" trademark and service mark, and such other trademarks, service marks, logo types, insignias, trade dress designs and commercial symbols as Franchisor may from time to time authorize or direct Developer to use in connection with the operation of a(n) \"El Pollo Locoยฎ\" restaurant (the \"El Pollo Locoยฎ Marks\"). Franchisor has a distinctive plan for the operation of retail outlets for the sale of fire-grilled food items and related products, which plan includes but is not limited to the El Pollo Locoยฎ Marks and the Operations Manual (the \"Manual\"), policies, standards, procedures, employee uniforms, signs, menu boards and related items, and the reputation and goodwill of the El Pollo Locoยฎ chain of restaurants (collectively, the \"El Pollo Locoยฎ System\").\\n\\nB.Developer represents that it is experienced in and has independent knowledge of the nature and specifics of the restaurant business. Developer represents that in entering into this Agreement it has relied solely on its personal knowledge and has not relied on any representations of Franchisor or any of its officers, directors, employees or agents, except those representations contained in any legally required Franchise Disclosure Document delivered to Developer.\\n\\nC.  Developer desires to obtain development rights for multiple restaurants under the El Pollo Locoยฎ System (each, an \"El Pollo Locoยฎ Restaurant\") from Franchisor within a specified geographical (the \"Territory\") specified in Exhibit \"A\" attached hereto and made a part hereof (or if single unit, replace with \"Developer desires to obtain development rights for a single restaurant under the El Pollo Locoยฎ System (each, an \"El Pollo Locoยฎ Restaurant\") from Franchisor within a specified address (the \"Territory\") specified in Exhibit \"A\" attached hereto and made a part hereof.\")\\n\\nD.Franchisor is willing to grant the (non-exclusive/exclusive) right to develop and open El Pollo Locoยฎ Restaurant(s) within the Territory referenced in Exhibit \"A.\"\\n\\nNOW, THEREFORE, in consideration of the mutual covenants and obligations herein contained, the parties hereto agree as follows:\\n\\n1.Development Rights in Territory.\\n\\n1.1. Franchisor hereby grants t',\n",
              "    'Highlight the parts (if any) of this contract related to \"Document Name\" that should be reviewed by a lawyer. Details: The name of the contract',\n",
              "    'FRANCHISE DEVELOPMENT AGREEMENT (Non-exclusive/Exclusive)',\n",
              "    1253,\n",
              "    1310),\n",
              "   ('EXHIBIT 10.13\\n\\n                             JOINT VENTURE AGREEMENT\\n\\nCollectible Concepts Group, Inc. (\"CCGI\") and Pivotal Self Service Tech, Inc. (\"PVSS\"), (the \"Parties\" or \"Joint Venturers\" if referred to collectively, or the \"Party\" or Joint Venturer\" if referred to singularly), by this Agreement associate themselves as business associates, and not as partners, in the formation of a joint venture (the \"Joint Venture\"), for the purpose of engaging generally in the business provided for by terms and provisions of this Agreement.\\n\\n1.   Name of the Joint Venture. The name of the Joint Venture will be MightyCell      Batteries, and may sometimes be referred to as \"MightyCell\" or the \"Joint      Venture\" in this Agreement. The principal office and place of business      shall be located in 1600 Lower State Road, Doylestown, PA 18901.\\n\\n2.   Scope of the Joint Venture Business. The Joint Venture is formed for the      purpose of engaging generally in the business of marketing batteries and      related products, (the \"Products\") that include the display of licensed      logos, images, brand names and other labels that differentiate them from      the branding (the \"PVSS Products\") under which PVSS and/or its affiliates,      sell to retailers and distributors in the normal course of their business.      Without in any way limiting the generality of the foregoing, the business      of the Joint Venture shall include:\\n\\n          (a)  The purchase of Products for resale;           (b)  The acquisition of a license(s) permitting the use of selected                images in the Products;           (c)  The sale and distribution of the Products to retailers and                distributors; and,           (d)  The transaction of such other and further business as is                necessary, advisable, or incidental to the business of the Joint                Venture.           (e)  Develop a global marketing program for licensed Products\\n\\n     Exhibit A attached hereto, describes by way of example but not limitation      the responsibilities of the Joint Venturers\\n\\n3.   Capital Contributions. Except as agreed upon by mutual consent, the Joint      Venturers shall not be required to make any capital contribution to the      Joint Venture.\\n\\n4.   Offices of the Joint Venture. The principal place of business of the Joint      Venture shall be at 1600 Lower State Road, in the City of Doylestown, Bucks      County, Pennsylvania, but may maintain such other offices as the Joint      Venturers may deem advisable at any other place or places within or without      the Commonwealth of Pennsylvania.\\n\\n5.   Powers and Authority of the Joint Venturers. The Joint Venturers shall have      full and complete charge of all affairs of the Joint Venture. The Joint      Venturers recognize that both of the Joint Venturers are and will continue      to be engaged in the conduct of their respective businesses for their own      account. Neither Joint Venturer shall be entitled to compensation for      services rendered to the Joint Venture as such, but each Joint Venturer      shall be reimbursed for all direct expenses, including travel, office, and      all other out-of-pocket expenses incurred in the operation of the affairs      of the Joint Venture and the promotion of its businesses.\\n\\n     It is agreed that either Joint Venturer shall, except as provided for      below, have authority to execute instruments of any character relating to      the affairs of the Joint Venture; provided, that without the written      consent or approval of both of the Joint Venturers: (i) the Joint Venture      shall incur no liability of any sort, nor any indebtedness for borrowed      funds; (ii) no assets owned in the name of the Joint Venture be disposed      of; and (iii) no commitment to purchase any item for the Joint Venture      shall be made.\\n\\n                                       39\\n\\n6.   Division of Income and Losses. All income and credits, and all losses and      deductions shall be owned and shared among the Joint Venturers as follows:\\n\\n     50% to Col',\n",
              "    'Highlight the parts (if any) of this contract related to \"Document Name\" that should be reviewed by a lawyer. Details: The name of the contract',\n",
              "    'JOINT VENTURE AGREEMENT',\n",
              "    44,\n",
              "    67),\n",
              "   ('Exhibit 10.1\\n\\nCERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY BRACKETED ASTERISKS [***], HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO RULE 24B-2 OF THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED. SUPPLY AGREEMENT\\n\\nTHIS SUPPLY AGREEMENT (\"Agreement\") is entered into as of this 15th day of May, 2013 (the \"Effective Date\") by and between Integra LifeSciences Corporation (\"Integra\"), a Delaware corporation with offices at 311 Enterprise Drive, Plainsboro, New Jersey 08536, and PcoMed, LLC (\"PcoMed\"), a Colorado limited liability company with offices at 105 S. Sunset Street, Longmont, Colorado 80501.\\n\\nRECITALS:\\n\\nWHEREAS, Integra is a medical device company that is developing and commercializing implantable spinal medical devices and procedures in the field of spinal surgery;\\n\\nWHEREAS, PcoMed has experience and expertise in the surface modification of medical device materials;\\n\\nWHEREAS, Integra desires to engage PcoMed to apply certain of its surface technologies onto Integra\\'s implantable spinal medical devices for preclinical, clinical and commercial use and distribution by Integra; and\\n\\nWHEREAS, PcoMed is willing to apply such surface technologies onto Integra\\'s implantable spinal medical devices and to grant Integra certain exclusive rights to use and commercialize those devices; and\\n\\nNOW, THEREFORE, in consideration of the mutual covenants and promises herein contained, the parties hereto agree as follows: 1. DEFINITIONS.\\n\\nAs used in this Agreement, the following initially capitalized terms, whether used in the singular or plural form, shall have the meanings set forth in this Section 1.\\n\\n1.1. \"Affiliate\" means any corporation, limited liability company, person or entity that directly or indirectly controls, is controlled by, or is under common control with, a party to this Agreement. For purposes of this Section 1.1, the term \"control\" (with a correlative meaning for \"controlled by\") means the possession, directly or indirectly, of the power to direct or cause the direction of the management and policies of the subject corporation, person or entity, whether through the ownership of voting securities, by contract or otherwise.\\n\\n1.2. \"*** Run\" means a single production run of PcoMed\\'s *** to apply the PcoMed Surface Modification Technology to Integra Products.\\n\\n1.3. \"*** Run Fee\" means the fee for a single *** Run. The *** Run Fee is exclusive of potential fees for any surface preparation requirements currently performed prior to PcoMed\\'s receipt of Integra Product.\\n\\n1.4. \"Confidential Disclosure Agreements\" means all Mutual Non-Disclosure Agreements previously or hereafter entered into by certain Integra Affiliates and PcoMed. 1 *** Portions of this page have been omitted pursuant to a request for Confidential Treatment filed separately with the Commission.\\n\\n\\n\\n\\n\\n1.5. \"Confidential Information\" means, whether disclosed in oral, written, graphic, electronic form, or other form, and whether developed by the disclosing party or by others, any confidential, non-public, proprietary information of Integra or PcoMed that is designated by the disclosing party as confidential or secret or that should reasonably be assumed by the receiving party to be confidential or secret. Confidential Information includes, without limitation: (i) specifications, know-how, trade secrets, designs, technical information, drawings, sketches, engineering drawings, work of authorship, software, prototypes, samples, models, business information, marketing information, current products and services, future products and services, proposed products and services, inventions, discoveries, devices, apparatus, equipment, algorithms, business methods, plans, assays, methods, procedures, processes, formulae, protocols, techniques, data, research and development data, experimental work, clinical data, engineering data, manufacturing data, technical or non-technical information, ideas, media, and unpublished patent applications; (ii) personnel and financial information, product cost informati',\n",
              "    'Highlight the parts (if any) of this contract related to \"Document Name\" that should be reviewed by a lawyer. Details: The name of the contract',\n",
              "    'SUPPLY AGREEMENT',\n",
              "    292,\n",
              "    308),\n",
              "   ('Exhibit 10.22   OUTSOURCE TECHNOLOGY DEVELOPMENT AGREEMENT   This Outsource Technology Development Agreement (this \"Agreement\") is entered into and effective as of this 1s t day of March, 2018 (the \"Effective Date\") by and between Document Security Systems, Inc., a corporation organized and existing under the laws of the State of New York (\"DSS\"), and HotApp International Ltd., a corporation organized and existing under the laws of Hong Kong (\"Developer\").   RECITALS:   WHEREAS, DSS is engaged in the business of, among other things, developing and licensing anti-counterfeiting technology, processes and products providing protection against a wide range of threats, including product diversion and counterfeiting, brand infringement, forgery, and unauthorized copying, scanning and photo imaging;   WHEREAS, Developer is engaged in the business of, among other things, software development; and   WHEREAS, DSS desires to retain Developer for the purpose of assisting DSS in developing an Android software application to be included as part of DSS\\'s AuthentiGuardยฎ Technology suite, and DSS is willing to grant Developer a non-exclusive, limited and non-transferable license for purposes of such development activities.   NOW, THEREFORE, for good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, the parties hereto agree as follows:   Capitalized terms contained herein shall have the meanings ascribed to them herein, or in Schedule 1 which is annexed hereto and made a part of this Agreement.   1. Development License and Fees.   1.1. Development License. Subject to the terms and conditions set forth herein, DSS hereby grants to Developer, and Developer accepts from DSS, for the Term, a non-exclusive, limited, and non-transferable license to install and use the Technology for the sole purpose of developing the Improvements (as defined hereunder) thereto for the benefit of DSS (the \"Technology Development Services License\").   1.2. Development Fees. As payment for Developer\\'s satisfactory performance of the services set forth in Schedule 1 hereto (the \"Technology Development Services\"), DSS shall pay Developer the sum of US $23,000 per month, for the duration of the Term hereof, with payments to commence on March 1, 2018.   2.  Term and Termination.   2.1. Term. The initial term of this Agreement shall commence on the Effective Date, and shall continue thereafter for a period of twelve (12) months (the \"Initial Term\"). The Initial Term shall automatically renew for one-month periods thereafter unless either party provides 30- days advance notice of termination, unless earlier terminated pursuant to Section 2.2 hereof. For purposes hereof, the Initial Term, together with any extension or renewal terms, shall hereinafter be collectively referred to as the \"Term\".   2.2. Early Termination.   2.2.1. Either party may terminate this Agreement prior to expiration of the Term: (i) upon thirty (30) days prior written notice, or (ii) immediately upon written notice to the other party if: (a) the other party declares or a petition is filed in any court for insolvency or bankruptcy and such petition is not dismissed in thirty (30) days; (b) the other party reorganizes under the relevant bankruptcy act or any similar statute in such party\\'s jurisdiction of incorporation; (c) the other party consents to the appointment of a trustee in bankruptcy or a receiver or similar entity; or (d) the Developer breaches DSS\\'s Technology or Intellectual Property rights contained herein.   2.2.2. Upon the expiration or termination of this Agreement, (i) the Technology Development Services License granted to Developer hereunder shall immediately cease, and (ii) Developer shall immediately cease use of all proprietary technology files heretofore delivered by DSS and shall deliver to DSS all such proprietary files along with any and all Improvements completed to date by Developer.     1\\n\\nSource: HF ENTERPRISES INC., S-1, 12/23/2019\\n\\n\\n\\n\\n\\n    3. Proprietary Rights.   3.1. Subject to Developer\\'s expressly granted rights under this Agr',\n",
              "    'Highlight the parts (if any) of this contract related to \"Document Name\" that should be reviewed by a lawyer. Details: The name of the contract',\n",
              "    'OUTSOURCE TECHNOLOGY DEVELOPMENT AGREEMENT',\n",
              "    16,\n",
              "    58),\n",
              "   ('Exhibit 7.1   Strategic Alliance Agreement\\n\\nTHIS AGREEMENT is made this 15 th day of July, 2010 (\"Effective Date\") by and between IMedicor, Inc, a Nevada Corporation whose address is 523 Avalon Gardens Drive, Nanuet, New York 10954, USA (\"IMedicor\") and USA Managed Care Organization (USA MCO) A Texas Corporation whose address is 916 South Capital of Texas highway, Austin Texas.\\n\\nWITNESSETH:   WHEREAS, iMedicor is a secure, HIPAA compliant online portal that creates a virtual healthcare community amongst physicians and other medical professionals for the purpose of real-time Health Information Exchange. Physicians are provided with a secure HIPPA compliant transport account(s), similar to e-mail with attachments, that enable them to share patient specific personal health information with other participating physicians. iMedicor also provides the ability to create social communities for the purpose of peer collaboration and the extension of referral networks. iMedicor\\'s portal also provides physicians with an extensive catalogue of Continuing Medical Education (CME), skill development and product specific educational resources;\\n\\nWHEREAS, USA MCO represents a network of physicians through which USA MCO provides products and services for the medical industry that: generate additional revenue Streams; provide cost savings, streamline workflow; help patients save time, money and doctors achieve better outcomes; and assist physicians and medical practices to find ways to enhance patient satisfaction;\\n\\nWHEREAS, both parties are interested in forming a strategic and marketing alliance beneficial to both organizations.\\n\\nNOW, THEREFORE, for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties agree as follows:\\n\\n1. OBLIGATIONS OF THE PARTIES   โInitiate a multi tiered marketing approach, by mutual consent of both parties, to integrate the iMedicor HIPAA Compliant transport network as a communications network throughout the USA MCO user base, โThe overall project would also include the ClearLobby pharmaceutical and medical device marketing platform and other value added services as mutually agreed into the future, as a Phase II activity. โA phased in approach for each of the components listed above with the first being the introduction of the core iMedicor, HIPAA compliant communication / transport system into the USA MCO network.\\n\\n\\n\\n\\n\\n    โThe integrated service will generate revenue sharing opportunities for both companies. โUSA MCO will allow access to their network to distribute promotional and educational material highlighting the value proposition of the iMedicor / USA MCO alliance. โAccess will only be through, and controlled by USA MCO โCommunication will be, but not limited to e-mail promotion, direct mail, bill stuffers, web site, newsletter or any other normal communication between USA MCO and their network of physicians and other healthcare providers upon mutual consent of both parties โAll material must be approved by USA MCO prior to any distribution to the USA MCO network. โOnce a physician or other healthcare provider enrolls in iMedicor they will become part of the regular internal iMedicor communications system. โEvery physician that enrolls in iMedicor, including those physicians or other qualified registrants into the iMedicor network that are invited into USA MCO physician communities, through the efforts of USA MCO will be tagged as originating from that source (the USA MCO network). โMonthly reports detailing revenue generated through subscriptions, ClearLobby or other methods will be detailed in the monthly reports. โAll revenue sharing will be reconciled monthly and funds distributed by the 20th of each month by wire transfer for all net collected revenues for the previous month (net of returns and refunds, if any). โIMedicor will make its records available for audit purposes at any time by USA MCO during regular business hours at the headquarters of iMedicor. โUSA MCO will not be responsible for any direct sales of the iMedicor communications system',\n",
              "    'Highlight the parts (if any) of this contract related to \"Document Name\" that should be reviewed by a lawyer. Details: The name of the contract',\n",
              "    'Strategic Alliance Agreement',\n",
              "    14,\n",
              "    42),\n",
              "   ('Exhibit 10.39\\n\\nIN ACCORDANCE WITH ITEM 601(b) OF REGULATION S-K, CERTAIN IDENTIFIED INFORMATION (THE \"CONFIDENTIAL INFORMATION\") HAS BEEN EXCLUDED FROM THIS EXHIBIT BECAUSE IT IS BOTH (I) NOT MATERIAL AND (II) WOULD LIKELY CAUSE COMPETITIVE HARM IF PUBLICLY DISCLOSED. THE CONFIDENTIAL INFORMATION IS DENOTED HEREIN BY [*****].\\n\\nAMENDMENT NO. 3 TO THE NONEXCLUSIVE VALUE ADDED DISTRIBUTOR AGREEMENT\\n\\nThis Amendment No. 3 (\"Amendment No. 3\") to the Nonexclusive Value Added Distributor Agreement, as amended (\"Agreement\\'\\'), by and between Cisco Systems, Inc. (\"Cisco\"), a California corporation having Its principal place of business at 170 West Tasman Drive, San Jose, CA, 95134, and ScanSource, Inc. (\"Distributor\"), a South Carolina corporation with a place of business at 6 Logue Court, Greenville, South Carolina, 29615, is effective as of the date last signed below (\"Amendment Effective Date\"). All capitalized terms contained herein shall have the same meaning as the terms defined in the Agreement unless specifically modified in this Amendment.\\n\\nWHEREAS, Cisco and Distributor have previously entered into the Agreement dated January 22, 2007, and\\n\\nWHEREAS, Cisco and Distributor wish to renew and update certain terms and conditions in the Agreement regarding payment; and,\\n\\nNOW WHEREFORE, the parties agree to further amend the Agreement as follows:\\n\\n1. The Term of the Agreement is hereby extended to January 20, 2012 unless sooner terminated as provided for in the Agreement. If the Agreement expired prior to the Amendment Effective Date, any orders received and Products and Services purchased between the date of expiration and the Amendment Effective Date shall be in all respects deemed made under the Agreement as in effect prior to this Amendment. The parties further agree that if Distributor places Purchase Orders after the expiration of the Agreement, and Cisco accepts such Purchase Orders, then any such Purchase Orders shall be governed by the terms and conditions of the Agreement; provided, however that acceptance by Cisco of any Purchase Order placed after the Agreement has expired will not be considered as an extension of the term of the Agreement nor a renewal thereof. Notwithstanding Cisco\\'s right to extend the term of the Agreement, each party acknowledges that the Agreement shall always be interpreted as being limited in duration to a definite term and that the other party has made no commitments whatsoever regarding the renewal of the Agreement beyond those expressly agreed in writing.\\n\\n2. Section 6.0 (\"Payment\") of the Agreement is modified by adding the following new Section 6.7: 6.7 [*****]\\n\\n3. Section 12 (\"Inventory Balance\") is deleted in its entirety and hereby replaced with the following:\\n\\n12.0 INVENTORY BALANCE\\n\\n12.1 Distributor shall have the option to return to Cisco, for credit, up [*****] of the dollar value of Products from the Wholesale Price List (or, if no Wholesale Price Lists exists for Distributor\\'s Territory, then the applicable price list) shipped to Distributor, net of credits, less returns to Cisco, in the preceding [*****] period (the \"Balancing Cap\") of the preceding Cisco fiscal quarter. The above-referenced cap shall be determined based on all Product purchases made under this Agreement. The responsibility to manage the Balancing Cap shall rest solely upon Distributor. Distributor shall be entitled to return Product once per quarter, provided such returns do not exceed the Balancing Cap. \"Dead on Arrival\" and Obsolete Products returned pursuant to Section 13 of this Agreement shall be excluded from calculation of the Balancing Cap. Cisco shall credit Distributor\\'s account in the amount of the price paid by Distributor therefore, less any price protection credits issued to Distributor related to the Product returned (the \"Return Credit\").\\n\\n12.2 For all returns made pursuant to this Section 12, the following requirements must be met by Distributor:\\n\\n12.2.1 [*****]\\n\\n12.2.2 [*****]\\n\\nSource: SCANSOURCE, INC., 10-K, 8/22/2019\\n\\n\\n\\n\\n\\nExhibit 10.39\\n\\n12.2.3 Distributor shall bear all shipping and handlin',\n",
              "    'Highlight the parts (if any) of this contract related to \"Document Name\" that should be reviewed by a lawyer. Details: The name of the contract',\n",
              "    'AMENDMENT NO. 3 TO THE NONEXCLUSIVE VALUE ADDED DISTRIBUTOR AGREEMENT',\n",
              "    329,\n",
              "    398),\n",
              "   ('SPONSORSHIP AGREEMENT     THIS SPONSORSHIP AGREEMENT (\"Agreement\") is entered into and effective as of the date first written above (\"Effective Date\") by  and among PEEK Investments LLC, a Delaware limited liability company (\"Purchaser\"), and each other party hereto identified on the signature  page(s) hereto (each, a \"Sponsor\"). Each term used and not otherwise defined herein shall have the meaning assigned to such term in the Offer.     RECITALS     WHEREAS, Purchaser is tentatively exploring, among other potential alternatives, a possible third-party tender offer to purchase all  outstanding shares of common stock, $0.001 par value per share (\"Shares\"), of a Delaware corporation (the \"Company\") upon the terms and  subject to the conditions set forth in the Offer to Purchase, related Letter of Transmittal, and other tender offer material provided by or on behalf of  Purchaser to the Sponsors (which, collectively, as amended or supplemented, constitute the \"Offer\");     WHEREAS, as requested by Purchaser for purposes of the Offer, each Sponsor has provided to Purchaser, and Purchaser has accepted  from such Sponsor, a commitment letter providing for a possible equity investment in Purchaser by such Sponsor (each, an \"Equity Commitment Letter\" and, with respect to any Sponsor(s), the Equity Commitment Letter(s) of such Sponsor(s)), which evidences the commitment of and by  such Sponsor to contribute capital to Purchaser in amounts and proportions and upon the terms and subject to the conditions and otherwise as  contemplated by such Equity Commitment Letter (each, a \"Commitment\" and, with respect to any Sponsor(s), the Commitment of such Sponsor (s));     WHEREAS, such capital contributions, if any, would be used to purchase Shares in the Offer and fund the payment or reimbursement of  fees, expenses, and costs related to the Offer (collectively, \"Transaction Costs\"); and     WHEREAS, each party hereto desires to establish certain terms and conditions related to the Offer and relationship among the Sponsors,  the related equity financing commitments, and the Offer;     NOW, THEREFORE, for good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, each party  hereto (\"Party\"), intending to be legally bound, hereby agrees as follows:     AGREEMENT     1. Pre-Acceptance Period. If and to the extent any such decision would or could (or would or could be reasonably foreseeable to)  adversely affect any Sponsor in any manner, each decision to be made by or on behalf of Purchaser with respect to the Offer (or any similar  transaction), any agreements related thereto (\"Related Agreements\"), or any transaction contemplated by the Offer or any Related Agreement  (\"Contemplated Transactions\" and, together with the Offer and Related Agreements, \"Offer Matters\"), or any Offer Matter or combination of  Offer Matters, in any case, on and from the Effective Date and until the Acceptance Time (\"Pre-Acceptance Period\") shall require the unanimous  consent of the Sponsors, including, without limitation, any (a) announcement of intention, commencement, amendment, supplement, termination,  extension, modification, or waiver of or related to the Offer or any term or condition thereof, including, without limitation, with respect to any  commencement date, initial offering period, offer price, type or form of consideration to be offered or paid, timing or other term of acceptance for  payment or payment of any subject security, withdrawal right, expiration date, subsequent offering period, or top-up option, (b) waiver of any  condition to or of the Offer or determination as to whether or not any such condition has been, is, or will be satisfied, (c) filing, dissemination, or  disclosure requirement or offering document or tender offer material, including, without limitation, with respect to any filing or exhibit, schedule,  attachment, amendment, or supplement thereto, (d) agreement, instrument, document, or matter related to any borrowing, incurrence of  indebtedness, or equity, debt, or other financing, (e) ',\n",
              "    'Highlight the parts (if any) of this contract related to \"Document Name\" that should be reviewed by a lawyer. Details: The name of the contract',\n",
              "    'SPONSORSHIP AGREEMENT',\n",
              "    31,\n",
              "    52),\n",
              "   ('[LOGO]\\n\\nAMENDMENT TO SECTION 2, PART B OF THE CO-BRANDING AGREEMENT\\n\\nThis amendment to Section 2 (titled \"Term\"), Part B of the Co-Branding Agreement is made effective December 9, 1996 by and between PC Quote, Inc. (hereinafter referred to as \"PCQ\") and A.B. Watley, Inc. (hereinafter referred to as \"ABW\"), who are also the parties contracted in the aforementioned Co-Branding Agreement. This Amendment shall apply to said PCQ and ABW and all of their subsidiaries and related companies.\\n\\n[***]\\n\\nSource: PCQUOTE COM INC, S-1/A, 7/21/1999\\n\\n\\n\\n\\n\\nAGREED TO BY:\\n\\n/s/ Steven Malin /s/ Howard Meltzer - -------------------------- --------------------------------- A.B. Watley, Inc. PC Quote, Inc. Mr. Steven Malin Mr. Howard Meltzer Director President Date:  12/5/96 Date:   12/12/96      -------------- ----------------\\n\\nSource: PCQUOTE COM INC, S-1/A, 7/21/1999',\n",
              "    'Highlight the parts (if any) of this contract related to \"Document Name\" that should be reviewed by a lawyer. Details: The name of the contract',\n",
              "    'AMENDMENT TO SECTION 2, PART B OF THE CO-BRANDING AGREEMENT',\n",
              "    8,\n",
              "    67),\n",
              "   ('Exhibit 10.65   JOINT VENTURE AGREEMENT MINDA IMPCO TECHNOLOGIES LIMITED   This Joint Venture Agreement (Agreement) is made and executed on this the 18th day of May, 2001   BETWEEN   IMPCO Technologies Inc., a company incorporated under the laws of the State of Delaware U.S.A. and having its principal office of business at 16804 Gridley Place, Cerritos, California 90703, U.S.A. (hereinafter referred to as \\'IMPCO\\', which terms shall unless repugnant to the subject or context mean and include its successors and permitted assigns), through Ms. Pearl Kamdar a duly authorized person and Director of Asia-Pacific Operations,   AND   MINDA INDUSTRIES LIMITED, a company incorporated under the Companies Act, 1956 having its registered office at 36-A, Rajasthan Udyog Nagar, Delhi-110 033, India, (hereinafter referred to as \\'MIL\\', which terms shall unless repugnant to the subject or context mean and include its successors and permitted assigns), through Mr. Nirmal K. Minda its Managing Director,   AND   Mr. Nirmal K. MINDA, s/o. Mr. S.L. Minda, r/o. A-15, Ashok Vihar, Phase-I, New Delhi-110 052 on in his individual capacity and on behalf of his relatives and associates listed in Schedule-I (hereinafter referred to as \\'MINDA\\', which terms shall unless repugnant to the subject or context mean and include his heirs, executors, administrators or successors and permitted assigns).   WHEREAS IMPCO is engaged in the business of development, manufacture and sale of alternate fuel management systems and components for operating motor vehicles, forklifts, industrial engines and other engines of various horsepower; and   WHEREAS MIL is engaged in the manufacturing and sale of auto electrical parts such as switches, lamps and horns; and   WHEREAS IMPCO and MIL/MINDA have entered into a joint venture to promote a company under the name of MINDA IMPCO LIMITED for manufacturing and selling alternate fuel management systems and components, including but not limited to CNG, LPG and Propane Kits for operating motor vehicles, forklifts, industrial engines and other engines of various horsepower in India ; and   WHEREAS, MIL represents that it has the technical, marketing skills and financial wherewithal to install, sell and service the alternate fuel systems and components manufactured by MINDA IMPCO Limited and enjoys a respected business relationship with   1\\n\\n\\n\\n\\n\\ncognizant governmental and industrial authorities, all of which may be advantageously employed in the safe and professional marketing of MINDA IMPCO Limited products, as specified above, in India with the approval of and in compliance with such governmental authorities; and   WHEREAS the Parties hereto have agreed, subject to obtaining all necessary approvals, permissions, consents, validations, confirmations, licenses and any other authorizations required to incorporate a company in India (\"the Joint Venture Company\" or the \"JVC\") with the main object of inter alia marketing and selling of alternate fuel management systems, including but not limited to CNG, LPG and Propane Kits and its components for automobiles and other associated and incidental services to customers; and   WHEREAS IMPCO will contribute to the JVC in cash and the JVC will issue equity shares to IMPCO; and   WHEREAS MIL/MINDA will contribute to the JVC in cash and subject to IMPCO\\'s consent in kind and the JVC will issue equity shares to MIL/MINDA; and   WHEREAS the Parties hereto are ready, willing and able to assist each other and cooperate in the manner set out hereinafter, to ensure the establishment and success of the JVC. The Parties shall cooperate with each other in the highest degree in the performance of all such acts and the passing of all resolutions as are required for the purpose of achieving the terms, purposes and intent of this Agreement and the Parties shall in particular exercise their respective voting and other rights and power of control over the JVC so as to give effect to the rights conferred upon the respective Parties by the terms of this Agreement.   NOW THEREFORE in consideration of the mutual',\n",
              "    'Highlight the parts (if any) of this contract related to \"Document Name\" that should be reviewed by a lawyer. Details: The name of the contract',\n",
              "    'JOINT VENTURE AGREEMENT',\n",
              "    16,\n",
              "    39),\n",
              "   ('EXHIBIT 10.3\\n\\n   [ABOUT LOGO]\\n\\nCO-BRANDING AGREEMENT\\n\\nThis Agreement (the \"Agreement\"), dated this 19th day of January, 2001 (the \"Effective Date\"), is by and between About.com, Inc. (\"About\"), a Delaware corporation, located at 1440 Broadway, 19th Floor, New York, NY 10018 and ebix.com, Inc. (\"ebix\"), a Delaware corporation, located at 1900 E.Golf Road, Schaumberg, IL 60173\\n\\nW I T N E S S E T H:\\n\\nWHEREAS, About owns and operates an Internet service known as About.com, currently located at the URL HTTP://WWW.ABOUT.COM, at which users may access a variety of content channels and a network of highly-targeted, topic-specific Web sites, and includes any site owned, operated or under the control of About (the \"About Network\");\\n\\nWHEREAS, ebix is the e-commerce portal for insurance on the Internet offering to consumers and insurance professionals a one-stop site, currently located at http://www.ebix.com for all kinds of insurance content ranging from consumer to business tools to broker to business tools as well as e-commerce functionality;\\n\\nWHEREAS, the parties desire to collaborate to create an independent co-branded channel on or accessible though the About Network at which visitors to the About Network may access insurance information, on the terms and conditions hereinafter set forth;\\n\\nWHEREAS, ebix desires to receive promotions on the About Network for the parties\\' Insurance Center and for the ebix Site (hereinafter defined).\\n\\nNOW, THEREFORE, in consideration of the agreements and obligations set forth herein and for other good and valuable consideration, the receipt and sufficiency of such is hereby acknowledged, the parties hereto hereby agree as follows:\\n\\n  1.  DEFINITIONS\\n\\n      \"ABOUT CONTENT\" means any and all textual, graphical, audio/visual or       other materials created or provided on or behalf of About for use on the       Insurance Center (other than the ebix Content), including but not limited       to the About Wrapper and the About Look and Feel (hereinafter defined).\\n\\n      \"ABOUT CUSTOMER\" means any individual or entity who has registered with       ebix either (i) through the registration process on the Insurance Center       or (ii) registers with ebix after accessing the ebix Site from a link on       the About Network.\\n\\n      \"ABOUT CUSTOMER DATA\" means information related specifically to About       Customers, including but not limited to: (i) internet addresses and       navigational information, including information disclosing the usage of       Links within or available through the Insurance Channel; (ii)       transactional information, including, but not limited to, names,       addresses, billing information, information requested; and (iii) any other       information that identifies an individual as an About Customer.\\n\\n      \"ABOUT LOOK AND FEEL\" means the distinctive and particular elements of       graphics (including the About Marks), design, organization, presentation,       layout, user interface, navigation, trade dress and stylistic convention       (including the digital implementations thereof) within the About Network       and the\\n\\n** Confidential treatment has been requested for portions of this document.    The redacted material has been filed with the commission pursuant to an    application for confidential treatment.\\n\\n      total appearance and impression substantially formed by the combination,       coordination and interaction of these elements.\\n\\n      \"ABOUT MARKS\" means the name, tradenames, trademarks, service marks, logos       and other distinctive brand marks of About, adopted by About, or used in       or relating to About\\'s business from time to time, whether or not in       connection with its performance of this Agreement,\\n\\n      \"ABOUT NETWORK\"\" means the About Site, all Web sites owned and operated       solely by About, and those portions of third party Web sites in which       About has a right to sell advertisements.\\n\\n      \"ABOUT SITE HOME PAGE\" means, with respect to the US version of the About       Site, the Web page that is displayed to the About User ',\n",
              "    'Highlight the parts (if any) of this contract related to \"Document Name\" that should be reviewed by a lawyer. Details: The name of the contract',\n",
              "    'CO-BRANDING AGREEMENT',\n",
              "    31,\n",
              "    52),\n",
              "   ('SPONSORSHIP AGREEMENT This agreement (the \"Agreement\") is made effective this 1st day of April, 2018 (\"Effective Date\") between Fruit of Life Productions LLC, (\"Promoter\") and Eco Science Solutions, Inc.,(\"Sponsor\"), 1135 Makawao Avenue, Suite 103-188, Makawao, Hawaii, 96768.\\n\\nContribution by Sponsor: In consideration for the right to sponsor the Kaya Fest and to be acknowledged by Fruit of Life Productions LLC., as a Promoter of the event during the term of this Agreement, Sponsor agrees to contract with Fruit of Life Productions LLC., for the amount of $250,000.00 to be paid in full upon signing of this agreement.\\n\\nBank Wire Transformation Information See Attached Wire Instructions\\n\\nSponsorship Benefits for Presenting Partner Sponsor:\\n\\n* Main Stage named after your brand * 4 10x10 on site vendor booths * 50 VIP Sponsor Passes / 50 GA tickets for both days * 4 Parking passes * Opportunity to participate in after party * Banner placement in venue (10) * Approved audio/video assets to be provided as promotional use for Herbo * Name and phrase called out on stage between performers set * Your logo and a link from our website to your website * Your logo on video wall * Your company name and logo as a presenting sponsor * Banner at main entrance of venue * On stage banner placement * Logo in Backstage/VIP area * Mention on social media * Logo on Step and Repeat * Logo on all promotional print\\n\\nTerms and Termination: The term of this agreement will begin on April 1, 2018 and continue until April 30, 2018 at 11:59pm.\\n\\nRelationship of Parties: The parties are independent contractors with respect to one another. Nothing in this Agreement shall create any association, joint venture, partnership or agency relationship of any kind between the parties.\\n\\n1\\n\\nSource: ECO SCIENCE SOLUTIONS, INC., 8-K, 4/6/2018\\n\\n\\n\\n\\n\\nIntellectual Property: Fruit of Life Productions LLC is the sole owner of all right, title and interest to all Kaya Fest information including Logo, tag lines, (Education before Recreation), Trademarks, trade names and copyrighted information. Sponsor agrees that it will not use Kaya Fest property in a manner that states or implies that Kaya Fest endorses Sponsor (or Sponsors products or services) without written approval from Fruit of Life Productions LLC.\\n\\nIdemnification: Sponsor shall indemnify and hold harmless, Fruit of Life Productions LLC, its related entities, partners, agents, officers, directors, employees, attorneys, heirs, successors, and assigns from against any and all claims, losses, damages, judgments, settlements, costs and expenses (including reasonable attorney\\'s fees and expenses), and liabilities of every kind incurred as a result of: (i) any act or omission by Sponsor or its officers, directors, entities, employees, agents; (ii) any use of Sponsor\\'s name, logo, Website, or other information, products, or service provided by Sponsor; and/or (iii) the inaccuracy or breach of any of the covenants, representations and warranties made by Sponsor in this Agreement. (iv) any changes in company value or brand value. The attendance and marketing reach estimates made in negotiations were made for the purposes of this agreement are mere estimate and not be interpreted as guaranties. . Confidentiality Confidential Information is all information that is marked such and all other information which a reasonable person would consider to be confidential. Confidential Information shall include, but is not limited to, information regarding the organization, its operations, programs, activities, financial condition, strategies, timelines, corporate/programming roadmap, surprise performers/guest appearances, event access information and membership or customer list. During the Term, each party shall use and reproduce the other party\\'s Confidential Information only for purposes of this Agreement with written authorization by disclosing party, and only to the extent necessary for such purpose. Each party shall restrict disclosure of the other party\\'s Confidential Information to its employees and agents with a reasonable need to',\n",
              "    'Highlight the parts (if any) of this contract related to \"Document Name\" that should be reviewed by a lawyer. Details: The name of the contract',\n",
              "    'SPONSORSHIP AGREEMENT',\n",
              "    0,\n",
              "    21),\n",
              "   ('Exhibit 10.2   FORM OF CONTENT LICENSE AGREEMENT   THIS CONTENT LICENSE AGREEMENT (this \"Agreement\"), dated as of ___________, 2015 (the \"Effective Date\"), is entered into between Beijing Sun Seven Stars Culture Development Limited, a P.R.C. company with an address at Eastern Fangzheng Road, Southern Dongying Village, Hancunhe Town, Fangshan District, Beijing City, P.R.C. (\"Licensor\"), and YOU ON DEMAND HOLDINGS, INC., a Nevada corporation with an address at 375 Greenwich Street, Suite 516, New York, New York 10013 (\"Licensee\").   WHEREAS, Licensor and Licensee have agreed to enter into this Agreement, pursuant to which Licensor shall license to Licensee certain video programming on the terms and subject to the conditions contained in this Agreement.   NOW, THEREFORE, in consideration of the foregoing, the mutual promises and covenants herein contained and other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, and incorporating the above recitals with and into this Agreement, the parties hereby agree as follows:   TERMS AND CONDITIONS   1. Definitions.   (a) \"Additional Title\" shall have the meaning specified in Section 5.   (b) \"Advertising\" shall have the meaning specified in Section 9.   (c) \"Affiliate(s)\" shall mean an entity controlling, controlled by or under common control with a party. \"Control,\" for purposes of this definition, means direct or indirect ownership or control of more than 50% of the voting interests of the subject entity.   (d) \"Confidential Information\" shall have the meaning specified in Section 14(a).   (e) \"Indemnified Party\" shall have the meaning specified in Section 13.   (f) \"Indemnifying Party\" shall have the meaning specified in Section 13.   (g) \"Licensor Marks\" shall have the meaning specified in Section 11.   (h) \"Materials\" shall have the meaning specified in Section 4(b).   (i) \"Mobile Sites\" shall mean any and all versions of the Licensee Sites optimized for delivery and/or distribution via a wireless network.   (j) \"Reports\" shall have the meaning specified in Section 8(b).\\n\\n  1\\n\\nSource: IDEANOMICS, INC., 8-K, 11/24/2015\\n\\n\\n\\n\\n\\n\\n\\n  (k) \"Share Consideration\" has the meaning specified in Section 10.   (l) \"Sites\" shall mean any and all websites, applications, products and other services through which Licensee (itself or through a third party) delivers content via the public Internet or an IP-based network, regardless of whether the device used to access such websites, applications, products or other services is a laptop or desktop computer, mobile device, tablet, mobile phone, set-top box, or other device.   (m) \"Term\" shall have the meaning specified in Section 7.   (n) \"Territory\" shall mean mainland China.   (o) \"Titles\" shall mean the programming listed on Schedule A (as Schedule A may be amended in accordance with Section 5 from time to time).   (p) \"Users\" shall mean all subscribers to Licensee\\'s services.   (q) \"VOD\" shall mean a system that allows for the exhibition of video programming chosen by a subscriber for display on that subscriber\\'s video display unit on an on-demand basis, such that a subscriber is able, at his or her discretion, to select the time for commencement of exhibition, and shall include subscription VOD (\"SVOD\"), transactional VOD (\"TVOD\"), ad-supported VOD (\"AVOD\") and free VOD.   2. Rights Granted.   (a) License Grant. In exchange for the Share Consideration, Licensor hereby grants to Licensee a non-exclusive, royalty-free, perpetual and non-perpetual license (subject to the duration for which Licensor has the rights to each Title as specified in Schedule A1-A5 of Schedule A) to:   i. license, exhibit, distribute, reproduce, transmit, perform, display, and otherwise exploit and make available each Title within the Territory in any language by VOD (including SVOD, TVOD, AVOD and free VOD) for Internet, TV and mobile platforms (including, but not limited to, OTT streaming services, Sites and Mobile Sites), except that for Titles listed in Schedule A1-A2 of Schedule A, Licensor can only grant Licensee distributio',\n",
              "    'Highlight the parts (if any) of this contract related to \"Document Name\" that should be reviewed by a lawyer. Details: The name of the contract',\n",
              "    'FORM OF CONTENT LICENSE AGREEMENT',\n",
              "    15,\n",
              "    48),\n",
              "   ('Exhibit 99.1 JOINT FILING AGREEMENT Additional Reporting Person (a): Merck Serono SA Address: Zone Industrielle 1267 Coinsins, Switzerland Additional Reporting Person (b): Merck KGaA Address: Frankfurter Str. 250 64293 Darmstadt, Germany Designated Filer: Ares Trading SA Issuer and CUSIP: Intrexon Corporation (46122T102) Dated: January 7, 2019 ARES TRADING SA ARES TRADING SA By: /s/ Cรฉdric Hyde By: /s/ Luigia Bocola Name: Cรฉdric Hyde Name: Luigia Bocola Title: CFO Title: Finance Manager MERCK SERONO SA, COINSINS, SWITZERLAND, AN AFFILIATE OF MERCK KGAA, DARMSTADT, GERMANY MERCK SERONO SA, COINSINS, SWITZERLAND, AN AFFILIATE OF MERCK KGAA, DARMSTADT, GERMANY By: /s/ Cรฉdric Hyde By: /s/ Tearaboth Te Name: Cรฉdric Hyde Name: Tearaboth Te Title: CFO Title: Treasury Director MERCK KGAA, DARMSTADT, GERMANY MERCK KGAA, DARMSTADT, GERMANY By: /s/ Rando Bruns By: /s/ Tim Nielsen Name: Rando Bruns Name: Tim Nielsen Title: Head of Treasury Title: Head of Capital Markets',\n",
              "    'Highlight the parts (if any) of this contract related to \"Document Name\" that should be reviewed by a lawyer. Details: The name of the contract',\n",
              "    'JOINT FILING AGREEMENT',\n",
              "    13,\n",
              "    35),\n",
              "   ('Exhibit 10.28   Execution Version   OUTSOURCING AGREEMENT\\n\\nThis OUTSOURCING AGREEMENT (this \"Agreement\") is made and entered into as of the 16t h day of May, 2017, by and among\\n\\nPhotronics, Inc., a Connecticut corporation with its principal place of business at 15 Secor Road, Brookfield, Connecticut, U.S.A (\"Photronics\"),\\n\\nDai Nippon Printing Co., Ltd., a Japanese corporation with its principal place of business at 1-1, Ichigaya Kagacho 1-chome, Shinjuku-ku, Tokyo, Japan (\"DNP\"),\\n\\nPhotronics DNP Photomask Corporation, a company limited by shares organized and formed under the Company Act of the Republic of China with its principal place of business at 4f, #2, Li-Hsin Road, Science Park, Hsinchu, Taiwan, ROC (\"PDMC\"), and\\n\\nXiamen American Japan Photronics Mask Co., Ltd., a limited liability company organized and formed under the People\\'s Republic of China with its principal place of business at R203-95, South Building of Torch Square, No. 56-58 Torch Road, Gaoxin District, Xiamen, Fujian Province, Peoples Republic of China (the \"Company\").\\n\\nEach of Photronics and DNP is hereinafter referred to as a \"Shareholder\" and collectively as the \"Shareholders\", each of the Shareholders and PDMC is hereinafter referred to as a \"Supplier\" and collectively as the \"Suppliers\", and each of the Suppliers and the Company is hereinafter referred to as a \"Party\" and collectively as the \"Parties.\"\\n\\nARTICLE 1. BACKGROUND   Photronics and DNP wish to participate in a joint venture, either directly or indirectly through their respective Affiliates, as equity interest owners in the Company, and to carry on the Business through the Company. The Parties are engaged, among other things, in the design, development, fabrication and sale of advanced photomasks. Photronics and DNP, directly or indirectly, are the shareholders of and own PDMC, a joint venture of Photronics and DNP in Taiwan. In connection with the formation of the Company, Photronics and DNP have entered into \"Joint Venture Operating Agreement\" (the \"China JV Operating Agreement\") dated as of the 16t h day of May, 2017. In connection with the China JV Operating Agreement and in order to support the business objective of the Company, including but not limited in order to (i) [***]the Company desires to outsource or [***]of the Company pursuant to the terms and conditions set forth herein.\\n\\nThe Parties hereby agree and confirm the exclusive distribution mechanism set forth in Section 10.1 hereof. All terms and conditions for [***]will be governed by this Agreement. Any and all [***]set forth in Section 5.15 of the China JV Operating Agreement.\\n\\n1.1 Defined Terms   Unless otherwise defined in this Agreement and Schedule 1 hereof, terms defined in the China JV Operating Agreement shall have the same meanings when used in this Agreement.\\n\\nSource: PHOTRONICS INC, 10-Q/A, 12/19/2017\\n\\n\\n\\n\\n\\n1.2 Incorporation by Reference   Section 12 (Miscellaneous) of the China JV Operating Agreement shall be incorporated by reference into and form an integral part of this Agreement, mutatis mutandis.\\n\\nARTICLE 2. PURCHASE ORDERS\\n\\n2.1 Outsource and Issuance of Purchase Orders   Subject to the terms and conditions mentioned hereunder, the Parties agree to the outsource model based on [***]as follows, and the Parties also agree that they may add additional Products to this Agreement through additional Purchase Orders [***]\\n\\nFor the avoidance of doubt, the outsource model is purely made based on the [***]\\n\\nMoreover, it is acknowledged by the Parties that[***] Therefore, subject to the prior notification to, and the instruction and the express approval of the customers, the Steering Committee could reasonably decide or change the outsource model at its own discretion in accordance with the China JV Operating Agreement.\\n\\nIn any case, none of the Parties shall unreasonably [***] of the Products to take advantage of the outsource relationship or [***]\\n\\nA. Outsource Transition Period   During the Outsource Transition Period, as for the Purchase Orders received by the Company from: (a) [***] (b) [***] (c) [***]\\n\\n(d) [***]',\n",
              "    'Highlight the parts (if any) of this contract related to \"Document Name\" that should be reviewed by a lawyer. Details: The name of the contract',\n",
              "    'OUTSOURCING AGREEMENT',\n",
              "    64,\n",
              "    85),\n",
              "   ('Exhibit 4.5\\n\\nCONSULTING AGREEMENT - DR. GAETANO MORELLO N.D. INC.\\n\\nTHIS AGREEMENT made effective the 10 day of January 2019 (the \"Effective Date\"),\\n\\nBETWEEN:\\n\\nEMERALD HEALTH NATURALS, INC., a company having its registered and records office at 7860 Venture Street, Burnaby, BC V5A 1V3\\n\\n(\"Emerald\" or the \"Company\")\\n\\nAND:\\n\\nDR. GAETANO MORELLO N.D. INC., Businessperson, having an office at 2975 East 4th Avenue, Vancouver, B.C. V5M 1L1\\n\\n(the \"Contractor\")\\n\\nWITNESSES THAT WHEREAS Emerald would like to engage the Contractor as an independent contractor of Emerald, and the Contractor would like to be engaged by Emerald as an independent contractor, on the terms and conditions contained herein;\\n\\nIN CONSIDERATION of the mutual agreements in this Agreement and subject to the terms and conditions specified in this Agreement, the parties agree as follows:\\n\\n1. Definitions\\n\\n1.1 In this Agreement, including the recitals and the schedules, the defined words and expressions have the meanings set out on Schedule \"A\" to this Agreement unless the context otherwise required.\\n\\n2. Scope of Engagement\\n\\n2.1 Position. The Company hereby engages the Contractor as an independent contractor and the Contractor hereby agrees to such engagement.\\n\\n2.2 Services. The Company engages the Contractor to fulfill the services (the \"Services\") as described on Schedule \"B\" on the terms and conditions of this Agreement. The Services may be replaced, amended, superseded, or supplemented from time to time by agreement between the Company and the Contractor.\\n\\n2.3 Reporting and Oversight Responsibility. The Contractor will report to and take instructions from Avtar Dhillon, President and Executive Chair.\\n\\n2.4 Commitment of the Contractor. The Contractor will devote sufficient time and attention to the business and affairs of Emerald to provide the Services, use his or her best efforts to promote the interests of Emerald, and will carry out his or her Services honestly, in good faith and in the best interests of Emerald.\\n\\n2.5 Not Employment. The parties acknowledge and agree that the relationship created by operation of this Agreement is not an employment relationship.\\n\\n3. Fees\\n\\n3.1 Fee. The Company will pay to the Contractor an annual fee (the \"Fee\") of $240,000. per year plus plus GST and applicable taxes, if any.\\n\\n\\n\\n\\n\\n3.2 Reimbursement of Expenses. Emerald will reimburse the Contractor for all reasonable expenses incurred in the performance of his or her Services, provided that the Contractor provides a written expense account in a form satisfactory to the Lead Director of the Company.\\n\\n3.3 Deductions and Remittances. Emerald shall not be obliged to deduct or retain from the Fees due to the Contractor, nor shall it be obliged to remit same to the required governmental authority, any amounts that may be required by law or regulation to be deducted, retained and remitted including, without limitation, Federal and Provincial or State Income Tax, Workers\\' Compensation and Pension Plan deductions and remittances. All such remittances and other payments are entirely the responsibility of the Contractor and the Contractor hereby indemnifies and saves Emerald and its Board members and officers harmless from any liability of any kind whatsoever that they may incur as a result of the Contractor\\'s failure to make such remittances or payments.\\n\\n3.4 Other Boards, Charities and Business Activities. The Contractor\\'s performance of personal, business or charitable activities or service on any boards of any private or public companies, shall be deemed not to be preventing the Contractor from meeting his or her obligations to Emerald hereunder, so long as same are not directly competitive with the business of the Company. Emerald acknowledges and agrees that the Contractor or Contractor may have other business involvements, business interests and sources of business income with parties that Emerald does or does not have a business relationship with. The Contractor is permitted to undertake such activities and retain all of the compensation received from such activities provided that ',\n",
              "    'Highlight the parts (if any) of this contract related to \"Document Name\" that should be reviewed by a lawyer. Details: The name of the contract',\n",
              "    'CONSULTING AGREEMENT',\n",
              "    13,\n",
              "    33),\n",
              "   ('Exhibit 10.26\\n\\nAGENCY AGREEMENT\\n\\nTHIS AGENCY AGREEMENT, dated November 9, 2005 (\"Agreement\"), between General Electric Capital Corporation, a Delaware corporation (together with its successors and assigns, if any, \"Lessor\"), and Duckwall-Alco Stores, Inc., a Kansas corporation (the \"Company\"). Capitalized terms not defined herein shall have the meanings assigned to them in the Lease (as that term is defined below).\\n\\nRECITALS:\\n\\nWHEREAS, Lessor and the Company have entered into a Master Lease Agreement dated November 9, 2005 wherein Lessor, as the lessor, has agreed to lease certain items of equipment to the Company (the Master Lease Agreement and all Schedules entered into from time to time thereunder are hereinafter collectively referred to as the \"Lease\"; and all equipment leased thereunder are hereinafter collectively referred to as the \"Equipment\"); capitalized terms used herein but not otherwise defined shall have the meanings as provided in the Lease; and\\n\\nWHEREAS, Lessor desires to appoint the Company its agent to order, receive and, in the name and on behalf of Lessor, the Equipment;\\n\\nNOW, THEREFORE, in consideration of the above premises and the mutual promises contained herein, as well as other good and valuable considerations, the receipt and sufficiency of which is hereby acknowledged, the parties hereto hereby agree as follows:\\n\\nARTICLE I  GENERAL UNDERTAKING\\n\\nSection 1.01 Appointment. Lessor hereby appoints the Company, and the Company hereby agrees to accept such appointment, as the agent of Lessor, without any fee for acting as such agent, pursuant to the terms and conditions of this Agreement, for the purpose of ordering and, subject to the conditions set forth in Section\\'s 2.01 and 2.05 hereof, accepting Equipment on Lessor\\'s behalf for leasing to the Company under the Lease from the respective supplier thereof (each a \"Supplier\" and collectively, the \"Suppliers\"). It is specifically agreed that all of the power and authority vested to the Company herein shall be subject to any modifications as may from time to time be made by Lessor.\\n\\nSection 1.02 Powers. Except as may be otherwise expressly provided in this Agreement, the Company is hereby granted the authority to act, and hereby agrees to act, on behalf of Lessor and in the name of Lessor, to the extent necessary to carry out its duties under this Agreement.\\n\\nSection 1.03 Master Lease. This Agreement is entered into in connection with and subject to the terms of the Lease and in the event of a conflict between the terms of this Agreement and the Lease, the Lease shall control. The Company and Lessor may from time to time hereafter enter into Equipment Schedules to the Lease, and it is the intent of the parties that this Agreement facilitate the leasing of Equipment under the Lease. EXCEPT AS PROVIDED IN ANY OTHER AGREEMENT, NOTHING IN THIS AGREEMENT SHALL BE OR SHALL BE DEEMED TO BE, A COMMITMENT ON THE PART OF EITHER THE COMPANY OR LESSOR TO EXECUTE OR OTHERWISE ENTER INTO ANY EQUIPMENT SCHEDULES AFTER THE DATE OF THIS AGREEMENT.\\n\\nARTICLE II  DUTIES OF AGENT\\n\\nSection 2.01 Equipment Orders. Upon the written acknowledgment by the Company and Lessor of each jointly approved purchase agreement, purchase order or invoice (\"Purchase Order\"), the Company, pursuant to the agency granted to it by Lessor in Article I hereof, may order, receive, accept the Equipment to be leased in accordance with the Economic Terms (as hereafter defined and described).\\n\\nUpon and as of the date of acceptance of the Equipment by the Company and satisfaction of the conditions precedent provided for in the Lease: (a) Lessor shall be unconditionally obligated to purchase such Equipment pursuant to the terms of the applicable Purchase Order and to lease such Equipment to the Company pursuant to the terms and conditions of the Lease and the applicable completed Schedule; and (b) the Company shall be unconditionally obligated to lease such Equipment from Lessor pursuant to the terms and conditions of the Lease and the applicable completed Schedule. The leasing of Equipment pursuant to',\n",
              "    'Highlight the parts (if any) of this contract related to \"Document Name\" that should be reviewed by a lawyer. Details: The name of the contract',\n",
              "    'AGENCY AGREEMENT',\n",
              "    38,\n",
              "    54),\n",
              "   ('Exhibit 10.5   INTELLECTUAL PROPERTY AGREEMENT   This INTELLECTUAL PROPERTY AGREEMENT, dated as of May 14, 2016 (this \"Agreement\"), is by and between WestRock Company, a Delaware corporation (\"Parent\"), and Ingevity Corporation, a Delaware corporation (\"SpinCo\"). Capitalized terms used herein and not otherwise defined shall have the respective meanings assigned to them in Section 1 or the Separation Agreement. SpinCo and Parent may be individually referred to herein as a \"Party\" and collectively as the \"Parties\".   R E C I T A L S   WHEREAS, Parent and SpinCo have entered into that certain Separation and Distribution Agreement, dated as of even date herewith, (the \"Separation Agreement\");   WHEREAS, the Separation Agreement sets forth the principal corporate transactions required to effect the Separation;   WHEREAS, Parent and SpinCo desire to enter into this Agreement to set forth the terms and conditions pertaining to the allocation of ownership and other rights associated with certain Intellectual Property; and   WHEREAS, this Agreement is deemed to be an Ancillary Agreement under the Separation Agreement.   NOW, THEREFORE, in consideration of the mutual agreements, provisions and covenants contained in this Agreement, and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Parties, intending to be legally bound, hereby agree as follows:   1. DEFINITIONS. For the purpose of this Agreement, the following terms shall have the following meanings:   1.1 \"Mill Recovery Technology/Intellectual Property\" shall mean all Technology, Software and Intellectual Property directed to mill-based recovery processes that generate biorefinery materials.   1.2 \"Common Information\" shall mean that Information that is related to, but not dedicated to, the SpinCo Assets, the SpinCo Liabilities, the SpinCo Business or the Transferred Entities.   1.3  \"Control\" or \"Controlled\" means, with respect to Intellectual Property, that SpinCo or a member of the SpinCo Group owns such Intellectual Property, in whole or in part, and/or has the right to grant a license to Parent with respect to such Intellectual Property as set forth herein and without incurring any financial or other obligations to any other Person, subject, in each case, to the terms of any license or other agreement to which SpinCo or any of the SpinCo Group is a party that relates to any such Intellectual Property.\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n  1.4 \"Improvements\" means any improvements, derivative works, enhancements, refinements, advances or other modifications with respect to any Licensed SpinCo IP (whether or not patentable or reduced to practice).   1.5 \"Intellectual Property\" shall mean all of the following whether arising under the Laws of the United States or of any other foreign or multinational jurisdiction: (a) patents, patent applications (including patents issued thereon) and statutory invention registrations, including reissues, divisions, continuations, continuations in part, substitutions, renewals, extensions and reexaminations of any of the foregoing, and all rights in any of the foregoing provided by international treaties or conventions, (b) trademarks, service marks, trade names, service names, trade dress, logos and other source or business identifiers, including all goodwill associated with any of the foregoing, and any and all common law rights in and to any of the foregoing, registrations and applications for registration of any of the foregoing, all rights in and to any of the foregoing provided by international treaties or conventions, and all reissues, extensions and renewals of any of the foregoing, (c) Internet domain names, accounts with Facebook, LinkedIn, Twitter and similar social media platforms, registrations and related rights, (d) copyrightable works, copyrights, moral rights, mask work rights, database rights and design rights, in each case, other than Software, whether or not registered, and all registrations and applications for registration of any of the foregoing, and all rights in and to any of the fore',\n",
              "    'Highlight the parts (if any) of this contract related to \"Document Name\" that should be reviewed by a lawyer. Details: The name of the contract',\n",
              "    'INTELLECTUAL PROPERTY AGREEMENT',\n",
              "    54,\n",
              "    85),\n",
              "   ('Exhibit 10.1 JOINT VENTURE AGREEMENT BETWEEN NOVO INTEGRATED SCIENCES INC. (\"NVOS\") AND HARVEST GOLD FARMS INC. (\"HGF\") FOR THE DEVELOPMENT, MANAGEMENT AND OPERATION OF HEMP FARMING AND MEDICINAL CROPS\\n\\n\\n\\n\\n\\nJOINT VENTURE AGREEMENT Dated as of December 19, 2019 This Joint Venture Agreement (the \"Agreement\") is entered into between Novo Integrated Sciences Inc., a Nevada Corporation with offices located at 11120 NE 2nd Street, Suite 200, Bellevue, Washington 98004, U.S.A (herein referred to as \"NVOS\") and Harvest Gold Farms Inc., a corporation organized under the laws of New Brunswick, Canada with offices located at 866 E. H. Daigle Blvd, Grand Falls, New Brunswick, E3Z 3E8, Canada (herein referred to as \"HGF\"). NVOS and HGF may be referred to herein collectively as the \"Parties\" and separately as a \"Party.\" RECEITALS WHEREAS, NVOS is willing to assist in development, assist in management and purchase biomass resulting from open field farming for health-related cash crops, in particular medicinal cannabis and industrial hemp; WHEREAS, NVOS is willing to develop and construct processing facilities as well as finished goods manufacturing and packaging facilities; WHEREAS, NVOS is willing to provide the Joint Venture access to its distribution pathways established either directly or indirectly through NVOS or its wholly or partially owned subsidiaries; WHEREAS, NVOS is willing to establish reasonable commercial cost bases to product processing and packaging ensuring a profitable and fully transparent Joint Venture; WHEREAS, NVOS is willing to utilize all applicable HGF tools and offerings for the purposes of developing a fully comprehensive North American business platform; WHEREAS, HGF is willing to work towards a mutually acceptable Joint Venture; WHEREAS, HGF is willing to engage to its fullest potential in the licencing, employment harvesting, legal right consulting, business development within its geographical jurisdiction; WHEREAS, HGF is willing assist in transport and distribution of raw and finished goods in both domestic and international jurisdictions; WHEREAS, HGF is willing to provide certified biomass to the JV on pre-determined, mutually agreed price per acre and participate on a net revenue split of products offered to market directly or indirectly through NVOS channels; NOW THEREFORE, the Parties agree to sign this Agreement for the purposes of developing, managing and arranging medicinal farming projects involving hemp and cannabis cash crops (hereinafter referred to as the \"Primary Project\") under the following terms set out in this Agreement for the noted project (herein, referred to as the \"Primary Contract\").\\n\\n\\n\\n\\n\\nARTICLE 1 - DEFINITIONS AND INTERPRETATION 1.1 For the purposes of this Agreement, unless the context otherwise requires, the following terms shall have the respective meanings set forth below and grammatical variations of such terms shall have corresponding meanings: (a) \"Action\" means any legal action, suit, claim, investigation, hearing or proceeding, including any audit, claim or assessment for Taxes or otherwise. (b) \"Agreement\" means this Joint Venture Agreement, dated December 19, 2019. (c) \"Company\" means the Joint Venture entity which will be registered and incorporated in a Canadian jurisdiction with its operating name as Novo Earth Therapeutics Inc. (d) \"Cost\" means cost of goods sold as defined in the financials of the Primary Project. (e) \"Effective Date\" is the date of the most recent final signature on this Agreement. (f) \"EPC\" means engineering, procurement, construction contracts. (g) \"HFG\" means Harvest Gold Farms Inc. (h) \"Joint Venture\" means a business arrangement where NVOS and HGF have agreed to pool their resources for the purpose of the Primary Project. (i) \"Law\" means any domestic or foreign, federal, state, provincial, municipal or local law, statute, ordinance, code, rule, or regulation having the force of law. (j) \"NHL\" means Novo Healthnet Limited. (k) \"NVOS\" means Novo Integrated Sciences Inc. (l) \"Parties\" means collectively, Harvest Gold Farms Inc. and Novo Inte',\n",
              "    'Highlight the parts (if any) of this contract related to \"Document Name\" that should be reviewed by a lawyer. Details: The name of the contract',\n",
              "    'JOINT VENTURE AGREEMENT',\n",
              "    207,\n",
              "    230),\n",
              "   ('EXHIBIT 99.4\\n\\n                            DATED 15TH DECEMBER 2001\\n\\n            CHINA ECONOMIC INFORMATION SERVICE OF XINHUA NEWS AGENCY\\n\\n                                       AND\\n\\n                        XINHUA FINANCIAL NETWORK LIMITED\\n\\n                                   ----------\\n\\n                            CONTENT LICENSE AGREEMENT                SUPPLEMENT TO THE EXCLUSIVE BROADCASTING AGREEMENT\\n\\n                                   ----------\\n\\n                                BAKER & McKENZIE                            14th Floor Hutchison House                                 10 Harcourt Road                                     Hong Kong                                  Tel: 2846-1888                                  Fax: 2845-0476\\n\\n                                     CONTENT\\n\\nClause                                                                      Page ------                                                                      ----                                                                           1.  Definitions and Interpretation.......................................     1 2.  Grant of Rights......................................................     2 3.  Delivery of Content..................................................     3 4.  Consideration........................................................     3 5.  Representations and Warranties.......................................     4 6.  Indemnity............................................................     4 7.  Term.................................................................     5 8.  Termination..........................................................     5 9.  Further Assurance....................................................     6 10. Entire Agreement; Amendments.........................................     6 11. Severance............................................................     6 12. No Waiver............................................................     6 13. Costs And Expenses...................................................     6 14. Counterparts.........................................................     6 15. Notice...............................................................     6 16. Governing Law And Arbitration........................................     7 Execution................................................................     8\\n\\nSchedule 1 - Contents\\n\\n                                       -i-\\n\\nTHIS AGREEMENT is made the 15th day of December 2001.\\n\\nBETWEEN\\n\\n(1)  CHINA ECONOMIC INFORMATION SERVICE OF XINHUA NEWS AGENCY, the organisation      within the Xinhua News Agency that is responsible for news and information      operations and business, registered in the People\\'s Republic of China with      offices at 57 Xuanwumen Xidajie, Beijing, the People\\'s Republic of China (      \"CEIS\"); and\\n\\n(2)  XINHUA FINANCIAL NETWORK LIMITED, a company incorporated in Hong Kong whose      registered office is at Room 2003-4, Vicwood Plaza, 199 Des Voeux Road      Central, Hong Kong (\"XFN\"),\\n\\n     (collectively referred to as \"PARTIES\"; individually, a \"PARTY\").\\n\\nSource: XINHUA SPORTS & ENTERTAINMENT LTD, F-1, 2/21/2007\\n\\n\\n\\n\\n\\nWHEREAS:\\n\\n(A)  CEIS is the owner and distributor of certain content of Xinhua News Agency      relating to financial and economic information;\\n\\n(B)  CEIS wishes to appoint XFN as its licensee to distribute the content to      users throughout the world in accordance with the terms and conditions of      this Agreement.\\n\\nIT IS HEREBY AGREED as follows:\\n\\n1.   DEFINITIONS AND INTERPRETATION\\n\\n1.1  In this Agreement unless the context otherwise requires the following words      shall have the following meaning:\\n\\n                 \"AFFILIATES\"       means any company, corporation, partnership, joint venture or                    other entity that directly or indirectly controls, is                    controlled by or is under common control with XFN;\\n\\n\"CONTENT\"          means real-time economic news including articles, reports,                    data, information and such materials that have or have ',\n",
              "    'Highlight the parts (if any) of this contract related to \"Document Name\" that should be reviewed by a lawyer. Details: The name of the contract',\n",
              "    'CONTENT LICENSE AGREEMENT',\n",
              "    315,\n",
              "    340),\n",
              "   ('Exhibit 10(xiv)\\n\\nMASTER SERVICES AGREEMENT Between RadialSpark, LLC and Clear Capital Page 1 of 10\\n\\n\\n\\n\\n\\nTHIS MASTER SERVICES AGREEMENT (\"Agreement\"), dated as of 09/24/2018 (the \"Effective Date\"), is between Clear Capital (the \"Company\") and RadialSpark, LLC (the \"Contractor\"). WHEREAS, Company desires from time to time to retain Contractor to perform certain management consulting services for Company; and WHEREAS, Contractor desires to perform such management consulting services for Company; NOW THEREFORE, in consideration of the foregoing premises, and the mutual covenants and agreements set forth herein, the parties hereto agree as follows: 1. PURPOSE OF ENGAGEMENT. (a) Company agrees to retain Contractor to perform the consulting services for Company, on a task by task basis (the \"Services\"), and Contractor agrees to furnish the Services on the terms and subject to the conditions set forth in this Agreement. During the term of this Agreement, Company and Contractor will develop and agree upon statements of work defining the Services and work product to be provided by Contractor, Contractor\\'s compensation, additional terms and conditions, if any, applicable to a particular engagement and such other details as the parties deem appropriate (each a \"Statement of Work\"). A Statement of Work may provide specifications for deliverables to be provided thereunder (the \"Specifications\"). Statements of Work that are from time to time agreed upon shall reference this Agreement, and shall be executed by the parties and attached hereto and shall form a part hereof. In all instances of a conflict, between the provisions of this Agreement and the specific provisions set forth in a Statement of Work, the provisions of this Agreement shall control. (b) Contractor shall provide sufficient qualified personnel to perform the Services in a professional and workmanlike manner in accordance with industry standards. A Statement of Work may designate certain individuals as \"Key Personnel\" for an engagement, and the parties subsequently may agree in writing that additional individuals are Key Personnel for such engagement. If there are Key Personnel for an engagement, Contractor shall provide the Services through those personnel and such additional personnel of Contractor as Contractor may from time to time determine to be required for the performance of the Services. Company shall have the right to interview and approve such additional personnel at Company\\'s request. If one or more Key Personnel terminate their employment with Contractor or otherwise become\\n\\nPage 2 of 10\\n\\n\\n\\n\\n\\nunavailable to work on an engagement for reasons beyond Contractor\\'s reasonable control, Contractor may provide the Services through other personnel with comparable training and experience. If Company becomes dissatisfied with any of Contractor\\'s personnel providing the Services, Company may notify Contractor of the details of its dissatisfaction, and the parties shall cooperate to remedy the problem as soon as possible. If Company reasonably requests, Contractor shall reassign the individual who is the subject of Company\\'s dissatisfaction and replace that person with other personnel in accordance with this Agreement. (c) Unless otherwise provided in a Statement of Work, Contractor shall provide the Services at Contractor\\'s facility. Contractor shall provide computing equipment consistent with the Services to be provided under the Statement of Work. When services are provided at a Company facility, Company shall provide workspace and other facilities such as computer support consistent with the requirements of the Services to be provided under the Statement of Work. Contractor shall cause its personnel at Company\\'s facility to comply with Company\\'s (i) safety and security rules and other rules applicable to those working in the facility, and (ii) Company\\'s policies concerning access to and security of any Company computer system to which Contractor may have access; provided, that Company has provided Contractor with copies of such rules and policies or has advised Contra',\n",
              "    'Highlight the parts (if any) of this contract related to \"Document Name\" that should be reviewed by a lawyer. Details: The name of the contract',\n",
              "    'MASTER SERVICES AGREEMENT (',\n",
              "    109,\n",
              "    136)]),\n",
              " (('Parties', 'possible negative'),\n",
              "  [('1                                                                     Exhibit 10.3\\n\\nI-on. (LOGO) www.i-on.com 561.394.9484 o 561.394-9773 fax 1733 avenida del sol, boca raton, florida, 33432\\n\\nWEB SITE HOSTING AGREEMENT\\n\\nThis WEB SITE HOSTING AGREEMENT (\"this Agreement\") is entered into this 6th day of April, 1999 by and between Centrack International, a Florida corporation (\"the Customer\"), and i-on interactive, a Florida corporation (\"i-on\").\\n\\nDEFINITIONS\\n\\nAs used in this Agreement, the term \"Web site\" shall mean a computer system intended to be accessed through the World Wide Web segment of the Internet, including software and content intended to be viewed and/or operated upon by persons accessing the computer system via the Internet. A Web site may exist on a single computer system with other Web sites.\\n\\nThe term \"Hosted Site\" shall mean the Web site of the Customer that is hosted by i-on under the terms and conditions of this Agreement.\\n\\nThe term \"Hosting Computer\" shall mean the computer system and related equipment on which the Hosted Site exists.\\n\\nSERVICES PROVIDED TO THE CUSTOMER\\n\\ni-on will maintain the operation of the Hosted Site continuously, twenty-four (24) hours per day, seven (7) days per week, including holidays, with the exception of reasonable hardware and software maintenance that must be performed on the Hosting Computer and/or the Hosted Site. i-on will use best efforts to schedule and perform such maintenance between the hours of 8pm and 8am Eastern Standard Time on weekdays, or during weekends.\\n\\nUnder this Agreement, i-on will provide the following limited services for the Hosted Site:\\n\\n      1. connectivity to the Internet via a T1 (that may be shared by other             Web sites) to a leading Internet backbone access provider such as             UUNET, and reasonable efforts to maintain such connectivity with the             phone company and the Internet backbone access provider;\\n\\n      2. use of the Hosting Computer (that may be shared by other Web sites)             as described in this Agreement and maintenance required to keep such             Hosting Computer in good working order;\\n\\n      3. physical space for the Hosting Computer at a facility that maintains             proper environmental conditions in the area(s) where the Hosting             Computer is located and maintains reasonable efforts to prevent             unauthorized access to the physical location of the Hosting             Computer;\\n\\n      4. an emergency electrical power backup system for the Hosting             Computer;\\n\\n      5. up to 150 MB of mirrored computer storage on the Hosting Computer;\\n\\n      6. archival backups of such mirrored computer storage on a weekly             basis;    2          7.  off-site storage of such backups at separate facility than the              location of the Hosting Computer;\\n\\n      8.  use of the Microsoft Windows NT Server 4.0 or higher operating              system software for the Hosting Computer and the Hosted Site;\\n\\n      9.  use of the Microsoft Internet Information Service (IIS) 3.0 or              higher Web server software for the Hosted Site (providing support              for the HTTP Web protocol);\\n\\n      10. use of the Microsoft SQL Server 6.5 or higher database server              software for the Hosted Site, within the boundaries of allocated              computer storage, per #5 above;\\n\\n      11. access to the Hosted Site via the ftp protocol to an administrative              account designated by the Customer for the Customer to maintain the              Hosted Site\\'s static content (such as HTML Web pages and computer              graphics);\\n\\n      12. up to 10 mailboxes accessible via the POP3 mail protocol that are              mapped to the Hosted Site\\'s Internet address;\\n\\n      13. up to 1 hour per month of Web site administration services at no              additional charge, limited to:\\n\\n               requests for changes to ftp/e-mail users and passwords;                   requests for e-mail configuration changes;                   modification of mail',\n",
              "    'Highlight the parts (if any) of this contract related to \"Parties\" that should be reviewed by a lawyer. Details: The two or more parties who signed the contract',\n",
              "    'I-ON INTERACTIVE, INC.',\n",
              "    0,\n",
              "    0),\n",
              "   ('1                                                                     Exhibit 10.3\\n\\nI-on. (LOGO) www.i-on.com 561.394.9484 o 561.394-9773 fax 1733 avenida del sol, boca raton, florida, 33432\\n\\nWEB SITE HOSTING AGREEMENT\\n\\nThis WEB SITE HOSTING AGREEMENT (\"this Agreement\") is entered into this 6th day of April, 1999 by and between Centrack International, a Florida corporation (\"the Customer\"), and i-on interactive, a Florida corporation (\"i-on\").\\n\\nDEFINITIONS\\n\\nAs used in this Agreement, the term \"Web site\" shall mean a computer system intended to be accessed through the World Wide Web segment of the Internet, including software and content intended to be viewed and/or operated upon by persons accessing the computer system via the Internet. A Web site may exist on a single computer system with other Web sites.\\n\\nThe term \"Hosted Site\" shall mean the Web site of the Customer that is hosted by i-on under the terms and conditions of this Agreement.\\n\\nThe term \"Hosting Computer\" shall mean the computer system and related equipment on which the Hosted Site exists.\\n\\nSERVICES PROVIDED TO THE CUSTOMER\\n\\ni-on will maintain the operation of the Hosted Site continuously, twenty-four (24) hours per day, seven (7) days per week, including holidays, with the exception of reasonable hardware and software maintenance that must be performed on the Hosting Computer and/or the Hosted Site. i-on will use best efforts to schedule and perform such maintenance between the hours of 8pm and 8am Eastern Standard Time on weekdays, or during weekends.\\n\\nUnder this Agreement, i-on will provide the following limited services for the Hosted Site:\\n\\n      1. connectivity to the Internet via a T1 (that may be shared by other             Web sites) to a leading Internet backbone access provider such as             UUNET, and reasonable efforts to maintain such connectivity with the             phone company and the Internet backbone access provider;\\n\\n      2. use of the Hosting Computer (that may be shared by other Web sites)             as described in this Agreement and maintenance required to keep such             Hosting Computer in good working order;\\n\\n      3. physical space for the Hosting Computer at a facility that maintains             proper environmental conditions in the area(s) where the Hosting             Computer is located and maintains reasonable efforts to prevent             unauthorized access to the physical location of the Hosting             Computer;\\n\\n      4. an emergency electrical power backup system for the Hosting             Computer;\\n\\n      5. up to 150 MB of mirrored computer storage on the Hosting Computer;\\n\\n      6. archival backups of such mirrored computer storage on a weekly             basis;    2          7.  off-site storage of such backups at separate facility than the              location of the Hosting Computer;\\n\\n      8.  use of the Microsoft Windows NT Server 4.0 or higher operating              system software for the Hosting Computer and the Hosted Site;\\n\\n      9.  use of the Microsoft Internet Information Service (IIS) 3.0 or              higher Web server software for the Hosted Site (providing support              for the HTTP Web protocol);\\n\\n      10. use of the Microsoft SQL Server 6.5 or higher database server              software for the Hosted Site, within the boundaries of allocated              computer storage, per #5 above;\\n\\n      11. access to the Hosted Site via the ftp protocol to an administrative              account designated by the Customer for the Customer to maintain the              Hosted Site\\'s static content (such as HTML Web pages and computer              graphics);\\n\\n      12. up to 10 mailboxes accessible via the POP3 mail protocol that are              mapped to the Hosted Site\\'s Internet address;\\n\\n      13. up to 1 hour per month of Web site administration services at no              additional charge, limited to:\\n\\n               requests for changes to ftp/e-mail users and passwords;                   requests for e-mail configuration changes;                   modification of mail',\n",
              "    'Highlight the parts (if any) of this contract related to \"Parties\" that should be reviewed by a lawyer. Details: The two or more parties who signed the contract',\n",
              "    'CENTRACK INTERNATIONAL, INC.',\n",
              "    0,\n",
              "    0),\n",
              "   ('Exhibit 10.2\\n\\n______________________________________________________________________________\\n\\nCO-PROMOTION AGREEMENT\\n\\nby and between\\n\\nDOVA PHARMACEUTICALS, INC.\\n\\nand\\n\\nVALEANT PHARMACEUTICALS NORTH AMERICA LLC\\n\\nSeptember 26, 2018\\n\\n______________________________________________________________________________\\n\\nCONFIDENTIAL TREATMENT HAS BEEN REQUESTED FOR PORTIONS OF THIS EXHIBIT. THE COPY FILED HEREWITH OMITS THE INFORMATION SUBJECT TO A CONFIDENTIALITY REQUEST. OMISSIONS ARE DESIGNATED [***]. A COMPLETE VERSION OF THIS EXHIBIT HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION.\\n\\nSource: DOVA PHARMACEUTICALS INC., 10-Q, 11/8/2018\\n\\n\\n\\n\\n\\nTABLE OF CONTENTS\\n\\nPage\\n\\nARTICLE 1 DEFINITIONS 1\\n\\nARTICLE 2 RIGHTS AND OBLIGATIONS 8\\n\\n2.1 Engagement; Grant of Rights. 8\\n\\n2.2 Retention of Rights. 9\\n\\n2.3 Non-Competition; Non-Solicitation. 9\\n\\n2.4 Dova Trademarks and Copyrights. 10\\n\\nARTICLE 3 JOINT STEERING COMMITTEE 11\\n\\n3.1 Formation of the JSC. 11\\n\\n3.2 Meetings and Minutes. 11\\n\\n3.3 Purpose of the JSC. 11\\n\\n3.4 Decision Making. 13\\n\\n3.5 Marketing Sub-Committee. 13\\n\\nARTICLE 4 VALEANT ACTIVITIES FOR THE PRODUCT 14\\n\\n4.1 Valeant Activities. 14\\n\\n4.2 Detailing. 15\\n\\n4.3 Compliance with Applicable Law. 17\\n\\n4.4 Field Force Personnel Training; Product Materials. 19\\n\\n4.5 Provisions Related to Field Force Personnel. 21\\n\\n4.6 Responsibility for Valeant Activity Costs and Expenses. 22\\n\\n4.7 Data Sharing. 22\\n\\nARTICLE 5 REGULATORY, SAFETY AND SURVEILLANCE, COMMERCIAL MATTERS 23\\n\\n5.1 Dova Responsibility. 23\\n\\n5.2 Valeant Involvement. 23\\n\\n5.3 Inspections. 23\\n\\n5.4 Pharmacovigilance. 24\\n\\n5.5 Unsolicited Requests for Medical Information. 24\\n\\n5.6 Recalls and Market Withdrawals. 25\\n\\n5.7 Certain Reporting Responsibilities. 25\\n\\n5.8 Booking of Sales Revenues. 25\\n\\n5.9 Returns. 25\\n\\nSource: DOVA PHARMACEUTICALS INC., 10-Q, 11/8/2018\\n\\n\\n\\n\\n\\ni\\n\\nCONFIDENTIAL TREATMENT HAS BEEN REQUESTED FOR PORTIONS OF THIS EXHIBIT. THE COPY FILED HEREWITH OMITS THE INFORMATION SUBJECT TO A CONFIDENTIALITY REQUEST. OMISSIONS ARE DESIGNATED [***]. A COMPLETE VERSION OF THIS EXHIBIT HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION.\\n\\nSource: DOVA PHARMACEUTICALS INC., 10-Q, 11/8/2018\\n\\n\\n\\n\\n\\nTABLE OF CONTENTS (continued)\\n\\n5.10 Manufacturing; Distribution; Marketing. 25\\n\\nARTICLE 6 FINANCIAL PROVISIONS 26\\n\\n6.1 Promotion Fee. 26\\n\\n6.2 Milestone Payment. 27\\n\\n6.3 Reports; Payments. 27\\n\\n6.4 Taxes. 28\\n\\n6.5 Determination of Specialty. 29\\n\\nARTICLE 7 AUDIT RIGHTS 30\\n\\n7.1 Recordkeeping. 30\\n\\n7.2 Valeant Rights. 30\\n\\n7.3 Dova Rights. 31\\n\\nARTICLE 8 INTELLECTUAL PROPERTY 32\\n\\n8.1 Ownership of Intellectual Property. 32\\n\\n8.2 Title to Trademarks and Copyrights. 32\\n\\n8.3 Protection of Trademarks and Copyrights. 32\\n\\n8.4 Disclosure of Know-How. 33\\n\\nARTICLE 9 CONFIDENTIALITY 33\\n\\n9.1 Confidential Information. 33\\n\\n9.2 Public Announcements. 34\\n\\nARTICLE 10 REPRESENTATIONS AND WARRANTIES; ADDITIONAL COVENANTS 35\\n\\n10.1 Representations and Warranties of Dova. 35\\n\\n10.2 Representations and Warranties of Valeant. 37\\n\\n10.3 Disclaimer of Warranty. 38\\n\\n10.4 Additional Covenants. 39\\n\\nARTICLE 11 INDEMNIFICATION; LIMITATIONS ON LIABILITY 39\\n\\n11.1 Indemnification by Dova. 39\\n\\n11.2 Indemnification by Valeant. 39\\n\\n11.3 Indemnification Procedures. 40\\n\\n11.4 Limitation of Liability. 40\\n\\n11.5 Insurance. 40\\n\\nARTICLE 12 TERM AND TERMINATION 41\\n\\n12.1 Term. 41\\n\\n12.2 Early Termination for Cause. 41\\n\\nSource: DOVA PHARMACEUTICALS INC., 10-Q, 11/8/2018\\n\\n\\n\\n\\n\\n12.3 Other Early Termination. 42\\n\\n12.4 Effects of Termination. 42\\n\\n12.5 Tail Period. 42\\n\\nii\\n\\nCONFIDENTIAL TREATMENT HAS BEEN REQUESTED FOR PORTIONS OF THIS EXHIBIT. THE COPY FILED HEREWITH OMITS THE INFORMATION SUBJECT TO A CONFIDENTIALITY REQUEST. OMISSIONS ARE DESIGNATED [***]. A COMPLETE VERSION OF THIS EXHIBIT HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION.\\n\\nSource: DOVA PHARMACEUTICALS INC., 10-Q, 11/8/2018\\n\\n\\n\\n\\n\\nTABLE OF CONTENTS (continued)\\n\\n12.6 Survival. 43\\n\\nARTICLE 13 MISCELLANEOUS 43\\n\\n13.1 Force Majeure. 43\\n\\n13.2 Assignment. 43\\n\\n13.3 Severability. 44\\n\\n13.4 Notices. 44\\n\\n13.5 Governing Law. 45\\n\\n13.6 Dispute Resolution. 45\\n\\n13.7 Waiver ',\n",
              "    'Highlight the parts (if any) of this contract related to \"Parties\" that should be reviewed by a lawyer. Details: The two or more parties who signed the contract',\n",
              "    'Dova and Valeant are each referred to individually as a \"Party\" and together as the \"Parties\".',\n",
              "    0,\n",
              "    0),\n",
              "   ('Exhibit 10.2\\n\\n______________________________________________________________________________\\n\\nCO-PROMOTION AGREEMENT\\n\\nby and between\\n\\nDOVA PHARMACEUTICALS, INC.\\n\\nand\\n\\nVALEANT PHARMACEUTICALS NORTH AMERICA LLC\\n\\nSeptember 26, 2018\\n\\n______________________________________________________________________________\\n\\nCONFIDENTIAL TREATMENT HAS BEEN REQUESTED FOR PORTIONS OF THIS EXHIBIT. THE COPY FILED HEREWITH OMITS THE INFORMATION SUBJECT TO A CONFIDENTIALITY REQUEST. OMISSIONS ARE DESIGNATED [***]. A COMPLETE VERSION OF THIS EXHIBIT HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION.\\n\\nSource: DOVA PHARMACEUTICALS INC., 10-Q, 11/8/2018\\n\\n\\n\\n\\n\\nTABLE OF CONTENTS\\n\\nPage\\n\\nARTICLE 1 DEFINITIONS 1\\n\\nARTICLE 2 RIGHTS AND OBLIGATIONS 8\\n\\n2.1 Engagement; Grant of Rights. 8\\n\\n2.2 Retention of Rights. 9\\n\\n2.3 Non-Competition; Non-Solicitation. 9\\n\\n2.4 Dova Trademarks and Copyrights. 10\\n\\nARTICLE 3 JOINT STEERING COMMITTEE 11\\n\\n3.1 Formation of the JSC. 11\\n\\n3.2 Meetings and Minutes. 11\\n\\n3.3 Purpose of the JSC. 11\\n\\n3.4 Decision Making. 13\\n\\n3.5 Marketing Sub-Committee. 13\\n\\nARTICLE 4 VALEANT ACTIVITIES FOR THE PRODUCT 14\\n\\n4.1 Valeant Activities. 14\\n\\n4.2 Detailing. 15\\n\\n4.3 Compliance with Applicable Law. 17\\n\\n4.4 Field Force Personnel Training; Product Materials. 19\\n\\n4.5 Provisions Related to Field Force Personnel. 21\\n\\n4.6 Responsibility for Valeant Activity Costs and Expenses. 22\\n\\n4.7 Data Sharing. 22\\n\\nARTICLE 5 REGULATORY, SAFETY AND SURVEILLANCE, COMMERCIAL MATTERS 23\\n\\n5.1 Dova Responsibility. 23\\n\\n5.2 Valeant Involvement. 23\\n\\n5.3 Inspections. 23\\n\\n5.4 Pharmacovigilance. 24\\n\\n5.5 Unsolicited Requests for Medical Information. 24\\n\\n5.6 Recalls and Market Withdrawals. 25\\n\\n5.7 Certain Reporting Responsibilities. 25\\n\\n5.8 Booking of Sales Revenues. 25\\n\\n5.9 Returns. 25\\n\\nSource: DOVA PHARMACEUTICALS INC., 10-Q, 11/8/2018\\n\\n\\n\\n\\n\\ni\\n\\nCONFIDENTIAL TREATMENT HAS BEEN REQUESTED FOR PORTIONS OF THIS EXHIBIT. THE COPY FILED HEREWITH OMITS THE INFORMATION SUBJECT TO A CONFIDENTIALITY REQUEST. OMISSIONS ARE DESIGNATED [***]. A COMPLETE VERSION OF THIS EXHIBIT HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION.\\n\\nSource: DOVA PHARMACEUTICALS INC., 10-Q, 11/8/2018\\n\\n\\n\\n\\n\\nTABLE OF CONTENTS (continued)\\n\\n5.10 Manufacturing; Distribution; Marketing. 25\\n\\nARTICLE 6 FINANCIAL PROVISIONS 26\\n\\n6.1 Promotion Fee. 26\\n\\n6.2 Milestone Payment. 27\\n\\n6.3 Reports; Payments. 27\\n\\n6.4 Taxes. 28\\n\\n6.5 Determination of Specialty. 29\\n\\nARTICLE 7 AUDIT RIGHTS 30\\n\\n7.1 Recordkeeping. 30\\n\\n7.2 Valeant Rights. 30\\n\\n7.3 Dova Rights. 31\\n\\nARTICLE 8 INTELLECTUAL PROPERTY 32\\n\\n8.1 Ownership of Intellectual Property. 32\\n\\n8.2 Title to Trademarks and Copyrights. 32\\n\\n8.3 Protection of Trademarks and Copyrights. 32\\n\\n8.4 Disclosure of Know-How. 33\\n\\nARTICLE 9 CONFIDENTIALITY 33\\n\\n9.1 Confidential Information. 33\\n\\n9.2 Public Announcements. 34\\n\\nARTICLE 10 REPRESENTATIONS AND WARRANTIES; ADDITIONAL COVENANTS 35\\n\\n10.1 Representations and Warranties of Dova. 35\\n\\n10.2 Representations and Warranties of Valeant. 37\\n\\n10.3 Disclaimer of Warranty. 38\\n\\n10.4 Additional Covenants. 39\\n\\nARTICLE 11 INDEMNIFICATION; LIMITATIONS ON LIABILITY 39\\n\\n11.1 Indemnification by Dova. 39\\n\\n11.2 Indemnification by Valeant. 39\\n\\n11.3 Indemnification Procedures. 40\\n\\n11.4 Limitation of Liability. 40\\n\\n11.5 Insurance. 40\\n\\nARTICLE 12 TERM AND TERMINATION 41\\n\\n12.1 Term. 41\\n\\n12.2 Early Termination for Cause. 41\\n\\nSource: DOVA PHARMACEUTICALS INC., 10-Q, 11/8/2018\\n\\n\\n\\n\\n\\n12.3 Other Early Termination. 42\\n\\n12.4 Effects of Termination. 42\\n\\n12.5 Tail Period. 42\\n\\nii\\n\\nCONFIDENTIAL TREATMENT HAS BEEN REQUESTED FOR PORTIONS OF THIS EXHIBIT. THE COPY FILED HEREWITH OMITS THE INFORMATION SUBJECT TO A CONFIDENTIALITY REQUEST. OMISSIONS ARE DESIGNATED [***]. A COMPLETE VERSION OF THIS EXHIBIT HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION.\\n\\nSource: DOVA PHARMACEUTICALS INC., 10-Q, 11/8/2018\\n\\n\\n\\n\\n\\nTABLE OF CONTENTS (continued)\\n\\n12.6 Survival. 43\\n\\nARTICLE 13 MISCELLANEOUS 43\\n\\n13.1 Force Majeure. 43\\n\\n13.2 Assignment. 43\\n\\n13.3 Severability. 44\\n\\n13.4 Notices. 44\\n\\n13.5 Governing Law. 45\\n\\n13.6 Dispute Resolution. 45\\n\\n13.7 Waiver ',\n",
              "    'Highlight the parts (if any) of this contract related to \"Parties\" that should be reviewed by a lawyer. Details: The two or more parties who signed the contract',\n",
              "    'Dova Pharmaceuticals, Inc.',\n",
              "    0,\n",
              "    0),\n",
              "   ('Exhibit 10.2\\n\\n______________________________________________________________________________\\n\\nCO-PROMOTION AGREEMENT\\n\\nby and between\\n\\nDOVA PHARMACEUTICALS, INC.\\n\\nand\\n\\nVALEANT PHARMACEUTICALS NORTH AMERICA LLC\\n\\nSeptember 26, 2018\\n\\n______________________________________________________________________________\\n\\nCONFIDENTIAL TREATMENT HAS BEEN REQUESTED FOR PORTIONS OF THIS EXHIBIT. THE COPY FILED HEREWITH OMITS THE INFORMATION SUBJECT TO A CONFIDENTIALITY REQUEST. OMISSIONS ARE DESIGNATED [***]. A COMPLETE VERSION OF THIS EXHIBIT HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION.\\n\\nSource: DOVA PHARMACEUTICALS INC., 10-Q, 11/8/2018\\n\\n\\n\\n\\n\\nTABLE OF CONTENTS\\n\\nPage\\n\\nARTICLE 1 DEFINITIONS 1\\n\\nARTICLE 2 RIGHTS AND OBLIGATIONS 8\\n\\n2.1 Engagement; Grant of Rights. 8\\n\\n2.2 Retention of Rights. 9\\n\\n2.3 Non-Competition; Non-Solicitation. 9\\n\\n2.4 Dova Trademarks and Copyrights. 10\\n\\nARTICLE 3 JOINT STEERING COMMITTEE 11\\n\\n3.1 Formation of the JSC. 11\\n\\n3.2 Meetings and Minutes. 11\\n\\n3.3 Purpose of the JSC. 11\\n\\n3.4 Decision Making. 13\\n\\n3.5 Marketing Sub-Committee. 13\\n\\nARTICLE 4 VALEANT ACTIVITIES FOR THE PRODUCT 14\\n\\n4.1 Valeant Activities. 14\\n\\n4.2 Detailing. 15\\n\\n4.3 Compliance with Applicable Law. 17\\n\\n4.4 Field Force Personnel Training; Product Materials. 19\\n\\n4.5 Provisions Related to Field Force Personnel. 21\\n\\n4.6 Responsibility for Valeant Activity Costs and Expenses. 22\\n\\n4.7 Data Sharing. 22\\n\\nARTICLE 5 REGULATORY, SAFETY AND SURVEILLANCE, COMMERCIAL MATTERS 23\\n\\n5.1 Dova Responsibility. 23\\n\\n5.2 Valeant Involvement. 23\\n\\n5.3 Inspections. 23\\n\\n5.4 Pharmacovigilance. 24\\n\\n5.5 Unsolicited Requests for Medical Information. 24\\n\\n5.6 Recalls and Market Withdrawals. 25\\n\\n5.7 Certain Reporting Responsibilities. 25\\n\\n5.8 Booking of Sales Revenues. 25\\n\\n5.9 Returns. 25\\n\\nSource: DOVA PHARMACEUTICALS INC., 10-Q, 11/8/2018\\n\\n\\n\\n\\n\\ni\\n\\nCONFIDENTIAL TREATMENT HAS BEEN REQUESTED FOR PORTIONS OF THIS EXHIBIT. THE COPY FILED HEREWITH OMITS THE INFORMATION SUBJECT TO A CONFIDENTIALITY REQUEST. OMISSIONS ARE DESIGNATED [***]. A COMPLETE VERSION OF THIS EXHIBIT HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION.\\n\\nSource: DOVA PHARMACEUTICALS INC., 10-Q, 11/8/2018\\n\\n\\n\\n\\n\\nTABLE OF CONTENTS (continued)\\n\\n5.10 Manufacturing; Distribution; Marketing. 25\\n\\nARTICLE 6 FINANCIAL PROVISIONS 26\\n\\n6.1 Promotion Fee. 26\\n\\n6.2 Milestone Payment. 27\\n\\n6.3 Reports; Payments. 27\\n\\n6.4 Taxes. 28\\n\\n6.5 Determination of Specialty. 29\\n\\nARTICLE 7 AUDIT RIGHTS 30\\n\\n7.1 Recordkeeping. 30\\n\\n7.2 Valeant Rights. 30\\n\\n7.3 Dova Rights. 31\\n\\nARTICLE 8 INTELLECTUAL PROPERTY 32\\n\\n8.1 Ownership of Intellectual Property. 32\\n\\n8.2 Title to Trademarks and Copyrights. 32\\n\\n8.3 Protection of Trademarks and Copyrights. 32\\n\\n8.4 Disclosure of Know-How. 33\\n\\nARTICLE 9 CONFIDENTIALITY 33\\n\\n9.1 Confidential Information. 33\\n\\n9.2 Public Announcements. 34\\n\\nARTICLE 10 REPRESENTATIONS AND WARRANTIES; ADDITIONAL COVENANTS 35\\n\\n10.1 Representations and Warranties of Dova. 35\\n\\n10.2 Representations and Warranties of Valeant. 37\\n\\n10.3 Disclaimer of Warranty. 38\\n\\n10.4 Additional Covenants. 39\\n\\nARTICLE 11 INDEMNIFICATION; LIMITATIONS ON LIABILITY 39\\n\\n11.1 Indemnification by Dova. 39\\n\\n11.2 Indemnification by Valeant. 39\\n\\n11.3 Indemnification Procedures. 40\\n\\n11.4 Limitation of Liability. 40\\n\\n11.5 Insurance. 40\\n\\nARTICLE 12 TERM AND TERMINATION 41\\n\\n12.1 Term. 41\\n\\n12.2 Early Termination for Cause. 41\\n\\nSource: DOVA PHARMACEUTICALS INC., 10-Q, 11/8/2018\\n\\n\\n\\n\\n\\n12.3 Other Early Termination. 42\\n\\n12.4 Effects of Termination. 42\\n\\n12.5 Tail Period. 42\\n\\nii\\n\\nCONFIDENTIAL TREATMENT HAS BEEN REQUESTED FOR PORTIONS OF THIS EXHIBIT. THE COPY FILED HEREWITH OMITS THE INFORMATION SUBJECT TO A CONFIDENTIALITY REQUEST. OMISSIONS ARE DESIGNATED [***]. A COMPLETE VERSION OF THIS EXHIBIT HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION.\\n\\nSource: DOVA PHARMACEUTICALS INC., 10-Q, 11/8/2018\\n\\n\\n\\n\\n\\nTABLE OF CONTENTS (continued)\\n\\n12.6 Survival. 43\\n\\nARTICLE 13 MISCELLANEOUS 43\\n\\n13.1 Force Majeure. 43\\n\\n13.2 Assignment. 43\\n\\n13.3 Severability. 44\\n\\n13.4 Notices. 44\\n\\n13.5 Governing Law. 45\\n\\n13.6 Dispute Resolution. 45\\n\\n13.7 Waiver ',\n",
              "    'Highlight the parts (if any) of this contract related to \"Parties\" that should be reviewed by a lawyer. Details: The two or more parties who signed the contract',\n",
              "    'Valeant Pharmaceuticals North America LLC',\n",
              "    0,\n",
              "    0),\n",
              "   (\"Exhibit 10.18 Confidential EXECUTION COPY\\n\\nCERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY [***], HAS BEEN OMITTED BECAUSE IT IS BOTH NOT MATERIAL AND WOULD BE COMPETITIVELY HARMFUL IF PUBLICLY DISCLOSED.\\n\\nDEVELOPMENT AND OPTION AGREEMENT\\n\\nbetween\\n\\nHARPOON THERAPEUTICS, INC.\\n\\nand\\n\\nABBVIE BIOTECHNOLOGY LTD\\n\\nDated as of November 20, 2019\\n\\nSource: HARPOON THERAPEUTICS, INC., 10-K, 3/12/2020\\n\\n\\n\\n\\n\\nTABLE OF CONTENTS\\n\\nARTICLE 1 DEFINITIONS 1\\n\\nARTICLE 2 COLLABORATION MANAGEMENT\\n\\n18\\n\\n2.1 Joint Governance Committee. 18 2.2 General Provisions Applicable to the JGC. 19 2.3 Discontinuation of the JGC. 20 2.4 Interactions Between the JGC and Internal Teams. 20 2.5 CMC Working Group. 21 2.6 Working Groups. 21 2.7 Expenses. 21\\n\\nARTICLE 3 DEVELOPMENT AND REGULATORY\\n\\n21\\n\\n3.1 Initial Development Plan and Activities. 21 3.2 AbbVie Option. 24 3.3 [***]. 25 3.4 Post-Exercise Development Activities. 26 3.5 Supply of Technology for Development Purposes. 27 3.6 Expenses and Invoicing. 27 3.7 Subcontracting. 28 3.8 Regulatory Matters. 28\\n\\nARTICLE 4 COMMERCIALIZATION 30\\n\\n4.1 In General. 30 4.2 Commercialization Diligence. 30 4.3 Booking of Sales; Distribution. 31 4.4 Product Trademarks. 31 4.5 Commercial Supply of Licensed Compounds or Licensed Products. 31\\n\\nARTICLE 5 GRANT OF RIGHTS\\n\\n33\\n\\n5.1 Grants to AbbVie. 33 5.2 Grants to Harpoon. 34 5.3 Sublicenses. 34 5.4 Distributorships. 34 5.5 Co-Promotion Rights. 34 5.6 Retention of Rights. 34 5.7 Confirmatory Patent License. 35 5.8 Exclusivity with Respect to the Territory. 35 5.9 In-License Agreements. 35\\n\\nARTICLE 6 PAYMENTS AND RECORDS\\n\\n36\\n\\n6.1 Upfront Payment. 36 6.2 Development and Regulatory Milestones. 36 6.3 First Commercial Sales Milestones. 37 6.4 Sales-Based Milestones. 37 6.5 Royalties. 38 6.6 Royalty Payments and Reports. 39 6.7 Mode of Payment; Offsets. 40 6.8 Withholding Taxes. 40\\n\\nSource: HARPOON THERAPEUTICS, INC., 10-K, 3/12/2020\\n\\n\\n\\n\\n\\n6.9 Indirect Taxes. 40 6.10 Interest on Late Payments. 41 6.11 Audit. 41 6.12 Audit Dispute. 41 6.13 Confidentiality. 41 6.14 [***] 41 6.15 No Other Compensation. 42\\n\\nARTICLE 7 INTELLECTUAL PROPERTY\\n\\n42\\n\\n7.1 Ownership of Intellectual Property. 42 7.2 Maintenance and Prosecution of Patents. 43 7.3 Enforcement of Patents. 45 7.4 Infringement Claims by Third Parties. 48 7.5 Invalidity or Unenforceability Defenses or Actions. 48 7.6 Product Trademarks. 49 7.7 International Nonproprietary Name. 50 7.8 Inventor's Remuneration. 50 7.9 Common Interest. 50\\n\\nARTICLE 8 PHARMACOVIGILANCE AND SAFETY\\n\\n50\\n\\n8.1 Pharmacovigilance. 50 8.2 Global Safety Database. 50\\n\\nARTICLE 9 CONFIDENTIALITY AND NON- DISCLOSURE\\n\\n51\\n\\n9.1 Product Information. 51 9.2 Confidentiality Obligations. 51 9.3 Permitted Disclosures. 52 9.4 Use of Name. 53 9.5 Public Announcements. 53 9.6 Publications. 54 9.7 Return of Confidential Information. 54 9.8 Survival. 54\\n\\nARTICLE 10 REPRESENTATIONS AND WARRANTIES\\n\\n55\\n\\n10.1 Mutual Representations and Warranties. 55 10.2 Additional Representations and Warranties of Harpoon. 55 10.3 Covenants of Harpoon. 58 10.4 Covenants of AbbVie. 58 10.5 DISCLAIMER OF WARRANTIES. 59\\n\\nARTICLE 11 INDEMNITY 60\\n\\n11.1 Indemnification of Harpoon. 60 11.2 Indemnification of AbbVie. 60 11.3 Notice of Claim. 60 11.4 Control of Defense. 61 11.5 Special, Indirect, and Other Losses. 61 11.6 Insurance. 61\\n\\nARTICLE 12 TERM AND TERMINATION\\n\\n62\\n\\n12.1 Term. 62\\n\\n- ii -\\n\\nSource: HARPOON THERAPEUTICS, INC., 10-K, 3/12/2020\\n\\n\\n\\n\\n\\n12.2 Termination for Material Breach. 62 12.3 Additional Termination Rights by AbbVie. 63 12.4 Termination for Insolvency. 63 12.5 Rights in Bankruptcy. 63 12.6 Termination in Entirety. 63 12.7 Reversion of Harpoon Products. 66 12.8 Termination of Terminated Territory. 67 12.9 Remedies. 67 12.10 Accrued Rights; Surviving Obligations. 67\\n\\nARTICLE 13 MISCELLANEOUS 68\\n\\n13.1 Force Majeure. 68 13.2 Change in Control of Harpoon. 68 13.3 Export Control. 69 13.4 Assignment. 69 13.5 Severability. 70 13.6 Governing Law, Jurisdiction and Service. 70 13.7 Dispute Resolution. 70 13.8 Notices. 71 13.9 Entire Agreement; Amendments. 72 13.10 English Language. 72 1\",\n",
              "    'Highlight the parts (if any) of this contract related to \"Parties\" that should be reviewed by a lawyer. Details: The two or more parties who signed the contract',\n",
              "    'AbbVie Biotechnology Ltd',\n",
              "    0,\n",
              "    0),\n",
              "   (\"Exhibit 10.18 Confidential EXECUTION COPY\\n\\nCERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY [***], HAS BEEN OMITTED BECAUSE IT IS BOTH NOT MATERIAL AND WOULD BE COMPETITIVELY HARMFUL IF PUBLICLY DISCLOSED.\\n\\nDEVELOPMENT AND OPTION AGREEMENT\\n\\nbetween\\n\\nHARPOON THERAPEUTICS, INC.\\n\\nand\\n\\nABBVIE BIOTECHNOLOGY LTD\\n\\nDated as of November 20, 2019\\n\\nSource: HARPOON THERAPEUTICS, INC., 10-K, 3/12/2020\\n\\n\\n\\n\\n\\nTABLE OF CONTENTS\\n\\nARTICLE 1 DEFINITIONS 1\\n\\nARTICLE 2 COLLABORATION MANAGEMENT\\n\\n18\\n\\n2.1 Joint Governance Committee. 18 2.2 General Provisions Applicable to the JGC. 19 2.3 Discontinuation of the JGC. 20 2.4 Interactions Between the JGC and Internal Teams. 20 2.5 CMC Working Group. 21 2.6 Working Groups. 21 2.7 Expenses. 21\\n\\nARTICLE 3 DEVELOPMENT AND REGULATORY\\n\\n21\\n\\n3.1 Initial Development Plan and Activities. 21 3.2 AbbVie Option. 24 3.3 [***]. 25 3.4 Post-Exercise Development Activities. 26 3.5 Supply of Technology for Development Purposes. 27 3.6 Expenses and Invoicing. 27 3.7 Subcontracting. 28 3.8 Regulatory Matters. 28\\n\\nARTICLE 4 COMMERCIALIZATION 30\\n\\n4.1 In General. 30 4.2 Commercialization Diligence. 30 4.3 Booking of Sales; Distribution. 31 4.4 Product Trademarks. 31 4.5 Commercial Supply of Licensed Compounds or Licensed Products. 31\\n\\nARTICLE 5 GRANT OF RIGHTS\\n\\n33\\n\\n5.1 Grants to AbbVie. 33 5.2 Grants to Harpoon. 34 5.3 Sublicenses. 34 5.4 Distributorships. 34 5.5 Co-Promotion Rights. 34 5.6 Retention of Rights. 34 5.7 Confirmatory Patent License. 35 5.8 Exclusivity with Respect to the Territory. 35 5.9 In-License Agreements. 35\\n\\nARTICLE 6 PAYMENTS AND RECORDS\\n\\n36\\n\\n6.1 Upfront Payment. 36 6.2 Development and Regulatory Milestones. 36 6.3 First Commercial Sales Milestones. 37 6.4 Sales-Based Milestones. 37 6.5 Royalties. 38 6.6 Royalty Payments and Reports. 39 6.7 Mode of Payment; Offsets. 40 6.8 Withholding Taxes. 40\\n\\nSource: HARPOON THERAPEUTICS, INC., 10-K, 3/12/2020\\n\\n\\n\\n\\n\\n6.9 Indirect Taxes. 40 6.10 Interest on Late Payments. 41 6.11 Audit. 41 6.12 Audit Dispute. 41 6.13 Confidentiality. 41 6.14 [***] 41 6.15 No Other Compensation. 42\\n\\nARTICLE 7 INTELLECTUAL PROPERTY\\n\\n42\\n\\n7.1 Ownership of Intellectual Property. 42 7.2 Maintenance and Prosecution of Patents. 43 7.3 Enforcement of Patents. 45 7.4 Infringement Claims by Third Parties. 48 7.5 Invalidity or Unenforceability Defenses or Actions. 48 7.6 Product Trademarks. 49 7.7 International Nonproprietary Name. 50 7.8 Inventor's Remuneration. 50 7.9 Common Interest. 50\\n\\nARTICLE 8 PHARMACOVIGILANCE AND SAFETY\\n\\n50\\n\\n8.1 Pharmacovigilance. 50 8.2 Global Safety Database. 50\\n\\nARTICLE 9 CONFIDENTIALITY AND NON- DISCLOSURE\\n\\n51\\n\\n9.1 Product Information. 51 9.2 Confidentiality Obligations. 51 9.3 Permitted Disclosures. 52 9.4 Use of Name. 53 9.5 Public Announcements. 53 9.6 Publications. 54 9.7 Return of Confidential Information. 54 9.8 Survival. 54\\n\\nARTICLE 10 REPRESENTATIONS AND WARRANTIES\\n\\n55\\n\\n10.1 Mutual Representations and Warranties. 55 10.2 Additional Representations and Warranties of Harpoon. 55 10.3 Covenants of Harpoon. 58 10.4 Covenants of AbbVie. 58 10.5 DISCLAIMER OF WARRANTIES. 59\\n\\nARTICLE 11 INDEMNITY 60\\n\\n11.1 Indemnification of Harpoon. 60 11.2 Indemnification of AbbVie. 60 11.3 Notice of Claim. 60 11.4 Control of Defense. 61 11.5 Special, Indirect, and Other Losses. 61 11.6 Insurance. 61\\n\\nARTICLE 12 TERM AND TERMINATION\\n\\n62\\n\\n12.1 Term. 62\\n\\n- ii -\\n\\nSource: HARPOON THERAPEUTICS, INC., 10-K, 3/12/2020\\n\\n\\n\\n\\n\\n12.2 Termination for Material Breach. 62 12.3 Additional Termination Rights by AbbVie. 63 12.4 Termination for Insolvency. 63 12.5 Rights in Bankruptcy. 63 12.6 Termination in Entirety. 63 12.7 Reversion of Harpoon Products. 66 12.8 Termination of Terminated Territory. 67 12.9 Remedies. 67 12.10 Accrued Rights; Surviving Obligations. 67\\n\\nARTICLE 13 MISCELLANEOUS 68\\n\\n13.1 Force Majeure. 68 13.2 Change in Control of Harpoon. 68 13.3 Export Control. 69 13.4 Assignment. 69 13.5 Severability. 70 13.6 Governing Law, Jurisdiction and Service. 70 13.7 Dispute Resolution. 70 13.8 Notices. 71 13.9 Entire Agreement; Amendments. 72 13.10 English Language. 72 1\",\n",
              "    'Highlight the parts (if any) of this contract related to \"Parties\" that should be reviewed by a lawyer. Details: The two or more parties who signed the contract',\n",
              "    'Harpoon Therapeutics, Inc.',\n",
              "    0,\n",
              "    0),\n",
              "   ('NON COMPETITION AGREEMENT AND RIGHT OF FIRST OFFER\\n\\nTHIS AGREEMENT is dated May 3,2006.\\n\\nBETWEEN:\\n\\nGLAMIS GOLD LTD., a company incorporated under the laws  of the Province of British Columbia, having an office at 310-5190  Neil Road, Reno, Nevada 89502\\n\\n(\"Glam is\")\\n\\nAND:\\n\\nWESTERN COPPER CORPORATION, a company  incorporated under the laws of the Province of British Columbia,  having an office at 2050-1111 West Georgia Street, Vancouver.  B.C. V6E 4M3\\n\\n(\"Western Copper\")\\n\\nWHEREAS:\\n\\n(A) Glamis, Western Copper and Western Silver Corporation (\"Western Silver\") are  parties to an arrangement agreement dated as of February 23, 2006 (the \"Arrangement  Agreement\"), pursuant to which, among other things, Western Copper will acquire certain assets  of Western Silver and Glamis will become the sole shareholder of Western Silver and the  indirect owner, through Western Silver, of certain corporations and mineral properties in Mexico  (the \"Arrangement\"); and\\n\\n(B) It is an obligation under the Arrangement Agreement that Western Copper agree  not to compete with Glamis in certain areas of Mexico and that Glamis grant Western Copper a  right of first offer with respect to the proposed disposition by Glamis of mineral properties or  legal interests therein located in Mexico that Glamis acquired under the Arrangement.\\n\\nNOW THEREFORE TIHS AGREEMENT WITNESSES that in consideration of the mutual  covenants and agreements contained herein and other good and valuable consideration, the  receipt and sufficiency of which is hereby acknowledged, the parties hereto covenant and agree  as follows: (Scheme B. mca)\\n\\n1I629<<7J\\n\\n\\n\\n\\n\\nPART I\\n\\nINTERPRETATION\\n\\nDefinitions\\n\\n1.1 In this Agreement, including the recitals, except as expressly provided or unless  the context otherwise requires,\\n\\n(a) Affiliate means, in respect of a party hereto, a corporation which is the subsidiary  of the party or vice versa or where each of the party and the corporation is controlled by  the same person,\\n\\n(b) Area of Non-Competition means the State of Zacatecas, Mexico and the area  extending 20 kilometers in all directions from the external boundary of each mineral  property owned or controlled by Western Silver or in which Western Silver holds any  legal interest, in Mexico, as at the Effective Date,\\n\\n(c) Business Day means a day which is not a Saturday, Sunday or a civic or statutory  holiday in Reno, Nevada and Vancouver, British Columbia,\\n\\n(d) Closing means the completion of the transactions contemplated by the  Arrangement Agreement,\\n\\n(e) Designated Mineral Property means a mineral property or individual mineral  concession within a mineral property, that is owned or controlled by Western Silver or in  which Western Silver holds any legal interest in Mexico as of the Effective Date,\\n\\n(f) Effective Date means May 3, 200ri or such later date as determined under the  Arrangement Agreement,\\n\\n(g) Mining Activities means any acquisition of mineral rights or any mineral  exploration or development activities, in any manner whatsoever, and\\n\\n(h) Person means an individual, corporation, body corporate, firm, limited liability  company, parmership, syndicate, joint venture, society, association, trust or  unincorporated organization.\\n\\nInterpretation\\n\\n1.2 In this Agreement, except as otherwise expressly provided or unless the context  otherwise requires,\\n\\n(a) the terms \"this Agreement\", \"hereof\\', \"herein\", \"hereunder\" and similar  expressions refer to this Agreement as from time to time supplemented or amended by  one or more agreements entered into pursuant to the applicable provisions of this  Agreement and not to any particular section or other portion,\\n\\n1162967.3\\n\\n\\n\\n\\n\\n- 3 \\'\\n\\n(b) a reference to a Part means a Part of this Agreement and the symbol ยง followed by  a number or some combination of numbers and letters refers to the provision of this  Agreement so designated and the symbol ยง followed by a letter within a provision refers  to a clause within such provision,\\n\\n(c) the headings used in this Agreement are for convenience only and do not form a  part of this Agreement and a',\n",
              "    'Highlight the parts (if any) of this contract related to \"Parties\" that should be reviewed by a lawyer. Details: The two or more parties who signed the contract',\n",
              "    'Bach of the parties hereto agree that all of their covenants, agreements and obligations hereunder shall extend to and be binding upon and may be enforced against any and  all of their respective subsidiaries and other Affiliates, as well as against the parties themselves,  as the case may be, and that the names of Glamis and Western Copper will herein be deemed to  refer collectively to Glamis and all of its subsidiaries and other Affiliates and to Western Copper  and all of its subsidiaries and other Affiliates, respectively.',\n",
              "    0,\n",
              "    0),\n",
              "   ('Exhibit 10.1\\n\\n\\n\\nSales, Marketing, Distribution, and Supply Agreement {***}   WHEREAS HEMISPHERX is a biopharmaceutical company with headquarters at One Penn Center, 1617 JFK Boulevard, Suite 500, Philadelphia, PA 19103, U.S. (\"HEMISPHERX\") and Scientific Products Pharmaceutical Co. LTD is a pharmaceutical company with its primary offices located at Tahlia Street, P.O Box 10485, Riyadh 11433 Saudi Arabia (\" SCIEN\"), each a \"Party\" together, \"Parties\", and   WHEREAS HEMISPHERX owns intellectual proprietary rights relating to Interferon alfa-n3 (human leukocyte derived), and   WHEREAS HEMISPHERX desires to have Interferon alfa-n3 (human leukocyte derived) provided to physicians to treat genital warts and other infections and diseases, including MERS, in the GCC (Gulf Cooperation Council) states , as appropriate, prior to regulatory approval in such countries and to have Interferon alfa-n3 (human leukocyte derived) approved by the regulatory authorities in each GCC country (Kingdom of Saudi Arabia, Bahrain, Qatar, Kuwait, United Arab emirates (UAE) and Sultanate of Oman)), and   WHEREAS SCIEN has sales, marketing, distribution capabilities in the GCC states, and   WHEREAS, AFTER A SUCCESSFUL CLINICAL TRIAL IN MERS, SCIEN affirms it has the ability to supply Interferon alfa-n3 (human leukocyte derived) in the GCC States prior to regulatory approval and simultaneously seek to gain regulatory approval in each of the GCC States. After the clinical trial in MERS has been conducted, in the event it is successful and the Hemispherx manufacturing site requires approved by the GCC / SFDA, the cost of any post-clinical trial inspection of the facility to be the responsibility of Scien or the regulatory authority, and subsequently to market, sell and distribute Interferon alfa-n3 (human leukocyte derived) in the GCC, and   WHEREAS, SCIEN desires to supply Interferon alfa-n3 (human leukocyte derived) under special approval from the Saudi Ministry of Health and for other GCC states where applicable, and   WHEREAS, HEMISPHERX desires to supply and sell Interferon alfa-n3 (human leukocyte derived)) to SCIEN, and SCIEN is willing to purchase Interferon alfa-n3 (human leukocyte derived) from HEMISPHERX for the purposes described in this agreement.   NOW THEREFORE, in consideration of the mutual covenants and agreements made herein, and for other good and valuable consideration, the receipt of which is hereby acknowledged, the Parties agree as follows:   I. DEFINITIONS   \"Affiliate\" means any corporation or other business entity, which controls, is controlled by, or is under the common control of a Party.   \"End User\" means a physician, medical facility or institution, or government agency that purchases Product with the intent of administering it to a patient.   \"Field\" means refractory/recurrent genital warts, recombinant interferon refractory patients and patients with other infectious diseases, e.g., MERS, influenza, West Nile Virus, and cancer, etc.   \"HEMISPHERX Intellectual Property\" means all HEMISPHERX patents, patent applications, know-how, and trademarks owned or controlled by HEMISPHERX up to the termination or expiration of this Agreement.   \"List Price\" means ${***}/Product Unit.   \"Product\" means an injectable formulation of clinical grade Interferon alfa-n3 (human leukocyte derived).\\n\\n{***} Confidential portions of this exhibit have been redacted and filed separately with the Commission pursuant to a confidential treatment request in accordance with Rule 24b-2 of the Securities Exchange Act of 1934, as amended.   Page 1 of 28\\n\\n\\n\\n\\n\\n\\n\\n  \"Product Data\" means all data possessed by HEMISPHERX relating to the use of Interferon alfa-n3 (human leukocyte derived) to treat patients in the Field and which is needed to obtain regulatory approval in the Territory.   \"Product Unit\" means 1 x1ml vial containing 5 million international units (I.U.) of Interferon alfa-n3 (human leukocyte derived)   \"Sales Price\" means the price SCIEN and/or its Affiliates charge an End User for a Product Unit.   \"Territory\" means the GCC States   \"Transfer Pri',\n",
              "    'Highlight the parts (if any) of this contract related to \"Parties\" that should be reviewed by a lawyer. Details: The two or more parties who signed the contract',\n",
              "    'Scientific Products Pharmaceutical Co. LTD.',\n",
              "    0,\n",
              "    0),\n",
              "   ('Exhibit 10.1\\n\\n\\n\\nSales, Marketing, Distribution, and Supply Agreement {***}   WHEREAS HEMISPHERX is a biopharmaceutical company with headquarters at One Penn Center, 1617 JFK Boulevard, Suite 500, Philadelphia, PA 19103, U.S. (\"HEMISPHERX\") and Scientific Products Pharmaceutical Co. LTD is a pharmaceutical company with its primary offices located at Tahlia Street, P.O Box 10485, Riyadh 11433 Saudi Arabia (\" SCIEN\"), each a \"Party\" together, \"Parties\", and   WHEREAS HEMISPHERX owns intellectual proprietary rights relating to Interferon alfa-n3 (human leukocyte derived), and   WHEREAS HEMISPHERX desires to have Interferon alfa-n3 (human leukocyte derived) provided to physicians to treat genital warts and other infections and diseases, including MERS, in the GCC (Gulf Cooperation Council) states , as appropriate, prior to regulatory approval in such countries and to have Interferon alfa-n3 (human leukocyte derived) approved by the regulatory authorities in each GCC country (Kingdom of Saudi Arabia, Bahrain, Qatar, Kuwait, United Arab emirates (UAE) and Sultanate of Oman)), and   WHEREAS SCIEN has sales, marketing, distribution capabilities in the GCC states, and   WHEREAS, AFTER A SUCCESSFUL CLINICAL TRIAL IN MERS, SCIEN affirms it has the ability to supply Interferon alfa-n3 (human leukocyte derived) in the GCC States prior to regulatory approval and simultaneously seek to gain regulatory approval in each of the GCC States. After the clinical trial in MERS has been conducted, in the event it is successful and the Hemispherx manufacturing site requires approved by the GCC / SFDA, the cost of any post-clinical trial inspection of the facility to be the responsibility of Scien or the regulatory authority, and subsequently to market, sell and distribute Interferon alfa-n3 (human leukocyte derived) in the GCC, and   WHEREAS, SCIEN desires to supply Interferon alfa-n3 (human leukocyte derived) under special approval from the Saudi Ministry of Health and for other GCC states where applicable, and   WHEREAS, HEMISPHERX desires to supply and sell Interferon alfa-n3 (human leukocyte derived)) to SCIEN, and SCIEN is willing to purchase Interferon alfa-n3 (human leukocyte derived) from HEMISPHERX for the purposes described in this agreement.   NOW THEREFORE, in consideration of the mutual covenants and agreements made herein, and for other good and valuable consideration, the receipt of which is hereby acknowledged, the Parties agree as follows:   I. DEFINITIONS   \"Affiliate\" means any corporation or other business entity, which controls, is controlled by, or is under the common control of a Party.   \"End User\" means a physician, medical facility or institution, or government agency that purchases Product with the intent of administering it to a patient.   \"Field\" means refractory/recurrent genital warts, recombinant interferon refractory patients and patients with other infectious diseases, e.g., MERS, influenza, West Nile Virus, and cancer, etc.   \"HEMISPHERX Intellectual Property\" means all HEMISPHERX patents, patent applications, know-how, and trademarks owned or controlled by HEMISPHERX up to the termination or expiration of this Agreement.   \"List Price\" means ${***}/Product Unit.   \"Product\" means an injectable formulation of clinical grade Interferon alfa-n3 (human leukocyte derived).\\n\\n{***} Confidential portions of this exhibit have been redacted and filed separately with the Commission pursuant to a confidential treatment request in accordance with Rule 24b-2 of the Securities Exchange Act of 1934, as amended.   Page 1 of 28\\n\\n\\n\\n\\n\\n\\n\\n  \"Product Data\" means all data possessed by HEMISPHERX relating to the use of Interferon alfa-n3 (human leukocyte derived) to treat patients in the Field and which is needed to obtain regulatory approval in the Territory.   \"Product Unit\" means 1 x1ml vial containing 5 million international units (I.U.) of Interferon alfa-n3 (human leukocyte derived)   \"Sales Price\" means the price SCIEN and/or its Affiliates charge an End User for a Product Unit.   \"Territory\" means the GCC States   \"Transfer Pri',\n",
              "    'Highlight the parts (if any) of this contract related to \"Parties\" that should be reviewed by a lawyer. Details: The two or more parties who signed the contract',\n",
              "    'Hemispherx Biopharma, Inc.',\n",
              "    0,\n",
              "    0),\n",
              "   ('Exhibit 10.1\\n\\n\\n\\nSales, Marketing, Distribution, and Supply Agreement {***}   WHEREAS HEMISPHERX is a biopharmaceutical company with headquarters at One Penn Center, 1617 JFK Boulevard, Suite 500, Philadelphia, PA 19103, U.S. (\"HEMISPHERX\") and Scientific Products Pharmaceutical Co. LTD is a pharmaceutical company with its primary offices located at Tahlia Street, P.O Box 10485, Riyadh 11433 Saudi Arabia (\" SCIEN\"), each a \"Party\" together, \"Parties\", and   WHEREAS HEMISPHERX owns intellectual proprietary rights relating to Interferon alfa-n3 (human leukocyte derived), and   WHEREAS HEMISPHERX desires to have Interferon alfa-n3 (human leukocyte derived) provided to physicians to treat genital warts and other infections and diseases, including MERS, in the GCC (Gulf Cooperation Council) states , as appropriate, prior to regulatory approval in such countries and to have Interferon alfa-n3 (human leukocyte derived) approved by the regulatory authorities in each GCC country (Kingdom of Saudi Arabia, Bahrain, Qatar, Kuwait, United Arab emirates (UAE) and Sultanate of Oman)), and   WHEREAS SCIEN has sales, marketing, distribution capabilities in the GCC states, and   WHEREAS, AFTER A SUCCESSFUL CLINICAL TRIAL IN MERS, SCIEN affirms it has the ability to supply Interferon alfa-n3 (human leukocyte derived) in the GCC States prior to regulatory approval and simultaneously seek to gain regulatory approval in each of the GCC States. After the clinical trial in MERS has been conducted, in the event it is successful and the Hemispherx manufacturing site requires approved by the GCC / SFDA, the cost of any post-clinical trial inspection of the facility to be the responsibility of Scien or the regulatory authority, and subsequently to market, sell and distribute Interferon alfa-n3 (human leukocyte derived) in the GCC, and   WHEREAS, SCIEN desires to supply Interferon alfa-n3 (human leukocyte derived) under special approval from the Saudi Ministry of Health and for other GCC states where applicable, and   WHEREAS, HEMISPHERX desires to supply and sell Interferon alfa-n3 (human leukocyte derived)) to SCIEN, and SCIEN is willing to purchase Interferon alfa-n3 (human leukocyte derived) from HEMISPHERX for the purposes described in this agreement.   NOW THEREFORE, in consideration of the mutual covenants and agreements made herein, and for other good and valuable consideration, the receipt of which is hereby acknowledged, the Parties agree as follows:   I. DEFINITIONS   \"Affiliate\" means any corporation or other business entity, which controls, is controlled by, or is under the common control of a Party.   \"End User\" means a physician, medical facility or institution, or government agency that purchases Product with the intent of administering it to a patient.   \"Field\" means refractory/recurrent genital warts, recombinant interferon refractory patients and patients with other infectious diseases, e.g., MERS, influenza, West Nile Virus, and cancer, etc.   \"HEMISPHERX Intellectual Property\" means all HEMISPHERX patents, patent applications, know-how, and trademarks owned or controlled by HEMISPHERX up to the termination or expiration of this Agreement.   \"List Price\" means ${***}/Product Unit.   \"Product\" means an injectable formulation of clinical grade Interferon alfa-n3 (human leukocyte derived).\\n\\n{***} Confidential portions of this exhibit have been redacted and filed separately with the Commission pursuant to a confidential treatment request in accordance with Rule 24b-2 of the Securities Exchange Act of 1934, as amended.   Page 1 of 28\\n\\n\\n\\n\\n\\n\\n\\n  \"Product Data\" means all data possessed by HEMISPHERX relating to the use of Interferon alfa-n3 (human leukocyte derived) to treat patients in the Field and which is needed to obtain regulatory approval in the Territory.   \"Product Unit\" means 1 x1ml vial containing 5 million international units (I.U.) of Interferon alfa-n3 (human leukocyte derived)   \"Sales Price\" means the price SCIEN and/or its Affiliates charge an End User for a Product Unit.   \"Territory\" means the GCC States   \"Transfer Pri',\n",
              "    'Highlight the parts (if any) of this contract related to \"Parties\" that should be reviewed by a lawyer. Details: The two or more parties who signed the contract',\n",
              "    'SCIENTIFIC PRODUCTS PHARMACEUTICAL CO. LTD',\n",
              "    0,\n",
              "    0),\n",
              "   ('Exhibit 10.1\\n\\n\\n\\nSales, Marketing, Distribution, and Supply Agreement {***}   WHEREAS HEMISPHERX is a biopharmaceutical company with headquarters at One Penn Center, 1617 JFK Boulevard, Suite 500, Philadelphia, PA 19103, U.S. (\"HEMISPHERX\") and Scientific Products Pharmaceutical Co. LTD is a pharmaceutical company with its primary offices located at Tahlia Street, P.O Box 10485, Riyadh 11433 Saudi Arabia (\" SCIEN\"), each a \"Party\" together, \"Parties\", and   WHEREAS HEMISPHERX owns intellectual proprietary rights relating to Interferon alfa-n3 (human leukocyte derived), and   WHEREAS HEMISPHERX desires to have Interferon alfa-n3 (human leukocyte derived) provided to physicians to treat genital warts and other infections and diseases, including MERS, in the GCC (Gulf Cooperation Council) states , as appropriate, prior to regulatory approval in such countries and to have Interferon alfa-n3 (human leukocyte derived) approved by the regulatory authorities in each GCC country (Kingdom of Saudi Arabia, Bahrain, Qatar, Kuwait, United Arab emirates (UAE) and Sultanate of Oman)), and   WHEREAS SCIEN has sales, marketing, distribution capabilities in the GCC states, and   WHEREAS, AFTER A SUCCESSFUL CLINICAL TRIAL IN MERS, SCIEN affirms it has the ability to supply Interferon alfa-n3 (human leukocyte derived) in the GCC States prior to regulatory approval and simultaneously seek to gain regulatory approval in each of the GCC States. After the clinical trial in MERS has been conducted, in the event it is successful and the Hemispherx manufacturing site requires approved by the GCC / SFDA, the cost of any post-clinical trial inspection of the facility to be the responsibility of Scien or the regulatory authority, and subsequently to market, sell and distribute Interferon alfa-n3 (human leukocyte derived) in the GCC, and   WHEREAS, SCIEN desires to supply Interferon alfa-n3 (human leukocyte derived) under special approval from the Saudi Ministry of Health and for other GCC states where applicable, and   WHEREAS, HEMISPHERX desires to supply and sell Interferon alfa-n3 (human leukocyte derived)) to SCIEN, and SCIEN is willing to purchase Interferon alfa-n3 (human leukocyte derived) from HEMISPHERX for the purposes described in this agreement.   NOW THEREFORE, in consideration of the mutual covenants and agreements made herein, and for other good and valuable consideration, the receipt of which is hereby acknowledged, the Parties agree as follows:   I. DEFINITIONS   \"Affiliate\" means any corporation or other business entity, which controls, is controlled by, or is under the common control of a Party.   \"End User\" means a physician, medical facility or institution, or government agency that purchases Product with the intent of administering it to a patient.   \"Field\" means refractory/recurrent genital warts, recombinant interferon refractory patients and patients with other infectious diseases, e.g., MERS, influenza, West Nile Virus, and cancer, etc.   \"HEMISPHERX Intellectual Property\" means all HEMISPHERX patents, patent applications, know-how, and trademarks owned or controlled by HEMISPHERX up to the termination or expiration of this Agreement.   \"List Price\" means ${***}/Product Unit.   \"Product\" means an injectable formulation of clinical grade Interferon alfa-n3 (human leukocyte derived).\\n\\n{***} Confidential portions of this exhibit have been redacted and filed separately with the Commission pursuant to a confidential treatment request in accordance with Rule 24b-2 of the Securities Exchange Act of 1934, as amended.   Page 1 of 28\\n\\n\\n\\n\\n\\n\\n\\n  \"Product Data\" means all data possessed by HEMISPHERX relating to the use of Interferon alfa-n3 (human leukocyte derived) to treat patients in the Field and which is needed to obtain regulatory approval in the Territory.   \"Product Unit\" means 1 x1ml vial containing 5 million international units (I.U.) of Interferon alfa-n3 (human leukocyte derived)   \"Sales Price\" means the price SCIEN and/or its Affiliates charge an End User for a Product Unit.   \"Territory\" means the GCC States   \"Transfer Pri',\n",
              "    'Highlight the parts (if any) of this contract related to \"Parties\" that should be reviewed by a lawyer. Details: The two or more parties who signed the contract',\n",
              "    'HEMISPHERX BIOPHARMA, INC',\n",
              "    0,\n",
              "    0),\n",
              "   ('EXHIBIT 10.23\\n\\nCOMPLETION AND LIOUDm MAINTENANCE 4GRFFMFST\\n\\nTHIS COMPLEHON AGREEMENT AND UQITDITV MAINTENANCE AGREEMENT ( \\'Agreement\") {5 made and entered into effective as of  June 29, 2006 between PRIMEEVERG\\\\\\'CORPORATION ( Time\"), GUARANTY BANK, FSB (\\'Guaranty\") and PRIME OFFSHORELT.C. T: Offshore\"!\\n\\nPrime is the majority shareholder of Prime Offshore L.L.C. COffshore\"! Offshore and Guaranty are parties to a Credit Agreement dated June 29,  2006, by and between Offshore as Borrower and Guaranty, as Agent and Lender i \"Credit Agreement\\'T wherein Guaranty is loaning certain funds  to Offshore to drill and complete wells and construct, install and operate in-field and flow pipelines, caissons, platforms and production facilities  for wells m South Padre Island Area OCS Blocks 1113, 1059, 1060, 1073 and 1133 and North Padre Island Area OCS Block 998 T\\'Derelopment  Project\").\\n\\n1. Completion Commrtiryr.t\\n\\nEach of the South Padre Island Area OCS Blocks 1113,1059,1060,1073 and 1133 and the North Padre Island Area OCS Block 998 shall be defined  as a \"Project Field.\\'\\'\\n\\nFor purposes ofthis Agreement, Project Completion shall consist oftwo components and be defined as:\\n\\nA) each Project Field in the Development Project having all planned in-field and flow pipelines, caissons, platforms and production facilities  for all the wells in such Project Field, for which Guaranty has loaned funds, installed and operationalsuch that the production from all such  wells can be transported to a readily available sales point for naturalgas. In addition, for each Project Field, Project Completion will include,  but not limited to:\\n\\na) obtaining required permits, easements and governmental approvals;\\n\\nb) executing necessary\" construction contract(s);\\n\\nc) completing tests considered usual and customary\" and required to be conducted with results tn accordance with those necessary\" to  permit operations;\\n\\nd) ensuring that each Project Field is free and clear of all bens other than those in favor of Guaranty and Permitted Liens under the Credit  Agreement and:\\n\\ne) causing all costs of the Development Project to be paid when due; and,\\n\\nB) the 12-inch loop pipeline fromNorth Padre Island Area OCS Block 996 to the pipeline owned by the Williams Companies Inc. having been  constructed and installed in accordance with the plans and specifications in the construction contracts).\\n\\n\\n\\n\\n\\nAs consideration for Guaranty entering into the Credit Agreement to provide such loans for the Development Project and to ensure Project  Completion. Prime absolutely and unconditionally warrants to Guaranty to fund the payment to Offshore of all costs that exzeed the available  commitments under the Credit Agreement, including interest, for Project Completion. In the event Offshore is in Default under Section 7.1(f), (g),  (h) and/or (i) ofthe Credit Agreement, then Prime absolutely and unconditionally warrants to Guaranty\" the assumption of all costs for Project  Completion.\\n\\n2. Licuieitv Maintenance\\n\\nPrime will, during the term of the Credit Agreement, maintain liquidity consisting of unused revolver availability\" under the Credit Agreement dated  December!, 2002, as amended, with Prime et aland Guaranty, and/or unrestricted cash and cash equivalents of $25,000,000. This required liquidity\"  win reduce dollar-for-dollar with any additional shareholder advance s and increase dollar-for-dollar to a maximum of $21,000,000 with any  repayment of shareholder advances. To the extent that shareholder repayment has occurred, Prime agrees to fund additional shareholder loans  equal to the amount repayed by the shareholder, as needed to ensure Project Clomp let ion\\n\\nThis Agreement shall remain in force until each component ofProject Completion is satisfied. Once a component is satisfied, Prime\\'s absolute and  unconditional warranty to Guaranty to fund the payment to Offshore of ad costs that esceed the available commitments under the Credit  Agreement for that conponent, including interest, wid ejpire.\\n\\nPrime understands that a breach ofobligations under this Agreement would result i',\n",
              "    'Highlight the parts (if any) of this contract related to \"Parties\" that should be reviewed by a lawyer. Details: The two or more parties who signed the contract',\n",
              "    'PRIMEEVERGY CORPORATION',\n",
              "    0,\n",
              "    0),\n",
              "   ('EXHIBIT 10.23\\n\\nCOMPLETION AND LIOUDm MAINTENANCE 4GRFFMFST\\n\\nTHIS COMPLEHON AGREEMENT AND UQITDITV MAINTENANCE AGREEMENT ( \\'Agreement\") {5 made and entered into effective as of  June 29, 2006 between PRIMEEVERG\\\\\\'CORPORATION ( Time\"), GUARANTY BANK, FSB (\\'Guaranty\") and PRIME OFFSHORELT.C. T: Offshore\"!\\n\\nPrime is the majority shareholder of Prime Offshore L.L.C. COffshore\"! Offshore and Guaranty are parties to a Credit Agreement dated June 29,  2006, by and between Offshore as Borrower and Guaranty, as Agent and Lender i \"Credit Agreement\\'T wherein Guaranty is loaning certain funds  to Offshore to drill and complete wells and construct, install and operate in-field and flow pipelines, caissons, platforms and production facilities  for wells m South Padre Island Area OCS Blocks 1113, 1059, 1060, 1073 and 1133 and North Padre Island Area OCS Block 998 T\\'Derelopment  Project\").\\n\\n1. Completion Commrtiryr.t\\n\\nEach of the South Padre Island Area OCS Blocks 1113,1059,1060,1073 and 1133 and the North Padre Island Area OCS Block 998 shall be defined  as a \"Project Field.\\'\\'\\n\\nFor purposes ofthis Agreement, Project Completion shall consist oftwo components and be defined as:\\n\\nA) each Project Field in the Development Project having all planned in-field and flow pipelines, caissons, platforms and production facilities  for all the wells in such Project Field, for which Guaranty has loaned funds, installed and operationalsuch that the production from all such  wells can be transported to a readily available sales point for naturalgas. In addition, for each Project Field, Project Completion will include,  but not limited to:\\n\\na) obtaining required permits, easements and governmental approvals;\\n\\nb) executing necessary\" construction contract(s);\\n\\nc) completing tests considered usual and customary\" and required to be conducted with results tn accordance with those necessary\" to  permit operations;\\n\\nd) ensuring that each Project Field is free and clear of all bens other than those in favor of Guaranty and Permitted Liens under the Credit  Agreement and:\\n\\ne) causing all costs of the Development Project to be paid when due; and,\\n\\nB) the 12-inch loop pipeline fromNorth Padre Island Area OCS Block 996 to the pipeline owned by the Williams Companies Inc. having been  constructed and installed in accordance with the plans and specifications in the construction contracts).\\n\\n\\n\\n\\n\\nAs consideration for Guaranty entering into the Credit Agreement to provide such loans for the Development Project and to ensure Project  Completion. Prime absolutely and unconditionally warrants to Guaranty to fund the payment to Offshore of all costs that exzeed the available  commitments under the Credit Agreement, including interest, for Project Completion. In the event Offshore is in Default under Section 7.1(f), (g),  (h) and/or (i) ofthe Credit Agreement, then Prime absolutely and unconditionally warrants to Guaranty\" the assumption of all costs for Project  Completion.\\n\\n2. Licuieitv Maintenance\\n\\nPrime will, during the term of the Credit Agreement, maintain liquidity consisting of unused revolver availability\" under the Credit Agreement dated  December!, 2002, as amended, with Prime et aland Guaranty, and/or unrestricted cash and cash equivalents of $25,000,000. This required liquidity\"  win reduce dollar-for-dollar with any additional shareholder advance s and increase dollar-for-dollar to a maximum of $21,000,000 with any  repayment of shareholder advances. To the extent that shareholder repayment has occurred, Prime agrees to fund additional shareholder loans  equal to the amount repayed by the shareholder, as needed to ensure Project Clomp let ion\\n\\nThis Agreement shall remain in force until each component ofProject Completion is satisfied. Once a component is satisfied, Prime\\'s absolute and  unconditional warranty to Guaranty to fund the payment to Offshore of ad costs that esceed the available commitments under the Credit  Agreement for that conponent, including interest, wid ejpire.\\n\\nPrime understands that a breach ofobligations under this Agreement would result i',\n",
              "    'Highlight the parts (if any) of this contract related to \"Parties\" that should be reviewed by a lawyer. Details: The two or more parties who signed the contract',\n",
              "    'PRIME OFFSHORE L.L.C.',\n",
              "    0,\n",
              "    0),\n",
              "   ('Exhibit 10.1 Certain portions of this exhibit have been omitted pursuant to Rule 601(b)(10) of Regulation S-K. The omitted information is (i) not material and (ii) would likely cause competitive harm to the Company if publicly disclosed. Information that has been omitted has been noted in this document with a placeholder identified by the mark \"[***]\". EXECUTION COPY PROMOTION AGREEMENT\\n\\nby and between\\n\\nSIGA TECHNOLOGIES, INC.\\n\\nand\\n\\nMERIDIAN MEDICAL TECHNOLOGIES, INC., a Pfizer company\\n\\nSource: SIGA TECHNOLOGIES INC, 8-K, 6/3/2019\\n\\n\\n\\n\\n\\nTABLE OF CONTENTS PAGE ARTICLE 1 DEFINITIONS 1 ARTICLE 2 GRANT OF RIGHTS 11 2.1 Grant of Rights to MMT 11 2.2 Negative Covenants 11 2.3 Non-Compete Covenant 11 2.4 Retained Rights 12 2.5 No Implied Licenses 12 2.6 [***] 12 ARTICLE 3 GOVERNANCE 12 3.1 Joint Steering Committee 12 3.2 Good Faith 12 3.3 Scope of Governance 13 ARTICLE 4 PROMOTION AND OTHER COMMERCIALIZATION 13 4.1 Promotion in the Territory 13 4.2 Diligence 14 4.3 Customer Contracts 14 4.4 Regulatory Matters 15 4.5 Discontinued Countries 15 ARTICLE 5 FORECASTING AND ORDERING 15 5.1 Product Forecasts 15 5.2 Purchase Orders 15 5.3 Delivery 16 5.4 Supply Limitation 16 5.5 Supply Penalties 16 5.6 Adverse Event Reporting 16 ARTICLE 6 PAYMENTS 16 6.1 Promotion Fee 16 6.2 Payments 17 6.3 Currency 17 6.4 Records 17 6.5 Audits 18 6.6 Blocked Payment and Indemnification 19 6.7 Source of Recovery 19 6.8 Taxes 19 ARTICLE 7 INTELLECTUAL PROPERTY 20 7.1 Ownership of SIGA Intellectual Property 20 7.2 Intellectual Property Maintenance 20 7.3 New Patents and Trademarks 20\\n\\n-i-\\n\\nSource: SIGA TECHNOLOGIES INC, 8-K, 6/3/2019\\n\\n\\n\\n\\n\\nTABLE OF CONTENTS (CONTINUED) PAGE ARTICLE 8 REPRESENTATIONS AND WARRANTIES; COVENANTS 21 8.1 Mutual Representations and Warranties 21 8.2 Additional Representations, Warranties and Covenants of SIGA 22 8.3 Additional Representations and Warranties of MMT 26 8.4 Covenants 27 8.5 No Other Representations or Warranties 29 ARTICLE 9 INDEMNIFICATION 29 9.1 Indemnification by SIGA 29 9.2 Indemnification by MMT 30 9.3 Indemnification Procedures 30 9.4 Insurance 31 9.5 Limitation of Liability 31 ARTICLE 10 CONFIDENTIALITY 31 10.1 Confidentiality 31 10.2 Authorized Disclosure 32 10.3 Technical Publication 33 10.4 Publicity; Terms of Agreement 33 10.5 Prior Confidentiality Agreements 34 10.6 Return of Confidential Information 34 10.7 Unauthorized Use 34 10.8 Exclusive Property 34 ARTICLE 11 TERM AND TERMINATION 35 11.1 Term 35 11.2 Termination for Cause 35 11.3 Termination Upon Certain Changes of Control 36 11.4 Termination for Failure to [***] 36 11.5 Termination for Convenience 36 11.6 Effect of Termination 36 11.7 Survival 36 ARTICLE 12 DISPUTE RESOLUTION 36 12.1 Executive Officer Resolution 36 12.2 Governing Law 37 12.3 Jurisdiction 37 12.4 NO JURY TRIAL 37 ARTICLE 13 MISCELLANEOUS 38 13.1 Entire Agreement; Amendment 38 13.2 Force Majeure 38\\n\\n-ii-\\n\\nSource: SIGA TECHNOLOGIES INC, 8-K, 6/3/2019\\n\\n\\n\\n\\n\\nTABLE OF CONTENTS (CONTINUED) PAGE 13.3 Notices 38 13.4 No Strict Construction; Interpretation; Headings 39 13.5 Assignment 40 13.6 Performance by Affiliates 40 13.7 Further Assurances and Actions 40 13.8 Severability 41 13.9 No Waiver 41 13.10 Relationship of the Parties 41 13.11 English Language 42 13.12 Counterparts 42 13.13 Schedules 42 13.14 Expenses 42\\n\\nExhibit A Permitted Subcontractors Exhibit B Business Plan Exhibit C SIGA Press Release Schedule 1 SIGA Patents Schedule 2 SIGA Trademarks Schedule 3 Safety Reporting Requirements Schedule 8.2(b) Encumbrances\\n\\n-iii-\\n\\nSource: SIGA TECHNOLOGIES INC, 8-K, 6/3/2019\\n\\n\\n\\n\\n\\nPROMOTION AGREEMENT This PROMOTION AGREEMENT  (this \"Agreement\") is entered into as of May 31, 2019 (the \"Effective Date\") by and between SIGA TECHNOLOGIES, INC., a Delaware corporation having an address at 31 East 62nd Street, New York, NY 10065 (\"SIGA\"), and MERIDIAN MEDICAL TECHNOLOGIES, INC., a Pfizer company, and Delaware corporation having an address at 6350 Stevens Forest Road, Suite #301, Columbia, MD 21046 (\"MMT\"). SIGA and MMT are sometimes referred to individually as a \"Party\" and collectively as the \"Part',\n",
              "    'Highlight the parts (if any) of this contract related to \"Parties\" that should be reviewed by a lawyer. Details: The two or more parties who signed the contract',\n",
              "    'SIGA and MMT are sometimes referred to individually as a \"Party\" and collectively as the \"Parties\". RECITALS',\n",
              "    0,\n",
              "    0),\n",
              "   ('COOPERATION AGREEMENT     made by and between     HPIL ENERGYTECH Inc.   and   GINARES GROUP AG     January 5, 2015\\n\\n\\n\\n\\n\\n\\n\\n    Table of Contents       1. Term........................................................................................................................................... 2 2. Goals And Objectives................................................................................................................ 2 3. Obligations Of The Parties........................................................................................................ 3 4. Confidentiality........................................................................................................................... 3 5. Relation Of The Parties............................................................................................................. 3 6. Closing....................................................................................................................................... 3 7. Representations, Warranties, And Covenants Of GINARES.................................................... 3 8. Representations, Warranties, And Covenants Of HPIL ET...................................................... 4 9. GINARES\\'s Indemnity.............................................................................................................. 5 10. HPIL ET\\'s Indemnity............................................................................................................... 5 11. Payment Of Expenses................................................................................................................ 5 12. Approval Of Counsel................................................................................................................. 5 13. Notices....................................................................................................................................... 6 14. Additional Undertakings............................................................................................................ 6   15. Compliance With The Foreign Corrupt Practices Act And Export Control And Antiboycott Laws...........................................................................................................................................   7 16. Arbitration.................................................................................................................................. 7 17. Governing Law.......................................................................................................................... 7 18. Binding Effect............................................................................................................................ 7 19. Counterparts............................................................................................................................... 7 20. No Reliance............................................................................................................................... 8 21. Early Termination...................................................................................................................... 8 22. Captions..................................................................................................................................... 8 23. Entire Agreement....................................................................................................................... 8         1\\n\\n\\n\\n\\n\\n    COOPERATION AGREEMENT   THIS COOPERATION AGREEMENT (\"Agreement\") is signed this 5th day of January, 2015 (the \"Closing Date\"), by and between HPIL ENERGYTECH Inc., a Nevada (USA) corporation (hereafter \"HPIL ET\") and GINARES GROUP AG,  a private company domiciled in Switzerland (hereafter \"GINARES\").   R E C I T A L S:   The following is a recital of facts underlying this Agreement:   A. HPIL ET is focused on investing in both private and public companies in the energy business sector. HPIL ET does not restrict its potential candidate target companies to any specific geographical location and thus acquires va',\n",
              "    'Highlight the parts (if any) of this contract related to \"Parties\" that should be reviewed by a lawyer. Details: The two or more parties who signed the contract',\n",
              "    'HPIL ET and GINARES (hereafter the \"Party\" or collectively the \"Partie',\n",
              "    0,\n",
              "    0),\n",
              "   ('Exhibit 4.1\\n\\nEXECUTION VERSION\\n\\nREINSURANCE GROUP OF AMERICA, INCORPORATED\\n\\nRGA CAPITAL TRUST I\\n\\nAMENDED AND RESTATED REMARKETING AGREEMENT\\n\\nFebruary 15, 2011\\n\\nBarclays Capital Inc.  745 Seventh Avenue  New York, NY 10019\\n\\nLadies and Gentlemen:\\n\\nReinsurance Group of America, Incorporated, a Missouri corporation (the \"Company\"), and RGA Capital Trust I, a Delaware statutory business  trust (the \"Trust\"), issued and sold to Lehman Brothers Inc. and Banc of America Securities LLC (the \"Underwriters\") pursuant to the  Underwriting Agreement, dated December 12, 2001 (the \"Underwriting Agreement\"), 4,500,000 Trust Preferred Income Equity Redeemable  Securities (\"PIERS\")1 units (the \"Firm Units\") issued pursuant to a Unit Agreement (the \"Unit Agreement\") dated as of December 18, 2001, as  supplemented September 12, 2008, among the Company, the Trust, The Bank of New York Mellon Trust Company, N.A., as successor unit agent  (in such capacity, the \"Unit Agent\"), as successor warrant agent (in such capacity, the \"Warrant Agent\"), and as successor property trustee (in  such capacity, the \"Property Trustee\"). In addition, the Company and the Trust granted to the Underwriters an option (the \"Option\") to purchase  up to an additional 675,000 Units (the \"Option Units\" and, together with the Firm Units, the \"Units\").\\n\\nEach Unit consists of a preferred security, liquidation preference $50 per security, of the Trust (each, a \"Preferred Security\") and a warrant (each,  a \"Warrant\") of the Company to purchase at any time prior to the close of business on December 15, 2050, shares (the \"Warrant Shares\") of  common stock, par value $0.01 per share, of the Company (\"Common Stock\"), subject to antidilution adjustments. Each Preferred Security  represents an undivided beneficial ownership interest in the assets of the Trust, which assets consist solely of the 5.75% Junior Subordinated  Deferrable Interest Debentures due 2051 of the Company (the \"Debentures\"). Certain payments on the Preferred Securities and Common Securities  (the \"Trust Securities\") are guaranteed (the \"Guarantee\") by the Company pursuant to the Guarantee Agreement (the \"Guarantee Agreement\")  dated as of December 18, 2001, between the Company and The Bank of New York Mellon Trust Company, as successor guarantee trustee (in such  capacity, the \"Guarantee Trustee\").\\n\\nThe Trust was formed on February 9, 2001 pursuant to a trust agreement dated as of February 8, 2001 (the \"Original Trust Agreement\") executed  by the Company, as depositor,\\n\\n\\n\\n1   \"Preferred Income Equity Redeemable SecuritiesSM\" and \"PIERSSM\" are service marks owned by Lehman Brothers Inc.\\n\\n\\n\\n\\n\\n\\n\\nand The Bank of New York (Delaware), as Delaware trustee (in such capacity, the \"Delaware Trustee\"), and a certificate of trust dated as of  February 8, 2001 (the \"Trust Certificate\") filed with the Secretary of State of the State of Delaware. The Trust is governed by, and the Preferred  Securities were issued under, the Original Trust Agreement, as amended and restated by the Amended and Restated Trust Agreement (the  \"Amended and Restated Trust Agreement\" and, together with the Original Trust Agreement, the \"Trust Agreement\")) dated as of December 18,  2001, among the Company, the Property Trustee, the Delaware Trustee and A. Greig Woodring, Jack B. Lay and Todd C. Larson, as the initial  administrative trustees (in such capacities, the \"Administrative Trustees\") which amended and restated the Original Trust Agreement.\\n\\nThe Trust used the proceeds from the sale of the Trust Securities to purchase the Debentures that were issued pursuant to the Indenture (the  \"Original Indenture\"), as supplemented by a Supplemental Indenture (the \"Supplemental Indenture\" and, together with the Original Indenture, as  so supplemented, the \"Indenture\"), in each case, dated as of December 18, 2001 between the Company and The Bank of New York Mellon Trust  Company, N.A., as successor indenture trustee (in such capacity, the \"Indenture Trustee\"). The Trust will, if and to the extent it receives the  proceeds of a payment on the Debentures, di',\n",
              "    'Highlight the parts (if any) of this contract related to \"Parties\" that should be reviewed by a lawyer. Details: The two or more parties who signed the contract',\n",
              "    'Remarketing Agent',\n",
              "    0,\n",
              "    0),\n",
              "   ('Exhibit 4.1\\n\\nEXECUTION VERSION\\n\\nREINSURANCE GROUP OF AMERICA, INCORPORATED\\n\\nRGA CAPITAL TRUST I\\n\\nAMENDED AND RESTATED REMARKETING AGREEMENT\\n\\nFebruary 15, 2011\\n\\nBarclays Capital Inc.  745 Seventh Avenue  New York, NY 10019\\n\\nLadies and Gentlemen:\\n\\nReinsurance Group of America, Incorporated, a Missouri corporation (the \"Company\"), and RGA Capital Trust I, a Delaware statutory business  trust (the \"Trust\"), issued and sold to Lehman Brothers Inc. and Banc of America Securities LLC (the \"Underwriters\") pursuant to the  Underwriting Agreement, dated December 12, 2001 (the \"Underwriting Agreement\"), 4,500,000 Trust Preferred Income Equity Redeemable  Securities (\"PIERS\")1 units (the \"Firm Units\") issued pursuant to a Unit Agreement (the \"Unit Agreement\") dated as of December 18, 2001, as  supplemented September 12, 2008, among the Company, the Trust, The Bank of New York Mellon Trust Company, N.A., as successor unit agent  (in such capacity, the \"Unit Agent\"), as successor warrant agent (in such capacity, the \"Warrant Agent\"), and as successor property trustee (in  such capacity, the \"Property Trustee\"). In addition, the Company and the Trust granted to the Underwriters an option (the \"Option\") to purchase  up to an additional 675,000 Units (the \"Option Units\" and, together with the Firm Units, the \"Units\").\\n\\nEach Unit consists of a preferred security, liquidation preference $50 per security, of the Trust (each, a \"Preferred Security\") and a warrant (each,  a \"Warrant\") of the Company to purchase at any time prior to the close of business on December 15, 2050, shares (the \"Warrant Shares\") of  common stock, par value $0.01 per share, of the Company (\"Common Stock\"), subject to antidilution adjustments. Each Preferred Security  represents an undivided beneficial ownership interest in the assets of the Trust, which assets consist solely of the 5.75% Junior Subordinated  Deferrable Interest Debentures due 2051 of the Company (the \"Debentures\"). Certain payments on the Preferred Securities and Common Securities  (the \"Trust Securities\") are guaranteed (the \"Guarantee\") by the Company pursuant to the Guarantee Agreement (the \"Guarantee Agreement\")  dated as of December 18, 2001, between the Company and The Bank of New York Mellon Trust Company, as successor guarantee trustee (in such  capacity, the \"Guarantee Trustee\").\\n\\nThe Trust was formed on February 9, 2001 pursuant to a trust agreement dated as of February 8, 2001 (the \"Original Trust Agreement\") executed  by the Company, as depositor,\\n\\n\\n\\n1   \"Preferred Income Equity Redeemable SecuritiesSM\" and \"PIERSSM\" are service marks owned by Lehman Brothers Inc.\\n\\n\\n\\n\\n\\n\\n\\nand The Bank of New York (Delaware), as Delaware trustee (in such capacity, the \"Delaware Trustee\"), and a certificate of trust dated as of  February 8, 2001 (the \"Trust Certificate\") filed with the Secretary of State of the State of Delaware. The Trust is governed by, and the Preferred  Securities were issued under, the Original Trust Agreement, as amended and restated by the Amended and Restated Trust Agreement (the  \"Amended and Restated Trust Agreement\" and, together with the Original Trust Agreement, the \"Trust Agreement\")) dated as of December 18,  2001, among the Company, the Property Trustee, the Delaware Trustee and A. Greig Woodring, Jack B. Lay and Todd C. Larson, as the initial  administrative trustees (in such capacities, the \"Administrative Trustees\") which amended and restated the Original Trust Agreement.\\n\\nThe Trust used the proceeds from the sale of the Trust Securities to purchase the Debentures that were issued pursuant to the Indenture (the  \"Original Indenture\"), as supplemented by a Supplemental Indenture (the \"Supplemental Indenture\" and, together with the Original Indenture, as  so supplemented, the \"Indenture\"), in each case, dated as of December 18, 2001 between the Company and The Bank of New York Mellon Trust  Company, N.A., as successor indenture trustee (in such capacity, the \"Indenture Trustee\"). The Trust will, if and to the extent it receives the  proceeds of a payment on the Debentures, di',\n",
              "    'Highlight the parts (if any) of this contract related to \"Parties\" that should be reviewed by a lawyer. Details: The two or more parties who signed the contract',\n",
              "    'together, the \"Issuers\"',\n",
              "    0,\n",
              "    0),\n",
              "   ('Exhibit 10.1\\n\\n  KIOSK CONCEPTS, INC.   MASTER FRANCHISE AGREEMENT           THE GRILLED CHEESE TRUCK, INC.           MASTER FRANCHISEE           DATE OF AGREEMENT\\n\\nSource: SOUPMAN, INC., 8-K, 8/14/2015\\n\\n\\n\\n\\n\\n\\n\\n            TABLE OF CONTENTS           1. GRANT OF FRANCHISE 1         1.1 Rights Granted to You 1   1.2 Non-Exclusive Grant 2   1.3 Our Reserved Rights 2         2. OPERATION OF THE FRANCHISED BUSINESS 2         2.1 Name of Franchised Business 2   2.2 Full Time, Attention and Best Efforts 2   2.3 Modifications to System and Manuals 3         3. INITIAL AND EXTENDED TERMS 3         3.1 Initial Term 3   3.2 Options to Renew 3   3.3 Renewal of Existing Agreement 4   3.4 Continued Compliance 4   3.5 Termination at End of Term 4         4. PAYMENT OF FEES 4         4.1 Initial Franchise Fee 4   4.2 Continuing Fees Payable to Us 4   4.3 Manner of Payment 5   4.4 Interest on Overdue Amounts 5   4.5 Late Fee; Insufficient Funds Fee 6   4.6 Unit Franchise Agreements and Revenue Reports 6   4.7 Security Interest 6   4.8 Reimbursement of Monies 7   4.9 Application of Fees 7         5. YOUR OBLIGATIONS 7         5.1 Sale of Unit Franchises; Minimum Development Quota 8   5.2 Initial Training and Services for Unit Franchisees 9   5.3 Use of Proprietary Marks 10   5.4 Place of Business 10   5.5 Insurance 10   5.6 Computer Hardware and Software 11   5.7 Payment of Taxes 12   5.8 Enforcement of Unit Franchise Agreements 12   5.9 Master Franchisee Training Program 12   5.10 Additional Training; Master Franchisee Meetings 13   5.11 Supplies and Equipment 13   5.12 Compliance with Governmental Regulations and Applicable Law 13   5.13 Office Location 13   5.14 Solicitation Advertising 14   5.15 Policies and Procedures 14   5.16 Changes to the System 14   5.17 Developments are Our Property 15   5.18 Financial Statements and Updated Unit Franchise Disclosure Document 15   5.19 Our Website 15\\n\\ni\\n\\nSource: SOUPMAN, INC., 8-K, 8/14/2015\\n\\n\\n\\n\\n\\n\\n\\n          6. PROPRIETARY MARKS 17         6.1 Our Representations 17   6.2 Your Representations 17   6.3 Your Acknowledgments 18   6.4 Changes in Law Affecting Proprietary Marks 19         7. NON-COMPETITION 20         7.1 Restrictions 20   7.2 Independent Covenants 20   7.3 Reduction of Scope 20   7.4 No Defense 20   7.5 Irreparable Injury 20   7.6 Additional Parties 20         8. MANUALS AND CONFIDENTIAL INFORMATION 21         8.1 Use of Manuals 21   8.2 Confidentiality of Information 21   8.3 Irreparable Injury from Disclosure of Confidential Information 21   8.4 Confidentiality Covenants from Individuals Associated with You 21         9. OUR OBLIGATIONS 22         9.1 Manuals and Assistance 22   9.2 Training Program 22   9.3 Advice and Assistance 22   9.4 Proprietary Marks 22   9.5 Advice 22         10. DEFAULT AND TERMINATION 22         10.1 Termination in the Event of Bankruptcy or Insolvency 22   10.2 Termination with Notice and Without Opportunity to Cure 23   10.3 Termination with Notice and Opportunity to Cure 24   10.4 Cross-Default 24   10.5 Our Right to Discontinue Services to You 25   10.6 Termination of This Agreement by You 25   10.7 Without Prejudice 25   10.8 Amendment Pursuant to Applicable Law 25         11. OBLIGATIONS UPON TERMINATION OR EXPIRATION 26         11.1 Cessation of Business 26   11.2 Cessation of Use of Confidential Information and Proprietary Marks 26   11.3 Cancellation of Assumed Name Registration 26   11.4 Payment of Monies Due; Liquidated Damages 26   11.5 Costs to Secure Compliance 27   11.6 Return of Manuals and Other Confidential Information 27   11.7 Irreparable Injury to Us 27   11.8 Compliance with Post-Term Covenants 27         12. TRANSFER OF INTEREST 27         12.1 Transfer by Us 27   12.2 Transfer by You 28   12.3 Granting of a Security Interest by You 28\\n\\nii\\n\\nSource: SOUPMAN, INC., 8-K, 8/14/2015\\n\\n\\n\\n\\n\\n\\n\\n              12.4 Transfer Upon Death or Disability 28   12.5 Non-waiver of Claims 29   12.6 Transfer by You in Bankruptcy - Right of First Refusal 29         13.   UNIT FRANCHISEES 29           13.1 Form of Unit Franchise Disclosure Document and Unit',\n",
              "    'Highlight the parts (if any) of this contract related to \"Parties\" that should be reviewed by a lawyer. Details: The two or more parties who signed the contract',\n",
              "    'Kiosk Concepts, Inc.',\n",
              "    0,\n",
              "    0),\n",
              "   ('Exhibit 10.1\\n\\n  KIOSK CONCEPTS, INC.   MASTER FRANCHISE AGREEMENT           THE GRILLED CHEESE TRUCK, INC.           MASTER FRANCHISEE           DATE OF AGREEMENT\\n\\nSource: SOUPMAN, INC., 8-K, 8/14/2015\\n\\n\\n\\n\\n\\n\\n\\n            TABLE OF CONTENTS           1. GRANT OF FRANCHISE 1         1.1 Rights Granted to You 1   1.2 Non-Exclusive Grant 2   1.3 Our Reserved Rights 2         2. OPERATION OF THE FRANCHISED BUSINESS 2         2.1 Name of Franchised Business 2   2.2 Full Time, Attention and Best Efforts 2   2.3 Modifications to System and Manuals 3         3. INITIAL AND EXTENDED TERMS 3         3.1 Initial Term 3   3.2 Options to Renew 3   3.3 Renewal of Existing Agreement 4   3.4 Continued Compliance 4   3.5 Termination at End of Term 4         4. PAYMENT OF FEES 4         4.1 Initial Franchise Fee 4   4.2 Continuing Fees Payable to Us 4   4.3 Manner of Payment 5   4.4 Interest on Overdue Amounts 5   4.5 Late Fee; Insufficient Funds Fee 6   4.6 Unit Franchise Agreements and Revenue Reports 6   4.7 Security Interest 6   4.8 Reimbursement of Monies 7   4.9 Application of Fees 7         5. YOUR OBLIGATIONS 7         5.1 Sale of Unit Franchises; Minimum Development Quota 8   5.2 Initial Training and Services for Unit Franchisees 9   5.3 Use of Proprietary Marks 10   5.4 Place of Business 10   5.5 Insurance 10   5.6 Computer Hardware and Software 11   5.7 Payment of Taxes 12   5.8 Enforcement of Unit Franchise Agreements 12   5.9 Master Franchisee Training Program 12   5.10 Additional Training; Master Franchisee Meetings 13   5.11 Supplies and Equipment 13   5.12 Compliance with Governmental Regulations and Applicable Law 13   5.13 Office Location 13   5.14 Solicitation Advertising 14   5.15 Policies and Procedures 14   5.16 Changes to the System 14   5.17 Developments are Our Property 15   5.18 Financial Statements and Updated Unit Franchise Disclosure Document 15   5.19 Our Website 15\\n\\ni\\n\\nSource: SOUPMAN, INC., 8-K, 8/14/2015\\n\\n\\n\\n\\n\\n\\n\\n          6. PROPRIETARY MARKS 17         6.1 Our Representations 17   6.2 Your Representations 17   6.3 Your Acknowledgments 18   6.4 Changes in Law Affecting Proprietary Marks 19         7. NON-COMPETITION 20         7.1 Restrictions 20   7.2 Independent Covenants 20   7.3 Reduction of Scope 20   7.4 No Defense 20   7.5 Irreparable Injury 20   7.6 Additional Parties 20         8. MANUALS AND CONFIDENTIAL INFORMATION 21         8.1 Use of Manuals 21   8.2 Confidentiality of Information 21   8.3 Irreparable Injury from Disclosure of Confidential Information 21   8.4 Confidentiality Covenants from Individuals Associated with You 21         9. OUR OBLIGATIONS 22         9.1 Manuals and Assistance 22   9.2 Training Program 22   9.3 Advice and Assistance 22   9.4 Proprietary Marks 22   9.5 Advice 22         10. DEFAULT AND TERMINATION 22         10.1 Termination in the Event of Bankruptcy or Insolvency 22   10.2 Termination with Notice and Without Opportunity to Cure 23   10.3 Termination with Notice and Opportunity to Cure 24   10.4 Cross-Default 24   10.5 Our Right to Discontinue Services to You 25   10.6 Termination of This Agreement by You 25   10.7 Without Prejudice 25   10.8 Amendment Pursuant to Applicable Law 25         11. OBLIGATIONS UPON TERMINATION OR EXPIRATION 26         11.1 Cessation of Business 26   11.2 Cessation of Use of Confidential Information and Proprietary Marks 26   11.3 Cancellation of Assumed Name Registration 26   11.4 Payment of Monies Due; Liquidated Damages 26   11.5 Costs to Secure Compliance 27   11.6 Return of Manuals and Other Confidential Information 27   11.7 Irreparable Injury to Us 27   11.8 Compliance with Post-Term Covenants 27         12. TRANSFER OF INTEREST 27         12.1 Transfer by Us 27   12.2 Transfer by You 28   12.3 Granting of a Security Interest by You 28\\n\\nii\\n\\nSource: SOUPMAN, INC., 8-K, 8/14/2015\\n\\n\\n\\n\\n\\n\\n\\n              12.4 Transfer Upon Death or Disability 28   12.5 Non-waiver of Claims 29   12.6 Transfer by You in Bankruptcy - Right of First Refusal 29         13.   UNIT FRANCHISEES 29           13.1 Form of Unit Franchise Disclosure Document and Unit',\n",
              "    'Highlight the parts (if any) of this contract related to \"Parties\" that should be reviewed by a lawyer. Details: The two or more parties who signed the contract',\n",
              "    'The Grilled Cheese Truck, Inc.',\n",
              "    0,\n",
              "    0),\n",
              "   ('Exhibit 10.1\\n\\n  KIOSK CONCEPTS, INC.   MASTER FRANCHISE AGREEMENT           THE GRILLED CHEESE TRUCK, INC.           MASTER FRANCHISEE           DATE OF AGREEMENT\\n\\nSource: SOUPMAN, INC., 8-K, 8/14/2015\\n\\n\\n\\n\\n\\n\\n\\n            TABLE OF CONTENTS           1. GRANT OF FRANCHISE 1         1.1 Rights Granted to You 1   1.2 Non-Exclusive Grant 2   1.3 Our Reserved Rights 2         2. OPERATION OF THE FRANCHISED BUSINESS 2         2.1 Name of Franchised Business 2   2.2 Full Time, Attention and Best Efforts 2   2.3 Modifications to System and Manuals 3         3. INITIAL AND EXTENDED TERMS 3         3.1 Initial Term 3   3.2 Options to Renew 3   3.3 Renewal of Existing Agreement 4   3.4 Continued Compliance 4   3.5 Termination at End of Term 4         4. PAYMENT OF FEES 4         4.1 Initial Franchise Fee 4   4.2 Continuing Fees Payable to Us 4   4.3 Manner of Payment 5   4.4 Interest on Overdue Amounts 5   4.5 Late Fee; Insufficient Funds Fee 6   4.6 Unit Franchise Agreements and Revenue Reports 6   4.7 Security Interest 6   4.8 Reimbursement of Monies 7   4.9 Application of Fees 7         5. YOUR OBLIGATIONS 7         5.1 Sale of Unit Franchises; Minimum Development Quota 8   5.2 Initial Training and Services for Unit Franchisees 9   5.3 Use of Proprietary Marks 10   5.4 Place of Business 10   5.5 Insurance 10   5.6 Computer Hardware and Software 11   5.7 Payment of Taxes 12   5.8 Enforcement of Unit Franchise Agreements 12   5.9 Master Franchisee Training Program 12   5.10 Additional Training; Master Franchisee Meetings 13   5.11 Supplies and Equipment 13   5.12 Compliance with Governmental Regulations and Applicable Law 13   5.13 Office Location 13   5.14 Solicitation Advertising 14   5.15 Policies and Procedures 14   5.16 Changes to the System 14   5.17 Developments are Our Property 15   5.18 Financial Statements and Updated Unit Franchise Disclosure Document 15   5.19 Our Website 15\\n\\ni\\n\\nSource: SOUPMAN, INC., 8-K, 8/14/2015\\n\\n\\n\\n\\n\\n\\n\\n          6. PROPRIETARY MARKS 17         6.1 Our Representations 17   6.2 Your Representations 17   6.3 Your Acknowledgments 18   6.4 Changes in Law Affecting Proprietary Marks 19         7. NON-COMPETITION 20         7.1 Restrictions 20   7.2 Independent Covenants 20   7.3 Reduction of Scope 20   7.4 No Defense 20   7.5 Irreparable Injury 20   7.6 Additional Parties 20         8. MANUALS AND CONFIDENTIAL INFORMATION 21         8.1 Use of Manuals 21   8.2 Confidentiality of Information 21   8.3 Irreparable Injury from Disclosure of Confidential Information 21   8.4 Confidentiality Covenants from Individuals Associated with You 21         9. OUR OBLIGATIONS 22         9.1 Manuals and Assistance 22   9.2 Training Program 22   9.3 Advice and Assistance 22   9.4 Proprietary Marks 22   9.5 Advice 22         10. DEFAULT AND TERMINATION 22         10.1 Termination in the Event of Bankruptcy or Insolvency 22   10.2 Termination with Notice and Without Opportunity to Cure 23   10.3 Termination with Notice and Opportunity to Cure 24   10.4 Cross-Default 24   10.5 Our Right to Discontinue Services to You 25   10.6 Termination of This Agreement by You 25   10.7 Without Prejudice 25   10.8 Amendment Pursuant to Applicable Law 25         11. OBLIGATIONS UPON TERMINATION OR EXPIRATION 26         11.1 Cessation of Business 26   11.2 Cessation of Use of Confidential Information and Proprietary Marks 26   11.3 Cancellation of Assumed Name Registration 26   11.4 Payment of Monies Due; Liquidated Damages 26   11.5 Costs to Secure Compliance 27   11.6 Return of Manuals and Other Confidential Information 27   11.7 Irreparable Injury to Us 27   11.8 Compliance with Post-Term Covenants 27         12. TRANSFER OF INTEREST 27         12.1 Transfer by Us 27   12.2 Transfer by You 28   12.3 Granting of a Security Interest by You 28\\n\\nii\\n\\nSource: SOUPMAN, INC., 8-K, 8/14/2015\\n\\n\\n\\n\\n\\n\\n\\n              12.4 Transfer Upon Death or Disability 28   12.5 Non-waiver of Claims 29   12.6 Transfer by You in Bankruptcy - Right of First Refusal 29         13.   UNIT FRANCHISEES 29           13.1 Form of Unit Franchise Disclosure Document and Unit',\n",
              "    'Highlight the parts (if any) of this contract related to \"Parties\" that should be reviewed by a lawyer. Details: The two or more parties who signed the contract',\n",
              "    'you',\n",
              "    0,\n",
              "    0),\n",
              "   ('Exhibit 10.1\\n\\n  KIOSK CONCEPTS, INC.   MASTER FRANCHISE AGREEMENT           THE GRILLED CHEESE TRUCK, INC.           MASTER FRANCHISEE           DATE OF AGREEMENT\\n\\nSource: SOUPMAN, INC., 8-K, 8/14/2015\\n\\n\\n\\n\\n\\n\\n\\n            TABLE OF CONTENTS           1. GRANT OF FRANCHISE 1         1.1 Rights Granted to You 1   1.2 Non-Exclusive Grant 2   1.3 Our Reserved Rights 2         2. OPERATION OF THE FRANCHISED BUSINESS 2         2.1 Name of Franchised Business 2   2.2 Full Time, Attention and Best Efforts 2   2.3 Modifications to System and Manuals 3         3. INITIAL AND EXTENDED TERMS 3         3.1 Initial Term 3   3.2 Options to Renew 3   3.3 Renewal of Existing Agreement 4   3.4 Continued Compliance 4   3.5 Termination at End of Term 4         4. PAYMENT OF FEES 4         4.1 Initial Franchise Fee 4   4.2 Continuing Fees Payable to Us 4   4.3 Manner of Payment 5   4.4 Interest on Overdue Amounts 5   4.5 Late Fee; Insufficient Funds Fee 6   4.6 Unit Franchise Agreements and Revenue Reports 6   4.7 Security Interest 6   4.8 Reimbursement of Monies 7   4.9 Application of Fees 7         5. YOUR OBLIGATIONS 7         5.1 Sale of Unit Franchises; Minimum Development Quota 8   5.2 Initial Training and Services for Unit Franchisees 9   5.3 Use of Proprietary Marks 10   5.4 Place of Business 10   5.5 Insurance 10   5.6 Computer Hardware and Software 11   5.7 Payment of Taxes 12   5.8 Enforcement of Unit Franchise Agreements 12   5.9 Master Franchisee Training Program 12   5.10 Additional Training; Master Franchisee Meetings 13   5.11 Supplies and Equipment 13   5.12 Compliance with Governmental Regulations and Applicable Law 13   5.13 Office Location 13   5.14 Solicitation Advertising 14   5.15 Policies and Procedures 14   5.16 Changes to the System 14   5.17 Developments are Our Property 15   5.18 Financial Statements and Updated Unit Franchise Disclosure Document 15   5.19 Our Website 15\\n\\ni\\n\\nSource: SOUPMAN, INC., 8-K, 8/14/2015\\n\\n\\n\\n\\n\\n\\n\\n          6. PROPRIETARY MARKS 17         6.1 Our Representations 17   6.2 Your Representations 17   6.3 Your Acknowledgments 18   6.4 Changes in Law Affecting Proprietary Marks 19         7. NON-COMPETITION 20         7.1 Restrictions 20   7.2 Independent Covenants 20   7.3 Reduction of Scope 20   7.4 No Defense 20   7.5 Irreparable Injury 20   7.6 Additional Parties 20         8. MANUALS AND CONFIDENTIAL INFORMATION 21         8.1 Use of Manuals 21   8.2 Confidentiality of Information 21   8.3 Irreparable Injury from Disclosure of Confidential Information 21   8.4 Confidentiality Covenants from Individuals Associated with You 21         9. OUR OBLIGATIONS 22         9.1 Manuals and Assistance 22   9.2 Training Program 22   9.3 Advice and Assistance 22   9.4 Proprietary Marks 22   9.5 Advice 22         10. DEFAULT AND TERMINATION 22         10.1 Termination in the Event of Bankruptcy or Insolvency 22   10.2 Termination with Notice and Without Opportunity to Cure 23   10.3 Termination with Notice and Opportunity to Cure 24   10.4 Cross-Default 24   10.5 Our Right to Discontinue Services to You 25   10.6 Termination of This Agreement by You 25   10.7 Without Prejudice 25   10.8 Amendment Pursuant to Applicable Law 25         11. OBLIGATIONS UPON TERMINATION OR EXPIRATION 26         11.1 Cessation of Business 26   11.2 Cessation of Use of Confidential Information and Proprietary Marks 26   11.3 Cancellation of Assumed Name Registration 26   11.4 Payment of Monies Due; Liquidated Damages 26   11.5 Costs to Secure Compliance 27   11.6 Return of Manuals and Other Confidential Information 27   11.7 Irreparable Injury to Us 27   11.8 Compliance with Post-Term Covenants 27         12. TRANSFER OF INTEREST 27         12.1 Transfer by Us 27   12.2 Transfer by You 28   12.3 Granting of a Security Interest by You 28\\n\\nii\\n\\nSource: SOUPMAN, INC., 8-K, 8/14/2015\\n\\n\\n\\n\\n\\n\\n\\n              12.4 Transfer Upon Death or Disability 28   12.5 Non-waiver of Claims 29   12.6 Transfer by You in Bankruptcy - Right of First Refusal 29         13.   UNIT FRANCHISEES 29           13.1 Form of Unit Franchise Disclosure Document and Unit',\n",
              "    'Highlight the parts (if any) of this contract related to \"Parties\" that should be reviewed by a lawyer. Details: The two or more parties who signed the contract',\n",
              "    'we',\n",
              "    0,\n",
              "    0),\n",
              "   ('Exhibit 10.1\\n\\n  KIOSK CONCEPTS, INC.   MASTER FRANCHISE AGREEMENT           THE GRILLED CHEESE TRUCK, INC.           MASTER FRANCHISEE           DATE OF AGREEMENT\\n\\nSource: SOUPMAN, INC., 8-K, 8/14/2015\\n\\n\\n\\n\\n\\n\\n\\n            TABLE OF CONTENTS           1. GRANT OF FRANCHISE 1         1.1 Rights Granted to You 1   1.2 Non-Exclusive Grant 2   1.3 Our Reserved Rights 2         2. OPERATION OF THE FRANCHISED BUSINESS 2         2.1 Name of Franchised Business 2   2.2 Full Time, Attention and Best Efforts 2   2.3 Modifications to System and Manuals 3         3. INITIAL AND EXTENDED TERMS 3         3.1 Initial Term 3   3.2 Options to Renew 3   3.3 Renewal of Existing Agreement 4   3.4 Continued Compliance 4   3.5 Termination at End of Term 4         4. PAYMENT OF FEES 4         4.1 Initial Franchise Fee 4   4.2 Continuing Fees Payable to Us 4   4.3 Manner of Payment 5   4.4 Interest on Overdue Amounts 5   4.5 Late Fee; Insufficient Funds Fee 6   4.6 Unit Franchise Agreements and Revenue Reports 6   4.7 Security Interest 6   4.8 Reimbursement of Monies 7   4.9 Application of Fees 7         5. YOUR OBLIGATIONS 7         5.1 Sale of Unit Franchises; Minimum Development Quota 8   5.2 Initial Training and Services for Unit Franchisees 9   5.3 Use of Proprietary Marks 10   5.4 Place of Business 10   5.5 Insurance 10   5.6 Computer Hardware and Software 11   5.7 Payment of Taxes 12   5.8 Enforcement of Unit Franchise Agreements 12   5.9 Master Franchisee Training Program 12   5.10 Additional Training; Master Franchisee Meetings 13   5.11 Supplies and Equipment 13   5.12 Compliance with Governmental Regulations and Applicable Law 13   5.13 Office Location 13   5.14 Solicitation Advertising 14   5.15 Policies and Procedures 14   5.16 Changes to the System 14   5.17 Developments are Our Property 15   5.18 Financial Statements and Updated Unit Franchise Disclosure Document 15   5.19 Our Website 15\\n\\ni\\n\\nSource: SOUPMAN, INC., 8-K, 8/14/2015\\n\\n\\n\\n\\n\\n\\n\\n          6. PROPRIETARY MARKS 17         6.1 Our Representations 17   6.2 Your Representations 17   6.3 Your Acknowledgments 18   6.4 Changes in Law Affecting Proprietary Marks 19         7. NON-COMPETITION 20         7.1 Restrictions 20   7.2 Independent Covenants 20   7.3 Reduction of Scope 20   7.4 No Defense 20   7.5 Irreparable Injury 20   7.6 Additional Parties 20         8. MANUALS AND CONFIDENTIAL INFORMATION 21         8.1 Use of Manuals 21   8.2 Confidentiality of Information 21   8.3 Irreparable Injury from Disclosure of Confidential Information 21   8.4 Confidentiality Covenants from Individuals Associated with You 21         9. OUR OBLIGATIONS 22         9.1 Manuals and Assistance 22   9.2 Training Program 22   9.3 Advice and Assistance 22   9.4 Proprietary Marks 22   9.5 Advice 22         10. DEFAULT AND TERMINATION 22         10.1 Termination in the Event of Bankruptcy or Insolvency 22   10.2 Termination with Notice and Without Opportunity to Cure 23   10.3 Termination with Notice and Opportunity to Cure 24   10.4 Cross-Default 24   10.5 Our Right to Discontinue Services to You 25   10.6 Termination of This Agreement by You 25   10.7 Without Prejudice 25   10.8 Amendment Pursuant to Applicable Law 25         11. OBLIGATIONS UPON TERMINATION OR EXPIRATION 26         11.1 Cessation of Business 26   11.2 Cessation of Use of Confidential Information and Proprietary Marks 26   11.3 Cancellation of Assumed Name Registration 26   11.4 Payment of Monies Due; Liquidated Damages 26   11.5 Costs to Secure Compliance 27   11.6 Return of Manuals and Other Confidential Information 27   11.7 Irreparable Injury to Us 27   11.8 Compliance with Post-Term Covenants 27         12. TRANSFER OF INTEREST 27         12.1 Transfer by Us 27   12.2 Transfer by You 28   12.3 Granting of a Security Interest by You 28\\n\\nii\\n\\nSource: SOUPMAN, INC., 8-K, 8/14/2015\\n\\n\\n\\n\\n\\n\\n\\n              12.4 Transfer Upon Death or Disability 28   12.5 Non-waiver of Claims 29   12.6 Transfer by You in Bankruptcy - Right of First Refusal 29         13.   UNIT FRANCHISEES 29           13.1 Form of Unit Franchise Disclosure Document and Unit',\n",
              "    'Highlight the parts (if any) of this contract related to \"Parties\" that should be reviewed by a lawyer. Details: The two or more parties who signed the contract',\n",
              "    'your',\n",
              "    0,\n",
              "    0),\n",
              "   ('OUTSOURCING AGREEMENT\\n\\nBY AND BETWEEN\\n\\nTRI CITY NATIONAL BANK\\n\\nand\\n\\nMARSHALL & ILSLEY CORPORATION acting through its division M&I DATA SERVICES\\n\\nDATED AS OF\\n\\nFebruary 16, 1998\\n\\nTABLE OF CONTENTS\\n\\nPage 1. DEFINITIONS  1.1 Background  1.2 Definitions      1.3 References  1.4 Interpretation   2. TERM    2.1 Initial Term     2.2 Extensions  3. APPOINTMENT  3.1 Performance by M&I Affiliates   3.2 Third Party Services  3.3 Proper Instructions   4. CONVERSION   4.1 Banking Applications  4.2 Development of Conversion Plan  4.3 Conversion Resources  4.4 Conversion Milestones      5. OUTSOURCING OF TRUST SERVICES    6. BANKING APPLICATIONS   6.1 Services to be Rendered    6.2 Banking Application Processing  6.3 Corporate Support Services      6.4 Item Processing Services   6.5 Automated Clearing House Services    6.6 Home Banking and Internet Services   6.7 Retail Delivery Systems    6.8 Visa Check/MasterMoney Card Services      6.9 EFT Services     7. FACILITIES MANAGEMENT  8. FEES    8.1 Fee Structure    8.2 Conversion  8.3 Pricing and Operational Assumptions  8.4 Banking Applications Services   8.5 Corporate Support Services      8.6 Item Processing Services   8.7 Management Services   8.8 Visa Check/MasterMoney Card Services      8.9 EFT Services     8.10 Training and Education    8.11 Excluded Costs  8.12 Disputed Amounts     8.13 Terms of Payment     8.14 Modification of Terms and Pricing   9. PERFORMANCE STANDARDS  9.1 General     9.2 Banking Applications  10. MODIFICATION OR TERMINATION OF SERVICES   10.1 Modifications to Services      10.2 Partial Termination by M&I     10.3 Partial Termination by Customer     10.4 Development of Custom Software\\n\\n\\n\\n\\n\\n11. TERMINATION      11.1 For Convenience      11.2 For Cause  11.3 Following Change in Control of Customer  11.4 Termination Assistance    12. EVENTS OF DEFAULT; REMEDIES     12.1 By M&I     12.2 By Customer     12.3 Remedies   13. DAMAGES     13.1 Direct Damages  13.2 No Consequential Damages  13.3 Equitable Relief     13.4 Limitation of Liability   13.5 Liquidated Damages   14. INSURANCE AND INDEMNITY    14.1 Insurance  14.2 Indemnity  14.3 Indemnification Procedures     15. DISPUTE RESOLUTION    15.1 Representatives of Parties     15.2 Continuity of Performance      16. REPRESENTATIONS AND WARRANTIES  16.1 By M&I     16.2 By Customer     17. CONFIDENTIALITY AND OWNERSHIP   17.1 Customer Data   17.2 M&I Systems     17.3 Confidential Information  17.4 Obligations of the Parties     17.5 Security   18. MANAGEMENT OF PROJECT      18.1 Account Representatives   18.2 Change Control Procedures      18.3 Reporting and Meetings    18.4 Development Projects and Technical Support    19. REGULATORY COMPLIANCE      20. DISASTER RECOVERY     20.1 Disaster Recovery Plan    20.2 Relocation      20.3 Resumption of Services    20.4 Annual Test     21. GENERAL TERMS AND CONDITIONS    21.1 Force Majeure   21.2 Transmission of Data      21.3 Equipment and Network     21.4 Reliance on Data     21.5 Data Backup     21.6 Balancing and Controls    21.7 Use of Services      21.8 Regulatory Assurances     21.9 IRS Filing      21.10 Affiliates     21.11 Future Acquisitions      22. MISCELLANEOUS PROVISIONS   22.1 Governing Law   22.2 Venue and Jurisdiction    22.3 Entire Agreement; Amendments   22.4 Assignment      22.5 Relationship of Parties   22.6 Notices    22.7 Headings   22.8 Counterparts    22.9 Waiver     22.10 Severability   22.11 Attorneys\\' Fees and Costs     22.12 Financial Statements     22.13 Publicity      22.14 Solicitation   22.15 No Third Party Beneficiaries  22.16 Construction   23. SOURCE CODE      23.1 Escrow     23.2 Copy of Source Code  23.3 Cost of Escrow  23.4 Customer\\'s Right to Obtain the Source Code    23.5 Use of Source Code\\n\\nSchedules\\n\\n4.2  Conversion Plan 6.2  Banking Application Services 8.1  Fee Schedule\\n\\nExhibits\\n\\nA    RDS Agreement B    ACH Authorization Agreement C    Attorney-in-Fact Appointment D    Affidavit\\n\\nOUTSOURCING AGREEMENT\\n\\n\\n\\n\\n\\n     This Outsourcing Agreement (\"Agreement\") is made as of the 16th day of February, 1998, by and between Tri City National Ban',\n",
              "    'Highlight the parts (if any) of this contract related to \"Parties\" that should be reviewed by a lawyer. Details: The two or more parties who signed the contract',\n",
              "    'Tri City National Bank',\n",
              "    0,\n",
              "    0),\n",
              "   ('OUTSOURCING AGREEMENT\\n\\nBY AND BETWEEN\\n\\nTRI CITY NATIONAL BANK\\n\\nand\\n\\nMARSHALL & ILSLEY CORPORATION acting through its division M&I DATA SERVICES\\n\\nDATED AS OF\\n\\nFebruary 16, 1998\\n\\nTABLE OF CONTENTS\\n\\nPage 1. DEFINITIONS  1.1 Background  1.2 Definitions      1.3 References  1.4 Interpretation   2. TERM    2.1 Initial Term     2.2 Extensions  3. APPOINTMENT  3.1 Performance by M&I Affiliates   3.2 Third Party Services  3.3 Proper Instructions   4. CONVERSION   4.1 Banking Applications  4.2 Development of Conversion Plan  4.3 Conversion Resources  4.4 Conversion Milestones      5. OUTSOURCING OF TRUST SERVICES    6. BANKING APPLICATIONS   6.1 Services to be Rendered    6.2 Banking Application Processing  6.3 Corporate Support Services      6.4 Item Processing Services   6.5 Automated Clearing House Services    6.6 Home Banking and Internet Services   6.7 Retail Delivery Systems    6.8 Visa Check/MasterMoney Card Services      6.9 EFT Services     7. FACILITIES MANAGEMENT  8. FEES    8.1 Fee Structure    8.2 Conversion  8.3 Pricing and Operational Assumptions  8.4 Banking Applications Services   8.5 Corporate Support Services      8.6 Item Processing Services   8.7 Management Services   8.8 Visa Check/MasterMoney Card Services      8.9 EFT Services     8.10 Training and Education    8.11 Excluded Costs  8.12 Disputed Amounts     8.13 Terms of Payment     8.14 Modification of Terms and Pricing   9. PERFORMANCE STANDARDS  9.1 General     9.2 Banking Applications  10. MODIFICATION OR TERMINATION OF SERVICES   10.1 Modifications to Services      10.2 Partial Termination by M&I     10.3 Partial Termination by Customer     10.4 Development of Custom Software\\n\\n\\n\\n\\n\\n11. TERMINATION      11.1 For Convenience      11.2 For Cause  11.3 Following Change in Control of Customer  11.4 Termination Assistance    12. EVENTS OF DEFAULT; REMEDIES     12.1 By M&I     12.2 By Customer     12.3 Remedies   13. DAMAGES     13.1 Direct Damages  13.2 No Consequential Damages  13.3 Equitable Relief     13.4 Limitation of Liability   13.5 Liquidated Damages   14. INSURANCE AND INDEMNITY    14.1 Insurance  14.2 Indemnity  14.3 Indemnification Procedures     15. DISPUTE RESOLUTION    15.1 Representatives of Parties     15.2 Continuity of Performance      16. REPRESENTATIONS AND WARRANTIES  16.1 By M&I     16.2 By Customer     17. CONFIDENTIALITY AND OWNERSHIP   17.1 Customer Data   17.2 M&I Systems     17.3 Confidential Information  17.4 Obligations of the Parties     17.5 Security   18. MANAGEMENT OF PROJECT      18.1 Account Representatives   18.2 Change Control Procedures      18.3 Reporting and Meetings    18.4 Development Projects and Technical Support    19. REGULATORY COMPLIANCE      20. DISASTER RECOVERY     20.1 Disaster Recovery Plan    20.2 Relocation      20.3 Resumption of Services    20.4 Annual Test     21. GENERAL TERMS AND CONDITIONS    21.1 Force Majeure   21.2 Transmission of Data      21.3 Equipment and Network     21.4 Reliance on Data     21.5 Data Backup     21.6 Balancing and Controls    21.7 Use of Services      21.8 Regulatory Assurances     21.9 IRS Filing      21.10 Affiliates     21.11 Future Acquisitions      22. MISCELLANEOUS PROVISIONS   22.1 Governing Law   22.2 Venue and Jurisdiction    22.3 Entire Agreement; Amendments   22.4 Assignment      22.5 Relationship of Parties   22.6 Notices    22.7 Headings   22.8 Counterparts    22.9 Waiver     22.10 Severability   22.11 Attorneys\\' Fees and Costs     22.12 Financial Statements     22.13 Publicity      22.14 Solicitation   22.15 No Third Party Beneficiaries  22.16 Construction   23. SOURCE CODE      23.1 Escrow     23.2 Copy of Source Code  23.3 Cost of Escrow  23.4 Customer\\'s Right to Obtain the Source Code    23.5 Use of Source Code\\n\\nSchedules\\n\\n4.2  Conversion Plan 6.2  Banking Application Services 8.1  Fee Schedule\\n\\nExhibits\\n\\nA    RDS Agreement B    ACH Authorization Agreement C    Attorney-in-Fact Appointment D    Affidavit\\n\\nOUTSOURCING AGREEMENT\\n\\n\\n\\n\\n\\n     This Outsourcing Agreement (\"Agreement\") is made as of the 16th day of February, 1998, by and between Tri City National Ban',\n",
              "    'Highlight the parts (if any) of this contract related to \"Parties\" that should be reviewed by a lawyer. Details: The two or more parties who signed the contract',\n",
              "    'Marshall & Ilsley Corporation',\n",
              "    0,\n",
              "    0),\n",
              "   (\"Exhibit 10.14(a)\\n\\nSECOND AMENDED AND RESTATED  EXCLUSIVE AGENCY AND  MARKETING AGREEMENT by and between MONSANTO COMPANY\\n\\nand\\n\\nTHE SCOTTS COMPANY LLC  Effective as of September 30, 1998\\n\\n\\n\\n\\n\\nTABLE OF CONTENTS\\n\\nArticle 1 - DEFINITIONS AND RULES OF CONSTRUCTION 1\\n\\n Section 1.1 Definitions 1\\n\\n Section 1.2 Rules of Construction and Interpretation 9\\n\\nArticle 2 - EXCLUSIVE AGENCY AND DISTRIBUTORSHIP 9\\n\\n Section 2.1 Appointment of the Exclusive Agent 9\\n\\n Section 2.2 The Agent's Obligations and Standards 10\\n\\n Section 2.3 Appointment of Sub-Agents and Sub-Distributors 13\\n\\n Section 2.4 Limitations on Agent 13\\n\\n Section 2.5 Changes to Markets 13\\n\\n Section 2.6 Scotts Miracle-Gro Sale Procedures 15\\n\\n Section 2.7 Compliance 15\\n\\nArticle 3 - ACCOUNTING AND CASH FLOW FOR THE ROUNDUP L&G BUSINESS 17\\n\\n Section 3.1 Bookkeeping and Financial Reporting 17\\n\\n Section 3.2 Ordering, Invoicing and Cash Flow Cycle 18\\n\\n Section 3.3 Expenses and Allocation Rules 19\\n\\n Section 3.4 Resolution of Disputes Arising under Article 3 20\\n\\n Section 3.5 Fixed Contribution to Expenses 20\\n\\n Section 3.6 Commission 20\\n\\n Section 3.7 [Intentionally deleted] 21\\n\\n Section 3.8 Additional Commission 21\\n\\nArticle 4 - ROUNDUP L&G BUSINESS MANAGEMENT STRUCTURE 23\\n\\n Section 4.1 Underlying principles for the Roundup L&G Business Management Structure. 23\\n\\n Section 4.2 Steering Committee 23\\n\\n Section 4.3 Business Units 25\\n\\n Section 4.4 Global Support Team 25\\n\\nArticle 5 - DUTIES AND OBLIGATIONS OF MONSANTO 26\\n\\n Section 5.1 Monsanto's Obligations and Rights 26\\n\\n Section 5.2 Warranties 27\\n\\nArticle 6 - REPORTS AND ADDITIONAL OBLIGATIONS OF THE PARTIES 27\\n\\n Section 6.1 Cooperation 27\\n\\n Section 6.2 Use of EDI 27\\n\\nii\\n\\n\\n\\n\\n\\n Section 6.3 The Agent's Systems and Reporting Obligation 27\\n\\n Section 6.4 Employee Incentives 28\\n\\n Section 6.5 Insurance 28\\n\\n Section 6.6 Liens 28\\n\\n Section 6.7 Promoting Safe Use-Practices 29\\n\\n Section 6.8 Monsanto Inspection Rights 29\\n\\n Section 6.9 Recalls 29\\n\\n Section 6.10 New Roundup Products 29\\n\\n Section 6.11 Additional Roundup Products 32\\n\\n Section 6.12 Confidentiality 34\\n\\n Section 6.13 Noncompetition 35\\n\\n Section 6.14 Industrial Property 37\\n\\n Section 6.15 Conflicts of Interest 38\\n\\n Section 6.16 Records Retention 39\\n\\n Section 6.17 Additional Covenant of the Agent 39\\n\\n Section 6.18 Roundup Telephone Number 39\\n\\n Section 6.19 Additional Obligations 39\\n\\nArticle 7 - [Reserved] 39\\n\\nArticle 8 - REPRESENTATIONS, WARRANTIES, AND COVENANTS 39\\n\\n Section 8.1 The Agent's Representations and Warranties 39\\n\\n Section 8.2 Monsanto's Representations and Warranties 40\\n\\nArticle 9 - INDEMNIFICATION 41\\n\\n Section 9.1 Indemnification and Claims Procedures 41\\n\\nArticle 10 - TERMS, TERMINATION, AND FORCE MAJEURE 42\\n\\n Section 10.1 Terms 42\\n\\n Section 10.2 [Reserved] 42\\n\\n Section 10.3 [Reserved] 42\\n\\n Section 10.4 Termination by Monsanto 42\\n\\n Section 10.5 Termination by the Agent 47\\n\\n Section 10.6 Roundup Sale 50\\n\\n Section 10.7 Effect of Termination 52\\n\\n Section 10.8 Force Majeure 53\\n\\niii\\n\\n\\n\\n\\n\\n Section 10.9 [Intentionally deleted] 53\\n\\nArticle 11 - MISCELLANEOUS 53\\n\\n Section 11.1 Relationship of the Parties 53\\n\\n Section 11.2 Interpretation in accordance with GAAP 54\\n\\n Section 11.3 Currency 54\\n\\n Section 11.4 Monsanto Obligations 54\\n\\n Section 11.5 Expenses 54\\n\\n Section 11.6 Entire Agreement 54\\n\\n Section 11.7 Modification and Waiver 55\\n\\n Section 11.8 Assignment 55\\n\\n Section 11.9 Notices 56\\n\\n Section 11.10 Severability 57\\n\\n Section 11.11 Equal Opportunity 57\\n\\n Section 11.12 Governing Law 58\\n\\n Section 11.13 Public Announcements 58\\n\\n Section 11.14 Counterparts 59\\n\\nLIST OF EXHIBITS  Exhibit D: Permitted Products LIST OF SCHEDULES    Schedule 1.1(a): Activated Included Markets  Schedule 1.1(b): Roundup Products  Schedule 2.2(a): Annual Business Plan Template  Schedule 3.2 (d): Form of Reconciliation Statement  Schedule 3.3(c): Income Statement Definitions and Allocation Methods  Schedule 4.2 (a): Steering Committee  Schedule 6.11(a): Additional Roundup Products  Schedule 6.11(f): Additional Roundup Products Trademarks\\n\\niv\\n\\n\\n\\n\\n\\nSECOND AMENDED AND RESTATED  EXCLUSIVE AGENCY AND  MARKETING AGREEMENT\\n\\nTHI\",\n",
              "    'Highlight the parts (if any) of this contract related to \"Parties\" that should be reviewed by a lawyer. Details: The two or more parties who signed the contract',\n",
              "    'The Scotts Company LLC',\n",
              "    0,\n",
              "    0),\n",
              "   (\"Exhibit 10.14(a)\\n\\nSECOND AMENDED AND RESTATED  EXCLUSIVE AGENCY AND  MARKETING AGREEMENT by and between MONSANTO COMPANY\\n\\nand\\n\\nTHE SCOTTS COMPANY LLC  Effective as of September 30, 1998\\n\\n\\n\\n\\n\\nTABLE OF CONTENTS\\n\\nArticle 1 - DEFINITIONS AND RULES OF CONSTRUCTION 1\\n\\n Section 1.1 Definitions 1\\n\\n Section 1.2 Rules of Construction and Interpretation 9\\n\\nArticle 2 - EXCLUSIVE AGENCY AND DISTRIBUTORSHIP 9\\n\\n Section 2.1 Appointment of the Exclusive Agent 9\\n\\n Section 2.2 The Agent's Obligations and Standards 10\\n\\n Section 2.3 Appointment of Sub-Agents and Sub-Distributors 13\\n\\n Section 2.4 Limitations on Agent 13\\n\\n Section 2.5 Changes to Markets 13\\n\\n Section 2.6 Scotts Miracle-Gro Sale Procedures 15\\n\\n Section 2.7 Compliance 15\\n\\nArticle 3 - ACCOUNTING AND CASH FLOW FOR THE ROUNDUP L&G BUSINESS 17\\n\\n Section 3.1 Bookkeeping and Financial Reporting 17\\n\\n Section 3.2 Ordering, Invoicing and Cash Flow Cycle 18\\n\\n Section 3.3 Expenses and Allocation Rules 19\\n\\n Section 3.4 Resolution of Disputes Arising under Article 3 20\\n\\n Section 3.5 Fixed Contribution to Expenses 20\\n\\n Section 3.6 Commission 20\\n\\n Section 3.7 [Intentionally deleted] 21\\n\\n Section 3.8 Additional Commission 21\\n\\nArticle 4 - ROUNDUP L&G BUSINESS MANAGEMENT STRUCTURE 23\\n\\n Section 4.1 Underlying principles for the Roundup L&G Business Management Structure. 23\\n\\n Section 4.2 Steering Committee 23\\n\\n Section 4.3 Business Units 25\\n\\n Section 4.4 Global Support Team 25\\n\\nArticle 5 - DUTIES AND OBLIGATIONS OF MONSANTO 26\\n\\n Section 5.1 Monsanto's Obligations and Rights 26\\n\\n Section 5.2 Warranties 27\\n\\nArticle 6 - REPORTS AND ADDITIONAL OBLIGATIONS OF THE PARTIES 27\\n\\n Section 6.1 Cooperation 27\\n\\n Section 6.2 Use of EDI 27\\n\\nii\\n\\n\\n\\n\\n\\n Section 6.3 The Agent's Systems and Reporting Obligation 27\\n\\n Section 6.4 Employee Incentives 28\\n\\n Section 6.5 Insurance 28\\n\\n Section 6.6 Liens 28\\n\\n Section 6.7 Promoting Safe Use-Practices 29\\n\\n Section 6.8 Monsanto Inspection Rights 29\\n\\n Section 6.9 Recalls 29\\n\\n Section 6.10 New Roundup Products 29\\n\\n Section 6.11 Additional Roundup Products 32\\n\\n Section 6.12 Confidentiality 34\\n\\n Section 6.13 Noncompetition 35\\n\\n Section 6.14 Industrial Property 37\\n\\n Section 6.15 Conflicts of Interest 38\\n\\n Section 6.16 Records Retention 39\\n\\n Section 6.17 Additional Covenant of the Agent 39\\n\\n Section 6.18 Roundup Telephone Number 39\\n\\n Section 6.19 Additional Obligations 39\\n\\nArticle 7 - [Reserved] 39\\n\\nArticle 8 - REPRESENTATIONS, WARRANTIES, AND COVENANTS 39\\n\\n Section 8.1 The Agent's Representations and Warranties 39\\n\\n Section 8.2 Monsanto's Representations and Warranties 40\\n\\nArticle 9 - INDEMNIFICATION 41\\n\\n Section 9.1 Indemnification and Claims Procedures 41\\n\\nArticle 10 - TERMS, TERMINATION, AND FORCE MAJEURE 42\\n\\n Section 10.1 Terms 42\\n\\n Section 10.2 [Reserved] 42\\n\\n Section 10.3 [Reserved] 42\\n\\n Section 10.4 Termination by Monsanto 42\\n\\n Section 10.5 Termination by the Agent 47\\n\\n Section 10.6 Roundup Sale 50\\n\\n Section 10.7 Effect of Termination 52\\n\\n Section 10.8 Force Majeure 53\\n\\niii\\n\\n\\n\\n\\n\\n Section 10.9 [Intentionally deleted] 53\\n\\nArticle 11 - MISCELLANEOUS 53\\n\\n Section 11.1 Relationship of the Parties 53\\n\\n Section 11.2 Interpretation in accordance with GAAP 54\\n\\n Section 11.3 Currency 54\\n\\n Section 11.4 Monsanto Obligations 54\\n\\n Section 11.5 Expenses 54\\n\\n Section 11.6 Entire Agreement 54\\n\\n Section 11.7 Modification and Waiver 55\\n\\n Section 11.8 Assignment 55\\n\\n Section 11.9 Notices 56\\n\\n Section 11.10 Severability 57\\n\\n Section 11.11 Equal Opportunity 57\\n\\n Section 11.12 Governing Law 58\\n\\n Section 11.13 Public Announcements 58\\n\\n Section 11.14 Counterparts 59\\n\\nLIST OF EXHIBITS  Exhibit D: Permitted Products LIST OF SCHEDULES    Schedule 1.1(a): Activated Included Markets  Schedule 1.1(b): Roundup Products  Schedule 2.2(a): Annual Business Plan Template  Schedule 3.2 (d): Form of Reconciliation Statement  Schedule 3.3(c): Income Statement Definitions and Allocation Methods  Schedule 4.2 (a): Steering Committee  Schedule 6.11(a): Additional Roundup Products  Schedule 6.11(f): Additional Roundup Products Trademarks\\n\\niv\\n\\n\\n\\n\\n\\nSECOND AMENDED AND RESTATED  EXCLUSIVE AGENCY AND  MARKETING AGREEMENT\\n\\nTHI\",\n",
              "    'Highlight the parts (if any) of this contract related to \"Parties\" that should be reviewed by a lawyer. Details: The two or more parties who signed the contract',\n",
              "    'Monsanto Company',\n",
              "    0,\n",
              "    0),\n",
              "   (\"Exhibit 10.14(a)\\n\\nSECOND AMENDED AND RESTATED  EXCLUSIVE AGENCY AND  MARKETING AGREEMENT by and between MONSANTO COMPANY\\n\\nand\\n\\nTHE SCOTTS COMPANY LLC  Effective as of September 30, 1998\\n\\n\\n\\n\\n\\nTABLE OF CONTENTS\\n\\nArticle 1 - DEFINITIONS AND RULES OF CONSTRUCTION 1\\n\\n Section 1.1 Definitions 1\\n\\n Section 1.2 Rules of Construction and Interpretation 9\\n\\nArticle 2 - EXCLUSIVE AGENCY AND DISTRIBUTORSHIP 9\\n\\n Section 2.1 Appointment of the Exclusive Agent 9\\n\\n Section 2.2 The Agent's Obligations and Standards 10\\n\\n Section 2.3 Appointment of Sub-Agents and Sub-Distributors 13\\n\\n Section 2.4 Limitations on Agent 13\\n\\n Section 2.5 Changes to Markets 13\\n\\n Section 2.6 Scotts Miracle-Gro Sale Procedures 15\\n\\n Section 2.7 Compliance 15\\n\\nArticle 3 - ACCOUNTING AND CASH FLOW FOR THE ROUNDUP L&G BUSINESS 17\\n\\n Section 3.1 Bookkeeping and Financial Reporting 17\\n\\n Section 3.2 Ordering, Invoicing and Cash Flow Cycle 18\\n\\n Section 3.3 Expenses and Allocation Rules 19\\n\\n Section 3.4 Resolution of Disputes Arising under Article 3 20\\n\\n Section 3.5 Fixed Contribution to Expenses 20\\n\\n Section 3.6 Commission 20\\n\\n Section 3.7 [Intentionally deleted] 21\\n\\n Section 3.8 Additional Commission 21\\n\\nArticle 4 - ROUNDUP L&G BUSINESS MANAGEMENT STRUCTURE 23\\n\\n Section 4.1 Underlying principles for the Roundup L&G Business Management Structure. 23\\n\\n Section 4.2 Steering Committee 23\\n\\n Section 4.3 Business Units 25\\n\\n Section 4.4 Global Support Team 25\\n\\nArticle 5 - DUTIES AND OBLIGATIONS OF MONSANTO 26\\n\\n Section 5.1 Monsanto's Obligations and Rights 26\\n\\n Section 5.2 Warranties 27\\n\\nArticle 6 - REPORTS AND ADDITIONAL OBLIGATIONS OF THE PARTIES 27\\n\\n Section 6.1 Cooperation 27\\n\\n Section 6.2 Use of EDI 27\\n\\nii\\n\\n\\n\\n\\n\\n Section 6.3 The Agent's Systems and Reporting Obligation 27\\n\\n Section 6.4 Employee Incentives 28\\n\\n Section 6.5 Insurance 28\\n\\n Section 6.6 Liens 28\\n\\n Section 6.7 Promoting Safe Use-Practices 29\\n\\n Section 6.8 Monsanto Inspection Rights 29\\n\\n Section 6.9 Recalls 29\\n\\n Section 6.10 New Roundup Products 29\\n\\n Section 6.11 Additional Roundup Products 32\\n\\n Section 6.12 Confidentiality 34\\n\\n Section 6.13 Noncompetition 35\\n\\n Section 6.14 Industrial Property 37\\n\\n Section 6.15 Conflicts of Interest 38\\n\\n Section 6.16 Records Retention 39\\n\\n Section 6.17 Additional Covenant of the Agent 39\\n\\n Section 6.18 Roundup Telephone Number 39\\n\\n Section 6.19 Additional Obligations 39\\n\\nArticle 7 - [Reserved] 39\\n\\nArticle 8 - REPRESENTATIONS, WARRANTIES, AND COVENANTS 39\\n\\n Section 8.1 The Agent's Representations and Warranties 39\\n\\n Section 8.2 Monsanto's Representations and Warranties 40\\n\\nArticle 9 - INDEMNIFICATION 41\\n\\n Section 9.1 Indemnification and Claims Procedures 41\\n\\nArticle 10 - TERMS, TERMINATION, AND FORCE MAJEURE 42\\n\\n Section 10.1 Terms 42\\n\\n Section 10.2 [Reserved] 42\\n\\n Section 10.3 [Reserved] 42\\n\\n Section 10.4 Termination by Monsanto 42\\n\\n Section 10.5 Termination by the Agent 47\\n\\n Section 10.6 Roundup Sale 50\\n\\n Section 10.7 Effect of Termination 52\\n\\n Section 10.8 Force Majeure 53\\n\\niii\\n\\n\\n\\n\\n\\n Section 10.9 [Intentionally deleted] 53\\n\\nArticle 11 - MISCELLANEOUS 53\\n\\n Section 11.1 Relationship of the Parties 53\\n\\n Section 11.2 Interpretation in accordance with GAAP 54\\n\\n Section 11.3 Currency 54\\n\\n Section 11.4 Monsanto Obligations 54\\n\\n Section 11.5 Expenses 54\\n\\n Section 11.6 Entire Agreement 54\\n\\n Section 11.7 Modification and Waiver 55\\n\\n Section 11.8 Assignment 55\\n\\n Section 11.9 Notices 56\\n\\n Section 11.10 Severability 57\\n\\n Section 11.11 Equal Opportunity 57\\n\\n Section 11.12 Governing Law 58\\n\\n Section 11.13 Public Announcements 58\\n\\n Section 11.14 Counterparts 59\\n\\nLIST OF EXHIBITS  Exhibit D: Permitted Products LIST OF SCHEDULES    Schedule 1.1(a): Activated Included Markets  Schedule 1.1(b): Roundup Products  Schedule 2.2(a): Annual Business Plan Template  Schedule 3.2 (d): Form of Reconciliation Statement  Schedule 3.3(c): Income Statement Definitions and Allocation Methods  Schedule 4.2 (a): Steering Committee  Schedule 6.11(a): Additional Roundup Products  Schedule 6.11(f): Additional Roundup Products Trademarks\\n\\niv\\n\\n\\n\\n\\n\\nSECOND AMENDED AND RESTATED  EXCLUSIVE AGENCY AND  MARKETING AGREEMENT\\n\\nTHI\",\n",
              "    'Highlight the parts (if any) of this contract related to \"Parties\" that should be reviewed by a lawyer. Details: The two or more parties who signed the contract',\n",
              "    'The Scotts Company',\n",
              "    0,\n",
              "    0),\n",
              "   (\"Exhibit 10.14(a)\\n\\nSECOND AMENDED AND RESTATED  EXCLUSIVE AGENCY AND  MARKETING AGREEMENT by and between MONSANTO COMPANY\\n\\nand\\n\\nTHE SCOTTS COMPANY LLC  Effective as of September 30, 1998\\n\\n\\n\\n\\n\\nTABLE OF CONTENTS\\n\\nArticle 1 - DEFINITIONS AND RULES OF CONSTRUCTION 1\\n\\n Section 1.1 Definitions 1\\n\\n Section 1.2 Rules of Construction and Interpretation 9\\n\\nArticle 2 - EXCLUSIVE AGENCY AND DISTRIBUTORSHIP 9\\n\\n Section 2.1 Appointment of the Exclusive Agent 9\\n\\n Section 2.2 The Agent's Obligations and Standards 10\\n\\n Section 2.3 Appointment of Sub-Agents and Sub-Distributors 13\\n\\n Section 2.4 Limitations on Agent 13\\n\\n Section 2.5 Changes to Markets 13\\n\\n Section 2.6 Scotts Miracle-Gro Sale Procedures 15\\n\\n Section 2.7 Compliance 15\\n\\nArticle 3 - ACCOUNTING AND CASH FLOW FOR THE ROUNDUP L&G BUSINESS 17\\n\\n Section 3.1 Bookkeeping and Financial Reporting 17\\n\\n Section 3.2 Ordering, Invoicing and Cash Flow Cycle 18\\n\\n Section 3.3 Expenses and Allocation Rules 19\\n\\n Section 3.4 Resolution of Disputes Arising under Article 3 20\\n\\n Section 3.5 Fixed Contribution to Expenses 20\\n\\n Section 3.6 Commission 20\\n\\n Section 3.7 [Intentionally deleted] 21\\n\\n Section 3.8 Additional Commission 21\\n\\nArticle 4 - ROUNDUP L&G BUSINESS MANAGEMENT STRUCTURE 23\\n\\n Section 4.1 Underlying principles for the Roundup L&G Business Management Structure. 23\\n\\n Section 4.2 Steering Committee 23\\n\\n Section 4.3 Business Units 25\\n\\n Section 4.4 Global Support Team 25\\n\\nArticle 5 - DUTIES AND OBLIGATIONS OF MONSANTO 26\\n\\n Section 5.1 Monsanto's Obligations and Rights 26\\n\\n Section 5.2 Warranties 27\\n\\nArticle 6 - REPORTS AND ADDITIONAL OBLIGATIONS OF THE PARTIES 27\\n\\n Section 6.1 Cooperation 27\\n\\n Section 6.2 Use of EDI 27\\n\\nii\\n\\n\\n\\n\\n\\n Section 6.3 The Agent's Systems and Reporting Obligation 27\\n\\n Section 6.4 Employee Incentives 28\\n\\n Section 6.5 Insurance 28\\n\\n Section 6.6 Liens 28\\n\\n Section 6.7 Promoting Safe Use-Practices 29\\n\\n Section 6.8 Monsanto Inspection Rights 29\\n\\n Section 6.9 Recalls 29\\n\\n Section 6.10 New Roundup Products 29\\n\\n Section 6.11 Additional Roundup Products 32\\n\\n Section 6.12 Confidentiality 34\\n\\n Section 6.13 Noncompetition 35\\n\\n Section 6.14 Industrial Property 37\\n\\n Section 6.15 Conflicts of Interest 38\\n\\n Section 6.16 Records Retention 39\\n\\n Section 6.17 Additional Covenant of the Agent 39\\n\\n Section 6.18 Roundup Telephone Number 39\\n\\n Section 6.19 Additional Obligations 39\\n\\nArticle 7 - [Reserved] 39\\n\\nArticle 8 - REPRESENTATIONS, WARRANTIES, AND COVENANTS 39\\n\\n Section 8.1 The Agent's Representations and Warranties 39\\n\\n Section 8.2 Monsanto's Representations and Warranties 40\\n\\nArticle 9 - INDEMNIFICATION 41\\n\\n Section 9.1 Indemnification and Claims Procedures 41\\n\\nArticle 10 - TERMS, TERMINATION, AND FORCE MAJEURE 42\\n\\n Section 10.1 Terms 42\\n\\n Section 10.2 [Reserved] 42\\n\\n Section 10.3 [Reserved] 42\\n\\n Section 10.4 Termination by Monsanto 42\\n\\n Section 10.5 Termination by the Agent 47\\n\\n Section 10.6 Roundup Sale 50\\n\\n Section 10.7 Effect of Termination 52\\n\\n Section 10.8 Force Majeure 53\\n\\niii\\n\\n\\n\\n\\n\\n Section 10.9 [Intentionally deleted] 53\\n\\nArticle 11 - MISCELLANEOUS 53\\n\\n Section 11.1 Relationship of the Parties 53\\n\\n Section 11.2 Interpretation in accordance with GAAP 54\\n\\n Section 11.3 Currency 54\\n\\n Section 11.4 Monsanto Obligations 54\\n\\n Section 11.5 Expenses 54\\n\\n Section 11.6 Entire Agreement 54\\n\\n Section 11.7 Modification and Waiver 55\\n\\n Section 11.8 Assignment 55\\n\\n Section 11.9 Notices 56\\n\\n Section 11.10 Severability 57\\n\\n Section 11.11 Equal Opportunity 57\\n\\n Section 11.12 Governing Law 58\\n\\n Section 11.13 Public Announcements 58\\n\\n Section 11.14 Counterparts 59\\n\\nLIST OF EXHIBITS  Exhibit D: Permitted Products LIST OF SCHEDULES    Schedule 1.1(a): Activated Included Markets  Schedule 1.1(b): Roundup Products  Schedule 2.2(a): Annual Business Plan Template  Schedule 3.2 (d): Form of Reconciliation Statement  Schedule 3.3(c): Income Statement Definitions and Allocation Methods  Schedule 4.2 (a): Steering Committee  Schedule 6.11(a): Additional Roundup Products  Schedule 6.11(f): Additional Roundup Products Trademarks\\n\\niv\\n\\n\\n\\n\\n\\nSECOND AMENDED AND RESTATED  EXCLUSIVE AGENCY AND  MARKETING AGREEMENT\\n\\nTHI\",\n",
              "    'Highlight the parts (if any) of this contract related to \"Parties\" that should be reviewed by a lawyer. Details: The two or more parties who signed the contract',\n",
              "    'the \"Agent\"',\n",
              "    0,\n",
              "    0),\n",
              "   ('SPONSORSHIP AGREEMENT     THIS SPONSORSHIP AGREEMENT (\"Agreement\") is entered into and effective as of the date first written above (\"Effective Date\") by  and among PEEK Investments LLC, a Delaware limited liability company (\"Purchaser\"), and each other party hereto identified on the signature  page(s) hereto (each, a \"Sponsor\"). Each term used and not otherwise defined herein shall have the meaning assigned to such term in the Offer.     RECITALS     WHEREAS, Purchaser is tentatively exploring, among other potential alternatives, a possible third-party tender offer to purchase all  outstanding shares of common stock, $0.001 par value per share (\"Shares\"), of a Delaware corporation (the \"Company\") upon the terms and  subject to the conditions set forth in the Offer to Purchase, related Letter of Transmittal, and other tender offer material provided by or on behalf of  Purchaser to the Sponsors (which, collectively, as amended or supplemented, constitute the \"Offer\");     WHEREAS, as requested by Purchaser for purposes of the Offer, each Sponsor has provided to Purchaser, and Purchaser has accepted  from such Sponsor, a commitment letter providing for a possible equity investment in Purchaser by such Sponsor (each, an \"Equity Commitment Letter\" and, with respect to any Sponsor(s), the Equity Commitment Letter(s) of such Sponsor(s)), which evidences the commitment of and by  such Sponsor to contribute capital to Purchaser in amounts and proportions and upon the terms and subject to the conditions and otherwise as  contemplated by such Equity Commitment Letter (each, a \"Commitment\" and, with respect to any Sponsor(s), the Commitment of such Sponsor (s));     WHEREAS, such capital contributions, if any, would be used to purchase Shares in the Offer and fund the payment or reimbursement of  fees, expenses, and costs related to the Offer (collectively, \"Transaction Costs\"); and     WHEREAS, each party hereto desires to establish certain terms and conditions related to the Offer and relationship among the Sponsors,  the related equity financing commitments, and the Offer;     NOW, THEREFORE, for good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, each party  hereto (\"Party\"), intending to be legally bound, hereby agrees as follows:     AGREEMENT     1. Pre-Acceptance Period. If and to the extent any such decision would or could (or would or could be reasonably foreseeable to)  adversely affect any Sponsor in any manner, each decision to be made by or on behalf of Purchaser with respect to the Offer (or any similar  transaction), any agreements related thereto (\"Related Agreements\"), or any transaction contemplated by the Offer or any Related Agreement  (\"Contemplated Transactions\" and, together with the Offer and Related Agreements, \"Offer Matters\"), or any Offer Matter or combination of  Offer Matters, in any case, on and from the Effective Date and until the Acceptance Time (\"Pre-Acceptance Period\") shall require the unanimous  consent of the Sponsors, including, without limitation, any (a) announcement of intention, commencement, amendment, supplement, termination,  extension, modification, or waiver of or related to the Offer or any term or condition thereof, including, without limitation, with respect to any  commencement date, initial offering period, offer price, type or form of consideration to be offered or paid, timing or other term of acceptance for  payment or payment of any subject security, withdrawal right, expiration date, subsequent offering period, or top-up option, (b) waiver of any  condition to or of the Offer or determination as to whether or not any such condition has been, is, or will be satisfied, (c) filing, dissemination, or  disclosure requirement or offering document or tender offer material, including, without limitation, with respect to any filing or exhibit, schedule,  attachment, amendment, or supplement thereto, (d) agreement, instrument, document, or matter related to any borrowing, incurrence of  indebtedness, or equity, debt, or other financing, (e) ',\n",
              "    'Highlight the parts (if any) of this contract related to \"Parties\" that should be reviewed by a lawyer. Details: The two or more parties who signed the contract',\n",
              "    'Platinum Partners Value Arbitrage Fund L.P.',\n",
              "    0,\n",
              "    0),\n",
              "   ('SPONSORSHIP AGREEMENT     THIS SPONSORSHIP AGREEMENT (\"Agreement\") is entered into and effective as of the date first written above (\"Effective Date\") by  and among PEEK Investments LLC, a Delaware limited liability company (\"Purchaser\"), and each other party hereto identified on the signature  page(s) hereto (each, a \"Sponsor\"). Each term used and not otherwise defined herein shall have the meaning assigned to such term in the Offer.     RECITALS     WHEREAS, Purchaser is tentatively exploring, among other potential alternatives, a possible third-party tender offer to purchase all  outstanding shares of common stock, $0.001 par value per share (\"Shares\"), of a Delaware corporation (the \"Company\") upon the terms and  subject to the conditions set forth in the Offer to Purchase, related Letter of Transmittal, and other tender offer material provided by or on behalf of  Purchaser to the Sponsors (which, collectively, as amended or supplemented, constitute the \"Offer\");     WHEREAS, as requested by Purchaser for purposes of the Offer, each Sponsor has provided to Purchaser, and Purchaser has accepted  from such Sponsor, a commitment letter providing for a possible equity investment in Purchaser by such Sponsor (each, an \"Equity Commitment Letter\" and, with respect to any Sponsor(s), the Equity Commitment Letter(s) of such Sponsor(s)), which evidences the commitment of and by  such Sponsor to contribute capital to Purchaser in amounts and proportions and upon the terms and subject to the conditions and otherwise as  contemplated by such Equity Commitment Letter (each, a \"Commitment\" and, with respect to any Sponsor(s), the Commitment of such Sponsor (s));     WHEREAS, such capital contributions, if any, would be used to purchase Shares in the Offer and fund the payment or reimbursement of  fees, expenses, and costs related to the Offer (collectively, \"Transaction Costs\"); and     WHEREAS, each party hereto desires to establish certain terms and conditions related to the Offer and relationship among the Sponsors,  the related equity financing commitments, and the Offer;     NOW, THEREFORE, for good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, each party  hereto (\"Party\"), intending to be legally bound, hereby agrees as follows:     AGREEMENT     1. Pre-Acceptance Period. If and to the extent any such decision would or could (or would or could be reasonably foreseeable to)  adversely affect any Sponsor in any manner, each decision to be made by or on behalf of Purchaser with respect to the Offer (or any similar  transaction), any agreements related thereto (\"Related Agreements\"), or any transaction contemplated by the Offer or any Related Agreement  (\"Contemplated Transactions\" and, together with the Offer and Related Agreements, \"Offer Matters\"), or any Offer Matter or combination of  Offer Matters, in any case, on and from the Effective Date and until the Acceptance Time (\"Pre-Acceptance Period\") shall require the unanimous  consent of the Sponsors, including, without limitation, any (a) announcement of intention, commencement, amendment, supplement, termination,  extension, modification, or waiver of or related to the Offer or any term or condition thereof, including, without limitation, with respect to any  commencement date, initial offering period, offer price, type or form of consideration to be offered or paid, timing or other term of acceptance for  payment or payment of any subject security, withdrawal right, expiration date, subsequent offering period, or top-up option, (b) waiver of any  condition to or of the Offer or determination as to whether or not any such condition has been, is, or will be satisfied, (c) filing, dissemination, or  disclosure requirement or offering document or tender offer material, including, without limitation, with respect to any filing or exhibit, schedule,  attachment, amendment, or supplement thereto, (d) agreement, instrument, document, or matter related to any borrowing, incurrence of  indebtedness, or equity, debt, or other financing, (e) ',\n",
              "    'Highlight the parts (if any) of this contract related to \"Parties\" that should be reviewed by a lawyer. Details: The two or more parties who signed the contract',\n",
              "    'Snowy August Fund I LP',\n",
              "    0,\n",
              "    0)]),\n",
              " (('Agreement Date', 'positive'),\n",
              "  [('1                                                                     Exhibit 10.3\\n\\nI-on. (LOGO) www.i-on.com 561.394.9484 o 561.394-9773 fax 1733 avenida del sol, boca raton, florida, 33432\\n\\nWEB SITE HOSTING AGREEMENT\\n\\nThis WEB SITE HOSTING AGREEMENT (\"this Agreement\") is entered into this 6th day of April, 1999 by and between Centrack International, a Florida corporation (\"the Customer\"), and i-on interactive, a Florida corporation (\"i-on\").\\n\\nDEFINITIONS\\n\\nAs used in this Agreement, the term \"Web site\" shall mean a computer system intended to be accessed through the World Wide Web segment of the Internet, including software and content intended to be viewed and/or operated upon by persons accessing the computer system via the Internet. A Web site may exist on a single computer system with other Web sites.\\n\\nThe term \"Hosted Site\" shall mean the Web site of the Customer that is hosted by i-on under the terms and conditions of this Agreement.\\n\\nThe term \"Hosting Computer\" shall mean the computer system and related equipment on which the Hosted Site exists.\\n\\nSERVICES PROVIDED TO THE CUSTOMER\\n\\ni-on will maintain the operation of the Hosted Site continuously, twenty-four (24) hours per day, seven (7) days per week, including holidays, with the exception of reasonable hardware and software maintenance that must be performed on the Hosting Computer and/or the Hosted Site. i-on will use best efforts to schedule and perform such maintenance between the hours of 8pm and 8am Eastern Standard Time on weekdays, or during weekends.\\n\\nUnder this Agreement, i-on will provide the following limited services for the Hosted Site:\\n\\n      1. connectivity to the Internet via a T1 (that may be shared by other             Web sites) to a leading Internet backbone access provider such as             UUNET, and reasonable efforts to maintain such connectivity with the             phone company and the Internet backbone access provider;\\n\\n      2. use of the Hosting Computer (that may be shared by other Web sites)             as described in this Agreement and maintenance required to keep such             Hosting Computer in good working order;\\n\\n      3. physical space for the Hosting Computer at a facility that maintains             proper environmental conditions in the area(s) where the Hosting             Computer is located and maintains reasonable efforts to prevent             unauthorized access to the physical location of the Hosting             Computer;\\n\\n      4. an emergency electrical power backup system for the Hosting             Computer;\\n\\n      5. up to 150 MB of mirrored computer storage on the Hosting Computer;\\n\\n      6. archival backups of such mirrored computer storage on a weekly             basis;    2          7.  off-site storage of such backups at separate facility than the              location of the Hosting Computer;\\n\\n      8.  use of the Microsoft Windows NT Server 4.0 or higher operating              system software for the Hosting Computer and the Hosted Site;\\n\\n      9.  use of the Microsoft Internet Information Service (IIS) 3.0 or              higher Web server software for the Hosted Site (providing support              for the HTTP Web protocol);\\n\\n      10. use of the Microsoft SQL Server 6.5 or higher database server              software for the Hosted Site, within the boundaries of allocated              computer storage, per #5 above;\\n\\n      11. access to the Hosted Site via the ftp protocol to an administrative              account designated by the Customer for the Customer to maintain the              Hosted Site\\'s static content (such as HTML Web pages and computer              graphics);\\n\\n      12. up to 10 mailboxes accessible via the POP3 mail protocol that are              mapped to the Hosted Site\\'s Internet address;\\n\\n      13. up to 1 hour per month of Web site administration services at no              additional charge, limited to:\\n\\n               requests for changes to ftp/e-mail users and passwords;                   requests for e-mail configuration changes;                   modification of mail',\n",
              "    'Highlight the parts (if any) of this contract related to \"Agreement Date\" that should be reviewed by a lawyer. Details: The date of the contract',\n",
              "    '6th day of April, 1999',\n",
              "    292,\n",
              "    314),\n",
              "   ('Exhibit 10.2\\n\\n______________________________________________________________________________\\n\\nCO-PROMOTION AGREEMENT\\n\\nby and between\\n\\nDOVA PHARMACEUTICALS, INC.\\n\\nand\\n\\nVALEANT PHARMACEUTICALS NORTH AMERICA LLC\\n\\nSeptember 26, 2018\\n\\n______________________________________________________________________________\\n\\nCONFIDENTIAL TREATMENT HAS BEEN REQUESTED FOR PORTIONS OF THIS EXHIBIT. THE COPY FILED HEREWITH OMITS THE INFORMATION SUBJECT TO A CONFIDENTIALITY REQUEST. OMISSIONS ARE DESIGNATED [***]. A COMPLETE VERSION OF THIS EXHIBIT HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION.\\n\\nSource: DOVA PHARMACEUTICALS INC., 10-Q, 11/8/2018\\n\\n\\n\\n\\n\\nTABLE OF CONTENTS\\n\\nPage\\n\\nARTICLE 1 DEFINITIONS 1\\n\\nARTICLE 2 RIGHTS AND OBLIGATIONS 8\\n\\n2.1 Engagement; Grant of Rights. 8\\n\\n2.2 Retention of Rights. 9\\n\\n2.3 Non-Competition; Non-Solicitation. 9\\n\\n2.4 Dova Trademarks and Copyrights. 10\\n\\nARTICLE 3 JOINT STEERING COMMITTEE 11\\n\\n3.1 Formation of the JSC. 11\\n\\n3.2 Meetings and Minutes. 11\\n\\n3.3 Purpose of the JSC. 11\\n\\n3.4 Decision Making. 13\\n\\n3.5 Marketing Sub-Committee. 13\\n\\nARTICLE 4 VALEANT ACTIVITIES FOR THE PRODUCT 14\\n\\n4.1 Valeant Activities. 14\\n\\n4.2 Detailing. 15\\n\\n4.3 Compliance with Applicable Law. 17\\n\\n4.4 Field Force Personnel Training; Product Materials. 19\\n\\n4.5 Provisions Related to Field Force Personnel. 21\\n\\n4.6 Responsibility for Valeant Activity Costs and Expenses. 22\\n\\n4.7 Data Sharing. 22\\n\\nARTICLE 5 REGULATORY, SAFETY AND SURVEILLANCE, COMMERCIAL MATTERS 23\\n\\n5.1 Dova Responsibility. 23\\n\\n5.2 Valeant Involvement. 23\\n\\n5.3 Inspections. 23\\n\\n5.4 Pharmacovigilance. 24\\n\\n5.5 Unsolicited Requests for Medical Information. 24\\n\\n5.6 Recalls and Market Withdrawals. 25\\n\\n5.7 Certain Reporting Responsibilities. 25\\n\\n5.8 Booking of Sales Revenues. 25\\n\\n5.9 Returns. 25\\n\\nSource: DOVA PHARMACEUTICALS INC., 10-Q, 11/8/2018\\n\\n\\n\\n\\n\\ni\\n\\nCONFIDENTIAL TREATMENT HAS BEEN REQUESTED FOR PORTIONS OF THIS EXHIBIT. THE COPY FILED HEREWITH OMITS THE INFORMATION SUBJECT TO A CONFIDENTIALITY REQUEST. OMISSIONS ARE DESIGNATED [***]. A COMPLETE VERSION OF THIS EXHIBIT HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION.\\n\\nSource: DOVA PHARMACEUTICALS INC., 10-Q, 11/8/2018\\n\\n\\n\\n\\n\\nTABLE OF CONTENTS (continued)\\n\\n5.10 Manufacturing; Distribution; Marketing. 25\\n\\nARTICLE 6 FINANCIAL PROVISIONS 26\\n\\n6.1 Promotion Fee. 26\\n\\n6.2 Milestone Payment. 27\\n\\n6.3 Reports; Payments. 27\\n\\n6.4 Taxes. 28\\n\\n6.5 Determination of Specialty. 29\\n\\nARTICLE 7 AUDIT RIGHTS 30\\n\\n7.1 Recordkeeping. 30\\n\\n7.2 Valeant Rights. 30\\n\\n7.3 Dova Rights. 31\\n\\nARTICLE 8 INTELLECTUAL PROPERTY 32\\n\\n8.1 Ownership of Intellectual Property. 32\\n\\n8.2 Title to Trademarks and Copyrights. 32\\n\\n8.3 Protection of Trademarks and Copyrights. 32\\n\\n8.4 Disclosure of Know-How. 33\\n\\nARTICLE 9 CONFIDENTIALITY 33\\n\\n9.1 Confidential Information. 33\\n\\n9.2 Public Announcements. 34\\n\\nARTICLE 10 REPRESENTATIONS AND WARRANTIES; ADDITIONAL COVENANTS 35\\n\\n10.1 Representations and Warranties of Dova. 35\\n\\n10.2 Representations and Warranties of Valeant. 37\\n\\n10.3 Disclaimer of Warranty. 38\\n\\n10.4 Additional Covenants. 39\\n\\nARTICLE 11 INDEMNIFICATION; LIMITATIONS ON LIABILITY 39\\n\\n11.1 Indemnification by Dova. 39\\n\\n11.2 Indemnification by Valeant. 39\\n\\n11.3 Indemnification Procedures. 40\\n\\n11.4 Limitation of Liability. 40\\n\\n11.5 Insurance. 40\\n\\nARTICLE 12 TERM AND TERMINATION 41\\n\\n12.1 Term. 41\\n\\n12.2 Early Termination for Cause. 41\\n\\nSource: DOVA PHARMACEUTICALS INC., 10-Q, 11/8/2018\\n\\n\\n\\n\\n\\n12.3 Other Early Termination. 42\\n\\n12.4 Effects of Termination. 42\\n\\n12.5 Tail Period. 42\\n\\nii\\n\\nCONFIDENTIAL TREATMENT HAS BEEN REQUESTED FOR PORTIONS OF THIS EXHIBIT. THE COPY FILED HEREWITH OMITS THE INFORMATION SUBJECT TO A CONFIDENTIALITY REQUEST. OMISSIONS ARE DESIGNATED [***]. A COMPLETE VERSION OF THIS EXHIBIT HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION.\\n\\nSource: DOVA PHARMACEUTICALS INC., 10-Q, 11/8/2018\\n\\n\\n\\n\\n\\nTABLE OF CONTENTS (continued)\\n\\n12.6 Survival. 43\\n\\nARTICLE 13 MISCELLANEOUS 43\\n\\n13.1 Force Majeure. 43\\n\\n13.2 Assignment. 43\\n\\n13.3 Severability. 44\\n\\n13.4 Notices. 44\\n\\n13.5 Governing Law. 45\\n\\n13.6 Dispute Resolution. 45\\n\\n13.7 Waiver ',\n",
              "    'Highlight the parts (if any) of this contract related to \"Agreement Date\" that should be reviewed by a lawyer. Details: The date of the contract',\n",
              "    'September 26, 2018',\n",
              "    210,\n",
              "    228),\n",
              "   ('Exhibit 10.13\\n\\nConfidential Materials omitted and filed separately with the Securities and Exchange Commission. Asterisks denote omissions.\\n\\nDATED: OCTOBER 15, 2009\\n\\nPACIRA PHARMACEUTICALS, INC.\\n\\nand\\n\\nEKR THERAPEUTICS, INC.        AMENDED AND RESTATED   STRATEGIC LICENSING, DISTRIBUTION AND MARKETING AGREEMENT\\n\\n\\n\\n\\n\\nTHIS AMENDED AND RESTATED STRATEGIC LICENSING, DISTRIBUTION AND MARKETING AGREEMENT (the  \"Agreement\") is made on October 15, 2009 (the \"Agreement Date\") and is effective as of the Effective Date (as defined below), between:   PACIRA PHARMACEUTICALS, INC. (F/K/A SKYEPHARMA, INC.) a company incorporated in the state of California whose principal place of business is 10450 Sciences Center Drive, San Diego, California 92121 USA (\"PPI\"); and   EKR THERAPEUTICS, INC., a company incorporated in the state of Delaware whose principal place of business is 1545 Route 206  South, Third Floor, Bedminster, New Jersey 07921 (\"EKR\").\\n\\nRecitals\\n\\nPPI owns and has all right title and interest in or has acquired exclusive rights to the PPI IP (as defined below), the Trademark (as  defined below) and the Product (as defined below).\\n\\nEKR has, among other things, specialized knowledge and expertise in relation to the marketing and sale of pharmaceutical products.\\n\\nPursuant to that certain Strategic Licensing, Distribution and Marketing Agreement between EKR and PPI dated as of August 10, 2007  (the \"Original Agreement\"), PPI granted and EKR acquired the exclusive right and license to sell, offer to sell, distribute and market the Product in  the Territory (as defined below) in the Field (as defined below).\\n\\nEKR and PPI desire to amend and restate the Original Agreement in its entirety as set forth herein in order to provide for: (i) certain  changes to the financial terms set forth in the Original Agreement, (ii) the transfer of Marketing Authorizations (as defined below) from PPI to      -1-\\n\\n\\n\\n\\n\\nEKR, and EKR\\'s assumption of obligations thereunder, (iii) the transfer of title to certain manufacturing equipment from PPI to EKR and the lease  of such equipment back from EKR to PPI and (iv) certain other changes as are set forth herein; all of the foregoing subject to and in accordance  with the terms and conditions of this Agreement.\\n\\nNOW THEREFORE, in consideration of the following mutual agreements and covenants set forth herein and intending to be legally  bound hereby, PPI and EKR (each, a \"Party\"  and collectively, the \"Parties\")  acknowledge and agree that this Agreement shall amend and  supersede in its entirety the Original Agreement and hereby agree as follows:\\n\\nOperative Provisions\\n\\n\\n\\n\\n\\n   -2-\\n\\n1. Definitions   1.1 As used in this Agreement, the following words and expressions have the following meanings:\\n\\n\"Affiliate\"\\n\\n\\n\\nWith respect to any Party to this Agreement shall mean any company, corporation, firm, individual or other  entity which Controls, is Controlled by or is under common Control with such Party to this Agreement for only  so long as such Control exists;\\n\\n\\n\\n\\n\\n   -3-\\n\\n\"Applicable Laws\"\\n\\n\\n\\nShall mean all laws, rules and regulations regarding the manufacture, packaging, labeling, import, export,  storage, distribution, representation, promotion, marketing and sale of the Products including but not limited to  the Federal Food, Drug and Cosmetic Act of 1938, as amended (\"FD&C Act\") and the Controlled Substances  Act, as amended (21 U.S.C. ยง801 et seq.), or as defined in attendant regulations promulgated under authorities  granted by the FD&C Act, together with any equivalent laws, rules, regulations, codes or guidelines having  effect in any jurisdiction in the Territory;\\n\\n\"Calendar Year\"    Shall mean the period of twelve months commencing on 1st January in any year, and each consecutive period  of twelve months thereafter during the Term;\\n\\n\"cGMP\"    Means Current Good Manufacturing Practices pursuant to 21 CFR Parts 210 and 211, as may be amended from  time to time;\\n\\n\"Commercial Launch\"\\n\\n\\n\\nShall mean the date of the first arm\\'s length sale by EKR to an unaffiliated Third Party customer for commercial  use of Pro',\n",
              "    'Highlight the parts (if any) of this contract related to \"Agreement Date\" that should be reviewed by a lawyer. Details: The date of the contract',\n",
              "    'October 15, 2009',\n",
              "    431,\n",
              "    447),\n",
              "   ('ENDORSEMENT\\n\\nContract Number: ENDORSEMENT\\n\\nEffective Date: July 1, 2019\\n\\nThrivent Life Insurance Company has been dissolved. (Thrivent Life Insurance Company was formerly known as Lutheran Brotherhood Variable Insurance Products Company.) All assets and related liabilities of Thrivent Life Insurance Company have been transferred to Thrivent Financial for Lutherans. That includes contracts of insurance, separate accounts, and cash and investment securities. Thrivent Financial for Lutherans now has all obligations under this contract. It is the same as if Thrivent Financial for Lutherans had originally issued the contract. All references to \"Thrivent Life Insurance Company\" are amended to read \"Thrivent Financial for Lutherans.\" All benefits and other terms of this contract remain unchanged except as described below.\\n\\nYou may direct inquiries to:\\n\\nThrivent Financial for Lutherans 4321 N. Ballard Road Appleton, WI 54919-0001 (800) 847-4836\\n\\nThe following amendments apply in lieu of any contract provisions to the contrary.\\n\\nThe following provisions are included as part of this contract:\\n\\nMAINTENANCE OF SOLVENCY. This provision applies only to benefits provided through the General Account. If the solvency of the Society becomes impaired, you may be required to make an extra payment. The Board of Directors will determine the amount of any extra payment. It will be based on each member\\'s fair share of the deficiency. You may make the extra payment by an equivalent reduction in benefits or by a payment in cash. If you do not make the extra payment within 60 days from the date we notify you of your share of the deficiency, the amount will be charged as an indebtedness against the contract with interest compounded at the rate of 5% per year.\\n\\nMEMBERSHIP. The person(s) named as the Insured(s) or the Annuitant(s) is a benefit member of the Society. Rights and privileges of membership are set forth in the Articles of Incorporation and Bylaws of the Society. These rights and privileges are separate from the ownership of this contract.\\n\\nDIVIDENDS. Each year, we will determine our divisible surplus. This contract\\'s share, if any, will be credited as a dividend. Since we do not expect this contract to contribute to divisible surplus, it is not expected that any dividends will be credited.\\n\\nDIVIDEND OPTIONS. If dividends are credited after premiums can no longer be paid under this contract, dividends will be paid in cash. Otherwise, dividends will be applied under the Payment of Premium option unless the Cash option has been chosen in writing.\\n\\nCash. Dividends are paid in cash.\\n\\nPayment of Premium. Dividends are applied as payment of a Net Premium. VB-TL-TFFL (18) page TL-1 @TL18#AA\\n\\nSource: THRIVENT VARIABLE INSURANCE ACCOUNT B, N-6, 7/1/2019\\n\\n\\n\\n\\n\\nContract Number: ENDORSEMENT (continued)\\n\\nThe following provisions of this contract are amended:\\n\\nDEFINITIONS\\n\\nThe DEFINITIONS section of the contract is amended to include the following:\\n\\nService Center. Where this contract is administered. Our Service Center address is 4321 North Ballard Road, Appleton, WI 54919-0001.\\n\\nAnd in the DEFINITIONS section, the definition:\\n\\nWe, Our, Us. Lutheran Brotherhood Variable Insurance Products Company.\\n\\nWhich previously was amended to read:\\n\\nWe, Our, Us. Thrivent Life Insurance Company.\\n\\nIs amended to read:\\n\\nWe, we, Our, our, Us, us, Society. Thrivent Financial for Lutherans.\\n\\nENTIRE CONTRACT\\n\\nIn the ENTIRE CONTRACT section, the first phrase and numbered list are amended to read:\\n\\nThe Entire Contract consists of: 1) This contract including any attached riders, amendments, or endorsements; 2) The Application attached to this contract; and 3) The Articles of Incorporation and Bylaws of the Society and all amendments to them. Benefits will not be reduced or eliminated by any future amendments to our Articles of Incorporation or Bylaws.\\n\\nASSIGNMENT\\n\\nThe ASSIGNMENT section is amended to include the following:\\n\\nYou may transfer ownership of this contract in accordance with our bylaws. Society membership rights and privileges cannot be transferred or assigned. VB-T',\n",
              "    'Highlight the parts (if any) of this contract related to \"Agreement Date\" that should be reviewed by a lawyer. Details: The date of the contract',\n",
              "    'July 1, 2019',\n",
              "    59,\n",
              "    71),\n",
              "   ('Exhibit 10.4   INTELLECTUAL PROPERTY AGREEMENT   This INTELLECTUAL PROPERTY AGREEMENT (this \"Agreement\" or \"IPA\"), effective as of this 30  day of June 2016 (the \"Effective Date\") among THE HERTZ CORPORATION, a Delaware corporation, with an address of 8501 Williams Road, Estero, Florida 33928 (hereinafter \"THC\"); HERTZ SYSTEM, INC., a Delaware corporation, with an address of 8501 Williams Road, Estero, Florida 33928, United States of America (hereinafter \"HSI\") and HERC RENTALS INC., a Delaware corporation, with an address of 27500 Riverview Center Blvd., Bonita Springs, Florida 34134, United States of America (hereinafter \"HERC\") (hereinafter referred to collectively as the \"Parties\" and individually as a \"Party\").   WITNESSETH   WHEREAS, both HSI and HERC are wholly-owned subsidiaries of THC, and THC is an indirect wholly-owned subsidiary of Hertz Global Holdings, Inc., a Delaware corporation (\"HGH\");   WHEREAS, THC is the owner of a unique plan or system (hereinafter the \"Hertz System\") for conducting, inter alia, the business of renting and leasing vehicles with and without drivers (hereinafter the \"Vehicle Rental Business\" or \"VRB\") which it conducts in collaboration with HSI which is the owner of all trademarks for HERTZ and HERTZ-formative trademarks and designs and other trademarks and designs worldwide in connection with the Vehicle Rental Business (the \"VRB Trademarks\") and Other Intellectual Property (as defined herein);   WHEREAS, THC is the owner of a unique plan or system for conducting an equipment rental business (hereinafter the \"Equipment Rental Business\" or \"ERB\" as further defined below) which it conducts through HERC;   WHEREAS, HGH has approved plans to separate the Vehicle Rental Business and the Equipment Rental Business into two independent, publicly traded companies (the \"Separation\") pursuant to, among other agreements, the Separation and Distribution Agreement by and between Hertz Rental Car Holding Company, Inc. (to be renamed \"Hertz Global Holdings, Inc.\" in connection with the Separation, \"New Hertz\") and HGH (to be renamed Herc Holdings Inc. in connection with the Separation) dated as of June 30, 2016 (the \"Distribution Agreement\");   WHEREAS, as a result of the Separation, THC and HSI will become indirect wholly-owned subsidiaries of New Hertz, and HERC will continue to be an indirect wholly-owned subsidiary of HGH;   WHEREAS, THC exercises control with respect to the use, registration and enforcement of all of its company trademarks through its subsidiary HSI. HERC uses certain HERTZ or HERTZ-formative trademarks in connection with the ERB with the\\n\\nth\\n\\n\\n\\n\\n\\n  permission of HSI and THC;   WHEREAS, HSI is the owner of certain foreign HERTZ and HERTZ-formative and other trademarks and logos (the \"HSI (HERTZ) Foreign ERB Trademarks\") used or to be used by HERC with the permission of HSI in connection with the Equipment Rental Business, including the trademark applications and registrations therefor as more fully set forth on Schedule A;   WHEREAS, HSI is the owner of certain United States HERTZ and HERTZ-formative and other trademarks and logos (the \"HSI (HERTZ) US ERB Trademarks\") used by HERC with the permission of HSI in connection with the Equipment Rental Business, including the trademark applications and registrations therefor as more fully set forth on Schedule B;   WHEREAS, HSI is the owner of certain foreign HERC trademarks and logos (the \"HSI HERC Foreign ERB Trademarks\") used by HERC with the permission of HSI in connection with the Equipment Rental Business, including the trademark applications and registrations therefor, as more fully set forth on Schedule C;   WHEREAS, HERC is the owner of certain US HERTZ-formative trademarks (the \"HERC (HERTZ) US ERB Trademarks\") used by HERC with the permission of HSI in connection with the Equipment Rental Business, including the trademark applications and registrations therefore as more fully set forth on Schedule D;   WHEREAS, HERC is the owner of certain US trademarks not derived from the HERTZ trademark (the \"HERC (HERC) US ERB Trademar',\n",
              "    'Highlight the parts (if any) of this contract related to \"Agreement Date\" that should be reviewed by a lawyer. Details: The date of the contract',\n",
              "    '30  day of June 2016',\n",
              "    136,\n",
              "    156),\n",
              "   ('Exhibit 10.4\\n\\nCOOPERATION AGREEMENT\\n\\n(2014 Amendment)\\n\\nThis Cooperation Agreement (2014 Amendment) (this \"Agreement\") is entered into on January 24, 2014 in Beijing by and between:\\n\\n(1) Nanjing Tuniu Technology Co., Ltd., with its registered address at 3-5/F Building No.6, Southeast University Science Park, 6 Changjianghou Street, Xuanwu District, Nanjing and its legal representative being Yu Dunde (\"Party A\");\\n\\n(2) Beijing Tuniu Technology Co., Ltd., with its registered address at R1006 10/F Building No.4, Yard No.1 of Shangdishi Street, Haidian District, Beijing and its legal representative being Yu Dunde (\"Party B\").\\n\\nWHEREAS\\n\\n1. Party A is a company with exclusively domestic capital incorporated under the laws of the People\\'s Republic of China, mainly engaged in the internet-based sale, promotion of tour products, room reservation and conference affairs services.\\n\\n2. Party B is a limited liability company incorporated under the laws of the People\\'s Republic of China, mainly engaged in research and development of computer software technology, technology transfer, technical consultancy and technical services, computer technology training, technical services and business consultancy services in relation to the internet-based sale and promotion of tour products.\\n\\n3. Party A intends to authorize Party B to provide to Party A and its subsidiaries the technical services and business consultancy services in relation to the internet-based sale and promotion of tour products, including but not limited to development, operation, maintenance of internet technology platform as well as consultancy services relating to sale and promotion of tour products or cooperation provided by Party B in other forms as required under this Agreement, and Party B agrees to accept such authorization.\\n\\n4. After an amiable consideration, the Parties unanimously agree that the establishment of a long-term and close cooperation relationship is in the best interests of the Parties and their beneficiaries.\\n\\n5. The Parties have entered into the Cooperation Agreement on September 17, 2008 in respect of the aforementioned cooperative matters (the \"Original Cooperation Agreement\").\\n\\n\\n\\n\\n\\nThe Parties unanimously agree to amend and restate the Original Cooperation Agreement through friendly negotiation and the Original Cooperation Agreement is amended and restated as follows:\\n\\n  1. Business Cooperation\\n\\nParty A and Party B unanimously agree that the proposed cooperation shall be the internet-based sale and promotion of tour products conducted by Party A and its subsidiaries or other value-added business carried out by Party A. Party B shall provide the business consultancy and technical services as well as the technical consultancy as set forth in Article 3 hereinafter to Party A and its subsidiaries to facilitate them to conduct the aforementioned business and supply relevant products and services.\\n\\n  2. Exclusive Cooperation\\n\\n\\n\\n2.1 Party A irrevocably undertakes that Party A will take Party B as its exclusive and sole partner to provide the business consultancy and technical services as well as technical consultancy to Party A and its subsidiaries. Party A shall not establish any same or similar cooperative relationship with any third party in respect of such businesses nor shall it make any same or similar arrangement, unless with the prior written consent of Party B.\\n\\n  2.2 Party A irrevocably undertakes that it will make best efforts to assist and endeavor to achieve the exclusive operation of thecooperative business to the extent permitted by laws.\\n\\n\\n\\n2.3 Party A irrevocably undertakes that, without Party B\\'s consent, Party A shall not conduct any other business or make any commercial arrangement, including without limitation being engaged in or otherwise participating in any commercial activities and businesses independently or together with any other person or entity, nor shall it carry out any activities that may be competitive with or cause adverse effect to Party B\\'s business.\\n\\n  3. Party B\\'s Services\\n\\nParty B undertakes to provide the following tec',\n",
              "    'Highlight the parts (if any) of this contract related to \"Agreement Date\" that should be reviewed by a lawyer. Details: The date of the contract',\n",
              "    'January 24, 2014',\n",
              "    137,\n",
              "    153),\n",
              "   ('EXHIBIT 10.13                  Cyberian Outpost, Inc. has omitted from this Exhibit 10.13 portions of the Agreement for which Cyberian Outpost, Inc. has requested confidential treatment from the Securities and Exchange Commission. The portions of the Agreement for which confidential treatment has been requested are marked with X\\'s in brackets and such confidential portions have been filed separately with the Securities and Exchange Commission.\\n\\n                              PROMOTION AGREEMENT\\n\\nThis Promotion Agreement (the \"Agreement\") is dated as of January 26, 1998 between CNET, Inc. (\"CNET\") and Cyberian Outpost, Inc. (the \"Company\"). Pursuant to this Agreement, CNET will provide various links and other online and television promotions (collectively, the \"Promotions\") to the Company to assist the Company in promoting its products and services and facilitating the sale of products to potential buyers through its Internet site. CNET will be compensated by the Company for providing the Promotions. Accordingly, the parties hereby agree as follows:\\n\\n1.   Background.\\n\\n     1.1  The Company. The Company operates an electronic retailing operation           through its Internet sites located at www.cyberianoutpost.com or           www.outpost.com (together with any successors to such sites, the           \"Company Site\"). Through the Company Site, the Company sells or           facilitates the sale of various products and services, either directly           or as an agent for third party vendors. All products and services           offered for sale through the Company Site are referred to as the           \"Products.\"\\n\\n     1.2  CNET. CNET produces television programs and operates a network of           Internet sites on the world wide web. For purposes of this Agreement,           the \"CNET Sites\" refer to any Internet sites operated by CNET or its           subsidiaries, including without limitation the sites referenced in           Section 2.5 and Exhibit A.\\n\\n2.   CNET\\'s Obligations.\\n\\n     2.1  TV Promotions. CNET will provide the Company one 15 second \"spot\" for           Promotions on its syndicated weekly TV program, TV.COM. Promotions           will run on each weekly episode of TV.COM during the Term; provided           that TV.COM remains on the air throughout such period. Should TV.COM           not be run on the air during a portion of the Term, CNET will run two           download.com banner advertising programs per month during such portion           of the Term in lieu of the foregoing TV.COM Promotions.\\n\\n     2.2  Banner Promotions. CNET will provide advertising banners to the           Company during the Term as described in Exhibit A.\\n\\n     2.3  Retail Promotions.\\n\\n            2.3.1  CNET will provide for various retail Promotions across the CNET                  Sites, which may include text/HTML links, buttons, portals and                  other fixed Promotions that include embedded links to the                  Company Site (the \"Retail Promotions\" and, together with the                  advertising banners contemplated in the preceding paragraph,                  the \"Online Promotions\").\\n\\n          2.3.2  Subject to Section 4 below, CNET will provide the Company with                  a total of at least (a) [XXXXXX] Retail Impressions during                  the first three months of the Term, (b) [XXXXXX] Retail                  Impressions during the second three months of the Term, (c)                  [XXXXXX] Retail Impressions during the third three months                  of the Term, and (d) [XXXXXX] Retail Impressions during                  the fourth three months of the Term. For such purposes, a                  \"Retail Impression\" means the display of one page of a CNET                  Site that contains at least one Retail Promotion. If CNET fails                  to provide the Retail Impressions required by the preceding                  sentence during the Term, then CNET will continue to display                  Retail Impressions in accordance with this Agreement following             ',\n",
              "    'Highlight the parts (if any) of this contract related to \"Agreement Date\" that should be reviewed by a lawyer. Details: The date of the contract',\n",
              "    'January 26, 1998',\n",
              "    558,\n",
              "    574),\n",
              "   ('Exhibit 10.10\\n\\nEXECUTION VERSION\\n\\nINTELLECTUAL PROPERTY AGREEMENT\\n\\nThis Intellectual Property Agreement (the \"Agreement\"), is entered into as of November 20, 2007 (the \"Effective Date\"), by and between Morgan Stanley & Co. Incorporated, a Delaware corporation (\"MS\") and MSCI Inc., a Delaware corporation (\"MSCI\"). (MS and MSCI individually referred to as a \"Party\" and collectively as the \"Parties\").   1. DEFINITIONS\\n\\n  1.1 Certain Definitions.\\n\\nAs used in this Agreement:\\n\\n  (a) \"Including\" and its derivatives, each whether or not capitalized in this Agreement, means \"including but not limited to\".\\n\\n  (b) \"Licensed Materials\" means, as applicable, the MS Licensed Materials and the MSCI Licensed Materials.\\n\\n\\n\\n(c) \"MS Licensed Materials\" means collectively, to the extent owned by a member of the MS Provider Group, any hardware settings and configurations, generic software libraries and routines, and generic document templates not separately commercialized by the MS Provider Group (as defined below) and used by MSCI prior to the Trigger Date. For the avoidance of doubt, the MS Licensed Materials does not include (i) any patent, trademark or service mark of the MS Provider Group, or (ii) any infrastructure hardware or software (e.g., monitoring software and systems, customized operating systems (and components such as AFS, DNS, AD, etc.), and middleware). For the avoidance of doubt, the document templates do not include any references to members of the MS Provider Group or its personnel.\\n\\n\\n\\n(d) \"MSCI Licensed Materials\" means collectively, to the extent owned by a member of the MSCI Provider Group, any hardware settings and configurations, generic software libraries and routines, and generic document templates not separately commercialized by the MSCI Provider Group (as defined below) and used by MS prior to the Trigger Date. For the avoidance of doubt, the MSCI Licensed Materials does not include (i) any patent, trademark or service mark of the MSCI Provider Group, (ii) any infrastructure hardware or software (e.g., monitoring software and systems, customized operating systems and middleware), or (iii) any software or data separately licensed to MS by the MSCI Provider Group (such as the Barra Aegis software or the MSCI indices). For the avoidance of doubt, the document templates do not include any references to members of the MSCI Provider Group or its personnel.\\n\\n  (e) \"Trigger Date\" means the date upon which Morgan Stanley shall cease to own more than 50% of the issued and outstanding shares of MSCI common stock.     1.2 Other Terms.\\n\\nOther terms used in this Agreement are defined in the context in which they are used and shall have the meanings there indicated.\\n\\n\\n\\n\\n\\n2. GRANT OF LICENSE\\n\\n  2.1 MS Grant.\\n\\nMS hereby grants (subject to any existing third party contractual obligations) to MSCI a non-exclusive, perpetual, irrevocable, world- wide, royalty-free license for MSCI to use, modify, copy, create derivative works of and sublicense, for any business purpose, the MS Licensed Materials.     2.2 MSCI Grant.\\n\\nMSCI hereby grants (subject to any existing third party contractual obligations) to MS a non-exclusive, perpetual, irrevocable, world- wide, royalty-free license for MS to use, modify, copy, create derivative works of and sublicense, for any business purpose, the MSCI Licensed Materials.     2.3 Internet and Subnet Addresses.\\n\\nFor the avoidance of doubt, this Agreement does not address or affect any rights of the Parties in or to internet or subnet addresses.   3. DELIVERY\\n\\n  3.1 No Support or Maintenance or Obligation to Deliver.\\n\\nThe Parties shall have no obligation to provide support or maintenance for the Licensed Materials, including any obligation to update or correct such Licensed Materials. The Parties shall have no obligation to provide copies of the Licensed Materials (including in the case of software, any source code and object code).   4. NO WARRANTIES\\n\\nTHE LICENSE GRANTS HEREUNDER ARE PROVIDED \"AS-IS\" WITH NO WARRANTIES, AND THE PARTIES EXPRESSLY EXCLUDE AND DISCLAIM ANY WARRANTIES UNDER OR ARISING AS A R',\n",
              "    'Highlight the parts (if any) of this contract related to \"Agreement Date\" that should be reviewed by a lawyer. Details: The date of the contract',\n",
              "    'November 20, 2007',\n",
              "    145,\n",
              "    162),\n",
              "   ('Exhibit 10.1\\n\\nStrategic Alliance Agreement\\n\\nAGREEMENT made as of  , 2013, between Freedom Mortgage Corporation, a New Jersey corporation (\"Freedom Mortgage\"), and Cherry Hill Mortgage Investment Corp., a Maryland corporation (\"Cherry Hill\").\\n\\nWITNESSETH:\\n\\nWHEREAS, Freedom Mortgage is a privately held, national mortgage bank that originates and services mortgage loans secured by liens on one- to four-family properties; and\\n\\nWHEREAS, Cherry Hill is a newly formed affiliate of Freedom Mortgage that intends to elect and qualify as a Real Estate Investment Trust under the Internal Revenue Code of 1986, as amended; and\\n\\nWHEREAS, Cherry Hill will have access to capital, including capital raised through one or more offerings of its securities; and\\n\\nWHEREAS, Cherry Hill will seek to benefit from having a consistent and predictable source of real estate assets from Freedom Mortgage, and Freedom Mortgage will seek to benefit from the liquidity available to Cherry Hill; and\\n\\nWHEREAS, the parties desire to set forth the terms of a strategic alliance that is expected to benefit them both;\\n\\nNOW, THEREFORE, in consideration of the foregoing, and of other good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, the parties here to agree as follows.\\n\\nSection 1. Definitions.\\n\\n(a) The following terms shall have the meanings specified wherever used in this Agreement.\\n\\nAcknowledgement Agreement: The Acknowledgement Agreement to be entered into by Freedom Mortgage, as Issuer, Cherry Hill, as Secured Party, and the Government National Mortgage Association.\\n\\nAction: Any civil, criminal, investigative or administrative claim, demand, action, suit, charge, citation, complaint, notice of violation, proceeding (public or private), litigation, prosecution, arbitration or inquiry by or before any Governmental Entity whether at law, in equity or otherwise.\\n\\nAgreement: This Strategic Alliance Agreement as the same may be amended in accordance with the terms hereof.\\n\\n1\\n\\n\\n\\n\\n\\nAncillary Agreements: The Acknowledgement Agreement, the Purchase Agreement and the Flow Agreement.\\n\\nBase Servicing Fee: As to any Mortgage Loan and any Collection Period, an amount equal to the product of the Base Servicing Fee Rate, the UPB of that Mortgage Loan as of the related Measurement Date and 1/12 or, for the first Collection Period, the number of days in such Collection Period divided by 360; provided, however, that payment of the Base Servicing Fee for any delinquent Mortgage Loan shall be suspended unless and until Freedom Mortgage recovers the amount thereof from payments in respect thereof from the related mortgagor or the amount thereof is otherwise recovered from liquidation of the related property.\\n\\nBase Servicing Fee Rate: As to any Mortgage Loan, the per annum rate specified to be payable to Freedom Mortgage to cover the actual costs of servicing. For example, the Base Servicing Fee Rate for the Mortgage Loans in the initial pool will be eight (8) basis points.\\n\\nBusiness Day: Any day other than a Saturday or Sunday or a day on which banks in New Jersey and New York are authorized or obligated by law to close.\\n\\nClosing: The closing of the initial public offering of the common stock of Cherry Hill.\\n\\nClosing Date: The date of the Closing.\\n\\nCollection Period: The period beginning on the Closing Date and ending on the last day of the calendar month in which the Closing Date occurs and each calendar month thereafter.\\n\\nExcess MSR: As to any Mortgage Loan, the portion of the servicing fee for that Mortgage Loan that exceeds the Base Servicing Fee.\\n\\nFlow Agreement : The Flow and Bulk Purchase Agreement to be entered into between Cherry Hill, as purchaser, and Freedom Mortgage, as seller, substantially in the form of Exhibit B attached hereto.\\n\\nGAAP: Generally accepted accounting principles in the United States as in effect from time to time as set forth in the statements, pronouncements and opinions of the Accounting Principles Board and the American Institute of Certified Public Accountants.\\n\\nGinnie Mae: The Government National Mortgage',\n",
              "    'Highlight the parts (if any) of this contract related to \"Agreement Date\" that should be reviewed by a lawyer. Details: The date of the contract',\n",
              "    ', 2013',\n",
              "    66,\n",
              "    72),\n",
              "   ('Exhibit 10.2    SHBV (HONG KONG) LTD.     and     WASTE2ENERGY GROUP HOLDINGS PLC\\n\\n   STRATEGIC ALLIANCE AGREEMENT\\n\\n   1\\n\\n\\n\\n\\n\\n        THIS AGREEMENT IS MADE ON THE 19  DAY OF MAY , 2010     PARTIES     (1) SHBV (HONG KONG) LTD, a company incorporated in Hong Kong whose registered office is at Unit 3208, 32/F Office Tower (\"SHBV\"); and  Convention Plaza, 1 Harbour Rd, Hong Kong     (2) WASTE2ENERGY GROUP HOLDINGS PLC a company incorporated in Isle of Man whose registered office is at Stanley House, Lord Street,  Douglas, Isle of Man 1M1 2BF (\"W2E\"),     each a \"Party\" and together the \"Parties\".     BACKGROUND     (A) SHBV is engaged in the business of design, marketing, manufacture, commissioning and post sales servicing of steam and hot water plant and  possesses certain proprietary products, technologies, formulations, know-how and/or rights within the fields of steam and hot water plant  and equipment, engineering, and process designs (hereinafter, \"SHBV Technologies\").     (B) W2E is a provider of engineered solutions for waste to energy plants (each being an \"Engineered Solution\") utilising W2E proprietary  technology for the destruction of waste through gasification and the conversion of latent energy into thermal energy.     (C) The Parties wish to collaborate together to provide for a world class manufacturing facility for W2E Equipment, for the integration of SHBV  Technologies into the Engineered Solution and to exploit joint sales channels and post sales support, for the mutual benefit of both  Parties.     (D) The Parties wish to cooperate and work together to promote, market and sell their respective products and services in accordance with the  terms of this Agreement.     AGREED PROVISIONS     1. DEFINITIONS AND INTERPRETATION     1.1 In this Agreement, the terms and expressions below shall have the following meanings:     2\\n\\nTH\\n\\n\\n\\n\\n\\n     Affiliates means subsidiaries or other entities that will be mutually agreed in writing.     Agreement means the body of this agreement and its schedules, as each may be amended from time to time in accordance with its  provisions;     Alliance means the strategic alliance between the Parties facilitated under this Agreement;     SHBV Boiler means a boiler that is manufactured and supplied by SHBV from time to time;     SHBV Technologies has the meaning given in Recital A above;     Commencement Date means the date of this Agreement;     Dispute means any dispute, issue or claim arising out of or relating to this Agreement;     Engineered Solution has the meaning given in Recital B above;     Good Industry Practice means the exercise of that degree of skill, diligence, prudence, foresight and practice which would reasonably and  ordinarily be expected from a skilled and experienced person engaged in performing obligations the same as or similar to the obligations  under this Agreement or any part of them (as appropriate to the context in which this expression is used);     Group means, in relation to any company, that company and the following for the time being: (i) its Holding Company, (ii) its Subsidiaries  and (iii) the Subsidiaries of its Holding Company;     Holding Company has the meaning given in $1159 Companies Act 2006;     Intellectual Property Rights means (i) patents, designs, trade marks and trade names (whether registered or unregistered), copyright and  related rights, database rights, know-how and confidential information; (ii) all other intellectual property rights and similar or equivalent  rights anywhere in the world which currently exist or are recognised in the future; and (iii) applications, extensions and renewals in  relation to any such rights;     Manufacturing Agreement has the meaning given in clause 5.1;     Subsidiary has the meaning given to it in $1159 Companies Act 2006;     Supply Agreement means an agreement under which an Engineered Solution is to be delivered to a customer of W2E by W2E or such  other entity established or nominated for that purpose;     Term has the meaning set out in Clause 3.1;     3\\n\\n\\n\\n\\n\\n     Territory shall mean',\n",
              "    'Highlight the parts (if any) of this contract related to \"Agreement Date\" that should be reviewed by a lawyer. Details: The date of the contract',\n",
              "    '19  DAY OF MAY , 2010',\n",
              "    164,\n",
              "    185),\n",
              "   ('EXHIBIT 10.2   ENDORSEMENT AGREEMENT ADDENDUM I   This Endorsement Agreement Addendum I (the \"Addendum\") is made and effective November 7, 2017,   BETWEEN:\\n\\n\\n\\nNational Football League Alumni - Northern California Chapter (\"NFLA-NC\"), a charitable corporation organized under the laws of California, having its principal office at 1311 Madison Avenue, Redwood CA 94061; National Football League Alumni, Inc. (\"NFLA\"), a charitable corporation organized under the laws of Florida, having its principal office at 8000 Midlantic Drive, 130 S., Mount Laurel, NJ. 08054.     AND:   Food For Athletes, Inc. a corporation organized under the laws of California / Gridiron BioNutrientsโข, a corporation organized under the laws of Nevada having their principal office(s) at 1147 N Roseburg CT, STE A/B Visalia, CA 93291 (collectively the \"Company\").   RECITALS   The NFLA, NFLA-NC and the Company (collectively the \"Parties\") agree that this Addendum I shall be affixed and be enforceable under the terms of the Endorsement Agreement executed by the Parties on October 30, 2017.   Parties agree to the addition of Gridiron CBD H2O Probioticโข Water to \"Licensed Products\" as follows:   SECTION ONE. DEFINITIONS    As used in this Agreement, the following terms shall be defined as follows:      F. \"Licensed Products\" shall mean BlackMP Living Water, BlackMP Concentrate, Zezel Probiotic Water, Zayin Sports Water, Gridiron CBD H2O Probioticsโข Water, Gridiron MVPโข and Gridiron MVPโข Concentrate using the Pro Football Legends Logo on the Licensed Products\\' affixed labels, hang-tags or packaging. Other products of the Company may be added to the list of Licensed Products during the Contract Period by written amendment to this Agreement. All amendments to this Agreement must be signed by all parties to this Agreement.   Endorsement Agreement Addendum I  Page 1 of 2\\n\\nSource: GRIDIRON BIONUTRIENTS, INC., 8-K, 12/6/2017\\n\\n\\n\\n\\n\\n      SECTION FOUR. REMUNERATION    C. A *donation of $0.05 per Unit sold of Licensed Products within the Contract Territory payable to the **NFL Alumni Northern California Chapter. Donated amounts will be allocated and dispersed to the Northern California Chapter beginning on the first full quarter [three (3) month period] of the Agreement and continue on a quarterly basis thereafter for the term of this Agreement. Where the following per Unit conversion shall apply for the term of this Agreement:\\n\\n a. (1) Bottle of BlackMP LivingWater = 1 Unit\\n\\n b. (1) 4oz bottle of BlackMPConcentrate = 30 Units\\n\\n c. (1) Bottle of Zezel ProbioticWater = 1 Unit\\n\\n d. (1) Bottle of Zayin Sports Water = 1 Unit  e. (1) Bottle Gridiron MVPโข Water= 1 Unit\\n\\n f. (1) Bottle Gridiron CBD H20 Probioticsโข Water = 1 Unit\\n\\n g. (1) 4oz bottle of Gridiron MVPโขConcentrate = 30 Units\\n\\n _____________  * The NFLA-NC will donate 15% of the above described proceeds to the NFLA.  ** The Company will provide to the NFLA-NC upon request the most recent quarterly sales report of the Company\\'s Licensed Products.   The parties have executed this Agreement on November 22nd, 2017.   Food For Athletes, Inc. / Gridiron BioNutrientsโข   By: /s/ Darren Long    Darren Long - CEO     The National Football League Alumni, Inc.   By: /s/ Elvis Gooden    Elvis Gooden - President     NFL Alumni - Northern California Chapter   By: /s/ Eric Price    Eric Price - President     Endorsement Agreement Addendum I  Page 2 of 2\\n\\nSource: GRIDIRON BIONUTRIENTS, INC., 8-K, 12/6/2017',\n",
              "    'Highlight the parts (if any) of this contract related to \"Agreement Date\" that should be reviewed by a lawyer. Details: The date of the contract',\n",
              "    'November 7, 2017',\n",
              "    127,\n",
              "    143),\n",
              "   ('EXHIBIT 10.1\\n\\nCorporate Sponsorship Agreement Between American Diabetes Association and Freeze Tag, Inc. This Agreement (\"Agreement\") is made effective March 22, 2018, by and between Freeze Tag Inc., a Delaware Corporation (\"Company\"), with its principal place of business located at 1720 Bray Central Drive, McKinney, TX 75069 and the American Diabetes Association, Inc. (\"Association\"), an Ohio not-for profit corporation, with its principal place of business located at 2451 Crystal Drive, Suite 900, Arlington, VA 22202. ADA and/or Company may be referred to as a \"Party\" or collectively as the \"Parties.\" 1. Purpose: The purpose of this Agreement is to benefit the Association and advance its not-for-profit mission through a National Sponsorship of Get Fit Don\\'t Sit DayT M. Company desires to assist the Association to carry out its mission and agrees to provide the support described in this Agreement. Company understands that as a not-for-profit charitable organization Association cannot promote or endorse Company\\'s products or services, either explicitly or implicitly. The Association may require that a disclaimer stating that Company\\'s participation in this Agreement does not convey or imply the Association\\'s approval, endorsement, certification, acceptance, or referral of any product or service of Company. 2. Scope: The Association agrees to identify and acknowledge Company as a supporter of the organization and the diabetes cause, as permitted in connection with qualified sponsorship payments and royalties under Section 513(i) and Section 512 of the Internal Revenue Code and Treasury regulations thereunder (\"Code\"). Company agrees not to knowingly take any actions that would jeopardize the tax-exempt status of Association under section 501(c)(3) of the Code. Company agrees to inform its business partners about Association\\'s tax-exempt status. Company agrees to provide its services, as defined in Attachment A, in accordance with all applicable laws and in accordance with standards of decorum and taste so as not to adversely reflect upon the Association or its mission. 3. Term: This Agreement shall commence on March 15, 2018 and will expire on March 14, 2020 unless terminated earlier pursuant to Section 13 of the Agreement (the \"Term\"). 4. Intellectual Property: The Association is the sole and exclusive owner of its name and logos, with or without accompanying words, and has the legal right to enter into this Agreement. In addition, any materials provided by or developed by the Association remain the property of the Association. The Association\\'s names, logos, and various marks, are \"the Association Marks\", as listed in Attachment B. The Association\\'s ownership of the Association Marks is or shall be secured through registration, or under common law, or both. Company\\'s use of the Association Marks does not create ownership rights in the Association Marks for Company. Company shall not, during the period of this Agreement, or any time thereafter, challenge Association\\'s exclusive ownership or registration of Association\\'s Marks, including any and all moral rights. Company is the sole and exclusive owner of its name, logos, and marks (the \"Company Marks\"), which include, without limitation, the names, logos, and marks listed in Attachment B as Company Marks. 1\\n\\nSource: FREEZE TAG, INC., 8-K, 4/11/2018\\n\\n\\n\\n\\n\\n5. License: The Association grants Company a non-exclusive, limited, revocable and conditional license during the term to use the Association Marks, solely to identify Company as a supporter of the Association. Use by Company of the Association Marks is limited to the particular Association Marks as authorized by the Association, which may not be revised or altered in any way, without prior written consent, must be displayed in the same form and colors, and does not extend to any other marks of the Association. Use by Company of the Association Marks on and in conjunction with its product or brand is conditioned upon Company\\'s observance of the specifications for permissible uses of the Association Marks as stated herein a',\n",
              "    'Highlight the parts (if any) of this contract related to \"Agreement Date\" that should be reviewed by a lawyer. Details: The date of the contract',\n",
              "    'March 22, 2018',\n",
              "    152,\n",
              "    166),\n",
              "   ('Exhibit 10.1 CERTAIN CONFIDENTIAL PORTIONS OF THIS EXHIBIT WERE OMITTED AND REPLACED WITH \"[***]\". A COMPLETE VERSION OF THIS EXHIBIT HAS BEEN FILED SEPARATELY WITH THE SECRETARY OF THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO AN APPLICATION REQUESTING CONFIDENTIAL TREATMENT PURSUANT TO RULE 24B-2 PROMULGATED UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED. AMENDMENT NO. 2 TO MANUFACTURING AND SUPPLY AGREEMENT THIS AMENDMENT NO. 2 (this \"Amendment\") to the Manufacturing and Supply Agreement dated as of December 8, 2009 (as amended by an amendment agreement dated 31 December 2013) (the \"Existing Agreement\"), by and between Columbia Laboratories, (Bermuda) Ltd., a limited company existing and organised under the laws of Bermuda, having a place of business at Canon\\'s Court, 22 Victoria Street, Hamilton HM12, Bermuda (\"Columbia\"), and Fleet Laboratories Limited, a limited private company existing and organised under the laws of England, having a place of business at 94 Rickmansworth Road, Watford Herts, WD18 7JJ, United Kingdom (\"Fleet\") is entered into on 2018 (the \"Effective Date\"). WHEREAS, Columbia and Fleet entered into the Existing Agreement pursuant to which Fleet has agreed to manufacture and supply to Columbia, and Columbia has agreed to purchase, certain Products; and WHEREAS, Columbia and Fleet wish to amend the Existing Agreement in accordance with the terms of this Amendment. NOW THEREFORE, in consideration of the foregoing and other good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, Columbia and Fleet agree as follows: General Capitalised terms used but not defined in this Amendment shall have the same meanings ascribed to such terms in the Existing Agreement. The following amendments to the Existing Agreement shall have effect on and from the Effective Date.\\n\\n1. The following definitions shall be added to Section 1 of the Existing Agreement:\\n\\n\"\"Ares Agreement\" means the supply agreement entered into between Columbia and Ares Trading S.A. (a subsidiary of Merck Serono S.A.) dated 7 January 2018.\"\\n\\n\"GDP\" means the EU guidelines for current Good Distribution Practice guidelines 2013/C 343/01 as amended.\"\\n\\n2. The definition of \"batch\" in Section 1 of the Existing Agreement shall be deleted in its entirety and replaced with the following:\\n\\n\"\"Batch\" means a quantity of [***] kilograms of material (or such other quantity as the Parties may agree in writing from time to time) produced in a process or series of processes that is expected to be homogeneous within specified limits.\"\\n\\n3. The following shall be added to Section 2.1 of the Existing Agreement (Regulatory Requirements) as a new Section 2.1 (d):\\n\\n\"2.1 (d) Subject to the prior written consent of Columbia (such consent not to be unreasonably withheld, delayed or conditioned), Fleet may subcontract all or part of the activities to be performed by it under this Agreement to any subcontractor provided that the subcontracting of any activities shall not relieve Fleet of, and Fleet shall remain solely liable for, its obligations under this Agreement. Columbia may subcontract all or any part of the activities performed by it under this Agreement to any subcontractor without the consent of Fleet.\"\\n\\n1\\n\\n\\n\\n\\n\\nCERTAIN CONFIDENTIAL PORTIONS OF THIS EXHIBIT WERE OMITTED AND REPLACED WITH \"[***]\". A COMPLETE VERSION OF THIS EXHIBIT HAS BEEN FILED SEPARATELY WITH THE SECRETARY OF THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO AN APPLICATION REQUESTING CONFIDENTIAL TREATMENT PURSUANT TO RULE 24B-2 PROMULGATED UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED. 4. The following new Sections 2.2 (b), 2.2 (c) and 2.2 (d) shall be added to Section 2.2 of the Existing Agreement (Regulatory Requirements):\\n\\n\"2.2 (b) Compliance with Brazilian Regulatory Authorities Regulations. Fleet hereby warrants that the facilities where the Product is manufactured complies in full with the relevant standards stipulated by the Brazil National Health Surveillance Agency (\"ANVISA\") and undertakes to ensure the facilities will continue to do',\n",
              "    'Highlight the parts (if any) of this contract related to \"Agreement Date\" that should be reviewed by a lawyer. Details: The date of the contract',\n",
              "    '2018',\n",
              "    1081,\n",
              "    1085),\n",
              "   ('1                                                                    Exhibit 10.16\\n\\n                                                                 CONFIDENTIAL Portions of this Exhibit have been omitted pursuant to a request for confidential treatment. The omitted portions, marked by [****], have been separately filed with the Commission.\\n\\n                           SPONSORSHIP AGREEMENT\\n\\nThis agreement (\"Agreement\") is entered into as of the 23rd day of September, 1997 (\"Effective Date\"), by and between Excite, Inc., a California corporation, located at 555 Broadway, Redwood City, California 94063 (\"Excite\"), and N2K Inc., a Pennsylvania corporation, located at 55 Broad Street, 26th Floor, New York, New York, 10004 (\"Sponsor\").\\n\\n                                 RECITALS\\n\\nA.   Excite maintains a site on the Internet at http://www.excite.com (the      \"Excite Site\") and owns and/or manages related Web Sites worldwide      (collectively, the \"Excite Network\") which, among other things, allow users      to search for and access content and other sites on the Internet.\\n\\nB.   Excite also maintains and/or manages certain Web pages which may be      delivered to users via email, desktop \"channels\" or Internet \"push\"      technologies (collectively, \"Broadcast Pages\") which may incorporate      content supplied to Excite by third parties for the purpose of providing      value to Excite users and providing access to the content, products and/or      services of such third parties.\\n\\nC.   Sponsor is in the business of distributing certain online retail music      merchandise and related content and maintains a Web site at      http://www.musicblvd.com (the \"Sponsor Site\") and other Web sites through      which it makes this merchandise and this content available to its users.\\n\\nD.   Sponsor wishes to be the exclusive retail store music sponsor of the Excite      Site and the Excite Broadcast Pages, to distribute its music-related      content through the Excite Site and the Excite Broadcast Pages and to      promote its online retail music merchandise business to Excite.com users.\\n\\nTherefore, the parties agree as follows:\\n\\n1.       EXCLUSIVITY, TERM AND RIGHT OF FIRST REFUSAL\\n\\n      a)       Sponsor will be the exclusive retail music store sponsor of                   the Excite Site and the Excite Broadcast Pages. Excite will                   not permit the display of advertising banners, promotional                   buttons, promotional links or other promotional materials for                   any retail sale of Music Products on the Excite Site, except                   those Music Products offered by Sponsor, nor advertising by                   any other Retail Music Store. \"Retail Music Store\" shall mean                   any entity which is primarily engaged in the sale of Music                   Products at retail to consumers. \"Music Products\"     2                                                                     CONFIDENTIAL\\n\\n              shall mean pre-recorded music hard goods, digitally                  distributed music (except live and/or cybercast events), music                  books (to the extent this Agreement does not conflict with                  Excite\\'s existing agreement with Amazon.com), music-related                  t-shirts and apparel, and music videos (except live and/or                  cybercast events).\\n\\n              Notwithstanding the foregoing, Excite may make available                  opportunities on the Excite Site to purchase Music Products                  from parties other than Sponsor if such Music Products are not                  available from Sponsor so long as, prior to entering into                  arrangements to make available opportunities to purchase Music                  Products from parties other than Sponsor, Excite notifies                  Sponsor of its interest in the Music Products and gives Sponsor                  thirty (30) days to make the desired Music Products available                  through the Sponsor Site. Excite and Sponsor acknowledge that ',\n",
              "    'Highlight the parts (if any) of this contract related to \"Agreement Date\" that should be reviewed by a lawyer. Details: The date of the contract',\n",
              "    '23rd day of September, 1997',\n",
              "    449,\n",
              "    476),\n",
              "   ('Exhibit 2.7 FORM OF TRADEMARK LICENSE AGREEMENT THIS TRADEMARK LICENSE AGREEMENT (this \"Agreement\"), made and entered into as of the [ ] day of [ ], 2020 (the \"Effective Date\"), by and between ARCONIC INC., a corporation organized under the laws of Delaware (\"Licensee\") and ARCONIC ROLLED PRODUCTS CORP., a corporation organized under the laws of Delaware (\"Licensor\"). WHEREAS, Licensor and Licensee entered into a Separation and Distribution Agreement having an effective date of the [ ] day of [ ], 2020 (\"Separation and Distribution Agreement\"); unless specifically defined in this Agreement, any capitalized term in this Agreement shall have the meaning set forth in the Separation and Distribution Agreement. WHEREAS, Licensor formerly operated as a business unit of Licensee; WHEREAS, as part of and further to the Separation and Distribution Agreement: (a) Licensor and Licensee are now two separate publicly traded companies; and (b) Licensor was assigned all right, title, and interest to the trademark \"ARMX\" (the \"Licensed Mark\"); WHEREAS, Licensee wishes to license from Licensor the right to the Licensed Mark as hereinafter defined below; WHEREAS, Licensee wishes to obtain from Licensor, subject to the terms and conditions set forth in this Agreement, the right and license to use, have used, manufacture, have manufactured, sell, have sold, advertise, have advertised, import, have imported, export, have exported, offer for sale, and have offered for sale the Licensed Products (later defined) using the Licensed Mark (the \"Licensed Purpose\"); WHEREAS, Licensor is willing to grant such rights, upon the terms and subject to the conditions set forth in this Agreement. NOW, THEREFORE, in consideration of the mutual agreements, provisions and covenants contained in this Agreement, and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties, intending to be legally bound, hereby agree as follows:\\n\\n1\\n\\nSource: ARCONIC ROLLED PRODUCTS CORP, 10-12B, 12/17/2019\\n\\n\\n\\n\\n\\n1. GRANT AND SCOPE OF LICENSE. 1.1 Grant of License. Licensor on behalf of itself and its Affliates hereby grants to Licensee the limited licenses to use and have used the Licensed Mark: (i) for the Licensed Products as set forth on Schedule 2; and (ii) as set forth on Schedule 1, concerning agreements entered into by Licensee prior to the Effective Date (\"Existing Agreements\"). For the avoidance of doubt, Licensor also grants to Licensee and its subsidiaries and affiliates a non-exclusive, worldwide royalty-free license for continued use of the Licensed Mark for the production and sale of inventory containing the Licensed Mark applied to such products during the Transition Period as set forth in section 8.2 of the Separation and Distribution Agreement and in Schedule 2 of this Agreement. Licensee will not, however, use the Licensed Mark except for the production and sale of inventory as provided in this Section 1.1 and in Section 8.2 of the Separation and Distribution Agreement and Schedule 2 of this Agreement. For avoidance of doubt, to the extent that any of the licenses granted by the terms of this Agreement include any right to sublicense, such right to sublicense shall extend to Licensee\\'s subsidiaries and joint venturers. 1.2 Goodwill. Licensee expressly recognizes and acknowledges that its use of the Licensed Mark shall inure solely to the benefit of Licensor, and shall not confer on Licensee any ownership rights to the Licensed Mark. Licensee agrees and covenants that it shall not challenge, contest, or take any actions inconsistent with Licensor\\'s exclusive rights of ownership of the Licensed Mark. 1.3 Trademark Notices. All print and electronic displays of the Licensed Mark by Licensee shall include at Licensor\\'s option, a notice to the effect that the Licensed Mark are owned by Licensor and used by Licensee under license from Licensor. 1.4 Licensee Cooperation. Licensee agrees to reasonably cooperate with Licensor in achieving registration of the Licensed Mark worldwide, and in maintaining and protectin',\n",
              "    'Highlight the parts (if any) of this contract related to \"Agreement Date\" that should be reviewed by a lawyer. Details: The date of the contract',\n",
              "    '[ ] day of [ ], 2020 (',\n",
              "    133,\n",
              "    155),\n",
              "   (\"Exhibit 10.18 Confidential EXECUTION COPY\\n\\nCERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY [***], HAS BEEN OMITTED BECAUSE IT IS BOTH NOT MATERIAL AND WOULD BE COMPETITIVELY HARMFUL IF PUBLICLY DISCLOSED.\\n\\nDEVELOPMENT AND OPTION AGREEMENT\\n\\nbetween\\n\\nHARPOON THERAPEUTICS, INC.\\n\\nand\\n\\nABBVIE BIOTECHNOLOGY LTD\\n\\nDated as of November 20, 2019\\n\\nSource: HARPOON THERAPEUTICS, INC., 10-K, 3/12/2020\\n\\n\\n\\n\\n\\nTABLE OF CONTENTS\\n\\nARTICLE 1 DEFINITIONS 1\\n\\nARTICLE 2 COLLABORATION MANAGEMENT\\n\\n18\\n\\n2.1 Joint Governance Committee. 18 2.2 General Provisions Applicable to the JGC. 19 2.3 Discontinuation of the JGC. 20 2.4 Interactions Between the JGC and Internal Teams. 20 2.5 CMC Working Group. 21 2.6 Working Groups. 21 2.7 Expenses. 21\\n\\nARTICLE 3 DEVELOPMENT AND REGULATORY\\n\\n21\\n\\n3.1 Initial Development Plan and Activities. 21 3.2 AbbVie Option. 24 3.3 [***]. 25 3.4 Post-Exercise Development Activities. 26 3.5 Supply of Technology for Development Purposes. 27 3.6 Expenses and Invoicing. 27 3.7 Subcontracting. 28 3.8 Regulatory Matters. 28\\n\\nARTICLE 4 COMMERCIALIZATION 30\\n\\n4.1 In General. 30 4.2 Commercialization Diligence. 30 4.3 Booking of Sales; Distribution. 31 4.4 Product Trademarks. 31 4.5 Commercial Supply of Licensed Compounds or Licensed Products. 31\\n\\nARTICLE 5 GRANT OF RIGHTS\\n\\n33\\n\\n5.1 Grants to AbbVie. 33 5.2 Grants to Harpoon. 34 5.3 Sublicenses. 34 5.4 Distributorships. 34 5.5 Co-Promotion Rights. 34 5.6 Retention of Rights. 34 5.7 Confirmatory Patent License. 35 5.8 Exclusivity with Respect to the Territory. 35 5.9 In-License Agreements. 35\\n\\nARTICLE 6 PAYMENTS AND RECORDS\\n\\n36\\n\\n6.1 Upfront Payment. 36 6.2 Development and Regulatory Milestones. 36 6.3 First Commercial Sales Milestones. 37 6.4 Sales-Based Milestones. 37 6.5 Royalties. 38 6.6 Royalty Payments and Reports. 39 6.7 Mode of Payment; Offsets. 40 6.8 Withholding Taxes. 40\\n\\nSource: HARPOON THERAPEUTICS, INC., 10-K, 3/12/2020\\n\\n\\n\\n\\n\\n6.9 Indirect Taxes. 40 6.10 Interest on Late Payments. 41 6.11 Audit. 41 6.12 Audit Dispute. 41 6.13 Confidentiality. 41 6.14 [***] 41 6.15 No Other Compensation. 42\\n\\nARTICLE 7 INTELLECTUAL PROPERTY\\n\\n42\\n\\n7.1 Ownership of Intellectual Property. 42 7.2 Maintenance and Prosecution of Patents. 43 7.3 Enforcement of Patents. 45 7.4 Infringement Claims by Third Parties. 48 7.5 Invalidity or Unenforceability Defenses or Actions. 48 7.6 Product Trademarks. 49 7.7 International Nonproprietary Name. 50 7.8 Inventor's Remuneration. 50 7.9 Common Interest. 50\\n\\nARTICLE 8 PHARMACOVIGILANCE AND SAFETY\\n\\n50\\n\\n8.1 Pharmacovigilance. 50 8.2 Global Safety Database. 50\\n\\nARTICLE 9 CONFIDENTIALITY AND NON- DISCLOSURE\\n\\n51\\n\\n9.1 Product Information. 51 9.2 Confidentiality Obligations. 51 9.3 Permitted Disclosures. 52 9.4 Use of Name. 53 9.5 Public Announcements. 53 9.6 Publications. 54 9.7 Return of Confidential Information. 54 9.8 Survival. 54\\n\\nARTICLE 10 REPRESENTATIONS AND WARRANTIES\\n\\n55\\n\\n10.1 Mutual Representations and Warranties. 55 10.2 Additional Representations and Warranties of Harpoon. 55 10.3 Covenants of Harpoon. 58 10.4 Covenants of AbbVie. 58 10.5 DISCLAIMER OF WARRANTIES. 59\\n\\nARTICLE 11 INDEMNITY 60\\n\\n11.1 Indemnification of Harpoon. 60 11.2 Indemnification of AbbVie. 60 11.3 Notice of Claim. 60 11.4 Control of Defense. 61 11.5 Special, Indirect, and Other Losses. 61 11.6 Insurance. 61\\n\\nARTICLE 12 TERM AND TERMINATION\\n\\n62\\n\\n12.1 Term. 62\\n\\n- ii -\\n\\nSource: HARPOON THERAPEUTICS, INC., 10-K, 3/12/2020\\n\\n\\n\\n\\n\\n12.2 Termination for Material Breach. 62 12.3 Additional Termination Rights by AbbVie. 63 12.4 Termination for Insolvency. 63 12.5 Rights in Bankruptcy. 63 12.6 Termination in Entirety. 63 12.7 Reversion of Harpoon Products. 66 12.8 Termination of Terminated Territory. 67 12.9 Remedies. 67 12.10 Accrued Rights; Surviving Obligations. 67\\n\\nARTICLE 13 MISCELLANEOUS 68\\n\\n13.1 Force Majeure. 68 13.2 Change in Control of Harpoon. 68 13.3 Export Control. 69 13.4 Assignment. 69 13.5 Severability. 70 13.6 Governing Law, Jurisdiction and Service. 70 13.7 Dispute Resolution. 70 13.8 Notices. 71 13.9 Entire Agreement; Amendments. 72 13.10 English Language. 72 1\",\n",
              "    'Highlight the parts (if any) of this contract related to \"Agreement Date\" that should be reviewed by a lawyer. Details: The date of the contract',\n",
              "    'November 20, 2019',\n",
              "    343,\n",
              "    360),\n",
              "   ('SCHEDULE TO Software License, Customization and Maintenance Agreement    Supplier Name:  Cardlytics, Inc.  Agreement Number:  CW251207\\n\\nSupplier Address:\\n\\n\\n\\n621 North Avenue NE Suite C-30 Atlanta, GA 30308\\n\\nAddendum Number:\\n\\n\\n\\nCW255039\\n\\nSupplier Telephone:  888.798.5802  Addendum Effective Date  March 3, 2011\\n\\nThis Schedule (\"Schedule\") is made as of the effective date set forth above to that Software License, Customization, and Maintenance Agreement, by and between Cardlytics, Inc. (\"Supplier\") and Bank of America, N. A, (\"Bank of America\"), dated November 5, 2010, as amended (\"SLCMA\"). Each capitalized term used but not defined herein shall have the meaning assigned in the SLCMA.\\n\\nWHEREAS, Bank of America and Supplier entered into the SLCMA in order to set forth the terms and conditions pursuant to which Supplier provides certain Software to Bank of America,\\n\\nWHEREAS, the parties desire to add to the SLCMA the Supplier Offer Placement System Software;\\n\\nNOW THEREFORE, in consideration of the promises and accords made herein, and the exchange of such good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, Bank of America and Supplier agree as follows:\\n\\nThe attached Schedule [A] is hereby incorporated into the SLCMA describing the Offer Placement System Software for use by Bank of America.\\n\\nTHE FOREGOING IS UNDERSTOOD AND AGREED TO BY:   Cardlytics, Inc. (\"Supplier\")   Bank of America, N.A. (\"Bank of America\")\\n\\nBy:  /s/ Scott Grimes  By:  /s/ Chandra Torrence\\n\\nName: Scott Grimes  Name: Chandra Torrence\\n\\nTitle:  Chief Executive Officer  Title:  V.P., Sourcing Manager\\n\\nDate:  3/4/11  Date:  3/3/11    1.\\n\\nSource: CARDLYTICS, INC., S-1, 1/12/2018',\n",
              "    'Highlight the parts (if any) of this contract related to \"Agreement Date\" that should be reviewed by a lawyer. Details: The date of the contract',\n",
              "    '3/4/11',\n",
              "    1638,\n",
              "    1644),\n",
              "   ('Exhibit 10.5\\n\\nNote: Portions of this exhibit indicated by\"[*]\" are subject to a confidential treatment request, and have been omitted from this exhibit. Complete, unredacted copies of this exhibit have been filed with the Securities and Exchange Commission as part of this Company\\'s confidential treatment request.\\n\\nDistributor Agreement                              ---------------------\\n\\nThis Distributor Agreement (the \"Agreement\") is made effective as of the 31st day of March, 2000 (the \"Effective Date\"), by and between Airspan Networks Incorporated, a company incorporated under the laws of the State of Washington having its principal office at 777 108th Avenue NE, Suite 1895, Bellevue, Washington 98004 (\"Airspan\") and GLS LLC, (\"Distributor\") a limited liability company incorporated under the laws of the State of South Dakota having its principal office at 501 Fourth Street, Sergeant Bluff, IA 51054.\\n\\nWITNESSETH:\\n\\nWHEREAS, Airspan is engaged in the design and manufacture of various telecommunications product lines, including, among others, those product lines more completely described in Schedule I hereto (the product lines described in Schedule I, as from time to time amended in accordance with the provisions of this Agreement, are hereinafter called the \"Airspan Products\") the hardware components thereof are sometimes referred to separately as \"Equipment,\" the software components thereof are sometimes referred to separately as \"Software\" as defined in Section 11.1, and an arrangement of Equipment which, when interfaced with Software, is operable to perform predetermined functions, is referred to as a \"System\");\\n\\nWHEREAS, Distributor is engaged in the promotion of sales of telecommunications products; and\\n\\nWHEREAS, Airspan desires to appoint Distributor as a Distributor for the Airspan Products for the territory described in Schedule II hereto (the \"Territory\").\\n\\nNOW, THEREFORE, in consideration of the mutual promises herein contained, it is hereby agreed as follows:\\n\\n1.   APPOINTMENT.      -----------\\n\\n1.1  Subject to the provisions of this Agreement, Airspan hereby appoints Distributor as an independent, exclusive distributor to assist Airspan in marketing the Airspan Products to customers in the Territory, and Distributor hereby accepts such appointment as of the Effective Date of this Agreement. Distributor\\'s appointment as a distributor of the Airspan Products grants to Distributor only a license to resell the\\n\\n- -------------------------------------------------------------------------------\\n\\nPage 1\\n\\nAirspan Products to Distributor\\'s customers in the Territory, and does not transfer any right, title, or interest in any of the Airspan Software to Distributor.\\n\\n1.2  Distributor\\'s relationship to Airspan is that of an independent contractor, and nothing in this Agreement shall constitute Distributor as the agent or employee of Airspan.  Distributor shall have no authority to accept any order or make any offer (except as herein stated), or execute any instrument or make any commitment on behalf of Airspan.  Specifically, without in any way limiting the generality of the foregoing, Distributor agrees not to make any representation, guarantee, or warranty on Airspan\\'s behalf concerning the Airspan Products, but will refer customers to Airspan\\'s printed literature. Nothing contained in this Agreement is to be construed as a limitation or restriction upon Airspan in the sale or other disposition of any of its products to any person, firm, or corporation inside or outside of the Territory. Airspan will pay no commissions under this Agreement.  Distributor\\'s compensation is to be obtained solely by the difference between the price Distributor pays to Airspan and the price Distributor charges its customers. The parties also acknowledge that this Agreement is not intended to create a joint venture or partnership between Airspan and Distributor.\\n\\n1.3  Distributor will use its best efforts to maintain and support the Airspan Products within the Territory by devoting such attention, time, and effort as may be reasonably necessar',\n",
              "    'Highlight the parts (if any) of this contract related to \"Agreement Date\" that should be reviewed by a lawyer. Details: The date of the contract',\n",
              "    '31st day of March, 2000',\n",
              "    463,\n",
              "    486),\n",
              "   ('EXHIBIT 10.6    TRANSPORTATION CONTRACT  SPECIFIC CONDITIONS\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n   PURPOSE\\n\\n  ECONOMIC CONDITIONS\\n\\n  CONTRACTED CAPACITY\\n\\n\\n\\n   POINTS OF ENTRANCE AND EXIT     MANSOYร - TUMACO\\n\\n\\n\\nDate Bogota D.C. January 30, 2012\\n\\nContract No. VIT-005-2012\\n\\nSENDER SOLANA PETROLEUM EXPLORATION  COLOMBIA LIMITED\\n\\nTAX ID 830.051.027-8\\n\\nSHIPPER ECOPETROL S.A.   TAX ID 899.999.068-1\\n\\nT Y P E  O F   CRUDE  OWN PRODUCTION x  PROPERTY\\n\\nTransportation Service of liquid hydrocarbons through the \"Trasandino\" Pipeline(OTA) and Mansoyรก-Orito (OMO) pipeline.\\n\\nEstimated Value of the Contract Six millions seven hundred forty five thousand dollars of The United States of  America (USD$6.745.000).  Rate \"Mansoyรก-Orito\" Pipeline (OMO) Cero point five one nine two dollars of The Untied States of America (USD$0,5192) per Barrel  Rate \"Trasandino\" Pipeline (OTA) Three dollars eleven forty three cents of dollars of The Untied States of America (USD$3,1143) per Barrel.\\n\\nPRODUCT Daily Average  (Barrels/calendar day)  Monthly average  (Barrels/month)  Crude 10.000 300.000\\n\\nTERM OF EXECUTION From January 30, 2012 until July 29, 2012\\n\\nPoint   #  Type of Point    Name of Point  Distance  (km)\\n\\n1 Point of Entrance  Entrance bridle to the srapers tramp in the PK 35+400 of  OMO 377,3  2 Point of Exit Exit bridle to the main tanks of Tumaco Plant.\\n\\n\\n\\n\\n\\n\\n\\n   SPECIFICATIONS OF PRODUCTS TO BE SHIPPED    PRODUCT CHARACTERISTICS\\n\\n   Quality Specifications of Crude:    Bases on the operating conditions of the \"Trasandino\" Pipeline, ECOPETROL shall only receive daily crude oil from the SENDER up to a maximum  equivalent to 12% of the total light crude received in the day at the Orito Plant.    The indicated Quality Specifications correspond to those which the final mix of crude delivered by the SENDER shall have. In the event in which  the Crude delivered by the SENDER fails to meet the Quality Specification and if the buying of dissolvent is required to make mixes, the SENDER  shall request approval from ECOPETROL before its delivery for transportation by ECOPETROL.    It is the SENDER\\'s responsibility to ensure its possession, control and entitlement to deliver or make deliver on its behalf the crude received by  ECOPETROL at the Entrance Point. The SENDER shall hold ECOPETROL harmless against any claim, action or damages which may result from  suits, claims or administrative, judicial or extrajudicial actions from any third persons alleging ownership or possession on the crude to be shipped.    BONDS\\n\\n   In witness whereof, and accepting the General Conditions and the Specific Conditions this Contract is subscribed in two (2) duplicates of the same  content in the city of Bogotรก on the thirtieth (30th) day of the month of January, 2012.\\n\\n\\n\\nCharacteristics Lower Limit Upper Limit  Temperature   120ยฐF  Viscosity   300 cSt 30ยบC.  Water and sediments (BSW)   0,5 % in volume  Salt   20 PTB  Steam pressure   Eleven (11) psi at 100ยฐF  Gravity in API degrees 18 degrees 50 degrees\\n\\nTYPE OF BOND AMOUNT  Performance Insurance Policy Four thousand forty seven millions of Colombian pesos ($4.047.000.000)\\n\\n  1\\n\\n\\n\\n\\n\\n\\n\\n   All notifications and communications to be delivered to the Parties as a result of the execution of the Contract hereof shall be made to the  addresses indicated as follows:    ECOPETROL\\n\\n  THE SENDER\\n\\n\\n\\n\\n\\nBY THE SENDER: BY ECOPETROL S.A.:  Signature \"/s/ Duncan Nightingale\" Signature \"/s/ Rafael Espinosa Rozo\"          Name: DUNCAN NIGHTINGALE Name: RAFAEL ESPINOSA ROZO  Title: Legal Representative  Pasaporte No. BA386341  Title: Pipelines Manager  C.C. No. 79.432.773 de Bogotรก D.C.          Signature \"/s/ Hugo Rodriguez\"             Name: HUGO RODRIGUEZ     Title: Legal Representative  C.C. No. 3.093.980\\n\\nADDRESS 5.1 Carrera 7 No. 37 - 69 Piso 9 Edificio Teusacรก  TELEPHONE 5.2 2343491 FAX 5.3 2343532 CITY 5.4 Bogotรก D.C.\\n\\nADDRESS 5.5 Calle 113 No. 7 - 80 Piso 17  TELEPHONE 5.6 6585757 FAX 5.7 2139327 CITY 5.8 Bogotรก D.C.\\n\\n  2\\n\\n\\n\\n\\n\\n   TRANSPORTATION CONTRACT  GENERAL CONDITIONS    The Contract hereof executed between ECOPETROL and the SENDER shall be comprised by t',\n",
              "    'Highlight the parts (if any) of this contract related to \"Agreement Date\" that should be reviewed by a lawyer. Details: The date of the contract',\n",
              "    'January 30, 2012',\n",
              "    202,\n",
              "    218),\n",
              "   ('Exhibit 10.1 NON-COMPETITION AGREEMENT AMENDMENT NO. 1   This NON-COMPETITION AGREEMENT AMENDMENT NO. 1 (this \"Amendment\") is entered into as of August 16, 2017, by and between VIVINT SOLAR, INC., a Delaware corporation (together with its successors and permitted assigns, \"Vivint Solar\"), and VIVINT, INC., a Utah corporation (together with its successors and permitted assigns \"Vivint\"). Each of Vivint Solar and Vivint may also be referred to herein individually as a \"Party\", and collectively as the \"Parties\".   RECITALS\\n\\nWHEREAS, Vivint Solar and Vivint are affiliate business entities, under the common control and ownership of 313 Acquisition, LLC, a Delaware limited liability company.\\n\\nWHEREAS, the Parties had entered into a Non-Competition Agreement dated September 30, 2014, by and between the Parties (collectively, the \"Non-Competition Agreement\") to set out certain restrictive covenants of each Party.\\n\\nWHEREAS, the Parties wish to amend the existing obligations under the Non-Competition Agreement.\\n\\nWHEREAS, the Parties also desire to extend the term of the non-solicitation obligations under the Non-Competition Agreement.\\n\\nAGREEMENT\\n\\nNOW, THEREFORE, in consideration of the mutual covenants, agreements and conditions set forth herein, and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Parties agree as follows:\\n\\n1. Definitions. Any capitalized term used but not defined in this Amendment will have the meaning set forth for that term in the Non-Competition Agreement or the Master Framework Agreement, dated September 30, 2016, by and between the Parties (the \"Master Framework Agreement\").\\n\\n2. Non-Competition. Section 2 of the Non-Competition Agreement shall be deleted in its entirety and the other provisions of the Non-Competition Agreement that relate to such Section 2, including, without limitation, Sections 5 and 6, shall be amended hereby to delete the applicable references, and provisions solely applicable to, Section 2, mutatis mutandis.   3. Non-Solicitation. Section 4 of the Non-Competition Agreement is hereby deleted in its entirety and replaced with the following:\\n\\n\"Term. This Agreement will become effective on the Effective Date, and will continue until the expiration of the \"Sales Term\" as that term is defined in the Sales Dealer Agreement dated as of August 16, 2017 between Vivint and Vivint Solar Developer, LLC (the \"Term\").\"   4. Continuation. This Amendment will apply and be effective only with respect to the provisions of the Non- Competition Agreement specifically referred to herein. Except as otherwise set forth in this Amendment, the Non-Competition Agreement will continue in full force and effect in accordance with its terms.\\n\\n1\\n\\n\\n\\n\\n\\n  5. Master Framework Agreement. This Amendment is governed by the Master Framework Agreement, including, without limitation, the provisions of Sections 4 (Confidentiality) and 6 (Miscellaneous) of the Master Framework Agreement.\\n\\n[SIGNATURE PAGES FOLLOW]\\n\\n2\\n\\n\\n\\n\\n\\n  IN WITNESS WHEREOF, the Parties have executed this Non-Competition Agreement Amendment No. 1 as of the date first written above.\\n\\n\\n\\nVIVINT SOLAR:     VIVINT SOLAR, INC., a Delaware corporation     By: /s/ David Bywater Name: David Bywater Title: Chief Executive Officer\\n\\n[SIGNATURE PAGES CONTINUE ON FOLLOWING PAGE]\\n\\n\\n\\n[SIGNATURE PAGE]\\n\\n\\n\\n\\n\\nVIVINT:     VIVINT, INC., a Utah corporation     By: /s/ Alex J. Dunn Name: Alex J. Dunn Title: President\\n\\n[SIGNATURE PAGE]',\n",
              "    'Highlight the parts (if any) of this contract related to \"Agreement Date\" that should be reviewed by a lawyer. Details: The date of the contract',\n",
              "    'August 16, 2017',\n",
              "    145,\n",
              "    160),\n",
              "   ('Exhibit 4.72\\n\\nConfidential\\n\\n(Translation, for reference only)\\n\\nStrategic Alliance Agreement\\n\\nThis Strategic Alliance Agreement (\"Agreement\") is executed on this 11th day of December, 2015 (\"Execution Date\") by and between ChipMOS TECHNOLOGIES INC., a company incorporated under the laws of Taiwan (\"ChipMOS\"), and Tsinghua Unigroup Ltd. (\"Tsinghua Unigroup\"), a company incorporated under the laws of the People\\'s Republic of China (\"PRC\"). ChipMOS and Tsinghua Unigroup shall collectively be referred to as the \"Parties.\"\\n\\nWHEREAS, Tsinghua Unigroup actively searches for investment targets which are leading companies in upstream, midstream, or downstream semiconductor industries, provides abundant funds to build strategic cooperation, and jointly shares the growing business opportunities of the semiconductor market in Mainland China; ChipMOS is a leading company engaged in the assembly and testing services of LCD drivers and wafer bumping process technologies.\\n\\nWHEREAS, ChipMOS and Tsinghua Unigroup will also, on the Execution Date, enter into the Share Subscription Agreement (\"Share Subscription Agreement\"). ChipMOS agrees, according to the terms and conditions of the Share Subscription Agreement, to increase its capital and issue 299,252,000 common shares through private placement (\"Private Placement Shares\") and the Private Placement Shares will be subscribed to by a company over which Tsinghua Unigroup has de facto control (\"Subscriber\"); Tsinghua Unigroup also agrees that such Private Placement Shares be subscribed to by the Subscriber from ChipMOS (\"Transaction\").\\n\\nWHEREAS, ChipMOS and Tsinghua Unigroup, in order to strengthen their relationship, are going to form a strategic alliance, establish a long-term cooperative relationship, share resources and networks, support each other in the semiconductor industry, and strive for expansion and growth. NOW, THEREFORE, the Parties hereby agree as follows:\\n\\n  Article 1 Strategic Alliance\\n\\n1.1 Content of Strategic Alliance and Expected Benefits After the Closing Date (as defined in the Share Subscription Agreement), Tsinghua Unigroup and ChipMOS shall cooperate, expand, strengthen and stabilize the relationship with the related upstream, midstream, and downstream industries engaged in the assembly and testing services of LCD drivers, microelectromechanical systems (MEMS), the Internet of Things (IoT) and Radio Frequency Integrated Circuits (RFIC) and/or wafer bumping services in Mainland China. Tsinghua Unigroup shall also introduce other potential suppliers, customers and business partners in Mainland China to ChipMOS.   - 1 -\\n\\n\\n\\n\\n\\nConfidential\\n\\n(Translation, for reference only)   1.2 Covenants of Parties\\n\\n(1) Tsinghua Unigroup covenants to follow the Share Subscription Agreement to subscribe for, via the Subscriber, in compliance with the requirements of Taiwan\\'s laws and regulations relating to securities transactions and PRC investment in Taiwan, at the Subscription Price per Share (as defined in the Share Subscription Agreement), 299,252,000 common shares through private placement from ChipMOS, and Tsinghua Unigroup shall comply with, and shall cause the Subscriber to comply with the content of the Share Subscription Agreement, Taiwan\\'s laws and regulations concerning securities transactions and PRC investments in Taiwan so that ChipMOS may make use of the Total Subscription Price (as defined in the Share Subscription Agreement) to replenish operating capital, recruit talents, and upgrade its technologies related to the semiconductor assembly and testing services, to create profits for each of the Parties and its shareholders.\\n\\n(2) ChipMOS covenants that part or all of the Total Subscription Price shall be used:\\n\\n  (a) To strengthen research and development, and technologies, and expand production capacity in Taiwan in order to strengthen itsroots in Taiwan, and increase job opportunities.\\n\\n\\n\\n(b) To increase the capital of ChipMOS TECHNOLOGIES (Shanghai) LTD. (\"ChipMOS Shanghai\"), and replenish the operating capital of ChipMOS Shanghai, in order to expand ChipMOS and its a',\n",
              "    'Highlight the parts (if any) of this contract related to \"Agreement Date\" that should be reviewed by a lawyer. Details: The date of the contract',\n",
              "    '11th day of December, 2015',\n",
              "    161,\n",
              "    187),\n",
              "   ('Exhibit 10.54 DISTRIBUTION AND DEVELOPMENT AGREEMENT This Distribution and Development Agreement (this \"Agreement\") is made and entered into as of May 1, 2016 by and between Sekisui Diagnostics, LLC and its Affiliates, a Delaware limited liability company with principal offices at 4 Hartwell Place, Lexington, Massachusetts 02421 (\"Sekisui\"), and Qualigen, Inc. and its Affiliates, a Delaware corporation with principal offices at 2042 Corte Del Nogal, Carlsbad, California 92011 (\"Qualigen\" and together with Sekisui, each a \"Party\" and together the \"Parties\"). WHEREAS, Qualigen is engaged in the manufacture, supply and development of certain clinical rapid diagnostic test devices and controls; and WHEREAS, Qualigen wishes to appoint Sekisui as its exclusive distributor for such products in the Territory (as defined below); and WHEREAS, Sekisui wishes to be appointed as the exclusive distributor of such products and to fund the development of certain future products. NOW, THEREFORE, in consideration of the mutual covenants hereinafter contained, the parties hereto agree as follows: 1. Definitions 1.1. Adverse Event shall mean an incident in which the Product was alleged to have caused or contributed to the death or serious injury of a patient or operator and would require submitting a Medical Devices Report to the FDA (as hereinafter defined) as per 21 CFR 803, or a similar report to a Competent Authority (as hereinafter defined) as per Vigilance Guidance MEDDEV 2.12-1. 1.2. Affiliate shall mean, (i) with respect to Qualigen, any corporation or other form of business organization, which directly or indirectly owns, controls, is controlled by, or is under common control with Qualigen, and (ii), with respect to Sekisui, shall mean Sekisui Diagnostics (UK) Ltd., Sekisui Diagnostics PEI, Inc., SEKISUI MEDICAL CO., LTD., and Sekisui Diagnostics GmbH. An entity shall be regarded as being in control of another entity if the former entity has the direct or indirect power to vote more than fifty percent (50%) of the outstanding voting securities (or other ownership interest for a business organization other than a corporation) of that entity, or the direct or indirect ability to direct or cause the direction of the general management and policies of the other entity. 1.3. Applicable Markets shall mean the United States, Canada, the European Union, Japan and other additional geographies that are added from time to time at the request of Sekisui, but only to the extent that it is commercially reasonable for Qualigen to expand to such additional geographies. 1.4. Available Margin is defined on Exhibit A. 1.5. Business Plan shall mean the business plan attached as Exhibit B hereto, which business plan may be amended from time to time by mutual agreement of Qualigen and Sekisui. 1.6. COGS is defined on Exhibit A.\\n\\nSource: RITTER PHARMACEUTICALS INC, S-4/A, 3/13/2020\\n\\n\\n\\n\\n\\n1.7. Competent Authority shall mean the governmental authority in a member state of the European Union which has competence in relation to the Products. 1.8. Development Plan shall mean the development plan attached as Exhibit C hereto, which development plan may be amended from time to time by mutual agreement of Qualigen and Sekisui. 1.9. Effective Date shall mean May 1, 2016. 1.10. European Union shall mean the countries in Europe that are under the CE mark regulatory regime. 1.11. Exclusivity Period shall mean the period from the Effective Date until December 31, 2018. 1.12. FDA shall mean the U.S. Food and Drug Administration or any successor agency. 1.13. Health Canada shall mean the department of the government of Canada with responsibility for national public health. 1.14. Intellectual Property Rights means all intellectual property rights in any jurisdiction worldwide, including, without limitation: (a) Patent Rights; (b) rights associated with works of authorship including copyrights, copyright applications, and copyright registrations; (c) rights relating to the protection of trade secrets, know-how or confidential information; and (d) rights in any trade names',\n",
              "    'Highlight the parts (if any) of this contract related to \"Agreement Date\" that should be reviewed by a lawyer. Details: The date of the contract',\n",
              "    'May 1, 2016',\n",
              "    147,\n",
              "    158),\n",
              "   ('Exhibit 10.28\\n\\n                              ENDORSEMENT AGREEMENT\\n\\n            This Endorsement Agreement (\"Agreement\") is made and entered into as of August 24, 1995, by and among the following parties:\\n\\n                  (a) Kathy Ireland, Inc. (\"KI Inc.\"), furnishing the services       of Kathy Ireland (\"KI\"), c/o The Sterling/Winters Co., 1900 Avenue of the       Stars, Suite #1640, Los Angeles, California 90067;\\n\\n                  (b) The Sterling/Winters Co. (\"SW\"), 1900 Avenue of the Stars,       Suite #1640, Los Angeles, California 90067; and\\n\\n                  (c) Diplomat Ambassador Eyewear Group (\"Diplomat\"), 1010 Arch       Street, 3rd Floor, Philadelphia, Pennsylvania 19107.\\n\\n            1. Recitals.\\n\\n                  (a) Whereas Diplomat has created a new product line to be known as \"Kathy Ireland Eyewear\" (\"KI Eyewear\");\\n\\n                  (b) Whereas Diplomat estimates on a non-binding basis that wholesale sales of KI Eyewear will reach $          during the first License Year, $          during the 2nd License Year, $          during the 3rd License Year, and $          during the 4th License Year (as those License Years are defined in subparagraph 3.(b) of this Agreement);\\n\\n                  (c) Whereas Diplomat desires to obtain the right to use the name, likeness and endorsement of KI in connection with the advertisement, promotion and sale of KI Eyewear; and\\n\\n                  (d) Whereas KI, Inc. has the authority to grant the right to use KI\\'s name, likeness and endorsement to Diplomat in connection with the advertisement, promotion and sale of KI Eyewear and desires to do so;\\n\\n                  (e) NOW THEREFORE, for and in consideration of the mutual promises and conditions contained in this Agreement, the parties hereby agree as follows.\\n\\n            2. Grant of License.\\n\\n                  (a) Products. Upon the terms and conditions set forth in this Agreement, KI, Inc. hereby grants to Diplomat and Diplomat hereby accepts the right, license and privilege of utilizing KI\\'s name and likeness solely upon and in connection with the manufacture, sale and distribution of the following products:\\n\\n                        (1) sunglasses, eyeglasses, readers and ophthalmic frames;\\n\\n                                       1\\n\\n                        (2) optical cases, optical eye chains, eye pins, and lens cleaning kits sold only in optical retailers; and\\n\\n                        (3) such other optical accessories as the parties shall agree.\\n\\n                  (b) Territory. The license hereby granted extends worldwide.\\n\\n                  (c) Term. The term of the license hereby granted shall commence August 1, 1995 and continue until January 30, 2000, unless sooner terminated in the manner provided in the immediately succeeding sentence or as otherwise provided in this Agreement. Notwithstanding the foregoing, if the management of Kmart stores elects not to carry KI eyewear prior to the end of the first license year (January 30, 1997), then either party shall have the right to terminate this Agreement as of such date.\\n\\n                  3. Terms of Payment.\\n\\n                  (a) Rate. Diplomat agrees to pay KI, Inc. as royalty a sum equal to  % of the net wholesale volume of the products covered by this Agreement by Diplomat and its affiliated, associated, or subsidiary companies. The term \"net wholesale volume\" shall mean gross sales to all customers; less returns, trade discounts and cash discounts; but no deduction shall be made for other discounts or uncollectible accounts. No costs incurred in the manufacture, sale, distribution, or exploitation of the products covered by this Agreement shall be deducted from any royalty payable by Diplomat.\\n\\n                  (b) Minimum Royalties. Diplomat agrees to pay KI, Inc. the minimum royalties set forth below as a minimum guarantee against royalties to be paid to KI, Inc. under subparagraph 3.(a), above:\\n\\n                  (1) 1st License Year (8/1/95 - 1/30/97):     $                   (2) 2nd License Year (2/1/97 - 1/30/98):     $                   (3) 3',\n",
              "    'Highlight the parts (if any) of this contract related to \"Agreement Date\" that should be reviewed by a lawyer. Details: The date of the contract',\n",
              "    'August 24, 1995',\n",
              "    152,\n",
              "    167),\n",
              "   ('Exhibit 10.11    Execution Copy    STRATEGIC ALLIANCE AGREEMENT    This STRATEGIC ALLIANCE AGREEMENT (this \"Agreement\") is made as of December 21, 2006 by and among OXBOW CARBON & MINERALS LLC, a Delaware limited liability company having a principal office address at 1601 Forum Place, Suite 1400, West Palm Beach, Florida 33401 (\"Oxbow\") and GLOBAL ENERGY, INC., an Ohio corporation having a principal office address at 312 Walnut Street, Suite 2650, Cincinnati, Ohio 45202 (\"Global Energy\"). Oxbow and Global each may be referred to from time to time herein as a \"Party\" and collectively as the \"Parties\".    RECITALS    WHEREAS, Oxbow is a world leader in petroleum coke trading, marketing, sales, and shipping; and    WHEREAS, Global Energy is a world leader in petroleum coke gasification, having optimized operations of the leading petroleum coke gasification technology, EGASโข technology, at its Wabash gasification facility in Indiana; and    WHEREAS, Oxbow leases a marine terminal site in Texas City, Texas which it believes to be well-suited for installation of petroleum coke gasification technology, in that gasification would optimize Oxbow\\'s flexibility in the sale and use of petroleum coke currently stored on the site, which could be converted into pipeline SNG or hydrogen, as well as being shipped onward to Oxbow\\'s traditional petroleum coke customers; and    WHEREAS, Global Energy is a leader in the development and permitting of gasification facilities, and currently is the only gasification facility owner/operator with permits to construct new gasification facilities (specifically, its Lima and Westfield Projects); and    WHEREAS, the Parties believe that an alliance as described in this Agreement will prove mutually beneficial;    NOW, THEREFORE, in consideration of the premises and for other good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, the Parties agree as follows:    AGREEMENT    1. Purchase of Shares. Global Energy shall issue and sell to Oxbow, and Oxbow shall purchase from Global Energy, on the Closing Date, Twenty-Five Thousand (25,000) common shares of Global Energy (the \"Shares\"), on the following terms and conditions, and subject to satisfaction of the conditions set forth in Section 6 hereof:    (a) Purchase Price. The purchase price for the Shares shall be Five Million and No/100 Dollars ($5,000,000.00), or $200.00 per Share.      1\\n\\n\\n\\n\\n\\n    (b) Payment. Payment of the Purchase Price shall be made on the Closing Date by wire transfer of immediately available funds to Global Energy, as applicable, at the applicable account designated by Global Energy, as follows:                                           Bank:     PNC Bank, N.A.                               Cincinnati, OH                          ABA No.:     042000398                          Account No.:     40-7690-5189                          Account Name:    Global Energy, Inc.                            (c) Closing. Unless this Agreement shall have been terminated and subject to the satisfaction or waiver of the conditions set forth in Section 6, the closing of the purchase of the Shares (the \"Closing\") shall take place at 11:00 a.m., on December 22, 2006 (such date of closing referred to herein as the \"Closing Date\") at the offices of Oxbow, 1601 Forum Place, Suite 1400, West Palm Beach, Florida 33401, unless another date, time or place is agreed to in writing by the parties hereto. At the Closing, Oxbow shall pay to Global Energy the Purchase Price and Global Energy shall deliver to Oxbow a stock certificate evidencing the issuance to Oxbow of the Shares. The Closing shall be deemed effective as of 12:01 a.m. U.S. Eastern Standard Time, on the Closing Date.    2. Strategic Alliance. The Parties hereby form a strategic alliance having the following key elements:    (a) Preferred Suppliers. Oxbow and Global Energy hereby designate one another as their preferred suppliers of certain goods and services, as follows:    (i) Oxbow shall be the preferred petroleum coke supplier to petroleum coke gasification ',\n",
              "    'Highlight the parts (if any) of this contract related to \"Agreement Date\" that should be reviewed by a lawyer. Details: The date of the contract',\n",
              "    'December 21, 2006',\n",
              "    134,\n",
              "    151),\n",
              "   ('NON COMPETITION AGREEMENT AND RIGHT OF FIRST OFFER\\n\\nTHIS AGREEMENT is dated May 3,2006.\\n\\nBETWEEN:\\n\\nGLAMIS GOLD LTD., a company incorporated under the laws  of the Province of British Columbia, having an office at 310-5190  Neil Road, Reno, Nevada 89502\\n\\n(\"Glam is\")\\n\\nAND:\\n\\nWESTERN COPPER CORPORATION, a company  incorporated under the laws of the Province of British Columbia,  having an office at 2050-1111 West Georgia Street, Vancouver.  B.C. V6E 4M3\\n\\n(\"Western Copper\")\\n\\nWHEREAS:\\n\\n(A) Glamis, Western Copper and Western Silver Corporation (\"Western Silver\") are  parties to an arrangement agreement dated as of February 23, 2006 (the \"Arrangement  Agreement\"), pursuant to which, among other things, Western Copper will acquire certain assets  of Western Silver and Glamis will become the sole shareholder of Western Silver and the  indirect owner, through Western Silver, of certain corporations and mineral properties in Mexico  (the \"Arrangement\"); and\\n\\n(B) It is an obligation under the Arrangement Agreement that Western Copper agree  not to compete with Glamis in certain areas of Mexico and that Glamis grant Western Copper a  right of first offer with respect to the proposed disposition by Glamis of mineral properties or  legal interests therein located in Mexico that Glamis acquired under the Arrangement.\\n\\nNOW THEREFORE TIHS AGREEMENT WITNESSES that in consideration of the mutual  covenants and agreements contained herein and other good and valuable consideration, the  receipt and sufficiency of which is hereby acknowledged, the parties hereto covenant and agree  as follows: (Scheme B. mca)\\n\\n1I629<<7J\\n\\n\\n\\n\\n\\nPART I\\n\\nINTERPRETATION\\n\\nDefinitions\\n\\n1.1 In this Agreement, including the recitals, except as expressly provided or unless  the context otherwise requires,\\n\\n(a) Affiliate means, in respect of a party hereto, a corporation which is the subsidiary  of the party or vice versa or where each of the party and the corporation is controlled by  the same person,\\n\\n(b) Area of Non-Competition means the State of Zacatecas, Mexico and the area  extending 20 kilometers in all directions from the external boundary of each mineral  property owned or controlled by Western Silver or in which Western Silver holds any  legal interest, in Mexico, as at the Effective Date,\\n\\n(c) Business Day means a day which is not a Saturday, Sunday or a civic or statutory  holiday in Reno, Nevada and Vancouver, British Columbia,\\n\\n(d) Closing means the completion of the transactions contemplated by the  Arrangement Agreement,\\n\\n(e) Designated Mineral Property means a mineral property or individual mineral  concession within a mineral property, that is owned or controlled by Western Silver or in  which Western Silver holds any legal interest in Mexico as of the Effective Date,\\n\\n(f) Effective Date means May 3, 200ri or such later date as determined under the  Arrangement Agreement,\\n\\n(g) Mining Activities means any acquisition of mineral rights or any mineral  exploration or development activities, in any manner whatsoever, and\\n\\n(h) Person means an individual, corporation, body corporate, firm, limited liability  company, parmership, syndicate, joint venture, society, association, trust or  unincorporated organization.\\n\\nInterpretation\\n\\n1.2 In this Agreement, except as otherwise expressly provided or unless the context  otherwise requires,\\n\\n(a) the terms \"this Agreement\", \"hereof\\', \"herein\", \"hereunder\" and similar  expressions refer to this Agreement as from time to time supplemented or amended by  one or more agreements entered into pursuant to the applicable provisions of this  Agreement and not to any particular section or other portion,\\n\\n1162967.3\\n\\n\\n\\n\\n\\n- 3 \\'\\n\\n(b) a reference to a Part means a Part of this Agreement and the symbol ยง followed by  a number or some combination of numbers and letters refers to the provision of this  Agreement so designated and the symbol ยง followed by a letter within a provision refers  to a clause within such provision,\\n\\n(c) the headings used in this Agreement are for convenience only and do not form a  part of this Agreement and a',\n",
              "    'Highlight the parts (if any) of this contract related to \"Agreement Date\" that should be reviewed by a lawyer. Details: The date of the contract',\n",
              "    'May 3,2006',\n",
              "    76,\n",
              "    86),\n",
              "   ('EXHIBIT 10.15\\n\\nCO-BRANDING AGREEMENT\\n\\nThis Agreement is made this 21st day of January 2003 by and between Lucent Technologies Inc., a Delaware corporation having a principal place of business at 600 Mountain Avenue, Murray Hill, New Jersey 07974 (\"Lucent\") and mPhase Technologies Inc., a New Jersey corporation located at 587 Connecticut Avenue, Norwalk, Connecticut 068545 (\"mPhase\") (each individually, \"a Party\" and, collectively, \"the Parties\"}.\\n\\nWHEREAS, mPhase wishes to use the Lucent Technologies name and Logo and the slogan TECHNOLOGY BY LUCENT TECHNOLOGIES on printed circuit boards, product packaging and in printed marketing materials (\"Approved Uses\") in connection with its multi-access product (the \"Goods\") and Lucent wishes to permit mPhase to do so.\\n\\nNOW THEREFORE, the Parties, for good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, agree as follows:\\n\\n1.       mPhase may apply only the exact logo shown on Schedule A of this          Agreement (the \"Lucent Co-Branding Logo\"} in Approved Uses for mPhase\\'s          Goods.\\n\\n2.       mPhase agrees to abide by the guidelines appearing on Schedule B of          this Agreement specifying the dimensions, requirements and          specifications, and the review process related to use of the Lucent          Co-Branding Logo. mPhase understands that these guidelines may be          updated from time to time and agrees to abide by those updates as well          as the guidelines provided herein.\\n\\n3.       In the event that mPhase\\'s use of the Lucent Co-Branding Logo, in the          sole judgment of Lucent, may adversely affect Lucent\\'s rights to the          mark shown on Schedule A or the marks and names LUCENT, LUCENT          TECHNOLOGIES or LUCENT INNOVATION RING DESIGN, Lucent may upon written          notification to mPhase, terminate this Agreement.\\n\\n4.       mPhase agrees that it acquires no rights to the Lucent Co-Branding Logo          nor to the marks LUCENT, LUCENT TECHNOLOGIES or LUCENT INNOVATION RING          DESIGN, by its use and that any use of the Lucent Co-Branding Logo by          mPhase inures to the benefit of Lucent.\\n\\n5.       mPhase agrees not to adopt any designation which is confusingly similar          to the Lucent Co-Branding Logo or Lucent\\'s marks LUCENT, LUCENT          TECHNOLOGIES or LUCENT INNOVATION RING DESIGN. Any attempt to do so          shall be a breach of this Agreement and Lucent may terminate this          Agreement without notice in the event of such a breach.\\n\\n6.       This Agreement shall terminate in the event of a significant change in          the management or ownership of mPhase or in the event mPhase is the          subject of any bankruptcy proceedings.\\n\\n7.       Lucent is generally aware of the current quality of mPhase\\'s Goods.          mPhase agrees to maintain the quality of its Goods associated with the          Lucent Co-Branding Logo to a level of quality comparable to the current          quality of their Goods.\\n\\n8.       If Lucent determines that mPhase\\'s Goods are no longer maintained at          the current level of quality, Lucent shall so notify mPhase, in          writing, and Lucent shall have the right to terminate this Agreement.\\n\\n9.       mPhase agrees to allow Lucent to inspect the Approved Uses bearing the          Lucent Co-Branding Logo, to ensure that those uses reviewed and          approved pursuant to the procedure set forth in Schedule B continue to          be in compliance with the terms of this Agreement.\\n\\n10.      In the event that mPhase becomes aware of any unauthorized use of the          Lucent Co-Branding Logo or other Lucent marks by third parties, mPhase          agrees to promptly notify Lucent and to cooperate fully, at Lucent\\'s          expense, in any enforcement of Lucent\\'s rights against such third\\n\\nSource: MPHASE TECHNOLOGIES INC, 10-K, 9/11/2003\\n\\n\\n\\n\\n\\nparties. Nothing contained in this paragraph shall be construed to          require Lucent to enforce any rights against third parties or to          restrict Lucent\\'s rights to licens',\n",
              "    'Highlight the parts (if any) of this contract related to \"Agreement Date\" that should be reviewed by a lawyer. Details: The date of the contract',\n",
              "    '21st day of January 2003',\n",
              "    66,\n",
              "    90),\n",
              "   ('Exhibit 10.17\\n\\nINTELLECTUAL PROPERTY AGREEMENT\\n\\nbetween\\n\\nTHE BABCOCK & WILCOX COMPANY\\n\\nand\\n\\nBABCOCK & WILCOX ENTERPRISES, INC.\\n\\ndated as of\\n\\nJune 26, 2015\\n\\n\\n\\n\\n\\nTABLE OF CONTENTS   ARTICLE I   DEFINITIONS     1\\n\\n  Section 1.1   Definitions     1\\n\\n  Section 1.2   Interpretation     4\\n\\nARTICLE II   INTELLECTUAL PROPERTY ASSIGNMENT AND OWNERSHIP     5\\n\\n  Section 2.1   Reserved     5\\n\\n  Section 2.2   Reserved     5\\n\\n  Section 2.3   Assistance by Employees; Inventor Compensation     5\\n\\n  Section 2.4   Ownership     6\\n\\n  Section 2.5   Rights Arising in the Future     6\\n\\n  Section 2.6   Abandonment of Certain Intellectual Property     7\\n\\n  Section 2.7   Reserved     7\\n\\n  Section 2.8   Steam/Its Generation and Use     7\\n\\nARTICLE III   TRADEMARKS     8\\n\\n  Section 3.1   House Marks     8\\n\\n  Section 3.2   Limited License to Use SpinCo House Marks     9\\n\\n  Section 3.3   Removal of Classes from SpinCo Marks    10\\n\\n  Section 3.4   RemainCo Marks    10\\n\\n  Section 3.5   Duty to Avoid Confusion    10\\n\\nARTICLE IV   SHARED LIBRARY MATERIALS    11\\n\\n  Section 4.1   Shared Library Materials    11\\n\\n  Section 4.2   Cross-License of Shared Library Materials    11\\n\\n  Section 4.3   Maintenance of Shared Library Materials    11\\n\\n  Section 4.4   Potential Allocation of Shared Library Materials    12\\n\\n  Section 4.5   Confidentiality and Trade Secret Status of Shared Library Materials    13\\n\\n  Section 4.6   Third Party Materials Contained in the Shared Library Materials    13\\n\\nARTICLE V   INTELLECTUAL PROPERTY LICENSES AND COVENANTS    13\\n\\n  Section 5.1   Cross-License of Shared Know-How    13\\n\\n  Section 5.2   Reserved    14\\n\\n  Section 5.3   Reserved    14    i\\n\\n\\n\\n\\n\\n  Section 5.4   Cross-Licenses of Software    14\\n\\n  Section 5.5   Reserved    15\\n\\n  Section 5.6   Sublicensing; Assignability    15\\n\\n  Section 5.7   Restrictions on Licensor Exploitation of Intellectual Property    16\\n\\n  Section 5.8   Third Party Agreements; Reservation of Rights    16\\n\\n  Section 5.9   Maintenance of Intellectual Property    16\\n\\n  Section 5.10   Covenants    17\\n\\nARTICLE VI   TECHNICAL ASSISTANCE AND TECHNOLOGY TRANSFER    17\\n\\n  Section 6.1   Reserved    17\\n\\n  Section 6.2   Reserved    17\\n\\n  Section 6.3   No Additional Technical Assistance    17\\n\\nARTICLE VII   NO WARRANTIES    18\\n\\nARTICLE VIII   THIRD-PARTY INFRINGEMENT    18\\n\\n  Section 8.1   No Obligation    18\\n\\n  Section 8.2   Notice Regarding Infringement    19\\n\\n  Section 8.3   Suits for Infringement    19\\n\\nARTICLE IX   CONFIDENTIALITY    21\\n\\nARTICLE X   MISCELLANEOUS    22\\n\\n  Section 10.1   Authority    22\\n\\n  Section 10.2   Entire Agreement    22\\n\\n  Section 10.3   Binding Effect; Third-Party Beneficiaries; Assignment    23\\n\\n  Section 10.4   Amendment    23\\n\\n  Section 10.5   Failure or Indulgence Not Waiver; Remedies Cumulative    23\\n\\n  Section 10.6   Notices    23\\n\\n  Section 10.7   Counterparts    23\\n\\n  Section 10.8   Severability    23\\n\\n  Section 10.9   Governing Law    24\\n\\n  Section 10.10   Construction    24\\n\\n  Section 10.11   Performance    24\\n\\nSCHEDULES   Schedule 1.1(e)   SpinCo Core Field; RemainCo Core Field Schedule 1.1(i)   Specific RemainCo Field; Specific SpinCo Field Schedule 1.1(o)   SpinCo House Marks Schedule 1.1(p)   RemainCo House Marks   ii\\n\\n\\n\\n\\n\\nSchedule 2.4(a)   RemainCo Ownership Schedule 2.4(b)   SpinCo Ownership Schedule 2.6   Abandonment of Certain Intellectual Property Schedule 3.1   SpinCo Trademarks Schedule 3.3   Required Actions and Filings Schedule 3.4   RemainCo Trademarks Schedule 4.1   Shared Library Materials Schedule 4.4   Nuclear Design Materials Schedule 5.4(a)   Foundational Software   iii\\n\\n\\n\\n\\n\\nINTELLECTUAL PROPERTY AGREEMENT\\n\\nThis INTELLECTUAL PROPERTY AGREEMENT (this \"Agreement\") is entered into as of June 26, 2015 (the \"Effective Date\"), between The Babcock & Wilcox Company, a Delaware corporation, (\"RemainCo\") and Babcock & Wilcox Enterprises, Inc., a Delaware corporation (\"SpinCo\"). RemainCo and SpinCo are sometimes referred to herein individually as a \"Party,\" and collectively as the \"Parties.\" Capitalized terms used herein and not otherwise defined shall have the meanings ascr',\n",
              "    'Highlight the parts (if any) of this contract related to \"Agreement Date\" that should be reviewed by a lawyer. Details: The date of the contract',\n",
              "    'June 26, 2015',\n",
              "    141,\n",
              "    154),\n",
              "   ('Exhibit 10.14\\n\\n[* * *] = Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 406 of the Securities Act of 1933, as amended.\\n\\nMANUFACTURING AND SUPPLY AGREEMENT\\n\\nDATED AS OF January 1, 2013\\n\\nBETWEEN\\n\\nVAPOTHERM, INC.\\n\\nAND\\n\\nMEDICA, S.p.A.\\n\\n\\n\\n\\n\\nTABLE OF CONTENTS Page ARTICLE 1 SALE AND PURCHASE 1\\n\\n1.1 Supply of Cartridge 1 1.2 [* * *] 1 1.3 Purchase of Cartridge 1\\n\\nARTICLE 2 FORECASTS; INVENTORY 1\\n\\n2.1 Rolling Forecasts 1 2.2 Inventory 2\\n\\nARTICLE 3 ORDERS, SHIPMENT, AND PAYMENT 2\\n\\n3.1 Price 2 3.2 Purchase Orders 2 3.3 Delivery 3 3.4 [* * *] 3 3.5 Delay in Delivery 3 3.6 Delivery Default Rights 3 3.7 Invoices and Payment Terms 3 3.8 Delay in Payment 4\\n\\nARTICLE 4 QUALITY OF THE CARTRIDGE 4\\n\\n4.1 Conformity with Specifications 4 4.2 Conditions to Rejection 4 4.3 Rejection 4 4.4 Nonconformity Default Rights 5 4.5 Acceptance of Cartridges 5 4.6 Quality Monitoring 5\\n\\nARTICLE 5 PRODUCTION PROCESS 5\\n\\n5.1 Joint Review Committee 5 5.2 Process Development 5 5.3 Inventory of Raw Materials and Spare Parts 5 5.4 [* * *] 5 -i-\\n\\n[* * *] = Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 406 of the Securities Act of 1933, as amended.\\n\\n\\n\\n\\n\\nARTICLE 6 QUALITY SYSTEM 6\\n\\n6.1 General Quality Statement 6 6.2 Quality System Changes 6 6.3 Vendor Quality 6 6.4 Vigilance System 6\\n\\nARTICLE 7 OTHER OBLIGATIONS OF MEDICA 7\\n\\n7.1 Debarment Certification 7 7.2 Permits and Certifications 7 7.3 Manufacturing Problems 7 7.4 Insurance 7\\n\\nARTICLE 8 INSPECITONS; RECORDS 8\\n\\n8.1 Notification of Inquiries and Inspections 8 8.2 Access to Medica Facilities and Records 8 8.3 Records 9\\n\\nARTICLE 9 CARTRIDGE RECALLS 9\\n\\n9.1 Cartridge Recalls 9 9.2 Notice of Events that May Lead to Cartridge Recall 9 9.3 Recall Due to Breach By Medica 9 9.4 Definition of Recall 9 9.5 Recall Process 10\\n\\nARTICLE 10 PUBLICITY; CONFIDENTIALITY; INTELLECTUAL PROPERTY 10\\n\\n10.1 Publicity 10 10.2 Confidentiality 10 10.3 Pre-existing and Independently Developed Intellectual Property 11 10.4 Ownership 11 10.5 [* * *] 11 10.6 Reservation of All Other Rights 11\\n\\nARTICLE 11 REPRESENTATIONS 12\\n\\n11.1 Representations of Medica 12 -ii-\\n\\n[* * *] = Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 406 of the Securities Act of 1933, as amended.\\n\\n\\n\\n\\n\\n11.2 Representations of Vapotherm 13\\n\\nARTICLE 12 INDEMNIFICATION 13\\n\\n12.1 Indemnification 13 12.2 Procedures Relating to Indemnification 14 12.3 No Liability for Consequential Damages 15 12.4 Limitation on Liability 15\\n\\nARTICLE 13 TERM AND TERMINATION; BUSINESS CONTINUITY 15\\n\\n13.1 Term 15 13.2 Termination 16 13.3 Effect of Termination 17 13.4 Business Continuity 17\\n\\nARTICLE 14 MISCELLANEOUS 18\\n\\n14.1 Definitions 18 14.2 Further Assurances 21 14.3 Governing Law 21 14.4 Dispute Resolution 21 14.5 Arbitration 22 14.6 Force Majeure 22 14.7 Assignment 22 14.8 Notices 22 14.9 Severability 23 14.10 Entire Agreement 23 14.11 Amendment 23 14.12 Independent Contractor 23 14.13 Counterparts 23 14.14 Compliance with Laws 24 -iii-\\n\\n[* * *] = Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 406 of the Securities Act of 1933, as amended.\\n\\n\\n\\n\\n\\nMANUFACTURING AND SUPPLY AGREEMENT\\n\\nThis Manufacturing and Supply Agreement (this \"Agreement\") is dated January 1st, 2013, between VAPOTHERM, INC., a Maryland corporation (\"Vapotherm\") and MEDICA S.p.A., an Italian company (\"Medica\").\\n\\nWHEREAS, Vapotherm sells systems it has developed for delivering humidified, blended medical gas therapy (the \"System\"), which system includes a vapor transfer cartridge;\\n\\nWHEREAS, Vapotherm and Medica wish for Medica to manufacture [* * *] (each, a \"Cartridge\" and collectively, the \"Cartridges\") for Va',\n",
              "    'Highlight the parts (if any) of this contract related to \"Agreement Date\" that should be reviewed by a lawyer. Details: The date of the contract',\n",
              "    'January 1st, 2013',\n",
              "    3660,\n",
              "    3677),\n",
              "   ('Exhibit 10.22\\n\\nSTRATEGIC ALLIANCE AGREEMENT\\n\\n(Hyatt Ziva Cancun)\\n\\nTHIS STRATEGIC ALLIANCE AGREEMENT (the \"Agreement\") is made and entered into as of December 14, 2016 (the \"Effective Date\"), by and between Hyatt Franchising Latin America, L.L.C., a limited liability company organized and existing under the laws of the State of Delaware (U.S.A.) with its principal place of business located at 71 South Wacker Drive, Chicago, Illinois 60606, U.S.A. (\"Hyatt\"), and Playa Hotels & Resorts, B.V., a private limited liability company organized and existing under the laws of the Netherlands with its registered address at Prins Bernhardplein 200, 1097 JB Amsterdam, the Netherlands (\"Playa\"). Hyatt and Playa are each referred to as a \"Party\" and collectively as the \"Parties.\"\\n\\nR E C I T A L S:\\n\\nWHEREAS, Hyatt and Playa are parties to that certain Master Development Agreement dated as of August 9, 2013 (as amended, the \"Master Development Agreement\") under which Hyatt granted Playa the exclusive (to the extent set forth therein) right, provided that Playa met certain conditions, to develop all-inclusive resorts under either or both of the Hyatt Zivaยฎ or Hyatt Zilaraยฎ brands and other aspects of the proprietary system owned by Hyatt or its affiliates (\"Hyatt All-Inclusive Resorts\") in the countries of Mexico, Costa Rica, the Dominican Republic, Jamaica and Panama, as their boundaries exist as of the Effective Date (the \"Market Area\"); and\\n\\nWHEREAS, simultaneously with signing this Agreement, Hyatt and Playa or its affiliates are terminating the Master Development Agreement and signing amendments to the following franchise agreements (collectively, the \"Existing Franchise Agreements\") covering the following Hyatt All-Inclusive Resorts:\\n\\n  โข   Franchise Agreement dated as of August 9, 2013, amended and restated on January 31, 2014 between Hyatt and Playa Hall JamaicanResort Limited for the operation of the Hyatt Ziva/Zilaraยฎ resort at 1 Ritz-Carlton Drive, Rose Hall, Montego Bay, Jamaica\\n\\n  โข   Franchise Agreement dated as of August 9, 2013, amended and restated on January 31, 2014 between Hyatt and Playa Cabos Baja, S. DeR.L. De C.V. for the operation of the Hyatt Zivaยฎ resort at Paseo de Malecรณn I-5 D, San Josรฉ del Cabo, 23405, Mexico\\n\\n  โข   Franchise Agreement dated as of August 9, 2013, amended and restated on January 31, 2014 between Hyatt and Cameron Del Pacifico S. De R.L. De C.V. for the operation of the Hyatt Zivaยฎ resort at Carretera Barra de Navidad Km. 3.5, Zona Hotelera, 48300, Puerto Vallarta, Jalisco, Mexico\\n\\n  โข   Franchise Agreement dated as of August 9, 2013, amended and restated on January 31, 2014 between Hyatt and Cameron Del Caribe S. De R.L. De C.V. for the operation of the Hyatt Zivaยฎ resort at Blvd. Kukulkan Km 9.5, Zona Hotelera, Punta Cancรบn, 77500, Cancรบn, Quintana Roo, Mexico\\n\\n\\n\\n\\n\\n  โข   Franchise Agreement dated as of August 9, 2013, amended and restated on January 31, 2014 between Hyatt and The Royal Cancun S. De R.L. De C.V. for the operation of the Hyatt Zilaraยฎ resort at Blvd. Kukulkan Km 11.5, Zona Hotelera, 77500 Cancรบn, Quintana Roo, Mexico; and\\n\\nWHEREAS, Hyatt and Playa have agreed to terminate the Master Development Agreement and to enter into this Agreement.\\n\\nNOW, THEREFORE, in consideration of the mutual covenants and agreements contained in this Amendment and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties agree as follows:\\n\\n1. First Offer for Development Opportunities. During the period beginning on the Effective Date and ending on December 31, 2018 (the \"Development Term\"), each Party (the \"Offering Party\") agrees to provide to the other Party (the \"Receiving Party\") a right of first offer with respect to any proposed offer or arrangement, which the Offering Party (or its affiliate) desires to accept, under which the Offering Party or one of its affiliates would acquire the ownership of real property in the Market Area (the \"Development Property\") on which a Hyatt All-Inclusive Resort would operate (a \"Development Opportunity\"',\n",
              "    'Highlight the parts (if any) of this contract related to \"Agreement Date\" that should be reviewed by a lawyer. Details: The date of the contract',\n",
              "    'December 14, 2016',\n",
              "    149,\n",
              "    166),\n",
              "   ('Exhibit 10.1\\n\\nCOOPERATION AGREEMENT\\n\\nThis Cooperation Agreement (\"Agreement\") is entered into as of June 18, 2020, by and between Spรดk Holdings, Inc., a Delaware corporation (the \"Company\"), and White Hat Strategic Partners LP, a Delaware limited partnership, White Hat SP GP LLC, a Delaware limited liability company, White Hat Capital Partners LP, a Delaware limited partnership, and White Hat Capital Partners GP LLC, a Delaware limited liability company (collectively, the \"White Hat Parties\") (each of the Company and the White Hat Parties, a \"Party\" to this Agreement, and collectively, the \"Parties\").\\n\\nRECITALS\\n\\nWHEREAS, the White Hat Parties have voting power or sole dispositive power or otherwise have beneficial ownership of 319,708 shares (the \"Current Position\") of the common stock, par value $0.0001 per share, of the Company (the \"Common Stock\") as of the date of this Agreement; and\\n\\nWHEREAS, as of the date of this Agreement, the Company and the White Hat Parties have determined to come to an agreement with respect to certain matters set forth below; and\\n\\nNOW, THEREFORE, in consideration of the foregoing premises and the mutual covenants and agreements contained herein, and for other good and valuable consideration, the receipt and sufficiency of which are acknowledged, the Parties to this Agreement, intending to be legally bound, agree as follows:\\n\\n1. Board Nominations; Certain Information.\\n\\n(a) Brett Shockley (the \"New Director\") has provided the Company with responses to a Director and Officer Questionnaire customarily used for NASDAQ-listed companies and certain biographical information in compliance with Item 401 of Regulation S-K as promulgated by the Securities and Exchange Commission (the \"SEC\") (collectively, the \"Information\"), has executed all documents required to be executed by directors of the Company, and has cooperated with a background check. (b) Based on the Information, the Nominating and Governance Committee (the \"Nominating Committee\") of the Board of Directors (the \"Board\") of the Company and the Board have determined that the New Director may serve as an \"independent\" director of the Company in accordance with the rules and listing standards of the NASDAQ National Market and applicable rules and regulations of the Securities Exchange Commission (the \"SEC\"). (c) Concurrently with the execution of this Agreement, the Board shall increase the size of the Board by one and appoint the New Director to the Board to fill the resulting vacancy. Concurrently with the execution of this Agreement, the Board shall also appoint the New Director to the Nominating Committee. (d) Concurrently with the execution of this Agreement, the White Hat Parties shall send a letter to the Corporate Secretary and Treasurer of the Company irrevocably withdrawing (i) the nomination letter they previously sent to the Company on May 26, 2020, and, accordingly, (ii) their nomination (the \"Nominations\") of three directors for election to the Board at the Company\\'s 2020 Annual Meeting of Stockholders (including any adjournments or postponements thereof, the \"2020 Annual Meeting\"). (e) The Nominating Committee and the Board shall take all necessary action to nominate Brett Shockley for election to the Board at the 2020 Annual Meeting, and to recommend his election and to support and solicit proxies in the same manner as the other candidates nominated by the Board in the Company\\'s proxy statements for the 2020 Annual Meeting. (f) Nothing in this Agreement shall be deemed to abridge or limit the fiduciary duties of any member of the Board under Delaware law. 2. Representations of the White Hat Parties. The White Hat Parties represent and warrant to the Company as of the date hereof as follows: (a) The White Hat Parties are the beneficial owners of 319,708 shares of Common Stock, such shares of Common Stock constitute all of the Common Stock beneficially owned by the White Hat Parties and the White Hat Parties have no agreements, understandings or undertakings with any third party to share or delegate disposition or voting control o',\n",
              "    'Highlight the parts (if any) of this contract related to \"Agreement Date\" that should be reviewed by a lawyer. Details: The date of the contract',\n",
              "    'June 18, 2020',\n",
              "    100,\n",
              "    113),\n",
              "   ('Exhibit 99.1 JOINT FILING AGREEMENT The undersigned hereby agree that the Schedule 13G/A with respect to the shares of Class A Common Stock, $0.001 par value per share, of The RMR Group Inc., dated as of December 31, 2019, is, and any amendments thereto (including amendments on Schedule 13D) signed by each of the undersigned shall be, filed on behalf of each of us pursuant to and in accordance with the provisions of Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended. January 22, 2020 (Date) ABP TRUST /s/ Adam D. Portnoy (Signature) Adam D. Portnoy, President (Name/Title) ADAM D. PORTNOY /s/ Adam D. Portnoy (Signature) 10',\n",
              "    'Highlight the parts (if any) of this contract related to \"Agreement Date\" that should be reviewed by a lawyer. Details: The date of the contract',\n",
              "    'January 22, 2020',\n",
              "    489,\n",
              "    505),\n",
              "   ('EXHIBIT 10.23\\n\\nCOMPLETION AND LIOUDm MAINTENANCE 4GRFFMFST\\n\\nTHIS COMPLEHON AGREEMENT AND UQITDITV MAINTENANCE AGREEMENT ( \\'Agreement\") {5 made and entered into effective as of  June 29, 2006 between PRIMEEVERG\\\\\\'CORPORATION ( Time\"), GUARANTY BANK, FSB (\\'Guaranty\") and PRIME OFFSHORELT.C. T: Offshore\"!\\n\\nPrime is the majority shareholder of Prime Offshore L.L.C. COffshore\"! Offshore and Guaranty are parties to a Credit Agreement dated June 29,  2006, by and between Offshore as Borrower and Guaranty, as Agent and Lender i \"Credit Agreement\\'T wherein Guaranty is loaning certain funds  to Offshore to drill and complete wells and construct, install and operate in-field and flow pipelines, caissons, platforms and production facilities  for wells m South Padre Island Area OCS Blocks 1113, 1059, 1060, 1073 and 1133 and North Padre Island Area OCS Block 998 T\\'Derelopment  Project\").\\n\\n1. Completion Commrtiryr.t\\n\\nEach of the South Padre Island Area OCS Blocks 1113,1059,1060,1073 and 1133 and the North Padre Island Area OCS Block 998 shall be defined  as a \"Project Field.\\'\\'\\n\\nFor purposes ofthis Agreement, Project Completion shall consist oftwo components and be defined as:\\n\\nA) each Project Field in the Development Project having all planned in-field and flow pipelines, caissons, platforms and production facilities  for all the wells in such Project Field, for which Guaranty has loaned funds, installed and operationalsuch that the production from all such  wells can be transported to a readily available sales point for naturalgas. In addition, for each Project Field, Project Completion will include,  but not limited to:\\n\\na) obtaining required permits, easements and governmental approvals;\\n\\nb) executing necessary\" construction contract(s);\\n\\nc) completing tests considered usual and customary\" and required to be conducted with results tn accordance with those necessary\" to  permit operations;\\n\\nd) ensuring that each Project Field is free and clear of all bens other than those in favor of Guaranty and Permitted Liens under the Credit  Agreement and:\\n\\ne) causing all costs of the Development Project to be paid when due; and,\\n\\nB) the 12-inch loop pipeline fromNorth Padre Island Area OCS Block 996 to the pipeline owned by the Williams Companies Inc. having been  constructed and installed in accordance with the plans and specifications in the construction contracts).\\n\\n\\n\\n\\n\\nAs consideration for Guaranty entering into the Credit Agreement to provide such loans for the Development Project and to ensure Project  Completion. Prime absolutely and unconditionally warrants to Guaranty to fund the payment to Offshore of all costs that exzeed the available  commitments under the Credit Agreement, including interest, for Project Completion. In the event Offshore is in Default under Section 7.1(f), (g),  (h) and/or (i) ofthe Credit Agreement, then Prime absolutely and unconditionally warrants to Guaranty\" the assumption of all costs for Project  Completion.\\n\\n2. Licuieitv Maintenance\\n\\nPrime will, during the term of the Credit Agreement, maintain liquidity consisting of unused revolver availability\" under the Credit Agreement dated  December!, 2002, as amended, with Prime et aland Guaranty, and/or unrestricted cash and cash equivalents of $25,000,000. This required liquidity\"  win reduce dollar-for-dollar with any additional shareholder advance s and increase dollar-for-dollar to a maximum of $21,000,000 with any  repayment of shareholder advances. To the extent that shareholder repayment has occurred, Prime agrees to fund additional shareholder loans  equal to the amount repayed by the shareholder, as needed to ensure Project Clomp let ion\\n\\nThis Agreement shall remain in force until each component ofProject Completion is satisfied. Once a component is satisfied, Prime\\'s absolute and  unconditional warranty to Guaranty to fund the payment to Offshore of ad costs that esceed the available commitments under the Credit  Agreement for that conponent, including interest, wid ejpire.\\n\\nPrime understands that a breach ofobligations under this Agreement would result i',\n",
              "    'Highlight the parts (if any) of this contract related to \"Agreement Date\" that should be reviewed by a lawyer. Details: The date of the contract',\n",
              "    'June 29, 2006',\n",
              "    177,\n",
              "    190),\n",
              "   ('ODM - SUPPLY AGREEMENT BETWEEN: ORGANIC PREPARATIONS INC. 2nd Floor, Transpacific Haus Lini Highway, Port Vila. Vanuatu \"the Manufacturer\" -- AND -- AGAPE ATP INTERNATIONAL HOLDING LIMITED Unit 05, 4F, Energy Plaza No. 92, Granville Road Tsim Sha Tsui East Kowloon, Hong Kong \"the Customer\"\\n\\nSource: AGAPE ATP CORP, 10-K/A, 12/2/2019\\n\\n\\n\\n\\n\\nODM SUPPLY AGREEMENT THIS AGREEMENT is made on the 15t h day of January 2018. BETWEEN: ORGANIC PREPARATIONS INC. 2nd Floor, Transpacific Haus Lini Highway, Port Vila. Vanuatu (\\'the Manufacturer\\') of one part AND: AGAPE ATP INTERNATIONAL HOLDING LIMITED Unit 05, 4F, Energy Plaza No. 92, Granville Road Tsim Sha Tsui East Kowloon, Hong Kong (\\'the Customer\\') of the other part. RECITALS a. The Manufacturer wishes to appoint the Customer to be the sole and exclusive agent for the promotion, sales, marketing distribution and administration of the Products listed in schedule A of this agreement. b. The Manufacturer and the Customer wish to record their agreement under the stipulations of this Agreement. NOW IT IS AGREED as follows:- 1. TERMS OF AGREEMENT 1.1 Commencement This agreement commences upon execution of this document. 1.2 Term This agreement is for a term of ten (10) years. 1.3 Renewal This agreement will be automatically renewed at the end of every ten (10) year term, with each subsequent term of renewal being for a ten (10) year term. A six (6) months notice must be given by either party of their intention to terminate relations due to any reason other than breach of this agreement. ODM Supply Agreement 2 Organic Preparations INC. & Agape ATP International Holding Limited\\n\\nSource: AGAPE ATP CORP, 10-K/A, 12/2/2019\\n\\n\\n\\n\\n\\n2. PROVISION OF DOCUMENTATION 2.1 Provision by the Manufacturer The Manufacturer agrees to supply to the Customer, within a reasonable period of time, all documentation and information relating to the Products and their Manufacture as is required for the registration of the Products in the Territories as listed in Schedule C of this document. The party responsible for documentation fees and costs will be the Customer. 2.2 Provision by the Customer The Customer agrees to supply to the Manufacturer at its own expense, within a reasonable period of time, all documentation and information as is reasonably required by or would be beneficial to the Manufacturer in the performance of its obligations under this agreement. 3. COVENANTS BY THE MANUFACTURER 3.1 Compliance with Local Laws and Regulations The Manufacturer covenants that it is and will remain for the term of this agreement in compliance with any and all Local Laws and Regulations. This includes without limitation laws relating to business practice, workplace relations, safety and taxation. 3.2 Manufacturing standards The Manufacturer covenants that it is and will remain for the term of this agreement in compliance with all International standards in production and manufacturing. 3.3 Packaging The Manufacturer covenants that it is and will remain for the term of this agreement in compliance with any and all packaging laws and regulations in all of the Territories. 3.4 Ability to Perform The Manufacturer covenants that it is willing and able to perform any and all of its obligations under this agreement. 3.5 Intellectual Property 3.5 (a) The Manufacturer covenants that the Products are clear of any Intellectual Property claims by third parties and that the Customer has full rights to sell and market the Products worldwide. The Manufacturer indemnifies the Customer for the same. ODM Supply Agreement 3 Organic Preparations INC. & Agape ATP International Holding Limited\\n\\nSource: AGAPE ATP CORP, 10-K/A, 12/2/2019\\n\\n\\n\\n\\n\\n3.5 (b) The composition of the below individuals is also relevant and related to the Intellectual Property of the Manufacturer. The following names listed as Medical Team members, and any subsequent consultations in that capacity, are considered the Intellectual Property of The Manufacturer: 1. Dr Lily Tomas 2. Dr Bernd Friedlander 3. Mr Markus Eistert 4. Dr Ed Smith 5. Mr Vic Cherikoff 6. Dr Pavel Yutsis 7. ',\n",
              "    'Highlight the parts (if any) of this contract related to \"Agreement Date\" that should be reviewed by a lawyer. Details: The date of the contract',\n",
              "    '15t h day of January 2018',\n",
              "    390,\n",
              "    415),\n",
              "   ('Exhibit 10.17    Program Content License Agreement     between     Phoenix Satellite Television Company Limited     and     Beijing Tianying Jiuzhou Network Technology Co., Ltd.     November 24, 2009\\n\\nSource: PHOENIX NEW MEDIA LTD, F-1, 4/21/2011\\n\\n\\n\\n\\n\\n     Program Content License Agreement     This Program Content License Agreement (\"Agreement\") is entered into between the following two parties on November 24, 2009 in Beijing:     Phoenix Satellite Television Company Limited (\"Party A\" or \"Phoenix Satellite TV\"), a foreign enterprise duly established and validly existing  under the laws of Hong Kong     Registered Address: No. 2-6, Dai King Street, Taipo Industrial Estate, Taipo, N. T., H.K.     Authorized Representative: Cui Qiang     and     Beijing Tianying Jiuzhou Network Technology Co., Ltd. (\"Party B\"), a limited liability company duly registered and validly existing under PRC laws     Address: Floor 5 Information Building, No. 12 Zhongguancun South Street, Haidian District, Beijing 100081 China     Legal Representative: Qiao Hai Yan     Party A and Party B are hereinafter referred to individually as a \"Party\" and collectively as \"Parties\".     WHEREAS:     1. Party A owns copyrights and other related rights to the programs listed in Exhibit 1 hereto, as amended from time to time;     2. In accordance with the \"Agreement Between Phoenix Satellite TV and Phoenix New Media Regarding Cooperation in the Fields of Content,  Branding, Promotion and Technology\" dated November 24, 2009 between Phoenix Satellite Television Holdings Limited and Phoenix  Online (Beijing) Information Technology Co., Ltd., Party B has the right to operate the Phoenix Satellite TV Websites (defined below)  and Other Websites (defined below), provide Internet information services such as news, entertainment, and business information, as  well as computer information services through such websites and transfer information from Phoenix Satellite TV to mobile network  clients, and authorize the use of the Phoenix Satellite TV program content by other information network service providers (collectively,  \"Party B Business\"); and     3. Both Parties agree that Party A will provide the program content of Phoenix Satellite TV to Party B, subject to the terms and conditions hereof.     2\\n\\nSource: PHOENIX NEW MEDIA LTD, F-1, 4/21/2011\\n\\n\\n\\n\\n\\n     NOW, THEREFORE, upon amicable consultation based on principles of equality, mutual benefit and complementary advantage, the Parties have  reached this Agreement as follows:     ARTICLE ONE DEFINITION     1.1 Unless otherwise referenced herein, each of the terms used herein shall have the meaning ascribed to it below:     (i) \"Affiliate\", with respect to any Party hereto, shall mean any legal person, non-legal person economic organization, or natural person,  which owns a controlling interest in, or which is controlling, controlled by or under common control with, such Party, directly or  indirectly.     As used in this Agreement, \"control\" means the power of any person to direct or cause the direction of management and policies  of another party on account of such person\\'s ownership of equity interest, voting right, the right to appoint directors, by contract  or otherwise.     (ii) \"Business Day\" shall mean a date on which commercial banks open for business, other than Saturdays, Sundays and public holidays  in mainland China.     (iii) \"Intellectual Property Right\" shall mean authorship right, proprietary trademark right, patent right, business secret ownership right  and other intellectual property right under PRC Law.     (iv) \"Other Websites\" shall mean Internet websites whose domain name are licensed by Party A or its Affiliate to Party B and which are  operated and managed by Party B upon Party A\\'s approval in writing, other than the Phoenix Satellite TV Websites.     (v) \"Phoenix Satellite TV Websites\" shall mean Internet websites which have the domain name of www.ifeng.com, www.phoenixtv.com  or www.phoenixtv.com.cn.     (vi) \"Program Content\", with respect to this Agreement, shall mean all program content',\n",
              "    'Highlight the parts (if any) of this contract related to \"Agreement Date\" that should be reviewed by a lawyer. Details: The date of the contract',\n",
              "    'November 24, 2009',\n",
              "    182,\n",
              "    199),\n",
              "   ('Exhibit D\\n\\nJOINT FILING AGREEMENT OneMain Holdings, Inc.\\n\\nIn accordance with Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended, the undersigned hereby confirm the agreement by and among them to the joint filing on behalf of them of the Statement on Schedule 13D and any and all further amendments thereto, with respect to the securities of the above referenced issuer, and that this Agreement be included as an Exhibit to such filing. This Agreement may be executed in any number of counterparts each of which shall be deemed to be an original and all of which together shall be deemed to constitute one and the same Agreement.\\n\\nIN WITNESS WHEREOF, the undersigned hereby execute this Agreement as of February 20, 2020. UNIFORM INVESTCO LP\\n\\nBy: Uniform InvestCo GP LLC, its General Partner By: Vรคrde Partners, Inc., its Manager\\n\\nBy: /s/ David A. Marple Name: David A. Marple Title: General Counsel\\n\\nUNIFORM INVESTCO GP LLC\\n\\nBy: Vรคrde Partners, Inc., its Manager\\n\\nBy: /s/ David A. Marple Name: David A. Marple Title: General Counsel\\n\\nTHE VรRDE FUND VI-A, L.P.\\n\\nBy: Vรคrde Investment Partners G.P., LLC, its General Partner By: Vรคrde Investment Partners UGP, LLC, its General Partner By: Vรคrde Partners, L.P., its Managing Member By: Vรคrde Partners, Inc., its General Partner\\n\\nBy: /s/ David A. Marple Name: David A. Marple Title: General Counsel\\n\\n\\n\\n\\n\\nVรRDE INVESTMENT PARTNERS, L.P.\\n\\nBy: Vรคrde Investment Partners G.P., LLC, its General Partner By: Vรคrde Investment Partners UGP, LLC, its General Partner By: Vรคrde Partners, L.P., its Managing Member By: Vรคrde Partners, Inc., its General Partner\\n\\nBy: /s/ David A. Marple Name: David A. Marple Title: General Counsel\\n\\nVรRDE INVESTMENT PARTNERS (OFFSHORE) MASTER, L.P.\\n\\nBy: Vรคrde Investment Partners G.P., LLC, its General Partner By: Vรคrde Investment Partners UGP, LLC, its General Partner By: Vรคrde Partners, L.P., its Managing Member By: Vรคrde Partners, Inc., its General Partner\\n\\nBy: /s/ David A. Marple Name: David A. Marple Title: General Counsel\\n\\nVรRDE INVESTMENT PARTNERS G.P., LLC\\n\\nBy: Vรคrde Investment Partners UGP, LLC, its General Partner By: Vรคrde Partners, L.P., its Managing Member By: Vรคrde Partners, Inc., its General Partner\\n\\nBy: /s/ David A. Marple Name: David A. Marple Title: General Counsel\\n\\nVรRDE INVESTMENT PARTNERS UGP, LLC\\n\\nBy: Vรคrde Partners, L.P., its Managing Member By: Vรคrde Partners, Inc., its General Partner\\n\\nBy: /s/ David A. Marple Name: David A. Marple Title: General Counsel\\n\\n\\n\\n\\n\\nTHE VรRDE SKYWAY MASTER FUND, L.P.\\n\\nBy: The Vรคrde Skyway Fund G.P., LLC, its General Partner By: The Vรคrde Skyway Fund UGP, LLC, its General Partner By: Vรคrde Partners, L.P., its Managing Member By: Vรคrde Partners, Inc., its General Partner\\n\\nBy: /s/ David A. Marple Name: David A. Marple Title: General Counsel\\n\\nTHE VรRDE SKYWAY FUND G.P., L.P.\\n\\nBy: The Vรคrde Skyway Fund UGP, LLC, its General Partner By: Vรคrde Partners, L.P., its Managing Member By: Vรคrde Partners, Inc., its General Partner\\n\\nBy: /s/ David A. Marple Name: David A. Marple Title: General Counsel\\n\\nTHE VรRDE SKYWAY FUND UGP, LLC\\n\\nBy: Vรคrde Partners, L.P., its Managing Member By: Vรคrde Partners, Inc., its General Partner\\n\\nBy: /s/ David A. Marple Name: David A. Marple Title: General Counsel\\n\\nTHE VรRDE FUND XII (MASTER), L.P.\\n\\nBy: The Vรคrde Fund XII G.P., L.P., its General Partner By: The Vรคrde Fund XII UGP, LLC, its General Partner By: Vรคrde Partners, L.P., its Managing Member By: Vรคrde Partners, Inc., its General Partner\\n\\nBy: /s/ David A. Marple Name: David A. Marple Title: General Counsel\\n\\n\\n\\n\\n\\nTHE VรRDE FUND XII G.P., L.P.\\n\\nBy: The Vรคrde Fund XII UGP, LLC, its General Partner By: Vรคrde Partners, L.P., its Managing Member By: Vรคrde Partners, Inc., its General Partner\\n\\nBy: /s/ David A. Marple Name: David A. Marple Title: General Counsel\\n\\nTHE VรRDE FUND XII UGP, LLC\\n\\nBy: Vรคrde Partners, L.P., its Managing Member By: Vรคrde Partners, Inc., its General Partner\\n\\nBy: /s/ David A. Marple Name: David A. Marple Title: General Counsel\\n\\nVรRDE CREDIT PARTNERS MASTER, L.P.\\n\\nBy: Vรคrde Credit Partners G.P., LLC, its General Partner By: Vรคrde Cre',\n",
              "    'Highlight the parts (if any) of this contract related to \"Agreement Date\" that should be reviewed by a lawyer. Details: The date of the contract',\n",
              "    'February 20, 2020',\n",
              "    719,\n",
              "    736),\n",
              "   ('EXHIBIT 10.2 EXECUTION VERSION NON-COMPETITION AND NON-SOLICITATION AGREEMENT THIS NON-COMPETITION AND NON-SOLICITATION AGREEMENT (this \"Agreement\"), dated as of August 1, 2019 (the \"Effective Date\"), is entered into by Quaker Chemical Corporation (\"Buyer\"), a Pennsylvania corporation, Gulf Houghton Lubricants Ltd., a company incorporated in the Cayman Islands (\"Gulf Houghton\"), Gulf Oil International Limited, a company incorporated in the Cayman Islands (\"Gulf International\"), and GOCL Corporation Limited, a public limited company incorporated in India (\"Gulf Oil\" and, together with Gulf Houghton and Gulf International, the \"Sellers\" and each, a \"Seller\"). In addition, Gulf Oil Lubricants India, Ltd, a public limited company incorporated in India (\"Gulf India\"), is executing this Agreement solely for purposes of Section 1(c) [Confidentiality; Non-competition; Non-solicitation]. BACKGROUND WHEREAS, Gulf Houghton owns 3,074,270.00 of the outstanding ordinary shares (the \"Shares\") in Global Houghton Ltd., an exempted company incorporated under the Laws of the Cayman Islands (the \"Company\"); Gulf International owns approximately 90% of Gulf Houghton; and Gulf Oil is an indirect owner of approximately 10% of Gulf Houghton. WHEREAS, The Company and its subsidiaries are engaged in the business of manufacturing, distributing and/or selling one or more of the following formulated chemical specialty product lines: fire resistant hydraulic fluids, semi-synthetic and specialty metalworking fluids, cleaning fluids, cold-rolling oils, hot-rolling oils, and specialty industrial greases (such business, as conducted by the Company and its Subsidiaries as of the Effective Date, the \"Company Business\"). WHEREAS, Buyer and its subsidiaries are engaged in the business of manufacturing, distributing and/or selling the following formulated chemical specialty product lines or chemical management services (\"CMS\"), (i) rolling lubricants (used by manufacturers of steel in the hot and cold rolling of steel and by manufacturers of aluminum in the hot rolling of aluminum); (ii) corrosion preventives (used by steel and metalworking customers generally to protect metal during manufacture, storage, and shipment); (iii) metal finishing compounds (used to prepare metal surfaces for special treatments such as, but not limited to, galvanizing and tin plating and to prepare metal for further processing); (iv) machining and grinding compounds (typically used by customers in cutting, shaping, and grinding metal parts which require special treatment to enable them to tolerate the manufacturing process, achieve closer tolerance, and improve tool life); (v) forming compounds (used generally to facilitate the drawing and extrusion of metal products); (vi) bio-lubricants (typically used in machinery in the forestry and construction industries); (vii) hydraulic fluids (used generally by steel, metalworking, mining, and other customers to operate hydraulic equipment); (viii) chemical milling maskants for the aerospace industry; (ix) temporary and permanent coatings for metal and concrete products, tubes and pipes and other applications; (x) construction products, such as flexible sealants and protective coatings, for various applications; (xi) various specialty greases used in automobile, industrial and various other applications; (xii) various die casting lubricants and mold release agents; (xiii) various dust suppressants, ground control agents and roofing products used in mining; and (xiv)\\n\\n\\n\\n\\n\\nprograms to provide CMS (such business, as conducted by Buyer and its subsidiaries as of the Effective Date, the \"Existing Business\" and, together with the Company Business, the \"Combined Business\"). WHEREAS, Buyer, Gulf Houghton and other shareholders of the Company are parties to a Share Purchase Agreement dated as of April 4, 2017, under which Buyer is acquiring the Shares (the \"Purchase Agreement\"). Capitalized terms used herein but not otherwise defined herein shall have the meanings given to such terms in the Purchase Agreement. WHEREAS, Sellers, together with the C',\n",
              "    'Highlight the parts (if any) of this contract related to \"Agreement Date\" that should be reviewed by a lawyer. Details: The date of the contract',\n",
              "    'August 1, 2019',\n",
              "    162,\n",
              "    176),\n",
              "   ('Exhibit 10.8 EXECUTION COPY CERTAIN INFORMATION HAS BEEN EXCLUDED FROM THIS EXHIBIT BECAUSE IT IS NOT MATERIAL AND WOULD LIKELY CAUSE COMPETITIVE HARM TO THE REGISTRANT IF PUBLICLY DISCLOSED. [***] OR [REDACTED] INDICATES THAT INFORMATION HAS BEEN REDACTED. SPONSORSHIP AND SERVICES AGREEMENT This SPONSORSHIP AND SERVICES AGREEMENT (the \"Agreement\") is made and entered into as of the 19t h day of December, 2018, by and among HOF Village, LLC, a Delaware limited liability company (\"HOFV\"), National Football Museum, Inc., d/b/a Pro Football Hall of Fame, an Ohio corporation (\"PFHOF\" and, together with HOFV, the \"HOF Entities\") and Constellation NewEnergy, Inc., a Delaware corporation, on behalf of itself and its retail affiliates and subsidiaries (collectively, \"Constellation\"). HOFV and/or PFHOF, on the one hand, and Constellation, on the other hand, are referred to herein as a \"Party\" and, collectively, as the \"Parties\". WITNESSETH: WHEREAS, Constellation desires to provide to the HOF Entities, and the HOF Entities desire to obtain from Constellation, certain of Constellation\\'s products and services listed and described in Exhibit A (collectively, the \"Products & Services\") for use in connection with the Johnson Controls Hall of Fame Village in Canton, Ohio (the \"Village\"); and WHEREAS, Constellation desires to become a sponsor of the Village and to obtain the rights set forth herein in connection with such sponsorship. NOW, THEREFORE, in consideration of the promises herein contained, the Parties hereto agree as follows: ARTICLE 1\\n\\nSUPPLY OF PRODUCTS & SERVICES 1.1 Sale of Products & Services. (a) The HOF Entities shall consult with Constellation to develop a comprehensive energy strategy with respect to the Products & Services listing in Exhibit A, which reflects sustainable product solutions, competitive market pricing (incorporating completion of the Supplier Component Questionnaire in the form of Exhibit B hereof for the applicable HOF Entity or affiliate), periodic reporting and analytics, regulatory/market intelligence and infrastructure services and equipment.\\n\\nSource: GPAQ ACQUISITION HOLDINGS, INC., S-4/A, 1/23/2020\\n\\n\\n\\n\\n\\n(b) The HOF Entities or their affiliates shall, during the Term (as defined below), purchase from Constellation, and Constellation shall sell to the HOF Entities and/or their affiliates, as applicable, such Products & Services as shall be requested by an HOF Entity or its affiliates, in each case at the applicable Market Prices for such Products & Services and on competitive terms. For purposes of this Section 1.1(b), (i) the \"Market Price\" of any Products & Services shall mean the price for such Products & Services established by Constellation as the competitive market price at which such Products & Services are to be made available to Constellation\\'s customers with a similar anticipated load profile within a specified utility service territory. Constellation shall invoice the applicable HOF Entity or its appropriate affiliate for all Products & Services purchased by such HOF Entity or its appropriate affiliate pursuant to the applicable Second Level Agreement (as defined below). In the event that the purchaser of Products & Services pursuant to this Article 1 is an affiliate of an HOF Entity (but not an HOF Entity), such affiliate shall be subject to Constellation\\'s credit approval of such affiliate as the contracting entity. In the event that such affiliate does not meet Constellation\\'s credit requirements (and in the event that such affiliate still desires to purchase such Products & Services), such affiliate shall provide to Constellation a surety bond reasonably acceptable to Constellation from a provider rated than A- (or an equivalent rating from S&P, Moody\\'s, Fitch or AM Best) or better prior to the purchase of such Products & Services. (c) The Parties agree and acknowledge that neither HOF Entity or any of its respective affiliates shall be subject to any individual minimum purchase requirement (whether in terms of price, quantity or any other criteria) under this Agreement with respec',\n",
              "    'Highlight the parts (if any) of this contract related to \"Agreement Date\" that should be reviewed by a lawyer. Details: The date of the contract',\n",
              "    '19t h day of December, 2018',\n",
              "    386,\n",
              "    413),\n",
              "   ('Exhibit 10.2 STRATEGIC ALLIANCE AGREEMENT dated as of August 26, 2015 among Sucampo Pharmaceuticals, Inc., Sucampo Pharma, LLC. and R-Tech Ueno, Ltd.\\n\\n\\n\\n\\n\\nTABLE OF CONTENTS\\n\\nARTICLE I DEFINITIONS AND INTERPRETATION\\n\\nSection 1.01 Definitions 2 Section 1.02 Interpretation 8\\n\\nARTICLE II TRANSACTION\\n\\nSection 2.01 Strategic Alliance 8 Section 2.02 Obligations of Acquiror 9 Section 2.03 Obligations of the Company 11\\n\\nARTICLE III REPRESENTATIONS AND WARRANTIES\\n\\nSection 3.01 Representations and Warranties of the Company 11 Section 3.02 Representations and Warranties of Acquiror 12\\n\\nARTICLE IV COVENANTS OF THE PARTIES\\n\\nSection 4.01 The Company\\'s Obligation 12 Section 4.02 Consummation of the Squeeze-out 15 Section 4.03 Applications and Consents; Governmental Communications and Filings 15 Section 4.04 Further Assurance 15 Section 4.05 Access 15 Section 4.06 Notifications 16 Section 4.07 Confidentiality 16 Section 4.08 Public Announcement 17 Section 4.09 No Lender Liability 17 Section 4.10 Employees of Company 17 Section 4.11 Development Programs and Clinical Trials 18\\n\\nARTICLE V INDEMNIFICATION\\n\\nSection 5.01 Indemnification by the Company 18 Section 5.02 Indemnification by Acquiror 18 Section 5.03 Indemnification Procedure 18 Section 5.04 Limitations 18\\n\\ni\\n\\n\\n\\n\\n\\nARTICLE VI TERMINATION\\n\\nSection 6.01 Termination 19 Section 6.02 Notice of Termination 19 Section 6.03 Effect of Termination 19\\n\\nARTICLE VII GUARANTEE\\n\\nSection 7.01 Guarantee 19\\n\\nARTICLE VIII MISCELLANEOUS\\n\\nSection 8.01 Governing Law 19 Section 8.02 Jurisdiction 19 Section 8.03 Cost and Expenses 20 Section 8.04 Assignment 20 Section 8.05 Amendments and Waivers 20 Section 8.06 Severability 20 Section 8.07 Counterparts 21 Section 8.08 Entire Agreement 21 Section 8.09 Notices 21 Section 8.10 Language 22 Section 8.11 Disclosure Schedules 22 Section 8.12 Fraud 22 Section 8.13 Third-party Beneficiaries 23\\n\\nii\\n\\n\\n\\n\\n\\nSTRATEGIC ALLIANCE AGREEMENT This STRATEGIC ALLIANCE AGREEMENT is made and entered into as of August 26, 2015 (this \"Agreement\"), by and among R-Tech Ueno, Ltd., a corporation organized under Japanese law (the \"Company\"), Sucampo Pharma, LLC., a corporation organized under Japanese law (\"Acquiror\"), and Sucampo Pharmaceuticals, Inc., a corporation organized under Delaware law (\"SPI,\" and, together with the Company and Acquiror, collectively, the \"Parties\"). RECITALS WHEREAS, the Acquiror is a wholly-owned subsidiary of SPI, which operates a biopharmaceutical business focused on the research and development of proprietary drugs; WHEREAS, the Company operates a drug discovery and manufacturing business; WHEREAS, Acquiror and the Company share the objective of creating a combined biopharmaceutical company that can drive considerable growth in global markets, including Japan; WHEREAS, the Company has currently in issuance and outstanding 19,312,300 shares of common stock (the \"Common Stock\") and stock options representing an additional 328,600 shares of Common Stock (the \"Stock Options\", and together with the issued and outstanding Common Stock, the \"Target Securities\"); WHEREAS, pursuant to the terms and subject to the conditions set forth herein, Acquiror has agreed to commence a tender offer bid (such tender offer bid, including any amendments or extensions thereto made in accordance with the terms of this Agreement and applicable Law, including Articles 27-2 through 27-22 of the FIEL, the \"Offer\") to acquire for cash (i) all of the issued and outstanding shares of Common Stock at a price per share of JPY1,900 (the \"Share Offer Price\") and (ii) all of the outstanding Stock Options at the price prescribed in this Agreement; WHEREAS, the Company has agreed, on the terms and subject to the conditions set forth herein, to support the Offer and recommend the holders of Target Securities to tender their shares of Common Stock and Stock Options to the Offer and publicly announce such statement; WHEREAS, Jefferies Finance LLC (\"Jefferies\") has entered into a financing commitment letter, dated as of August 26, 2015, between SPI and Jefferies (the \"Financing Commitment\"), pursuant',\n",
              "    'Highlight the parts (if any) of this contract related to \"Agreement Date\" that should be reviewed by a lawyer. Details: The date of the contract',\n",
              "    'August 26, 2015',\n",
              "    54,\n",
              "    69),\n",
              "   ('EXHIBIT 10.65   EXHIBIT II   NOVEMBER 1, 2002, RATE FT-A AGREEMENT   BETWEEN LG&E AND TENNESSEE GAS PIPELINE COMPANY\\n\\n\\n\\n\\n\\n  Service Package No: 40715 Amendment No:   GAS TRANSPORTATION AGREEMENT (For Use under FT-A Rate Schedule)   THIS AGREEMENT is made and entered into as of the 1st day of November, 2002, by and between TENNESSEE GAS PIPELINE COMPANY, a Delaware Corporation, hereinafter referred to as \"Transporter\" and LOUISVILLE GAS AND ELECTRIC COMPANY, a Kentucky Corporation, hereinafter referred to as \"Shipper.\" Transporter and Shipper shall collectively be referred to herein as the \"Parties.\"   ARTICLE I - DEFINITIONS   1.1 TRANSPORTATION QUANTITY - shall mean the maximum daily quantity of gas which Transporter agrees to receive and transport on a firm basis, subject to Article II herein, for the account of Shipper hereunder on each day during each year during the term hereof, which shall be 51,000 dekatherms. Any limitations on the quantities to be received from each Point of Receipt and/or delivered to each Point of Delivery shall be as specified on Exhibit \"A\" attached hereto.   1.2 EQUIVALENT QUANTITY - shall be as defined in Article I of the General Terms and Conditions of Transporter\\'s FERC Gas Tariff.   ARTICLE II - TRANSPORTATION   Transportation Service - Transporter agrees to accept and receive daily on a firm basis, at the Point(s) of Receipt from Shipper or for Shipper\\'s account such quantity of gas as Shipper makes available up to the Transportation Quantity, and to deliver to or for the account of Shipper to the Point(s) of Delivery an Equivalent Quantity of gas.   ARTICLE III - POINT(S) OF RECEIPT AND DELIVERY   The Primary Point(s) of Receipt and Delivery shall be those points specified on Exhibit \"A\" attached hereto.   ARTICLE IV   4.1 All facilities are in place to render the service provided for in this Agreement.   4.2 Pursuant to Article VIII, Section 1 of the General Terms and Conditions of Transporter\\'s Tariff (\"GT&C\"), Transporter shall cause the delivery of natural gas to Shipper at the Shipper\\'s Primary Point of Delivery as nearly as practicable to Transporter\\'s line pressure, provided that such line pressure shall not be less than 500 pounds per square inch gauge at Monroe, meter number 020843, and 600 pounds per square inch gauge at Calvary, meter number 020844. Transporter shall be obligated to provide such minimum pressures only to the extent that capacity is reserved by Shipper and scheduled by Transporter at the Primary Delivery Point(s) described above. Such minimum pressure obligation is subject to the GT&C including, but not limited to, Article X - Excuse of Performances.   In the event Transporter is unable to maintain the minimum pressure(s) described herein but Shipper is still able to take receipt of the scheduled quantity at the Primary Delivery Point(s) described above, then Shipper shall be considered unharmed by Transporter\\'s inability to maintain such minimum pressure(s). Subject to the foregoing, any failure on Transporter\\'s part to deliver the scheduled quantity at the Primary Delivery Point(s)   1\\n\\n\\n\\n\\n\\n  described above shall entitle Shipper to the limited remedy specified in Rate Schedule FT-A, Section 7 - Failure of Transporter.   ARTICLE V - QUALITY SPECIFICATIONS AND STANDARDS FOR MEASUREMENT   For all gas received, transported and delivered hereunder the Parties agree to the Quality Specifications and Standards for Measurement as specified in the General Terms and Conditions of Transporter\\'s FERC Gas Tariff Volume No. 1. To the extent that no new measurement facilities are installed to provide service hereunder, measurement operations will continue in the manner in which they have previously been handled. In the event that such facilities are not operated by Transporter or a downstream pipeline, then responsibility for operations shall be deemed to be Shipper\\'s.   ARTICLE VI - RATES AND CHARGES FOR GAS TRANSPORTATION   6.1 TRANSPORTATION RATES - Commencing upon the effective date hereof, the rates, charges, and surcharges to be paid by Shipper to Transporter for ',\n",
              "    'Highlight the parts (if any) of this contract related to \"Agreement Date\" that should be reviewed by a lawyer. Details: The date of the contract',\n",
              "    '1st day of November, 2002',\n",
              "    282,\n",
              "    307),\n",
              "   ('Exhibit 1.1\\n\\n                                1,265,000 Shares                    (subject to increase up to 1,454,750 shares                       in the event of an oversubscription)\\n\\n                              AFSALA BANCORP, INC.                             (a Delaware corporation)\\n\\n                                  COMMON STOCK                            ($0.10 Par Value Per Share)\\n\\n                      Subscription Price: $10.00 Per Share\\n\\n                                AGENCY AGREEMENT\\n\\n                                                            ____________, 1996\\n\\nCapital Resources, Inc. 1701 K Street, N.W. Suite 700 Washington, D.C. 20006\\n\\nLadies and Gentlemen:\\n\\n                  AFSALA  Bancorp,  Inc. (the  \"Company\") and Amsterdam  Federal Savings and Loan  Association,  a federally  chartered  mutual  savings and loan association  (\"Association\"),  with its deposit  accounts insured by the Savings Association   Insurance  Fund  (\"SAIF\")  administered  by  the  Federal  Deposit Insurance  Corporation  (\"FDIC\"),  hereby  confirm their  agreement with Capital Resources, Inc. (\"Capital Resources\") as follows:\\n\\n                  SECTION 1. The Offering.  The Association,  in accordance with and pursuant to its plan of conversion  adopted by the Board of Directors of the Association  (the \"Plan\"),  intends to be converted  from a  federally-chartered mutual savings and loan association to a federally-chartered  stock savings bank and will  sell all of its  issued  and  outstanding  stock to the  Company.  The Company  will  offer  and  sell its  common  stock  (the  \"Common  Stock\")  in a subscription  offering  (\"Subscription  Offering\") to (1) tax qualified employee benefit plans of the Association,  (2) depositors of the Association as of March 31, 1995 (\"Eligible Account  Holders\"),  (3) depositors of the Association as of June 30, 1996  (\"Supplemental  Eligible  Account  Holders\"),  (4) certain  other deposit  account  holders  and  borrower  members  of  the  Association  (\"Other Members\") and (5) to its employees,  officers and directors,  pursuant to rights to  subscribe  for shares of Common Stock (the  \"Shares\").  Subject to the prior subscription rights of the above-listed  parties, the Company may offer for sale in a public offering (the \"Public  Offering,\" and when referred to together with the Subscription  Offering,  the \"Subscription and Public Offerings\")  conducted after the Subscription  Offering, the Shares not so subscribed for or ordered in the  Subscription  Offering  to the  general  public  (all such  offerees  being referred to in the aggregate as \"Eligible Offerees\"). Shares may also be sold in the Public Offering by a selling group of  broker-dealers  organized and managed by Capital  Resources.  It is  acknowledged  that the  purchase of Shares in the Subscription  and Public  Offerings  is subject to maximum and minimum  purchase limitations as described in the Plan and that the Company may reject in whole or in part any subscriptions received from subscribers in the Public Offering.\\n\\n                  The  Company  and the  Association  desire to  retain  Capital Resources to assist the Company with its sale of the Shares in the  Subscription and Public  Offerings.  By and  through  this  Agreement,  the  Company  and the Association confirm the retention of Capital Resources to assist the Company and the Association during the Subscription and Public Offerings.\\n\\n                  The  Company  has  filed  with  the  Securities  and  Exchange Commission  (the  \"Commission\")  a registration  statement on Form S-l (File No. 333-6399)  containing an offering  prospectus  relating to the  Subscription and Public  Offerings for the registration of the Shares under the Securities Act of 1933, as amended (the \"1933 Act\"),  and has filed such  amendments  thereto,  if any, and such amended  prospectuses as may have been required to the date hereof (the  \"Registration  Statement\").  The prospectus,  as amended,  included in the Registration   Statement  at  the  time  it  initially  become',\n",
              "    'Highlight the parts (if any) of this contract related to \"Agreement Date\" that should be reviewed by a lawyer. Details: The date of the contract',\n",
              "    '____________, 1996',\n",
              "    563,\n",
              "    581),\n",
              "   ('Exhibit 10.1 Certain portions of this exhibit have been omitted pursuant to Rule 601(b)(10) of Regulation S-K. The omitted information is (i) not material and (ii) would likely cause competitive harm to the Company if publicly disclosed. Information that has been omitted has been noted in this document with a placeholder identified by the mark \"[***]\". EXECUTION COPY PROMOTION AGREEMENT\\n\\nby and between\\n\\nSIGA TECHNOLOGIES, INC.\\n\\nand\\n\\nMERIDIAN MEDICAL TECHNOLOGIES, INC., a Pfizer company\\n\\nSource: SIGA TECHNOLOGIES INC, 8-K, 6/3/2019\\n\\n\\n\\n\\n\\nTABLE OF CONTENTS PAGE ARTICLE 1 DEFINITIONS 1 ARTICLE 2 GRANT OF RIGHTS 11 2.1 Grant of Rights to MMT 11 2.2 Negative Covenants 11 2.3 Non-Compete Covenant 11 2.4 Retained Rights 12 2.5 No Implied Licenses 12 2.6 [***] 12 ARTICLE 3 GOVERNANCE 12 3.1 Joint Steering Committee 12 3.2 Good Faith 12 3.3 Scope of Governance 13 ARTICLE 4 PROMOTION AND OTHER COMMERCIALIZATION 13 4.1 Promotion in the Territory 13 4.2 Diligence 14 4.3 Customer Contracts 14 4.4 Regulatory Matters 15 4.5 Discontinued Countries 15 ARTICLE 5 FORECASTING AND ORDERING 15 5.1 Product Forecasts 15 5.2 Purchase Orders 15 5.3 Delivery 16 5.4 Supply Limitation 16 5.5 Supply Penalties 16 5.6 Adverse Event Reporting 16 ARTICLE 6 PAYMENTS 16 6.1 Promotion Fee 16 6.2 Payments 17 6.3 Currency 17 6.4 Records 17 6.5 Audits 18 6.6 Blocked Payment and Indemnification 19 6.7 Source of Recovery 19 6.8 Taxes 19 ARTICLE 7 INTELLECTUAL PROPERTY 20 7.1 Ownership of SIGA Intellectual Property 20 7.2 Intellectual Property Maintenance 20 7.3 New Patents and Trademarks 20\\n\\n-i-\\n\\nSource: SIGA TECHNOLOGIES INC, 8-K, 6/3/2019\\n\\n\\n\\n\\n\\nTABLE OF CONTENTS (CONTINUED) PAGE ARTICLE 8 REPRESENTATIONS AND WARRANTIES; COVENANTS 21 8.1 Mutual Representations and Warranties 21 8.2 Additional Representations, Warranties and Covenants of SIGA 22 8.3 Additional Representations and Warranties of MMT 26 8.4 Covenants 27 8.5 No Other Representations or Warranties 29 ARTICLE 9 INDEMNIFICATION 29 9.1 Indemnification by SIGA 29 9.2 Indemnification by MMT 30 9.3 Indemnification Procedures 30 9.4 Insurance 31 9.5 Limitation of Liability 31 ARTICLE 10 CONFIDENTIALITY 31 10.1 Confidentiality 31 10.2 Authorized Disclosure 32 10.3 Technical Publication 33 10.4 Publicity; Terms of Agreement 33 10.5 Prior Confidentiality Agreements 34 10.6 Return of Confidential Information 34 10.7 Unauthorized Use 34 10.8 Exclusive Property 34 ARTICLE 11 TERM AND TERMINATION 35 11.1 Term 35 11.2 Termination for Cause 35 11.3 Termination Upon Certain Changes of Control 36 11.4 Termination for Failure to [***] 36 11.5 Termination for Convenience 36 11.6 Effect of Termination 36 11.7 Survival 36 ARTICLE 12 DISPUTE RESOLUTION 36 12.1 Executive Officer Resolution 36 12.2 Governing Law 37 12.3 Jurisdiction 37 12.4 NO JURY TRIAL 37 ARTICLE 13 MISCELLANEOUS 38 13.1 Entire Agreement; Amendment 38 13.2 Force Majeure 38\\n\\n-ii-\\n\\nSource: SIGA TECHNOLOGIES INC, 8-K, 6/3/2019\\n\\n\\n\\n\\n\\nTABLE OF CONTENTS (CONTINUED) PAGE 13.3 Notices 38 13.4 No Strict Construction; Interpretation; Headings 39 13.5 Assignment 40 13.6 Performance by Affiliates 40 13.7 Further Assurances and Actions 40 13.8 Severability 41 13.9 No Waiver 41 13.10 Relationship of the Parties 41 13.11 English Language 42 13.12 Counterparts 42 13.13 Schedules 42 13.14 Expenses 42\\n\\nExhibit A Permitted Subcontractors Exhibit B Business Plan Exhibit C SIGA Press Release Schedule 1 SIGA Patents Schedule 2 SIGA Trademarks Schedule 3 Safety Reporting Requirements Schedule 8.2(b) Encumbrances\\n\\n-iii-\\n\\nSource: SIGA TECHNOLOGIES INC, 8-K, 6/3/2019\\n\\n\\n\\n\\n\\nPROMOTION AGREEMENT This PROMOTION AGREEMENT  (this \"Agreement\") is entered into as of May 31, 2019 (the \"Effective Date\") by and between SIGA TECHNOLOGIES, INC., a Delaware corporation having an address at 31 East 62nd Street, New York, NY 10065 (\"SIGA\"), and MERIDIAN MEDICAL TECHNOLOGIES, INC., a Pfizer company, and Delaware corporation having an address at 6350 Stevens Forest Road, Suite #301, Columbia, MD 21046 (\"MMT\"). SIGA and MMT are sometimes referred to individually as a \"Party\" and collectively as the \"Part',\n",
              "    'Highlight the parts (if any) of this contract related to \"Agreement Date\" that should be reviewed by a lawyer. Details: The date of the contract',\n",
              "    'May 31, 2019',\n",
              "    3661,\n",
              "    3673),\n",
              "   ('COOPERATION AGREEMENT     made by and between     HPIL ENERGYTECH Inc.   and   GINARES GROUP AG     January 5, 2015\\n\\n\\n\\n\\n\\n\\n\\n    Table of Contents       1. Term........................................................................................................................................... 2 2. Goals And Objectives................................................................................................................ 2 3. Obligations Of The Parties........................................................................................................ 3 4. Confidentiality........................................................................................................................... 3 5. Relation Of The Parties............................................................................................................. 3 6. Closing....................................................................................................................................... 3 7. Representations, Warranties, And Covenants Of GINARES.................................................... 3 8. Representations, Warranties, And Covenants Of HPIL ET...................................................... 4 9. GINARES\\'s Indemnity.............................................................................................................. 5 10. HPIL ET\\'s Indemnity............................................................................................................... 5 11. Payment Of Expenses................................................................................................................ 5 12. Approval Of Counsel................................................................................................................. 5 13. Notices....................................................................................................................................... 6 14. Additional Undertakings............................................................................................................ 6   15. Compliance With The Foreign Corrupt Practices Act And Export Control And Antiboycott Laws...........................................................................................................................................   7 16. Arbitration.................................................................................................................................. 7 17. Governing Law.......................................................................................................................... 7 18. Binding Effect............................................................................................................................ 7 19. Counterparts............................................................................................................................... 7 20. No Reliance............................................................................................................................... 8 21. Early Termination...................................................................................................................... 8 22. Captions..................................................................................................................................... 8 23. Entire Agreement....................................................................................................................... 8         1\\n\\n\\n\\n\\n\\n    COOPERATION AGREEMENT   THIS COOPERATION AGREEMENT (\"Agreement\") is signed this 5th day of January, 2015 (the \"Closing Date\"), by and between HPIL ENERGYTECH Inc., a Nevada (USA) corporation (hereafter \"HPIL ET\") and GINARES GROUP AG,  a private company domiciled in Switzerland (hereafter \"GINARES\").   R E C I T A L S:   The following is a recital of facts underlying this Agreement:   A. HPIL ET is focused on investing in both private and public companies in the energy business sector. HPIL ET does not restrict its potential candidate target companies to any specific geographical location and thus acquires va',\n",
              "    'Highlight the parts (if any) of this contract related to \"Agreement Date\" that should be reviewed by a lawyer. Details: The date of the contract',\n",
              "    '5th day of January, 2015',\n",
              "    3560,\n",
              "    3584),\n",
              "   ('LIMITED POWER OF ATTORNEY\\n\\nKNOW ALL MEN BY THESE PRESENTS, dated as of January 1, 2004, that FEDERATED INVESTMENT MANAGEMENT COMPANY, a statutory trust duly organized under the laws of the State of Delaware (the \"Adviser\"), does hereby nominate, constitute and appoint FEDERATED ADVISORY SERVICES COMPANY, a statutory trust duly organized under the laws of the State of Delaware (\"FASC\"), to act hereunder as the true and lawful agent and attorney-in-fact of the Adviser, acting on behalf of each of the funds or accounts for which Adviser acts as investment adviser or subadviser shown on Schedule 1 attached hereto and incorporated by reference herein (each such fund or account being hereinafter referred to as a \"Fund\" and collectively as the \"Funds\"), for the specific purpose of executing and delivering all such agreements, instruments, contracts, assignments, bond powers, stock powers, transfer instructions, receipts, waivers, consents and other documents, and performing all such acts, as Adviser, or FASC acting as agent for the Adviser pursuant to the Services Agreement dated as of January 1, 2004 between the Adviser and FASC (such agreement, as may be amended, supplemented or otherwise modified from time to time is hereinafter referred to as the \"Services Agreement\"), may deem necessary or reasonably desirable, related to the acquisition, disposition and/or reinvestment of the funds and assets of a Fund in accordance with Adviser\\'s supervision of the investment, sale and reinvestment of the funds and assets of each Fund pursuant to the authority granted to the Adviser as investment adviser or subadviser of each Fund under the Adviser\\'s investment advisory or subadvisory contract for such Fund (such investment advisory or subadvisory contract, as may be amended, supplemented or otherwise modified from time to time is hereinafter referred to as the \"Investment Advisory Contract\").\\n\\nThe Adviser hereby ratifies and confirms as good and effectual, at law or in equity, all that FASC, and its officers and employees, may do by virtue hereof. However, despite the above provisions, nothing herein shall be construed as imposing a duty on FASC to act or assume responsibility for any matters referred to above or other matters even though FASC may have power or authority hereunder to do so. Nothing in this Limited Power of Attorney shall be construed (i) to be an amendment or modifications of, or supplement to, the Investment Advisory Contract, (ii) to amend, modify, limit or denigrate any duties, obligations or liabilities of the Adviser under the terms of the Investment Advisory Contract or (iii) exonerate, relieve or release the Adviser from any losses, obligations, penalties, actions, judgments and suits and other costs, expenses and disbursements of any kind or nature whatsoever which may be imposed on, incurred by or asserted against the Adviser (x) under the terms of the Investment Advisory Contract or (y) at law, or in equity, for the performance of its duties as the investment adviser or subadviser of any of the Funds.\\n\\nThe Adviser hereby agrees to indemnify and save harmless FASC and its trustees, officers and employees (each of the foregoing an \"Indemnified Party\" and collectively the \"Indemnified Parties\") against and from any and all losses, obligations, penalties, actions, judgments and suits and other costs, expenses and disbursements of any kind or nature whatsoever which may be imposed on, incurred by or asserted against an Indemnified Party, other than as a consequence of gross negligence or willful misconduct on the part of an Indemnified Party, arising out of or in connection with this Limited Power of Attorney or any other agreement, instrument or document executed in connection with the exercise of the authority granted to FASC herein to act on behalf of the Adviser, including without limitation the reasonable costs, expenses and disbursements in connection with defending such Indemnified Party against any claim or liability related to the exercise or performance of any of FASC\\'s powers or duties under this Limited',\n",
              "    'Highlight the parts (if any) of this contract related to \"Agreement Date\" that should be reviewed by a lawyer. Details: The date of the contract',\n",
              "    'January 1, 2004',\n",
              "    71,\n",
              "    86),\n",
              "   ('CORPORATE SPONSORSHIP AGREEMENT\\n\\nThis agreement (the \"Agreement\") is entered into as of May 18, 2010, (the \"Effective Date\") by and between Phoenix Performance, LLC, 481  Schuylkill Road, Phoenixville, PA 19460 (\"Vendor\") and Torvec Inc.., a New York corporation with its principal place of business located at 1999  Mt Read Blvd, Building 3, Rochester, NY. 14615 (Torvec).\\n\\nRECITALS\\n\\nWHEREAS, the parties desire to enter into an agreement regarding promotional, marketing and sponsorship activities designed to be of  mutual benefit as described herein; and\\n\\nNOW, THEREFORE, for and in consideration of the mutual covenants, rights and obligations set forth in this Agreement, the parties agree  as follows:\\n\\n1. Term\\n\\nThe term of this Agreement (the \"Term\") shall commence on the Effective Date and conclude on October 31, 2010, unless renewed by  agreement or sooner terminated in accordance with this Agreement.\\n\\n2. Termination\\n\\n(a) Either party may terminate this Agreement immediately if the other party (i) files a petition commencing a voluntary case under the  Bankruptcy Code; (ii) makes a general assignment for the benefit of creditors; (iii) admits in writing its inability to pay its debts as they become  due; (iv) seeks, consents to or acquiesces in the appointment of any trustee, receiver or liquidator of it or any part of its property; or (v) has  commenced against it an involuntary case under the Bankruptcy Code or a proceeding under any receivership, composition, readjustment,  liquidation, insolvency, dissolution or like law or statute, which case or proceeding is not dismissed or vacated within sixty (60) days.\\n\\n(b) Upon termination of this Agreement, NEITHER PARTY SHALL BE LIABLE TO THE OTHER FOR ANY CONSEQUENTIAL,  EXEMPLARY, SPECIAL, INCIDENTAL OR PUNITIVE DAMAGES, EVEN IF IT HAS BEEN ADVISED OF THE POSSIBILITY OF SUCH  DAMAGES, WHICH ARE RELATED TO THE AGREEMENT OR ITS BREACH.\\n\\nPreparation, maintenance and running of one (1) T-1 C5 Corvette race vehicle to race in:\\n\\na. 1 round of the World Challenge series in the GTS class (Mosport Double);\\n\\nb. 4 rounds of SCCA National Racing (events to be finalized but at this time expected to be NJMP, Road America, Watkins Glen  Double);\\n\\nc. the SCCA runoffs at Road America.\\n\\n.\\n\\n5. Payment and Other Consideration\\n\\nAs consideration for the benefits it receives under this Agreement, Torvec shall provide the following to Vendor:\\n\\nSee Exhibit A\\n\\nThe schedule set forth in Exhibit A will constitute invoicing for the events. Notwithstanding the above, Torvec may, in its sole  discretion, cancel its participation in any of the above-referenced events by notifying Vendor of such cancellation not later than two weeks  prior to the due date(s) for payment hereunder. All checks shall be made payabe to: Phoenix Performance, LLC and mailed to 481, Schuylkill  Rd, Phoenixville, Pa. 19460.\\n\\n(b) Equipment\\n\\n           3.     Responsibilities and Benefits\\n\\n        Vendor shall be responsible for the following in 2010:\\n\\n  4.  Torvec Benefits\\n\\n     During the Term of this Agreement, Torvec shall be entitled to the following sponsorship benefits:\\n\\n  a)  Primary sponsorship rights to all of Vendor\\'s participation efforts in the above race events.\\n\\n  b)  The right to specify and approve all team sponsorship identification markings, logos, graphics, etc. for vehicle livery, team  equipment and uniforms.\\n\\n  c)  Sole right to disapprove any driver selected by Vendor for any reason. The driver for these events will be John Heinricy.\\n\\n  (a)  Payment Schedule\\n\\n\\n\\n\\n\\nTorvec will provide to Vendor the use of up to 2 Differential units to be used in the T-1 C5 Corvette for testing, evaluation and racing  purposes..\\n\\n6. Grant of License\\n\\nEach party shall have a non-exclusive, royalty free, non-transferable license to use the name, logo, any item used in connection with that  name or logo, and the registered symbols and trademarks of the other party (the \"Trademarks\") only for the purposes set forth in this Agreement.  Neither party will use the other\\'s Trademarks without obtaining the prior approval of the other pa',\n",
              "    'Highlight the parts (if any) of this contract related to \"Agreement Date\" that should be reviewed by a lawyer. Details: The date of the contract',\n",
              "    'May 18, 2010',\n",
              "    88,\n",
              "    100),\n",
              "   ('EXHIBIT 10.1   ENDORSEMENT AGREEMENT   This Endorsement Agreement (\"Agreement\") made October 30, 2017, between National Football League Alumni - Northern California Chapter (\"NFLA-NC\"), a charitable corporation organized under the laws of California, having its principal office at 1311 Madison Avenue, Redwood CA 94061; National Football League Alumni, Inc. (\"NFLA\"), a charitable corporation organized under the laws of Florida, having its principal office at 8000 Midlantic Drive, 130 S., Mount Laurel, NJ. 08054 and Food For Athletes, Inc. a corporation organized under the laws of California / Gridiron BioNutrientsโข, a corporation organized under the laws of Nevada having their principal office(s) at 1119 West 1st Ave., STE G, Spokane, WA 99201 (collectively the \"Company\").   RECITALS   A. Whereas, NFLA is a nationwide group of former National Football League players, coaches, and other employees whose mission is to serve, assist and inform players and their families. The association offers a variety of medical, financial and social programs to help members lead healthy, productive and connected lives.    B. Whereas, NFLA-NC is a local Chapter of the NFLA and supports the organizations \"Caring for Kids\" initiative through fundraising for youth-related charities.    C. The Company desires to obtain the rights to use the Pro Football Legends Logo of the NFLA in connection with the advertisement and promotion of certain of its products. An image of the Pro Football Legends Logo is depicted in Exhibit A.    D. The NFLA agrees to license such rights to the Company.   In consideration of the matters described above, and of the mutual benefits and obligations set forth in this Agreement, the parties agree as follows:   SECTION ONE. DEFINITIONS   As used in this Agreement, the following terms shall be defined as follows:   A. \"Contract Period\" shall mean that period of time of three (3) years commencing on November 1st, 2017 and concluding November 2nd, 2020, unless terminated sooner or extended as provided in this Agreement.    B. \"Contract Territory\" shall mean worldwide.    C. \"Contract Year\" shall mean each of the consecutive 12-month periods beginning on the effective date of the Agreement of the Contract Period.   1\\n\\nSource: GRIDIRON BIONUTRIENTS, INC., 8-K, 12/6/2017\\n\\n\\n\\n\\n\\n      D. \"Gross Sales\" shall mean total revenues, under generally accepted accounting principles, from sales of the Licensed Products, but does not include any revenue from sales, use or other transaction taxes, duties, handling, graphics, embroidery or shipping.    E. \"Net Sales\" shall mean Gross Sales less Product returns, trade discounts, samples, allowances, value added services, markdowns, customer charge backs and liquidation sales (substantially discounted and out of ordinary distribution channel) of Licensed Products.    F. \"Licensed Products\" shall mean BlackMP Living Water, BlackMP Concentrate, Zezel Probiotic Water, Zayin Sports Water, Gridiron MVPโข and Gridiron MVPโข Concentrate using the Pro Football Legends Logo on the Licensed Products\\' affixed labels, hang-tags or packaging. Other products of the Company may be added to the list of Licensed Products during the Contract Period by written amendment to this Agreement. All amendments to this Agreement must be signed by all parties to this Agreement.    G. \"Products\" shall mean goods manufactured, distributed or otherwise sold by the Company.    H. \"Licensed Marks\" shall mean in connection with the rights and benefits granted to Company hereunder as set forth in General Terms. Company may utilize only the logo and other trademarks listed on Exhibit A (the \"Licensed Marks\") during the Term and within the Territory solely in connection with advertising and promotional materials that identify Company as a sponsor of the Pro Football Legends, provided that NFLA first approves all such uses in writing. Any use of the Licensed Marks will bear the trademark and/or copyright notices required by NFLA to facilitate its trademark protection program and will be a \"work made for hire\" for NFLA. All of Company',\n",
              "    'Highlight the parts (if any) of this contract related to \"Agreement Date\" that should be reviewed by a lawyer. Details: The date of the contract',\n",
              "    'October 30, 2017',\n",
              "    85,\n",
              "    101),\n",
              "   ('1\\n\\n                                  EXHIBIT 10.13\\n\\n                                                                  EXECUTION COPY\\n\\n                              ENDORSEMENT AGREEMENT                               ---------------------\\n\\n         This Endorsement Agreement (\"Agreement\") is made this 13th day of October, 1999 by and between SQUARE TWO GOLF INC., a New Jersey corporation (the \"Company\"), and KATHY WHITWORTH, an individual, with an address at 302 La Mancha Court, Santa Fe, New Mexico, 87501 (the \"Professional\").\\n\\n                                    RECITALS                                     --------\\n\\n         WHEREAS, the Company manufactures and sells women\\'s golf clubs and other golf equipment;\\n\\n         WHEREAS, the Professional is a retired Ladies Professional Golf Association (\"LPGA\") Tour Professional;\\n\\n         WHEREAS, the Company desires to utilize the services of the Professional in connection with the promotion, marketing, and sale of a signature line of women\\'s golf clubs and the Company\\'s other products and services; and\\n\\n         WHEREAS, the Company and the Professional desire to enter into an agreement pursuant to which the Professional will serve the Company as an independent contractor, on the terms and subject to the conditions set forth herein.\\n\\n         NOW, THEREFORE, in consideration of the mutual covenants and agreements contained herein, the Company and the Professional hereby agree as follows:\\n\\n1.       TERM.\\n\\n         1.1 The term of this Agreement shall begin on January 1, 2000 and continue for an initial period of five (5) years unless earlier terminated in accordance with Section 7 hereof, and may be renewed under Section 8 hereof (the initial period plus any renewal period, the \"Term\").\\n\\n2.       ENDORSEMENT SERVICES.\\n\\n         During the Term, the Professional will provide the services described in this Section 2 (the \"Services\"):\\n\\n         2.1 The Professional hereby grants to the Company an exclusive license to use her name, likeness, image and personal identification, singly or in any combination, in connection with the production, use, marketing and sale of a \"Kathy Whitworth\" signature line of women\\'s golf clubs (the \"Products\"), as described more fully in Section 3 below.\\n\\n   2\\n\\n                                                                  EXECUTION COPY\\n\\n         2.2 The Professional agrees to serve as a professional golf instructor during up to ten (10) golf clinics hosted by the Company per calendar year at locations within the United States to be determined by the Company. The golf clinics shall be one or two day events.\\n\\n         2.3 The Professional agrees to serve as a spokesperson for the Company at up to two (2) Professional Golf Association merchandise shows, including but not limited to the PGA Merchandise Shows.\\n\\n         2.4 The Professional hereby grants to the Company the exclusive and worldwide right to use her name, likeness, image and personal identification, singly or in any combination, during the Term and for a period of six (6) months after the Term as provided in Section 2.8, in the creation of two (2) print advertisements per year and one (1) television advertisement per year (together, the \"Advertisements\") for any golf equipment, along with all rights in any images, videos, advertisement copy or other materials created by the Professional or others. The Professional agrees that the Company shall own all such materials and all intellectual property rights&bbsp;therein for use in perpetuity in any media now known or hereafter devised or developed, including but not limited to the internet. The Professional hereby grants to the Company the worldwide right during the Term and for a period of six (6) months after the Term as provided in Section 2.8 to use, reproduce, print, publish, distribute, broadcast, modify, edit, condense, or expand any materials containing her name, image, likeness or personal identification that are created hereunder.\\n\\n         2.5 The Professional hereby grants to the Company an exclusive license to use her name, lik',\n",
              "    'Highlight the parts (if any) of this contract related to \"Agreement Date\" that should be reviewed by a lawyer. Details: The date of the contract',\n",
              "    '13th day of October, 1999',\n",
              "    302,\n",
              "    327),\n",
              "   ('Exhibit 10.2\\n\\nIN ACCORDANCE WITH ITEM 601(b) OF REGULATION S-K, CERTAIN IDENTIFIED INFORMATION (THE \"CONFIDENTIAL INFORMATION\") HAS BEEN EXCLUDED FROM THIS EXHIBIT BECAUSE IT IS BOTH (I) NOT MATERIAL AND (II) WOULD LIKELY CAUSE COMPETITIVE HARM IF PUBLICLY DISCLOSED. THE CONFIDENTIAL INFORMATION IS DENOTED HEREIN BY [*****].\\n\\nZEBRAยฎ PARTNERCONNECT PROGRAM\\n\\nADDENDUM TO\\n\\nZEBRAยฎ PARTNERCONNECT DISTRIBUTOR AGREEMENT\\n\\nTHIS ADDENDUM (\"Addendum\") is made on the 4th day of February 2019 (\"Effective Date\") between the following parties: Zebra Technologies International, LLC, with an office at 3 Overlook Point, Lincolnshire IL 60069 (\"Zebra\");\\n\\nZebra Technologies do Brasil - Comรฉrcio de Produtos de Informรฅtica Ltda., a company incorporated and organized under the laws of Brazil, with offices at Av. Magalhรคes de Castro, 4800, sala 72-A, Cidade Jardim, CEP 05676-120, Sรคo Paulo, sp (\"Zebra Brazil\")\\n\\nXplore Technologies Corporation of America, a company with its principal place of business at 8601 RR 2222, Building 2, Suite #100, Austin, Texas 78730, U.S.A. (\"Xplore\");\\n\\n(collectively \"Zebra\")\\n\\nAND\\n\\nScanSource, Inc., a company incorporated in South Carolina, with its registered office at 6 Logue Court, Greenville, South Carolina 29615 (\"ScanSource\").\\n\\nScanSource Latin America, Inc. a ScanSource Affiliate incorporated in Florida, whose registered business address is 1935 NW 87 Avenue, Miami, Florida 33172 (\"ScanSource Latin America\")\\n\\nScanSource Brazil Distribuidora de Technologias, Ltda., a ScanSource Affiliate incorporated and organized under the laws of Brazil, with offices in the City of Sรคo Josรฉ dos Pinhais, State of Paranรฅ, at Avenida Rui Barbosa, 2529, Modulos 11 and 12, Bairro Jardim Ipรฉ, CEP: 83055-320, enrolled with the Taxpayer Register (CNPJ/MF) under No. 05.607.657/0001-35 (\"ScanSource Brazil\")\\n\\nSCANSOURCE DE MEXICO S. DE R.L. DE C.V., a ScanSource Affiliate incorporated in Mexico, whose registered business address is Calle 4 No. 298, Colonia Franccionamiento Industrial Alce Blanco, Naucalpan de Juarez, Estado de Mรฉxico 53370 (\"ScanSource Mexico\")\\n\\n(Collectively \"Distributor\\')\\n\\n\"Zebra\" and the \"Distributor\" are referred to collectively as \\'Parties\" and individually as a \"Party\".\\n\\nWHEREAS: (A) On February 12, 2014 the Parties entered into an agreement that was renamed, as of April 11, 2016, to: PartnerConnectTM EVM Distribution Agreement, (as amended) (\"Distribution Agreement\"), which relates to Zebra Enterprise Visibility and Mobility (\\'EVM\") products and services, and which, as acknowledged by the Parties by entering into this Amendment, is in full force and effect and valid as when this Amendment is executed;\\n\\n(B) Distributor purchases Products from Zebra under the Distributor Agreement;\\n\\n(C)\\u200b Zebra has recently completed the acquisition of Xplore, which transaction closed on August 14, 2018;\\n\\n(D) Zebra has expanded its products portfolio by adding the product families listed in Exhibit A, that as of the Effective Date hereof are branded Xplore or Motion Computing, thereto (\"Xplore Products\"); (E) Xplore, now a Zebra Affiliate, is the seller of Xplore Products;\\n\\nSource: SCANSOURCE, INC., 10-Q, 5/9/2019\\n\\n\\n\\n\\n\\n(F) Xplore wishes to sell Xplore Products to Distributor and Distributor wishes to purchase such products from Xplore pursuant to the terms and conditions of the Distributor Agreement by entering into this Addendum; and\\n\\n(G) The Parties desire to amend the Distributor Agreement by adding Xplore Products and authorizing Distributor to purchase such products from Xplore for further resale to members of the Zebra PartnerConnect Program in the Market or Territory. THEREFORE, in consideration of the mutual covenants and promises, and subject to the terms and conditions of the Distributor Agreement, the Parties agree as follows:\\n\\n1. Expressions used in this Addendum shall have the same meanings given to them in the Distributor Agreement, unless the context requires otherwise.\\n\\n2. This Addendum automatically incorporates any future amendments to the Distributor Agreement and such amendments will be made part of this Addendum ',\n",
              "    'Highlight the parts (if any) of this contract related to \"Agreement Date\" that should be reviewed by a lawyer. Details: The date of the contract',\n",
              "    '4th day of February 2019',\n",
              "    459,\n",
              "    483),\n",
              "   (\"ADDENDUM REQUIRED BY THE DEPARTMENT OF LAW OF THE STATE OF NEW YORK   The following Items are required to be included within the Disclosure Document and shall be deemed to supersede the language in the Disclosure Document itself:   3. LITIGATION   Neither the Franchisor, its Predecessor nor any person listed under Item 2 or an affiliate offering franchises under Franchisor's principal trademark:     (A) has an administrative, criminal or civil action pending against that person alleging: a felony; a violation of a franchise, antitrust or securities law; fraud; embezzlement; fraudulent conversion; misappropriation of property; unfair or deceptive practices; or comparable civil or misdemeanor allegations.\\n\\n  (B) has been convicted of a felony or pleaded nolo contendere to a felony charge or, within the ten year period immediately preceding the application for registration, has been convicted of or pleaded nolo contendere to a misdemeanor charge or has been the subject of a civil action alleging: violation of a franchise; anti-fraud or securities law; fraud; embezzlement; fraudulent conversion or misappropriation of property; unfair or deceptive practices; or comparable allegations.\\n\\n  (C) is subject to a currently effective injunctive or restrictive order or decree relating to the franchise, or under a Federal, State or Canadian franchise, securities, antitrust, trade regulation or trade practice law, resulting from a concluded or pending action or proceeding brought by a public agency; or is subject to any currently effective order of any national securities association or national securities exchange, as defined in the Securities and Exchange Act of 1934, suspending or expelling such person from membership in such association or exchange; or is subject to a currently effective injunctive or restrictive order relating to any other business activity as a result of an action brought by a public agency or department, including, without limitation, actions affecting a license as a real estate broker or sales agent.   4. BANKRUPTCY   Neither the Franchisor, its affiliate, its predecessor, officers, or general partner during the ten year period immediately before the date of the disclosure document: (a) filed as debtor (or had filed against it) a petition to start an action under the U.S. Bankruptcy Code (or any comparable foreign law); (b) obtained a discharge of its debts under the bankruptcy code; or (c) was a principal officer of a company or a general partner in a partnership that either filed as a debtor (or had filed against it) a petition to start an action under the U.S. Bankruptcy Code or that obtained a discharge of its debts under the U.S. Bankruptcy Code during or within one year after the officer or general partner of the Franchisor held this position in the company or partnership.   IN WITNESS WHEREOF, the parties hereto have duly executed, sealed and delivered this Addendum dated this ______ day of ______________, 2015.\\n\\n2\\n\\nSource: SOUPMAN, INC., 8-K, 8/14/2015\\n\\n\\n\\n\\n\\n\\n\\n              ATTEST   KIOSK CONCEPTS, INC.:                 By:       Witness   Name:       Title:                     MASTER FRANCHISEE: THE GRILLED CHEESE TRUCK, INC.                 By:           Name:       Title:               Witness\\n\\n3\\n\\nSource: SOUPMAN, INC., 8-K, 8/14/2015\",\n",
              "    'Highlight the parts (if any) of this contract related to \"Agreement Date\" that should be reviewed by a lawyer. Details: The date of the contract',\n",
              "    '______ day of ______________, 2015.',\n",
              "    2947,\n",
              "    2982),\n",
              "   ('VISP WEB SITE BUILDING AND HOSTING AGREEMENT\\n\\nThis Agreement is made on this 12th day of May 2003 by and between YourNetPlus.com, Inc., a New York Corporation; with its principle office located at 501 Route 208, Monroe, NY 10950 (\"Provider\") and Kingdom Connect, Inc., a Corporation with its principle office located at 1045 Stephanie Way, Minden, NV 89423 (\"KCI\").\\n\\nWhereas, Provider is in the business of providing websites and internet connectivity which may be Private Labeled or offered as same service.\\n\\nWhereas KCI wishes to purchase the services of Provider on behalf of KCI\\'s customers.\\n\\nWhereas, Provider agrees to provide VISP setup, maintenance, and technical support services for five thousand (5,000) websites for KCI\\'s customers over the next five years.\\n\\nBe it agreed on this day that the following agreement will govern the relationship between our two companies.\\n\\n1    TERM\\n\\nThis agreement shall be for a term of five years from the date of this document. This agreement shall renew automatically each year thereafter, unless either party serves written notice of its intention not to renew, on the other at least 90 days prior to the expiration of the then current term of this agreement.\\n\\n2    PROVIDER\\'S  REPRESENTATIONS\\n\\nYournetplus, one of the largest private label internet service providers in the United States agrees to allow us to prepay for our customers all set up, development, maintenance, and service fees associated with five thousand VISP websites for the customers of KCI at no charge to the customer (churches). Provider represents that these fees normally are charged to the customer according to the following schedule:\\n\\n$299.00 one time start-up and developmental fee due at contract signing\\n\\n$29.95 monthly maintenance and service fee\\n\\n24/7 \"800\" Number Customer Service / Tech Support $25.00 per month for private labeled service and Free for the first 90 days for generic service.  If the ISP does not have 250 users within the first 90 days we will charge $25.00 each month thereafter.\\n\\n3    PROVIDER\\'S  RESPONSIBILITIES\\n\\nProvider agrees to provide KCI with VISP Private labeled website building and maintenance capabilities. Deliverables shall include: Sales collateral materials including brochures and flyers to help KCI sign customers to the service. A fully staffed back end including; Billing, real time credit card transactions, administrative reports, Customer and technical support, Online Customer Account Maintenance, Private labeled E-Mail Server, Administrative E-Mail Addresses, vacation e-mail, Web based and POP Access, Online Interfaces, a private labeled Internet portal for KCI and include an affiliate program.\\n\\nKCI\\'s Customers will receive an initial VISP web site setup including 5Mbs of storage space, maintenance of the site, technical support, and any services necessary for use of the site for no charge.\\n\\n4    KCI\\'S  RESPONSIBILITIES\\n\\nTo market Private Labeled Service to retail and wholesale clients of KCI.\\n\\nKCI, its officers, directors, employees and any authorized sub-licensee will (I) conduct their business in an honest, professional and ethical manner and (ii) not commit any action or omission to act which could adversely affect PROVIDER, its name, reputation or ability to conduct its business. KCI shall promptly and fully cooperate with Provider to address and resolve all issues, problems, administrative procedures, End User complaints, regulatory investigations or inquiries or any other circumstances arising from KCI\\'s use of Provider\\'s services.\\n\\n5    PROPRIETARY  INFORMATION\\n\\nThe parties understand and agree that the terms and conditions of this Agreement, all documents and invoices and all communications between the parties regarding this Agreement or the Service to be provided as well as such information relevant to any other agreement between the parties (collectively \"Confidential Information\"), are strictly confidential between KCI and Provider. For purposes of this Agreement, \"Confidential Information\" shall mean information in written or other tangible form specifically labeled as such w',\n",
              "    'Highlight the parts (if any) of this contract related to \"Agreement Date\" that should be reviewed by a lawyer. Details: The date of the contract',\n",
              "    '12th day of May 2003',\n",
              "    77,\n",
              "    97),\n",
              "   ('Exhibit A\\n\\nJOINT FILING AGREEMENT\\n\\nPursuant to and in accordance with the Securities Exchange Act of 1934, as amended, and the rules and regulations thereunder (the \"Exchange Act\") the undersigned hereby agree to the joint filing of Clarus IV-A, L.P., Clarus IV-B, L.P., Clarus IV-C, L.P., Clarus IV-D, L.P., Clarus IV GP, L.P., Blackstone Clarus GP L.P., Blackstone Clarus GP L.L.C., Blackstone Holdings II L.P., Blackstone Holdings I/II GP L.L.C., The Blackstone Group Inc., Blackstone Group Management L.L.C. and Stephen A. Schwarzman, on behalf of each of them of any filing required by such party under Section 13 of the Exchange Act or any rule or regulation thereunder (including any amendment, restatement, supplement, and/or exhibit thereto) with respect to securities of Galera Therapeutics, Inc., a Delaware corporation, and further agree to the filing, furnishing, and/or incorporation by reference of this Agreement as an exhibit thereto. Each of them is responsible for the timely filing of such filings and any amendments thereto, and for the completeness and accuracy of the information concerning such person contained therein; but none of them is responsible for the completeness or accuracy of the information concerning the other persons making the filing, unless such person knows or has reason to believe that such information is inaccurate. This Agreement shall remain in full force and effect until revoked by any party hereto in a signed writing provided to each other party hereto, and then only with respect to such revoking party. This Agreement may be executed in any number of counterparts all of which taken together shall constitute one and the same instrument.\\n\\nIN WITNESS WHEREOF, the undersigned hereby execute this Agreement this 14t h day of February 2020. CLARUS IV-A, L.P. By: Clarus IV GP, L.P., its general partner By: Blackstone Clarus GP L.P., its general partner By: Blackstone Clarus GP L.L.C., its general partner\\n\\nBy: /s/ John G. Finley Name: John G. Finley Title: Chief Legal Officer\\n\\nCLARUS IV-B, L.P. By: Clarus IV GP, L.P., its general partner By: Blackstone Clarus GP L.P., its general partner By: Blackstone Clarus GP L.L.C., its general partner\\n\\nBy: /s/ John G. Finley Name: John G. Finley Title: Chief Legal Officer\\n\\nCLARUS IV-C, L.P. By: Clarus IV GP, L.P., its general partner By: Blackstone Clarus GP L.P., its general partner By: Blackstone Clarus GP L.L.C., its general partner\\n\\nBy: /s/ John G. Finley Name: John G. Finley Title: Chief Legal Officer\\n\\n[Galera Therapeutics, Inc. - Joint Filing Agreement]\\n\\n\\n\\n\\n\\nCLARUS IV-D, L.P. By: Clarus IV GP, L.P., its general partner By: Blackstone Clarus GP L.P., its general partner By: Blackstone Clarus GP L.L.C., its general partner\\n\\nBy: /s/ John G. Finley Name: John G. Finley Title: Chief Legal Officer\\n\\nCLARUS IV GP, L.P. By: Blackstone Clarus GP L.P., its general partner By: Blackstone Clarus GP L.L.C., its general partner\\n\\nBy: /s/ John G. Finley Name: John G. Finley Title: Chief Legal Officer\\n\\nBLACKSTONE CLARUS GP L.P. By: Blackstone Clarus GP L.L.C., its general partner\\n\\nBy: /s/ John G. Finley Name: John G. Finley Title: Chief Legal Officer\\n\\nBLACKSTONE CLARUS GP L.L.C.\\n\\nBy: /s/ John G. Finley Name: John G. Finley Title: Chief Legal Officer\\n\\nBLACKSTONE HOLDINGS II L.P. By: Blackstone Holdings I/II GP L.L.C., its general partner\\n\\nBy: /s/ John G. Finley Name: John G. Finley Title: Chief Legal Officer\\n\\nBLACKSTONE HOLDINGS I/II GP L.L.C.\\n\\nBy: /s/ John G. Finley Name: John G. Finley Title: Chief Legal Officer\\n\\nTHE BLACKSTONE GROUP INC.\\n\\nBy: /s/ John G. Finley Name: John G. Finley Title: Chief Legal Officer\\n\\n[Galera Therapeutics, Inc. - Joint Filing Agreement]\\n\\n\\n\\n\\n\\nBLACKSTONE GROUP MANAGEMENT L.L.C.\\n\\nBy: /s/ John G. Finley Name: John G. Finley Title: Chief Legal Officer\\n\\n/s/ Stephen A. Schwarzman Stephen A. Schwarzman\\n\\n[Galera Therapeutics, Inc. - Joint Filing Agreement]',\n",
              "    'Highlight the parts (if any) of this contract related to \"Agreement Date\" that should be reviewed by a lawyer. Details: The date of the contract',\n",
              "    '14t h day of February 2020',\n",
              "    1766,\n",
              "    1792),\n",
              "   ('Exhibit 4.1\\n\\nEXECUTION VERSION\\n\\nREINSURANCE GROUP OF AMERICA, INCORPORATED\\n\\nRGA CAPITAL TRUST I\\n\\nAMENDED AND RESTATED REMARKETING AGREEMENT\\n\\nFebruary 15, 2011\\n\\nBarclays Capital Inc.  745 Seventh Avenue  New York, NY 10019\\n\\nLadies and Gentlemen:\\n\\nReinsurance Group of America, Incorporated, a Missouri corporation (the \"Company\"), and RGA Capital Trust I, a Delaware statutory business  trust (the \"Trust\"), issued and sold to Lehman Brothers Inc. and Banc of America Securities LLC (the \"Underwriters\") pursuant to the  Underwriting Agreement, dated December 12, 2001 (the \"Underwriting Agreement\"), 4,500,000 Trust Preferred Income Equity Redeemable  Securities (\"PIERS\")1 units (the \"Firm Units\") issued pursuant to a Unit Agreement (the \"Unit Agreement\") dated as of December 18, 2001, as  supplemented September 12, 2008, among the Company, the Trust, The Bank of New York Mellon Trust Company, N.A., as successor unit agent  (in such capacity, the \"Unit Agent\"), as successor warrant agent (in such capacity, the \"Warrant Agent\"), and as successor property trustee (in  such capacity, the \"Property Trustee\"). In addition, the Company and the Trust granted to the Underwriters an option (the \"Option\") to purchase  up to an additional 675,000 Units (the \"Option Units\" and, together with the Firm Units, the \"Units\").\\n\\nEach Unit consists of a preferred security, liquidation preference $50 per security, of the Trust (each, a \"Preferred Security\") and a warrant (each,  a \"Warrant\") of the Company to purchase at any time prior to the close of business on December 15, 2050, shares (the \"Warrant Shares\") of  common stock, par value $0.01 per share, of the Company (\"Common Stock\"), subject to antidilution adjustments. Each Preferred Security  represents an undivided beneficial ownership interest in the assets of the Trust, which assets consist solely of the 5.75% Junior Subordinated  Deferrable Interest Debentures due 2051 of the Company (the \"Debentures\"). Certain payments on the Preferred Securities and Common Securities  (the \"Trust Securities\") are guaranteed (the \"Guarantee\") by the Company pursuant to the Guarantee Agreement (the \"Guarantee Agreement\")  dated as of December 18, 2001, between the Company and The Bank of New York Mellon Trust Company, as successor guarantee trustee (in such  capacity, the \"Guarantee Trustee\").\\n\\nThe Trust was formed on February 9, 2001 pursuant to a trust agreement dated as of February 8, 2001 (the \"Original Trust Agreement\") executed  by the Company, as depositor,\\n\\n\\n\\n1   \"Preferred Income Equity Redeemable SecuritiesSM\" and \"PIERSSM\" are service marks owned by Lehman Brothers Inc.\\n\\n\\n\\n\\n\\n\\n\\nand The Bank of New York (Delaware), as Delaware trustee (in such capacity, the \"Delaware Trustee\"), and a certificate of trust dated as of  February 8, 2001 (the \"Trust Certificate\") filed with the Secretary of State of the State of Delaware. The Trust is governed by, and the Preferred  Securities were issued under, the Original Trust Agreement, as amended and restated by the Amended and Restated Trust Agreement (the  \"Amended and Restated Trust Agreement\" and, together with the Original Trust Agreement, the \"Trust Agreement\")) dated as of December 18,  2001, among the Company, the Property Trustee, the Delaware Trustee and A. Greig Woodring, Jack B. Lay and Todd C. Larson, as the initial  administrative trustees (in such capacities, the \"Administrative Trustees\") which amended and restated the Original Trust Agreement.\\n\\nThe Trust used the proceeds from the sale of the Trust Securities to purchase the Debentures that were issued pursuant to the Indenture (the  \"Original Indenture\"), as supplemented by a Supplemental Indenture (the \"Supplemental Indenture\" and, together with the Original Indenture, as  so supplemented, the \"Indenture\"), in each case, dated as of December 18, 2001 between the Company and The Bank of New York Mellon Trust  Company, N.A., as successor indenture trustee (in such capacity, the \"Indenture Trustee\"). The Trust will, if and to the extent it receives the  proceeds of a payment on the Debentures, di',\n",
              "    'Highlight the parts (if any) of this contract related to \"Agreement Date\" that should be reviewed by a lawyer. Details: The date of the contract',\n",
              "    'February 15, 2011',\n",
              "    141,\n",
              "    158),\n",
              "   ('1                                                                    EXHIBIT 10.13\\n\\n2\\n\\n                            BIOPURE CORPORATION                                 AGENCY AGREEMENT\\n\\n   This \"Agency\" Agreement is made as of March 29, 1999, by and between Biopure Corporation, a Delaware corporation (the \"Company\") and the Agent named on the signature page hereof (the \"Agent\").\\n\\n   WHEREAS, the Company is preparing to manufacture and sell Oxyglobin(R) brand veterinary products (\"Products\") enumerated on the Company\\'s veterinary products agency price list (Exhibit A)(as such list may be changed by the Company from time to time, the \"Price List\"); and\\n\\n   WHEREAS, the Agent and the Company wish to enter into an arrangement wherein the Agent would promote, sell, and collect payment for, such Products for the Company as a representative (\"Agent\") of the Company within the United States of America to duly licensed veterinarians (the \"Customers\") on the terms provided herein;\\n\\n   NOW, THEREFORE, in consideration of the premises and of the mutual promises and covenants contained herein, the parties hereby agree as follows:\\n\\n                      1. APPOINTMENT AND ACCEPTANCE.\\n\\n   1.1. Appointment. Subject to the terms and conditions of this Agreement, the Company hereby appoints the Agent, and the Agent hereby accepts appointment, as an authorized distributor agent within the Territory, (Territory as outlined in section 1.2), for the promotion, sale and collection of payment for, the Products to Customers. The Company has appointed a limited number of Agents; however, the Company retains the right to itself, and/or appoint others to, promote, sell, and collect payment for, and distribute, the Products to Customers in the Territory.\\n\\n   1.2. Territory. The Territory is defined as that geographical area in which said Agent is represented by a full time field sales representative, and of which assigned Distributor agrees to be responsible for mutually agreed upon quarterly and annual sales objectives as described in the \"Business Plan\". Compensation by the Company to the Agent will be limited to the area stated as follows:\\n\\n   The 48 Continental United States (including DC) plus Alaska    3\\n\\n                                    -2-\\n\\nNo compensation will be earned by the Agent for sales generated from customers in geographical areas not indicated in this section 1.2.\\n\\n   1.3. Business Plan. The Company and the Agent will jointly develop a written business plan for the promotion, distribution and sale of the Products to Customers in the Territory for each year (Nov 1 - Oct 31) during the term of this Agreement (a \"Contract Year\") and, on a nonbinding preliminary basis, for the next succeeding Contract Year (a \"Business Plan\"). Each Business Plan will include, among other things, sales and marketing strategies, advertising and promotion plans, financial projections (including projected sales, expenses and other customary items) and Agent performance criteria (including, but not limited to, market penetration, sales promotion execution, Product availability/accessibility and trade support). In the event of any conflict between this Agreement and a Business Plan, this Agreement will govern. The Business Plan relating to Contract Year ending Oct 31, 1999 will be agreed upon at least thirty (30) days after the Agent Launch Date (as defined below) or at a mutually agreed upon date and location. The Business Plan relating to all Contract Years thereafter will be agreed upon not less than sixty (60) days (or at a mutually agreed upon date and location) prior to the start of the Contract Year to which it relates. The Company and the Agent will negotiate the terms and conditions of each Business Plan in good faith, using their respective best efforts to agree upon such terms and conditions. The parties will review each then-current Business Plan quarterly and update such Business Plan from time to time as may be mutually agreed upon in writing. For purposes of this Agreement, \"Agent Launch Date\" means the date specified by the Company to the A',\n",
              "    'Highlight the parts (if any) of this contract related to \"Agreement Date\" that should be reviewed by a lawyer. Details: The date of the contract',\n",
              "    'March 29, 1999',\n",
              "    226,\n",
              "    240),\n",
              "   ('1                                                                 EXHIBIT 10.17\\n\\n                       [MEDICAL MANAGER LETTERHEAD]\\n\\n              TECHNICAL INFRASTRUCTURE MAINTENANCE AGREEMENT\\n\\nDate:                           March 1, 1998\\n\\nContract No.:                   pr-4544\\n\\n                                 Between\\n\\nClient Name:                    MEDICAL MANAGER MIDWEST, INC.                                 53702 Generations Drive                                 South Bend, IN 46635 Principle Contact:              Tom Liddell\\n\\n                                   And\\n\\nCustomer Name:                  MTS, INC.                                 9931 Corporate Service Drive                                 Louisville, KY 40223 Principle Contact:              Gail Knopf\\n\\nANNUAL FEE.    [ ] Technical Support     Hours Maximum: [*]; If                    Retainer $[*]         support extends beyond [*] hours,                                          Support will be charged at [*] per                                          hour.\\n\\n[*].\\n\\nMEDICAL MANAGER, MIDWEST, INC., hereinafter referred to as \"MMMW\", hereby agrees to provide service with respect to the technical infrastructure and MTS, INC., hereinafter referred to as \"Customer\", agrees to accept such service, subject to the following terms and conditions:\\n\\nTHE ATTACHED TERMS AND CONDITIONS ARE PART OF THIS AGREEMENT. THIS AGREEMENT IS THE SOLE AND EXCLUSIVE AGREEMENT BETWEEN THE PARTIES RELATING TO SERVICES FOR THE ABOVE ITEMS. THE \"Customer\" HAS READ THIS AGREEMENT, UNDERSTANDS IT AND AGREES TO BE BOUND BY IT.\\n\\n                           TERMS AND CONDITIONS\\n\\n1. TECHNICAL INFRASTRUCTURE\\n\\n      (a)      Technical Infrastructure Maintenance Agreement covers                   applicable items that make up the underlying technical                   infrastructure that is required to run an application. This                   would include items such as hardware, operating system,                   network connections, etc.\\n\\n      (b)      Maintenance refers to the services involved in maintenance of                   equipment already purchased.\\n\\n      (c)      This Agreement shall be effective on the date of signed                   acceptance (\"Effective Date\") by MMMW.\\n\\n      (d)      Renewal agreement shall be effective on the \"Effective Date\"                   if it is signed and returned to MMMW by the \"Effective Date.\"\\n\\n      (e)      Renewal agreement not signed and received by MMMW by the                   \"Effective Date\" will suspend all coverage of technical                   infrastructure support between the \"Effective Date\" and the                   actual date of receival of the renewal technical                   infrastructure maintenance agreement. Services provided                   between these two dates are billable.\\n\\n[*] Confidential portions omitted and filed separately with the Securities and     Exchange Commission.\\n\\n2 2.  TERM\\n\\n (a)   MMMW provided Customer with an all inclusive warranty for a period of           12 months commencing on the date of installation to include system           purchased by Customer from MMMW. Upon expiration of that 12 months,           MMMW affords the Customer the opportunity of a continuation of support           on an annual basis as follows: The Initial Term of this Technical           Infrastructure Maintenance Agreement is twelve months, commencing on           the Effective Date. The support agreement will be subject to prior           inspection and acceptance of the hardware for service and to the           Customer\\'s payment of any charges for the inspection and/or the           pre-agreement servicing and repair of the hardware, such estimates to           be approved in advance by Customer.\\n\\n (b)   MMMW shall make two options of hardware support available to Customer:\\n\\n       TECHNICAL SUPPORT RETAINER is a Support Plan that allows the Customer\\n\\n\\n\\n\\n\\n       to pay a Retainer that provides technical Related Support by qualified           Support Analysts and Field Technicians. This Support Plan covers a 12',\n",
              "    'Highlight the parts (if any) of this contract related to \"Agreement Date\" that should be reviewed by a lawyer. Details: The date of the contract',\n",
              "    'March 1, 1998',\n",
              "    228,\n",
              "    241),\n",
              "   (\"Exhibit 10.47   Cooperation Agreement of 50MWp Photovoltaic Grid-connected Power Generation Project in Yangqiao of Fenyi County   Party A: People's Government of Fenyi County Party B: Xinyu Xinwei New Energy Co., Ltd.   Party A welcomes and supports Party B to invest and develop new energy project in Fenyi County, and Party B is willing to invest and build 50MWp photovoltaic grid-connected power generation project in Fenyi County; both parties, in the principle of equality, mutual benefits, win-win cooperation and solid progress, reach the following cooperation agreement as for relevant matters of the project:   I. Party A supports and guarantees the project construction and development of Party B, and will provide the most preferential policies and all- round service in the aspects of preliminary work, construction and grid-connected of the project, and actively coordinate relevant departments and units to help Party B accelerate project construction progress. Party B will give full play to the advantages in funds, talents, technologies, and etc. to accelerate the preliminary work progress of the project, ensure the early commencement of the project and produce benefits upon early completion.   II. As required by Party B building PV grid-connected power station project, Party A accepts the Cooperation Agreement of 50MWp Photovoltaic Grid-connected Power Generation Project in Yangqiao Town of Fenyi County signed by Party B and Yangqiao Town of Fenyi County, and actively coordinates Yangqiao Town to perform relevant responsibilities.   III. In the principle of win-win cooperation, based on 50MWp photovoltaic grid-connected power generation project in Yangqiao Town, Party B will vigorously promote the application of PV products, improve local energy-saving and emission reduction benefits, increase local fiscal levy, enhance villagers' income and increase villagers' employment.   IV. Party B promises that land nature will not be changed for building large-scale PV grid-connected power generation project in the plot; comprehensive development will be carried out according to relevant national stipulations, such commercial crops will be interplanted as agriculture and forestry as well as medicinal materials; local employees will enjoy the priority to be employed; local building materials will be adopted and relevant expenses will be paid on schedule.   V. Party B will register a foreign-funded company in Fenyi County before implementing the project; Party A will offer all the preferential policies to the company as per local investment promotion policies for foreign investment introduction.   Party A: People's Government of Fenyi County (seal) Rao Cheng (signature) June 25, 2014   Party B: Xinyu Xinwei New Energy Co., Ltd. (seal) Xiahou Min (signature) June 25, 2014\",\n",
              "    'Highlight the parts (if any) of this contract related to \"Agreement Date\" that should be reviewed by a lawyer. Details: The date of the contract',\n",
              "    'June 25, 2014',\n",
              "    2709,\n",
              "    2722),\n",
              "   ('1                                                                    EXHIBIT 10.17\\n\\n               PRODUCT DEVELOPMENT AND CO-BRANDING AGREEMENT\\n\\n                         \"SONGS 4 WORSHIP SERIES\"\\n\\n                      EXCLUDING CONFIDENTIAL PORTIONS\\n\\n/1/ Indicates information which has been redacted pursuant to a request for     confidential treatment.\\n\\n2\\n\\n                    INDEX TO THE CONFIDENTIAL PORTIONS\\n\\n      PAGE                      SECTION                     LINE(S)          ----                      -------                     -------                                                             1                          1(c)                    3, 4, and 5           3                          3(a)              4, 5, 10, 11, 12 and 13           4                          4(c)                     2, 4 and 5           4                          4(d)                   2, 3, 4 and 5           5                           5                           2\\n\\n3\\n\\n               PRODUCT DEVELOPMENT AND CO-BRANDING AGREEMENT                             \"SONGS 4 WORSHIP SERIES\"\\n\\n      This Agreement, entered into this the 10th day of January 2000, by and between INTEGRITY INCORPORATED, a Delaware corporation with principal offices at 1000 Cody Road, Mobile, Alabama (\"Integrity\") and TIME LIFE, INC., a Delaware corporation d/b/a Time Life Music, with principal offices located at 2000 Duke Street, Alexandria, Virginia 22314 (\"TL\"). The parties wish to produce a series of recorded compilations and companion song books featuring praise and worship repertoires, which will be co-branded and co-marketed throughout the world. Now, therefore, the parties agree as follows:\\n\\n1.       Product Concept and Creation.\\n\\n      a.       Product description. The product to be created under the                   series trade name \"Songs 4 Worship\" will be a praise and                   worship continuity series, with each volume in the series                   containing approximately 22 songs. Each volume will be                   manufactured in Double CD, Double Cassette, and song book                   formats, with standard double jewel boxes, inlays, booklets                   and j-cards (the \"Product\"). TL and Integrity will jointly                   develop the repertoire, and all repertoire selections are                   subject to master, mechanical and print rights clearance in                   accordance with the financial terms established below. The                   exact songbook format, song selection and number of songbook                   volumes has not yet been determined, and TL has no obligation                   to sell any songbooks produced pursuant to this Agreement.\\n\\n      b.       Branding. The Product will prominently display the \"Songs 4                   Worship\" logo and trademark (or other logo as mutually                   approved) and will also bear the labels of \"Time Life Music\"                   and \"Integrity Music\" in equal proportion on the exterior of                   Product packaging. The \"Integrity Music\" and \"Time Life Music\"                   logos will be used on advertising whenever possible, and it is                   understood that neither logo will be used without the other                   with reference to the Product.\\n\\n      c.       Integrity\\'s responsibilities. Integrity will obtain master                   lease and print agreements with all third party owners of                   masters embodied in the Product at its own expense. Mechanical                   rates will not exceed [**]/1/ percent ([**]/1/%) of the                   then-current statutory rate, and Print licenses will not                   exceed a prorated portion of [**]/1/ percent ([**]/1/%) of the                   retail selling price, Integrity will also manufacture the                   Product and sell to TL its requirements for resale.\\n\\n--------------- /1/ Indicates information which has been redacted pursuant to a request for     confidential treatment.\\n\\n4\\n\\nSource: INTEGRITY MEDIA INC, 10-K405, 3/29/20',\n",
              "    'Highlight the parts (if any) of this contract related to \"Agreement Date\" that should be reviewed by a lawyer. Details: The date of the contract',\n",
              "    '10th day of January 2000',\n",
              "    1135,\n",
              "    1159),\n",
              "   ('EXHIBIT 10.25                                RESELLER AGREEMENT\\n\\nTHIS AGREEMENT (the \"AGREEMENT\") entered into as of the 19 day of March, 2004 (the \"EFFECTIVE DATE\") provides the terms and conditions under which MediaNet Group Technologies, Inc., a Nevada corporation having an address at 5100 W. Copans Road Suite 710 Margate, FL 33063 USA (\"MEDIANET GROUP TECHNOLOGIES\"), authorizes International Direct Response, Inc., a Pennsylvania Corporation, having an address at 1125 Lancaster Avenue, Berwyn, PA 19312(\"RESELLER\") to be its true and lawful representative and agent for the purpose of reselling licenses of the MediaNet Group Technologies Portals (\"PORTALS\") and other MediaNet Group Technologies products and services in accordance with the terms and conditions contained in this Agreement. This Agreement, together with the other agreements and schedules referenced in it, contains the complete terms and conditions between the parties.\\n\\nMEDIANET GROUP TECHNOLOGIES AND RESELLER AGREE AS FOLLOWS:\\n\\n1.   LICENSE\\n\\nReseller is hereunder licensed to market MediaNet Group Technologies\\' Brand-A-Port portals (\"PORTALS\") and to resell MediaNet Group Technologies products and services for compensation in accordance with the annexed \"RESELLING SCHEDULE.\" Under the terms and conditions as outlined in this Agreement.\\n\\n2.   RESELLING\\n\\nThe Reseller intends to market the Portals to companies and various businesses and individuals (\"BUYERS\") who may include corporations, small businesses, religious organizations, network marketing, franchise, business opportunities, chains, charities, organizations and other companies that would have a use for individual and multiple portals. The purpose of this Agreement is to define the scope of compensation for the marketing of Portals to these potential customers. During the Term of this Agreement, Reseller shall have the right to market Brand-A-Port Portals, both through the existing Brand-A-Port Portal under the License and independently to Buyers for resale, subject to approval by MediaNet Group Technologies.\\n\\n3.   COMPENSATION\\n\\nMediaNet Group Technologies shall pay Reseller a fee in accordance with the annexed Fee Schedule. MediaNet Group Technologies will remit payment as directed by Reseller in the time frames noted on the Compensation Schedule attached hereto.\\n\\n4.   PUBLICITY AND ADVERTISING\\n\\nSubject to Section 7, Reseller and MediaNet Group Technologies agree that broad publicity with respect to the relationship developed by this Agreement, and the advantages of such relationship, will be permitted and actively encouraged and supported by both parties. This publicity initiative will include, but is not limited to, a press releases issued by Reseller and MediaNet Group Technologies, publicizing the strategic alliance between the parties, on site promotion and email campaigns. In this regard, Reseller and MediaNet Group Technologies shall agree on the form, content of the press release prior to its release. MediaNet Group Technologies must approve any advertising prior to issuance and placement.\\n\\n5.   PROPRIETARY RIGHTS\\n\\n5.1 OWNERSHIP. RESELLER understands and agrees that MediaNet Group      Technologies is the exclusive holder of and shall retain, all right, title      and interest in and to the Portal, Content and Engine and the All Pages,      including without limitation all intellectual Property therein site      (EXCLUDING PROPRIETARY PAGES PROVIDED BY RESELLER OR BUYERS).\\n\\nReseller Agreement                                     Initials ______   _______                                        1\\n\\n5.2 INTELLECTUAL PROPERTY. Nothing herein shall grant a party any right,      title or interest in the other party\\'s Intellectual Property, except as      explicitly set forth herein. At no time during or after the Term of this      Agreement shall a party challenge or assist others to challenge the other      party\\'s Intellectual Property or the registration thereof or attempt to      register any trademarks, marks or trade names confusingly similar to those      or the other party.\\n\\n5.3 INTELLECTUAL P',\n",
              "    'Highlight the parts (if any) of this contract related to \"Agreement Date\" that should be reviewed by a lawyer. Details: The date of the contract',\n",
              "    '19 day of March, 2004',\n",
              "    121,\n",
              "    142),\n",
              "   ('Exhibit 10.2    INTELLECTUAL PROPERTY AGREEMENT        between        SONY ELECTRONICS INC.        and        GSI TECHNOLOGY, INC.        August 28, 2009\\n\\n\\n\\n\\n\\n     TABLE OF CONTENTS\\n\\n   i\\n\\n    Page        1. Definitions 1            1.1 IP Agreement 2    1.2 Asset Purchase Agreement 2    1.3 Effective Date 2    1.4 Licensed Patent(s) 2    1.5 Transferred Patent(s) 3         2. Assignment 3         3. Licenses 3            3.1 Grant by SONY 3    3.2 Grant Back by PURCHASER 4    3.3 No Implied License or Other Assignment 4    3.4 No Sublicense Rights 4         4. Each Party\\'s Sole Right to the Intellectual Property 4         5. Restrictions on Use of SONY Trademarks 5            5.1 No Trademark License 5    5.2 Removal of SONY Trademarks 5    5.3 Packaging 5    5.4 No Affiliation 6    5.5 JTAG / Mask Works 6         6. Payment 6         7. Term and Termination 7            7.1 Term 7    7.2 Termination 7    7.3 Insolvency 7    7.4 Continuing Obligations 8         8. Representations and Warranties 8            8.1 Power and Authority 8    8.2 Essential Patents 8    8.3 Ownership 8    8.4 Validity and Enforceability 8    8.5 Sufficiency 9    8.6 Non-infringement by the Business 9    8.7 Infringement by a Third Party 10    8.8 Intellectual Property Development 10\\n\\n\\n\\n\\n\\n     TABLE OF CONTENTS  (continued)\\n\\n   ii\\n\\n    Page           8.9 Material Intellectual Property Agreements 11    8.10 Royalties 11    8.11 No Loss of Rights 12    8.12 Transferability 12    8.13 No SRAM Product Warranty Issues 12    8.14 Disclaimer 12         9. Miscellaneous 13            9.1 Notices 13    9.2 Expenses 14    9.3 Successors and Assigns 14    9.4 Waiver 15    9.5 Entire Agreement 15    9.6 Amendments and Supplements 15    9.7 Rights of Third Parties 15    9.8 Further Assurances 16    9.9 Applicable Law 16    9.10 Execution in Counterparts 16    9.11 Titles and Headings 16    9.12 Invalid Provisions 16    9.13 Transfer Taxes 17    9.14 Attorneys\\' Fees 17\\n\\n\\n\\n\\n\\n     INTELLECTUAL PROPERTY AGREEMENT     This Intellectual Property Agreement is made and entered into as of August 28, 2009 by and between GSI Technology, Inc., a Delaware  corporation (\"PURCHASER\"), on the one hand, and Sony Electronics Inc. (\"SONY\"), a Delaware corporation, on the other hand. PURCHASER  and SONY are referred to individually as a \"Party\" and collectively as the \"Parties\".     RECITALS     WHEREAS, SONY presently conducts the business of manufacturing, marketing and selling SRAM products (the \"Business\");     WHEREAS, SONY has agreed to sell and PURCHASER has agreed to purchase certain assets, rights and properties of SONY used or  useful in connection with the Business, all on the terms and subject to the conditions set forth in the Asset Purchase Agreement of even date  herewith;     WHEREAS, SONY has or will transfer title to the Transferred Assets to PURCHASER under the Asset Purchase Agreement;     WHEREAS, SONY is the owner of certain intellectual property related to the Business; and     WHEREAS, SONY desires to transfer certain patents to PURCHASER and grant to PURCHASER a license under certain intellectual  property related to the SRAM Products.     NOW, THEREFORE, in consideration of the mutual covenants, representations, warranties and agreements herein contained, the Parties  hereto agree as follows:     1. Definitions     As used in this IP Agreement, all capitalized terms shall have the meaning ascribed to them as set forth in the Asset Purchase  Agreement, except for terms defined herein, including the following terms, which shall have the meanings set forth below:     1\\n\\n\\n\\n\\n\\n     1.1 IP Agreement     The term \"IP Agreement\" means this Intellectual Property Agreement, including all attached Exhibits hereto, and any  amendments or supplements agreed to in writing and signed by SONY and PURCHASER.     1.2 Asset Purchase Agreement     The term \"Asset Purchase Agreement\" means the Asset Purchase Agreement dated August 28, 2009 between SONY and  PURCHASER to which this IP Agreement is attached as Exhibit F.     1.3 Effective Date     The term \"Effective Date\" me',\n",
              "    'Highlight the parts (if any) of this contract related to \"Agreement Date\" that should be reviewed by a lawyer. Details: The date of the contract',\n",
              "    'August 28, 2009',\n",
              "    138,\n",
              "    153),\n",
              "   ('ENDORSEMENT LICENSING AND CO-BRANDING AGREEMENT   This ENDORSEMENT LICENSING AND CO-BRANDING AGREEMENT is entered into on July 26, 2013 (the \"Effective Date\") by and between Marine MP, LLC (\"Lender\"), for services of Arnold Schwarzenegger (\"Endorser\"), and Fitness Publications, Inc. (\"Fitness\") (collectively, Lender, Endorser, and Fitness are referred to as the \"AS Parties\") and MusclePharm Corporation with its principal place of business in Denver, Colorado and its subsidiaries, (collectively, \"MusclePharm\" or the \"Company\").   RECITALS   WHEREAS, the AS Parties have the rights necessary to license the use of the rights of publicity with respect to name, voice, approved signature, approved photographs, approved images, and approved likenesses of Arnold Schwarzenegger (the \"Name and Appearance Rights\") and the use of the Name and Appearance Rights as trademarks or service marks (the \"Trademarks\"); and   WHEREAS, MusclePharm is engaged in the business of developing and marketing nutritional products for athletes and fitness enthusiasts, and   WHEREAS, MusclePharm from time to time uses consumer, celebrity, and expert endorsements or testimonials to promote MusclePharm Products (as defined in Section 2(b) of this Agreement) in marketing and advertising materials, and   WHEREAS, MusclePharm desires to develop, market, promote and sell in conjunction and in cooperation with the Endorser a unique Arnold Schwarzenegger customized product line approved by the Endorser initially comprised of between four to eight (4 to 8) products, subject to Section 2(b) below), that will be marketed and advertised under the Endorser\\'s name and likeness, all subject to the Endorser\\'s approval, as described in Section 12, (the \"AS Product Line\"); and   WHEREAS, MusclePharm desires to engage Endorser, and Endorser desires to accept the engagement, as more fully described in this Agreement, whereby Endorser will lend his name, reputation, and appearance to (i) endorse and promote MusclePharm and its Products and (ii) to develop the AS Product Line and several related promotional giveaway items that will depict the Endorser\\'s name and likeness solely in conjunction with the MusclePharm logo or images of the AS Product Line on the permitted promotional products (the \"Promotional Products\") set forth on Exhibit A attached hereto, as may be amended in writing by the parties hereto from time to time (collectively, the Promotional Products and the AS Product Line are referred to as the \"Licensed Products\").   NOW, THEREFORE, in consideration of the mutual promises and agreements set forth below, the parties agree as follows:\\n\\n\\n\\nSource: MUSCLEPHARM CORP, 10-K/A, 2/8/2017\\n\\n\\n\\n\\n\\n\\n\\n  1. Term:   (a) This Agreement shall have an Initial Term of three (3) years. The Term shall commence on July 23, 2013 and shall expire on July 22, 2016, unless otherwise terminated earlier pursuant to Section 9 of this Agreement. The period from July 23, 2013 to July 22, 2014 shall be referred to as the \"First Contract Year\". The period from July 23, 2014 to July 22, 2015 shall be referred to as the \"Second Contract Year\". The period from July 23, 2015 to July 22, 2016 shall be referred to as the \"Third Contract Year\".   (b) In the event that MusclePharm shall achieve Net Sales (as defined below) of $20 million (the \"First Renewal Threshold\") in the aggregate during the Third Contract Year, then this Agreement shall automatically be renewed for an additional term of three (3) years (the \"First Additional Term\") on the same terms and conditions for the Initial Term except that: (i) no additional Stock Compensation (as defined below) shall be issued in connection with the renewal Term, (ii) the Cash Compensation for the First Additional Term shall be as set forth in Section 7 and Exhibit \"C\" Section (2) attached hereto, (iii) Endorser shall only be obligated to make two (2) Appearances in each Contract Year during the First Additional Term pursuant to Section 4(a)(ii) below and (iv) the marketing budget to promote the Licensed Products shall be $5.0 million during each Contract Ye',\n",
              "    'Highlight the parts (if any) of this contract related to \"Agreement Date\" that should be reviewed by a lawyer. Details: The date of the contract',\n",
              "    'July 26, 2013',\n",
              "    122,\n",
              "    135),\n",
              "   ('Exhibit 10.12 Certain identified information has been excluded because it is both not material and would likely cause competitive harm if publicly disclosed.\\n\\nMaster Service Agreement This Master Service Agreement (\"Agreement\"), entered into on May 25th, 2018 by and between CRO Consulting (Pty) Limited, whose Registered Office is at OnQ House 250 Market Street Fairland Johannesburg 2170 South Africa (hereinafter referred to as \"CRO\") and Purinix Pharmaceuticals LLC whose Registered Office is at 1266 East Main Street, Suite 700R, Stamford, CT 06902, USA (hereinafter referred to as \"Client\"). 1.0 Services 1.1. Client requires CRO to carry out Clinical Research Services in South Africa (\"Services\"). CRO will carry out the tasks agreed and summarised in the Addenda to this Master Service Agreement. 1.2. This Agreement forms the basis for a working relationship between Client and CRO. This Agreement will be supplemented, in the form of Project-specific Addenda, as the need arises. The Project-specific Addenda will contain the detailed requirements of each Project for which Services are contracted to CRO by Client and all fees to be paid by Client. 1.3. Client will provide CRO with the documents and information necessary as requested by CRO for the conduct of the Services. 1.4. CRO agrees to perform the specific tasks set forth in the Project-specific Addenda in a professional manner, in strict accordance with the terms and conditions contained herein, relevant professional standards including in accordance with the Protocol and applicable amendments and ICH GCP Guidelines (ICH Harmonised Tripartite Guideline for Good Clinical Practice, May 1996) and all other relevant laws, rules, regulations and guidelines. 1.5. CRO agrees to perform these Services according to CRO\\'s Standard Operating Procedures (SOPs) or other guidelines as provided, which are provided to Client on request. 1.6 CRO may not subcontract any parts of the Services to a third party without the prior written approval of Client, which approval shall not unreasonably be withheld. CRO will remain fully liable for the acts and omissions of its employees and approved subcontractors as if performed by CRO. 1.7 CRO will provide Client with a weekly written report summarizing the Services including all clinical study activity and any other information reasonably requested by Client. 2.0 Payment 2.1 Client will pay CRO for satisfactory performance of Services as agreed in each Project-specific Addendum to this Agreement. Confidential Page 1 of 7 Initials: CL MD Version Jan16_v1\\n\\n\\n\\n\\n\\nCertain identified information has been excluded because it is both not material and would likely cause competitive harm if publicly disclosed. 2.2 Routine telephone calls, mobile calls, faxes and photocopying will be included in the rate provided by CRO. For clarity, there shall be no payment obligations other than as agreed in each Project-specific Addendum. 2.4 CRO will provide a detailed account of all time and tasks, as against project specific task and time addenda, and will be payable within 30 days of receipt of invoice by Client. 2.5. Changes in scope may be incorporated into this Agreement or the Project-specific Addenda upon the written consent of both parties. 2.6. In the event of a conflict between the terms of this Agreement and the Project-specific Addenda the terms of this Agreement shall prevail unless specifically stated in the Project-specific Addenda. 3.0 Period of the Agreement 3.1. This Agreement shall take effect on the date of signature of the Agreement by both parties and shall terminate when all obligations required of both parties hereunder are performed unless either terminated earlier or extended by the parties pursuant to the terms of this Agreement subject to clause 4.0. 4.0 Termination 4.1. Either party may terminate this Agreement on thirty (30) days written notice if the other materially breaches this Agreement; provided, however that the party in breach shall have the right to cure such breach within thirty (30) days after receipt of written notice of the ot',\n",
              "    'Highlight the parts (if any) of this contract related to \"Agreement Date\" that should be reviewed by a lawyer. Details: The date of the contract',\n",
              "    'May 25th, 2018',\n",
              "    245,\n",
              "    259),\n",
              "   ('Exhibit 10.4 CONSULTING AGREEMENT This Consulting Agreement (\"Agreement\") is made and entered into as of May 1, 2019 (\"Effective Date\") by and between Driven Deliveries, Inc. (\"Company\"), a Nevada corporation, and TruckThat LLC (\"Consultant\"). Company and Consultant shall sometimes be referred to herein singularly as a \"Party\" or collectively as the \"Parties\" to this Agreement. WHEREAS, the Company desires to retain Consultant as an independent contractor to perform consulting services for the Company, and Consultant is willing to perform such services on the terms set forth below. In consideration of the mutual promises contained here, the Parties hereby agree as follows: 1. Services and Compensation. 1.1. Services. Consultant shall perform the following services: - The Consultant will provide the Company services as a Strategic Marketing & Fundraising Consultant. - The Consultant shall be responsible for the strategic planning of business expansion, including Fundraising and Stock Promotion, of the Company and its subsidiaries. - These Services shall include Marketing guidance and support, not limited to: โ Graphics โ Web โ Social โ Brand - These Services will include updates to investor decks, customer sales decks and other marketing material available to the public - The Company will provide the Consultant with the appropriate level of resources and information to perform such duties, and the Consultant shall be reimbursed for fees and expenses approved by the Company. - The Consultant will report directly to the CEO of the and will keep the CEO informed of all matters concerning the Services as requested by the CEO from time to time. - The Consultant acknowledges that he may be required to travel in order to provide the Services. 1.2 Compensation. The Company shall pay Consultant a flat fee consulting rate of $18,000 per month. 1.3 Expenses. The Company shall reimburse Consultant, in accordance with Company policy, for all reasonable expenses incurred by Consultant in performing the Services pursuant to this Agreement, but only if Consultant receives written consent from an authorized agent of the Company prior to incurring such expenses and submits receipts for such expenses to the Company in accordance with the Company\\'s general expense reimbursement policies.\\n\\nTruckThat LLC Consulting Agreement Page 1 of 7\\n\\n\\n\\n\\n\\n2. Confidentiality. 2.1. Definition of Confidential Information. \"Confidential Information\" means any nonpublic information that relates to the actual or anticipated business and/or products, research or development of the Company, its affiliates or subsidiaries, or to the Company\\'s, its affiliates\\' or subsidiaries\\' technical data, trade secrets, or know-how, including, but not limited to, research, product plans, or other information regarding the Company\\'s, its affiliates\\' or subsidiaries\\' products or services and markets therefore, customer lists and customers (including, but not limited to, customers of the Company on whom Consultant called or with whom Consultant became acquainted during the term of this Agreement), software, developments, inventions, processes, formulas, technology, designs, drawings, engineering, hardware configuration information, marketing, finances, and other business information disclosed by the Company, its affiliates or subsidiaries, either directly or indirectly, in writing, orally or by drawings or inspection of premises, parts, equipment, or other property of Company, its affiliates or subsidiaries. Notwithstanding the foregoing, Confidential Information shall not include any such information which Consultant can establish (i) was publicly known or made generally available prior to the time of disclosure to Consultant; (ii) becomes publicly known or made generally available after disclosure to Consultant through no wrongful action or inaction of Consultant; or (iii) is in the rightful possession of Consultant, without confidentiality obligations, at the time of disclosure as shown by Consultant\\'s then-contemporaneous written records. 2.2. Nonuse and Nondisclosure. During an',\n",
              "    'Highlight the parts (if any) of this contract related to \"Agreement Date\" that should be reviewed by a lawyer. Details: The date of the contract',\n",
              "    'May 1, 2019',\n",
              "    105,\n",
              "    116),\n",
              "   ('EXHIBIT 10.15\\n\\n                      SPONSORSHIP AND DEVELOPMENT AGREEMENT\\n\\n      This Agreement is made as of August 6, 2004 (the \"Effective Date\") by and between TEKNIK DIGITAL ARTS INC., a Nevada corporation with offices at 7377 E. Doubletree Ranch Road, Suite 270, Scottsdale, Arizona 85258 (\"TDA\") and RICK SMITH ENTERPRISES (\"Smith\"), c/o GAYLORD SPORTS MANAGEMENT, 14646 N. Kierland Blvd., Suite 230, Scottsdale, Arizona 85254 Attention: Steve Loy.\\n\\n                                    RECITALS\\n\\n      TDA is in the business of developing and publishing interactive entertainment software products. TDA desires to have Smith assist in the development, endorsement and publicizing of TDA\\'s golf instruction related software products.\\n\\n      THEREFORE, TDA and Smith agree as follows:\\n\\n1.    DEVELOPMENT, PRODUCTION, COMMERCIAL AND PUBLICITY SERVICES\\n\\n      1.1 General. Smith agrees to cooperate, consult with and aid TDA in connection with the development of TDA\\'s \"Golf Instruction Related Product\" (hereinafter defined) and the advertising, marketing and publicity thereof. As used herein, the term \"Golf Instruction Related Product\" shall mean any interactive entertainment software product related to golf instruction which is produced and released during the \"Term\" (hereinafter defined in Section 5.1) and which may be published in multiple versions (e.g., versions for play on handheld mobile devices (including cell phones), for sale in any and all territories.\\n\\n2.    GRANT OF RIGHTS; COOPERATIONS\\n\\n      2.1 Publicity Rights. Smith hereby grants to TDA the following rights (the \"Rights\"):\\n\\n            (a) the right to use and reuse Smith\\'s name, voice, likeness,       facsimile signature, personal statistics, biographical information and any       reproduction or simulation thereof (\"Smith\\'s Likeness\") in TDA\\'s Golf       Instruction Related Products and on packaging for TDA\\'s Golf Instruction       Related Products in any fashion, said grant of rights being limited to the       world (the \"Contract Territory\")\";\\n\\n            (b) the right to use and reuse Smith\\'s Likeness in TDA\\'s general       internal, non-public corporate promotional materials (such as TDA\\'s Annual       Report), corporate advertising and in other forms of publicity;\\n\\n            (c) the right to use and reuse Smith\\'s Likeness in and in connection       with the marketing, advertising, promoting and publicizing of TDA\\'s Golf       Instruction Related Products, by any and all means now known or hereafter       developed;\\n\\n            (d) the exclusive right to use and reuse the results and proceeds of       the in connection with TDA\\'s Golf Instruction Related Products; and\\n\\n            (e) with Smith\\'s prior reasonable approval, the right to license to       third parties any of the foregoing rights but only in connection with or       directly related to the marketing and sale of TDA\\'s Golf Instruction       Related Products.\\n\\nSmith agrees to cooperate in good faith with TDA in connection with TDA\\'s exercise of the Rights in accordance with the terms of this Agreement.\\n\\n      2.2 Limitations of License\\n\\n            (a) The Rights granted in Section 2.1 above will only be used by TDA       in connection with its Golf Instruction Related Products. TDA does not       have the right to use the Rights in any product whatsoever released before       or after the Term.\\n\\n            (b) TDA shall not utilize Smith\\'s Likeness in a manner that would       constitute an endorsement of any product or service other than TDA\\'s Golf       Instruction Related Products.\\n\\n                                       1\\n\\n      2.3 Smith as Featured Swing Instructor. TDA agrees that Smith will be the featured Instructor on all packaging of, and promotional materials related to, TDA\\'s Golf Instruction Related Product.\\n\\n      2.4 No Obligation to Use. Except as set forth in Section 2.3 above, the payment to Smith of the sums required under this Agreement shall fully discharge all obligations of TDA to use Smith\\'s Likeness under this Agreement.\\n\\n      2.5 Approvals. TDA agrees that no us',\n",
              "    'Highlight the parts (if any) of this contract related to \"Agreement Date\" that should be reviewed by a lawyer. Details: The date of the contract',\n",
              "    'August 6, 2004',\n",
              "    111,\n",
              "    125),\n",
              "   ('Exhibit 10.17\\n\\nIMMUNOTOLERANCE, INC.\\n\\nCONSULTING AGREEMENT\\n\\nThis Consulting Agreement (the \"Agreement\"), made this 27t h day of March, 2017 is entered into by Immunotolerance, Inc., a Delaware corporation (the \"Company\"), and Alan Crane, an individual (the \"Consultant\").\\n\\nWHEREAS, the Company and the Consultant desire to establish the terms and conditions under which the Consultant will provide services to the Company.\\n\\nNOW, THEREFORE, in consideration of the mutual covenants and promises contained herein and other good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged by the parties hereto, the parties agree as follows:\\n\\n1. Services. The Consultant agrees to perform such consulting, advisory and related services to and for the Company as may be reasonably requested from time to time by the Company, including, but not limited to, the services specified on Schedule A to this Agreement. The Consultant also agrees to provide the Company with related services that may be requested from time to time by the Company. During the Consultation Period (as defined below) and for a period of one year thereafter, except in connection with his performance of the Services, the Consultant shall not engage in any activity in the field described on Schedule A to this Agreement, and he shall not assist any other person or organization that engages in any such activity.\\n\\n2. Term. This Agreement shall commence on the Effective Date and shall continue until the four-year anniversary of the Effective Date (such period, as it may be extended, either by the mutual written agreement of the parties or automatically, or earlier terminated being referred to as the \"Consultation Period\"), unless sooner terminated in accordance with the provisions of Section 4, and shall automatically renew for successive one-year periods, unless the Company provides 90 days\\' notice of termination before any such successive period.\\n\\n3. Compensation.\\n\\n3.1 Shares. In connection with the execution of this Agreement, Consultant and Company shall enter into a Restricted Stock Agreement. Subject to approval of the Board of Directors of the Company, the Company shall issue and sell to the Consultant, and the Consultant shall purchase from the Company, subject to the terms and conditions set forth in this Agreement and the Restricted Stock Agreement, 1,990,000 shares (the \"Shares\") of common stock, $0.0001 par value, of the Company (\"Common Stock\"), at a purchase price of $0.0001 per share, for an aggregate purchase price of $190. Such Shares are in addition to the 10,000 shares of Common Stock held by the Consultant as of the date hereof. The Consultant agrees that the Shares shall be subject to the terms of the Restricted Stock Agreement.\\n\\n3.2 Expenses. The Company shall reimburse the Consultant for all reasonable and necessary documented out of pocket expenses incurred or paid by the Consultant in connection with, or related to, the performance of Consultant\\'s services under this Agreement.\\n\\n\\n\\n\\n\\nThe Consultant shall submit to the Company itemized monthly statements, in a form satisfactory to the Company, of such expenses incurred in the previous month. The Company shall pay to the Consultant amounts shown on each such statement within thirty (30) days after receipt thereof.\\n\\n3.3 Benefits. The Consultant shall not be entitled to any benefits, coverages or privileges, including, without limitation, health insurance, social security, unemployment, medical or pension payments, made available to employees of the Company.\\n\\n4. Termination. The Company may terminate the Consultation Period at any time for Cause (as defined below). In the event of such termination, the Consultant shall be entitled to payment hereunder and for expenses paid or incurred prior to the effective date of termination. Such payments shall constitute full settlement of any and all claims of the Consultant of every description against the Company. Notwithstanding the foregoing, the Company may terminate the Consultation Period effective immediately upon receipt of written',\n",
              "    'Highlight the parts (if any) of this contract related to \"Agreement Date\" that should be reviewed by a lawyer. Details: The date of the contract',\n",
              "    '27t h day of March, 2017',\n",
              "    115,\n",
              "    139),\n",
              "   ('CELEBRITY ENDORSEMENT AGREEMENT     THIS AGREEMENT is made as of this March 14, 2012 but effective as of March 1, 2012 (\"Effective Date\") by and between Bizzingo, Inc., a Nevada  corporation with offices at 63 Main Street, Suite 202, Flemington, NJ 08822 (\"Bizzingo\") and Joseph Theismann, an individual whose address is 21495  Ridgetop Circle, Suite 304A, Sterling Virginia 20166 (\"Theismann\") (collectively the \"Parties\").     WITNESSETH:     WHEREAS, Theismann is recognized and widely known throughout the world as a retired, hall of fame professional athlete, and sports celebrity; and     WHEREAS, Theismann\\'s name, by virtue of his ability and experience, has acquired a meaning in the mind of the purchasing public important to the  advertising, promotion, and sale of services and merchandise; and     WHEREAS, Bizzingo has developed a B2B interactive platform which engages in business social media including mobile and Internet applications  (\"Network\"); and     WHEREAS, Bizzingo is desirous of acquiring the rights to utilize Theismann\\'s name in connection with the advertisement, promotion, and sale of the  Network as provided herein and Theismann is willing to grant such right     NOW, THEREFORE, in consideration of the mutual covenants set forth herein and for other good and valuable consideration, it is agreed as  follows:     1. GRANT OF RIGHTS. Subject to the terms and conditions set forth herein, Theismann hereby grants to Bizzingo and its affiliates the unlimited  right and privilege during the Term (as defined herein) and within the Territory to use the Property (as defined herein) in connection with the  advertisement, promotion, and sale of the Network in the Territory whether through film, television, radio, print and Internet media, including the right to use  the Property in or on the Network. It being understood and agreed that Bizzingo shall have the right to exhibit commercials, infomercials, advertisements and  otherwise make use of all Property on a worldwide basis and that Bizzingo and its affiliates shall be the sole owner of all commercials, promotional materials and  other items produced or created hereunder and all related rights worldwide, including, without limitation, copyright, trademark and intellectual property rights,  subject however to the terms and conditions herein. Theismann agrees to cooperate with Bizzzingo\\'s promotional efforts in this regard. In addition, as  reasonably requested by Bizzingo, Theismann agrees to provide Bizzingo with such signatures, photographs and the like in order to fulfill his obligations  hereunder.\\n\\n1\\n\\nSource: BIZZINGO, INC., 8-K, 3/22/2012\\n\\n\\n\\n\\n\\n   Bizzingo agrees that any use of the Property for advertising, promotional or sale purposes will be approved in advance by Theismann. Theismann  agrees that such material, submitted for approval as provided herein may be deemed by Bizzingo to have been approved hereunder if the same is  not disapproved by the Theismann in writing within fourteen (14) days after Theismann\\'s receipt thereof. Theismann agrees that any material  submitted hereunder will not be unreasonably disapproved and, if it is disapproved, that Theismann shall advise Bizzingo in writing of the specific  grounds therefor at the time of disapproval and provide Bizzingo with specific changes or alterations to such materials. Bizzingo thereafter shall  have the right and privileged to use such Property as provided in this Agreement subject to such changes or alterations.     Except as stated herein, no other rights or privileges are granted to Bizzingo by Theismann.     \"Property\" as stated herein shall mean Theismann\\'s name (including \"Joe Theismann\", \"Theismann\" \"J. Theismann\"), nicknames, initials,  autograph, facsimile signature, photograph, image, likeness, voice, video portrayals, biographical data, character, symbols, and/or other  endorsement, and any variations or deviations thereof.     \"Territory\" as stated herein shall mean worldwide.     2. TERM. Unless sooner terminated under the provisions hereof, this Agreement shall commence on the Effect',\n",
              "    'Highlight the parts (if any) of this contract related to \"Agreement Date\" that should be reviewed by a lawyer. Details: The date of the contract',\n",
              "    'March 14, 2012',\n",
              "    70,\n",
              "    84),\n",
              "   (\"EXHIBIT D JOINT FILING AGREEMENT MFA FINANCIAL, INC. In accordance with Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended, the undersigned hereby confirm the agreement by and among them to the joint filing on behalf of them of the Statement on Schedule 13D and any and all further amendments thereto, with respect to the securities of the above referenced issuer, and that this Agreement be included as an Exhibit to such filing. This Agreement may be executed in any number of counterparts each of which shall be deemed to be an original and all of which together shall be deemed to constitute one and the same Agreement. IN WITNESS WHEREOF, the undersigned hereby execute this Agreement as of July 6, 2020. ATHENE ANNUITY AND LIFE COMPANY By: Apollo Insurance Solutions Group LP, its investment adviser By: AISG GP Ltd., its general partner By: /s/ Matthew S. O'Mara Matthew S. O'Mara Authorized Signatory ATHENE ANNUITY & LIFE ASSURANCE COMPANY By: Apollo Insurance Solutions Group LP, its investment adviser By: AISG GP Ltd., its general partner By: /s/ Matthew S. O'Mara Matthew S. O'Mara Authorized Signatory ATHENE USA CORPORATION By: Apollo Insurance Solutions Group LP, its investment adviser By: AISG GP Ltd., its general partner By: /s/ Matthew S. O'Mara Matthew S. O'Mara Authorized Signatory\\n\\n\\n\\n\\n\\nATHENE LIFE RE LTD. By: Apollo Insurance Solutions Group LP, its investment adviser By: AISG GP Ltd., its general partner By: /s/ Matthew S. O'Mara Matthew S. O'Mara Authorized Signatory ATHENE HOLDING LTD. By: Apollo Insurance Solutions Group LP, its investment adviser By: AISG GP Ltd., its general partner By: /s/ Matthew S. O'Mara Matthew S. O'Mara Authorized Signatory APOLLO INSURANCE SOLUTIONS GROUP LP By: AISG GP Ltd., its general partner By: /s/ Matthew S. O'Mara Matthew S. O'Mara Authorized Signatory AISG GP LTD. By: /s/ Matthew S. O'Mara Matthew S. O'Mara Authorized Signatory APOLLO LIFE ASSET, L.P. By: Apollo Life Asset GP, LLC, its general partner By: /s/ William B. Kuesel William B. Kuesel Vice President\\n\\n\\n\\n\\n\\nAPOLLO LIFE ASSET GP, LLC By: /s/ William B. Kuesel William B. Kuesel Vice President APOLLO CAPITAL MANAGEMENT, L.P. By: Apollo Capital Management GP, LLC, its general partner By: /s/ William B. Kuesel William B. Kuesel Vice President APOLLO CAPITAL MANAGEMENT GP, LLC By: /s/ William B. Kuesel William B. Kuesel Vice President APOLLO MANAGEMENT HOLDINGS, L.P. By: Apollo Management Holdings GP, LLC, its general partner By: /s/ William B. Kuesel William B. Kuesel Vice President APOLLO MANAGEMENT HOLDINGS GP, LLC By: /s/ William B. Kuesel William B. Kuesel Vice President OMAHA EQUITY AGGREGATOR, L.P. By: AP Omaha Advisors, LLC, its general partner By: Apollo Hybrid Value Advisors, L.P., its sole member By: Apollo Hybrid Value Capital Management, LLC, its general partner By: /s/ Joseph D. Glatt Joseph D. Glatt Vice President\\n\\n\\n\\n\\n\\nAP OMAHA ADVISORS, LLC By: Apollo Hybrid Value Advisors, L.P., its sole member By: Apollo Hybrid Value Capital Management, LLC, its general partner By: /s/ Joseph D. Glatt Joseph D. Glatt Vice President APOLLO HYBRID VALUE ADVISORS, L.P. By: Apollo Hybrid Value Capital Management, LLC, its general partner By: /s/ Joseph D. Glatt Joseph D. Glatt Vice President APOLLO HYBRID VALUE CAPITAL MANAGEMENT, LLC By: /s/ Joseph D. Glatt Joseph D. Glatt Vice President APH HOLDINGS, L.P. By: Apollo Principal Holdings III GP, Ltd., its general partner By: /s/ William B. Kuesel William B. Kuesel Vice President APOLLO PRINCIPAL HOLDINGS III GP, LTD. By: /s/ William B. Kuesel William B. Kuesel Vice President\",\n",
              "    'Highlight the parts (if any) of this contract related to \"Agreement Date\" that should be reviewed by a lawyer. Details: The date of the contract',\n",
              "    'July 6, 2020',\n",
              "    713,\n",
              "    725),\n",
              "   ('Exhibit 4.5 SUPPLY AGREEMENT between PROFOUND MEDICAL INC. and PHILIPS MEDICAL SYSTEMS NEDERLAND B.V.\\n\\n\\n\\n\\n\\nTHIS AGREEMENT is made July 31, 2017 BETWEEN: PROFOUND MEDICAL INC., a company incorporated under the laws of the province of Ontario and having its registered address at 2400 Skymark, Unit 6, Mississauga, Ontario L4W 5K5, Canada (hereinafter referred to as \"Customer\") - and - PHILIPS MEDICAL SYSTEMS NEDERLAND B.V., a company incorporated under the laws of the Netherlands with its principal place of business at Veenpluis 4-6 5684 PC Best, the Netherlands (hereinafter referred to as \"Philips\") Customer and Philips hereinafter also collectively referred to as the \"Parties\" and individually as a \"Party\". WHEREAS: A. Pursuant to the Asset and Share Purchase Agreement (the \"Purchase Agreement\") entered into on June 30, 2017 by Customer, Koninklijke Philips NV (\"Philips NV\") N.V. and Customer agreed to execute and deliver (or cause to be executed and delivered) certain ancillary agreements one of which is this Agreement; B. Prior to the consummation of the transactions contemplated by the Purchase Agreement, Philips manufactured the Product in-house and did not outsource the manufacturing to an independent facility, and as a result, Philips has intimate knowledge of the manufacturing process and requirements for the Product; C. Customer originally desired to take over responsibility for the manufacture of the Product immediately upon closing of the transactions contemplated by the Purchase Agreement; D. As Philips historically manufactured the Product in-house, to enable Customer to prepare for and realize the transition of the manufacturing of the Product to Customer\\'s organization, Customer requires the assistance of Philips to continue manufacturing the Product until such time as the manufacturing process can be transitioned to Customer hereunder; E. Until such time as the manufacturing of the Product can be transitioned to Customer in accordance with the terms of this Agreement, Philips agrees to supply, as a contract manufacturer to Customer, on a temporary basis for the Term (as defined herein), the Product, and Customer wishes to buy such Products from Philips under this Agreement;\\n\\n\\n\\n\\n\\nF. Customer acknowledges and agrees that it assumes all obligations and liabilities as the legal manufacturer of the Product as from the Effective Date, on the terms and conditions set out in this Agreement. NOW IT IS HEREBY AGREED as follows: 1. DEFINITIONS The following terms used in this Agreement shall have the meaning set forth below: \"Affiliate\" means, with respect to any Person, any other Person that directly, or indirectly through one or more intermediaries, controls, is controlled by or is under common control with the specified Person. As used in this definition, \"control\", \"controlled by\" and \"under common control with\" means possession, directly or indirectly, of power to direct or cause the direction of management or policies of such Person (whether through ownership of securities or other partnership or ownership interests, as trustee, personal representative or executive or by contract, credit agreement or otherwise), provided that in any event, any Person which owns directly, indirectly or beneficially 50% or more of the securities having voting power for the election of directors or other governing body of a corporation or 50% or more of the partnership interests or other ownership interests of any other Person will be deemed to control such Person. \"Agreement\" means this Supply Agreement including any and all of its Schedules as attached hereto and as may be amended or supplemented from time to time in accordance with the provisions hereof. \"Business Day\" means any day other than a Saturday, Sunday or statutory holiday, in the Province of Ontario or the Netherlands. \"Claim\" means any claim, action, cause of action, demand, lawsuit, arbitration, inquiry, audit, notice of violation, proceeding, litigation, citation, summons, subpoena or investigation of any nature, civil, criminal, administrative, regulatory or other',\n",
              "    'Highlight the parts (if any) of this contract related to \"Agreement Date\" that should be reviewed by a lawyer. Details: The date of the contract',\n",
              "    'July 31, 2017',\n",
              "    130,\n",
              "    143),\n",
              "   ('OUTSOURCING AGREEMENT\\n\\nBY AND BETWEEN\\n\\nTRI CITY NATIONAL BANK\\n\\nand\\n\\nMARSHALL & ILSLEY CORPORATION acting through its division M&I DATA SERVICES\\n\\nDATED AS OF\\n\\nFebruary 16, 1998\\n\\nTABLE OF CONTENTS\\n\\nPage 1. DEFINITIONS  1.1 Background  1.2 Definitions      1.3 References  1.4 Interpretation   2. TERM    2.1 Initial Term     2.2 Extensions  3. APPOINTMENT  3.1 Performance by M&I Affiliates   3.2 Third Party Services  3.3 Proper Instructions   4. CONVERSION   4.1 Banking Applications  4.2 Development of Conversion Plan  4.3 Conversion Resources  4.4 Conversion Milestones      5. OUTSOURCING OF TRUST SERVICES    6. BANKING APPLICATIONS   6.1 Services to be Rendered    6.2 Banking Application Processing  6.3 Corporate Support Services      6.4 Item Processing Services   6.5 Automated Clearing House Services    6.6 Home Banking and Internet Services   6.7 Retail Delivery Systems    6.8 Visa Check/MasterMoney Card Services      6.9 EFT Services     7. FACILITIES MANAGEMENT  8. FEES    8.1 Fee Structure    8.2 Conversion  8.3 Pricing and Operational Assumptions  8.4 Banking Applications Services   8.5 Corporate Support Services      8.6 Item Processing Services   8.7 Management Services   8.8 Visa Check/MasterMoney Card Services      8.9 EFT Services     8.10 Training and Education    8.11 Excluded Costs  8.12 Disputed Amounts     8.13 Terms of Payment     8.14 Modification of Terms and Pricing   9. PERFORMANCE STANDARDS  9.1 General     9.2 Banking Applications  10. MODIFICATION OR TERMINATION OF SERVICES   10.1 Modifications to Services      10.2 Partial Termination by M&I     10.3 Partial Termination by Customer     10.4 Development of Custom Software\\n\\n\\n\\n\\n\\n11. TERMINATION      11.1 For Convenience      11.2 For Cause  11.3 Following Change in Control of Customer  11.4 Termination Assistance    12. EVENTS OF DEFAULT; REMEDIES     12.1 By M&I     12.2 By Customer     12.3 Remedies   13. DAMAGES     13.1 Direct Damages  13.2 No Consequential Damages  13.3 Equitable Relief     13.4 Limitation of Liability   13.5 Liquidated Damages   14. INSURANCE AND INDEMNITY    14.1 Insurance  14.2 Indemnity  14.3 Indemnification Procedures     15. DISPUTE RESOLUTION    15.1 Representatives of Parties     15.2 Continuity of Performance      16. REPRESENTATIONS AND WARRANTIES  16.1 By M&I     16.2 By Customer     17. CONFIDENTIALITY AND OWNERSHIP   17.1 Customer Data   17.2 M&I Systems     17.3 Confidential Information  17.4 Obligations of the Parties     17.5 Security   18. MANAGEMENT OF PROJECT      18.1 Account Representatives   18.2 Change Control Procedures      18.3 Reporting and Meetings    18.4 Development Projects and Technical Support    19. REGULATORY COMPLIANCE      20. DISASTER RECOVERY     20.1 Disaster Recovery Plan    20.2 Relocation      20.3 Resumption of Services    20.4 Annual Test     21. GENERAL TERMS AND CONDITIONS    21.1 Force Majeure   21.2 Transmission of Data      21.3 Equipment and Network     21.4 Reliance on Data     21.5 Data Backup     21.6 Balancing and Controls    21.7 Use of Services      21.8 Regulatory Assurances     21.9 IRS Filing      21.10 Affiliates     21.11 Future Acquisitions      22. MISCELLANEOUS PROVISIONS   22.1 Governing Law   22.2 Venue and Jurisdiction    22.3 Entire Agreement; Amendments   22.4 Assignment      22.5 Relationship of Parties   22.6 Notices    22.7 Headings   22.8 Counterparts    22.9 Waiver     22.10 Severability   22.11 Attorneys\\' Fees and Costs     22.12 Financial Statements     22.13 Publicity      22.14 Solicitation   22.15 No Third Party Beneficiaries  22.16 Construction   23. SOURCE CODE      23.1 Escrow     23.2 Copy of Source Code  23.3 Cost of Escrow  23.4 Customer\\'s Right to Obtain the Source Code    23.5 Use of Source Code\\n\\nSchedules\\n\\n4.2  Conversion Plan 6.2  Banking Application Services 8.1  Fee Schedule\\n\\nExhibits\\n\\nA    RDS Agreement B    ACH Authorization Agreement C    Attorney-in-Fact Appointment D    Affidavit\\n\\nOUTSOURCING AGREEMENT\\n\\n\\n\\n\\n\\n     This Outsourcing Agreement (\"Agreement\") is made as of the 16th day of February, 1998, by and between Tri City National Ban',\n",
              "    'Highlight the parts (if any) of this contract related to \"Agreement Date\" that should be reviewed by a lawyer. Details: The date of the contract',\n",
              "    '16th day of February, 1998',\n",
              "    4032,\n",
              "    4058),\n",
              "   ('Exhibit 10.1 COOPERATION AGREEMENT This Cooperation Agreement (this \"Agreement\"), dated as of May 13, 2020, is by and among MG Capital Management Ltd., a Cayman Islands company limited by shares (\"MG Capital\"), Percy Rockdale LLC, a Michigan limited liability company (\"Percy Rockdale\"), Rio Royal LLC, a Michigan limited liability company (\"Rio Royal\", and together with MG Capital and Percy Rockdale, the \"MG Capital Parties\") and HC2 Holdings, Inc., a Delaware corporation (the \"Company\"). Each of the MG Capital Parties and the Company are referred to herein as a \"Party\" and collectively, as the \"Parties.\" RECITALS WHEREAS, as of the date hereof, the MG Capital Parties may be deemed to beneficially own 2,703,537 shares of the Company\\'s common stock, $0.001 par value per share (the \"Common Stock\"), which represents approximately 5.8% of the Common Stock issued and outstanding on the date hereof; WHEREAS, in consideration of the agreements and obligations of the Company, as set forth in this Agreement and subject to the terms and conditions contained herein, the MG Capital Parties are agreeing (i) to irrevocably withdraw the notice of stockholder nomination of individuals for election as directors of the Company at the Company\\'s 2020 Annual Meeting of Stockholders (the \"2020 Annual Meeting\") submitted to the Company on February 13, 2020 (the \"Nomination Notice\"), and any related materials or notices submitted to the Company in connection therewith and (ii) to terminate its solicitation of proxies in connection with the 2020 Annual Meeting; WHEREAS, as of the date hereof, the Company and the MG Capital Parties have determined that it is in their respective best interests to come to an agreement to modify the composition of the Company\\'s board of directors (the \"Board\") and as to certain other matters, as provided herein; and WHEREAS, the Board and the Nominating and Governance Committee of the Board have selected their 2020 Director Slate (as defined herein) for the 2020 Annual Meeting. NOW, THEREFORE, in consideration of the foregoing premises and the mutual covenants and agreements contained herein, and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Parties, intending to be legally bound hereby, agree as follows: 1. Board of Directors. (a) Appointments. Simultaneously with the execution and delivery of this Agreement, the Board and its committees shall take such actions (with such actions deemed to have to occurred substantially simultaneously) as are necessary (i) to increase the size of the Board from six (6) to ten (10) Directors, and (ii) to appoint each of Kenneth S. Courtis and Michael Gorzynski (the \"MG Capital Designees\") and (iii) to appoint each of Avram A. Glazer and Shelly Lombard (together with the MG Capital Designees, the \"New Directors\") to the Board. (b) Board Size. From the date of this Agreement through the completion of the 2020 Annual Meeting, the Board will not increase the size of the Board above ten (10) directors without the unanimous approval of the Board. From the completion of the Company\\'s 2020 Annual Meeting through the end of the Standstill Period (as hereinafter defined), the Board will not increase the size of the Board above seven (7) directors without the unanimous approval of the Board. (c) Board Chairman Succession. Consistent with the actions previously taken by the Board and the Glazer Agreement, and as of the date hereof, Mr. Glazer will be appointed as Chairman of the Board, succeeding Mr. Gfeller, who is being replaced as Chairman of the Board effective as of the date hereof.\\n\\n\\n\\n\\n\\n(d) New Director Information. As a condition to the New Directors\\' appointment to the Board and any subsequent nomination for election as a director at any future Company annual meeting of stockholders, he or she must provide any information required to be disclosed in a proxy statement or other filing under applicable law, stock exchange rules or listing standards. (e) Date of the 2020 Annual Meeting. The Company agrees that it shall hold the 2',\n",
              "    'Highlight the parts (if any) of this contract related to \"Agreement Date\" that should be reviewed by a lawyer. Details: The date of the contract',\n",
              "    'May 13, 2020',\n",
              "    94,\n",
              "    106),\n",
              "   ('Exhibit 10.1\\n\\nCERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY BRACKETED ASTERISKS [***], HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO RULE 24B-2 OF THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED. SUPPLY AGREEMENT\\n\\nTHIS SUPPLY AGREEMENT (\"Agreement\") is entered into as of this 15th day of May, 2013 (the \"Effective Date\") by and between Integra LifeSciences Corporation (\"Integra\"), a Delaware corporation with offices at 311 Enterprise Drive, Plainsboro, New Jersey 08536, and PcoMed, LLC (\"PcoMed\"), a Colorado limited liability company with offices at 105 S. Sunset Street, Longmont, Colorado 80501.\\n\\nRECITALS:\\n\\nWHEREAS, Integra is a medical device company that is developing and commercializing implantable spinal medical devices and procedures in the field of spinal surgery;\\n\\nWHEREAS, PcoMed has experience and expertise in the surface modification of medical device materials;\\n\\nWHEREAS, Integra desires to engage PcoMed to apply certain of its surface technologies onto Integra\\'s implantable spinal medical devices for preclinical, clinical and commercial use and distribution by Integra; and\\n\\nWHEREAS, PcoMed is willing to apply such surface technologies onto Integra\\'s implantable spinal medical devices and to grant Integra certain exclusive rights to use and commercialize those devices; and\\n\\nNOW, THEREFORE, in consideration of the mutual covenants and promises herein contained, the parties hereto agree as follows: 1. DEFINITIONS.\\n\\nAs used in this Agreement, the following initially capitalized terms, whether used in the singular or plural form, shall have the meanings set forth in this Section 1.\\n\\n1.1. \"Affiliate\" means any corporation, limited liability company, person or entity that directly or indirectly controls, is controlled by, or is under common control with, a party to this Agreement. For purposes of this Section 1.1, the term \"control\" (with a correlative meaning for \"controlled by\") means the possession, directly or indirectly, of the power to direct or cause the direction of the management and policies of the subject corporation, person or entity, whether through the ownership of voting securities, by contract or otherwise.\\n\\n1.2. \"*** Run\" means a single production run of PcoMed\\'s *** to apply the PcoMed Surface Modification Technology to Integra Products.\\n\\n1.3. \"*** Run Fee\" means the fee for a single *** Run. The *** Run Fee is exclusive of potential fees for any surface preparation requirements currently performed prior to PcoMed\\'s receipt of Integra Product.\\n\\n1.4. \"Confidential Disclosure Agreements\" means all Mutual Non-Disclosure Agreements previously or hereafter entered into by certain Integra Affiliates and PcoMed. 1 *** Portions of this page have been omitted pursuant to a request for Confidential Treatment filed separately with the Commission.\\n\\n\\n\\n\\n\\n1.5. \"Confidential Information\" means, whether disclosed in oral, written, graphic, electronic form, or other form, and whether developed by the disclosing party or by others, any confidential, non-public, proprietary information of Integra or PcoMed that is designated by the disclosing party as confidential or secret or that should reasonably be assumed by the receiving party to be confidential or secret. Confidential Information includes, without limitation: (i) specifications, know-how, trade secrets, designs, technical information, drawings, sketches, engineering drawings, work of authorship, software, prototypes, samples, models, business information, marketing information, current products and services, future products and services, proposed products and services, inventions, discoveries, devices, apparatus, equipment, algorithms, business methods, plans, assays, methods, procedures, processes, formulae, protocols, techniques, data, research and development data, experimental work, clinical data, engineering data, manufacturing data, technical or non-technical information, ideas, media, and unpublished patent applications; (ii) personnel and financial information, product cost informati',\n",
              "    'Highlight the parts (if any) of this contract related to \"Agreement Date\" that should be reviewed by a lawyer. Details: The date of the contract',\n",
              "    '15th day of May, 2013',\n",
              "    350,\n",
              "    371),\n",
              "   ('Exhibit 10.22   OUTSOURCE TECHNOLOGY DEVELOPMENT AGREEMENT   This Outsource Technology Development Agreement (this \"Agreement\") is entered into and effective as of this 1s t day of March, 2018 (the \"Effective Date\") by and between Document Security Systems, Inc., a corporation organized and existing under the laws of the State of New York (\"DSS\"), and HotApp International Ltd., a corporation organized and existing under the laws of Hong Kong (\"Developer\").   RECITALS:   WHEREAS, DSS is engaged in the business of, among other things, developing and licensing anti-counterfeiting technology, processes and products providing protection against a wide range of threats, including product diversion and counterfeiting, brand infringement, forgery, and unauthorized copying, scanning and photo imaging;   WHEREAS, Developer is engaged in the business of, among other things, software development; and   WHEREAS, DSS desires to retain Developer for the purpose of assisting DSS in developing an Android software application to be included as part of DSS\\'s AuthentiGuardยฎ Technology suite, and DSS is willing to grant Developer a non-exclusive, limited and non-transferable license for purposes of such development activities.   NOW, THEREFORE, for good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, the parties hereto agree as follows:   Capitalized terms contained herein shall have the meanings ascribed to them herein, or in Schedule 1 which is annexed hereto and made a part of this Agreement.   1. Development License and Fees.   1.1. Development License. Subject to the terms and conditions set forth herein, DSS hereby grants to Developer, and Developer accepts from DSS, for the Term, a non-exclusive, limited, and non-transferable license to install and use the Technology for the sole purpose of developing the Improvements (as defined hereunder) thereto for the benefit of DSS (the \"Technology Development Services License\").   1.2. Development Fees. As payment for Developer\\'s satisfactory performance of the services set forth in Schedule 1 hereto (the \"Technology Development Services\"), DSS shall pay Developer the sum of US $23,000 per month, for the duration of the Term hereof, with payments to commence on March 1, 2018.   2.  Term and Termination.   2.1. Term. The initial term of this Agreement shall commence on the Effective Date, and shall continue thereafter for a period of twelve (12) months (the \"Initial Term\"). The Initial Term shall automatically renew for one-month periods thereafter unless either party provides 30- days advance notice of termination, unless earlier terminated pursuant to Section 2.2 hereof. For purposes hereof, the Initial Term, together with any extension or renewal terms, shall hereinafter be collectively referred to as the \"Term\".   2.2. Early Termination.   2.2.1. Either party may terminate this Agreement prior to expiration of the Term: (i) upon thirty (30) days prior written notice, or (ii) immediately upon written notice to the other party if: (a) the other party declares or a petition is filed in any court for insolvency or bankruptcy and such petition is not dismissed in thirty (30) days; (b) the other party reorganizes under the relevant bankruptcy act or any similar statute in such party\\'s jurisdiction of incorporation; (c) the other party consents to the appointment of a trustee in bankruptcy or a receiver or similar entity; or (d) the Developer breaches DSS\\'s Technology or Intellectual Property rights contained herein.   2.2.2. Upon the expiration or termination of this Agreement, (i) the Technology Development Services License granted to Developer hereunder shall immediately cease, and (ii) Developer shall immediately cease use of all proprietary technology files heretofore delivered by DSS and shall deliver to DSS all such proprietary files along with any and all Improvements completed to date by Developer.     1\\n\\nSource: HF ENTERPRISES INC., S-1, 12/23/2019\\n\\n\\n\\n\\n\\n    3. Proprietary Rights.   3.1. Subject to Developer\\'s expressly granted rights under this Agr',\n",
              "    'Highlight the parts (if any) of this contract related to \"Agreement Date\" that should be reviewed by a lawyer. Details: The date of the contract',\n",
              "    '1s t day of March, 2018',\n",
              "    169,\n",
              "    192),\n",
              "   ('Exhibit 7.1   Strategic Alliance Agreement\\n\\nTHIS AGREEMENT is made this 15 th day of July, 2010 (\"Effective Date\") by and between IMedicor, Inc, a Nevada Corporation whose address is 523 Avalon Gardens Drive, Nanuet, New York 10954, USA (\"IMedicor\") and USA Managed Care Organization (USA MCO) A Texas Corporation whose address is 916 South Capital of Texas highway, Austin Texas.\\n\\nWITNESSETH:   WHEREAS, iMedicor is a secure, HIPAA compliant online portal that creates a virtual healthcare community amongst physicians and other medical professionals for the purpose of real-time Health Information Exchange. Physicians are provided with a secure HIPPA compliant transport account(s), similar to e-mail with attachments, that enable them to share patient specific personal health information with other participating physicians. iMedicor also provides the ability to create social communities for the purpose of peer collaboration and the extension of referral networks. iMedicor\\'s portal also provides physicians with an extensive catalogue of Continuing Medical Education (CME), skill development and product specific educational resources;\\n\\nWHEREAS, USA MCO represents a network of physicians through which USA MCO provides products and services for the medical industry that: generate additional revenue Streams; provide cost savings, streamline workflow; help patients save time, money and doctors achieve better outcomes; and assist physicians and medical practices to find ways to enhance patient satisfaction;\\n\\nWHEREAS, both parties are interested in forming a strategic and marketing alliance beneficial to both organizations.\\n\\nNOW, THEREFORE, for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties agree as follows:\\n\\n1. OBLIGATIONS OF THE PARTIES   โInitiate a multi tiered marketing approach, by mutual consent of both parties, to integrate the iMedicor HIPAA Compliant transport network as a communications network throughout the USA MCO user base, โThe overall project would also include the ClearLobby pharmaceutical and medical device marketing platform and other value added services as mutually agreed into the future, as a Phase II activity. โA phased in approach for each of the components listed above with the first being the introduction of the core iMedicor, HIPAA compliant communication / transport system into the USA MCO network.\\n\\n\\n\\n\\n\\n    โThe integrated service will generate revenue sharing opportunities for both companies. โUSA MCO will allow access to their network to distribute promotional and educational material highlighting the value proposition of the iMedicor / USA MCO alliance. โAccess will only be through, and controlled by USA MCO โCommunication will be, but not limited to e-mail promotion, direct mail, bill stuffers, web site, newsletter or any other normal communication between USA MCO and their network of physicians and other healthcare providers upon mutual consent of both parties โAll material must be approved by USA MCO prior to any distribution to the USA MCO network. โOnce a physician or other healthcare provider enrolls in iMedicor they will become part of the regular internal iMedicor communications system. โEvery physician that enrolls in iMedicor, including those physicians or other qualified registrants into the iMedicor network that are invited into USA MCO physician communities, through the efforts of USA MCO will be tagged as originating from that source (the USA MCO network). โMonthly reports detailing revenue generated through subscriptions, ClearLobby or other methods will be detailed in the monthly reports. โAll revenue sharing will be reconciled monthly and funds distributed by the 20th of each month by wire transfer for all net collected revenues for the previous month (net of returns and refunds, if any). โIMedicor will make its records available for audit purposes at any time by USA MCO during regular business hours at the headquarters of iMedicor. โUSA MCO will not be responsible for any direct sales of the iMedicor communications system',\n",
              "    'Highlight the parts (if any) of this contract related to \"Agreement Date\" that should be reviewed by a lawyer. Details: The date of the contract',\n",
              "    '15 th day of July, 2010',\n",
              "    72,\n",
              "    95),\n",
              "   ('EXHIBIT 10.12\\n\\n                                ENDORSEMENT AGREEMENT\\n\\n       This Endorsement Agreement is made and entered into this first (1st)  day of January, 1996, by and between Teardrop Putter Corporation having its  principal office at 207 WatersEdge, Shelter Cove, Hilton Head Island, South  Carolina 29928 (hereinafter referred to as \"TPC\"), and Consolidated Artists  Inc., Sommerville House, Phillips Street, St. Helier, Jersey JE1 1DE, Channel  Islands, British Isles (hereinafter referred to as \"Consolidated Artists\").\\n\\n                                     WITNESSETH:\\n\\n    WHEREAS, Brett Ogle (hereinafter referred to as \"Ogle\") is recognized  and widely known throughout the world as an expert golfer; and\\n\\n    WHEREAS, Ogle\\'s name, by virtue of his ability and extensive experience, has acquired a secondary meaning in the mind of the purchasing public important to the advertisement, promotion and sale of golf putters; and\\n\\n    WHEREAS, TPC is engaged in the manufacture, distribution and sale of golf putters, and is desirous of acquiring the exclusive right to utilize Ogle\\'s name in connection with the advertisement, promotion and sale of the Teardrop Putter; and\\n\\n    WHEREAS, Consolidated Artists holds all rights to and in Ogle\\'s name and endorsement for purposes of this Agreement; and\\n\\n    WHEREAS, Consolidated Artists being exclusively entitled to such rights within the Contract Territory (as hereinafter defined)\\n\\n                                        - 2 -\\n\\nhas agreed to authorize such use upon the terms and conditions hereinafter contained;\\n\\n    NOW, THEREFORE, for and in consideration of the premises and mutual covenants herein set forth and for other good and valuable consideration, it is agreed as follows:\\n\\n    1.    DEFINITIONS: As used herein, the terms set forth below shall be defined as follows:\\n\\n         (a)  \"Ogle Endorsement\" shall mean the name, likeness, photograph, and               endorsement of Ogle.\\n\\n         (b)  \"Endorsed Product\" shall mean a putter manufactured, distributed,               promoted, advertised and sold by TPC bearing the \"Teardrop               Putter\" name and/or logo.\\n\\n         (c)  \"Contract Territory\" shall mean the entire world.\\n\\n         (d)  \"Contract Period\" shall mean that period of time commencing               January 1, 1996, and concluding December 31, 1998, unless sooner               terminated in accordance with the terms and conditions hereof.\\n\\n         (e)  \"Contract Year\" shall mean that twelve (12)month period of time               commencing each first (1st) day of January throughout the               Contract Period.\\n\\n         (f)  \"Major Tournament\" shall mean any of the following tournaments:               the Masters, the U.S. Open, the British Open and the PGA               Championship.\\n\\n                                        - 3 -\\n\\n         (g)  \"PGA Tour Tournament\" shall mean PGA Tour tournaments, excluding               the Major Tournaments.\\n\\n         (h)  \"International Tournament\" shall mean European PGA Tour               tournaments (excluding the British Open),Japan PGA Tour               tournaments and Australian PGA Tour tournaments.\\n\\n    2.    OGLE TO USE ENDORSED PRODUCT. Consolidated Artists agrees to cause Ogle to use the Endorsed Product during the Contract Period and throughout the Contract Territory whenever he is playing competitive golf or otherwise participating in golf clinics and outings.\\n\\n    3.    GRANT OF ENDORSEMENT RIGHTS. Subject to the terms and conditions set forth herein, Consolidated Artists grants to TPC the exclusive right and license, within the Contract Territory and during the Contract Period, to use the Ogle Endorsement in connection with the manufacture, distribution, advertisement, promotion and sale of the Endorsed Product.\\n\\n\\n\\n\\n\\n    4.    CLOTHING IDENTIFICATION. Consolidated Artists agrees to cause Ogle to wear a patch and/or an embroidered non-patch bearing the Teardrop name and/or logo on the right chest, left sleeve, and back of his golf shirt and/or sweater (near the collar) and/or rain gear whene',\n",
              "    'Highlight the parts (if any) of this contract related to \"Agreement Date\" that should be reviewed by a lawyer. Details: The date of the contract',\n",
              "    '(1st)  day of January, 1996',\n",
              "    140,\n",
              "    167),\n",
              "   ('[LOGO]\\n\\nAMENDMENT TO SECTION 2, PART B OF THE CO-BRANDING AGREEMENT\\n\\nThis amendment to Section 2 (titled \"Term\"), Part B of the Co-Branding Agreement is made effective December 9, 1996 by and between PC Quote, Inc. (hereinafter referred to as \"PCQ\") and A.B. Watley, Inc. (hereinafter referred to as \"ABW\"), who are also the parties contracted in the aforementioned Co-Branding Agreement. This Amendment shall apply to said PCQ and ABW and all of their subsidiaries and related companies.\\n\\n[***]\\n\\nSource: PCQUOTE COM INC, S-1/A, 7/21/1999\\n\\n\\n\\n\\n\\nAGREED TO BY:\\n\\n/s/ Steven Malin /s/ Howard Meltzer - -------------------------- --------------------------------- A.B. Watley, Inc. PC Quote, Inc. Mr. Steven Malin Mr. Howard Meltzer Director President Date:  12/5/96 Date:   12/12/96      -------------- ----------------\\n\\nSource: PCQUOTE COM INC, S-1/A, 7/21/1999',\n",
              "    'Highlight the parts (if any) of this contract related to \"Agreement Date\" that should be reviewed by a lawyer. Details: The date of the contract',\n",
              "    'December 9, 1996',\n",
              "    168,\n",
              "    184),\n",
              "   ('Exhibit 10.65   JOINT VENTURE AGREEMENT MINDA IMPCO TECHNOLOGIES LIMITED   This Joint Venture Agreement (Agreement) is made and executed on this the 18th day of May, 2001   BETWEEN   IMPCO Technologies Inc., a company incorporated under the laws of the State of Delaware U.S.A. and having its principal office of business at 16804 Gridley Place, Cerritos, California 90703, U.S.A. (hereinafter referred to as \\'IMPCO\\', which terms shall unless repugnant to the subject or context mean and include its successors and permitted assigns), through Ms. Pearl Kamdar a duly authorized person and Director of Asia-Pacific Operations,   AND   MINDA INDUSTRIES LIMITED, a company incorporated under the Companies Act, 1956 having its registered office at 36-A, Rajasthan Udyog Nagar, Delhi-110 033, India, (hereinafter referred to as \\'MIL\\', which terms shall unless repugnant to the subject or context mean and include its successors and permitted assigns), through Mr. Nirmal K. Minda its Managing Director,   AND   Mr. Nirmal K. MINDA, s/o. Mr. S.L. Minda, r/o. A-15, Ashok Vihar, Phase-I, New Delhi-110 052 on in his individual capacity and on behalf of his relatives and associates listed in Schedule-I (hereinafter referred to as \\'MINDA\\', which terms shall unless repugnant to the subject or context mean and include his heirs, executors, administrators or successors and permitted assigns).   WHEREAS IMPCO is engaged in the business of development, manufacture and sale of alternate fuel management systems and components for operating motor vehicles, forklifts, industrial engines and other engines of various horsepower; and   WHEREAS MIL is engaged in the manufacturing and sale of auto electrical parts such as switches, lamps and horns; and   WHEREAS IMPCO and MIL/MINDA have entered into a joint venture to promote a company under the name of MINDA IMPCO LIMITED for manufacturing and selling alternate fuel management systems and components, including but not limited to CNG, LPG and Propane Kits for operating motor vehicles, forklifts, industrial engines and other engines of various horsepower in India ; and   WHEREAS, MIL represents that it has the technical, marketing skills and financial wherewithal to install, sell and service the alternate fuel systems and components manufactured by MINDA IMPCO Limited and enjoys a respected business relationship with   1\\n\\n\\n\\n\\n\\ncognizant governmental and industrial authorities, all of which may be advantageously employed in the safe and professional marketing of MINDA IMPCO Limited products, as specified above, in India with the approval of and in compliance with such governmental authorities; and   WHEREAS the Parties hereto have agreed, subject to obtaining all necessary approvals, permissions, consents, validations, confirmations, licenses and any other authorizations required to incorporate a company in India (\"the Joint Venture Company\" or the \"JVC\") with the main object of inter alia marketing and selling of alternate fuel management systems, including but not limited to CNG, LPG and Propane Kits and its components for automobiles and other associated and incidental services to customers; and   WHEREAS IMPCO will contribute to the JVC in cash and the JVC will issue equity shares to IMPCO; and   WHEREAS MIL/MINDA will contribute to the JVC in cash and subject to IMPCO\\'s consent in kind and the JVC will issue equity shares to MIL/MINDA; and   WHEREAS the Parties hereto are ready, willing and able to assist each other and cooperate in the manner set out hereinafter, to ensure the establishment and success of the JVC. The Parties shall cooperate with each other in the highest degree in the performance of all such acts and the passing of all resolutions as are required for the purpose of achieving the terms, purposes and intent of this Agreement and the Parties shall in particular exercise their respective voting and other rights and power of control over the JVC so as to give effect to the rights conferred upon the respective Parties by the terms of this Agreement.   NOW THEREFORE in consideration of the mutual',\n",
              "    'Highlight the parts (if any) of this contract related to \"Agreement Date\" that should be reviewed by a lawyer. Details: The date of the contract',\n",
              "    '18th day of May, 2001',\n",
              "    149,\n",
              "    170),\n",
              "   ('EXHIBIT 10.3\\n\\n   [ABOUT LOGO]\\n\\nCO-BRANDING AGREEMENT\\n\\nThis Agreement (the \"Agreement\"), dated this 19th day of January, 2001 (the \"Effective Date\"), is by and between About.com, Inc. (\"About\"), a Delaware corporation, located at 1440 Broadway, 19th Floor, New York, NY 10018 and ebix.com, Inc. (\"ebix\"), a Delaware corporation, located at 1900 E.Golf Road, Schaumberg, IL 60173\\n\\nW I T N E S S E T H:\\n\\nWHEREAS, About owns and operates an Internet service known as About.com, currently located at the URL HTTP://WWW.ABOUT.COM, at which users may access a variety of content channels and a network of highly-targeted, topic-specific Web sites, and includes any site owned, operated or under the control of About (the \"About Network\");\\n\\nWHEREAS, ebix is the e-commerce portal for insurance on the Internet offering to consumers and insurance professionals a one-stop site, currently located at http://www.ebix.com for all kinds of insurance content ranging from consumer to business tools to broker to business tools as well as e-commerce functionality;\\n\\nWHEREAS, the parties desire to collaborate to create an independent co-branded channel on or accessible though the About Network at which visitors to the About Network may access insurance information, on the terms and conditions hereinafter set forth;\\n\\nWHEREAS, ebix desires to receive promotions on the About Network for the parties\\' Insurance Center and for the ebix Site (hereinafter defined).\\n\\nNOW, THEREFORE, in consideration of the agreements and obligations set forth herein and for other good and valuable consideration, the receipt and sufficiency of such is hereby acknowledged, the parties hereto hereby agree as follows:\\n\\n  1.  DEFINITIONS\\n\\n      \"ABOUT CONTENT\" means any and all textual, graphical, audio/visual or       other materials created or provided on or behalf of About for use on the       Insurance Center (other than the ebix Content), including but not limited       to the About Wrapper and the About Look and Feel (hereinafter defined).\\n\\n      \"ABOUT CUSTOMER\" means any individual or entity who has registered with       ebix either (i) through the registration process on the Insurance Center       or (ii) registers with ebix after accessing the ebix Site from a link on       the About Network.\\n\\n      \"ABOUT CUSTOMER DATA\" means information related specifically to About       Customers, including but not limited to: (i) internet addresses and       navigational information, including information disclosing the usage of       Links within or available through the Insurance Channel; (ii)       transactional information, including, but not limited to, names,       addresses, billing information, information requested; and (iii) any other       information that identifies an individual as an About Customer.\\n\\n      \"ABOUT LOOK AND FEEL\" means the distinctive and particular elements of       graphics (including the About Marks), design, organization, presentation,       layout, user interface, navigation, trade dress and stylistic convention       (including the digital implementations thereof) within the About Network       and the\\n\\n** Confidential treatment has been requested for portions of this document.    The redacted material has been filed with the commission pursuant to an    application for confidential treatment.\\n\\n      total appearance and impression substantially formed by the combination,       coordination and interaction of these elements.\\n\\n      \"ABOUT MARKS\" means the name, tradenames, trademarks, service marks, logos       and other distinctive brand marks of About, adopted by About, or used in       or relating to About\\'s business from time to time, whether or not in       connection with its performance of this Agreement,\\n\\n      \"ABOUT NETWORK\"\" means the About Site, all Web sites owned and operated       solely by About, and those portions of third party Web sites in which       About has a right to sell advertisements.\\n\\n      \"ABOUT SITE HOME PAGE\" means, with respect to the US version of the About       Site, the Web page that is displayed to the About User ',\n",
              "    'Highlight the parts (if any) of this contract related to \"Agreement Date\" that should be reviewed by a lawyer. Details: The date of the contract',\n",
              "    '19th day of January, 2001',\n",
              "    99,\n",
              "    124),\n",
              "   ('SPONSORSHIP AGREEMENT This agreement (the \"Agreement\") is made effective this 1st day of April, 2018 (\"Effective Date\") between Fruit of Life Productions LLC, (\"Promoter\") and Eco Science Solutions, Inc.,(\"Sponsor\"), 1135 Makawao Avenue, Suite 103-188, Makawao, Hawaii, 96768.\\n\\nContribution by Sponsor: In consideration for the right to sponsor the Kaya Fest and to be acknowledged by Fruit of Life Productions LLC., as a Promoter of the event during the term of this Agreement, Sponsor agrees to contract with Fruit of Life Productions LLC., for the amount of $250,000.00 to be paid in full upon signing of this agreement.\\n\\nBank Wire Transformation Information See Attached Wire Instructions\\n\\nSponsorship Benefits for Presenting Partner Sponsor:\\n\\n* Main Stage named after your brand * 4 10x10 on site vendor booths * 50 VIP Sponsor Passes / 50 GA tickets for both days * 4 Parking passes * Opportunity to participate in after party * Banner placement in venue (10) * Approved audio/video assets to be provided as promotional use for Herbo * Name and phrase called out on stage between performers set * Your logo and a link from our website to your website * Your logo on video wall * Your company name and logo as a presenting sponsor * Banner at main entrance of venue * On stage banner placement * Logo in Backstage/VIP area * Mention on social media * Logo on Step and Repeat * Logo on all promotional print\\n\\nTerms and Termination: The term of this agreement will begin on April 1, 2018 and continue until April 30, 2018 at 11:59pm.\\n\\nRelationship of Parties: The parties are independent contractors with respect to one another. Nothing in this Agreement shall create any association, joint venture, partnership or agency relationship of any kind between the parties.\\n\\n1\\n\\nSource: ECO SCIENCE SOLUTIONS, INC., 8-K, 4/6/2018\\n\\n\\n\\n\\n\\nIntellectual Property: Fruit of Life Productions LLC is the sole owner of all right, title and interest to all Kaya Fest information including Logo, tag lines, (Education before Recreation), Trademarks, trade names and copyrighted information. Sponsor agrees that it will not use Kaya Fest property in a manner that states or implies that Kaya Fest endorses Sponsor (or Sponsors products or services) without written approval from Fruit of Life Productions LLC.\\n\\nIdemnification: Sponsor shall indemnify and hold harmless, Fruit of Life Productions LLC, its related entities, partners, agents, officers, directors, employees, attorneys, heirs, successors, and assigns from against any and all claims, losses, damages, judgments, settlements, costs and expenses (including reasonable attorney\\'s fees and expenses), and liabilities of every kind incurred as a result of: (i) any act or omission by Sponsor or its officers, directors, entities, employees, agents; (ii) any use of Sponsor\\'s name, logo, Website, or other information, products, or service provided by Sponsor; and/or (iii) the inaccuracy or breach of any of the covenants, representations and warranties made by Sponsor in this Agreement. (iv) any changes in company value or brand value. The attendance and marketing reach estimates made in negotiations were made for the purposes of this agreement are mere estimate and not be interpreted as guaranties. . Confidentiality Confidential Information is all information that is marked such and all other information which a reasonable person would consider to be confidential. Confidential Information shall include, but is not limited to, information regarding the organization, its operations, programs, activities, financial condition, strategies, timelines, corporate/programming roadmap, surprise performers/guest appearances, event access information and membership or customer list. During the Term, each party shall use and reproduce the other party\\'s Confidential Information only for purposes of this Agreement with written authorization by disclosing party, and only to the extent necessary for such purpose. Each party shall restrict disclosure of the other party\\'s Confidential Information to its employees and agents with a reasonable need to',\n",
              "    'Highlight the parts (if any) of this contract related to \"Agreement Date\" that should be reviewed by a lawyer. Details: The date of the contract',\n",
              "    '1st day of April, 2018 (',\n",
              "    78,\n",
              "    102),\n",
              "   ('Exhibit 10.2   FORM OF CONTENT LICENSE AGREEMENT   THIS CONTENT LICENSE AGREEMENT (this \"Agreement\"), dated as of ___________, 2015 (the \"Effective Date\"), is entered into between Beijing Sun Seven Stars Culture Development Limited, a P.R.C. company with an address at Eastern Fangzheng Road, Southern Dongying Village, Hancunhe Town, Fangshan District, Beijing City, P.R.C. (\"Licensor\"), and YOU ON DEMAND HOLDINGS, INC., a Nevada corporation with an address at 375 Greenwich Street, Suite 516, New York, New York 10013 (\"Licensee\").   WHEREAS, Licensor and Licensee have agreed to enter into this Agreement, pursuant to which Licensor shall license to Licensee certain video programming on the terms and subject to the conditions contained in this Agreement.   NOW, THEREFORE, in consideration of the foregoing, the mutual promises and covenants herein contained and other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, and incorporating the above recitals with and into this Agreement, the parties hereby agree as follows:   TERMS AND CONDITIONS   1. Definitions.   (a) \"Additional Title\" shall have the meaning specified in Section 5.   (b) \"Advertising\" shall have the meaning specified in Section 9.   (c) \"Affiliate(s)\" shall mean an entity controlling, controlled by or under common control with a party. \"Control,\" for purposes of this definition, means direct or indirect ownership or control of more than 50% of the voting interests of the subject entity.   (d) \"Confidential Information\" shall have the meaning specified in Section 14(a).   (e) \"Indemnified Party\" shall have the meaning specified in Section 13.   (f) \"Indemnifying Party\" shall have the meaning specified in Section 13.   (g) \"Licensor Marks\" shall have the meaning specified in Section 11.   (h) \"Materials\" shall have the meaning specified in Section 4(b).   (i) \"Mobile Sites\" shall mean any and all versions of the Licensee Sites optimized for delivery and/or distribution via a wireless network.   (j) \"Reports\" shall have the meaning specified in Section 8(b).\\n\\n  1\\n\\nSource: IDEANOMICS, INC., 8-K, 11/24/2015\\n\\n\\n\\n\\n\\n\\n\\n  (k) \"Share Consideration\" has the meaning specified in Section 10.   (l) \"Sites\" shall mean any and all websites, applications, products and other services through which Licensee (itself or through a third party) delivers content via the public Internet or an IP-based network, regardless of whether the device used to access such websites, applications, products or other services is a laptop or desktop computer, mobile device, tablet, mobile phone, set-top box, or other device.   (m) \"Term\" shall have the meaning specified in Section 7.   (n) \"Territory\" shall mean mainland China.   (o) \"Titles\" shall mean the programming listed on Schedule A (as Schedule A may be amended in accordance with Section 5 from time to time).   (p) \"Users\" shall mean all subscribers to Licensee\\'s services.   (q) \"VOD\" shall mean a system that allows for the exhibition of video programming chosen by a subscriber for display on that subscriber\\'s video display unit on an on-demand basis, such that a subscriber is able, at his or her discretion, to select the time for commencement of exhibition, and shall include subscription VOD (\"SVOD\"), transactional VOD (\"TVOD\"), ad-supported VOD (\"AVOD\") and free VOD.   2. Rights Granted.   (a) License Grant. In exchange for the Share Consideration, Licensor hereby grants to Licensee a non-exclusive, royalty-free, perpetual and non-perpetual license (subject to the duration for which Licensor has the rights to each Title as specified in Schedule A1-A5 of Schedule A) to:   i. license, exhibit, distribute, reproduce, transmit, perform, display, and otherwise exploit and make available each Title within the Territory in any language by VOD (including SVOD, TVOD, AVOD and free VOD) for Internet, TV and mobile platforms (including, but not limited to, OTT streaming services, Sites and Mobile Sites), except that for Titles listed in Schedule A1-A2 of Schedule A, Licensor can only grant Licensee distributio',\n",
              "    'Highlight the parts (if any) of this contract related to \"Agreement Date\" that should be reviewed by a lawyer. Details: The date of the contract',\n",
              "    '___________, 2015',\n",
              "    114,\n",
              "    131),\n",
              "   ('Exhibit 10.28   Execution Version   OUTSOURCING AGREEMENT\\n\\nThis OUTSOURCING AGREEMENT (this \"Agreement\") is made and entered into as of the 16t h day of May, 2017, by and among\\n\\nPhotronics, Inc., a Connecticut corporation with its principal place of business at 15 Secor Road, Brookfield, Connecticut, U.S.A (\"Photronics\"),\\n\\nDai Nippon Printing Co., Ltd., a Japanese corporation with its principal place of business at 1-1, Ichigaya Kagacho 1-chome, Shinjuku-ku, Tokyo, Japan (\"DNP\"),\\n\\nPhotronics DNP Photomask Corporation, a company limited by shares organized and formed under the Company Act of the Republic of China with its principal place of business at 4f, #2, Li-Hsin Road, Science Park, Hsinchu, Taiwan, ROC (\"PDMC\"), and\\n\\nXiamen American Japan Photronics Mask Co., Ltd., a limited liability company organized and formed under the People\\'s Republic of China with its principal place of business at R203-95, South Building of Torch Square, No. 56-58 Torch Road, Gaoxin District, Xiamen, Fujian Province, Peoples Republic of China (the \"Company\").\\n\\nEach of Photronics and DNP is hereinafter referred to as a \"Shareholder\" and collectively as the \"Shareholders\", each of the Shareholders and PDMC is hereinafter referred to as a \"Supplier\" and collectively as the \"Suppliers\", and each of the Suppliers and the Company is hereinafter referred to as a \"Party\" and collectively as the \"Parties.\"\\n\\nARTICLE 1. BACKGROUND   Photronics and DNP wish to participate in a joint venture, either directly or indirectly through their respective Affiliates, as equity interest owners in the Company, and to carry on the Business through the Company. The Parties are engaged, among other things, in the design, development, fabrication and sale of advanced photomasks. Photronics and DNP, directly or indirectly, are the shareholders of and own PDMC, a joint venture of Photronics and DNP in Taiwan. In connection with the formation of the Company, Photronics and DNP have entered into \"Joint Venture Operating Agreement\" (the \"China JV Operating Agreement\") dated as of the 16t h day of May, 2017. In connection with the China JV Operating Agreement and in order to support the business objective of the Company, including but not limited in order to (i) [***]the Company desires to outsource or [***]of the Company pursuant to the terms and conditions set forth herein.\\n\\nThe Parties hereby agree and confirm the exclusive distribution mechanism set forth in Section 10.1 hereof. All terms and conditions for [***]will be governed by this Agreement. Any and all [***]set forth in Section 5.15 of the China JV Operating Agreement.\\n\\n1.1 Defined Terms   Unless otherwise defined in this Agreement and Schedule 1 hereof, terms defined in the China JV Operating Agreement shall have the same meanings when used in this Agreement.\\n\\nSource: PHOTRONICS INC, 10-Q/A, 12/19/2017\\n\\n\\n\\n\\n\\n1.2 Incorporation by Reference   Section 12 (Miscellaneous) of the China JV Operating Agreement shall be incorporated by reference into and form an integral part of this Agreement, mutatis mutandis.\\n\\nARTICLE 2. PURCHASE ORDERS\\n\\n2.1 Outsource and Issuance of Purchase Orders   Subject to the terms and conditions mentioned hereunder, the Parties agree to the outsource model based on [***]as follows, and the Parties also agree that they may add additional Products to this Agreement through additional Purchase Orders [***]\\n\\nFor the avoidance of doubt, the outsource model is purely made based on the [***]\\n\\nMoreover, it is acknowledged by the Parties that[***] Therefore, subject to the prior notification to, and the instruction and the express approval of the customers, the Steering Committee could reasonably decide or change the outsource model at its own discretion in accordance with the China JV Operating Agreement.\\n\\nIn any case, none of the Parties shall unreasonably [***] of the Products to take advantage of the outsource relationship or [***]\\n\\nA. Outsource Transition Period   During the Outsource Transition Period, as for the Purchase Orders received by the Company from: (a) [***] (b) [***] (c) [***]\\n\\n(d) [***]',\n",
              "    'Highlight the parts (if any) of this contract related to \"Agreement Date\" that should be reviewed by a lawyer. Details: The date of the contract',\n",
              "    '16t h day of May, 2017,',\n",
              "    140,\n",
              "    163),\n",
              "   ('Exhibit 4.5\\n\\nCONSULTING AGREEMENT - DR. GAETANO MORELLO N.D. INC.\\n\\nTHIS AGREEMENT made effective the 10 day of January 2019 (the \"Effective Date\"),\\n\\nBETWEEN:\\n\\nEMERALD HEALTH NATURALS, INC., a company having its registered and records office at 7860 Venture Street, Burnaby, BC V5A 1V3\\n\\n(\"Emerald\" or the \"Company\")\\n\\nAND:\\n\\nDR. GAETANO MORELLO N.D. INC., Businessperson, having an office at 2975 East 4th Avenue, Vancouver, B.C. V5M 1L1\\n\\n(the \"Contractor\")\\n\\nWITNESSES THAT WHEREAS Emerald would like to engage the Contractor as an independent contractor of Emerald, and the Contractor would like to be engaged by Emerald as an independent contractor, on the terms and conditions contained herein;\\n\\nIN CONSIDERATION of the mutual agreements in this Agreement and subject to the terms and conditions specified in this Agreement, the parties agree as follows:\\n\\n1. Definitions\\n\\n1.1 In this Agreement, including the recitals and the schedules, the defined words and expressions have the meanings set out on Schedule \"A\" to this Agreement unless the context otherwise required.\\n\\n2. Scope of Engagement\\n\\n2.1 Position. The Company hereby engages the Contractor as an independent contractor and the Contractor hereby agrees to such engagement.\\n\\n2.2 Services. The Company engages the Contractor to fulfill the services (the \"Services\") as described on Schedule \"B\" on the terms and conditions of this Agreement. The Services may be replaced, amended, superseded, or supplemented from time to time by agreement between the Company and the Contractor.\\n\\n2.3 Reporting and Oversight Responsibility. The Contractor will report to and take instructions from Avtar Dhillon, President and Executive Chair.\\n\\n2.4 Commitment of the Contractor. The Contractor will devote sufficient time and attention to the business and affairs of Emerald to provide the Services, use his or her best efforts to promote the interests of Emerald, and will carry out his or her Services honestly, in good faith and in the best interests of Emerald.\\n\\n2.5 Not Employment. The parties acknowledge and agree that the relationship created by operation of this Agreement is not an employment relationship.\\n\\n3. Fees\\n\\n3.1 Fee. The Company will pay to the Contractor an annual fee (the \"Fee\") of $240,000. per year plus plus GST and applicable taxes, if any.\\n\\n\\n\\n\\n\\n3.2 Reimbursement of Expenses. Emerald will reimburse the Contractor for all reasonable expenses incurred in the performance of his or her Services, provided that the Contractor provides a written expense account in a form satisfactory to the Lead Director of the Company.\\n\\n3.3 Deductions and Remittances. Emerald shall not be obliged to deduct or retain from the Fees due to the Contractor, nor shall it be obliged to remit same to the required governmental authority, any amounts that may be required by law or regulation to be deducted, retained and remitted including, without limitation, Federal and Provincial or State Income Tax, Workers\\' Compensation and Pension Plan deductions and remittances. All such remittances and other payments are entirely the responsibility of the Contractor and the Contractor hereby indemnifies and saves Emerald and its Board members and officers harmless from any liability of any kind whatsoever that they may incur as a result of the Contractor\\'s failure to make such remittances or payments.\\n\\n3.4 Other Boards, Charities and Business Activities. The Contractor\\'s performance of personal, business or charitable activities or service on any boards of any private or public companies, shall be deemed not to be preventing the Contractor from meeting his or her obligations to Emerald hereunder, so long as same are not directly competitive with the business of the Company. Emerald acknowledges and agrees that the Contractor or Contractor may have other business involvements, business interests and sources of business income with parties that Emerald does or does not have a business relationship with. The Contractor is permitted to undertake such activities and retain all of the compensation received from such activities provided that ',\n",
              "    'Highlight the parts (if any) of this contract related to \"Agreement Date\" that should be reviewed by a lawyer. Details: The date of the contract',\n",
              "    '10 day of January 2019',\n",
              "    101,\n",
              "    123),\n",
              "   ('EXHIBIT 10.11\\n\\n                                                    CONFIDENTIAL TREATMENT\\n\\n                                                   Portions indicated by a                                                     [***] have been omitted                                                     and filed separately                                                     with the Commission\\n\\nPCQUOTE\\n\\n- ---------------------------------------------------------------------------- CO-BRANDING AGREEMENT\\n\\nThis agreement is made effective   Oct. 11, 1996 by and between PC QUOTE, INC. (hereinafter referred to as \"PCQ\"), a Delaware Corporation with its principal place of business at 300 South Wacker Drive, Chicago, Illinois 60605 and AB Wately, Inc. (hereinafter referred to as \"ABW\") with its principal place of business at 33 West 17th Street, New York, NY  10011. This agreement shall apply to said ABW and all of its subsidiaries and related companies.\\n\\nDefinitions:\\n\\nSOFTWARE\\n\\nPC QUOTE 6.0-TM- for Windows on the Internet is a software application that displays market data information, provided via the digital Hyperfeed, in the form of quotes, charts, graphs, tables, board views, tickers and other analytical tools.\\n\\nHYPERFEED\\n\\nThe PC Quote proprietary digital data feed transmitted via satellite, land line, or Internet with advanced compression technology, containing financial market information obtained by PCQ from the institutions and exchanges listed in Section 5 of this Agreement.  This market data includes stock quotes, futures and options trading, commodities, and other related information.\\n\\nWitnesseth:\\n\\nNOW, THEREFORE, for good and valuable consideration, and in consideration of the mutual covenants and conditions herein set forth, and with the intent to be legally bound thereby, ABW and PCQ hereby agree to the following:\\n\\n1.  The Co-Branded Service\\n\\n    A.  PCQ agrees to allow ABW to co-brand the PCQ SOFTWARE in order to provide a value added service on ABW\\'s World Wide Web site.  The co-branded SOFTWARE will be made available via ABW software housed at the ABW office listed in this Agreement.  The server will be accessed by all ABW subscribers in order to download the SOFTWARE and receive the HYPERFEED.\\n\\n    B.  PCQ will provide a continuous HYPERFEED to the ABW servers; however, PCQ will control the receipt of the HYPERFEED by ABW clients via a remote access server on PCQ\\'s site that will authorize each new ABW account.  ABW agrees to sign up all new subscribers to the co-branded service, including execution of all applicable service and exchange agreements, will send to PCQ the executed subscriber\\n\\nagreements before access to the quote servers will be provided to ABW clients by PCQ.  PCQ shall have the sole ability to authorize access to the market data contained in the HYPERFEED by ABW clients.\\n\\nSource: PCQUOTE COM INC, S-1/A, 7/21/1999\\n\\n\\n\\n\\n\\n    D.  PCQ and Townsend shall retain title and all copyrights or proprietary rights to the SOFTWARE and HYPERFEED provided to ABW and ABW\\'s clients pursuant to the Agreement.  ABW will not provide any unauthorized access to the co-branded service, nor reproduce or redistribute the service in any way.\\n\\n    E.  ABW agrees to include the following in the co-branded pages displaying quotes:  \"All quotes provided by PC Quote, Inc.\"  ABW also agrees to include the following disclaimer on the access page to the co-branded service:\\n\\n         \"PC Quote is not subject to liability for truth, accuracy, or           completeness of the market data information nor is PC Quote liable           for errors, mistakes or omissions in the data or for any delays or           interruptions in the end user\\'s receipt of the data.  PC Quote does           not warrant that the data provided may be relied upon for trading           purposes.\"\\n\\n    2.  Term\\n\\n    A.  [***]  The effective date for purposes of this Agreement is the contract date as specified on the signature page of this Agreement.  Neither PCQ nor ABW shall terminate or alter this Agreement except as stated herein.\\n\\n    B.  [***]  Notice expressing ',\n",
              "    'Highlight the parts (if any) of this contract related to \"Agreement Date\" that should be reviewed by a lawyer. Details: The date of the contract',\n",
              "    'Oct. 11, 1996',\n",
              "    534,\n",
              "    547),\n",
              "   ('Exhibit 10.26\\n\\nAGENCY AGREEMENT\\n\\nTHIS AGENCY AGREEMENT, dated November 9, 2005 (\"Agreement\"), between General Electric Capital Corporation, a Delaware corporation (together with its successors and assigns, if any, \"Lessor\"), and Duckwall-Alco Stores, Inc., a Kansas corporation (the \"Company\"). Capitalized terms not defined herein shall have the meanings assigned to them in the Lease (as that term is defined below).\\n\\nRECITALS:\\n\\nWHEREAS, Lessor and the Company have entered into a Master Lease Agreement dated November 9, 2005 wherein Lessor, as the lessor, has agreed to lease certain items of equipment to the Company (the Master Lease Agreement and all Schedules entered into from time to time thereunder are hereinafter collectively referred to as the \"Lease\"; and all equipment leased thereunder are hereinafter collectively referred to as the \"Equipment\"); capitalized terms used herein but not otherwise defined shall have the meanings as provided in the Lease; and\\n\\nWHEREAS, Lessor desires to appoint the Company its agent to order, receive and, in the name and on behalf of Lessor, the Equipment;\\n\\nNOW, THEREFORE, in consideration of the above premises and the mutual promises contained herein, as well as other good and valuable considerations, the receipt and sufficiency of which is hereby acknowledged, the parties hereto hereby agree as follows:\\n\\nARTICLE I  GENERAL UNDERTAKING\\n\\nSection 1.01 Appointment. Lessor hereby appoints the Company, and the Company hereby agrees to accept such appointment, as the agent of Lessor, without any fee for acting as such agent, pursuant to the terms and conditions of this Agreement, for the purpose of ordering and, subject to the conditions set forth in Section\\'s 2.01 and 2.05 hereof, accepting Equipment on Lessor\\'s behalf for leasing to the Company under the Lease from the respective supplier thereof (each a \"Supplier\" and collectively, the \"Suppliers\"). It is specifically agreed that all of the power and authority vested to the Company herein shall be subject to any modifications as may from time to time be made by Lessor.\\n\\nSection 1.02 Powers. Except as may be otherwise expressly provided in this Agreement, the Company is hereby granted the authority to act, and hereby agrees to act, on behalf of Lessor and in the name of Lessor, to the extent necessary to carry out its duties under this Agreement.\\n\\nSection 1.03 Master Lease. This Agreement is entered into in connection with and subject to the terms of the Lease and in the event of a conflict between the terms of this Agreement and the Lease, the Lease shall control. The Company and Lessor may from time to time hereafter enter into Equipment Schedules to the Lease, and it is the intent of the parties that this Agreement facilitate the leasing of Equipment under the Lease. EXCEPT AS PROVIDED IN ANY OTHER AGREEMENT, NOTHING IN THIS AGREEMENT SHALL BE OR SHALL BE DEEMED TO BE, A COMMITMENT ON THE PART OF EITHER THE COMPANY OR LESSOR TO EXECUTE OR OTHERWISE ENTER INTO ANY EQUIPMENT SCHEDULES AFTER THE DATE OF THIS AGREEMENT.\\n\\nARTICLE II  DUTIES OF AGENT\\n\\nSection 2.01 Equipment Orders. Upon the written acknowledgment by the Company and Lessor of each jointly approved purchase agreement, purchase order or invoice (\"Purchase Order\"), the Company, pursuant to the agency granted to it by Lessor in Article I hereof, may order, receive, accept the Equipment to be leased in accordance with the Economic Terms (as hereafter defined and described).\\n\\nUpon and as of the date of acceptance of the Equipment by the Company and satisfaction of the conditions precedent provided for in the Lease: (a) Lessor shall be unconditionally obligated to purchase such Equipment pursuant to the terms of the applicable Purchase Order and to lease such Equipment to the Company pursuant to the terms and conditions of the Lease and the applicable completed Schedule; and (b) the Company shall be unconditionally obligated to lease such Equipment from Lessor pursuant to the terms and conditions of the Lease and the applicable completed Schedule. The leasing of Equipment pursuant to',\n",
              "    'Highlight the parts (if any) of this contract related to \"Agreement Date\" that should be reviewed by a lawyer. Details: The date of the contract',\n",
              "    'November 9, 2005',\n",
              "    62,\n",
              "    78),\n",
              "   ('Exhibit 10.5   INTELLECTUAL PROPERTY AGREEMENT   This INTELLECTUAL PROPERTY AGREEMENT, dated as of May 14, 2016 (this \"Agreement\"), is by and between WestRock Company, a Delaware corporation (\"Parent\"), and Ingevity Corporation, a Delaware corporation (\"SpinCo\"). Capitalized terms used herein and not otherwise defined shall have the respective meanings assigned to them in Section 1 or the Separation Agreement. SpinCo and Parent may be individually referred to herein as a \"Party\" and collectively as the \"Parties\".   R E C I T A L S   WHEREAS, Parent and SpinCo have entered into that certain Separation and Distribution Agreement, dated as of even date herewith, (the \"Separation Agreement\");   WHEREAS, the Separation Agreement sets forth the principal corporate transactions required to effect the Separation;   WHEREAS, Parent and SpinCo desire to enter into this Agreement to set forth the terms and conditions pertaining to the allocation of ownership and other rights associated with certain Intellectual Property; and   WHEREAS, this Agreement is deemed to be an Ancillary Agreement under the Separation Agreement.   NOW, THEREFORE, in consideration of the mutual agreements, provisions and covenants contained in this Agreement, and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Parties, intending to be legally bound, hereby agree as follows:   1. DEFINITIONS. For the purpose of this Agreement, the following terms shall have the following meanings:   1.1 \"Mill Recovery Technology/Intellectual Property\" shall mean all Technology, Software and Intellectual Property directed to mill-based recovery processes that generate biorefinery materials.   1.2 \"Common Information\" shall mean that Information that is related to, but not dedicated to, the SpinCo Assets, the SpinCo Liabilities, the SpinCo Business or the Transferred Entities.   1.3  \"Control\" or \"Controlled\" means, with respect to Intellectual Property, that SpinCo or a member of the SpinCo Group owns such Intellectual Property, in whole or in part, and/or has the right to grant a license to Parent with respect to such Intellectual Property as set forth herein and without incurring any financial or other obligations to any other Person, subject, in each case, to the terms of any license or other agreement to which SpinCo or any of the SpinCo Group is a party that relates to any such Intellectual Property.\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n  1.4 \"Improvements\" means any improvements, derivative works, enhancements, refinements, advances or other modifications with respect to any Licensed SpinCo IP (whether or not patentable or reduced to practice).   1.5 \"Intellectual Property\" shall mean all of the following whether arising under the Laws of the United States or of any other foreign or multinational jurisdiction: (a) patents, patent applications (including patents issued thereon) and statutory invention registrations, including reissues, divisions, continuations, continuations in part, substitutions, renewals, extensions and reexaminations of any of the foregoing, and all rights in any of the foregoing provided by international treaties or conventions, (b) trademarks, service marks, trade names, service names, trade dress, logos and other source or business identifiers, including all goodwill associated with any of the foregoing, and any and all common law rights in and to any of the foregoing, registrations and applications for registration of any of the foregoing, all rights in and to any of the foregoing provided by international treaties or conventions, and all reissues, extensions and renewals of any of the foregoing, (c) Internet domain names, accounts with Facebook, LinkedIn, Twitter and similar social media platforms, registrations and related rights, (d) copyrightable works, copyrights, moral rights, mask work rights, database rights and design rights, in each case, other than Software, whether or not registered, and all registrations and applications for registration of any of the foregoing, and all rights in and to any of the fore',\n",
              "    'Highlight the parts (if any) of this contract related to \"Agreement Date\" that should be reviewed by a lawyer. Details: The date of the contract',\n",
              "    'May 14, 2016',\n",
              "    99,\n",
              "    111),\n",
              "   ('Exhibit 10.1 JOINT VENTURE AGREEMENT BETWEEN NOVO INTEGRATED SCIENCES INC. (\"NVOS\") AND HARVEST GOLD FARMS INC. (\"HGF\") FOR THE DEVELOPMENT, MANAGEMENT AND OPERATION OF HEMP FARMING AND MEDICINAL CROPS\\n\\n\\n\\n\\n\\nJOINT VENTURE AGREEMENT Dated as of December 19, 2019 This Joint Venture Agreement (the \"Agreement\") is entered into between Novo Integrated Sciences Inc., a Nevada Corporation with offices located at 11120 NE 2nd Street, Suite 200, Bellevue, Washington 98004, U.S.A (herein referred to as \"NVOS\") and Harvest Gold Farms Inc., a corporation organized under the laws of New Brunswick, Canada with offices located at 866 E. H. Daigle Blvd, Grand Falls, New Brunswick, E3Z 3E8, Canada (herein referred to as \"HGF\"). NVOS and HGF may be referred to herein collectively as the \"Parties\" and separately as a \"Party.\" RECEITALS WHEREAS, NVOS is willing to assist in development, assist in management and purchase biomass resulting from open field farming for health-related cash crops, in particular medicinal cannabis and industrial hemp; WHEREAS, NVOS is willing to develop and construct processing facilities as well as finished goods manufacturing and packaging facilities; WHEREAS, NVOS is willing to provide the Joint Venture access to its distribution pathways established either directly or indirectly through NVOS or its wholly or partially owned subsidiaries; WHEREAS, NVOS is willing to establish reasonable commercial cost bases to product processing and packaging ensuring a profitable and fully transparent Joint Venture; WHEREAS, NVOS is willing to utilize all applicable HGF tools and offerings for the purposes of developing a fully comprehensive North American business platform; WHEREAS, HGF is willing to work towards a mutually acceptable Joint Venture; WHEREAS, HGF is willing to engage to its fullest potential in the licencing, employment harvesting, legal right consulting, business development within its geographical jurisdiction; WHEREAS, HGF is willing assist in transport and distribution of raw and finished goods in both domestic and international jurisdictions; WHEREAS, HGF is willing to provide certified biomass to the JV on pre-determined, mutually agreed price per acre and participate on a net revenue split of products offered to market directly or indirectly through NVOS channels; NOW THEREFORE, the Parties agree to sign this Agreement for the purposes of developing, managing and arranging medicinal farming projects involving hemp and cannabis cash crops (hereinafter referred to as the \"Primary Project\") under the following terms set out in this Agreement for the noted project (herein, referred to as the \"Primary Contract\").\\n\\n\\n\\n\\n\\nARTICLE 1 - DEFINITIONS AND INTERPRETATION 1.1 For the purposes of this Agreement, unless the context otherwise requires, the following terms shall have the respective meanings set forth below and grammatical variations of such terms shall have corresponding meanings: (a) \"Action\" means any legal action, suit, claim, investigation, hearing or proceeding, including any audit, claim or assessment for Taxes or otherwise. (b) \"Agreement\" means this Joint Venture Agreement, dated December 19, 2019. (c) \"Company\" means the Joint Venture entity which will be registered and incorporated in a Canadian jurisdiction with its operating name as Novo Earth Therapeutics Inc. (d) \"Cost\" means cost of goods sold as defined in the financials of the Primary Project. (e) \"Effective Date\" is the date of the most recent final signature on this Agreement. (f) \"EPC\" means engineering, procurement, construction contracts. (g) \"HFG\" means Harvest Gold Farms Inc. (h) \"Joint Venture\" means a business arrangement where NVOS and HGF have agreed to pool their resources for the purpose of the Primary Project. (i) \"Law\" means any domestic or foreign, federal, state, provincial, municipal or local law, statute, ordinance, code, rule, or regulation having the force of law. (j) \"NHL\" means Novo Healthnet Limited. (k) \"NVOS\" means Novo Integrated Sciences Inc. (l) \"Parties\" means collectively, Harvest Gold Farms Inc. and Novo Inte',\n",
              "    'Highlight the parts (if any) of this contract related to \"Agreement Date\" that should be reviewed by a lawyer. Details: The date of the contract',\n",
              "    'December 19, 2019',\n",
              "    243,\n",
              "    260),\n",
              "   ('EXHIBIT 99.4\\n\\n                            DATED 15TH DECEMBER 2001\\n\\n            CHINA ECONOMIC INFORMATION SERVICE OF XINHUA NEWS AGENCY\\n\\n                                       AND\\n\\n                        XINHUA FINANCIAL NETWORK LIMITED\\n\\n                                   ----------\\n\\n                            CONTENT LICENSE AGREEMENT                SUPPLEMENT TO THE EXCLUSIVE BROADCASTING AGREEMENT\\n\\n                                   ----------\\n\\n                                BAKER & McKENZIE                            14th Floor Hutchison House                                 10 Harcourt Road                                     Hong Kong                                  Tel: 2846-1888                                  Fax: 2845-0476\\n\\n                                     CONTENT\\n\\nClause                                                                      Page ------                                                                      ----                                                                           1.  Definitions and Interpretation.......................................     1 2.  Grant of Rights......................................................     2 3.  Delivery of Content..................................................     3 4.  Consideration........................................................     3 5.  Representations and Warranties.......................................     4 6.  Indemnity............................................................     4 7.  Term.................................................................     5 8.  Termination..........................................................     5 9.  Further Assurance....................................................     6 10. Entire Agreement; Amendments.........................................     6 11. Severance............................................................     6 12. No Waiver............................................................     6 13. Costs And Expenses...................................................     6 14. Counterparts.........................................................     6 15. Notice...............................................................     6 16. Governing Law And Arbitration........................................     7 Execution................................................................     8\\n\\nSchedule 1 - Contents\\n\\n                                       -i-\\n\\nTHIS AGREEMENT is made the 15th day of December 2001.\\n\\nBETWEEN\\n\\n(1)  CHINA ECONOMIC INFORMATION SERVICE OF XINHUA NEWS AGENCY, the organisation      within the Xinhua News Agency that is responsible for news and information      operations and business, registered in the People\\'s Republic of China with      offices at 57 Xuanwumen Xidajie, Beijing, the People\\'s Republic of China (      \"CEIS\"); and\\n\\n(2)  XINHUA FINANCIAL NETWORK LIMITED, a company incorporated in Hong Kong whose      registered office is at Room 2003-4, Vicwood Plaza, 199 Des Voeux Road      Central, Hong Kong (\"XFN\"),\\n\\n     (collectively referred to as \"PARTIES\"; individually, a \"PARTY\").\\n\\nSource: XINHUA SPORTS & ENTERTAINMENT LTD, F-1, 2/21/2007\\n\\n\\n\\n\\n\\nWHEREAS:\\n\\n(A)  CEIS is the owner and distributor of certain content of Xinhua News Agency      relating to financial and economic information;\\n\\n(B)  CEIS wishes to appoint XFN as its licensee to distribute the content to      users throughout the world in accordance with the terms and conditions of      this Agreement.\\n\\nIT IS HEREBY AGREED as follows:\\n\\n1.   DEFINITIONS AND INTERPRETATION\\n\\n1.1  In this Agreement unless the context otherwise requires the following words      shall have the following meaning:\\n\\n                 \"AFFILIATES\"       means any company, corporation, partnership, joint venture or                    other entity that directly or indirectly controls, is                    controlled by or is under common control with XFN;\\n\\n\"CONTENT\"          means real-time economic news including articles, reports,                    data, information and such materials that have or have ',\n",
              "    'Highlight the parts (if any) of this contract related to \"Agreement Date\" that should be reviewed by a lawyer. Details: The date of the contract',\n",
              "    '15th day of December 2001',\n",
              "    2487,\n",
              "    2512),\n",
              "   ('Exhibit 10(xiv)\\n\\nMASTER SERVICES AGREEMENT Between RadialSpark, LLC and Clear Capital Page 1 of 10\\n\\n\\n\\n\\n\\nTHIS MASTER SERVICES AGREEMENT (\"Agreement\"), dated as of 09/24/2018 (the \"Effective Date\"), is between Clear Capital (the \"Company\") and RadialSpark, LLC (the \"Contractor\"). WHEREAS, Company desires from time to time to retain Contractor to perform certain management consulting services for Company; and WHEREAS, Contractor desires to perform such management consulting services for Company; NOW THEREFORE, in consideration of the foregoing premises, and the mutual covenants and agreements set forth herein, the parties hereto agree as follows: 1. PURPOSE OF ENGAGEMENT. (a) Company agrees to retain Contractor to perform the consulting services for Company, on a task by task basis (the \"Services\"), and Contractor agrees to furnish the Services on the terms and subject to the conditions set forth in this Agreement. During the term of this Agreement, Company and Contractor will develop and agree upon statements of work defining the Services and work product to be provided by Contractor, Contractor\\'s compensation, additional terms and conditions, if any, applicable to a particular engagement and such other details as the parties deem appropriate (each a \"Statement of Work\"). A Statement of Work may provide specifications for deliverables to be provided thereunder (the \"Specifications\"). Statements of Work that are from time to time agreed upon shall reference this Agreement, and shall be executed by the parties and attached hereto and shall form a part hereof. In all instances of a conflict, between the provisions of this Agreement and the specific provisions set forth in a Statement of Work, the provisions of this Agreement shall control. (b) Contractor shall provide sufficient qualified personnel to perform the Services in a professional and workmanlike manner in accordance with industry standards. A Statement of Work may designate certain individuals as \"Key Personnel\" for an engagement, and the parties subsequently may agree in writing that additional individuals are Key Personnel for such engagement. If there are Key Personnel for an engagement, Contractor shall provide the Services through those personnel and such additional personnel of Contractor as Contractor may from time to time determine to be required for the performance of the Services. Company shall have the right to interview and approve such additional personnel at Company\\'s request. If one or more Key Personnel terminate their employment with Contractor or otherwise become\\n\\nPage 2 of 10\\n\\n\\n\\n\\n\\nunavailable to work on an engagement for reasons beyond Contractor\\'s reasonable control, Contractor may provide the Services through other personnel with comparable training and experience. If Company becomes dissatisfied with any of Contractor\\'s personnel providing the Services, Company may notify Contractor of the details of its dissatisfaction, and the parties shall cooperate to remedy the problem as soon as possible. If Company reasonably requests, Contractor shall reassign the individual who is the subject of Company\\'s dissatisfaction and replace that person with other personnel in accordance with this Agreement. (c) Unless otherwise provided in a Statement of Work, Contractor shall provide the Services at Contractor\\'s facility. Contractor shall provide computing equipment consistent with the Services to be provided under the Statement of Work. When services are provided at a Company facility, Company shall provide workspace and other facilities such as computer support consistent with the requirements of the Services to be provided under the Statement of Work. Contractor shall cause its personnel at Company\\'s facility to comply with Company\\'s (i) safety and security rules and other rules applicable to those working in the facility, and (ii) Company\\'s policies concerning access to and security of any Company computer system to which Contractor may have access; provided, that Company has provided Contractor with copies of such rules and policies or has advised Contra',\n",
              "    'Highlight the parts (if any) of this contract related to \"Agreement Date\" that should be reviewed by a lawyer. Details: The date of the contract',\n",
              "    '9/24/2018',\n",
              "    163,\n",
              "    172)]),\n",
              " (('Renewal Term', 'possible negative'),\n",
              "  [('1                                                                     Exhibit 10.3\\n\\nI-on. (LOGO) www.i-on.com 561.394.9484 o 561.394-9773 fax 1733 avenida del sol, boca raton, florida, 33432\\n\\nWEB SITE HOSTING AGREEMENT\\n\\nThis WEB SITE HOSTING AGREEMENT (\"this Agreement\") is entered into this 6th day of April, 1999 by and between Centrack International, a Florida corporation (\"the Customer\"), and i-on interactive, a Florida corporation (\"i-on\").\\n\\nDEFINITIONS\\n\\nAs used in this Agreement, the term \"Web site\" shall mean a computer system intended to be accessed through the World Wide Web segment of the Internet, including software and content intended to be viewed and/or operated upon by persons accessing the computer system via the Internet. A Web site may exist on a single computer system with other Web sites.\\n\\nThe term \"Hosted Site\" shall mean the Web site of the Customer that is hosted by i-on under the terms and conditions of this Agreement.\\n\\nThe term \"Hosting Computer\" shall mean the computer system and related equipment on which the Hosted Site exists.\\n\\nSERVICES PROVIDED TO THE CUSTOMER\\n\\ni-on will maintain the operation of the Hosted Site continuously, twenty-four (24) hours per day, seven (7) days per week, including holidays, with the exception of reasonable hardware and software maintenance that must be performed on the Hosting Computer and/or the Hosted Site. i-on will use best efforts to schedule and perform such maintenance between the hours of 8pm and 8am Eastern Standard Time on weekdays, or during weekends.\\n\\nUnder this Agreement, i-on will provide the following limited services for the Hosted Site:\\n\\n      1. connectivity to the Internet via a T1 (that may be shared by other             Web sites) to a leading Internet backbone access provider such as             UUNET, and reasonable efforts to maintain such connectivity with the             phone company and the Internet backbone access provider;\\n\\n      2. use of the Hosting Computer (that may be shared by other Web sites)             as described in this Agreement and maintenance required to keep such             Hosting Computer in good working order;\\n\\n      3. physical space for the Hosting Computer at a facility that maintains             proper environmental conditions in the area(s) where the Hosting             Computer is located and maintains reasonable efforts to prevent             unauthorized access to the physical location of the Hosting             Computer;\\n\\n      4. an emergency electrical power backup system for the Hosting             Computer;\\n\\n      5. up to 150 MB of mirrored computer storage on the Hosting Computer;\\n\\n      6. archival backups of such mirrored computer storage on a weekly             basis;    2          7.  off-site storage of such backups at separate facility than the              location of the Hosting Computer;\\n\\n      8.  use of the Microsoft Windows NT Server 4.0 or higher operating              system software for the Hosting Computer and the Hosted Site;\\n\\n      9.  use of the Microsoft Internet Information Service (IIS) 3.0 or              higher Web server software for the Hosted Site (providing support              for the HTTP Web protocol);\\n\\n      10. use of the Microsoft SQL Server 6.5 or higher database server              software for the Hosted Site, within the boundaries of allocated              computer storage, per #5 above;\\n\\n      11. access to the Hosted Site via the ftp protocol to an administrative              account designated by the Customer for the Customer to maintain the              Hosted Site\\'s static content (such as HTML Web pages and computer              graphics);\\n\\n      12. up to 10 mailboxes accessible via the POP3 mail protocol that are              mapped to the Hosted Site\\'s Internet address;\\n\\n      13. up to 1 hour per month of Web site administration services at no              additional charge, limited to:\\n\\n               requests for changes to ftp/e-mail users and passwords;                   requests for e-mail configuration changes;                   modification of mail',\n",
              "    'Highlight the parts (if any) of this contract related to \"Renewal Term\" that should be reviewed by a lawyer. Details: What is the renewal term after the initial term expires? This includes automatic extensions and unilateral extensions with prior notice.',\n",
              "    'Agreement, which notice must be given not less than fifteen (15) days before the end of the respective initial or renewal term.',\n",
              "    0,\n",
              "    0),\n",
              "   ('1                                                                     Exhibit 10.3\\n\\nI-on. (LOGO) www.i-on.com 561.394.9484 o 561.394-9773 fax 1733 avenida del sol, boca raton, florida, 33432\\n\\nWEB SITE HOSTING AGREEMENT\\n\\nThis WEB SITE HOSTING AGREEMENT (\"this Agreement\") is entered into this 6th day of April, 1999 by and between Centrack International, a Florida corporation (\"the Customer\"), and i-on interactive, a Florida corporation (\"i-on\").\\n\\nDEFINITIONS\\n\\nAs used in this Agreement, the term \"Web site\" shall mean a computer system intended to be accessed through the World Wide Web segment of the Internet, including software and content intended to be viewed and/or operated upon by persons accessing the computer system via the Internet. A Web site may exist on a single computer system with other Web sites.\\n\\nThe term \"Hosted Site\" shall mean the Web site of the Customer that is hosted by i-on under the terms and conditions of this Agreement.\\n\\nThe term \"Hosting Computer\" shall mean the computer system and related equipment on which the Hosted Site exists.\\n\\nSERVICES PROVIDED TO THE CUSTOMER\\n\\ni-on will maintain the operation of the Hosted Site continuously, twenty-four (24) hours per day, seven (7) days per week, including holidays, with the exception of reasonable hardware and software maintenance that must be performed on the Hosting Computer and/or the Hosted Site. i-on will use best efforts to schedule and perform such maintenance between the hours of 8pm and 8am Eastern Standard Time on weekdays, or during weekends.\\n\\nUnder this Agreement, i-on will provide the following limited services for the Hosted Site:\\n\\n      1. connectivity to the Internet via a T1 (that may be shared by other             Web sites) to a leading Internet backbone access provider such as             UUNET, and reasonable efforts to maintain such connectivity with the             phone company and the Internet backbone access provider;\\n\\n      2. use of the Hosting Computer (that may be shared by other Web sites)             as described in this Agreement and maintenance required to keep such             Hosting Computer in good working order;\\n\\n      3. physical space for the Hosting Computer at a facility that maintains             proper environmental conditions in the area(s) where the Hosting             Computer is located and maintains reasonable efforts to prevent             unauthorized access to the physical location of the Hosting             Computer;\\n\\n      4. an emergency electrical power backup system for the Hosting             Computer;\\n\\n      5. up to 150 MB of mirrored computer storage on the Hosting Computer;\\n\\n      6. archival backups of such mirrored computer storage on a weekly             basis;    2          7.  off-site storage of such backups at separate facility than the              location of the Hosting Computer;\\n\\n      8.  use of the Microsoft Windows NT Server 4.0 or higher operating              system software for the Hosting Computer and the Hosted Site;\\n\\n      9.  use of the Microsoft Internet Information Service (IIS) 3.0 or              higher Web server software for the Hosted Site (providing support              for the HTTP Web protocol);\\n\\n      10. use of the Microsoft SQL Server 6.5 or higher database server              software for the Hosted Site, within the boundaries of allocated              computer storage, per #5 above;\\n\\n      11. access to the Hosted Site via the ftp protocol to an administrative              account designated by the Customer for the Customer to maintain the              Hosted Site\\'s static content (such as HTML Web pages and computer              graphics);\\n\\n      12. up to 10 mailboxes accessible via the POP3 mail protocol that are              mapped to the Hosted Site\\'s Internet address;\\n\\n      13. up to 1 hour per month of Web site administration services at no              additional charge, limited to:\\n\\n               requests for changes to ftp/e-mail users and passwords;                   requests for e-mail configuration changes;                   modification of mail',\n",
              "    'Highlight the parts (if any) of this contract related to \"Renewal Term\" that should be reviewed by a lawyer. Details: What is the renewal term after the initial term expires? This includes automatic extensions and unilateral extensions with prior notice.',\n",
              "    'This Agreement shall automatically be renewed for one (1) or more one (1) month periods unless either the Customer or i-on gives notice to the other party of its intention not to renew the',\n",
              "    0,\n",
              "    0),\n",
              "   ('Exhibit 10.13\\n\\nConfidential Materials omitted and filed separately with the Securities and Exchange Commission. Asterisks denote omissions.\\n\\nDATED: OCTOBER 15, 2009\\n\\nPACIRA PHARMACEUTICALS, INC.\\n\\nand\\n\\nEKR THERAPEUTICS, INC.        AMENDED AND RESTATED   STRATEGIC LICENSING, DISTRIBUTION AND MARKETING AGREEMENT\\n\\n\\n\\n\\n\\nTHIS AMENDED AND RESTATED STRATEGIC LICENSING, DISTRIBUTION AND MARKETING AGREEMENT (the  \"Agreement\") is made on October 15, 2009 (the \"Agreement Date\") and is effective as of the Effective Date (as defined below), between:   PACIRA PHARMACEUTICALS, INC. (F/K/A SKYEPHARMA, INC.) a company incorporated in the state of California whose principal place of business is 10450 Sciences Center Drive, San Diego, California 92121 USA (\"PPI\"); and   EKR THERAPEUTICS, INC., a company incorporated in the state of Delaware whose principal place of business is 1545 Route 206  South, Third Floor, Bedminster, New Jersey 07921 (\"EKR\").\\n\\nRecitals\\n\\nPPI owns and has all right title and interest in or has acquired exclusive rights to the PPI IP (as defined below), the Trademark (as  defined below) and the Product (as defined below).\\n\\nEKR has, among other things, specialized knowledge and expertise in relation to the marketing and sale of pharmaceutical products.\\n\\nPursuant to that certain Strategic Licensing, Distribution and Marketing Agreement between EKR and PPI dated as of August 10, 2007  (the \"Original Agreement\"), PPI granted and EKR acquired the exclusive right and license to sell, offer to sell, distribute and market the Product in  the Territory (as defined below) in the Field (as defined below).\\n\\nEKR and PPI desire to amend and restate the Original Agreement in its entirety as set forth herein in order to provide for: (i) certain  changes to the financial terms set forth in the Original Agreement, (ii) the transfer of Marketing Authorizations (as defined below) from PPI to      -1-\\n\\n\\n\\n\\n\\nEKR, and EKR\\'s assumption of obligations thereunder, (iii) the transfer of title to certain manufacturing equipment from PPI to EKR and the lease  of such equipment back from EKR to PPI and (iv) certain other changes as are set forth herein; all of the foregoing subject to and in accordance  with the terms and conditions of this Agreement.\\n\\nNOW THEREFORE, in consideration of the following mutual agreements and covenants set forth herein and intending to be legally  bound hereby, PPI and EKR (each, a \"Party\"  and collectively, the \"Parties\")  acknowledge and agree that this Agreement shall amend and  supersede in its entirety the Original Agreement and hereby agree as follows:\\n\\nOperative Provisions\\n\\n\\n\\n\\n\\n   -2-\\n\\n1. Definitions   1.1 As used in this Agreement, the following words and expressions have the following meanings:\\n\\n\"Affiliate\"\\n\\n\\n\\nWith respect to any Party to this Agreement shall mean any company, corporation, firm, individual or other  entity which Controls, is Controlled by or is under common Control with such Party to this Agreement for only  so long as such Control exists;\\n\\n\\n\\n\\n\\n   -3-\\n\\n\"Applicable Laws\"\\n\\n\\n\\nShall mean all laws, rules and regulations regarding the manufacture, packaging, labeling, import, export,  storage, distribution, representation, promotion, marketing and sale of the Products including but not limited to  the Federal Food, Drug and Cosmetic Act of 1938, as amended (\"FD&C Act\") and the Controlled Substances  Act, as amended (21 U.S.C. ยง801 et seq.), or as defined in attendant regulations promulgated under authorities  granted by the FD&C Act, together with any equivalent laws, rules, regulations, codes or guidelines having  effect in any jurisdiction in the Territory;\\n\\n\"Calendar Year\"    Shall mean the period of twelve months commencing on 1st January in any year, and each consecutive period  of twelve months thereafter during the Term;\\n\\n\"cGMP\"    Means Current Good Manufacturing Practices pursuant to 21 CFR Parts 210 and 211, as may be amended from  time to time;\\n\\n\"Commercial Launch\"\\n\\n\\n\\nShall mean the date of the first arm\\'s length sale by EKR to an unaffiliated Third Party customer for commercial  use of Pro',\n",
              "    'Highlight the parts (if any) of this contract related to \"Renewal Term\" that should be reviewed by a lawyer. Details: What is the renewal term after the initial term expires? This includes automatic extensions and unilateral extensions with prior notice.',\n",
              "    'Thereafter  the term of this Agreement shall automatically renew for consecutive periods of two (2) years each.',\n",
              "    0,\n",
              "    0),\n",
              "   ('Exhibit 10.8\\n\\neGAIN COMMUNICATIONS CORPORATION\\n\\nHOSTING AGREEMENT\\n\\n1. Hosting Agreement. This Agreement (including its Exhibit A and all other documents referenced herein) is entered into by eGain Communications Corporation (\"eGain\") and Eliance Corporation (\"Customer\") for the purpose of providing Customer with Web-based access to eGain\\'s software specified in Exhibit A, including any updates, upgrades or revisions provided under this Agreement (\"Software\"), and certain other services relating to the processing of and response to online inquiries and messages (\"Online Messages\") received by Customer from its customers and other users of Customer\\'s Web site (\"Users\").\\n\\n2. Provision of Services. eGain will provide Customer with access, maintenance and related hosting services (\"Hosting Services\") to the Software installed on eGain\\'s servers and other equipment (the \"eGain System\"). Customer agrees, as reasonably requested by eGain, to provide eGain with access to Customer\\'s premises and equipment and to otherwise cooperate with eGain in performing the services. During the term of this Agreement, Customer may obtain information (\"Reports\") regarding Customer\\'s use of the Software and the quantity and handling of Online Messages routed to the eGain System by accessing the eGain System through a password-protected Web site made available by eGain. Customer shall be responsible for maintaining the confidentiality of such passwords and shall permit only authorized employees of Customer to access the eGain System. The Hosting Services, and the hosting fees specified in Exhibit A, do not include any deployment, training or other consulting or professional services which, if applicable, will be specified in a Statement of Work, signed by both parties, and incorporated herein by this reference.\\n\\n2.1 Customer Support. eGain will provide live telephone support to Customer 24-hours-a-day, seven-days-a-week by a trained eGain customer support representative.\\n\\n3. Customer\\'s Responsibilities. Customer agrees that it shall be responsible for providing and maintaining its own Internet access and all necessary telecommunications equipment, software and other materials (\"Customer Equipment\") at Customer\\'s location necessary for accessing the Software and the eGain System through the Internet. Customer agrees to notify eGain of any changes in the Customer Equipment, including any system configuration changes or any hardware or software upgrades, which may affect the Hosting Services provided hereunder. The eGain System is only to be used for lawful purposes. Customer agrees not to transmit, re-transmit or store materials on or through the eGain System or the Software that are harmful to the eGain System or Software, or in violation of any applicable laws or regulations, including without limitation laws relating to infringement of intellectual property and proprietary rights of others. To the extent that certain components of the Software may be downloaded to Customer\\'s or User\\'s computer as a result of accessing the Software as part of the Hosting Services, eGain grants Customers a non-exclusive, non-transferable, limited license, with right to sublicense solely to Users, to use such Software only in connection with the Hosting Services. Neither Customer nor Users are otherwise permitted to use the Software, nor will Customer or Users disassemble, decompile or otherwise attempt to discern the source code of such Software. Customer agrees that, except as expressly set forth in this Section and in Section 11, it will not rent, lease, sublicense, re-sell, time-share or otherwise assign to any third party this Agreement or any of Customer\\'s rights or licenses to access the Software or the eGain System, nor shall Customer use, or authorize others to use, the Software, Hosting Services or the eGain System to operate a service bureau. Notwithstanding the preceding sentence, Customer shall be permitted to provide access to the eGain System to its employees and agents located worldwide.\\n\\n4. Proprietary Rights. Except for the limited access right gra',\n",
              "    'Highlight the parts (if any) of this contract related to \"Renewal Term\" that should be reviewed by a lawyer. Details: What is the renewal term after the initial term expires? This includes automatic extensions and unilateral extensions with prior notice.',\n",
              "    'This Agreement shall continue in effect from the Effective Date for a one (1) year period, unless earlier terminated as set forth below, and thereafter shall renew automatically for successive one (1) year periods unless either party gives the other party at least thirty (30) days prior written notice of its intent not to renew the Agreement.',\n",
              "    0,\n",
              "    0)]),\n",
              " (('Notice Period To Terminate Renewal', 'possible negative'),\n",
              "  [('1                                                                     Exhibit 10.3\\n\\nI-on. (LOGO) www.i-on.com 561.394.9484 o 561.394-9773 fax 1733 avenida del sol, boca raton, florida, 33432\\n\\nWEB SITE HOSTING AGREEMENT\\n\\nThis WEB SITE HOSTING AGREEMENT (\"this Agreement\") is entered into this 6th day of April, 1999 by and between Centrack International, a Florida corporation (\"the Customer\"), and i-on interactive, a Florida corporation (\"i-on\").\\n\\nDEFINITIONS\\n\\nAs used in this Agreement, the term \"Web site\" shall mean a computer system intended to be accessed through the World Wide Web segment of the Internet, including software and content intended to be viewed and/or operated upon by persons accessing the computer system via the Internet. A Web site may exist on a single computer system with other Web sites.\\n\\nThe term \"Hosted Site\" shall mean the Web site of the Customer that is hosted by i-on under the terms and conditions of this Agreement.\\n\\nThe term \"Hosting Computer\" shall mean the computer system and related equipment on which the Hosted Site exists.\\n\\nSERVICES PROVIDED TO THE CUSTOMER\\n\\ni-on will maintain the operation of the Hosted Site continuously, twenty-four (24) hours per day, seven (7) days per week, including holidays, with the exception of reasonable hardware and software maintenance that must be performed on the Hosting Computer and/or the Hosted Site. i-on will use best efforts to schedule and perform such maintenance between the hours of 8pm and 8am Eastern Standard Time on weekdays, or during weekends.\\n\\nUnder this Agreement, i-on will provide the following limited services for the Hosted Site:\\n\\n      1. connectivity to the Internet via a T1 (that may be shared by other             Web sites) to a leading Internet backbone access provider such as             UUNET, and reasonable efforts to maintain such connectivity with the             phone company and the Internet backbone access provider;\\n\\n      2. use of the Hosting Computer (that may be shared by other Web sites)             as described in this Agreement and maintenance required to keep such             Hosting Computer in good working order;\\n\\n      3. physical space for the Hosting Computer at a facility that maintains             proper environmental conditions in the area(s) where the Hosting             Computer is located and maintains reasonable efforts to prevent             unauthorized access to the physical location of the Hosting             Computer;\\n\\n      4. an emergency electrical power backup system for the Hosting             Computer;\\n\\n      5. up to 150 MB of mirrored computer storage on the Hosting Computer;\\n\\n      6. archival backups of such mirrored computer storage on a weekly             basis;    2          7.  off-site storage of such backups at separate facility than the              location of the Hosting Computer;\\n\\n      8.  use of the Microsoft Windows NT Server 4.0 or higher operating              system software for the Hosting Computer and the Hosted Site;\\n\\n      9.  use of the Microsoft Internet Information Service (IIS) 3.0 or              higher Web server software for the Hosted Site (providing support              for the HTTP Web protocol);\\n\\n      10. use of the Microsoft SQL Server 6.5 or higher database server              software for the Hosted Site, within the boundaries of allocated              computer storage, per #5 above;\\n\\n      11. access to the Hosted Site via the ftp protocol to an administrative              account designated by the Customer for the Customer to maintain the              Hosted Site\\'s static content (such as HTML Web pages and computer              graphics);\\n\\n      12. up to 10 mailboxes accessible via the POP3 mail protocol that are              mapped to the Hosted Site\\'s Internet address;\\n\\n      13. up to 1 hour per month of Web site administration services at no              additional charge, limited to:\\n\\n               requests for changes to ftp/e-mail users and passwords;                   requests for e-mail configuration changes;                   modification of mail',\n",
              "    'Highlight the parts (if any) of this contract related to \"Notice Period To Terminate Renewal\" that should be reviewed by a lawyer. Details: What is the notice period required to terminate renewal?',\n",
              "    'Agreement, which notice must be given not less than fifteen (15) days before the end of the respective initial or renewal term.',\n",
              "    0,\n",
              "    0),\n",
              "   ('1                                                                     Exhibit 10.3\\n\\nI-on. (LOGO) www.i-on.com 561.394.9484 o 561.394-9773 fax 1733 avenida del sol, boca raton, florida, 33432\\n\\nWEB SITE HOSTING AGREEMENT\\n\\nThis WEB SITE HOSTING AGREEMENT (\"this Agreement\") is entered into this 6th day of April, 1999 by and between Centrack International, a Florida corporation (\"the Customer\"), and i-on interactive, a Florida corporation (\"i-on\").\\n\\nDEFINITIONS\\n\\nAs used in this Agreement, the term \"Web site\" shall mean a computer system intended to be accessed through the World Wide Web segment of the Internet, including software and content intended to be viewed and/or operated upon by persons accessing the computer system via the Internet. A Web site may exist on a single computer system with other Web sites.\\n\\nThe term \"Hosted Site\" shall mean the Web site of the Customer that is hosted by i-on under the terms and conditions of this Agreement.\\n\\nThe term \"Hosting Computer\" shall mean the computer system and related equipment on which the Hosted Site exists.\\n\\nSERVICES PROVIDED TO THE CUSTOMER\\n\\ni-on will maintain the operation of the Hosted Site continuously, twenty-four (24) hours per day, seven (7) days per week, including holidays, with the exception of reasonable hardware and software maintenance that must be performed on the Hosting Computer and/or the Hosted Site. i-on will use best efforts to schedule and perform such maintenance between the hours of 8pm and 8am Eastern Standard Time on weekdays, or during weekends.\\n\\nUnder this Agreement, i-on will provide the following limited services for the Hosted Site:\\n\\n      1. connectivity to the Internet via a T1 (that may be shared by other             Web sites) to a leading Internet backbone access provider such as             UUNET, and reasonable efforts to maintain such connectivity with the             phone company and the Internet backbone access provider;\\n\\n      2. use of the Hosting Computer (that may be shared by other Web sites)             as described in this Agreement and maintenance required to keep such             Hosting Computer in good working order;\\n\\n      3. physical space for the Hosting Computer at a facility that maintains             proper environmental conditions in the area(s) where the Hosting             Computer is located and maintains reasonable efforts to prevent             unauthorized access to the physical location of the Hosting             Computer;\\n\\n      4. an emergency electrical power backup system for the Hosting             Computer;\\n\\n      5. up to 150 MB of mirrored computer storage on the Hosting Computer;\\n\\n      6. archival backups of such mirrored computer storage on a weekly             basis;    2          7.  off-site storage of such backups at separate facility than the              location of the Hosting Computer;\\n\\n      8.  use of the Microsoft Windows NT Server 4.0 or higher operating              system software for the Hosting Computer and the Hosted Site;\\n\\n      9.  use of the Microsoft Internet Information Service (IIS) 3.0 or              higher Web server software for the Hosted Site (providing support              for the HTTP Web protocol);\\n\\n      10. use of the Microsoft SQL Server 6.5 or higher database server              software for the Hosted Site, within the boundaries of allocated              computer storage, per #5 above;\\n\\n      11. access to the Hosted Site via the ftp protocol to an administrative              account designated by the Customer for the Customer to maintain the              Hosted Site\\'s static content (such as HTML Web pages and computer              graphics);\\n\\n      12. up to 10 mailboxes accessible via the POP3 mail protocol that are              mapped to the Hosted Site\\'s Internet address;\\n\\n      13. up to 1 hour per month of Web site administration services at no              additional charge, limited to:\\n\\n               requests for changes to ftp/e-mail users and passwords;                   requests for e-mail configuration changes;                   modification of mail',\n",
              "    'Highlight the parts (if any) of this contract related to \"Notice Period To Terminate Renewal\" that should be reviewed by a lawyer. Details: What is the notice period required to terminate renewal?',\n",
              "    'This Agreement shall automatically be renewed for one (1) or more one (1) month periods unless either the Customer or i-on gives notice to the other party of its intention not to renew the',\n",
              "    0,\n",
              "    0),\n",
              "   ('Exhibit 10.13\\n\\nConfidential Materials omitted and filed separately with the Securities and Exchange Commission. Asterisks denote omissions.\\n\\nDATED: OCTOBER 15, 2009\\n\\nPACIRA PHARMACEUTICALS, INC.\\n\\nand\\n\\nEKR THERAPEUTICS, INC.        AMENDED AND RESTATED   STRATEGIC LICENSING, DISTRIBUTION AND MARKETING AGREEMENT\\n\\n\\n\\n\\n\\nTHIS AMENDED AND RESTATED STRATEGIC LICENSING, DISTRIBUTION AND MARKETING AGREEMENT (the  \"Agreement\") is made on October 15, 2009 (the \"Agreement Date\") and is effective as of the Effective Date (as defined below), between:   PACIRA PHARMACEUTICALS, INC. (F/K/A SKYEPHARMA, INC.) a company incorporated in the state of California whose principal place of business is 10450 Sciences Center Drive, San Diego, California 92121 USA (\"PPI\"); and   EKR THERAPEUTICS, INC., a company incorporated in the state of Delaware whose principal place of business is 1545 Route 206  South, Third Floor, Bedminster, New Jersey 07921 (\"EKR\").\\n\\nRecitals\\n\\nPPI owns and has all right title and interest in or has acquired exclusive rights to the PPI IP (as defined below), the Trademark (as  defined below) and the Product (as defined below).\\n\\nEKR has, among other things, specialized knowledge and expertise in relation to the marketing and sale of pharmaceutical products.\\n\\nPursuant to that certain Strategic Licensing, Distribution and Marketing Agreement between EKR and PPI dated as of August 10, 2007  (the \"Original Agreement\"), PPI granted and EKR acquired the exclusive right and license to sell, offer to sell, distribute and market the Product in  the Territory (as defined below) in the Field (as defined below).\\n\\nEKR and PPI desire to amend and restate the Original Agreement in its entirety as set forth herein in order to provide for: (i) certain  changes to the financial terms set forth in the Original Agreement, (ii) the transfer of Marketing Authorizations (as defined below) from PPI to      -1-\\n\\n\\n\\n\\n\\nEKR, and EKR\\'s assumption of obligations thereunder, (iii) the transfer of title to certain manufacturing equipment from PPI to EKR and the lease  of such equipment back from EKR to PPI and (iv) certain other changes as are set forth herein; all of the foregoing subject to and in accordance  with the terms and conditions of this Agreement.\\n\\nNOW THEREFORE, in consideration of the following mutual agreements and covenants set forth herein and intending to be legally  bound hereby, PPI and EKR (each, a \"Party\"  and collectively, the \"Parties\")  acknowledge and agree that this Agreement shall amend and  supersede in its entirety the Original Agreement and hereby agree as follows:\\n\\nOperative Provisions\\n\\n\\n\\n\\n\\n   -2-\\n\\n1. Definitions   1.1 As used in this Agreement, the following words and expressions have the following meanings:\\n\\n\"Affiliate\"\\n\\n\\n\\nWith respect to any Party to this Agreement shall mean any company, corporation, firm, individual or other  entity which Controls, is Controlled by or is under common Control with such Party to this Agreement for only  so long as such Control exists;\\n\\n\\n\\n\\n\\n   -3-\\n\\n\"Applicable Laws\"\\n\\n\\n\\nShall mean all laws, rules and regulations regarding the manufacture, packaging, labeling, import, export,  storage, distribution, representation, promotion, marketing and sale of the Products including but not limited to  the Federal Food, Drug and Cosmetic Act of 1938, as amended (\"FD&C Act\") and the Controlled Substances  Act, as amended (21 U.S.C. ยง801 et seq.), or as defined in attendant regulations promulgated under authorities  granted by the FD&C Act, together with any equivalent laws, rules, regulations, codes or guidelines having  effect in any jurisdiction in the Territory;\\n\\n\"Calendar Year\"    Shall mean the period of twelve months commencing on 1st January in any year, and each consecutive period  of twelve months thereafter during the Term;\\n\\n\"cGMP\"    Means Current Good Manufacturing Practices pursuant to 21 CFR Parts 210 and 211, as may be amended from  time to time;\\n\\n\"Commercial Launch\"\\n\\n\\n\\nShall mean the date of the first arm\\'s length sale by EKR to an unaffiliated Third Party customer for commercial  use of Pro',\n",
              "    'Highlight the parts (if any) of this contract related to \"Notice Period To Terminate Renewal\" that should be reviewed by a lawyer. Details: What is the notice period required to terminate renewal?',\n",
              "    'Notwithstanding the foregoing, this  Agreement can be terminated by EKR at the end of the Initial Term by delivery of written notice to PPI at least one hundred eighty (180)  days prior to the end of the Initial Term or any renewal term.',\n",
              "    0,\n",
              "    0),\n",
              "   ('Exhibit 10.8\\n\\neGAIN COMMUNICATIONS CORPORATION\\n\\nHOSTING AGREEMENT\\n\\n1. Hosting Agreement. This Agreement (including its Exhibit A and all other documents referenced herein) is entered into by eGain Communications Corporation (\"eGain\") and Eliance Corporation (\"Customer\") for the purpose of providing Customer with Web-based access to eGain\\'s software specified in Exhibit A, including any updates, upgrades or revisions provided under this Agreement (\"Software\"), and certain other services relating to the processing of and response to online inquiries and messages (\"Online Messages\") received by Customer from its customers and other users of Customer\\'s Web site (\"Users\").\\n\\n2. Provision of Services. eGain will provide Customer with access, maintenance and related hosting services (\"Hosting Services\") to the Software installed on eGain\\'s servers and other equipment (the \"eGain System\"). Customer agrees, as reasonably requested by eGain, to provide eGain with access to Customer\\'s premises and equipment and to otherwise cooperate with eGain in performing the services. During the term of this Agreement, Customer may obtain information (\"Reports\") regarding Customer\\'s use of the Software and the quantity and handling of Online Messages routed to the eGain System by accessing the eGain System through a password-protected Web site made available by eGain. Customer shall be responsible for maintaining the confidentiality of such passwords and shall permit only authorized employees of Customer to access the eGain System. The Hosting Services, and the hosting fees specified in Exhibit A, do not include any deployment, training or other consulting or professional services which, if applicable, will be specified in a Statement of Work, signed by both parties, and incorporated herein by this reference.\\n\\n2.1 Customer Support. eGain will provide live telephone support to Customer 24-hours-a-day, seven-days-a-week by a trained eGain customer support representative.\\n\\n3. Customer\\'s Responsibilities. Customer agrees that it shall be responsible for providing and maintaining its own Internet access and all necessary telecommunications equipment, software and other materials (\"Customer Equipment\") at Customer\\'s location necessary for accessing the Software and the eGain System through the Internet. Customer agrees to notify eGain of any changes in the Customer Equipment, including any system configuration changes or any hardware or software upgrades, which may affect the Hosting Services provided hereunder. The eGain System is only to be used for lawful purposes. Customer agrees not to transmit, re-transmit or store materials on or through the eGain System or the Software that are harmful to the eGain System or Software, or in violation of any applicable laws or regulations, including without limitation laws relating to infringement of intellectual property and proprietary rights of others. To the extent that certain components of the Software may be downloaded to Customer\\'s or User\\'s computer as a result of accessing the Software as part of the Hosting Services, eGain grants Customers a non-exclusive, non-transferable, limited license, with right to sublicense solely to Users, to use such Software only in connection with the Hosting Services. Neither Customer nor Users are otherwise permitted to use the Software, nor will Customer or Users disassemble, decompile or otherwise attempt to discern the source code of such Software. Customer agrees that, except as expressly set forth in this Section and in Section 11, it will not rent, lease, sublicense, re-sell, time-share or otherwise assign to any third party this Agreement or any of Customer\\'s rights or licenses to access the Software or the eGain System, nor shall Customer use, or authorize others to use, the Software, Hosting Services or the eGain System to operate a service bureau. Notwithstanding the preceding sentence, Customer shall be permitted to provide access to the eGain System to its employees and agents located worldwide.\\n\\n4. Proprietary Rights. Except for the limited access right gra',\n",
              "    'Highlight the parts (if any) of this contract related to \"Notice Period To Terminate Renewal\" that should be reviewed by a lawyer. Details: What is the notice period required to terminate renewal?',\n",
              "    'This Agreement shall continue in effect from the Effective Date for a one (1) year period, unless earlier terminated as set forth below, and thereafter shall renew automatically for successive one (1) year periods unless either party gives the other party at least thirty (30) days prior written notice of its intent not to renew the Agreement.',\n",
              "    0,\n",
              "    0)]),\n",
              " (('Cap On Liability', 'possible negative'),\n",
              "  [('1                                                                     Exhibit 10.3\\n\\nI-on. (LOGO) www.i-on.com 561.394.9484 o 561.394-9773 fax 1733 avenida del sol, boca raton, florida, 33432\\n\\nWEB SITE HOSTING AGREEMENT\\n\\nThis WEB SITE HOSTING AGREEMENT (\"this Agreement\") is entered into this 6th day of April, 1999 by and between Centrack International, a Florida corporation (\"the Customer\"), and i-on interactive, a Florida corporation (\"i-on\").\\n\\nDEFINITIONS\\n\\nAs used in this Agreement, the term \"Web site\" shall mean a computer system intended to be accessed through the World Wide Web segment of the Internet, including software and content intended to be viewed and/or operated upon by persons accessing the computer system via the Internet. A Web site may exist on a single computer system with other Web sites.\\n\\nThe term \"Hosted Site\" shall mean the Web site of the Customer that is hosted by i-on under the terms and conditions of this Agreement.\\n\\nThe term \"Hosting Computer\" shall mean the computer system and related equipment on which the Hosted Site exists.\\n\\nSERVICES PROVIDED TO THE CUSTOMER\\n\\ni-on will maintain the operation of the Hosted Site continuously, twenty-four (24) hours per day, seven (7) days per week, including holidays, with the exception of reasonable hardware and software maintenance that must be performed on the Hosting Computer and/or the Hosted Site. i-on will use best efforts to schedule and perform such maintenance between the hours of 8pm and 8am Eastern Standard Time on weekdays, or during weekends.\\n\\nUnder this Agreement, i-on will provide the following limited services for the Hosted Site:\\n\\n      1. connectivity to the Internet via a T1 (that may be shared by other             Web sites) to a leading Internet backbone access provider such as             UUNET, and reasonable efforts to maintain such connectivity with the             phone company and the Internet backbone access provider;\\n\\n      2. use of the Hosting Computer (that may be shared by other Web sites)             as described in this Agreement and maintenance required to keep such             Hosting Computer in good working order;\\n\\n      3. physical space for the Hosting Computer at a facility that maintains             proper environmental conditions in the area(s) where the Hosting             Computer is located and maintains reasonable efforts to prevent             unauthorized access to the physical location of the Hosting             Computer;\\n\\n      4. an emergency electrical power backup system for the Hosting             Computer;\\n\\n      5. up to 150 MB of mirrored computer storage on the Hosting Computer;\\n\\n      6. archival backups of such mirrored computer storage on a weekly             basis;    2          7.  off-site storage of such backups at separate facility than the              location of the Hosting Computer;\\n\\n      8.  use of the Microsoft Windows NT Server 4.0 or higher operating              system software for the Hosting Computer and the Hosted Site;\\n\\n      9.  use of the Microsoft Internet Information Service (IIS) 3.0 or              higher Web server software for the Hosted Site (providing support              for the HTTP Web protocol);\\n\\n      10. use of the Microsoft SQL Server 6.5 or higher database server              software for the Hosted Site, within the boundaries of allocated              computer storage, per #5 above;\\n\\n      11. access to the Hosted Site via the ftp protocol to an administrative              account designated by the Customer for the Customer to maintain the              Hosted Site\\'s static content (such as HTML Web pages and computer              graphics);\\n\\n      12. up to 10 mailboxes accessible via the POP3 mail protocol that are              mapped to the Hosted Site\\'s Internet address;\\n\\n      13. up to 1 hour per month of Web site administration services at no              additional charge, limited to:\\n\\n               requests for changes to ftp/e-mail users and passwords;                   requests for e-mail configuration changes;                   modification of mail',\n",
              "    'Highlight the parts (if any) of this contract related to \"Cap On Liability\" that should be reviewed by a lawyer. Details: Does the contract include a cap on liability upon the breach of a partyโs obligation? This includes time limitation for the counterparty to bring claims or maximum amount for recovery.',\n",
              "    \"i-on will not be liable under any circumstances for any lost profits or other consequential damages, even if i-on has been advised as to the possibility of such damages. i-on's liability for damages to the Customer for any cause whatsoever, regardless of the form of action, and whether in contract or in tort, including negligence, shall be limited to one (1) month's fees and the remaining portion of any prepaid fees.\",\n",
              "    0,\n",
              "    0)]),\n",
              " (('Effective Date', 'positive'),\n",
              "  [('Exhibit 10.2\\n\\n______________________________________________________________________________\\n\\nCO-PROMOTION AGREEMENT\\n\\nby and between\\n\\nDOVA PHARMACEUTICALS, INC.\\n\\nand\\n\\nVALEANT PHARMACEUTICALS NORTH AMERICA LLC\\n\\nSeptember 26, 2018\\n\\n______________________________________________________________________________\\n\\nCONFIDENTIAL TREATMENT HAS BEEN REQUESTED FOR PORTIONS OF THIS EXHIBIT. THE COPY FILED HEREWITH OMITS THE INFORMATION SUBJECT TO A CONFIDENTIALITY REQUEST. OMISSIONS ARE DESIGNATED [***]. A COMPLETE VERSION OF THIS EXHIBIT HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION.\\n\\nSource: DOVA PHARMACEUTICALS INC., 10-Q, 11/8/2018\\n\\n\\n\\n\\n\\nTABLE OF CONTENTS\\n\\nPage\\n\\nARTICLE 1 DEFINITIONS 1\\n\\nARTICLE 2 RIGHTS AND OBLIGATIONS 8\\n\\n2.1 Engagement; Grant of Rights. 8\\n\\n2.2 Retention of Rights. 9\\n\\n2.3 Non-Competition; Non-Solicitation. 9\\n\\n2.4 Dova Trademarks and Copyrights. 10\\n\\nARTICLE 3 JOINT STEERING COMMITTEE 11\\n\\n3.1 Formation of the JSC. 11\\n\\n3.2 Meetings and Minutes. 11\\n\\n3.3 Purpose of the JSC. 11\\n\\n3.4 Decision Making. 13\\n\\n3.5 Marketing Sub-Committee. 13\\n\\nARTICLE 4 VALEANT ACTIVITIES FOR THE PRODUCT 14\\n\\n4.1 Valeant Activities. 14\\n\\n4.2 Detailing. 15\\n\\n4.3 Compliance with Applicable Law. 17\\n\\n4.4 Field Force Personnel Training; Product Materials. 19\\n\\n4.5 Provisions Related to Field Force Personnel. 21\\n\\n4.6 Responsibility for Valeant Activity Costs and Expenses. 22\\n\\n4.7 Data Sharing. 22\\n\\nARTICLE 5 REGULATORY, SAFETY AND SURVEILLANCE, COMMERCIAL MATTERS 23\\n\\n5.1 Dova Responsibility. 23\\n\\n5.2 Valeant Involvement. 23\\n\\n5.3 Inspections. 23\\n\\n5.4 Pharmacovigilance. 24\\n\\n5.5 Unsolicited Requests for Medical Information. 24\\n\\n5.6 Recalls and Market Withdrawals. 25\\n\\n5.7 Certain Reporting Responsibilities. 25\\n\\n5.8 Booking of Sales Revenues. 25\\n\\n5.9 Returns. 25\\n\\nSource: DOVA PHARMACEUTICALS INC., 10-Q, 11/8/2018\\n\\n\\n\\n\\n\\ni\\n\\nCONFIDENTIAL TREATMENT HAS BEEN REQUESTED FOR PORTIONS OF THIS EXHIBIT. THE COPY FILED HEREWITH OMITS THE INFORMATION SUBJECT TO A CONFIDENTIALITY REQUEST. OMISSIONS ARE DESIGNATED [***]. A COMPLETE VERSION OF THIS EXHIBIT HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION.\\n\\nSource: DOVA PHARMACEUTICALS INC., 10-Q, 11/8/2018\\n\\n\\n\\n\\n\\nTABLE OF CONTENTS (continued)\\n\\n5.10 Manufacturing; Distribution; Marketing. 25\\n\\nARTICLE 6 FINANCIAL PROVISIONS 26\\n\\n6.1 Promotion Fee. 26\\n\\n6.2 Milestone Payment. 27\\n\\n6.3 Reports; Payments. 27\\n\\n6.4 Taxes. 28\\n\\n6.5 Determination of Specialty. 29\\n\\nARTICLE 7 AUDIT RIGHTS 30\\n\\n7.1 Recordkeeping. 30\\n\\n7.2 Valeant Rights. 30\\n\\n7.3 Dova Rights. 31\\n\\nARTICLE 8 INTELLECTUAL PROPERTY 32\\n\\n8.1 Ownership of Intellectual Property. 32\\n\\n8.2 Title to Trademarks and Copyrights. 32\\n\\n8.3 Protection of Trademarks and Copyrights. 32\\n\\n8.4 Disclosure of Know-How. 33\\n\\nARTICLE 9 CONFIDENTIALITY 33\\n\\n9.1 Confidential Information. 33\\n\\n9.2 Public Announcements. 34\\n\\nARTICLE 10 REPRESENTATIONS AND WARRANTIES; ADDITIONAL COVENANTS 35\\n\\n10.1 Representations and Warranties of Dova. 35\\n\\n10.2 Representations and Warranties of Valeant. 37\\n\\n10.3 Disclaimer of Warranty. 38\\n\\n10.4 Additional Covenants. 39\\n\\nARTICLE 11 INDEMNIFICATION; LIMITATIONS ON LIABILITY 39\\n\\n11.1 Indemnification by Dova. 39\\n\\n11.2 Indemnification by Valeant. 39\\n\\n11.3 Indemnification Procedures. 40\\n\\n11.4 Limitation of Liability. 40\\n\\n11.5 Insurance. 40\\n\\nARTICLE 12 TERM AND TERMINATION 41\\n\\n12.1 Term. 41\\n\\n12.2 Early Termination for Cause. 41\\n\\nSource: DOVA PHARMACEUTICALS INC., 10-Q, 11/8/2018\\n\\n\\n\\n\\n\\n12.3 Other Early Termination. 42\\n\\n12.4 Effects of Termination. 42\\n\\n12.5 Tail Period. 42\\n\\nii\\n\\nCONFIDENTIAL TREATMENT HAS BEEN REQUESTED FOR PORTIONS OF THIS EXHIBIT. THE COPY FILED HEREWITH OMITS THE INFORMATION SUBJECT TO A CONFIDENTIALITY REQUEST. OMISSIONS ARE DESIGNATED [***]. A COMPLETE VERSION OF THIS EXHIBIT HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION.\\n\\nSource: DOVA PHARMACEUTICALS INC., 10-Q, 11/8/2018\\n\\n\\n\\n\\n\\nTABLE OF CONTENTS (continued)\\n\\n12.6 Survival. 43\\n\\nARTICLE 13 MISCELLANEOUS 43\\n\\n13.1 Force Majeure. 43\\n\\n13.2 Assignment. 43\\n\\n13.3 Severability. 44\\n\\n13.4 Notices. 44\\n\\n13.5 Governing Law. 45\\n\\n13.6 Dispute Resolution. 45\\n\\n13.7 Waiver ',\n",
              "    'Highlight the parts (if any) of this contract related to \"Effective Date\" that should be reviewed by a lawyer. Details: The date when the contract is effective\\xa0',\n",
              "    'September 26, 2018',\n",
              "    210,\n",
              "    228),\n",
              "   ('Exhibit 10.13\\n\\nConfidential Materials omitted and filed separately with the Securities and Exchange Commission. Asterisks denote omissions.\\n\\nDATED: OCTOBER 15, 2009\\n\\nPACIRA PHARMACEUTICALS, INC.\\n\\nand\\n\\nEKR THERAPEUTICS, INC.        AMENDED AND RESTATED   STRATEGIC LICENSING, DISTRIBUTION AND MARKETING AGREEMENT\\n\\n\\n\\n\\n\\nTHIS AMENDED AND RESTATED STRATEGIC LICENSING, DISTRIBUTION AND MARKETING AGREEMENT (the  \"Agreement\") is made on October 15, 2009 (the \"Agreement Date\") and is effective as of the Effective Date (as defined below), between:   PACIRA PHARMACEUTICALS, INC. (F/K/A SKYEPHARMA, INC.) a company incorporated in the state of California whose principal place of business is 10450 Sciences Center Drive, San Diego, California 92121 USA (\"PPI\"); and   EKR THERAPEUTICS, INC., a company incorporated in the state of Delaware whose principal place of business is 1545 Route 206  South, Third Floor, Bedminster, New Jersey 07921 (\"EKR\").\\n\\nRecitals\\n\\nPPI owns and has all right title and interest in or has acquired exclusive rights to the PPI IP (as defined below), the Trademark (as  defined below) and the Product (as defined below).\\n\\nEKR has, among other things, specialized knowledge and expertise in relation to the marketing and sale of pharmaceutical products.\\n\\nPursuant to that certain Strategic Licensing, Distribution and Marketing Agreement between EKR and PPI dated as of August 10, 2007  (the \"Original Agreement\"), PPI granted and EKR acquired the exclusive right and license to sell, offer to sell, distribute and market the Product in  the Territory (as defined below) in the Field (as defined below).\\n\\nEKR and PPI desire to amend and restate the Original Agreement in its entirety as set forth herein in order to provide for: (i) certain  changes to the financial terms set forth in the Original Agreement, (ii) the transfer of Marketing Authorizations (as defined below) from PPI to      -1-\\n\\n\\n\\n\\n\\nEKR, and EKR\\'s assumption of obligations thereunder, (iii) the transfer of title to certain manufacturing equipment from PPI to EKR and the lease  of such equipment back from EKR to PPI and (iv) certain other changes as are set forth herein; all of the foregoing subject to and in accordance  with the terms and conditions of this Agreement.\\n\\nNOW THEREFORE, in consideration of the following mutual agreements and covenants set forth herein and intending to be legally  bound hereby, PPI and EKR (each, a \"Party\"  and collectively, the \"Parties\")  acknowledge and agree that this Agreement shall amend and  supersede in its entirety the Original Agreement and hereby agree as follows:\\n\\nOperative Provisions\\n\\n\\n\\n\\n\\n   -2-\\n\\n1. Definitions   1.1 As used in this Agreement, the following words and expressions have the following meanings:\\n\\n\"Affiliate\"\\n\\n\\n\\nWith respect to any Party to this Agreement shall mean any company, corporation, firm, individual or other  entity which Controls, is Controlled by or is under common Control with such Party to this Agreement for only  so long as such Control exists;\\n\\n\\n\\n\\n\\n   -3-\\n\\n\"Applicable Laws\"\\n\\n\\n\\nShall mean all laws, rules and regulations regarding the manufacture, packaging, labeling, import, export,  storage, distribution, representation, promotion, marketing and sale of the Products including but not limited to  the Federal Food, Drug and Cosmetic Act of 1938, as amended (\"FD&C Act\") and the Controlled Substances  Act, as amended (21 U.S.C. ยง801 et seq.), or as defined in attendant regulations promulgated under authorities  granted by the FD&C Act, together with any equivalent laws, rules, regulations, codes or guidelines having  effect in any jurisdiction in the Territory;\\n\\n\"Calendar Year\"    Shall mean the period of twelve months commencing on 1st January in any year, and each consecutive period  of twelve months thereafter during the Term;\\n\\n\"cGMP\"    Means Current Good Manufacturing Practices pursuant to 21 CFR Parts 210 and 211, as may be amended from  time to time;\\n\\n\"Commercial Launch\"\\n\\n\\n\\nShall mean the date of the first arm\\'s length sale by EKR to an unaffiliated Third Party customer for commercial  use of Pro',\n",
              "    'Highlight the parts (if any) of this contract related to \"Effective Date\" that should be reviewed by a lawyer. Details: The date when the contract is effective\\xa0',\n",
              "    'August 10, 2007',\n",
              "    1389,\n",
              "    1404),\n",
              "   ('ENDORSEMENT\\n\\nContract Number: ENDORSEMENT\\n\\nEffective Date: July 1, 2019\\n\\nThrivent Life Insurance Company has been dissolved. (Thrivent Life Insurance Company was formerly known as Lutheran Brotherhood Variable Insurance Products Company.) All assets and related liabilities of Thrivent Life Insurance Company have been transferred to Thrivent Financial for Lutherans. That includes contracts of insurance, separate accounts, and cash and investment securities. Thrivent Financial for Lutherans now has all obligations under this contract. It is the same as if Thrivent Financial for Lutherans had originally issued the contract. All references to \"Thrivent Life Insurance Company\" are amended to read \"Thrivent Financial for Lutherans.\" All benefits and other terms of this contract remain unchanged except as described below.\\n\\nYou may direct inquiries to:\\n\\nThrivent Financial for Lutherans 4321 N. Ballard Road Appleton, WI 54919-0001 (800) 847-4836\\n\\nThe following amendments apply in lieu of any contract provisions to the contrary.\\n\\nThe following provisions are included as part of this contract:\\n\\nMAINTENANCE OF SOLVENCY. This provision applies only to benefits provided through the General Account. If the solvency of the Society becomes impaired, you may be required to make an extra payment. The Board of Directors will determine the amount of any extra payment. It will be based on each member\\'s fair share of the deficiency. You may make the extra payment by an equivalent reduction in benefits or by a payment in cash. If you do not make the extra payment within 60 days from the date we notify you of your share of the deficiency, the amount will be charged as an indebtedness against the contract with interest compounded at the rate of 5% per year.\\n\\nMEMBERSHIP. The person(s) named as the Insured(s) or the Annuitant(s) is a benefit member of the Society. Rights and privileges of membership are set forth in the Articles of Incorporation and Bylaws of the Society. These rights and privileges are separate from the ownership of this contract.\\n\\nDIVIDENDS. Each year, we will determine our divisible surplus. This contract\\'s share, if any, will be credited as a dividend. Since we do not expect this contract to contribute to divisible surplus, it is not expected that any dividends will be credited.\\n\\nDIVIDEND OPTIONS. If dividends are credited after premiums can no longer be paid under this contract, dividends will be paid in cash. Otherwise, dividends will be applied under the Payment of Premium option unless the Cash option has been chosen in writing.\\n\\nCash. Dividends are paid in cash.\\n\\nPayment of Premium. Dividends are applied as payment of a Net Premium. VB-TL-TFFL (18) page TL-1 @TL18#AA\\n\\nSource: THRIVENT VARIABLE INSURANCE ACCOUNT B, N-6, 7/1/2019\\n\\n\\n\\n\\n\\nContract Number: ENDORSEMENT (continued)\\n\\nThe following provisions of this contract are amended:\\n\\nDEFINITIONS\\n\\nThe DEFINITIONS section of the contract is amended to include the following:\\n\\nService Center. Where this contract is administered. Our Service Center address is 4321 North Ballard Road, Appleton, WI 54919-0001.\\n\\nAnd in the DEFINITIONS section, the definition:\\n\\nWe, Our, Us. Lutheran Brotherhood Variable Insurance Products Company.\\n\\nWhich previously was amended to read:\\n\\nWe, Our, Us. Thrivent Life Insurance Company.\\n\\nIs amended to read:\\n\\nWe, we, Our, our, Us, us, Society. Thrivent Financial for Lutherans.\\n\\nENTIRE CONTRACT\\n\\nIn the ENTIRE CONTRACT section, the first phrase and numbered list are amended to read:\\n\\nThe Entire Contract consists of: 1) This contract including any attached riders, amendments, or endorsements; 2) The Application attached to this contract; and 3) The Articles of Incorporation and Bylaws of the Society and all amendments to them. Benefits will not be reduced or eliminated by any future amendments to our Articles of Incorporation or Bylaws.\\n\\nASSIGNMENT\\n\\nThe ASSIGNMENT section is amended to include the following:\\n\\nYou may transfer ownership of this contract in accordance with our bylaws. Society membership rights and privileges cannot be transferred or assigned. VB-T',\n",
              "    'Highlight the parts (if any) of this contract related to \"Effective Date\" that should be reviewed by a lawyer. Details: The date when the contract is effective\\xa0',\n",
              "    'July 1, 2019',\n",
              "    59,\n",
              "    71),\n",
              "   ('Exhibit 10.4   INTELLECTUAL PROPERTY AGREEMENT   This INTELLECTUAL PROPERTY AGREEMENT (this \"Agreement\" or \"IPA\"), effective as of this 30  day of June 2016 (the \"Effective Date\") among THE HERTZ CORPORATION, a Delaware corporation, with an address of 8501 Williams Road, Estero, Florida 33928 (hereinafter \"THC\"); HERTZ SYSTEM, INC., a Delaware corporation, with an address of 8501 Williams Road, Estero, Florida 33928, United States of America (hereinafter \"HSI\") and HERC RENTALS INC., a Delaware corporation, with an address of 27500 Riverview Center Blvd., Bonita Springs, Florida 34134, United States of America (hereinafter \"HERC\") (hereinafter referred to collectively as the \"Parties\" and individually as a \"Party\").   WITNESSETH   WHEREAS, both HSI and HERC are wholly-owned subsidiaries of THC, and THC is an indirect wholly-owned subsidiary of Hertz Global Holdings, Inc., a Delaware corporation (\"HGH\");   WHEREAS, THC is the owner of a unique plan or system (hereinafter the \"Hertz System\") for conducting, inter alia, the business of renting and leasing vehicles with and without drivers (hereinafter the \"Vehicle Rental Business\" or \"VRB\") which it conducts in collaboration with HSI which is the owner of all trademarks for HERTZ and HERTZ-formative trademarks and designs and other trademarks and designs worldwide in connection with the Vehicle Rental Business (the \"VRB Trademarks\") and Other Intellectual Property (as defined herein);   WHEREAS, THC is the owner of a unique plan or system for conducting an equipment rental business (hereinafter the \"Equipment Rental Business\" or \"ERB\" as further defined below) which it conducts through HERC;   WHEREAS, HGH has approved plans to separate the Vehicle Rental Business and the Equipment Rental Business into two independent, publicly traded companies (the \"Separation\") pursuant to, among other agreements, the Separation and Distribution Agreement by and between Hertz Rental Car Holding Company, Inc. (to be renamed \"Hertz Global Holdings, Inc.\" in connection with the Separation, \"New Hertz\") and HGH (to be renamed Herc Holdings Inc. in connection with the Separation) dated as of June 30, 2016 (the \"Distribution Agreement\");   WHEREAS, as a result of the Separation, THC and HSI will become indirect wholly-owned subsidiaries of New Hertz, and HERC will continue to be an indirect wholly-owned subsidiary of HGH;   WHEREAS, THC exercises control with respect to the use, registration and enforcement of all of its company trademarks through its subsidiary HSI. HERC uses certain HERTZ or HERTZ-formative trademarks in connection with the ERB with the\\n\\nth\\n\\n\\n\\n\\n\\n  permission of HSI and THC;   WHEREAS, HSI is the owner of certain foreign HERTZ and HERTZ-formative and other trademarks and logos (the \"HSI (HERTZ) Foreign ERB Trademarks\") used or to be used by HERC with the permission of HSI in connection with the Equipment Rental Business, including the trademark applications and registrations therefor as more fully set forth on Schedule A;   WHEREAS, HSI is the owner of certain United States HERTZ and HERTZ-formative and other trademarks and logos (the \"HSI (HERTZ) US ERB Trademarks\") used by HERC with the permission of HSI in connection with the Equipment Rental Business, including the trademark applications and registrations therefor as more fully set forth on Schedule B;   WHEREAS, HSI is the owner of certain foreign HERC trademarks and logos (the \"HSI HERC Foreign ERB Trademarks\") used by HERC with the permission of HSI in connection with the Equipment Rental Business, including the trademark applications and registrations therefor, as more fully set forth on Schedule C;   WHEREAS, HERC is the owner of certain US HERTZ-formative trademarks (the \"HERC (HERTZ) US ERB Trademarks\") used by HERC with the permission of HSI in connection with the Equipment Rental Business, including the trademark applications and registrations therefore as more fully set forth on Schedule D;   WHEREAS, HERC is the owner of certain US trademarks not derived from the HERTZ trademark (the \"HERC (HERC) US ERB Trademar',\n",
              "    'Highlight the parts (if any) of this contract related to \"Effective Date\" that should be reviewed by a lawyer. Details: The date when the contract is effective\\xa0',\n",
              "    '30  day of June 2016',\n",
              "    136,\n",
              "    156),\n",
              "   ('Exhibit 10.4\\n\\nCOOPERATION AGREEMENT\\n\\n(2014 Amendment)\\n\\nThis Cooperation Agreement (2014 Amendment) (this \"Agreement\") is entered into on January 24, 2014 in Beijing by and between:\\n\\n(1) Nanjing Tuniu Technology Co., Ltd., with its registered address at 3-5/F Building No.6, Southeast University Science Park, 6 Changjianghou Street, Xuanwu District, Nanjing and its legal representative being Yu Dunde (\"Party A\");\\n\\n(2) Beijing Tuniu Technology Co., Ltd., with its registered address at R1006 10/F Building No.4, Yard No.1 of Shangdishi Street, Haidian District, Beijing and its legal representative being Yu Dunde (\"Party B\").\\n\\nWHEREAS\\n\\n1. Party A is a company with exclusively domestic capital incorporated under the laws of the People\\'s Republic of China, mainly engaged in the internet-based sale, promotion of tour products, room reservation and conference affairs services.\\n\\n2. Party B is a limited liability company incorporated under the laws of the People\\'s Republic of China, mainly engaged in research and development of computer software technology, technology transfer, technical consultancy and technical services, computer technology training, technical services and business consultancy services in relation to the internet-based sale and promotion of tour products.\\n\\n3. Party A intends to authorize Party B to provide to Party A and its subsidiaries the technical services and business consultancy services in relation to the internet-based sale and promotion of tour products, including but not limited to development, operation, maintenance of internet technology platform as well as consultancy services relating to sale and promotion of tour products or cooperation provided by Party B in other forms as required under this Agreement, and Party B agrees to accept such authorization.\\n\\n4. After an amiable consideration, the Parties unanimously agree that the establishment of a long-term and close cooperation relationship is in the best interests of the Parties and their beneficiaries.\\n\\n5. The Parties have entered into the Cooperation Agreement on September 17, 2008 in respect of the aforementioned cooperative matters (the \"Original Cooperation Agreement\").\\n\\n\\n\\n\\n\\nThe Parties unanimously agree to amend and restate the Original Cooperation Agreement through friendly negotiation and the Original Cooperation Agreement is amended and restated as follows:\\n\\n  1. Business Cooperation\\n\\nParty A and Party B unanimously agree that the proposed cooperation shall be the internet-based sale and promotion of tour products conducted by Party A and its subsidiaries or other value-added business carried out by Party A. Party B shall provide the business consultancy and technical services as well as the technical consultancy as set forth in Article 3 hereinafter to Party A and its subsidiaries to facilitate them to conduct the aforementioned business and supply relevant products and services.\\n\\n  2. Exclusive Cooperation\\n\\n\\n\\n2.1 Party A irrevocably undertakes that Party A will take Party B as its exclusive and sole partner to provide the business consultancy and technical services as well as technical consultancy to Party A and its subsidiaries. Party A shall not establish any same or similar cooperative relationship with any third party in respect of such businesses nor shall it make any same or similar arrangement, unless with the prior written consent of Party B.\\n\\n  2.2 Party A irrevocably undertakes that it will make best efforts to assist and endeavor to achieve the exclusive operation of thecooperative business to the extent permitted by laws.\\n\\n\\n\\n2.3 Party A irrevocably undertakes that, without Party B\\'s consent, Party A shall not conduct any other business or make any commercial arrangement, including without limitation being engaged in or otherwise participating in any commercial activities and businesses independently or together with any other person or entity, nor shall it carry out any activities that may be competitive with or cause adverse effect to Party B\\'s business.\\n\\n  3. Party B\\'s Services\\n\\nParty B undertakes to provide the following tec',\n",
              "    'Highlight the parts (if any) of this contract related to \"Effective Date\" that should be reviewed by a lawyer. Details: The date when the contract is effective\\xa0',\n",
              "    'January 24, 2014',\n",
              "    137,\n",
              "    153),\n",
              "   ('Exhibit 10.10\\n\\nEXECUTION VERSION\\n\\nINTELLECTUAL PROPERTY AGREEMENT\\n\\nThis Intellectual Property Agreement (the \"Agreement\"), is entered into as of November 20, 2007 (the \"Effective Date\"), by and between Morgan Stanley & Co. Incorporated, a Delaware corporation (\"MS\") and MSCI Inc., a Delaware corporation (\"MSCI\"). (MS and MSCI individually referred to as a \"Party\" and collectively as the \"Parties\").   1. DEFINITIONS\\n\\n  1.1 Certain Definitions.\\n\\nAs used in this Agreement:\\n\\n  (a) \"Including\" and its derivatives, each whether or not capitalized in this Agreement, means \"including but not limited to\".\\n\\n  (b) \"Licensed Materials\" means, as applicable, the MS Licensed Materials and the MSCI Licensed Materials.\\n\\n\\n\\n(c) \"MS Licensed Materials\" means collectively, to the extent owned by a member of the MS Provider Group, any hardware settings and configurations, generic software libraries and routines, and generic document templates not separately commercialized by the MS Provider Group (as defined below) and used by MSCI prior to the Trigger Date. For the avoidance of doubt, the MS Licensed Materials does not include (i) any patent, trademark or service mark of the MS Provider Group, or (ii) any infrastructure hardware or software (e.g., monitoring software and systems, customized operating systems (and components such as AFS, DNS, AD, etc.), and middleware). For the avoidance of doubt, the document templates do not include any references to members of the MS Provider Group or its personnel.\\n\\n\\n\\n(d) \"MSCI Licensed Materials\" means collectively, to the extent owned by a member of the MSCI Provider Group, any hardware settings and configurations, generic software libraries and routines, and generic document templates not separately commercialized by the MSCI Provider Group (as defined below) and used by MS prior to the Trigger Date. For the avoidance of doubt, the MSCI Licensed Materials does not include (i) any patent, trademark or service mark of the MSCI Provider Group, (ii) any infrastructure hardware or software (e.g., monitoring software and systems, customized operating systems and middleware), or (iii) any software or data separately licensed to MS by the MSCI Provider Group (such as the Barra Aegis software or the MSCI indices). For the avoidance of doubt, the document templates do not include any references to members of the MSCI Provider Group or its personnel.\\n\\n  (e) \"Trigger Date\" means the date upon which Morgan Stanley shall cease to own more than 50% of the issued and outstanding shares of MSCI common stock.     1.2 Other Terms.\\n\\nOther terms used in this Agreement are defined in the context in which they are used and shall have the meanings there indicated.\\n\\n\\n\\n\\n\\n2. GRANT OF LICENSE\\n\\n  2.1 MS Grant.\\n\\nMS hereby grants (subject to any existing third party contractual obligations) to MSCI a non-exclusive, perpetual, irrevocable, world- wide, royalty-free license for MSCI to use, modify, copy, create derivative works of and sublicense, for any business purpose, the MS Licensed Materials.     2.2 MSCI Grant.\\n\\nMSCI hereby grants (subject to any existing third party contractual obligations) to MS a non-exclusive, perpetual, irrevocable, world- wide, royalty-free license for MS to use, modify, copy, create derivative works of and sublicense, for any business purpose, the MSCI Licensed Materials.     2.3 Internet and Subnet Addresses.\\n\\nFor the avoidance of doubt, this Agreement does not address or affect any rights of the Parties in or to internet or subnet addresses.   3. DELIVERY\\n\\n  3.1 No Support or Maintenance or Obligation to Deliver.\\n\\nThe Parties shall have no obligation to provide support or maintenance for the Licensed Materials, including any obligation to update or correct such Licensed Materials. The Parties shall have no obligation to provide copies of the Licensed Materials (including in the case of software, any source code and object code).   4. NO WARRANTIES\\n\\nTHE LICENSE GRANTS HEREUNDER ARE PROVIDED \"AS-IS\" WITH NO WARRANTIES, AND THE PARTIES EXPRESSLY EXCLUDE AND DISCLAIM ANY WARRANTIES UNDER OR ARISING AS A R',\n",
              "    'Highlight the parts (if any) of this contract related to \"Effective Date\" that should be reviewed by a lawyer. Details: The date when the contract is effective\\xa0',\n",
              "    'November 20, 2007',\n",
              "    145,\n",
              "    162),\n",
              "   ('Exhibit 10.2    SHBV (HONG KONG) LTD.     and     WASTE2ENERGY GROUP HOLDINGS PLC\\n\\n   STRATEGIC ALLIANCE AGREEMENT\\n\\n   1\\n\\n\\n\\n\\n\\n        THIS AGREEMENT IS MADE ON THE 19  DAY OF MAY , 2010     PARTIES     (1) SHBV (HONG KONG) LTD, a company incorporated in Hong Kong whose registered office is at Unit 3208, 32/F Office Tower (\"SHBV\"); and  Convention Plaza, 1 Harbour Rd, Hong Kong     (2) WASTE2ENERGY GROUP HOLDINGS PLC a company incorporated in Isle of Man whose registered office is at Stanley House, Lord Street,  Douglas, Isle of Man 1M1 2BF (\"W2E\"),     each a \"Party\" and together the \"Parties\".     BACKGROUND     (A) SHBV is engaged in the business of design, marketing, manufacture, commissioning and post sales servicing of steam and hot water plant and  possesses certain proprietary products, technologies, formulations, know-how and/or rights within the fields of steam and hot water plant  and equipment, engineering, and process designs (hereinafter, \"SHBV Technologies\").     (B) W2E is a provider of engineered solutions for waste to energy plants (each being an \"Engineered Solution\") utilising W2E proprietary  technology for the destruction of waste through gasification and the conversion of latent energy into thermal energy.     (C) The Parties wish to collaborate together to provide for a world class manufacturing facility for W2E Equipment, for the integration of SHBV  Technologies into the Engineered Solution and to exploit joint sales channels and post sales support, for the mutual benefit of both  Parties.     (D) The Parties wish to cooperate and work together to promote, market and sell their respective products and services in accordance with the  terms of this Agreement.     AGREED PROVISIONS     1. DEFINITIONS AND INTERPRETATION     1.1 In this Agreement, the terms and expressions below shall have the following meanings:     2\\n\\nTH\\n\\n\\n\\n\\n\\n     Affiliates means subsidiaries or other entities that will be mutually agreed in writing.     Agreement means the body of this agreement and its schedules, as each may be amended from time to time in accordance with its  provisions;     Alliance means the strategic alliance between the Parties facilitated under this Agreement;     SHBV Boiler means a boiler that is manufactured and supplied by SHBV from time to time;     SHBV Technologies has the meaning given in Recital A above;     Commencement Date means the date of this Agreement;     Dispute means any dispute, issue or claim arising out of or relating to this Agreement;     Engineered Solution has the meaning given in Recital B above;     Good Industry Practice means the exercise of that degree of skill, diligence, prudence, foresight and practice which would reasonably and  ordinarily be expected from a skilled and experienced person engaged in performing obligations the same as or similar to the obligations  under this Agreement or any part of them (as appropriate to the context in which this expression is used);     Group means, in relation to any company, that company and the following for the time being: (i) its Holding Company, (ii) its Subsidiaries  and (iii) the Subsidiaries of its Holding Company;     Holding Company has the meaning given in $1159 Companies Act 2006;     Intellectual Property Rights means (i) patents, designs, trade marks and trade names (whether registered or unregistered), copyright and  related rights, database rights, know-how and confidential information; (ii) all other intellectual property rights and similar or equivalent  rights anywhere in the world which currently exist or are recognised in the future; and (iii) applications, extensions and renewals in  relation to any such rights;     Manufacturing Agreement has the meaning given in clause 5.1;     Subsidiary has the meaning given to it in $1159 Companies Act 2006;     Supply Agreement means an agreement under which an Engineered Solution is to be delivered to a customer of W2E by W2E or such  other entity established or nominated for that purpose;     Term has the meaning set out in Clause 3.1;     3\\n\\n\\n\\n\\n\\n     Territory shall mean',\n",
              "    'Highlight the parts (if any) of this contract related to \"Effective Date\" that should be reviewed by a lawyer. Details: The date when the contract is effective\\xa0',\n",
              "    '19  DAY OF MAY , 2010',\n",
              "    164,\n",
              "    185),\n",
              "   ('Exhibit 10.2    SHBV (HONG KONG) LTD.     and     WASTE2ENERGY GROUP HOLDINGS PLC\\n\\n   STRATEGIC ALLIANCE AGREEMENT\\n\\n   1\\n\\n\\n\\n\\n\\n        THIS AGREEMENT IS MADE ON THE 19  DAY OF MAY , 2010     PARTIES     (1) SHBV (HONG KONG) LTD, a company incorporated in Hong Kong whose registered office is at Unit 3208, 32/F Office Tower (\"SHBV\"); and  Convention Plaza, 1 Harbour Rd, Hong Kong     (2) WASTE2ENERGY GROUP HOLDINGS PLC a company incorporated in Isle of Man whose registered office is at Stanley House, Lord Street,  Douglas, Isle of Man 1M1 2BF (\"W2E\"),     each a \"Party\" and together the \"Parties\".     BACKGROUND     (A) SHBV is engaged in the business of design, marketing, manufacture, commissioning and post sales servicing of steam and hot water plant and  possesses certain proprietary products, technologies, formulations, know-how and/or rights within the fields of steam and hot water plant  and equipment, engineering, and process designs (hereinafter, \"SHBV Technologies\").     (B) W2E is a provider of engineered solutions for waste to energy plants (each being an \"Engineered Solution\") utilising W2E proprietary  technology for the destruction of waste through gasification and the conversion of latent energy into thermal energy.     (C) The Parties wish to collaborate together to provide for a world class manufacturing facility for W2E Equipment, for the integration of SHBV  Technologies into the Engineered Solution and to exploit joint sales channels and post sales support, for the mutual benefit of both  Parties.     (D) The Parties wish to cooperate and work together to promote, market and sell their respective products and services in accordance with the  terms of this Agreement.     AGREED PROVISIONS     1. DEFINITIONS AND INTERPRETATION     1.1 In this Agreement, the terms and expressions below shall have the following meanings:     2\\n\\nTH\\n\\n\\n\\n\\n\\n     Affiliates means subsidiaries or other entities that will be mutually agreed in writing.     Agreement means the body of this agreement and its schedules, as each may be amended from time to time in accordance with its  provisions;     Alliance means the strategic alliance between the Parties facilitated under this Agreement;     SHBV Boiler means a boiler that is manufactured and supplied by SHBV from time to time;     SHBV Technologies has the meaning given in Recital A above;     Commencement Date means the date of this Agreement;     Dispute means any dispute, issue or claim arising out of or relating to this Agreement;     Engineered Solution has the meaning given in Recital B above;     Good Industry Practice means the exercise of that degree of skill, diligence, prudence, foresight and practice which would reasonably and  ordinarily be expected from a skilled and experienced person engaged in performing obligations the same as or similar to the obligations  under this Agreement or any part of them (as appropriate to the context in which this expression is used);     Group means, in relation to any company, that company and the following for the time being: (i) its Holding Company, (ii) its Subsidiaries  and (iii) the Subsidiaries of its Holding Company;     Holding Company has the meaning given in $1159 Companies Act 2006;     Intellectual Property Rights means (i) patents, designs, trade marks and trade names (whether registered or unregistered), copyright and  related rights, database rights, know-how and confidential information; (ii) all other intellectual property rights and similar or equivalent  rights anywhere in the world which currently exist or are recognised in the future; and (iii) applications, extensions and renewals in  relation to any such rights;     Manufacturing Agreement has the meaning given in clause 5.1;     Subsidiary has the meaning given to it in $1159 Companies Act 2006;     Supply Agreement means an agreement under which an Engineered Solution is to be delivered to a customer of W2E by W2E or such  other entity established or nominated for that purpose;     Term has the meaning set out in Clause 3.1;     3\\n\\n\\n\\n\\n\\n     Territory shall mean',\n",
              "    'Highlight the parts (if any) of this contract related to \"Effective Date\" that should be reviewed by a lawyer. Details: The date when the contract is effective\\xa0',\n",
              "    'Commencement Date means the date of this Agreement',\n",
              "    2374,\n",
              "    2424),\n",
              "   ('EXHIBIT 10.2   ENDORSEMENT AGREEMENT ADDENDUM I   This Endorsement Agreement Addendum I (the \"Addendum\") is made and effective November 7, 2017,   BETWEEN:\\n\\n\\n\\nNational Football League Alumni - Northern California Chapter (\"NFLA-NC\"), a charitable corporation organized under the laws of California, having its principal office at 1311 Madison Avenue, Redwood CA 94061; National Football League Alumni, Inc. (\"NFLA\"), a charitable corporation organized under the laws of Florida, having its principal office at 8000 Midlantic Drive, 130 S., Mount Laurel, NJ. 08054.     AND:   Food For Athletes, Inc. a corporation organized under the laws of California / Gridiron BioNutrientsโข, a corporation organized under the laws of Nevada having their principal office(s) at 1147 N Roseburg CT, STE A/B Visalia, CA 93291 (collectively the \"Company\").   RECITALS   The NFLA, NFLA-NC and the Company (collectively the \"Parties\") agree that this Addendum I shall be affixed and be enforceable under the terms of the Endorsement Agreement executed by the Parties on October 30, 2017.   Parties agree to the addition of Gridiron CBD H2O Probioticโข Water to \"Licensed Products\" as follows:   SECTION ONE. DEFINITIONS    As used in this Agreement, the following terms shall be defined as follows:      F. \"Licensed Products\" shall mean BlackMP Living Water, BlackMP Concentrate, Zezel Probiotic Water, Zayin Sports Water, Gridiron CBD H2O Probioticsโข Water, Gridiron MVPโข and Gridiron MVPโข Concentrate using the Pro Football Legends Logo on the Licensed Products\\' affixed labels, hang-tags or packaging. Other products of the Company may be added to the list of Licensed Products during the Contract Period by written amendment to this Agreement. All amendments to this Agreement must be signed by all parties to this Agreement.   Endorsement Agreement Addendum I  Page 1 of 2\\n\\nSource: GRIDIRON BIONUTRIENTS, INC., 8-K, 12/6/2017\\n\\n\\n\\n\\n\\n      SECTION FOUR. REMUNERATION    C. A *donation of $0.05 per Unit sold of Licensed Products within the Contract Territory payable to the **NFL Alumni Northern California Chapter. Donated amounts will be allocated and dispersed to the Northern California Chapter beginning on the first full quarter [three (3) month period] of the Agreement and continue on a quarterly basis thereafter for the term of this Agreement. Where the following per Unit conversion shall apply for the term of this Agreement:\\n\\n a. (1) Bottle of BlackMP LivingWater = 1 Unit\\n\\n b. (1) 4oz bottle of BlackMPConcentrate = 30 Units\\n\\n c. (1) Bottle of Zezel ProbioticWater = 1 Unit\\n\\n d. (1) Bottle of Zayin Sports Water = 1 Unit  e. (1) Bottle Gridiron MVPโข Water= 1 Unit\\n\\n f. (1) Bottle Gridiron CBD H20 Probioticsโข Water = 1 Unit\\n\\n g. (1) 4oz bottle of Gridiron MVPโขConcentrate = 30 Units\\n\\n _____________  * The NFLA-NC will donate 15% of the above described proceeds to the NFLA.  ** The Company will provide to the NFLA-NC upon request the most recent quarterly sales report of the Company\\'s Licensed Products.   The parties have executed this Agreement on November 22nd, 2017.   Food For Athletes, Inc. / Gridiron BioNutrientsโข   By: /s/ Darren Long    Darren Long - CEO     The National Football League Alumni, Inc.   By: /s/ Elvis Gooden    Elvis Gooden - President     NFL Alumni - Northern California Chapter   By: /s/ Eric Price    Eric Price - President     Endorsement Agreement Addendum I  Page 2 of 2\\n\\nSource: GRIDIRON BIONUTRIENTS, INC., 8-K, 12/6/2017',\n",
              "    'Highlight the parts (if any) of this contract related to \"Effective Date\" that should be reviewed by a lawyer. Details: The date when the contract is effective\\xa0',\n",
              "    'November 7, 2017',\n",
              "    127,\n",
              "    143),\n",
              "   ('EXHIBIT 10.1\\n\\nCorporate Sponsorship Agreement Between American Diabetes Association and Freeze Tag, Inc. This Agreement (\"Agreement\") is made effective March 22, 2018, by and between Freeze Tag Inc., a Delaware Corporation (\"Company\"), with its principal place of business located at 1720 Bray Central Drive, McKinney, TX 75069 and the American Diabetes Association, Inc. (\"Association\"), an Ohio not-for profit corporation, with its principal place of business located at 2451 Crystal Drive, Suite 900, Arlington, VA 22202. ADA and/or Company may be referred to as a \"Party\" or collectively as the \"Parties.\" 1. Purpose: The purpose of this Agreement is to benefit the Association and advance its not-for-profit mission through a National Sponsorship of Get Fit Don\\'t Sit DayT M. Company desires to assist the Association to carry out its mission and agrees to provide the support described in this Agreement. Company understands that as a not-for-profit charitable organization Association cannot promote or endorse Company\\'s products or services, either explicitly or implicitly. The Association may require that a disclaimer stating that Company\\'s participation in this Agreement does not convey or imply the Association\\'s approval, endorsement, certification, acceptance, or referral of any product or service of Company. 2. Scope: The Association agrees to identify and acknowledge Company as a supporter of the organization and the diabetes cause, as permitted in connection with qualified sponsorship payments and royalties under Section 513(i) and Section 512 of the Internal Revenue Code and Treasury regulations thereunder (\"Code\"). Company agrees not to knowingly take any actions that would jeopardize the tax-exempt status of Association under section 501(c)(3) of the Code. Company agrees to inform its business partners about Association\\'s tax-exempt status. Company agrees to provide its services, as defined in Attachment A, in accordance with all applicable laws and in accordance with standards of decorum and taste so as not to adversely reflect upon the Association or its mission. 3. Term: This Agreement shall commence on March 15, 2018 and will expire on March 14, 2020 unless terminated earlier pursuant to Section 13 of the Agreement (the \"Term\"). 4. Intellectual Property: The Association is the sole and exclusive owner of its name and logos, with or without accompanying words, and has the legal right to enter into this Agreement. In addition, any materials provided by or developed by the Association remain the property of the Association. The Association\\'s names, logos, and various marks, are \"the Association Marks\", as listed in Attachment B. The Association\\'s ownership of the Association Marks is or shall be secured through registration, or under common law, or both. Company\\'s use of the Association Marks does not create ownership rights in the Association Marks for Company. Company shall not, during the period of this Agreement, or any time thereafter, challenge Association\\'s exclusive ownership or registration of Association\\'s Marks, including any and all moral rights. Company is the sole and exclusive owner of its name, logos, and marks (the \"Company Marks\"), which include, without limitation, the names, logos, and marks listed in Attachment B as Company Marks. 1\\n\\nSource: FREEZE TAG, INC., 8-K, 4/11/2018\\n\\n\\n\\n\\n\\n5. License: The Association grants Company a non-exclusive, limited, revocable and conditional license during the term to use the Association Marks, solely to identify Company as a supporter of the Association. Use by Company of the Association Marks is limited to the particular Association Marks as authorized by the Association, which may not be revised or altered in any way, without prior written consent, must be displayed in the same form and colors, and does not extend to any other marks of the Association. Use by Company of the Association Marks on and in conjunction with its product or brand is conditioned upon Company\\'s observance of the specifications for permissible uses of the Association Marks as stated herein a',\n",
              "    'Highlight the parts (if any) of this contract related to \"Effective Date\" that should be reviewed by a lawyer. Details: The date when the contract is effective\\xa0',\n",
              "    'This Agreement shall commence on March 15, 2018 and will expire on March 14, 2020 unless terminated earlier pursuant to Section 13 of the Agreement (the \"Term\").',\n",
              "    2113,\n",
              "    2274),\n",
              "   ('Exhibit 10.1 CERTAIN CONFIDENTIAL PORTIONS OF THIS EXHIBIT WERE OMITTED AND REPLACED WITH \"[***]\". A COMPLETE VERSION OF THIS EXHIBIT HAS BEEN FILED SEPARATELY WITH THE SECRETARY OF THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO AN APPLICATION REQUESTING CONFIDENTIAL TREATMENT PURSUANT TO RULE 24B-2 PROMULGATED UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED. AMENDMENT NO. 2 TO MANUFACTURING AND SUPPLY AGREEMENT THIS AMENDMENT NO. 2 (this \"Amendment\") to the Manufacturing and Supply Agreement dated as of December 8, 2009 (as amended by an amendment agreement dated 31 December 2013) (the \"Existing Agreement\"), by and between Columbia Laboratories, (Bermuda) Ltd., a limited company existing and organised under the laws of Bermuda, having a place of business at Canon\\'s Court, 22 Victoria Street, Hamilton HM12, Bermuda (\"Columbia\"), and Fleet Laboratories Limited, a limited private company existing and organised under the laws of England, having a place of business at 94 Rickmansworth Road, Watford Herts, WD18 7JJ, United Kingdom (\"Fleet\") is entered into on 2018 (the \"Effective Date\"). WHEREAS, Columbia and Fleet entered into the Existing Agreement pursuant to which Fleet has agreed to manufacture and supply to Columbia, and Columbia has agreed to purchase, certain Products; and WHEREAS, Columbia and Fleet wish to amend the Existing Agreement in accordance with the terms of this Amendment. NOW THEREFORE, in consideration of the foregoing and other good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, Columbia and Fleet agree as follows: General Capitalised terms used but not defined in this Amendment shall have the same meanings ascribed to such terms in the Existing Agreement. The following amendments to the Existing Agreement shall have effect on and from the Effective Date.\\n\\n1. The following definitions shall be added to Section 1 of the Existing Agreement:\\n\\n\"\"Ares Agreement\" means the supply agreement entered into between Columbia and Ares Trading S.A. (a subsidiary of Merck Serono S.A.) dated 7 January 2018.\"\\n\\n\"GDP\" means the EU guidelines for current Good Distribution Practice guidelines 2013/C 343/01 as amended.\"\\n\\n2. The definition of \"batch\" in Section 1 of the Existing Agreement shall be deleted in its entirety and replaced with the following:\\n\\n\"\"Batch\" means a quantity of [***] kilograms of material (or such other quantity as the Parties may agree in writing from time to time) produced in a process or series of processes that is expected to be homogeneous within specified limits.\"\\n\\n3. The following shall be added to Section 2.1 of the Existing Agreement (Regulatory Requirements) as a new Section 2.1 (d):\\n\\n\"2.1 (d) Subject to the prior written consent of Columbia (such consent not to be unreasonably withheld, delayed or conditioned), Fleet may subcontract all or part of the activities to be performed by it under this Agreement to any subcontractor provided that the subcontracting of any activities shall not relieve Fleet of, and Fleet shall remain solely liable for, its obligations under this Agreement. Columbia may subcontract all or any part of the activities performed by it under this Agreement to any subcontractor without the consent of Fleet.\"\\n\\n1\\n\\n\\n\\n\\n\\nCERTAIN CONFIDENTIAL PORTIONS OF THIS EXHIBIT WERE OMITTED AND REPLACED WITH \"[***]\". A COMPLETE VERSION OF THIS EXHIBIT HAS BEEN FILED SEPARATELY WITH THE SECRETARY OF THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO AN APPLICATION REQUESTING CONFIDENTIAL TREATMENT PURSUANT TO RULE 24B-2 PROMULGATED UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED. 4. The following new Sections 2.2 (b), 2.2 (c) and 2.2 (d) shall be added to Section 2.2 of the Existing Agreement (Regulatory Requirements):\\n\\n\"2.2 (b) Compliance with Brazilian Regulatory Authorities Regulations. Fleet hereby warrants that the facilities where the Product is manufactured complies in full with the relevant standards stipulated by the Brazil National Health Surveillance Agency (\"ANVISA\") and undertakes to ensure the facilities will continue to do',\n",
              "    'Highlight the parts (if any) of this contract related to \"Effective Date\" that should be reviewed by a lawyer. Details: The date when the contract is effective\\xa0',\n",
              "    '2018',\n",
              "    1081,\n",
              "    1085),\n",
              "   ('1                                                                    Exhibit 10.16\\n\\n                                                                 CONFIDENTIAL Portions of this Exhibit have been omitted pursuant to a request for confidential treatment. The omitted portions, marked by [****], have been separately filed with the Commission.\\n\\n                           SPONSORSHIP AGREEMENT\\n\\nThis agreement (\"Agreement\") is entered into as of the 23rd day of September, 1997 (\"Effective Date\"), by and between Excite, Inc., a California corporation, located at 555 Broadway, Redwood City, California 94063 (\"Excite\"), and N2K Inc., a Pennsylvania corporation, located at 55 Broad Street, 26th Floor, New York, New York, 10004 (\"Sponsor\").\\n\\n                                 RECITALS\\n\\nA.   Excite maintains a site on the Internet at http://www.excite.com (the      \"Excite Site\") and owns and/or manages related Web Sites worldwide      (collectively, the \"Excite Network\") which, among other things, allow users      to search for and access content and other sites on the Internet.\\n\\nB.   Excite also maintains and/or manages certain Web pages which may be      delivered to users via email, desktop \"channels\" or Internet \"push\"      technologies (collectively, \"Broadcast Pages\") which may incorporate      content supplied to Excite by third parties for the purpose of providing      value to Excite users and providing access to the content, products and/or      services of such third parties.\\n\\nC.   Sponsor is in the business of distributing certain online retail music      merchandise and related content and maintains a Web site at      http://www.musicblvd.com (the \"Sponsor Site\") and other Web sites through      which it makes this merchandise and this content available to its users.\\n\\nD.   Sponsor wishes to be the exclusive retail store music sponsor of the Excite      Site and the Excite Broadcast Pages, to distribute its music-related      content through the Excite Site and the Excite Broadcast Pages and to      promote its online retail music merchandise business to Excite.com users.\\n\\nTherefore, the parties agree as follows:\\n\\n1.       EXCLUSIVITY, TERM AND RIGHT OF FIRST REFUSAL\\n\\n      a)       Sponsor will be the exclusive retail music store sponsor of                   the Excite Site and the Excite Broadcast Pages. Excite will                   not permit the display of advertising banners, promotional                   buttons, promotional links or other promotional materials for                   any retail sale of Music Products on the Excite Site, except                   those Music Products offered by Sponsor, nor advertising by                   any other Retail Music Store. \"Retail Music Store\" shall mean                   any entity which is primarily engaged in the sale of Music                   Products at retail to consumers. \"Music Products\"     2                                                                     CONFIDENTIAL\\n\\n              shall mean pre-recorded music hard goods, digitally                  distributed music (except live and/or cybercast events), music                  books (to the extent this Agreement does not conflict with                  Excite\\'s existing agreement with Amazon.com), music-related                  t-shirts and apparel, and music videos (except live and/or                  cybercast events).\\n\\n              Notwithstanding the foregoing, Excite may make available                  opportunities on the Excite Site to purchase Music Products                  from parties other than Sponsor if such Music Products are not                  available from Sponsor so long as, prior to entering into                  arrangements to make available opportunities to purchase Music                  Products from parties other than Sponsor, Excite notifies                  Sponsor of its interest in the Music Products and gives Sponsor                  thirty (30) days to make the desired Music Products available                  through the Sponsor Site. Excite and Sponsor acknowledge that ',\n",
              "    'Highlight the parts (if any) of this contract related to \"Effective Date\" that should be reviewed by a lawyer. Details: The date when the contract is effective\\xa0',\n",
              "    '23rd day of September, 1997',\n",
              "    449,\n",
              "    476),\n",
              "   ('Exhibit 2.7 FORM OF TRADEMARK LICENSE AGREEMENT THIS TRADEMARK LICENSE AGREEMENT (this \"Agreement\"), made and entered into as of the [ ] day of [ ], 2020 (the \"Effective Date\"), by and between ARCONIC INC., a corporation organized under the laws of Delaware (\"Licensee\") and ARCONIC ROLLED PRODUCTS CORP., a corporation organized under the laws of Delaware (\"Licensor\"). WHEREAS, Licensor and Licensee entered into a Separation and Distribution Agreement having an effective date of the [ ] day of [ ], 2020 (\"Separation and Distribution Agreement\"); unless specifically defined in this Agreement, any capitalized term in this Agreement shall have the meaning set forth in the Separation and Distribution Agreement. WHEREAS, Licensor formerly operated as a business unit of Licensee; WHEREAS, as part of and further to the Separation and Distribution Agreement: (a) Licensor and Licensee are now two separate publicly traded companies; and (b) Licensor was assigned all right, title, and interest to the trademark \"ARMX\" (the \"Licensed Mark\"); WHEREAS, Licensee wishes to license from Licensor the right to the Licensed Mark as hereinafter defined below; WHEREAS, Licensee wishes to obtain from Licensor, subject to the terms and conditions set forth in this Agreement, the right and license to use, have used, manufacture, have manufactured, sell, have sold, advertise, have advertised, import, have imported, export, have exported, offer for sale, and have offered for sale the Licensed Products (later defined) using the Licensed Mark (the \"Licensed Purpose\"); WHEREAS, Licensor is willing to grant such rights, upon the terms and subject to the conditions set forth in this Agreement. NOW, THEREFORE, in consideration of the mutual agreements, provisions and covenants contained in this Agreement, and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties, intending to be legally bound, hereby agree as follows:\\n\\n1\\n\\nSource: ARCONIC ROLLED PRODUCTS CORP, 10-12B, 12/17/2019\\n\\n\\n\\n\\n\\n1. GRANT AND SCOPE OF LICENSE. 1.1 Grant of License. Licensor on behalf of itself and its Affliates hereby grants to Licensee the limited licenses to use and have used the Licensed Mark: (i) for the Licensed Products as set forth on Schedule 2; and (ii) as set forth on Schedule 1, concerning agreements entered into by Licensee prior to the Effective Date (\"Existing Agreements\"). For the avoidance of doubt, Licensor also grants to Licensee and its subsidiaries and affiliates a non-exclusive, worldwide royalty-free license for continued use of the Licensed Mark for the production and sale of inventory containing the Licensed Mark applied to such products during the Transition Period as set forth in section 8.2 of the Separation and Distribution Agreement and in Schedule 2 of this Agreement. Licensee will not, however, use the Licensed Mark except for the production and sale of inventory as provided in this Section 1.1 and in Section 8.2 of the Separation and Distribution Agreement and Schedule 2 of this Agreement. For avoidance of doubt, to the extent that any of the licenses granted by the terms of this Agreement include any right to sublicense, such right to sublicense shall extend to Licensee\\'s subsidiaries and joint venturers. 1.2 Goodwill. Licensee expressly recognizes and acknowledges that its use of the Licensed Mark shall inure solely to the benefit of Licensor, and shall not confer on Licensee any ownership rights to the Licensed Mark. Licensee agrees and covenants that it shall not challenge, contest, or take any actions inconsistent with Licensor\\'s exclusive rights of ownership of the Licensed Mark. 1.3 Trademark Notices. All print and electronic displays of the Licensed Mark by Licensee shall include at Licensor\\'s option, a notice to the effect that the Licensed Mark are owned by Licensor and used by Licensee under license from Licensor. 1.4 Licensee Cooperation. Licensee agrees to reasonably cooperate with Licensor in achieving registration of the Licensed Mark worldwide, and in maintaining and protectin',\n",
              "    'Highlight the parts (if any) of this contract related to \"Effective Date\" that should be reviewed by a lawyer. Details: The date when the contract is effective\\xa0',\n",
              "    '[ ] day of [ ], 2020',\n",
              "    133,\n",
              "    153),\n",
              "   ('Exhibit 10.1   COOPERATION AGREEMENT BETWEEN THE CITY OF FORT STOCKTON, TEXAS AND STW RESOURCES HOLDING CORP. REGARDING DEVELOPMENT OF WATER WELL(S) IN THE CAPITAN REEF AQUIFER FORMATION\\n\\nThis AGREEMENT regarding development of water well(s) in the Capitan Reef Aquifer Formation (the \"AGREEMENT\") is entered into by the City of Fort Stockton, Texas, a Texas Type A-General Law city (\"COFS\") and STW Resources Holding Corp., a Nevada corporation (\"STW\"), effective as of the last date of signature on the signature pages below. STW and COFS are sometimes individually referred to as a \"Party\" and collectively referred to as the \"Parties.\"\\n\\nWHEREAS, the City of Fort Stockton, Texas (\"COFS\") owns the surface and groundwater rights to several areas of the Capitan Reef Aquifer Formation; and\\n\\nWHEREAS, COFS has an existing Capitan Reef Aquifer (\"CRA\") water well located at Section 112 on COFS property, which is currently drilled to an approximate depth of 3,500 feet (the \"Existing CRA Well\"), and also owns property at Section 71; and\\n\\nWHEREAS, STW desires to attempt to deepen the Existing CRA Well in order to make it a producing water well and/or drill an alternate well(s) at its own expense, and to lease CRA groundwater rights from Sections 112 and 71 of COFS property; and   WHEREAS, STW and COFS desire to work together for the development of a CRA water supply project within the area that will serve to meet the future needs of COFS and the municipal and industrial needs within the region.\\n\\nTHE PARTIES HEREBY AGREE AS FOLLOWS:\\n\\n1.  Leasing of Property  and Drilling  of Water Well(s). COFS hereby grants, leases and lets unto STW the right to explore for, drill for, produce, utilize, transport, and treat groundwater from the CRA only from beneath the surface of the property more specifically described in Exhibit \"A,\" which is attached hereto and fully incorporated into this AGREEMENT (hereinafter collectively referred to as the \"Property\"). STW is further authorized to drill, deepen, and/or rework at its expense the Existing CRA Well on Section 112 of the Property from its current depth of approximately 3,500 feet to approximately 4,000 feet, so as to determine the following to be verified by a study to be performed by a hydrogeologist mutually agreed upon by both Parties (\"Post-Well Study\"): (a) the gallons per day (\"GPD\") of maximum water capacity of the Existing CRA Well or alternate well, as may be required under Section 5 of the AGREEMENT; and (b) the quality of the water to be obtained from the Existing CRA Well or alternate well. The rights granted to STW under this AGREEMENT also include the right of access to the Property to perform the activities authorized herein.   2.  Acces s and Surface Use. STW agrees to coordinate reasonably with COFS with respect to location of any new wells, roadways, power infrastructure, and other improvements that are to be constructed or used on the Property. COFS shall provide STW rent free site leases for the commercially reasonable amounts of surface area required for CRA pumping and filling stations located on the Property. STW shall pay for or repair all actual damages to roads, fences, or improvements caused by its activities on the Property within sixty (60) days of the occurrence, and will fill and level all pits, mounds, ruts, and shall restore the surface to as near its original condition as is reasonably practicable within ninety (90) days after termination of the provisions of this AGREEMENT related only to the Property. Upon termination of the provisions of this AGREEMENT related to the Property only, STW, or its successors or assigns, shall transfer title of all water conveyance pipelines from the Property to COFS. STW shall administer and provide all necessary and reasonable insurance to insure its activities on the Property in relation to the AGREEMENT and shall list COFS as additional insured.\\n\\n  -1-\\n\\n\\n\\n\\n\\n    3.  Term.  Subject to the other provisions contained herein, this AGREEMENT shall be for a term of thirty (30) years from the Effective Date, which shall automatically rene',\n",
              "    'Highlight the parts (if any) of this contract related to \"Effective Date\" that should be reviewed by a lawyer. Details: The date when the contract is effective\\xa0',\n",
              "    'effective as of the last date of signature on the signature pages below',\n",
              "    455,\n",
              "    526),\n",
              "   (\"Exhibit 10.18 Confidential EXECUTION COPY\\n\\nCERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY [***], HAS BEEN OMITTED BECAUSE IT IS BOTH NOT MATERIAL AND WOULD BE COMPETITIVELY HARMFUL IF PUBLICLY DISCLOSED.\\n\\nDEVELOPMENT AND OPTION AGREEMENT\\n\\nbetween\\n\\nHARPOON THERAPEUTICS, INC.\\n\\nand\\n\\nABBVIE BIOTECHNOLOGY LTD\\n\\nDated as of November 20, 2019\\n\\nSource: HARPOON THERAPEUTICS, INC., 10-K, 3/12/2020\\n\\n\\n\\n\\n\\nTABLE OF CONTENTS\\n\\nARTICLE 1 DEFINITIONS 1\\n\\nARTICLE 2 COLLABORATION MANAGEMENT\\n\\n18\\n\\n2.1 Joint Governance Committee. 18 2.2 General Provisions Applicable to the JGC. 19 2.3 Discontinuation of the JGC. 20 2.4 Interactions Between the JGC and Internal Teams. 20 2.5 CMC Working Group. 21 2.6 Working Groups. 21 2.7 Expenses. 21\\n\\nARTICLE 3 DEVELOPMENT AND REGULATORY\\n\\n21\\n\\n3.1 Initial Development Plan and Activities. 21 3.2 AbbVie Option. 24 3.3 [***]. 25 3.4 Post-Exercise Development Activities. 26 3.5 Supply of Technology for Development Purposes. 27 3.6 Expenses and Invoicing. 27 3.7 Subcontracting. 28 3.8 Regulatory Matters. 28\\n\\nARTICLE 4 COMMERCIALIZATION 30\\n\\n4.1 In General. 30 4.2 Commercialization Diligence. 30 4.3 Booking of Sales; Distribution. 31 4.4 Product Trademarks. 31 4.5 Commercial Supply of Licensed Compounds or Licensed Products. 31\\n\\nARTICLE 5 GRANT OF RIGHTS\\n\\n33\\n\\n5.1 Grants to AbbVie. 33 5.2 Grants to Harpoon. 34 5.3 Sublicenses. 34 5.4 Distributorships. 34 5.5 Co-Promotion Rights. 34 5.6 Retention of Rights. 34 5.7 Confirmatory Patent License. 35 5.8 Exclusivity with Respect to the Territory. 35 5.9 In-License Agreements. 35\\n\\nARTICLE 6 PAYMENTS AND RECORDS\\n\\n36\\n\\n6.1 Upfront Payment. 36 6.2 Development and Regulatory Milestones. 36 6.3 First Commercial Sales Milestones. 37 6.4 Sales-Based Milestones. 37 6.5 Royalties. 38 6.6 Royalty Payments and Reports. 39 6.7 Mode of Payment; Offsets. 40 6.8 Withholding Taxes. 40\\n\\nSource: HARPOON THERAPEUTICS, INC., 10-K, 3/12/2020\\n\\n\\n\\n\\n\\n6.9 Indirect Taxes. 40 6.10 Interest on Late Payments. 41 6.11 Audit. 41 6.12 Audit Dispute. 41 6.13 Confidentiality. 41 6.14 [***] 41 6.15 No Other Compensation. 42\\n\\nARTICLE 7 INTELLECTUAL PROPERTY\\n\\n42\\n\\n7.1 Ownership of Intellectual Property. 42 7.2 Maintenance and Prosecution of Patents. 43 7.3 Enforcement of Patents. 45 7.4 Infringement Claims by Third Parties. 48 7.5 Invalidity or Unenforceability Defenses or Actions. 48 7.6 Product Trademarks. 49 7.7 International Nonproprietary Name. 50 7.8 Inventor's Remuneration. 50 7.9 Common Interest. 50\\n\\nARTICLE 8 PHARMACOVIGILANCE AND SAFETY\\n\\n50\\n\\n8.1 Pharmacovigilance. 50 8.2 Global Safety Database. 50\\n\\nARTICLE 9 CONFIDENTIALITY AND NON- DISCLOSURE\\n\\n51\\n\\n9.1 Product Information. 51 9.2 Confidentiality Obligations. 51 9.3 Permitted Disclosures. 52 9.4 Use of Name. 53 9.5 Public Announcements. 53 9.6 Publications. 54 9.7 Return of Confidential Information. 54 9.8 Survival. 54\\n\\nARTICLE 10 REPRESENTATIONS AND WARRANTIES\\n\\n55\\n\\n10.1 Mutual Representations and Warranties. 55 10.2 Additional Representations and Warranties of Harpoon. 55 10.3 Covenants of Harpoon. 58 10.4 Covenants of AbbVie. 58 10.5 DISCLAIMER OF WARRANTIES. 59\\n\\nARTICLE 11 INDEMNITY 60\\n\\n11.1 Indemnification of Harpoon. 60 11.2 Indemnification of AbbVie. 60 11.3 Notice of Claim. 60 11.4 Control of Defense. 61 11.5 Special, Indirect, and Other Losses. 61 11.6 Insurance. 61\\n\\nARTICLE 12 TERM AND TERMINATION\\n\\n62\\n\\n12.1 Term. 62\\n\\n- ii -\\n\\nSource: HARPOON THERAPEUTICS, INC., 10-K, 3/12/2020\\n\\n\\n\\n\\n\\n12.2 Termination for Material Breach. 62 12.3 Additional Termination Rights by AbbVie. 63 12.4 Termination for Insolvency. 63 12.5 Rights in Bankruptcy. 63 12.6 Termination in Entirety. 63 12.7 Reversion of Harpoon Products. 66 12.8 Termination of Terminated Territory. 67 12.9 Remedies. 67 12.10 Accrued Rights; Surviving Obligations. 67\\n\\nARTICLE 13 MISCELLANEOUS 68\\n\\n13.1 Force Majeure. 68 13.2 Change in Control of Harpoon. 68 13.3 Export Control. 69 13.4 Assignment. 69 13.5 Severability. 70 13.6 Governing Law, Jurisdiction and Service. 70 13.7 Dispute Resolution. 70 13.8 Notices. 71 13.9 Entire Agreement; Amendments. 72 13.10 English Language. 72 1\",\n",
              "    'Highlight the parts (if any) of this contract related to \"Effective Date\" that should be reviewed by a lawyer. Details: The date when the contract is effective\\xa0',\n",
              "    'November 20, 2019',\n",
              "    343,\n",
              "    360),\n",
              "   ('SCHEDULE TO Software License, Customization and Maintenance Agreement    Supplier Name:  Cardlytics, Inc.  Agreement Number:  CW251207\\n\\nSupplier Address:\\n\\n\\n\\n621 North Avenue NE Suite C-30 Atlanta, GA 30308\\n\\nAddendum Number:\\n\\n\\n\\nCW255039\\n\\nSupplier Telephone:  888.798.5802  Addendum Effective Date  March 3, 2011\\n\\nThis Schedule (\"Schedule\") is made as of the effective date set forth above to that Software License, Customization, and Maintenance Agreement, by and between Cardlytics, Inc. (\"Supplier\") and Bank of America, N. A, (\"Bank of America\"), dated November 5, 2010, as amended (\"SLCMA\"). Each capitalized term used but not defined herein shall have the meaning assigned in the SLCMA.\\n\\nWHEREAS, Bank of America and Supplier entered into the SLCMA in order to set forth the terms and conditions pursuant to which Supplier provides certain Software to Bank of America,\\n\\nWHEREAS, the parties desire to add to the SLCMA the Supplier Offer Placement System Software;\\n\\nNOW THEREFORE, in consideration of the promises and accords made herein, and the exchange of such good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, Bank of America and Supplier agree as follows:\\n\\nThe attached Schedule [A] is hereby incorporated into the SLCMA describing the Offer Placement System Software for use by Bank of America.\\n\\nTHE FOREGOING IS UNDERSTOOD AND AGREED TO BY:   Cardlytics, Inc. (\"Supplier\")   Bank of America, N.A. (\"Bank of America\")\\n\\nBy:  /s/ Scott Grimes  By:  /s/ Chandra Torrence\\n\\nName: Scott Grimes  Name: Chandra Torrence\\n\\nTitle:  Chief Executive Officer  Title:  V.P., Sourcing Manager\\n\\nDate:  3/4/11  Date:  3/3/11    1.\\n\\nSource: CARDLYTICS, INC., S-1, 1/12/2018',\n",
              "    'Highlight the parts (if any) of this contract related to \"Effective Date\" that should be reviewed by a lawyer. Details: The date when the contract is effective\\xa0',\n",
              "    'March 3, 2011',\n",
              "    297,\n",
              "    310),\n",
              "   ('Exhibit 10.5\\n\\nNote: Portions of this exhibit indicated by\"[*]\" are subject to a confidential treatment request, and have been omitted from this exhibit. Complete, unredacted copies of this exhibit have been filed with the Securities and Exchange Commission as part of this Company\\'s confidential treatment request.\\n\\nDistributor Agreement                              ---------------------\\n\\nThis Distributor Agreement (the \"Agreement\") is made effective as of the 31st day of March, 2000 (the \"Effective Date\"), by and between Airspan Networks Incorporated, a company incorporated under the laws of the State of Washington having its principal office at 777 108th Avenue NE, Suite 1895, Bellevue, Washington 98004 (\"Airspan\") and GLS LLC, (\"Distributor\") a limited liability company incorporated under the laws of the State of South Dakota having its principal office at 501 Fourth Street, Sergeant Bluff, IA 51054.\\n\\nWITNESSETH:\\n\\nWHEREAS, Airspan is engaged in the design and manufacture of various telecommunications product lines, including, among others, those product lines more completely described in Schedule I hereto (the product lines described in Schedule I, as from time to time amended in accordance with the provisions of this Agreement, are hereinafter called the \"Airspan Products\") the hardware components thereof are sometimes referred to separately as \"Equipment,\" the software components thereof are sometimes referred to separately as \"Software\" as defined in Section 11.1, and an arrangement of Equipment which, when interfaced with Software, is operable to perform predetermined functions, is referred to as a \"System\");\\n\\nWHEREAS, Distributor is engaged in the promotion of sales of telecommunications products; and\\n\\nWHEREAS, Airspan desires to appoint Distributor as a Distributor for the Airspan Products for the territory described in Schedule II hereto (the \"Territory\").\\n\\nNOW, THEREFORE, in consideration of the mutual promises herein contained, it is hereby agreed as follows:\\n\\n1.   APPOINTMENT.      -----------\\n\\n1.1  Subject to the provisions of this Agreement, Airspan hereby appoints Distributor as an independent, exclusive distributor to assist Airspan in marketing the Airspan Products to customers in the Territory, and Distributor hereby accepts such appointment as of the Effective Date of this Agreement. Distributor\\'s appointment as a distributor of the Airspan Products grants to Distributor only a license to resell the\\n\\n- -------------------------------------------------------------------------------\\n\\nPage 1\\n\\nAirspan Products to Distributor\\'s customers in the Territory, and does not transfer any right, title, or interest in any of the Airspan Software to Distributor.\\n\\n1.2  Distributor\\'s relationship to Airspan is that of an independent contractor, and nothing in this Agreement shall constitute Distributor as the agent or employee of Airspan.  Distributor shall have no authority to accept any order or make any offer (except as herein stated), or execute any instrument or make any commitment on behalf of Airspan.  Specifically, without in any way limiting the generality of the foregoing, Distributor agrees not to make any representation, guarantee, or warranty on Airspan\\'s behalf concerning the Airspan Products, but will refer customers to Airspan\\'s printed literature. Nothing contained in this Agreement is to be construed as a limitation or restriction upon Airspan in the sale or other disposition of any of its products to any person, firm, or corporation inside or outside of the Territory. Airspan will pay no commissions under this Agreement.  Distributor\\'s compensation is to be obtained solely by the difference between the price Distributor pays to Airspan and the price Distributor charges its customers. The parties also acknowledge that this Agreement is not intended to create a joint venture or partnership between Airspan and Distributor.\\n\\n1.3  Distributor will use its best efforts to maintain and support the Airspan Products within the Territory by devoting such attention, time, and effort as may be reasonably necessar',\n",
              "    'Highlight the parts (if any) of this contract related to \"Effective Date\" that should be reviewed by a lawyer. Details: The date when the contract is effective\\xa0',\n",
              "    '31st day of March, 2000',\n",
              "    463,\n",
              "    486),\n",
              "   ('EXHIBIT 10.6    TRANSPORTATION CONTRACT  SPECIFIC CONDITIONS\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n   PURPOSE\\n\\n  ECONOMIC CONDITIONS\\n\\n  CONTRACTED CAPACITY\\n\\n\\n\\n   POINTS OF ENTRANCE AND EXIT     MANSOYร - TUMACO\\n\\n\\n\\nDate Bogota D.C. January 30, 2012\\n\\nContract No. VIT-005-2012\\n\\nSENDER SOLANA PETROLEUM EXPLORATION  COLOMBIA LIMITED\\n\\nTAX ID 830.051.027-8\\n\\nSHIPPER ECOPETROL S.A.   TAX ID 899.999.068-1\\n\\nT Y P E  O F   CRUDE  OWN PRODUCTION x  PROPERTY\\n\\nTransportation Service of liquid hydrocarbons through the \"Trasandino\" Pipeline(OTA) and Mansoyรก-Orito (OMO) pipeline.\\n\\nEstimated Value of the Contract Six millions seven hundred forty five thousand dollars of The United States of  America (USD$6.745.000).  Rate \"Mansoyรก-Orito\" Pipeline (OMO) Cero point five one nine two dollars of The Untied States of America (USD$0,5192) per Barrel  Rate \"Trasandino\" Pipeline (OTA) Three dollars eleven forty three cents of dollars of The Untied States of America (USD$3,1143) per Barrel.\\n\\nPRODUCT Daily Average  (Barrels/calendar day)  Monthly average  (Barrels/month)  Crude 10.000 300.000\\n\\nTERM OF EXECUTION From January 30, 2012 until July 29, 2012\\n\\nPoint   #  Type of Point    Name of Point  Distance  (km)\\n\\n1 Point of Entrance  Entrance bridle to the srapers tramp in the PK 35+400 of  OMO 377,3  2 Point of Exit Exit bridle to the main tanks of Tumaco Plant.\\n\\n\\n\\n\\n\\n\\n\\n   SPECIFICATIONS OF PRODUCTS TO BE SHIPPED    PRODUCT CHARACTERISTICS\\n\\n   Quality Specifications of Crude:    Bases on the operating conditions of the \"Trasandino\" Pipeline, ECOPETROL shall only receive daily crude oil from the SENDER up to a maximum  equivalent to 12% of the total light crude received in the day at the Orito Plant.    The indicated Quality Specifications correspond to those which the final mix of crude delivered by the SENDER shall have. In the event in which  the Crude delivered by the SENDER fails to meet the Quality Specification and if the buying of dissolvent is required to make mixes, the SENDER  shall request approval from ECOPETROL before its delivery for transportation by ECOPETROL.    It is the SENDER\\'s responsibility to ensure its possession, control and entitlement to deliver or make deliver on its behalf the crude received by  ECOPETROL at the Entrance Point. The SENDER shall hold ECOPETROL harmless against any claim, action or damages which may result from  suits, claims or administrative, judicial or extrajudicial actions from any third persons alleging ownership or possession on the crude to be shipped.    BONDS\\n\\n   In witness whereof, and accepting the General Conditions and the Specific Conditions this Contract is subscribed in two (2) duplicates of the same  content in the city of Bogotรก on the thirtieth (30th) day of the month of January, 2012.\\n\\n\\n\\nCharacteristics Lower Limit Upper Limit  Temperature   120ยฐF  Viscosity   300 cSt 30ยบC.  Water and sediments (BSW)   0,5 % in volume  Salt   20 PTB  Steam pressure   Eleven (11) psi at 100ยฐF  Gravity in API degrees 18 degrees 50 degrees\\n\\nTYPE OF BOND AMOUNT  Performance Insurance Policy Four thousand forty seven millions of Colombian pesos ($4.047.000.000)\\n\\n  1\\n\\n\\n\\n\\n\\n\\n\\n   All notifications and communications to be delivered to the Parties as a result of the execution of the Contract hereof shall be made to the  addresses indicated as follows:    ECOPETROL\\n\\n  THE SENDER\\n\\n\\n\\n\\n\\nBY THE SENDER: BY ECOPETROL S.A.:  Signature \"/s/ Duncan Nightingale\" Signature \"/s/ Rafael Espinosa Rozo\"          Name: DUNCAN NIGHTINGALE Name: RAFAEL ESPINOSA ROZO  Title: Legal Representative  Pasaporte No. BA386341  Title: Pipelines Manager  C.C. No. 79.432.773 de Bogotรก D.C.          Signature \"/s/ Hugo Rodriguez\"             Name: HUGO RODRIGUEZ     Title: Legal Representative  C.C. No. 3.093.980\\n\\nADDRESS 5.1 Carrera 7 No. 37 - 69 Piso 9 Edificio Teusacรก  TELEPHONE 5.2 2343491 FAX 5.3 2343532 CITY 5.4 Bogotรก D.C.\\n\\nADDRESS 5.5 Calle 113 No. 7 - 80 Piso 17  TELEPHONE 5.6 6585757 FAX 5.7 2139327 CITY 5.8 Bogotรก D.C.\\n\\n  2\\n\\n\\n\\n\\n\\n   TRANSPORTATION CONTRACT  GENERAL CONDITIONS    The Contract hereof executed between ECOPETROL and the SENDER shall be comprised by t',\n",
              "    'Highlight the parts (if any) of this contract related to \"Effective Date\" that should be reviewed by a lawyer. Details: The date when the contract is effective\\xa0',\n",
              "    'January 30, 2012',\n",
              "    202,\n",
              "    218),\n",
              "   ('Exhibit 10.28\\n\\n                              ENDORSEMENT AGREEMENT\\n\\n            This Endorsement Agreement (\"Agreement\") is made and entered into as of August 24, 1995, by and among the following parties:\\n\\n                  (a) Kathy Ireland, Inc. (\"KI Inc.\"), furnishing the services       of Kathy Ireland (\"KI\"), c/o The Sterling/Winters Co., 1900 Avenue of the       Stars, Suite #1640, Los Angeles, California 90067;\\n\\n                  (b) The Sterling/Winters Co. (\"SW\"), 1900 Avenue of the Stars,       Suite #1640, Los Angeles, California 90067; and\\n\\n                  (c) Diplomat Ambassador Eyewear Group (\"Diplomat\"), 1010 Arch       Street, 3rd Floor, Philadelphia, Pennsylvania 19107.\\n\\n            1. Recitals.\\n\\n                  (a) Whereas Diplomat has created a new product line to be known as \"Kathy Ireland Eyewear\" (\"KI Eyewear\");\\n\\n                  (b) Whereas Diplomat estimates on a non-binding basis that wholesale sales of KI Eyewear will reach $          during the first License Year, $          during the 2nd License Year, $          during the 3rd License Year, and $          during the 4th License Year (as those License Years are defined in subparagraph 3.(b) of this Agreement);\\n\\n                  (c) Whereas Diplomat desires to obtain the right to use the name, likeness and endorsement of KI in connection with the advertisement, promotion and sale of KI Eyewear; and\\n\\n                  (d) Whereas KI, Inc. has the authority to grant the right to use KI\\'s name, likeness and endorsement to Diplomat in connection with the advertisement, promotion and sale of KI Eyewear and desires to do so;\\n\\n                  (e) NOW THEREFORE, for and in consideration of the mutual promises and conditions contained in this Agreement, the parties hereby agree as follows.\\n\\n            2. Grant of License.\\n\\n                  (a) Products. Upon the terms and conditions set forth in this Agreement, KI, Inc. hereby grants to Diplomat and Diplomat hereby accepts the right, license and privilege of utilizing KI\\'s name and likeness solely upon and in connection with the manufacture, sale and distribution of the following products:\\n\\n                        (1) sunglasses, eyeglasses, readers and ophthalmic frames;\\n\\n                                       1\\n\\n                        (2) optical cases, optical eye chains, eye pins, and lens cleaning kits sold only in optical retailers; and\\n\\n                        (3) such other optical accessories as the parties shall agree.\\n\\n                  (b) Territory. The license hereby granted extends worldwide.\\n\\n                  (c) Term. The term of the license hereby granted shall commence August 1, 1995 and continue until January 30, 2000, unless sooner terminated in the manner provided in the immediately succeeding sentence or as otherwise provided in this Agreement. Notwithstanding the foregoing, if the management of Kmart stores elects not to carry KI eyewear prior to the end of the first license year (January 30, 1997), then either party shall have the right to terminate this Agreement as of such date.\\n\\n                  3. Terms of Payment.\\n\\n                  (a) Rate. Diplomat agrees to pay KI, Inc. as royalty a sum equal to  % of the net wholesale volume of the products covered by this Agreement by Diplomat and its affiliated, associated, or subsidiary companies. The term \"net wholesale volume\" shall mean gross sales to all customers; less returns, trade discounts and cash discounts; but no deduction shall be made for other discounts or uncollectible accounts. No costs incurred in the manufacture, sale, distribution, or exploitation of the products covered by this Agreement shall be deducted from any royalty payable by Diplomat.\\n\\n                  (b) Minimum Royalties. Diplomat agrees to pay KI, Inc. the minimum royalties set forth below as a minimum guarantee against royalties to be paid to KI, Inc. under subparagraph 3.(a), above:\\n\\n                  (1) 1st License Year (8/1/95 - 1/30/97):     $                   (2) 2nd License Year (2/1/97 - 1/30/98):     $                   (3) 3',\n",
              "    'Highlight the parts (if any) of this contract related to \"Effective Date\" that should be reviewed by a lawyer. Details: The date when the contract is effective\\xa0',\n",
              "    'August 1, 1995',\n",
              "    2665,\n",
              "    2679),\n",
              "   ('NON COMPETITION AGREEMENT AND RIGHT OF FIRST OFFER\\n\\nTHIS AGREEMENT is dated May 3,2006.\\n\\nBETWEEN:\\n\\nGLAMIS GOLD LTD., a company incorporated under the laws  of the Province of British Columbia, having an office at 310-5190  Neil Road, Reno, Nevada 89502\\n\\n(\"Glam is\")\\n\\nAND:\\n\\nWESTERN COPPER CORPORATION, a company  incorporated under the laws of the Province of British Columbia,  having an office at 2050-1111 West Georgia Street, Vancouver.  B.C. V6E 4M3\\n\\n(\"Western Copper\")\\n\\nWHEREAS:\\n\\n(A) Glamis, Western Copper and Western Silver Corporation (\"Western Silver\") are  parties to an arrangement agreement dated as of February 23, 2006 (the \"Arrangement  Agreement\"), pursuant to which, among other things, Western Copper will acquire certain assets  of Western Silver and Glamis will become the sole shareholder of Western Silver and the  indirect owner, through Western Silver, of certain corporations and mineral properties in Mexico  (the \"Arrangement\"); and\\n\\n(B) It is an obligation under the Arrangement Agreement that Western Copper agree  not to compete with Glamis in certain areas of Mexico and that Glamis grant Western Copper a  right of first offer with respect to the proposed disposition by Glamis of mineral properties or  legal interests therein located in Mexico that Glamis acquired under the Arrangement.\\n\\nNOW THEREFORE TIHS AGREEMENT WITNESSES that in consideration of the mutual  covenants and agreements contained herein and other good and valuable consideration, the  receipt and sufficiency of which is hereby acknowledged, the parties hereto covenant and agree  as follows: (Scheme B. mca)\\n\\n1I629<<7J\\n\\n\\n\\n\\n\\nPART I\\n\\nINTERPRETATION\\n\\nDefinitions\\n\\n1.1 In this Agreement, including the recitals, except as expressly provided or unless  the context otherwise requires,\\n\\n(a) Affiliate means, in respect of a party hereto, a corporation which is the subsidiary  of the party or vice versa or where each of the party and the corporation is controlled by  the same person,\\n\\n(b) Area of Non-Competition means the State of Zacatecas, Mexico and the area  extending 20 kilometers in all directions from the external boundary of each mineral  property owned or controlled by Western Silver or in which Western Silver holds any  legal interest, in Mexico, as at the Effective Date,\\n\\n(c) Business Day means a day which is not a Saturday, Sunday or a civic or statutory  holiday in Reno, Nevada and Vancouver, British Columbia,\\n\\n(d) Closing means the completion of the transactions contemplated by the  Arrangement Agreement,\\n\\n(e) Designated Mineral Property means a mineral property or individual mineral  concession within a mineral property, that is owned or controlled by Western Silver or in  which Western Silver holds any legal interest in Mexico as of the Effective Date,\\n\\n(f) Effective Date means May 3, 200ri or such later date as determined under the  Arrangement Agreement,\\n\\n(g) Mining Activities means any acquisition of mineral rights or any mineral  exploration or development activities, in any manner whatsoever, and\\n\\n(h) Person means an individual, corporation, body corporate, firm, limited liability  company, parmership, syndicate, joint venture, society, association, trust or  unincorporated organization.\\n\\nInterpretation\\n\\n1.2 In this Agreement, except as otherwise expressly provided or unless the context  otherwise requires,\\n\\n(a) the terms \"this Agreement\", \"hereof\\', \"herein\", \"hereunder\" and similar  expressions refer to this Agreement as from time to time supplemented or amended by  one or more agreements entered into pursuant to the applicable provisions of this  Agreement and not to any particular section or other portion,\\n\\n1162967.3\\n\\n\\n\\n\\n\\n- 3 \\'\\n\\n(b) a reference to a Part means a Part of this Agreement and the symbol ยง followed by  a number or some combination of numbers and letters refers to the provision of this  Agreement so designated and the symbol ยง followed by a letter within a provision refers  to a clause within such provision,\\n\\n(c) the headings used in this Agreement are for convenience only and do not form a  part of this Agreement and a',\n",
              "    'Highlight the parts (if any) of this contract related to \"Effective Date\" that should be reviewed by a lawyer. Details: The date when the contract is effective\\xa0',\n",
              "    'Effective Date means May 3, 200ri or such later date as determined under the  Arrangement Agreement,',\n",
              "    2790,\n",
              "    2890),\n",
              "   ('Exhibit 10.17\\n\\nINTELLECTUAL PROPERTY AGREEMENT\\n\\nbetween\\n\\nTHE BABCOCK & WILCOX COMPANY\\n\\nand\\n\\nBABCOCK & WILCOX ENTERPRISES, INC.\\n\\ndated as of\\n\\nJune 26, 2015\\n\\n\\n\\n\\n\\nTABLE OF CONTENTS   ARTICLE I   DEFINITIONS     1\\n\\n  Section 1.1   Definitions     1\\n\\n  Section 1.2   Interpretation     4\\n\\nARTICLE II   INTELLECTUAL PROPERTY ASSIGNMENT AND OWNERSHIP     5\\n\\n  Section 2.1   Reserved     5\\n\\n  Section 2.2   Reserved     5\\n\\n  Section 2.3   Assistance by Employees; Inventor Compensation     5\\n\\n  Section 2.4   Ownership     6\\n\\n  Section 2.5   Rights Arising in the Future     6\\n\\n  Section 2.6   Abandonment of Certain Intellectual Property     7\\n\\n  Section 2.7   Reserved     7\\n\\n  Section 2.8   Steam/Its Generation and Use     7\\n\\nARTICLE III   TRADEMARKS     8\\n\\n  Section 3.1   House Marks     8\\n\\n  Section 3.2   Limited License to Use SpinCo House Marks     9\\n\\n  Section 3.3   Removal of Classes from SpinCo Marks    10\\n\\n  Section 3.4   RemainCo Marks    10\\n\\n  Section 3.5   Duty to Avoid Confusion    10\\n\\nARTICLE IV   SHARED LIBRARY MATERIALS    11\\n\\n  Section 4.1   Shared Library Materials    11\\n\\n  Section 4.2   Cross-License of Shared Library Materials    11\\n\\n  Section 4.3   Maintenance of Shared Library Materials    11\\n\\n  Section 4.4   Potential Allocation of Shared Library Materials    12\\n\\n  Section 4.5   Confidentiality and Trade Secret Status of Shared Library Materials    13\\n\\n  Section 4.6   Third Party Materials Contained in the Shared Library Materials    13\\n\\nARTICLE V   INTELLECTUAL PROPERTY LICENSES AND COVENANTS    13\\n\\n  Section 5.1   Cross-License of Shared Know-How    13\\n\\n  Section 5.2   Reserved    14\\n\\n  Section 5.3   Reserved    14    i\\n\\n\\n\\n\\n\\n  Section 5.4   Cross-Licenses of Software    14\\n\\n  Section 5.5   Reserved    15\\n\\n  Section 5.6   Sublicensing; Assignability    15\\n\\n  Section 5.7   Restrictions on Licensor Exploitation of Intellectual Property    16\\n\\n  Section 5.8   Third Party Agreements; Reservation of Rights    16\\n\\n  Section 5.9   Maintenance of Intellectual Property    16\\n\\n  Section 5.10   Covenants    17\\n\\nARTICLE VI   TECHNICAL ASSISTANCE AND TECHNOLOGY TRANSFER    17\\n\\n  Section 6.1   Reserved    17\\n\\n  Section 6.2   Reserved    17\\n\\n  Section 6.3   No Additional Technical Assistance    17\\n\\nARTICLE VII   NO WARRANTIES    18\\n\\nARTICLE VIII   THIRD-PARTY INFRINGEMENT    18\\n\\n  Section 8.1   No Obligation    18\\n\\n  Section 8.2   Notice Regarding Infringement    19\\n\\n  Section 8.3   Suits for Infringement    19\\n\\nARTICLE IX   CONFIDENTIALITY    21\\n\\nARTICLE X   MISCELLANEOUS    22\\n\\n  Section 10.1   Authority    22\\n\\n  Section 10.2   Entire Agreement    22\\n\\n  Section 10.3   Binding Effect; Third-Party Beneficiaries; Assignment    23\\n\\n  Section 10.4   Amendment    23\\n\\n  Section 10.5   Failure or Indulgence Not Waiver; Remedies Cumulative    23\\n\\n  Section 10.6   Notices    23\\n\\n  Section 10.7   Counterparts    23\\n\\n  Section 10.8   Severability    23\\n\\n  Section 10.9   Governing Law    24\\n\\n  Section 10.10   Construction    24\\n\\n  Section 10.11   Performance    24\\n\\nSCHEDULES   Schedule 1.1(e)   SpinCo Core Field; RemainCo Core Field Schedule 1.1(i)   Specific RemainCo Field; Specific SpinCo Field Schedule 1.1(o)   SpinCo House Marks Schedule 1.1(p)   RemainCo House Marks   ii\\n\\n\\n\\n\\n\\nSchedule 2.4(a)   RemainCo Ownership Schedule 2.4(b)   SpinCo Ownership Schedule 2.6   Abandonment of Certain Intellectual Property Schedule 3.1   SpinCo Trademarks Schedule 3.3   Required Actions and Filings Schedule 3.4   RemainCo Trademarks Schedule 4.1   Shared Library Materials Schedule 4.4   Nuclear Design Materials Schedule 5.4(a)   Foundational Software   iii\\n\\n\\n\\n\\n\\nINTELLECTUAL PROPERTY AGREEMENT\\n\\nThis INTELLECTUAL PROPERTY AGREEMENT (this \"Agreement\") is entered into as of June 26, 2015 (the \"Effective Date\"), between The Babcock & Wilcox Company, a Delaware corporation, (\"RemainCo\") and Babcock & Wilcox Enterprises, Inc., a Delaware corporation (\"SpinCo\"). RemainCo and SpinCo are sometimes referred to herein individually as a \"Party,\" and collectively as the \"Parties.\" Capitalized terms used herein and not otherwise defined shall have the meanings ascr',\n",
              "    'Highlight the parts (if any) of this contract related to \"Effective Date\" that should be reviewed by a lawyer. Details: The date when the contract is effective\\xa0',\n",
              "    'June 26, 2015',\n",
              "    141,\n",
              "    154),\n",
              "   ('Exhibit 10.22\\n\\nSTRATEGIC ALLIANCE AGREEMENT\\n\\n(Hyatt Ziva Cancun)\\n\\nTHIS STRATEGIC ALLIANCE AGREEMENT (the \"Agreement\") is made and entered into as of December 14, 2016 (the \"Effective Date\"), by and between Hyatt Franchising Latin America, L.L.C., a limited liability company organized and existing under the laws of the State of Delaware (U.S.A.) with its principal place of business located at 71 South Wacker Drive, Chicago, Illinois 60606, U.S.A. (\"Hyatt\"), and Playa Hotels & Resorts, B.V., a private limited liability company organized and existing under the laws of the Netherlands with its registered address at Prins Bernhardplein 200, 1097 JB Amsterdam, the Netherlands (\"Playa\"). Hyatt and Playa are each referred to as a \"Party\" and collectively as the \"Parties.\"\\n\\nR E C I T A L S:\\n\\nWHEREAS, Hyatt and Playa are parties to that certain Master Development Agreement dated as of August 9, 2013 (as amended, the \"Master Development Agreement\") under which Hyatt granted Playa the exclusive (to the extent set forth therein) right, provided that Playa met certain conditions, to develop all-inclusive resorts under either or both of the Hyatt Zivaยฎ or Hyatt Zilaraยฎ brands and other aspects of the proprietary system owned by Hyatt or its affiliates (\"Hyatt All-Inclusive Resorts\") in the countries of Mexico, Costa Rica, the Dominican Republic, Jamaica and Panama, as their boundaries exist as of the Effective Date (the \"Market Area\"); and\\n\\nWHEREAS, simultaneously with signing this Agreement, Hyatt and Playa or its affiliates are terminating the Master Development Agreement and signing amendments to the following franchise agreements (collectively, the \"Existing Franchise Agreements\") covering the following Hyatt All-Inclusive Resorts:\\n\\n  โข   Franchise Agreement dated as of August 9, 2013, amended and restated on January 31, 2014 between Hyatt and Playa Hall JamaicanResort Limited for the operation of the Hyatt Ziva/Zilaraยฎ resort at 1 Ritz-Carlton Drive, Rose Hall, Montego Bay, Jamaica\\n\\n  โข   Franchise Agreement dated as of August 9, 2013, amended and restated on January 31, 2014 between Hyatt and Playa Cabos Baja, S. DeR.L. De C.V. for the operation of the Hyatt Zivaยฎ resort at Paseo de Malecรณn I-5 D, San Josรฉ del Cabo, 23405, Mexico\\n\\n  โข   Franchise Agreement dated as of August 9, 2013, amended and restated on January 31, 2014 between Hyatt and Cameron Del Pacifico S. De R.L. De C.V. for the operation of the Hyatt Zivaยฎ resort at Carretera Barra de Navidad Km. 3.5, Zona Hotelera, 48300, Puerto Vallarta, Jalisco, Mexico\\n\\n  โข   Franchise Agreement dated as of August 9, 2013, amended and restated on January 31, 2014 between Hyatt and Cameron Del Caribe S. De R.L. De C.V. for the operation of the Hyatt Zivaยฎ resort at Blvd. Kukulkan Km 9.5, Zona Hotelera, Punta Cancรบn, 77500, Cancรบn, Quintana Roo, Mexico\\n\\n\\n\\n\\n\\n  โข   Franchise Agreement dated as of August 9, 2013, amended and restated on January 31, 2014 between Hyatt and The Royal Cancun S. De R.L. De C.V. for the operation of the Hyatt Zilaraยฎ resort at Blvd. Kukulkan Km 11.5, Zona Hotelera, 77500 Cancรบn, Quintana Roo, Mexico; and\\n\\nWHEREAS, Hyatt and Playa have agreed to terminate the Master Development Agreement and to enter into this Agreement.\\n\\nNOW, THEREFORE, in consideration of the mutual covenants and agreements contained in this Amendment and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties agree as follows:\\n\\n1. First Offer for Development Opportunities. During the period beginning on the Effective Date and ending on December 31, 2018 (the \"Development Term\"), each Party (the \"Offering Party\") agrees to provide to the other Party (the \"Receiving Party\") a right of first offer with respect to any proposed offer or arrangement, which the Offering Party (or its affiliate) desires to accept, under which the Offering Party or one of its affiliates would acquire the ownership of real property in the Market Area (the \"Development Property\") on which a Hyatt All-Inclusive Resort would operate (a \"Development Opportunity\"',\n",
              "    'Highlight the parts (if any) of this contract related to \"Effective Date\" that should be reviewed by a lawyer. Details: The date when the contract is effective\\xa0',\n",
              "    'December 14, 2016',\n",
              "    149,\n",
              "    166),\n",
              "   ('EXHIBIT 10.23\\n\\nCOMPLETION AND LIOUDm MAINTENANCE 4GRFFMFST\\n\\nTHIS COMPLEHON AGREEMENT AND UQITDITV MAINTENANCE AGREEMENT ( \\'Agreement\") {5 made and entered into effective as of  June 29, 2006 between PRIMEEVERG\\\\\\'CORPORATION ( Time\"), GUARANTY BANK, FSB (\\'Guaranty\") and PRIME OFFSHORELT.C. T: Offshore\"!\\n\\nPrime is the majority shareholder of Prime Offshore L.L.C. COffshore\"! Offshore and Guaranty are parties to a Credit Agreement dated June 29,  2006, by and between Offshore as Borrower and Guaranty, as Agent and Lender i \"Credit Agreement\\'T wherein Guaranty is loaning certain funds  to Offshore to drill and complete wells and construct, install and operate in-field and flow pipelines, caissons, platforms and production facilities  for wells m South Padre Island Area OCS Blocks 1113, 1059, 1060, 1073 and 1133 and North Padre Island Area OCS Block 998 T\\'Derelopment  Project\").\\n\\n1. Completion Commrtiryr.t\\n\\nEach of the South Padre Island Area OCS Blocks 1113,1059,1060,1073 and 1133 and the North Padre Island Area OCS Block 998 shall be defined  as a \"Project Field.\\'\\'\\n\\nFor purposes ofthis Agreement, Project Completion shall consist oftwo components and be defined as:\\n\\nA) each Project Field in the Development Project having all planned in-field and flow pipelines, caissons, platforms and production facilities  for all the wells in such Project Field, for which Guaranty has loaned funds, installed and operationalsuch that the production from all such  wells can be transported to a readily available sales point for naturalgas. In addition, for each Project Field, Project Completion will include,  but not limited to:\\n\\na) obtaining required permits, easements and governmental approvals;\\n\\nb) executing necessary\" construction contract(s);\\n\\nc) completing tests considered usual and customary\" and required to be conducted with results tn accordance with those necessary\" to  permit operations;\\n\\nd) ensuring that each Project Field is free and clear of all bens other than those in favor of Guaranty and Permitted Liens under the Credit  Agreement and:\\n\\ne) causing all costs of the Development Project to be paid when due; and,\\n\\nB) the 12-inch loop pipeline fromNorth Padre Island Area OCS Block 996 to the pipeline owned by the Williams Companies Inc. having been  constructed and installed in accordance with the plans and specifications in the construction contracts).\\n\\n\\n\\n\\n\\nAs consideration for Guaranty entering into the Credit Agreement to provide such loans for the Development Project and to ensure Project  Completion. Prime absolutely and unconditionally warrants to Guaranty to fund the payment to Offshore of all costs that exzeed the available  commitments under the Credit Agreement, including interest, for Project Completion. In the event Offshore is in Default under Section 7.1(f), (g),  (h) and/or (i) ofthe Credit Agreement, then Prime absolutely and unconditionally warrants to Guaranty\" the assumption of all costs for Project  Completion.\\n\\n2. Licuieitv Maintenance\\n\\nPrime will, during the term of the Credit Agreement, maintain liquidity consisting of unused revolver availability\" under the Credit Agreement dated  December!, 2002, as amended, with Prime et aland Guaranty, and/or unrestricted cash and cash equivalents of $25,000,000. This required liquidity\"  win reduce dollar-for-dollar with any additional shareholder advance s and increase dollar-for-dollar to a maximum of $21,000,000 with any  repayment of shareholder advances. To the extent that shareholder repayment has occurred, Prime agrees to fund additional shareholder loans  equal to the amount repayed by the shareholder, as needed to ensure Project Clomp let ion\\n\\nThis Agreement shall remain in force until each component ofProject Completion is satisfied. Once a component is satisfied, Prime\\'s absolute and  unconditional warranty to Guaranty to fund the payment to Offshore of ad costs that esceed the available commitments under the Credit  Agreement for that conponent, including interest, wid ejpire.\\n\\nPrime understands that a breach ofobligations under this Agreement would result i',\n",
              "    'Highlight the parts (if any) of this contract related to \"Effective Date\" that should be reviewed by a lawyer. Details: The date when the contract is effective\\xa0',\n",
              "    'June 29, 2006',\n",
              "    177,\n",
              "    190),\n",
              "   ('ODM - SUPPLY AGREEMENT BETWEEN: ORGANIC PREPARATIONS INC. 2nd Floor, Transpacific Haus Lini Highway, Port Vila. Vanuatu \"the Manufacturer\" -- AND -- AGAPE ATP INTERNATIONAL HOLDING LIMITED Unit 05, 4F, Energy Plaza No. 92, Granville Road Tsim Sha Tsui East Kowloon, Hong Kong \"the Customer\"\\n\\nSource: AGAPE ATP CORP, 10-K/A, 12/2/2019\\n\\n\\n\\n\\n\\nODM SUPPLY AGREEMENT THIS AGREEMENT is made on the 15t h day of January 2018. BETWEEN: ORGANIC PREPARATIONS INC. 2nd Floor, Transpacific Haus Lini Highway, Port Vila. Vanuatu (\\'the Manufacturer\\') of one part AND: AGAPE ATP INTERNATIONAL HOLDING LIMITED Unit 05, 4F, Energy Plaza No. 92, Granville Road Tsim Sha Tsui East Kowloon, Hong Kong (\\'the Customer\\') of the other part. RECITALS a. The Manufacturer wishes to appoint the Customer to be the sole and exclusive agent for the promotion, sales, marketing distribution and administration of the Products listed in schedule A of this agreement. b. The Manufacturer and the Customer wish to record their agreement under the stipulations of this Agreement. NOW IT IS AGREED as follows:- 1. TERMS OF AGREEMENT 1.1 Commencement This agreement commences upon execution of this document. 1.2 Term This agreement is for a term of ten (10) years. 1.3 Renewal This agreement will be automatically renewed at the end of every ten (10) year term, with each subsequent term of renewal being for a ten (10) year term. A six (6) months notice must be given by either party of their intention to terminate relations due to any reason other than breach of this agreement. ODM Supply Agreement 2 Organic Preparations INC. & Agape ATP International Holding Limited\\n\\nSource: AGAPE ATP CORP, 10-K/A, 12/2/2019\\n\\n\\n\\n\\n\\n2. PROVISION OF DOCUMENTATION 2.1 Provision by the Manufacturer The Manufacturer agrees to supply to the Customer, within a reasonable period of time, all documentation and information relating to the Products and their Manufacture as is required for the registration of the Products in the Territories as listed in Schedule C of this document. The party responsible for documentation fees and costs will be the Customer. 2.2 Provision by the Customer The Customer agrees to supply to the Manufacturer at its own expense, within a reasonable period of time, all documentation and information as is reasonably required by or would be beneficial to the Manufacturer in the performance of its obligations under this agreement. 3. COVENANTS BY THE MANUFACTURER 3.1 Compliance with Local Laws and Regulations The Manufacturer covenants that it is and will remain for the term of this agreement in compliance with any and all Local Laws and Regulations. This includes without limitation laws relating to business practice, workplace relations, safety and taxation. 3.2 Manufacturing standards The Manufacturer covenants that it is and will remain for the term of this agreement in compliance with all International standards in production and manufacturing. 3.3 Packaging The Manufacturer covenants that it is and will remain for the term of this agreement in compliance with any and all packaging laws and regulations in all of the Territories. 3.4 Ability to Perform The Manufacturer covenants that it is willing and able to perform any and all of its obligations under this agreement. 3.5 Intellectual Property 3.5 (a) The Manufacturer covenants that the Products are clear of any Intellectual Property claims by third parties and that the Customer has full rights to sell and market the Products worldwide. The Manufacturer indemnifies the Customer for the same. ODM Supply Agreement 3 Organic Preparations INC. & Agape ATP International Holding Limited\\n\\nSource: AGAPE ATP CORP, 10-K/A, 12/2/2019\\n\\n\\n\\n\\n\\n3.5 (b) The composition of the below individuals is also relevant and related to the Intellectual Property of the Manufacturer. The following names listed as Medical Team members, and any subsequent consultations in that capacity, are considered the Intellectual Property of The Manufacturer: 1. Dr Lily Tomas 2. Dr Bernd Friedlander 3. Mr Markus Eistert 4. Dr Ed Smith 5. Mr Vic Cherikoff 6. Dr Pavel Yutsis 7. ',\n",
              "    'Highlight the parts (if any) of this contract related to \"Effective Date\" that should be reviewed by a lawyer. Details: The date when the contract is effective\\xa0',\n",
              "    'This agreement commences upon execution of this document.',\n",
              "    1113,\n",
              "    1170),\n",
              "   ('Exhibit 10.17    Program Content License Agreement     between     Phoenix Satellite Television Company Limited     and     Beijing Tianying Jiuzhou Network Technology Co., Ltd.     November 24, 2009\\n\\nSource: PHOENIX NEW MEDIA LTD, F-1, 4/21/2011\\n\\n\\n\\n\\n\\n     Program Content License Agreement     This Program Content License Agreement (\"Agreement\") is entered into between the following two parties on November 24, 2009 in Beijing:     Phoenix Satellite Television Company Limited (\"Party A\" or \"Phoenix Satellite TV\"), a foreign enterprise duly established and validly existing  under the laws of Hong Kong     Registered Address: No. 2-6, Dai King Street, Taipo Industrial Estate, Taipo, N. T., H.K.     Authorized Representative: Cui Qiang     and     Beijing Tianying Jiuzhou Network Technology Co., Ltd. (\"Party B\"), a limited liability company duly registered and validly existing under PRC laws     Address: Floor 5 Information Building, No. 12 Zhongguancun South Street, Haidian District, Beijing 100081 China     Legal Representative: Qiao Hai Yan     Party A and Party B are hereinafter referred to individually as a \"Party\" and collectively as \"Parties\".     WHEREAS:     1. Party A owns copyrights and other related rights to the programs listed in Exhibit 1 hereto, as amended from time to time;     2. In accordance with the \"Agreement Between Phoenix Satellite TV and Phoenix New Media Regarding Cooperation in the Fields of Content,  Branding, Promotion and Technology\" dated November 24, 2009 between Phoenix Satellite Television Holdings Limited and Phoenix  Online (Beijing) Information Technology Co., Ltd., Party B has the right to operate the Phoenix Satellite TV Websites (defined below)  and Other Websites (defined below), provide Internet information services such as news, entertainment, and business information, as  well as computer information services through such websites and transfer information from Phoenix Satellite TV to mobile network  clients, and authorize the use of the Phoenix Satellite TV program content by other information network service providers (collectively,  \"Party B Business\"); and     3. Both Parties agree that Party A will provide the program content of Phoenix Satellite TV to Party B, subject to the terms and conditions hereof.     2\\n\\nSource: PHOENIX NEW MEDIA LTD, F-1, 4/21/2011\\n\\n\\n\\n\\n\\n     NOW, THEREFORE, upon amicable consultation based on principles of equality, mutual benefit and complementary advantage, the Parties have  reached this Agreement as follows:     ARTICLE ONE DEFINITION     1.1 Unless otherwise referenced herein, each of the terms used herein shall have the meaning ascribed to it below:     (i) \"Affiliate\", with respect to any Party hereto, shall mean any legal person, non-legal person economic organization, or natural person,  which owns a controlling interest in, or which is controlling, controlled by or under common control with, such Party, directly or  indirectly.     As used in this Agreement, \"control\" means the power of any person to direct or cause the direction of management and policies  of another party on account of such person\\'s ownership of equity interest, voting right, the right to appoint directors, by contract  or otherwise.     (ii) \"Business Day\" shall mean a date on which commercial banks open for business, other than Saturdays, Sundays and public holidays  in mainland China.     (iii) \"Intellectual Property Right\" shall mean authorship right, proprietary trademark right, patent right, business secret ownership right  and other intellectual property right under PRC Law.     (iv) \"Other Websites\" shall mean Internet websites whose domain name are licensed by Party A or its Affiliate to Party B and which are  operated and managed by Party B upon Party A\\'s approval in writing, other than the Phoenix Satellite TV Websites.     (v) \"Phoenix Satellite TV Websites\" shall mean Internet websites which have the domain name of www.ifeng.com, www.phoenixtv.com  or www.phoenixtv.com.cn.     (vi) \"Program Content\", with respect to this Agreement, shall mean all program content',\n",
              "    'Highlight the parts (if any) of this contract related to \"Effective Date\" that should be reviewed by a lawyer. Details: The date when the contract is effective\\xa0',\n",
              "    'November 24, 2009',\n",
              "    182,\n",
              "    199),\n",
              "   ('EXHIBIT 10.2 EXECUTION VERSION NON-COMPETITION AND NON-SOLICITATION AGREEMENT THIS NON-COMPETITION AND NON-SOLICITATION AGREEMENT (this \"Agreement\"), dated as of August 1, 2019 (the \"Effective Date\"), is entered into by Quaker Chemical Corporation (\"Buyer\"), a Pennsylvania corporation, Gulf Houghton Lubricants Ltd., a company incorporated in the Cayman Islands (\"Gulf Houghton\"), Gulf Oil International Limited, a company incorporated in the Cayman Islands (\"Gulf International\"), and GOCL Corporation Limited, a public limited company incorporated in India (\"Gulf Oil\" and, together with Gulf Houghton and Gulf International, the \"Sellers\" and each, a \"Seller\"). In addition, Gulf Oil Lubricants India, Ltd, a public limited company incorporated in India (\"Gulf India\"), is executing this Agreement solely for purposes of Section 1(c) [Confidentiality; Non-competition; Non-solicitation]. BACKGROUND WHEREAS, Gulf Houghton owns 3,074,270.00 of the outstanding ordinary shares (the \"Shares\") in Global Houghton Ltd., an exempted company incorporated under the Laws of the Cayman Islands (the \"Company\"); Gulf International owns approximately 90% of Gulf Houghton; and Gulf Oil is an indirect owner of approximately 10% of Gulf Houghton. WHEREAS, The Company and its subsidiaries are engaged in the business of manufacturing, distributing and/or selling one or more of the following formulated chemical specialty product lines: fire resistant hydraulic fluids, semi-synthetic and specialty metalworking fluids, cleaning fluids, cold-rolling oils, hot-rolling oils, and specialty industrial greases (such business, as conducted by the Company and its Subsidiaries as of the Effective Date, the \"Company Business\"). WHEREAS, Buyer and its subsidiaries are engaged in the business of manufacturing, distributing and/or selling the following formulated chemical specialty product lines or chemical management services (\"CMS\"), (i) rolling lubricants (used by manufacturers of steel in the hot and cold rolling of steel and by manufacturers of aluminum in the hot rolling of aluminum); (ii) corrosion preventives (used by steel and metalworking customers generally to protect metal during manufacture, storage, and shipment); (iii) metal finishing compounds (used to prepare metal surfaces for special treatments such as, but not limited to, galvanizing and tin plating and to prepare metal for further processing); (iv) machining and grinding compounds (typically used by customers in cutting, shaping, and grinding metal parts which require special treatment to enable them to tolerate the manufacturing process, achieve closer tolerance, and improve tool life); (v) forming compounds (used generally to facilitate the drawing and extrusion of metal products); (vi) bio-lubricants (typically used in machinery in the forestry and construction industries); (vii) hydraulic fluids (used generally by steel, metalworking, mining, and other customers to operate hydraulic equipment); (viii) chemical milling maskants for the aerospace industry; (ix) temporary and permanent coatings for metal and concrete products, tubes and pipes and other applications; (x) construction products, such as flexible sealants and protective coatings, for various applications; (xi) various specialty greases used in automobile, industrial and various other applications; (xii) various die casting lubricants and mold release agents; (xiii) various dust suppressants, ground control agents and roofing products used in mining; and (xiv)\\n\\n\\n\\n\\n\\nprograms to provide CMS (such business, as conducted by Buyer and its subsidiaries as of the Effective Date, the \"Existing Business\" and, together with the Company Business, the \"Combined Business\"). WHEREAS, Buyer, Gulf Houghton and other shareholders of the Company are parties to a Share Purchase Agreement dated as of April 4, 2017, under which Buyer is acquiring the Shares (the \"Purchase Agreement\"). Capitalized terms used herein but not otherwise defined herein shall have the meanings given to such terms in the Purchase Agreement. WHEREAS, Sellers, together with the C',\n",
              "    'Highlight the parts (if any) of this contract related to \"Effective Date\" that should be reviewed by a lawyer. Details: The date when the contract is effective\\xa0',\n",
              "    'August 1, 2019',\n",
              "    162,\n",
              "    176),\n",
              "   ('Exhibit 10.1 Certain portions of this exhibit have been omitted pursuant to Rule 601(b)(10) of Regulation S-K. The omitted information is (i) not material and (ii) would likely cause competitive harm to the Company if publicly disclosed. Information that has been omitted has been noted in this document with a placeholder identified by the mark \"[***]\". EXECUTION COPY PROMOTION AGREEMENT\\n\\nby and between\\n\\nSIGA TECHNOLOGIES, INC.\\n\\nand\\n\\nMERIDIAN MEDICAL TECHNOLOGIES, INC., a Pfizer company\\n\\nSource: SIGA TECHNOLOGIES INC, 8-K, 6/3/2019\\n\\n\\n\\n\\n\\nTABLE OF CONTENTS PAGE ARTICLE 1 DEFINITIONS 1 ARTICLE 2 GRANT OF RIGHTS 11 2.1 Grant of Rights to MMT 11 2.2 Negative Covenants 11 2.3 Non-Compete Covenant 11 2.4 Retained Rights 12 2.5 No Implied Licenses 12 2.6 [***] 12 ARTICLE 3 GOVERNANCE 12 3.1 Joint Steering Committee 12 3.2 Good Faith 12 3.3 Scope of Governance 13 ARTICLE 4 PROMOTION AND OTHER COMMERCIALIZATION 13 4.1 Promotion in the Territory 13 4.2 Diligence 14 4.3 Customer Contracts 14 4.4 Regulatory Matters 15 4.5 Discontinued Countries 15 ARTICLE 5 FORECASTING AND ORDERING 15 5.1 Product Forecasts 15 5.2 Purchase Orders 15 5.3 Delivery 16 5.4 Supply Limitation 16 5.5 Supply Penalties 16 5.6 Adverse Event Reporting 16 ARTICLE 6 PAYMENTS 16 6.1 Promotion Fee 16 6.2 Payments 17 6.3 Currency 17 6.4 Records 17 6.5 Audits 18 6.6 Blocked Payment and Indemnification 19 6.7 Source of Recovery 19 6.8 Taxes 19 ARTICLE 7 INTELLECTUAL PROPERTY 20 7.1 Ownership of SIGA Intellectual Property 20 7.2 Intellectual Property Maintenance 20 7.3 New Patents and Trademarks 20\\n\\n-i-\\n\\nSource: SIGA TECHNOLOGIES INC, 8-K, 6/3/2019\\n\\n\\n\\n\\n\\nTABLE OF CONTENTS (CONTINUED) PAGE ARTICLE 8 REPRESENTATIONS AND WARRANTIES; COVENANTS 21 8.1 Mutual Representations and Warranties 21 8.2 Additional Representations, Warranties and Covenants of SIGA 22 8.3 Additional Representations and Warranties of MMT 26 8.4 Covenants 27 8.5 No Other Representations or Warranties 29 ARTICLE 9 INDEMNIFICATION 29 9.1 Indemnification by SIGA 29 9.2 Indemnification by MMT 30 9.3 Indemnification Procedures 30 9.4 Insurance 31 9.5 Limitation of Liability 31 ARTICLE 10 CONFIDENTIALITY 31 10.1 Confidentiality 31 10.2 Authorized Disclosure 32 10.3 Technical Publication 33 10.4 Publicity; Terms of Agreement 33 10.5 Prior Confidentiality Agreements 34 10.6 Return of Confidential Information 34 10.7 Unauthorized Use 34 10.8 Exclusive Property 34 ARTICLE 11 TERM AND TERMINATION 35 11.1 Term 35 11.2 Termination for Cause 35 11.3 Termination Upon Certain Changes of Control 36 11.4 Termination for Failure to [***] 36 11.5 Termination for Convenience 36 11.6 Effect of Termination 36 11.7 Survival 36 ARTICLE 12 DISPUTE RESOLUTION 36 12.1 Executive Officer Resolution 36 12.2 Governing Law 37 12.3 Jurisdiction 37 12.4 NO JURY TRIAL 37 ARTICLE 13 MISCELLANEOUS 38 13.1 Entire Agreement; Amendment 38 13.2 Force Majeure 38\\n\\n-ii-\\n\\nSource: SIGA TECHNOLOGIES INC, 8-K, 6/3/2019\\n\\n\\n\\n\\n\\nTABLE OF CONTENTS (CONTINUED) PAGE 13.3 Notices 38 13.4 No Strict Construction; Interpretation; Headings 39 13.5 Assignment 40 13.6 Performance by Affiliates 40 13.7 Further Assurances and Actions 40 13.8 Severability 41 13.9 No Waiver 41 13.10 Relationship of the Parties 41 13.11 English Language 42 13.12 Counterparts 42 13.13 Schedules 42 13.14 Expenses 42\\n\\nExhibit A Permitted Subcontractors Exhibit B Business Plan Exhibit C SIGA Press Release Schedule 1 SIGA Patents Schedule 2 SIGA Trademarks Schedule 3 Safety Reporting Requirements Schedule 8.2(b) Encumbrances\\n\\n-iii-\\n\\nSource: SIGA TECHNOLOGIES INC, 8-K, 6/3/2019\\n\\n\\n\\n\\n\\nPROMOTION AGREEMENT This PROMOTION AGREEMENT  (this \"Agreement\") is entered into as of May 31, 2019 (the \"Effective Date\") by and between SIGA TECHNOLOGIES, INC., a Delaware corporation having an address at 31 East 62nd Street, New York, NY 10065 (\"SIGA\"), and MERIDIAN MEDICAL TECHNOLOGIES, INC., a Pfizer company, and Delaware corporation having an address at 6350 Stevens Forest Road, Suite #301, Columbia, MD 21046 (\"MMT\"). SIGA and MMT are sometimes referred to individually as a \"Party\" and collectively as the \"Part',\n",
              "    'Highlight the parts (if any) of this contract related to \"Effective Date\" that should be reviewed by a lawyer. Details: The date when the contract is effective\\xa0',\n",
              "    'May 31, 2019',\n",
              "    3661,\n",
              "    3673),\n",
              "   ('COOPERATION AGREEMENT     made by and between     HPIL ENERGYTECH Inc.   and   GINARES GROUP AG     January 5, 2015\\n\\n\\n\\n\\n\\n\\n\\n    Table of Contents       1. Term........................................................................................................................................... 2 2. Goals And Objectives................................................................................................................ 2 3. Obligations Of The Parties........................................................................................................ 3 4. Confidentiality........................................................................................................................... 3 5. Relation Of The Parties............................................................................................................. 3 6. Closing....................................................................................................................................... 3 7. Representations, Warranties, And Covenants Of GINARES.................................................... 3 8. Representations, Warranties, And Covenants Of HPIL ET...................................................... 4 9. GINARES\\'s Indemnity.............................................................................................................. 5 10. HPIL ET\\'s Indemnity............................................................................................................... 5 11. Payment Of Expenses................................................................................................................ 5 12. Approval Of Counsel................................................................................................................. 5 13. Notices....................................................................................................................................... 6 14. Additional Undertakings............................................................................................................ 6   15. Compliance With The Foreign Corrupt Practices Act And Export Control And Antiboycott Laws...........................................................................................................................................   7 16. Arbitration.................................................................................................................................. 7 17. Governing Law.......................................................................................................................... 7 18. Binding Effect............................................................................................................................ 7 19. Counterparts............................................................................................................................... 7 20. No Reliance............................................................................................................................... 8 21. Early Termination...................................................................................................................... 8 22. Captions..................................................................................................................................... 8 23. Entire Agreement....................................................................................................................... 8         1\\n\\n\\n\\n\\n\\n    COOPERATION AGREEMENT   THIS COOPERATION AGREEMENT (\"Agreement\") is signed this 5th day of January, 2015 (the \"Closing Date\"), by and between HPIL ENERGYTECH Inc., a Nevada (USA) corporation (hereafter \"HPIL ET\") and GINARES GROUP AG,  a private company domiciled in Switzerland (hereafter \"GINARES\").   R E C I T A L S:   The following is a recital of facts underlying this Agreement:   A. HPIL ET is focused on investing in both private and public companies in the energy business sector. HPIL ET does not restrict its potential candidate target companies to any specific geographical location and thus acquires va',\n",
              "    'Highlight the parts (if any) of this contract related to \"Effective Date\" that should be reviewed by a lawyer. Details: The date when the contract is effective\\xa0',\n",
              "    '5th day of January, 2015',\n",
              "    3560,\n",
              "    3584),\n",
              "   ('CORPORATE SPONSORSHIP AGREEMENT\\n\\nThis agreement (the \"Agreement\") is entered into as of May 18, 2010, (the \"Effective Date\") by and between Phoenix Performance, LLC, 481  Schuylkill Road, Phoenixville, PA 19460 (\"Vendor\") and Torvec Inc.., a New York corporation with its principal place of business located at 1999  Mt Read Blvd, Building 3, Rochester, NY. 14615 (Torvec).\\n\\nRECITALS\\n\\nWHEREAS, the parties desire to enter into an agreement regarding promotional, marketing and sponsorship activities designed to be of  mutual benefit as described herein; and\\n\\nNOW, THEREFORE, for and in consideration of the mutual covenants, rights and obligations set forth in this Agreement, the parties agree  as follows:\\n\\n1. Term\\n\\nThe term of this Agreement (the \"Term\") shall commence on the Effective Date and conclude on October 31, 2010, unless renewed by  agreement or sooner terminated in accordance with this Agreement.\\n\\n2. Termination\\n\\n(a) Either party may terminate this Agreement immediately if the other party (i) files a petition commencing a voluntary case under the  Bankruptcy Code; (ii) makes a general assignment for the benefit of creditors; (iii) admits in writing its inability to pay its debts as they become  due; (iv) seeks, consents to or acquiesces in the appointment of any trustee, receiver or liquidator of it or any part of its property; or (v) has  commenced against it an involuntary case under the Bankruptcy Code or a proceeding under any receivership, composition, readjustment,  liquidation, insolvency, dissolution or like law or statute, which case or proceeding is not dismissed or vacated within sixty (60) days.\\n\\n(b) Upon termination of this Agreement, NEITHER PARTY SHALL BE LIABLE TO THE OTHER FOR ANY CONSEQUENTIAL,  EXEMPLARY, SPECIAL, INCIDENTAL OR PUNITIVE DAMAGES, EVEN IF IT HAS BEEN ADVISED OF THE POSSIBILITY OF SUCH  DAMAGES, WHICH ARE RELATED TO THE AGREEMENT OR ITS BREACH.\\n\\nPreparation, maintenance and running of one (1) T-1 C5 Corvette race vehicle to race in:\\n\\na. 1 round of the World Challenge series in the GTS class (Mosport Double);\\n\\nb. 4 rounds of SCCA National Racing (events to be finalized but at this time expected to be NJMP, Road America, Watkins Glen  Double);\\n\\nc. the SCCA runoffs at Road America.\\n\\n.\\n\\n5. Payment and Other Consideration\\n\\nAs consideration for the benefits it receives under this Agreement, Torvec shall provide the following to Vendor:\\n\\nSee Exhibit A\\n\\nThe schedule set forth in Exhibit A will constitute invoicing for the events. Notwithstanding the above, Torvec may, in its sole  discretion, cancel its participation in any of the above-referenced events by notifying Vendor of such cancellation not later than two weeks  prior to the due date(s) for payment hereunder. All checks shall be made payabe to: Phoenix Performance, LLC and mailed to 481, Schuylkill  Rd, Phoenixville, Pa. 19460.\\n\\n(b) Equipment\\n\\n           3.     Responsibilities and Benefits\\n\\n        Vendor shall be responsible for the following in 2010:\\n\\n  4.  Torvec Benefits\\n\\n     During the Term of this Agreement, Torvec shall be entitled to the following sponsorship benefits:\\n\\n  a)  Primary sponsorship rights to all of Vendor\\'s participation efforts in the above race events.\\n\\n  b)  The right to specify and approve all team sponsorship identification markings, logos, graphics, etc. for vehicle livery, team  equipment and uniforms.\\n\\n  c)  Sole right to disapprove any driver selected by Vendor for any reason. The driver for these events will be John Heinricy.\\n\\n  (a)  Payment Schedule\\n\\n\\n\\n\\n\\nTorvec will provide to Vendor the use of up to 2 Differential units to be used in the T-1 C5 Corvette for testing, evaluation and racing  purposes..\\n\\n6. Grant of License\\n\\nEach party shall have a non-exclusive, royalty free, non-transferable license to use the name, logo, any item used in connection with that  name or logo, and the registered symbols and trademarks of the other party (the \"Trademarks\") only for the purposes set forth in this Agreement.  Neither party will use the other\\'s Trademarks without obtaining the prior approval of the other pa',\n",
              "    'Highlight the parts (if any) of this contract related to \"Effective Date\" that should be reviewed by a lawyer. Details: The date when the contract is effective\\xa0',\n",
              "    'May 18, 2010',\n",
              "    88,\n",
              "    100),\n",
              "   ('1\\n\\n                                  EXHIBIT 10.13\\n\\n                                                                  EXECUTION COPY\\n\\n                              ENDORSEMENT AGREEMENT                               ---------------------\\n\\n         This Endorsement Agreement (\"Agreement\") is made this 13th day of October, 1999 by and between SQUARE TWO GOLF INC., a New Jersey corporation (the \"Company\"), and KATHY WHITWORTH, an individual, with an address at 302 La Mancha Court, Santa Fe, New Mexico, 87501 (the \"Professional\").\\n\\n                                    RECITALS                                     --------\\n\\n         WHEREAS, the Company manufactures and sells women\\'s golf clubs and other golf equipment;\\n\\n         WHEREAS, the Professional is a retired Ladies Professional Golf Association (\"LPGA\") Tour Professional;\\n\\n         WHEREAS, the Company desires to utilize the services of the Professional in connection with the promotion, marketing, and sale of a signature line of women\\'s golf clubs and the Company\\'s other products and services; and\\n\\n         WHEREAS, the Company and the Professional desire to enter into an agreement pursuant to which the Professional will serve the Company as an independent contractor, on the terms and subject to the conditions set forth herein.\\n\\n         NOW, THEREFORE, in consideration of the mutual covenants and agreements contained herein, the Company and the Professional hereby agree as follows:\\n\\n1.       TERM.\\n\\n         1.1 The term of this Agreement shall begin on January 1, 2000 and continue for an initial period of five (5) years unless earlier terminated in accordance with Section 7 hereof, and may be renewed under Section 8 hereof (the initial period plus any renewal period, the \"Term\").\\n\\n2.       ENDORSEMENT SERVICES.\\n\\n         During the Term, the Professional will provide the services described in this Section 2 (the \"Services\"):\\n\\n         2.1 The Professional hereby grants to the Company an exclusive license to use her name, likeness, image and personal identification, singly or in any combination, in connection with the production, use, marketing and sale of a \"Kathy Whitworth\" signature line of women\\'s golf clubs (the \"Products\"), as described more fully in Section 3 below.\\n\\n   2\\n\\n                                                                  EXECUTION COPY\\n\\n         2.2 The Professional agrees to serve as a professional golf instructor during up to ten (10) golf clinics hosted by the Company per calendar year at locations within the United States to be determined by the Company. The golf clinics shall be one or two day events.\\n\\n         2.3 The Professional agrees to serve as a spokesperson for the Company at up to two (2) Professional Golf Association merchandise shows, including but not limited to the PGA Merchandise Shows.\\n\\n         2.4 The Professional hereby grants to the Company the exclusive and worldwide right to use her name, likeness, image and personal identification, singly or in any combination, during the Term and for a period of six (6) months after the Term as provided in Section 2.8, in the creation of two (2) print advertisements per year and one (1) television advertisement per year (together, the \"Advertisements\") for any golf equipment, along with all rights in any images, videos, advertisement copy or other materials created by the Professional or others. The Professional agrees that the Company shall own all such materials and all intellectual property rights&bbsp;therein for use in perpetuity in any media now known or hereafter devised or developed, including but not limited to the internet. The Professional hereby grants to the Company the worldwide right during the Term and for a period of six (6) months after the Term as provided in Section 2.8 to use, reproduce, print, publish, distribute, broadcast, modify, edit, condense, or expand any materials containing her name, image, likeness or personal identification that are created hereunder.\\n\\n         2.5 The Professional hereby grants to the Company an exclusive license to use her name, lik',\n",
              "    'Highlight the parts (if any) of this contract related to \"Effective Date\" that should be reviewed by a lawyer. Details: The date when the contract is effective\\xa0',\n",
              "    'The term of this Agreement shall begin on January 1, 2000 and continue for an initial period of five (5) years unless earlier terminated in accordance with Section 7 hereof, and may be renewed under Section 8 hereof (the initial period plus any renewal period, the \"Term\").',\n",
              "    1490,\n",
              "    1763),\n",
              "   ('Exhibit 10.2\\n\\nIN ACCORDANCE WITH ITEM 601(b) OF REGULATION S-K, CERTAIN IDENTIFIED INFORMATION (THE \"CONFIDENTIAL INFORMATION\") HAS BEEN EXCLUDED FROM THIS EXHIBIT BECAUSE IT IS BOTH (I) NOT MATERIAL AND (II) WOULD LIKELY CAUSE COMPETITIVE HARM IF PUBLICLY DISCLOSED. THE CONFIDENTIAL INFORMATION IS DENOTED HEREIN BY [*****].\\n\\nZEBRAยฎ PARTNERCONNECT PROGRAM\\n\\nADDENDUM TO\\n\\nZEBRAยฎ PARTNERCONNECT DISTRIBUTOR AGREEMENT\\n\\nTHIS ADDENDUM (\"Addendum\") is made on the 4th day of February 2019 (\"Effective Date\") between the following parties: Zebra Technologies International, LLC, with an office at 3 Overlook Point, Lincolnshire IL 60069 (\"Zebra\");\\n\\nZebra Technologies do Brasil - Comรฉrcio de Produtos de Informรฅtica Ltda., a company incorporated and organized under the laws of Brazil, with offices at Av. Magalhรคes de Castro, 4800, sala 72-A, Cidade Jardim, CEP 05676-120, Sรคo Paulo, sp (\"Zebra Brazil\")\\n\\nXplore Technologies Corporation of America, a company with its principal place of business at 8601 RR 2222, Building 2, Suite #100, Austin, Texas 78730, U.S.A. (\"Xplore\");\\n\\n(collectively \"Zebra\")\\n\\nAND\\n\\nScanSource, Inc., a company incorporated in South Carolina, with its registered office at 6 Logue Court, Greenville, South Carolina 29615 (\"ScanSource\").\\n\\nScanSource Latin America, Inc. a ScanSource Affiliate incorporated in Florida, whose registered business address is 1935 NW 87 Avenue, Miami, Florida 33172 (\"ScanSource Latin America\")\\n\\nScanSource Brazil Distribuidora de Technologias, Ltda., a ScanSource Affiliate incorporated and organized under the laws of Brazil, with offices in the City of Sรคo Josรฉ dos Pinhais, State of Paranรฅ, at Avenida Rui Barbosa, 2529, Modulos 11 and 12, Bairro Jardim Ipรฉ, CEP: 83055-320, enrolled with the Taxpayer Register (CNPJ/MF) under No. 05.607.657/0001-35 (\"ScanSource Brazil\")\\n\\nSCANSOURCE DE MEXICO S. DE R.L. DE C.V., a ScanSource Affiliate incorporated in Mexico, whose registered business address is Calle 4 No. 298, Colonia Franccionamiento Industrial Alce Blanco, Naucalpan de Juarez, Estado de Mรฉxico 53370 (\"ScanSource Mexico\")\\n\\n(Collectively \"Distributor\\')\\n\\n\"Zebra\" and the \"Distributor\" are referred to collectively as \\'Parties\" and individually as a \"Party\".\\n\\nWHEREAS: (A) On February 12, 2014 the Parties entered into an agreement that was renamed, as of April 11, 2016, to: PartnerConnectTM EVM Distribution Agreement, (as amended) (\"Distribution Agreement\"), which relates to Zebra Enterprise Visibility and Mobility (\\'EVM\") products and services, and which, as acknowledged by the Parties by entering into this Amendment, is in full force and effect and valid as when this Amendment is executed;\\n\\n(B) Distributor purchases Products from Zebra under the Distributor Agreement;\\n\\n(C)\\u200b Zebra has recently completed the acquisition of Xplore, which transaction closed on August 14, 2018;\\n\\n(D) Zebra has expanded its products portfolio by adding the product families listed in Exhibit A, that as of the Effective Date hereof are branded Xplore or Motion Computing, thereto (\"Xplore Products\"); (E) Xplore, now a Zebra Affiliate, is the seller of Xplore Products;\\n\\nSource: SCANSOURCE, INC., 10-Q, 5/9/2019\\n\\n\\n\\n\\n\\n(F) Xplore wishes to sell Xplore Products to Distributor and Distributor wishes to purchase such products from Xplore pursuant to the terms and conditions of the Distributor Agreement by entering into this Addendum; and\\n\\n(G) The Parties desire to amend the Distributor Agreement by adding Xplore Products and authorizing Distributor to purchase such products from Xplore for further resale to members of the Zebra PartnerConnect Program in the Market or Territory. THEREFORE, in consideration of the mutual covenants and promises, and subject to the terms and conditions of the Distributor Agreement, the Parties agree as follows:\\n\\n1. Expressions used in this Addendum shall have the same meanings given to them in the Distributor Agreement, unless the context requires otherwise.\\n\\n2. This Addendum automatically incorporates any future amendments to the Distributor Agreement and such amendments will be made part of this Addendum ',\n",
              "    'Highlight the parts (if any) of this contract related to \"Effective Date\" that should be reviewed by a lawyer. Details: The date when the contract is effective\\xa0',\n",
              "    '4th day of February 2019',\n",
              "    459,\n",
              "    483),\n",
              "   ('Exhibit 10.4\\n\\n                              CO-BRANDING AGREEMENT\\n\\nThis Co-Branding Agreement (this \"Agreement\") dated September 30, 1999 (the \"Effective Date\") is entered into between VerticalNet, Inc., a Pennsylvania corporation having a principal place of business at 700 Dresher Road, Suite 100, Horsham, Pennsylvania, PA 19044 (\"VerticalNet\"), and PaperExchange.com, LLC, a Delaware limited liability company having a principal place of business at 545 Boylston Street, 8th Floor, Boston, MA 02116 (\"PaperExchange\"). In consideration of the mutual covenants herein, and intending to be legally bound hereby, the parties agree as follows:\\n\\n1. DEFINITIONS\\n\\n      1.1. Affiliate shall mean, when used with reference to a party, any individual or entity directly or indirectly controlling, controlled by or under common control with such party. For purposes of this definition, \"control\" means the direct or indirect ownership of at least 50% of the outstanding voting securities of a party, or the right to control the policy decisions of such party.\\n\\n      1.2. Career Center Net Revenue shall have the meaning ascribed thereto in Section 7.1.1  [Co-Branded Career Center].\\n\\n      1.3. Co-Branded Career Center shall mean the \"Career Center\" portion of Pulp and Paper Online located at: http://www.pulpandpaperonline.com/Content/CareerCenter/Home/JobScan_Home.asp (or a successor Site thereto).\\n\\n      1.4. Co-Branded Equipment Listings shall mean the \"Auctions\" portion of Pulp and Paper Online located at: http://www2.pulpandpaperonline.com/content/auctions/home.asp (or a successor Site thereto).\\n\\n      1.5. Co-Branded Sites shall mean the Co-Branded Career Center and the Co-Branded Equipment Listings.\\n\\n      1.6. Co-Branded URLs shall mean the mutually agreed-upon URLs which shall be registered jointly by VerticalNet and PaperExchange and shall route users through to the Co-Branded Sites.\\n\\n      1.7. Confidential Information shall mean all proprietary and confidential information of a party, including, without limitation, trade secrets, technical information, business information, sales information, customer and potential customer lists and identities, product sales plans, sublicense agreements, inventions, developments, discoveries, software, know-how, methods, techniques, formulae, data, processes and other trade secrets and proprietary ideas, whether or not protectable under patent, trademark, copyright or other areas of law, that the other party has access to or receives, but does not include information that (a) is or becomes publicly available through no fault of receiving party; (b) was already known to the receiving party at the time it was disclosed to the receiving party, as evidenced by written records of the receiving party; (c) is independently developed by employees of the receiving party who had no knowledge of or\\n\\n* Confidential Treatment Requested: material has been omitted and filed   separately with the Commission.\\n\\naccess to such information, as evidenced by written records of the receiving party; or (d) is received from a third party who is under no obligation of confidentiality to the disclosing party.\\n\\n      1.8. Equipment Listings Net Revenue shall have the meaning ascribed thereto in Section 7.1.2  [Co-Branded Equipment Listings].\\n\\n      1.9. Initial Term shall mean the Effective Date through the day prior to the fourth anniversary of the Effective Date, unless earlier terminated pursuant to Section 8.\\n\\n      1.10. Intellectual Property shall mean any and all trade secrets, patents, copyrights, trademarks, URLs, trade dress, brand features, know-how and similar rights of any type under the laws of any applicable governmental authority, including, without limitation, all applications and registrations relating to any of the foregoing.\\n\\n      1.11. Intellectual Property Rights shall mean all rights in and to Intellectual Property.\\n\\n      1.12. Link shall mean a link (including, but not limited to, a hyperlink, button or banner) that connects two Sites in a manner so that when a user clicks on the link, the user is tra',\n",
              "    'Highlight the parts (if any) of this contract related to \"Effective Date\" that should be reviewed by a lawyer. Details: The date when the contract is effective\\xa0',\n",
              "    'September 30, 1999',\n",
              "    119,\n",
              "    137),\n",
              "   ('1                                                                    EXHIBIT 10.13\\n\\n2\\n\\n                            BIOPURE CORPORATION                                 AGENCY AGREEMENT\\n\\n   This \"Agency\" Agreement is made as of March 29, 1999, by and between Biopure Corporation, a Delaware corporation (the \"Company\") and the Agent named on the signature page hereof (the \"Agent\").\\n\\n   WHEREAS, the Company is preparing to manufacture and sell Oxyglobin(R) brand veterinary products (\"Products\") enumerated on the Company\\'s veterinary products agency price list (Exhibit A)(as such list may be changed by the Company from time to time, the \"Price List\"); and\\n\\n   WHEREAS, the Agent and the Company wish to enter into an arrangement wherein the Agent would promote, sell, and collect payment for, such Products for the Company as a representative (\"Agent\") of the Company within the United States of America to duly licensed veterinarians (the \"Customers\") on the terms provided herein;\\n\\n   NOW, THEREFORE, in consideration of the premises and of the mutual promises and covenants contained herein, the parties hereby agree as follows:\\n\\n                      1. APPOINTMENT AND ACCEPTANCE.\\n\\n   1.1. Appointment. Subject to the terms and conditions of this Agreement, the Company hereby appoints the Agent, and the Agent hereby accepts appointment, as an authorized distributor agent within the Territory, (Territory as outlined in section 1.2), for the promotion, sale and collection of payment for, the Products to Customers. The Company has appointed a limited number of Agents; however, the Company retains the right to itself, and/or appoint others to, promote, sell, and collect payment for, and distribute, the Products to Customers in the Territory.\\n\\n   1.2. Territory. The Territory is defined as that geographical area in which said Agent is represented by a full time field sales representative, and of which assigned Distributor agrees to be responsible for mutually agreed upon quarterly and annual sales objectives as described in the \"Business Plan\". Compensation by the Company to the Agent will be limited to the area stated as follows:\\n\\n   The 48 Continental United States (including DC) plus Alaska    3\\n\\n                                    -2-\\n\\nNo compensation will be earned by the Agent for sales generated from customers in geographical areas not indicated in this section 1.2.\\n\\n   1.3. Business Plan. The Company and the Agent will jointly develop a written business plan for the promotion, distribution and sale of the Products to Customers in the Territory for each year (Nov 1 - Oct 31) during the term of this Agreement (a \"Contract Year\") and, on a nonbinding preliminary basis, for the next succeeding Contract Year (a \"Business Plan\"). Each Business Plan will include, among other things, sales and marketing strategies, advertising and promotion plans, financial projections (including projected sales, expenses and other customary items) and Agent performance criteria (including, but not limited to, market penetration, sales promotion execution, Product availability/accessibility and trade support). In the event of any conflict between this Agreement and a Business Plan, this Agreement will govern. The Business Plan relating to Contract Year ending Oct 31, 1999 will be agreed upon at least thirty (30) days after the Agent Launch Date (as defined below) or at a mutually agreed upon date and location. The Business Plan relating to all Contract Years thereafter will be agreed upon not less than sixty (60) days (or at a mutually agreed upon date and location) prior to the start of the Contract Year to which it relates. The Company and the Agent will negotiate the terms and conditions of each Business Plan in good faith, using their respective best efforts to agree upon such terms and conditions. The parties will review each then-current Business Plan quarterly and update such Business Plan from time to time as may be mutually agreed upon in writing. For purposes of this Agreement, \"Agent Launch Date\" means the date specified by the Company to the A',\n",
              "    'Highlight the parts (if any) of this contract related to \"Effective Date\" that should be reviewed by a lawyer. Details: The date when the contract is effective\\xa0',\n",
              "    'March 29, 1999',\n",
              "    226,\n",
              "    240),\n",
              "   ('1                                                                 EXHIBIT 10.17\\n\\n                       [MEDICAL MANAGER LETTERHEAD]\\n\\n              TECHNICAL INFRASTRUCTURE MAINTENANCE AGREEMENT\\n\\nDate:                           March 1, 1998\\n\\nContract No.:                   pr-4544\\n\\n                                 Between\\n\\nClient Name:                    MEDICAL MANAGER MIDWEST, INC.                                 53702 Generations Drive                                 South Bend, IN 46635 Principle Contact:              Tom Liddell\\n\\n                                   And\\n\\nCustomer Name:                  MTS, INC.                                 9931 Corporate Service Drive                                 Louisville, KY 40223 Principle Contact:              Gail Knopf\\n\\nANNUAL FEE.    [ ] Technical Support     Hours Maximum: [*]; If                    Retainer $[*]         support extends beyond [*] hours,                                          Support will be charged at [*] per                                          hour.\\n\\n[*].\\n\\nMEDICAL MANAGER, MIDWEST, INC., hereinafter referred to as \"MMMW\", hereby agrees to provide service with respect to the technical infrastructure and MTS, INC., hereinafter referred to as \"Customer\", agrees to accept such service, subject to the following terms and conditions:\\n\\nTHE ATTACHED TERMS AND CONDITIONS ARE PART OF THIS AGREEMENT. THIS AGREEMENT IS THE SOLE AND EXCLUSIVE AGREEMENT BETWEEN THE PARTIES RELATING TO SERVICES FOR THE ABOVE ITEMS. THE \"Customer\" HAS READ THIS AGREEMENT, UNDERSTANDS IT AND AGREES TO BE BOUND BY IT.\\n\\n                           TERMS AND CONDITIONS\\n\\n1. TECHNICAL INFRASTRUCTURE\\n\\n      (a)      Technical Infrastructure Maintenance Agreement covers                   applicable items that make up the underlying technical                   infrastructure that is required to run an application. This                   would include items such as hardware, operating system,                   network connections, etc.\\n\\n      (b)      Maintenance refers to the services involved in maintenance of                   equipment already purchased.\\n\\n      (c)      This Agreement shall be effective on the date of signed                   acceptance (\"Effective Date\") by MMMW.\\n\\n      (d)      Renewal agreement shall be effective on the \"Effective Date\"                   if it is signed and returned to MMMW by the \"Effective Date.\"\\n\\n      (e)      Renewal agreement not signed and received by MMMW by the                   \"Effective Date\" will suspend all coverage of technical                   infrastructure support between the \"Effective Date\" and the                   actual date of receival of the renewal technical                   infrastructure maintenance agreement. Services provided                   between these two dates are billable.\\n\\n[*] Confidential portions omitted and filed separately with the Securities and     Exchange Commission.\\n\\n2 2.  TERM\\n\\n (a)   MMMW provided Customer with an all inclusive warranty for a period of           12 months commencing on the date of installation to include system           purchased by Customer from MMMW. Upon expiration of that 12 months,           MMMW affords the Customer the opportunity of a continuation of support           on an annual basis as follows: The Initial Term of this Technical           Infrastructure Maintenance Agreement is twelve months, commencing on           the Effective Date. The support agreement will be subject to prior           inspection and acceptance of the hardware for service and to the           Customer\\'s payment of any charges for the inspection and/or the           pre-agreement servicing and repair of the hardware, such estimates to           be approved in advance by Customer.\\n\\n (b)   MMMW shall make two options of hardware support available to Customer:\\n\\n       TECHNICAL SUPPORT RETAINER is a Support Plan that allows the Customer\\n\\n\\n\\n\\n\\n       to pay a Retainer that provides technical Related Support by qualified           Support Analysts and Field Technicians. This Support Plan covers a 12',\n",
              "    'Highlight the parts (if any) of this contract related to \"Effective Date\" that should be reviewed by a lawyer. Details: The date when the contract is effective\\xa0',\n",
              "    'This Agreement shall be effective on the date of signed                   acceptance (\"Effective Date\") by MMMW.',\n",
              "    2147,\n",
              "    2259),\n",
              "   ('Exhibit 10.1\\n\\n\\n\\nOceanic Time Warner Cable and Watchit Media Content and License Agreement\\n\\nEffective Dates: September 1, 2006, August 31, 2007\\n\\nWatchit agrees to provide Oceanic Time Warner Cable the following content:\\n\\n- Watchit Gaming Guides - Lunchtime with Ira segments every week\\n\\nWatchit will provide the content on BetaSp format and reserves the right to modify the content to reflect sponsorship by an advertiser and advertisers.\\n\\nOceanic Time Warner Cable agrees to not edit or modify the above content.\\n\\nOceanic Time Warner Cable will use the content solely on channel 777, the Las Vegas channel.\\n\\nIn the event that Oceanic Time Warner Cable removes the above content and or terminates this agreement prior to December 31, 2006, Oceanic Time Warner Cable agrees to pay a cancellation fee of Five Thousand Dollars ($5,000) per month multiplied by the number of months remain on the agreement.\\n\\nWatchit shall have the exclusive right to sell third party advertising as sponsors of their content and will have the right to brand the content under the Watchit brand and place a \"bug\" on the screen identifying the content with a Watchit trademark.\\n\\nOceanic Time Warner Cable will include the following disclaimer on the Watchit Content: \"The materials shown are for entertainment purposes only and does not provide any guarantees of winning or improving your odds of winning on this program. The rules of the games as shown may not apply to all properties and may change from time to time.\"\\n\\nOcean Time Warner Cable will provide Watchit with data on viewership to both Channel 777 and specifically to the content provided by Watchit.\\n\\nOcean Time Warner Cable will be able to not include any content that it deems inappropriate or distasteful.\\n\\nThis agreement will be in effect until the end of 2006 and will be evaluated at that time.\\n\\nBoth parties agree to discuss use of information gathered form this arrangement before using it in any kind of promotional or public message.\\n\\nAccepted by:\\n\\n            Oceanic Time Warner Cable/Date\\n\\nWatchit Media/Date\\n\\nSource: WATCHIT MEDIA, INC., 8-K, 12/1/2006',\n",
              "    'Highlight the parts (if any) of this contract related to \"Effective Date\" that should be reviewed by a lawyer. Details: The date when the contract is effective\\xa0',\n",
              "    'Effective Dates: September 1, 2006, August 31, 2007',\n",
              "    91,\n",
              "    142),\n",
              "   ('EXHIBIT 10.25                                RESELLER AGREEMENT\\n\\nTHIS AGREEMENT (the \"AGREEMENT\") entered into as of the 19 day of March, 2004 (the \"EFFECTIVE DATE\") provides the terms and conditions under which MediaNet Group Technologies, Inc., a Nevada corporation having an address at 5100 W. Copans Road Suite 710 Margate, FL 33063 USA (\"MEDIANET GROUP TECHNOLOGIES\"), authorizes International Direct Response, Inc., a Pennsylvania Corporation, having an address at 1125 Lancaster Avenue, Berwyn, PA 19312(\"RESELLER\") to be its true and lawful representative and agent for the purpose of reselling licenses of the MediaNet Group Technologies Portals (\"PORTALS\") and other MediaNet Group Technologies products and services in accordance with the terms and conditions contained in this Agreement. This Agreement, together with the other agreements and schedules referenced in it, contains the complete terms and conditions between the parties.\\n\\nMEDIANET GROUP TECHNOLOGIES AND RESELLER AGREE AS FOLLOWS:\\n\\n1.   LICENSE\\n\\nReseller is hereunder licensed to market MediaNet Group Technologies\\' Brand-A-Port portals (\"PORTALS\") and to resell MediaNet Group Technologies products and services for compensation in accordance with the annexed \"RESELLING SCHEDULE.\" Under the terms and conditions as outlined in this Agreement.\\n\\n2.   RESELLING\\n\\nThe Reseller intends to market the Portals to companies and various businesses and individuals (\"BUYERS\") who may include corporations, small businesses, religious organizations, network marketing, franchise, business opportunities, chains, charities, organizations and other companies that would have a use for individual and multiple portals. The purpose of this Agreement is to define the scope of compensation for the marketing of Portals to these potential customers. During the Term of this Agreement, Reseller shall have the right to market Brand-A-Port Portals, both through the existing Brand-A-Port Portal under the License and independently to Buyers for resale, subject to approval by MediaNet Group Technologies.\\n\\n3.   COMPENSATION\\n\\nMediaNet Group Technologies shall pay Reseller a fee in accordance with the annexed Fee Schedule. MediaNet Group Technologies will remit payment as directed by Reseller in the time frames noted on the Compensation Schedule attached hereto.\\n\\n4.   PUBLICITY AND ADVERTISING\\n\\nSubject to Section 7, Reseller and MediaNet Group Technologies agree that broad publicity with respect to the relationship developed by this Agreement, and the advantages of such relationship, will be permitted and actively encouraged and supported by both parties. This publicity initiative will include, but is not limited to, a press releases issued by Reseller and MediaNet Group Technologies, publicizing the strategic alliance between the parties, on site promotion and email campaigns. In this regard, Reseller and MediaNet Group Technologies shall agree on the form, content of the press release prior to its release. MediaNet Group Technologies must approve any advertising prior to issuance and placement.\\n\\n5.   PROPRIETARY RIGHTS\\n\\n5.1 OWNERSHIP. RESELLER understands and agrees that MediaNet Group      Technologies is the exclusive holder of and shall retain, all right, title      and interest in and to the Portal, Content and Engine and the All Pages,      including without limitation all intellectual Property therein site      (EXCLUDING PROPRIETARY PAGES PROVIDED BY RESELLER OR BUYERS).\\n\\nReseller Agreement                                     Initials ______   _______                                        1\\n\\n5.2 INTELLECTUAL PROPERTY. Nothing herein shall grant a party any right,      title or interest in the other party\\'s Intellectual Property, except as      explicitly set forth herein. At no time during or after the Term of this      Agreement shall a party challenge or assist others to challenge the other      party\\'s Intellectual Property or the registration thereof or attempt to      register any trademarks, marks or trade names confusingly similar to those      or the other party.\\n\\n5.3 INTELLECTUAL P',\n",
              "    'Highlight the parts (if any) of this contract related to \"Effective Date\" that should be reviewed by a lawyer. Details: The date when the contract is effective\\xa0',\n",
              "    '19 day of March, 2004',\n",
              "    121,\n",
              "    142),\n",
              "   ('ENDORSEMENT LICENSING AND CO-BRANDING AGREEMENT   This ENDORSEMENT LICENSING AND CO-BRANDING AGREEMENT is entered into on July 26, 2013 (the \"Effective Date\") by and between Marine MP, LLC (\"Lender\"), for services of Arnold Schwarzenegger (\"Endorser\"), and Fitness Publications, Inc. (\"Fitness\") (collectively, Lender, Endorser, and Fitness are referred to as the \"AS Parties\") and MusclePharm Corporation with its principal place of business in Denver, Colorado and its subsidiaries, (collectively, \"MusclePharm\" or the \"Company\").   RECITALS   WHEREAS, the AS Parties have the rights necessary to license the use of the rights of publicity with respect to name, voice, approved signature, approved photographs, approved images, and approved likenesses of Arnold Schwarzenegger (the \"Name and Appearance Rights\") and the use of the Name and Appearance Rights as trademarks or service marks (the \"Trademarks\"); and   WHEREAS, MusclePharm is engaged in the business of developing and marketing nutritional products for athletes and fitness enthusiasts, and   WHEREAS, MusclePharm from time to time uses consumer, celebrity, and expert endorsements or testimonials to promote MusclePharm Products (as defined in Section 2(b) of this Agreement) in marketing and advertising materials, and   WHEREAS, MusclePharm desires to develop, market, promote and sell in conjunction and in cooperation with the Endorser a unique Arnold Schwarzenegger customized product line approved by the Endorser initially comprised of between four to eight (4 to 8) products, subject to Section 2(b) below), that will be marketed and advertised under the Endorser\\'s name and likeness, all subject to the Endorser\\'s approval, as described in Section 12, (the \"AS Product Line\"); and   WHEREAS, MusclePharm desires to engage Endorser, and Endorser desires to accept the engagement, as more fully described in this Agreement, whereby Endorser will lend his name, reputation, and appearance to (i) endorse and promote MusclePharm and its Products and (ii) to develop the AS Product Line and several related promotional giveaway items that will depict the Endorser\\'s name and likeness solely in conjunction with the MusclePharm logo or images of the AS Product Line on the permitted promotional products (the \"Promotional Products\") set forth on Exhibit A attached hereto, as may be amended in writing by the parties hereto from time to time (collectively, the Promotional Products and the AS Product Line are referred to as the \"Licensed Products\").   NOW, THEREFORE, in consideration of the mutual promises and agreements set forth below, the parties agree as follows:\\n\\n\\n\\nSource: MUSCLEPHARM CORP, 10-K/A, 2/8/2017\\n\\n\\n\\n\\n\\n\\n\\n  1. Term:   (a) This Agreement shall have an Initial Term of three (3) years. The Term shall commence on July 23, 2013 and shall expire on July 22, 2016, unless otherwise terminated earlier pursuant to Section 9 of this Agreement. The period from July 23, 2013 to July 22, 2014 shall be referred to as the \"First Contract Year\". The period from July 23, 2014 to July 22, 2015 shall be referred to as the \"Second Contract Year\". The period from July 23, 2015 to July 22, 2016 shall be referred to as the \"Third Contract Year\".   (b) In the event that MusclePharm shall achieve Net Sales (as defined below) of $20 million (the \"First Renewal Threshold\") in the aggregate during the Third Contract Year, then this Agreement shall automatically be renewed for an additional term of three (3) years (the \"First Additional Term\") on the same terms and conditions for the Initial Term except that: (i) no additional Stock Compensation (as defined below) shall be issued in connection with the renewal Term, (ii) the Cash Compensation for the First Additional Term shall be as set forth in Section 7 and Exhibit \"C\" Section (2) attached hereto, (iii) Endorser shall only be obligated to make two (2) Appearances in each Contract Year during the First Additional Term pursuant to Section 4(a)(ii) below and (iv) the marketing budget to promote the Licensed Products shall be $5.0 million during each Contract Ye',\n",
              "    'Highlight the parts (if any) of this contract related to \"Effective Date\" that should be reviewed by a lawyer. Details: The date when the contract is effective\\xa0',\n",
              "    'July 26, 2013',\n",
              "    122,\n",
              "    135),\n",
              "   ('Exhibit 10.12 Certain identified information has been excluded because it is both not material and would likely cause competitive harm if publicly disclosed.\\n\\nMaster Service Agreement This Master Service Agreement (\"Agreement\"), entered into on May 25th, 2018 by and between CRO Consulting (Pty) Limited, whose Registered Office is at OnQ House 250 Market Street Fairland Johannesburg 2170 South Africa (hereinafter referred to as \"CRO\") and Purinix Pharmaceuticals LLC whose Registered Office is at 1266 East Main Street, Suite 700R, Stamford, CT 06902, USA (hereinafter referred to as \"Client\"). 1.0 Services 1.1. Client requires CRO to carry out Clinical Research Services in South Africa (\"Services\"). CRO will carry out the tasks agreed and summarised in the Addenda to this Master Service Agreement. 1.2. This Agreement forms the basis for a working relationship between Client and CRO. This Agreement will be supplemented, in the form of Project-specific Addenda, as the need arises. The Project-specific Addenda will contain the detailed requirements of each Project for which Services are contracted to CRO by Client and all fees to be paid by Client. 1.3. Client will provide CRO with the documents and information necessary as requested by CRO for the conduct of the Services. 1.4. CRO agrees to perform the specific tasks set forth in the Project-specific Addenda in a professional manner, in strict accordance with the terms and conditions contained herein, relevant professional standards including in accordance with the Protocol and applicable amendments and ICH GCP Guidelines (ICH Harmonised Tripartite Guideline for Good Clinical Practice, May 1996) and all other relevant laws, rules, regulations and guidelines. 1.5. CRO agrees to perform these Services according to CRO\\'s Standard Operating Procedures (SOPs) or other guidelines as provided, which are provided to Client on request. 1.6 CRO may not subcontract any parts of the Services to a third party without the prior written approval of Client, which approval shall not unreasonably be withheld. CRO will remain fully liable for the acts and omissions of its employees and approved subcontractors as if performed by CRO. 1.7 CRO will provide Client with a weekly written report summarizing the Services including all clinical study activity and any other information reasonably requested by Client. 2.0 Payment 2.1 Client will pay CRO for satisfactory performance of Services as agreed in each Project-specific Addendum to this Agreement. Confidential Page 1 of 7 Initials: CL MD Version Jan16_v1\\n\\n\\n\\n\\n\\nCertain identified information has been excluded because it is both not material and would likely cause competitive harm if publicly disclosed. 2.2 Routine telephone calls, mobile calls, faxes and photocopying will be included in the rate provided by CRO. For clarity, there shall be no payment obligations other than as agreed in each Project-specific Addendum. 2.4 CRO will provide a detailed account of all time and tasks, as against project specific task and time addenda, and will be payable within 30 days of receipt of invoice by Client. 2.5. Changes in scope may be incorporated into this Agreement or the Project-specific Addenda upon the written consent of both parties. 2.6. In the event of a conflict between the terms of this Agreement and the Project-specific Addenda the terms of this Agreement shall prevail unless specifically stated in the Project-specific Addenda. 3.0 Period of the Agreement 3.1. This Agreement shall take effect on the date of signature of the Agreement by both parties and shall terminate when all obligations required of both parties hereunder are performed unless either terminated earlier or extended by the parties pursuant to the terms of this Agreement subject to clause 4.0. 4.0 Termination 4.1. Either party may terminate this Agreement on thirty (30) days written notice if the other materially breaches this Agreement; provided, however that the party in breach shall have the right to cure such breach within thirty (30) days after receipt of written notice of the ot',\n",
              "    'Highlight the parts (if any) of this contract related to \"Effective Date\" that should be reviewed by a lawyer. Details: The date when the contract is effective\\xa0',\n",
              "    'This Agreement shall take effect on the date of signature of the Agreement by both parties and shall terminate when all obligations required of both parties hereunder are performed unless either terminated earlier or extended by the parties pursuant to the terms of this Agreement subject to clause 4.0.',\n",
              "    3496,\n",
              "    3799),\n",
              "   ('Exhibit 10.4 CONSULTING AGREEMENT This Consulting Agreement (\"Agreement\") is made and entered into as of May 1, 2019 (\"Effective Date\") by and between Driven Deliveries, Inc. (\"Company\"), a Nevada corporation, and TruckThat LLC (\"Consultant\"). Company and Consultant shall sometimes be referred to herein singularly as a \"Party\" or collectively as the \"Parties\" to this Agreement. WHEREAS, the Company desires to retain Consultant as an independent contractor to perform consulting services for the Company, and Consultant is willing to perform such services on the terms set forth below. In consideration of the mutual promises contained here, the Parties hereby agree as follows: 1. Services and Compensation. 1.1. Services. Consultant shall perform the following services: - The Consultant will provide the Company services as a Strategic Marketing & Fundraising Consultant. - The Consultant shall be responsible for the strategic planning of business expansion, including Fundraising and Stock Promotion, of the Company and its subsidiaries. - These Services shall include Marketing guidance and support, not limited to: โ Graphics โ Web โ Social โ Brand - These Services will include updates to investor decks, customer sales decks and other marketing material available to the public - The Company will provide the Consultant with the appropriate level of resources and information to perform such duties, and the Consultant shall be reimbursed for fees and expenses approved by the Company. - The Consultant will report directly to the CEO of the and will keep the CEO informed of all matters concerning the Services as requested by the CEO from time to time. - The Consultant acknowledges that he may be required to travel in order to provide the Services. 1.2 Compensation. The Company shall pay Consultant a flat fee consulting rate of $18,000 per month. 1.3 Expenses. The Company shall reimburse Consultant, in accordance with Company policy, for all reasonable expenses incurred by Consultant in performing the Services pursuant to this Agreement, but only if Consultant receives written consent from an authorized agent of the Company prior to incurring such expenses and submits receipts for such expenses to the Company in accordance with the Company\\'s general expense reimbursement policies.\\n\\nTruckThat LLC Consulting Agreement Page 1 of 7\\n\\n\\n\\n\\n\\n2. Confidentiality. 2.1. Definition of Confidential Information. \"Confidential Information\" means any nonpublic information that relates to the actual or anticipated business and/or products, research or development of the Company, its affiliates or subsidiaries, or to the Company\\'s, its affiliates\\' or subsidiaries\\' technical data, trade secrets, or know-how, including, but not limited to, research, product plans, or other information regarding the Company\\'s, its affiliates\\' or subsidiaries\\' products or services and markets therefore, customer lists and customers (including, but not limited to, customers of the Company on whom Consultant called or with whom Consultant became acquainted during the term of this Agreement), software, developments, inventions, processes, formulas, technology, designs, drawings, engineering, hardware configuration information, marketing, finances, and other business information disclosed by the Company, its affiliates or subsidiaries, either directly or indirectly, in writing, orally or by drawings or inspection of premises, parts, equipment, or other property of Company, its affiliates or subsidiaries. Notwithstanding the foregoing, Confidential Information shall not include any such information which Consultant can establish (i) was publicly known or made generally available prior to the time of disclosure to Consultant; (ii) becomes publicly known or made generally available after disclosure to Consultant through no wrongful action or inaction of Consultant; or (iii) is in the rightful possession of Consultant, without confidentiality obligations, at the time of disclosure as shown by Consultant\\'s then-contemporaneous written records. 2.2. Nonuse and Nondisclosure. During an',\n",
              "    'Highlight the parts (if any) of this contract related to \"Effective Date\" that should be reviewed by a lawyer. Details: The date when the contract is effective\\xa0',\n",
              "    'May 1, 2019',\n",
              "    105,\n",
              "    116),\n",
              "   ('EXHIBIT 10.15\\n\\n                      SPONSORSHIP AND DEVELOPMENT AGREEMENT\\n\\n      This Agreement is made as of August 6, 2004 (the \"Effective Date\") by and between TEKNIK DIGITAL ARTS INC., a Nevada corporation with offices at 7377 E. Doubletree Ranch Road, Suite 270, Scottsdale, Arizona 85258 (\"TDA\") and RICK SMITH ENTERPRISES (\"Smith\"), c/o GAYLORD SPORTS MANAGEMENT, 14646 N. Kierland Blvd., Suite 230, Scottsdale, Arizona 85254 Attention: Steve Loy.\\n\\n                                    RECITALS\\n\\n      TDA is in the business of developing and publishing interactive entertainment software products. TDA desires to have Smith assist in the development, endorsement and publicizing of TDA\\'s golf instruction related software products.\\n\\n      THEREFORE, TDA and Smith agree as follows:\\n\\n1.    DEVELOPMENT, PRODUCTION, COMMERCIAL AND PUBLICITY SERVICES\\n\\n      1.1 General. Smith agrees to cooperate, consult with and aid TDA in connection with the development of TDA\\'s \"Golf Instruction Related Product\" (hereinafter defined) and the advertising, marketing and publicity thereof. As used herein, the term \"Golf Instruction Related Product\" shall mean any interactive entertainment software product related to golf instruction which is produced and released during the \"Term\" (hereinafter defined in Section 5.1) and which may be published in multiple versions (e.g., versions for play on handheld mobile devices (including cell phones), for sale in any and all territories.\\n\\n2.    GRANT OF RIGHTS; COOPERATIONS\\n\\n      2.1 Publicity Rights. Smith hereby grants to TDA the following rights (the \"Rights\"):\\n\\n            (a) the right to use and reuse Smith\\'s name, voice, likeness,       facsimile signature, personal statistics, biographical information and any       reproduction or simulation thereof (\"Smith\\'s Likeness\") in TDA\\'s Golf       Instruction Related Products and on packaging for TDA\\'s Golf Instruction       Related Products in any fashion, said grant of rights being limited to the       world (the \"Contract Territory\")\";\\n\\n            (b) the right to use and reuse Smith\\'s Likeness in TDA\\'s general       internal, non-public corporate promotional materials (such as TDA\\'s Annual       Report), corporate advertising and in other forms of publicity;\\n\\n            (c) the right to use and reuse Smith\\'s Likeness in and in connection       with the marketing, advertising, promoting and publicizing of TDA\\'s Golf       Instruction Related Products, by any and all means now known or hereafter       developed;\\n\\n            (d) the exclusive right to use and reuse the results and proceeds of       the in connection with TDA\\'s Golf Instruction Related Products; and\\n\\n            (e) with Smith\\'s prior reasonable approval, the right to license to       third parties any of the foregoing rights but only in connection with or       directly related to the marketing and sale of TDA\\'s Golf Instruction       Related Products.\\n\\nSmith agrees to cooperate in good faith with TDA in connection with TDA\\'s exercise of the Rights in accordance with the terms of this Agreement.\\n\\n      2.2 Limitations of License\\n\\n            (a) The Rights granted in Section 2.1 above will only be used by TDA       in connection with its Golf Instruction Related Products. TDA does not       have the right to use the Rights in any product whatsoever released before       or after the Term.\\n\\n            (b) TDA shall not utilize Smith\\'s Likeness in a manner that would       constitute an endorsement of any product or service other than TDA\\'s Golf       Instruction Related Products.\\n\\n                                       1\\n\\n      2.3 Smith as Featured Swing Instructor. TDA agrees that Smith will be the featured Instructor on all packaging of, and promotional materials related to, TDA\\'s Golf Instruction Related Product.\\n\\n      2.4 No Obligation to Use. Except as set forth in Section 2.3 above, the payment to Smith of the sums required under this Agreement shall fully discharge all obligations of TDA to use Smith\\'s Likeness under this Agreement.\\n\\n      2.5 Approvals. TDA agrees that no us',\n",
              "    'Highlight the parts (if any) of this contract related to \"Effective Date\" that should be reviewed by a lawyer. Details: The date when the contract is effective\\xa0',\n",
              "    'August 6, 2004',\n",
              "    111,\n",
              "    125),\n",
              "   ('CELEBRITY ENDORSEMENT AGREEMENT     THIS AGREEMENT is made as of this March 14, 2012 but effective as of March 1, 2012 (\"Effective Date\") by and between Bizzingo, Inc., a Nevada  corporation with offices at 63 Main Street, Suite 202, Flemington, NJ 08822 (\"Bizzingo\") and Joseph Theismann, an individual whose address is 21495  Ridgetop Circle, Suite 304A, Sterling Virginia 20166 (\"Theismann\") (collectively the \"Parties\").     WITNESSETH:     WHEREAS, Theismann is recognized and widely known throughout the world as a retired, hall of fame professional athlete, and sports celebrity; and     WHEREAS, Theismann\\'s name, by virtue of his ability and experience, has acquired a meaning in the mind of the purchasing public important to the  advertising, promotion, and sale of services and merchandise; and     WHEREAS, Bizzingo has developed a B2B interactive platform which engages in business social media including mobile and Internet applications  (\"Network\"); and     WHEREAS, Bizzingo is desirous of acquiring the rights to utilize Theismann\\'s name in connection with the advertisement, promotion, and sale of the  Network as provided herein and Theismann is willing to grant such right     NOW, THEREFORE, in consideration of the mutual covenants set forth herein and for other good and valuable consideration, it is agreed as  follows:     1. GRANT OF RIGHTS. Subject to the terms and conditions set forth herein, Theismann hereby grants to Bizzingo and its affiliates the unlimited  right and privilege during the Term (as defined herein) and within the Territory to use the Property (as defined herein) in connection with the  advertisement, promotion, and sale of the Network in the Territory whether through film, television, radio, print and Internet media, including the right to use  the Property in or on the Network. It being understood and agreed that Bizzingo shall have the right to exhibit commercials, infomercials, advertisements and  otherwise make use of all Property on a worldwide basis and that Bizzingo and its affiliates shall be the sole owner of all commercials, promotional materials and  other items produced or created hereunder and all related rights worldwide, including, without limitation, copyright, trademark and intellectual property rights,  subject however to the terms and conditions herein. Theismann agrees to cooperate with Bizzzingo\\'s promotional efforts in this regard. In addition, as  reasonably requested by Bizzingo, Theismann agrees to provide Bizzingo with such signatures, photographs and the like in order to fulfill his obligations  hereunder.\\n\\n1\\n\\nSource: BIZZINGO, INC., 8-K, 3/22/2012\\n\\n\\n\\n\\n\\n   Bizzingo agrees that any use of the Property for advertising, promotional or sale purposes will be approved in advance by Theismann. Theismann  agrees that such material, submitted for approval as provided herein may be deemed by Bizzingo to have been approved hereunder if the same is  not disapproved by the Theismann in writing within fourteen (14) days after Theismann\\'s receipt thereof. Theismann agrees that any material  submitted hereunder will not be unreasonably disapproved and, if it is disapproved, that Theismann shall advise Bizzingo in writing of the specific  grounds therefor at the time of disapproval and provide Bizzingo with specific changes or alterations to such materials. Bizzingo thereafter shall  have the right and privileged to use such Property as provided in this Agreement subject to such changes or alterations.     Except as stated herein, no other rights or privileges are granted to Bizzingo by Theismann.     \"Property\" as stated herein shall mean Theismann\\'s name (including \"Joe Theismann\", \"Theismann\" \"J. Theismann\"), nicknames, initials,  autograph, facsimile signature, photograph, image, likeness, voice, video portrayals, biographical data, character, symbols, and/or other  endorsement, and any variations or deviations thereof.     \"Territory\" as stated herein shall mean worldwide.     2. TERM. Unless sooner terminated under the provisions hereof, this Agreement shall commence on the Effect',\n",
              "    'Highlight the parts (if any) of this contract related to \"Effective Date\" that should be reviewed by a lawyer. Details: The date when the contract is effective\\xa0',\n",
              "    'March 1, 2012',\n",
              "    105,\n",
              "    118),\n",
              "   ('Exhibit 4.5 SUPPLY AGREEMENT between PROFOUND MEDICAL INC. and PHILIPS MEDICAL SYSTEMS NEDERLAND B.V.\\n\\n\\n\\n\\n\\nTHIS AGREEMENT is made July 31, 2017 BETWEEN: PROFOUND MEDICAL INC., a company incorporated under the laws of the province of Ontario and having its registered address at 2400 Skymark, Unit 6, Mississauga, Ontario L4W 5K5, Canada (hereinafter referred to as \"Customer\") - and - PHILIPS MEDICAL SYSTEMS NEDERLAND B.V., a company incorporated under the laws of the Netherlands with its principal place of business at Veenpluis 4-6 5684 PC Best, the Netherlands (hereinafter referred to as \"Philips\") Customer and Philips hereinafter also collectively referred to as the \"Parties\" and individually as a \"Party\". WHEREAS: A. Pursuant to the Asset and Share Purchase Agreement (the \"Purchase Agreement\") entered into on June 30, 2017 by Customer, Koninklijke Philips NV (\"Philips NV\") N.V. and Customer agreed to execute and deliver (or cause to be executed and delivered) certain ancillary agreements one of which is this Agreement; B. Prior to the consummation of the transactions contemplated by the Purchase Agreement, Philips manufactured the Product in-house and did not outsource the manufacturing to an independent facility, and as a result, Philips has intimate knowledge of the manufacturing process and requirements for the Product; C. Customer originally desired to take over responsibility for the manufacture of the Product immediately upon closing of the transactions contemplated by the Purchase Agreement; D. As Philips historically manufactured the Product in-house, to enable Customer to prepare for and realize the transition of the manufacturing of the Product to Customer\\'s organization, Customer requires the assistance of Philips to continue manufacturing the Product until such time as the manufacturing process can be transitioned to Customer hereunder; E. Until such time as the manufacturing of the Product can be transitioned to Customer in accordance with the terms of this Agreement, Philips agrees to supply, as a contract manufacturer to Customer, on a temporary basis for the Term (as defined herein), the Product, and Customer wishes to buy such Products from Philips under this Agreement;\\n\\n\\n\\n\\n\\nF. Customer acknowledges and agrees that it assumes all obligations and liabilities as the legal manufacturer of the Product as from the Effective Date, on the terms and conditions set out in this Agreement. NOW IT IS HEREBY AGREED as follows: 1. DEFINITIONS The following terms used in this Agreement shall have the meaning set forth below: \"Affiliate\" means, with respect to any Person, any other Person that directly, or indirectly through one or more intermediaries, controls, is controlled by or is under common control with the specified Person. As used in this definition, \"control\", \"controlled by\" and \"under common control with\" means possession, directly or indirectly, of power to direct or cause the direction of management or policies of such Person (whether through ownership of securities or other partnership or ownership interests, as trustee, personal representative or executive or by contract, credit agreement or otherwise), provided that in any event, any Person which owns directly, indirectly or beneficially 50% or more of the securities having voting power for the election of directors or other governing body of a corporation or 50% or more of the partnership interests or other ownership interests of any other Person will be deemed to control such Person. \"Agreement\" means this Supply Agreement including any and all of its Schedules as attached hereto and as may be amended or supplemented from time to time in accordance with the provisions hereof. \"Business Day\" means any day other than a Saturday, Sunday or statutory holiday, in the Province of Ontario or the Netherlands. \"Claim\" means any claim, action, cause of action, demand, lawsuit, arbitration, inquiry, audit, notice of violation, proceeding, litigation, citation, summons, subpoena or investigation of any nature, civil, criminal, administrative, regulatory or other',\n",
              "    'Highlight the parts (if any) of this contract related to \"Effective Date\" that should be reviewed by a lawyer. Details: The date when the contract is effective\\xa0',\n",
              "    'July 31, 2017',\n",
              "    130,\n",
              "    143),\n",
              "   (\"Exhibit 10.14(a)\\n\\nSECOND AMENDED AND RESTATED  EXCLUSIVE AGENCY AND  MARKETING AGREEMENT by and between MONSANTO COMPANY\\n\\nand\\n\\nTHE SCOTTS COMPANY LLC  Effective as of September 30, 1998\\n\\n\\n\\n\\n\\nTABLE OF CONTENTS\\n\\nArticle 1 - DEFINITIONS AND RULES OF CONSTRUCTION 1\\n\\n Section 1.1 Definitions 1\\n\\n Section 1.2 Rules of Construction and Interpretation 9\\n\\nArticle 2 - EXCLUSIVE AGENCY AND DISTRIBUTORSHIP 9\\n\\n Section 2.1 Appointment of the Exclusive Agent 9\\n\\n Section 2.2 The Agent's Obligations and Standards 10\\n\\n Section 2.3 Appointment of Sub-Agents and Sub-Distributors 13\\n\\n Section 2.4 Limitations on Agent 13\\n\\n Section 2.5 Changes to Markets 13\\n\\n Section 2.6 Scotts Miracle-Gro Sale Procedures 15\\n\\n Section 2.7 Compliance 15\\n\\nArticle 3 - ACCOUNTING AND CASH FLOW FOR THE ROUNDUP L&G BUSINESS 17\\n\\n Section 3.1 Bookkeeping and Financial Reporting 17\\n\\n Section 3.2 Ordering, Invoicing and Cash Flow Cycle 18\\n\\n Section 3.3 Expenses and Allocation Rules 19\\n\\n Section 3.4 Resolution of Disputes Arising under Article 3 20\\n\\n Section 3.5 Fixed Contribution to Expenses 20\\n\\n Section 3.6 Commission 20\\n\\n Section 3.7 [Intentionally deleted] 21\\n\\n Section 3.8 Additional Commission 21\\n\\nArticle 4 - ROUNDUP L&G BUSINESS MANAGEMENT STRUCTURE 23\\n\\n Section 4.1 Underlying principles for the Roundup L&G Business Management Structure. 23\\n\\n Section 4.2 Steering Committee 23\\n\\n Section 4.3 Business Units 25\\n\\n Section 4.4 Global Support Team 25\\n\\nArticle 5 - DUTIES AND OBLIGATIONS OF MONSANTO 26\\n\\n Section 5.1 Monsanto's Obligations and Rights 26\\n\\n Section 5.2 Warranties 27\\n\\nArticle 6 - REPORTS AND ADDITIONAL OBLIGATIONS OF THE PARTIES 27\\n\\n Section 6.1 Cooperation 27\\n\\n Section 6.2 Use of EDI 27\\n\\nii\\n\\n\\n\\n\\n\\n Section 6.3 The Agent's Systems and Reporting Obligation 27\\n\\n Section 6.4 Employee Incentives 28\\n\\n Section 6.5 Insurance 28\\n\\n Section 6.6 Liens 28\\n\\n Section 6.7 Promoting Safe Use-Practices 29\\n\\n Section 6.8 Monsanto Inspection Rights 29\\n\\n Section 6.9 Recalls 29\\n\\n Section 6.10 New Roundup Products 29\\n\\n Section 6.11 Additional Roundup Products 32\\n\\n Section 6.12 Confidentiality 34\\n\\n Section 6.13 Noncompetition 35\\n\\n Section 6.14 Industrial Property 37\\n\\n Section 6.15 Conflicts of Interest 38\\n\\n Section 6.16 Records Retention 39\\n\\n Section 6.17 Additional Covenant of the Agent 39\\n\\n Section 6.18 Roundup Telephone Number 39\\n\\n Section 6.19 Additional Obligations 39\\n\\nArticle 7 - [Reserved] 39\\n\\nArticle 8 - REPRESENTATIONS, WARRANTIES, AND COVENANTS 39\\n\\n Section 8.1 The Agent's Representations and Warranties 39\\n\\n Section 8.2 Monsanto's Representations and Warranties 40\\n\\nArticle 9 - INDEMNIFICATION 41\\n\\n Section 9.1 Indemnification and Claims Procedures 41\\n\\nArticle 10 - TERMS, TERMINATION, AND FORCE MAJEURE 42\\n\\n Section 10.1 Terms 42\\n\\n Section 10.2 [Reserved] 42\\n\\n Section 10.3 [Reserved] 42\\n\\n Section 10.4 Termination by Monsanto 42\\n\\n Section 10.5 Termination by the Agent 47\\n\\n Section 10.6 Roundup Sale 50\\n\\n Section 10.7 Effect of Termination 52\\n\\n Section 10.8 Force Majeure 53\\n\\niii\\n\\n\\n\\n\\n\\n Section 10.9 [Intentionally deleted] 53\\n\\nArticle 11 - MISCELLANEOUS 53\\n\\n Section 11.1 Relationship of the Parties 53\\n\\n Section 11.2 Interpretation in accordance with GAAP 54\\n\\n Section 11.3 Currency 54\\n\\n Section 11.4 Monsanto Obligations 54\\n\\n Section 11.5 Expenses 54\\n\\n Section 11.6 Entire Agreement 54\\n\\n Section 11.7 Modification and Waiver 55\\n\\n Section 11.8 Assignment 55\\n\\n Section 11.9 Notices 56\\n\\n Section 11.10 Severability 57\\n\\n Section 11.11 Equal Opportunity 57\\n\\n Section 11.12 Governing Law 58\\n\\n Section 11.13 Public Announcements 58\\n\\n Section 11.14 Counterparts 59\\n\\nLIST OF EXHIBITS  Exhibit D: Permitted Products LIST OF SCHEDULES    Schedule 1.1(a): Activated Included Markets  Schedule 1.1(b): Roundup Products  Schedule 2.2(a): Annual Business Plan Template  Schedule 3.2 (d): Form of Reconciliation Statement  Schedule 3.3(c): Income Statement Definitions and Allocation Methods  Schedule 4.2 (a): Steering Committee  Schedule 6.11(a): Additional Roundup Products  Schedule 6.11(f): Additional Roundup Products Trademarks\\n\\niv\\n\\n\\n\\n\\n\\nSECOND AMENDED AND RESTATED  EXCLUSIVE AGENCY AND  MARKETING AGREEMENT\\n\\nTHI\",\n",
              "    'Highlight the parts (if any) of this contract related to \"Effective Date\" that should be reviewed by a lawyer. Details: The date when the contract is effective\\xa0',\n",
              "    'September 30, 1998',\n",
              "    167,\n",
              "    185),\n",
              "   ('Exhibit 10.1\\n\\nCERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY BRACKETED ASTERISKS [***], HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO RULE 24B-2 OF THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED. SUPPLY AGREEMENT\\n\\nTHIS SUPPLY AGREEMENT (\"Agreement\") is entered into as of this 15th day of May, 2013 (the \"Effective Date\") by and between Integra LifeSciences Corporation (\"Integra\"), a Delaware corporation with offices at 311 Enterprise Drive, Plainsboro, New Jersey 08536, and PcoMed, LLC (\"PcoMed\"), a Colorado limited liability company with offices at 105 S. Sunset Street, Longmont, Colorado 80501.\\n\\nRECITALS:\\n\\nWHEREAS, Integra is a medical device company that is developing and commercializing implantable spinal medical devices and procedures in the field of spinal surgery;\\n\\nWHEREAS, PcoMed has experience and expertise in the surface modification of medical device materials;\\n\\nWHEREAS, Integra desires to engage PcoMed to apply certain of its surface technologies onto Integra\\'s implantable spinal medical devices for preclinical, clinical and commercial use and distribution by Integra; and\\n\\nWHEREAS, PcoMed is willing to apply such surface technologies onto Integra\\'s implantable spinal medical devices and to grant Integra certain exclusive rights to use and commercialize those devices; and\\n\\nNOW, THEREFORE, in consideration of the mutual covenants and promises herein contained, the parties hereto agree as follows: 1. DEFINITIONS.\\n\\nAs used in this Agreement, the following initially capitalized terms, whether used in the singular or plural form, shall have the meanings set forth in this Section 1.\\n\\n1.1. \"Affiliate\" means any corporation, limited liability company, person or entity that directly or indirectly controls, is controlled by, or is under common control with, a party to this Agreement. For purposes of this Section 1.1, the term \"control\" (with a correlative meaning for \"controlled by\") means the possession, directly or indirectly, of the power to direct or cause the direction of the management and policies of the subject corporation, person or entity, whether through the ownership of voting securities, by contract or otherwise.\\n\\n1.2. \"*** Run\" means a single production run of PcoMed\\'s *** to apply the PcoMed Surface Modification Technology to Integra Products.\\n\\n1.3. \"*** Run Fee\" means the fee for a single *** Run. The *** Run Fee is exclusive of potential fees for any surface preparation requirements currently performed prior to PcoMed\\'s receipt of Integra Product.\\n\\n1.4. \"Confidential Disclosure Agreements\" means all Mutual Non-Disclosure Agreements previously or hereafter entered into by certain Integra Affiliates and PcoMed. 1 *** Portions of this page have been omitted pursuant to a request for Confidential Treatment filed separately with the Commission.\\n\\n\\n\\n\\n\\n1.5. \"Confidential Information\" means, whether disclosed in oral, written, graphic, electronic form, or other form, and whether developed by the disclosing party or by others, any confidential, non-public, proprietary information of Integra or PcoMed that is designated by the disclosing party as confidential or secret or that should reasonably be assumed by the receiving party to be confidential or secret. Confidential Information includes, without limitation: (i) specifications, know-how, trade secrets, designs, technical information, drawings, sketches, engineering drawings, work of authorship, software, prototypes, samples, models, business information, marketing information, current products and services, future products and services, proposed products and services, inventions, discoveries, devices, apparatus, equipment, algorithms, business methods, plans, assays, methods, procedures, processes, formulae, protocols, techniques, data, research and development data, experimental work, clinical data, engineering data, manufacturing data, technical or non-technical information, ideas, media, and unpublished patent applications; (ii) personnel and financial information, product cost informati',\n",
              "    'Highlight the parts (if any) of this contract related to \"Effective Date\" that should be reviewed by a lawyer. Details: The date when the contract is effective\\xa0',\n",
              "    '15th day of May, 2013',\n",
              "    350,\n",
              "    371),\n",
              "   ('Exhibit 10.22   OUTSOURCE TECHNOLOGY DEVELOPMENT AGREEMENT   This Outsource Technology Development Agreement (this \"Agreement\") is entered into and effective as of this 1s t day of March, 2018 (the \"Effective Date\") by and between Document Security Systems, Inc., a corporation organized and existing under the laws of the State of New York (\"DSS\"), and HotApp International Ltd., a corporation organized and existing under the laws of Hong Kong (\"Developer\").   RECITALS:   WHEREAS, DSS is engaged in the business of, among other things, developing and licensing anti-counterfeiting technology, processes and products providing protection against a wide range of threats, including product diversion and counterfeiting, brand infringement, forgery, and unauthorized copying, scanning and photo imaging;   WHEREAS, Developer is engaged in the business of, among other things, software development; and   WHEREAS, DSS desires to retain Developer for the purpose of assisting DSS in developing an Android software application to be included as part of DSS\\'s AuthentiGuardยฎ Technology suite, and DSS is willing to grant Developer a non-exclusive, limited and non-transferable license for purposes of such development activities.   NOW, THEREFORE, for good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, the parties hereto agree as follows:   Capitalized terms contained herein shall have the meanings ascribed to them herein, or in Schedule 1 which is annexed hereto and made a part of this Agreement.   1. Development License and Fees.   1.1. Development License. Subject to the terms and conditions set forth herein, DSS hereby grants to Developer, and Developer accepts from DSS, for the Term, a non-exclusive, limited, and non-transferable license to install and use the Technology for the sole purpose of developing the Improvements (as defined hereunder) thereto for the benefit of DSS (the \"Technology Development Services License\").   1.2. Development Fees. As payment for Developer\\'s satisfactory performance of the services set forth in Schedule 1 hereto (the \"Technology Development Services\"), DSS shall pay Developer the sum of US $23,000 per month, for the duration of the Term hereof, with payments to commence on March 1, 2018.   2.  Term and Termination.   2.1. Term. The initial term of this Agreement shall commence on the Effective Date, and shall continue thereafter for a period of twelve (12) months (the \"Initial Term\"). The Initial Term shall automatically renew for one-month periods thereafter unless either party provides 30- days advance notice of termination, unless earlier terminated pursuant to Section 2.2 hereof. For purposes hereof, the Initial Term, together with any extension or renewal terms, shall hereinafter be collectively referred to as the \"Term\".   2.2. Early Termination.   2.2.1. Either party may terminate this Agreement prior to expiration of the Term: (i) upon thirty (30) days prior written notice, or (ii) immediately upon written notice to the other party if: (a) the other party declares or a petition is filed in any court for insolvency or bankruptcy and such petition is not dismissed in thirty (30) days; (b) the other party reorganizes under the relevant bankruptcy act or any similar statute in such party\\'s jurisdiction of incorporation; (c) the other party consents to the appointment of a trustee in bankruptcy or a receiver or similar entity; or (d) the Developer breaches DSS\\'s Technology or Intellectual Property rights contained herein.   2.2.2. Upon the expiration or termination of this Agreement, (i) the Technology Development Services License granted to Developer hereunder shall immediately cease, and (ii) Developer shall immediately cease use of all proprietary technology files heretofore delivered by DSS and shall deliver to DSS all such proprietary files along with any and all Improvements completed to date by Developer.     1\\n\\nSource: HF ENTERPRISES INC., S-1, 12/23/2019\\n\\n\\n\\n\\n\\n    3. Proprietary Rights.   3.1. Subject to Developer\\'s expressly granted rights under this Agr',\n",
              "    'Highlight the parts (if any) of this contract related to \"Effective Date\" that should be reviewed by a lawyer. Details: The date when the contract is effective\\xa0',\n",
              "    '1s t day of March, 2018',\n",
              "    169,\n",
              "    192),\n",
              "   ('Exhibit 7.1   Strategic Alliance Agreement\\n\\nTHIS AGREEMENT is made this 15 th day of July, 2010 (\"Effective Date\") by and between IMedicor, Inc, a Nevada Corporation whose address is 523 Avalon Gardens Drive, Nanuet, New York 10954, USA (\"IMedicor\") and USA Managed Care Organization (USA MCO) A Texas Corporation whose address is 916 South Capital of Texas highway, Austin Texas.\\n\\nWITNESSETH:   WHEREAS, iMedicor is a secure, HIPAA compliant online portal that creates a virtual healthcare community amongst physicians and other medical professionals for the purpose of real-time Health Information Exchange. Physicians are provided with a secure HIPPA compliant transport account(s), similar to e-mail with attachments, that enable them to share patient specific personal health information with other participating physicians. iMedicor also provides the ability to create social communities for the purpose of peer collaboration and the extension of referral networks. iMedicor\\'s portal also provides physicians with an extensive catalogue of Continuing Medical Education (CME), skill development and product specific educational resources;\\n\\nWHEREAS, USA MCO represents a network of physicians through which USA MCO provides products and services for the medical industry that: generate additional revenue Streams; provide cost savings, streamline workflow; help patients save time, money and doctors achieve better outcomes; and assist physicians and medical practices to find ways to enhance patient satisfaction;\\n\\nWHEREAS, both parties are interested in forming a strategic and marketing alliance beneficial to both organizations.\\n\\nNOW, THEREFORE, for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties agree as follows:\\n\\n1. OBLIGATIONS OF THE PARTIES   โInitiate a multi tiered marketing approach, by mutual consent of both parties, to integrate the iMedicor HIPAA Compliant transport network as a communications network throughout the USA MCO user base, โThe overall project would also include the ClearLobby pharmaceutical and medical device marketing platform and other value added services as mutually agreed into the future, as a Phase II activity. โA phased in approach for each of the components listed above with the first being the introduction of the core iMedicor, HIPAA compliant communication / transport system into the USA MCO network.\\n\\n\\n\\n\\n\\n    โThe integrated service will generate revenue sharing opportunities for both companies. โUSA MCO will allow access to their network to distribute promotional and educational material highlighting the value proposition of the iMedicor / USA MCO alliance. โAccess will only be through, and controlled by USA MCO โCommunication will be, but not limited to e-mail promotion, direct mail, bill stuffers, web site, newsletter or any other normal communication between USA MCO and their network of physicians and other healthcare providers upon mutual consent of both parties โAll material must be approved by USA MCO prior to any distribution to the USA MCO network. โOnce a physician or other healthcare provider enrolls in iMedicor they will become part of the regular internal iMedicor communications system. โEvery physician that enrolls in iMedicor, including those physicians or other qualified registrants into the iMedicor network that are invited into USA MCO physician communities, through the efforts of USA MCO will be tagged as originating from that source (the USA MCO network). โMonthly reports detailing revenue generated through subscriptions, ClearLobby or other methods will be detailed in the monthly reports. โAll revenue sharing will be reconciled monthly and funds distributed by the 20th of each month by wire transfer for all net collected revenues for the previous month (net of returns and refunds, if any). โIMedicor will make its records available for audit purposes at any time by USA MCO during regular business hours at the headquarters of iMedicor. โUSA MCO will not be responsible for any direct sales of the iMedicor communications system',\n",
              "    'Highlight the parts (if any) of this contract related to \"Effective Date\" that should be reviewed by a lawyer. Details: The date when the contract is effective\\xa0',\n",
              "    '15 th day of July, 2010',\n",
              "    72,\n",
              "    95),\n",
              "   ('SPONSORSHIP AGREEMENT     THIS SPONSORSHIP AGREEMENT (\"Agreement\") is entered into and effective as of the date first written above (\"Effective Date\") by  and among PEEK Investments LLC, a Delaware limited liability company (\"Purchaser\"), and each other party hereto identified on the signature  page(s) hereto (each, a \"Sponsor\"). Each term used and not otherwise defined herein shall have the meaning assigned to such term in the Offer.     RECITALS     WHEREAS, Purchaser is tentatively exploring, among other potential alternatives, a possible third-party tender offer to purchase all  outstanding shares of common stock, $0.001 par value per share (\"Shares\"), of a Delaware corporation (the \"Company\") upon the terms and  subject to the conditions set forth in the Offer to Purchase, related Letter of Transmittal, and other tender offer material provided by or on behalf of  Purchaser to the Sponsors (which, collectively, as amended or supplemented, constitute the \"Offer\");     WHEREAS, as requested by Purchaser for purposes of the Offer, each Sponsor has provided to Purchaser, and Purchaser has accepted  from such Sponsor, a commitment letter providing for a possible equity investment in Purchaser by such Sponsor (each, an \"Equity Commitment Letter\" and, with respect to any Sponsor(s), the Equity Commitment Letter(s) of such Sponsor(s)), which evidences the commitment of and by  such Sponsor to contribute capital to Purchaser in amounts and proportions and upon the terms and subject to the conditions and otherwise as  contemplated by such Equity Commitment Letter (each, a \"Commitment\" and, with respect to any Sponsor(s), the Commitment of such Sponsor (s));     WHEREAS, such capital contributions, if any, would be used to purchase Shares in the Offer and fund the payment or reimbursement of  fees, expenses, and costs related to the Offer (collectively, \"Transaction Costs\"); and     WHEREAS, each party hereto desires to establish certain terms and conditions related to the Offer and relationship among the Sponsors,  the related equity financing commitments, and the Offer;     NOW, THEREFORE, for good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, each party  hereto (\"Party\"), intending to be legally bound, hereby agrees as follows:     AGREEMENT     1. Pre-Acceptance Period. If and to the extent any such decision would or could (or would or could be reasonably foreseeable to)  adversely affect any Sponsor in any manner, each decision to be made by or on behalf of Purchaser with respect to the Offer (or any similar  transaction), any agreements related thereto (\"Related Agreements\"), or any transaction contemplated by the Offer or any Related Agreement  (\"Contemplated Transactions\" and, together with the Offer and Related Agreements, \"Offer Matters\"), or any Offer Matter or combination of  Offer Matters, in any case, on and from the Effective Date and until the Acceptance Time (\"Pre-Acceptance Period\") shall require the unanimous  consent of the Sponsors, including, without limitation, any (a) announcement of intention, commencement, amendment, supplement, termination,  extension, modification, or waiver of or related to the Offer or any term or condition thereof, including, without limitation, with respect to any  commencement date, initial offering period, offer price, type or form of consideration to be offered or paid, timing or other term of acceptance for  payment or payment of any subject security, withdrawal right, expiration date, subsequent offering period, or top-up option, (b) waiver of any  condition to or of the Offer or determination as to whether or not any such condition has been, is, or will be satisfied, (c) filing, dissemination, or  disclosure requirement or offering document or tender offer material, including, without limitation, with respect to any filing or exhibit, schedule,  attachment, amendment, or supplement thereto, (d) agreement, instrument, document, or matter related to any borrowing, incurrence of  indebtedness, or equity, debt, or other financing, (e) ',\n",
              "    'Highlight the parts (if any) of this contract related to \"Effective Date\" that should be reviewed by a lawyer. Details: The date when the contract is effective\\xa0',\n",
              "    'THIS SPONSORSHIP AGREEMENT (\"Agreement\") is entered into and effective as of the date first written above (\"Effective Date\") by  and among PEEK Investments LLC, a Delaware limited liability company (\"Purchaser\"), and each other party hereto identified on the signature  page(s) hereto (each, a \"Sponsor\").',\n",
              "    26,\n",
              "    331),\n",
              "   ('[LOGO]\\n\\nAMENDMENT TO SECTION 2, PART B OF THE CO-BRANDING AGREEMENT\\n\\nThis amendment to Section 2 (titled \"Term\"), Part B of the Co-Branding Agreement is made effective December 9, 1996 by and between PC Quote, Inc. (hereinafter referred to as \"PCQ\") and A.B. Watley, Inc. (hereinafter referred to as \"ABW\"), who are also the parties contracted in the aforementioned Co-Branding Agreement. This Amendment shall apply to said PCQ and ABW and all of their subsidiaries and related companies.\\n\\n[***]\\n\\nSource: PCQUOTE COM INC, S-1/A, 7/21/1999\\n\\n\\n\\n\\n\\nAGREED TO BY:\\n\\n/s/ Steven Malin /s/ Howard Meltzer - -------------------------- --------------------------------- A.B. Watley, Inc. PC Quote, Inc. Mr. Steven Malin Mr. Howard Meltzer Director President Date:  12/5/96 Date:   12/12/96      -------------- ----------------\\n\\nSource: PCQUOTE COM INC, S-1/A, 7/21/1999',\n",
              "    'Highlight the parts (if any) of this contract related to \"Effective Date\" that should be reviewed by a lawyer. Details: The date when the contract is effective\\xa0',\n",
              "    'December 9, 1996',\n",
              "    168,\n",
              "    184),\n",
              "   ('EXHIBIT 10.3\\n\\n   [ABOUT LOGO]\\n\\nCO-BRANDING AGREEMENT\\n\\nThis Agreement (the \"Agreement\"), dated this 19th day of January, 2001 (the \"Effective Date\"), is by and between About.com, Inc. (\"About\"), a Delaware corporation, located at 1440 Broadway, 19th Floor, New York, NY 10018 and ebix.com, Inc. (\"ebix\"), a Delaware corporation, located at 1900 E.Golf Road, Schaumberg, IL 60173\\n\\nW I T N E S S E T H:\\n\\nWHEREAS, About owns and operates an Internet service known as About.com, currently located at the URL HTTP://WWW.ABOUT.COM, at which users may access a variety of content channels and a network of highly-targeted, topic-specific Web sites, and includes any site owned, operated or under the control of About (the \"About Network\");\\n\\nWHEREAS, ebix is the e-commerce portal for insurance on the Internet offering to consumers and insurance professionals a one-stop site, currently located at http://www.ebix.com for all kinds of insurance content ranging from consumer to business tools to broker to business tools as well as e-commerce functionality;\\n\\nWHEREAS, the parties desire to collaborate to create an independent co-branded channel on or accessible though the About Network at which visitors to the About Network may access insurance information, on the terms and conditions hereinafter set forth;\\n\\nWHEREAS, ebix desires to receive promotions on the About Network for the parties\\' Insurance Center and for the ebix Site (hereinafter defined).\\n\\nNOW, THEREFORE, in consideration of the agreements and obligations set forth herein and for other good and valuable consideration, the receipt and sufficiency of such is hereby acknowledged, the parties hereto hereby agree as follows:\\n\\n  1.  DEFINITIONS\\n\\n      \"ABOUT CONTENT\" means any and all textual, graphical, audio/visual or       other materials created or provided on or behalf of About for use on the       Insurance Center (other than the ebix Content), including but not limited       to the About Wrapper and the About Look and Feel (hereinafter defined).\\n\\n      \"ABOUT CUSTOMER\" means any individual or entity who has registered with       ebix either (i) through the registration process on the Insurance Center       or (ii) registers with ebix after accessing the ebix Site from a link on       the About Network.\\n\\n      \"ABOUT CUSTOMER DATA\" means information related specifically to About       Customers, including but not limited to: (i) internet addresses and       navigational information, including information disclosing the usage of       Links within or available through the Insurance Channel; (ii)       transactional information, including, but not limited to, names,       addresses, billing information, information requested; and (iii) any other       information that identifies an individual as an About Customer.\\n\\n      \"ABOUT LOOK AND FEEL\" means the distinctive and particular elements of       graphics (including the About Marks), design, organization, presentation,       layout, user interface, navigation, trade dress and stylistic convention       (including the digital implementations thereof) within the About Network       and the\\n\\n** Confidential treatment has been requested for portions of this document.    The redacted material has been filed with the commission pursuant to an    application for confidential treatment.\\n\\n      total appearance and impression substantially formed by the combination,       coordination and interaction of these elements.\\n\\n      \"ABOUT MARKS\" means the name, tradenames, trademarks, service marks, logos       and other distinctive brand marks of About, adopted by About, or used in       or relating to About\\'s business from time to time, whether or not in       connection with its performance of this Agreement,\\n\\n      \"ABOUT NETWORK\"\" means the About Site, all Web sites owned and operated       solely by About, and those portions of third party Web sites in which       About has a right to sell advertisements.\\n\\n      \"ABOUT SITE HOME PAGE\" means, with respect to the US version of the About       Site, the Web page that is displayed to the About User ',\n",
              "    'Highlight the parts (if any) of this contract related to \"Effective Date\" that should be reviewed by a lawyer. Details: The date when the contract is effective\\xa0',\n",
              "    '19th day of January, 2001',\n",
              "    99,\n",
              "    124),\n",
              "   ('SPONSORSHIP AGREEMENT This agreement (the \"Agreement\") is made effective this 1st day of April, 2018 (\"Effective Date\") between Fruit of Life Productions LLC, (\"Promoter\") and Eco Science Solutions, Inc.,(\"Sponsor\"), 1135 Makawao Avenue, Suite 103-188, Makawao, Hawaii, 96768.\\n\\nContribution by Sponsor: In consideration for the right to sponsor the Kaya Fest and to be acknowledged by Fruit of Life Productions LLC., as a Promoter of the event during the term of this Agreement, Sponsor agrees to contract with Fruit of Life Productions LLC., for the amount of $250,000.00 to be paid in full upon signing of this agreement.\\n\\nBank Wire Transformation Information See Attached Wire Instructions\\n\\nSponsorship Benefits for Presenting Partner Sponsor:\\n\\n* Main Stage named after your brand * 4 10x10 on site vendor booths * 50 VIP Sponsor Passes / 50 GA tickets for both days * 4 Parking passes * Opportunity to participate in after party * Banner placement in venue (10) * Approved audio/video assets to be provided as promotional use for Herbo * Name and phrase called out on stage between performers set * Your logo and a link from our website to your website * Your logo on video wall * Your company name and logo as a presenting sponsor * Banner at main entrance of venue * On stage banner placement * Logo in Backstage/VIP area * Mention on social media * Logo on Step and Repeat * Logo on all promotional print\\n\\nTerms and Termination: The term of this agreement will begin on April 1, 2018 and continue until April 30, 2018 at 11:59pm.\\n\\nRelationship of Parties: The parties are independent contractors with respect to one another. Nothing in this Agreement shall create any association, joint venture, partnership or agency relationship of any kind between the parties.\\n\\n1\\n\\nSource: ECO SCIENCE SOLUTIONS, INC., 8-K, 4/6/2018\\n\\n\\n\\n\\n\\nIntellectual Property: Fruit of Life Productions LLC is the sole owner of all right, title and interest to all Kaya Fest information including Logo, tag lines, (Education before Recreation), Trademarks, trade names and copyrighted information. Sponsor agrees that it will not use Kaya Fest property in a manner that states or implies that Kaya Fest endorses Sponsor (or Sponsors products or services) without written approval from Fruit of Life Productions LLC.\\n\\nIdemnification: Sponsor shall indemnify and hold harmless, Fruit of Life Productions LLC, its related entities, partners, agents, officers, directors, employees, attorneys, heirs, successors, and assigns from against any and all claims, losses, damages, judgments, settlements, costs and expenses (including reasonable attorney\\'s fees and expenses), and liabilities of every kind incurred as a result of: (i) any act or omission by Sponsor or its officers, directors, entities, employees, agents; (ii) any use of Sponsor\\'s name, logo, Website, or other information, products, or service provided by Sponsor; and/or (iii) the inaccuracy or breach of any of the covenants, representations and warranties made by Sponsor in this Agreement. (iv) any changes in company value or brand value. The attendance and marketing reach estimates made in negotiations were made for the purposes of this agreement are mere estimate and not be interpreted as guaranties. . Confidentiality Confidential Information is all information that is marked such and all other information which a reasonable person would consider to be confidential. Confidential Information shall include, but is not limited to, information regarding the organization, its operations, programs, activities, financial condition, strategies, timelines, corporate/programming roadmap, surprise performers/guest appearances, event access information and membership or customer list. During the Term, each party shall use and reproduce the other party\\'s Confidential Information only for purposes of this Agreement with written authorization by disclosing party, and only to the extent necessary for such purpose. Each party shall restrict disclosure of the other party\\'s Confidential Information to its employees and agents with a reasonable need to',\n",
              "    'Highlight the parts (if any) of this contract related to \"Effective Date\" that should be reviewed by a lawyer. Details: The date when the contract is effective\\xa0',\n",
              "    '1st day of April, 2018',\n",
              "    78,\n",
              "    100),\n",
              "   ('Exhibit 10.6\\n\\nGoosehead Insurance Agency, LLC Franchise Agreement\\n\\nExhibit A Declarations Page 1 1.2 The \"Approved Location\" under this Agreement will be: . 2 4.1 You elect to pay the Initial Franchise Fee in one of the following ways: (check only one): โ In its entirety at the time you enter into this Agreement, in which case the amount of the Initial Franchise Fee shall be: ($ ). โ You shall pay a portion of the Initial Franchise Fee at the time you enter into this Agreement in the amount of ($ ), and shall pay the remaining portion of ($ ), plus interest, according to the terms of the 60-month Promissory Note attached to this Agreement as Exhibit I. 3 4.2 The \"Commencement Date\" will be: . Initials Franchisee Franchisor\\n\\n\\n\\n\\n\\nGoosehead Insurance Agency, LLC Franchise Agreement\\n\\nTABLE OF CONTENTS Section Title Page# Recitals 2 1 Grant 2 2 Term And Renewal 3 3 Our Duties 4 4 Fees; Sales Reporting 6 5 Franchised Business Commencement 9 6 Operating Principal, Personnel, And Training 11 7 Purchase of Products and Services 13 8 Your Duties 15 9 Proprietary Marks 20 10 Confidential Brand Standards Manuals 23 11 Confidential Information 24 12 Accounting, Financial And Other Records, And Inspections 25 13 Marketing 27 14 Technology 31 15 Insurance 35 16 Transfer Of Interest 38 17 Default And Termination 43 18 Obligations Upon Termination Or Expiration 46 19 Covenants 49 20 Taxes, Permits, And Indebtedness 51 21 Independent Contractor And Indemnification 52 22 Force Majeure 53 23 Approvals And Waivers 54 24 Notices 54 25 Entire Agreement And Amendment 54 26 Severability And Construction 55 27 Applicable Law And Dispute Resolution 55 28 Acknowledgments 57 Exhibits A Declarations Page E ADA Certification B Guarantee, Indemnification, and Acknowledgement F1- 3 Sample Forms of Non-Disclosure and Non- Competition Agreements C List of Principals G Site Selection Addendum D ACH - Authorization Agreement for H Lease Rider Prearranged Payments (Direct Debits) I Promissory Note\\n\\ni\\n\\n\\n\\n\\n\\nGoosehead Insurance Agency, LLC Franchise Agreement THIS FRANCHISE AGREEMENT (the \"Agreement\") is made and entered into as of the \"Effective Date\" that we have indicated on the signature page of this Agreement by and between: โ Goosehead Insurance Agency, LLC, a Delaware limited liability company, with its principal place of business at 1500 Solana Blvd., Suite 450, Westlake, Texas 76262 (\"we,\" \"us,\" or \"our\"); and โ a [resident of] [corporation organized in] [limited liability company organized in] the state of and having offices at (\"you\" or the \"Franchisee\").\\n\\nIntroduction\\n\\nWe have developed our own distinctive and proprietary systems for insurance services, including home insurance, automobile insurance, life insurance, specialty lines, and business insurance (the \"System\"). Our System includes (among other things): business processes, technologies, trade secrets, customer lists, knowledge, know-how, trade names, service marks, trademarks, logos, emblems, trade dress and other intellectual property; distinctive signage; standards, specifications and sources for services, products, supplies, appearance, operations and management control; safety standards; training and assistance; purchasing programs; and advertising, marketing, promotional and sales programs; all of which we may periodically change, discontinue, improve, modify and further develop.\\n\\nWe identify the System by means of our Proprietary Marks. Our proprietary marks include certain trade names (for example, the mark \"Goosehead Insurance\" and logo), service marks, trademarks, logos, emblems, and indicia of origin, as well as other trade names, service marks, and trademarks that we may periodically specify in writing for use in connection with the System (all of these are referred to as our \"Proprietary Marks\"). We continue to develop, use, and control the use of our Proprietary Marks in order to identify for the public the source of services and products marketed under those marks and under the System, and to represent the System\\'s high standards of quality, appearance, and service.\\n\\nWe are in',\n",
              "    'Highlight the parts (if any) of this contract related to \"Effective Date\" that should be reviewed by a lawyer. Details: The date when the contract is effective\\xa0',\n",
              "    'THIS FRANCHISE AGREEMENT (the \"Agreement\") is made and entered into as of the \"Effective Date\" that we have indicated on the signature page of this Agreement by and between:',\n",
              "    2055,\n",
              "    2228),\n",
              "   ('Exhibit 10.2   FORM OF CONTENT LICENSE AGREEMENT   THIS CONTENT LICENSE AGREEMENT (this \"Agreement\"), dated as of ___________, 2015 (the \"Effective Date\"), is entered into between Beijing Sun Seven Stars Culture Development Limited, a P.R.C. company with an address at Eastern Fangzheng Road, Southern Dongying Village, Hancunhe Town, Fangshan District, Beijing City, P.R.C. (\"Licensor\"), and YOU ON DEMAND HOLDINGS, INC., a Nevada corporation with an address at 375 Greenwich Street, Suite 516, New York, New York 10013 (\"Licensee\").   WHEREAS, Licensor and Licensee have agreed to enter into this Agreement, pursuant to which Licensor shall license to Licensee certain video programming on the terms and subject to the conditions contained in this Agreement.   NOW, THEREFORE, in consideration of the foregoing, the mutual promises and covenants herein contained and other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, and incorporating the above recitals with and into this Agreement, the parties hereby agree as follows:   TERMS AND CONDITIONS   1. Definitions.   (a) \"Additional Title\" shall have the meaning specified in Section 5.   (b) \"Advertising\" shall have the meaning specified in Section 9.   (c) \"Affiliate(s)\" shall mean an entity controlling, controlled by or under common control with a party. \"Control,\" for purposes of this definition, means direct or indirect ownership or control of more than 50% of the voting interests of the subject entity.   (d) \"Confidential Information\" shall have the meaning specified in Section 14(a).   (e) \"Indemnified Party\" shall have the meaning specified in Section 13.   (f) \"Indemnifying Party\" shall have the meaning specified in Section 13.   (g) \"Licensor Marks\" shall have the meaning specified in Section 11.   (h) \"Materials\" shall have the meaning specified in Section 4(b).   (i) \"Mobile Sites\" shall mean any and all versions of the Licensee Sites optimized for delivery and/or distribution via a wireless network.   (j) \"Reports\" shall have the meaning specified in Section 8(b).\\n\\n  1\\n\\nSource: IDEANOMICS, INC., 8-K, 11/24/2015\\n\\n\\n\\n\\n\\n\\n\\n  (k) \"Share Consideration\" has the meaning specified in Section 10.   (l) \"Sites\" shall mean any and all websites, applications, products and other services through which Licensee (itself or through a third party) delivers content via the public Internet or an IP-based network, regardless of whether the device used to access such websites, applications, products or other services is a laptop or desktop computer, mobile device, tablet, mobile phone, set-top box, or other device.   (m) \"Term\" shall have the meaning specified in Section 7.   (n) \"Territory\" shall mean mainland China.   (o) \"Titles\" shall mean the programming listed on Schedule A (as Schedule A may be amended in accordance with Section 5 from time to time).   (p) \"Users\" shall mean all subscribers to Licensee\\'s services.   (q) \"VOD\" shall mean a system that allows for the exhibition of video programming chosen by a subscriber for display on that subscriber\\'s video display unit on an on-demand basis, such that a subscriber is able, at his or her discretion, to select the time for commencement of exhibition, and shall include subscription VOD (\"SVOD\"), transactional VOD (\"TVOD\"), ad-supported VOD (\"AVOD\") and free VOD.   2. Rights Granted.   (a) License Grant. In exchange for the Share Consideration, Licensor hereby grants to Licensee a non-exclusive, royalty-free, perpetual and non-perpetual license (subject to the duration for which Licensor has the rights to each Title as specified in Schedule A1-A5 of Schedule A) to:   i. license, exhibit, distribute, reproduce, transmit, perform, display, and otherwise exploit and make available each Title within the Territory in any language by VOD (including SVOD, TVOD, AVOD and free VOD) for Internet, TV and mobile platforms (including, but not limited to, OTT streaming services, Sites and Mobile Sites), except that for Titles listed in Schedule A1-A2 of Schedule A, Licensor can only grant Licensee distributio',\n",
              "    'Highlight the parts (if any) of this contract related to \"Effective Date\" that should be reviewed by a lawyer. Details: The date when the contract is effective\\xa0',\n",
              "    '__________, 2015',\n",
              "    115,\n",
              "    131),\n",
              "   ('Exhibit 4.5\\n\\nCONSULTING AGREEMENT - DR. GAETANO MORELLO N.D. INC.\\n\\nTHIS AGREEMENT made effective the 10 day of January 2019 (the \"Effective Date\"),\\n\\nBETWEEN:\\n\\nEMERALD HEALTH NATURALS, INC., a company having its registered and records office at 7860 Venture Street, Burnaby, BC V5A 1V3\\n\\n(\"Emerald\" or the \"Company\")\\n\\nAND:\\n\\nDR. GAETANO MORELLO N.D. INC., Businessperson, having an office at 2975 East 4th Avenue, Vancouver, B.C. V5M 1L1\\n\\n(the \"Contractor\")\\n\\nWITNESSES THAT WHEREAS Emerald would like to engage the Contractor as an independent contractor of Emerald, and the Contractor would like to be engaged by Emerald as an independent contractor, on the terms and conditions contained herein;\\n\\nIN CONSIDERATION of the mutual agreements in this Agreement and subject to the terms and conditions specified in this Agreement, the parties agree as follows:\\n\\n1. Definitions\\n\\n1.1 In this Agreement, including the recitals and the schedules, the defined words and expressions have the meanings set out on Schedule \"A\" to this Agreement unless the context otherwise required.\\n\\n2. Scope of Engagement\\n\\n2.1 Position. The Company hereby engages the Contractor as an independent contractor and the Contractor hereby agrees to such engagement.\\n\\n2.2 Services. The Company engages the Contractor to fulfill the services (the \"Services\") as described on Schedule \"B\" on the terms and conditions of this Agreement. The Services may be replaced, amended, superseded, or supplemented from time to time by agreement between the Company and the Contractor.\\n\\n2.3 Reporting and Oversight Responsibility. The Contractor will report to and take instructions from Avtar Dhillon, President and Executive Chair.\\n\\n2.4 Commitment of the Contractor. The Contractor will devote sufficient time and attention to the business and affairs of Emerald to provide the Services, use his or her best efforts to promote the interests of Emerald, and will carry out his or her Services honestly, in good faith and in the best interests of Emerald.\\n\\n2.5 Not Employment. The parties acknowledge and agree that the relationship created by operation of this Agreement is not an employment relationship.\\n\\n3. Fees\\n\\n3.1 Fee. The Company will pay to the Contractor an annual fee (the \"Fee\") of $240,000. per year plus plus GST and applicable taxes, if any.\\n\\n\\n\\n\\n\\n3.2 Reimbursement of Expenses. Emerald will reimburse the Contractor for all reasonable expenses incurred in the performance of his or her Services, provided that the Contractor provides a written expense account in a form satisfactory to the Lead Director of the Company.\\n\\n3.3 Deductions and Remittances. Emerald shall not be obliged to deduct or retain from the Fees due to the Contractor, nor shall it be obliged to remit same to the required governmental authority, any amounts that may be required by law or regulation to be deducted, retained and remitted including, without limitation, Federal and Provincial or State Income Tax, Workers\\' Compensation and Pension Plan deductions and remittances. All such remittances and other payments are entirely the responsibility of the Contractor and the Contractor hereby indemnifies and saves Emerald and its Board members and officers harmless from any liability of any kind whatsoever that they may incur as a result of the Contractor\\'s failure to make such remittances or payments.\\n\\n3.4 Other Boards, Charities and Business Activities. The Contractor\\'s performance of personal, business or charitable activities or service on any boards of any private or public companies, shall be deemed not to be preventing the Contractor from meeting his or her obligations to Emerald hereunder, so long as same are not directly competitive with the business of the Company. Emerald acknowledges and agrees that the Contractor or Contractor may have other business involvements, business interests and sources of business income with parties that Emerald does or does not have a business relationship with. The Contractor is permitted to undertake such activities and retain all of the compensation received from such activities provided that ',\n",
              "    'Highlight the parts (if any) of this contract related to \"Effective Date\" that should be reviewed by a lawyer. Details: The date when the contract is effective\\xa0',\n",
              "    '10 day of January 2019',\n",
              "    101,\n",
              "    123),\n",
              "   ('EXHIBIT 10.11\\n\\n                                                    CONFIDENTIAL TREATMENT\\n\\n                                                   Portions indicated by a                                                     [***] have been omitted                                                     and filed separately                                                     with the Commission\\n\\nPCQUOTE\\n\\n- ---------------------------------------------------------------------------- CO-BRANDING AGREEMENT\\n\\nThis agreement is made effective   Oct. 11, 1996 by and between PC QUOTE, INC. (hereinafter referred to as \"PCQ\"), a Delaware Corporation with its principal place of business at 300 South Wacker Drive, Chicago, Illinois 60605 and AB Wately, Inc. (hereinafter referred to as \"ABW\") with its principal place of business at 33 West 17th Street, New York, NY  10011. This agreement shall apply to said ABW and all of its subsidiaries and related companies.\\n\\nDefinitions:\\n\\nSOFTWARE\\n\\nPC QUOTE 6.0-TM- for Windows on the Internet is a software application that displays market data information, provided via the digital Hyperfeed, in the form of quotes, charts, graphs, tables, board views, tickers and other analytical tools.\\n\\nHYPERFEED\\n\\nThe PC Quote proprietary digital data feed transmitted via satellite, land line, or Internet with advanced compression technology, containing financial market information obtained by PCQ from the institutions and exchanges listed in Section 5 of this Agreement.  This market data includes stock quotes, futures and options trading, commodities, and other related information.\\n\\nWitnesseth:\\n\\nNOW, THEREFORE, for good and valuable consideration, and in consideration of the mutual covenants and conditions herein set forth, and with the intent to be legally bound thereby, ABW and PCQ hereby agree to the following:\\n\\n1.  The Co-Branded Service\\n\\n    A.  PCQ agrees to allow ABW to co-brand the PCQ SOFTWARE in order to provide a value added service on ABW\\'s World Wide Web site.  The co-branded SOFTWARE will be made available via ABW software housed at the ABW office listed in this Agreement.  The server will be accessed by all ABW subscribers in order to download the SOFTWARE and receive the HYPERFEED.\\n\\n    B.  PCQ will provide a continuous HYPERFEED to the ABW servers; however, PCQ will control the receipt of the HYPERFEED by ABW clients via a remote access server on PCQ\\'s site that will authorize each new ABW account.  ABW agrees to sign up all new subscribers to the co-branded service, including execution of all applicable service and exchange agreements, will send to PCQ the executed subscriber\\n\\nagreements before access to the quote servers will be provided to ABW clients by PCQ.  PCQ shall have the sole ability to authorize access to the market data contained in the HYPERFEED by ABW clients.\\n\\nSource: PCQUOTE COM INC, S-1/A, 7/21/1999\\n\\n\\n\\n\\n\\n    D.  PCQ and Townsend shall retain title and all copyrights or proprietary rights to the SOFTWARE and HYPERFEED provided to ABW and ABW\\'s clients pursuant to the Agreement.  ABW will not provide any unauthorized access to the co-branded service, nor reproduce or redistribute the service in any way.\\n\\n    E.  ABW agrees to include the following in the co-branded pages displaying quotes:  \"All quotes provided by PC Quote, Inc.\"  ABW also agrees to include the following disclaimer on the access page to the co-branded service:\\n\\n         \"PC Quote is not subject to liability for truth, accuracy, or           completeness of the market data information nor is PC Quote liable           for errors, mistakes or omissions in the data or for any delays or           interruptions in the end user\\'s receipt of the data.  PC Quote does           not warrant that the data provided may be relied upon for trading           purposes.\"\\n\\n    2.  Term\\n\\n    A.  [***]  The effective date for purposes of this Agreement is the contract date as specified on the signature page of this Agreement.  Neither PCQ nor ABW shall terminate or alter this Agreement except as stated herein.\\n\\n    B.  [***]  Notice expressing ',\n",
              "    'Highlight the parts (if any) of this contract related to \"Effective Date\" that should be reviewed by a lawyer. Details: The date when the contract is effective\\xa0',\n",
              "    'The effective date for purposes of this Agreement is the contract date as specified on the signature page of this Agreement.',\n",
              "    3851,\n",
              "    3975),\n",
              "   ('Exhibit 10.1 JOINT VENTURE AGREEMENT BETWEEN NOVO INTEGRATED SCIENCES INC. (\"NVOS\") AND HARVEST GOLD FARMS INC. (\"HGF\") FOR THE DEVELOPMENT, MANAGEMENT AND OPERATION OF HEMP FARMING AND MEDICINAL CROPS\\n\\n\\n\\n\\n\\nJOINT VENTURE AGREEMENT Dated as of December 19, 2019 This Joint Venture Agreement (the \"Agreement\") is entered into between Novo Integrated Sciences Inc., a Nevada Corporation with offices located at 11120 NE 2nd Street, Suite 200, Bellevue, Washington 98004, U.S.A (herein referred to as \"NVOS\") and Harvest Gold Farms Inc., a corporation organized under the laws of New Brunswick, Canada with offices located at 866 E. H. Daigle Blvd, Grand Falls, New Brunswick, E3Z 3E8, Canada (herein referred to as \"HGF\"). NVOS and HGF may be referred to herein collectively as the \"Parties\" and separately as a \"Party.\" RECEITALS WHEREAS, NVOS is willing to assist in development, assist in management and purchase biomass resulting from open field farming for health-related cash crops, in particular medicinal cannabis and industrial hemp; WHEREAS, NVOS is willing to develop and construct processing facilities as well as finished goods manufacturing and packaging facilities; WHEREAS, NVOS is willing to provide the Joint Venture access to its distribution pathways established either directly or indirectly through NVOS or its wholly or partially owned subsidiaries; WHEREAS, NVOS is willing to establish reasonable commercial cost bases to product processing and packaging ensuring a profitable and fully transparent Joint Venture; WHEREAS, NVOS is willing to utilize all applicable HGF tools and offerings for the purposes of developing a fully comprehensive North American business platform; WHEREAS, HGF is willing to work towards a mutually acceptable Joint Venture; WHEREAS, HGF is willing to engage to its fullest potential in the licencing, employment harvesting, legal right consulting, business development within its geographical jurisdiction; WHEREAS, HGF is willing assist in transport and distribution of raw and finished goods in both domestic and international jurisdictions; WHEREAS, HGF is willing to provide certified biomass to the JV on pre-determined, mutually agreed price per acre and participate on a net revenue split of products offered to market directly or indirectly through NVOS channels; NOW THEREFORE, the Parties agree to sign this Agreement for the purposes of developing, managing and arranging medicinal farming projects involving hemp and cannabis cash crops (hereinafter referred to as the \"Primary Project\") under the following terms set out in this Agreement for the noted project (herein, referred to as the \"Primary Contract\").\\n\\n\\n\\n\\n\\nARTICLE 1 - DEFINITIONS AND INTERPRETATION 1.1 For the purposes of this Agreement, unless the context otherwise requires, the following terms shall have the respective meanings set forth below and grammatical variations of such terms shall have corresponding meanings: (a) \"Action\" means any legal action, suit, claim, investigation, hearing or proceeding, including any audit, claim or assessment for Taxes or otherwise. (b) \"Agreement\" means this Joint Venture Agreement, dated December 19, 2019. (c) \"Company\" means the Joint Venture entity which will be registered and incorporated in a Canadian jurisdiction with its operating name as Novo Earth Therapeutics Inc. (d) \"Cost\" means cost of goods sold as defined in the financials of the Primary Project. (e) \"Effective Date\" is the date of the most recent final signature on this Agreement. (f) \"EPC\" means engineering, procurement, construction contracts. (g) \"HFG\" means Harvest Gold Farms Inc. (h) \"Joint Venture\" means a business arrangement where NVOS and HGF have agreed to pool their resources for the purpose of the Primary Project. (i) \"Law\" means any domestic or foreign, federal, state, provincial, municipal or local law, statute, ordinance, code, rule, or regulation having the force of law. (j) \"NHL\" means Novo Healthnet Limited. (k) \"NVOS\" means Novo Integrated Sciences Inc. (l) \"Parties\" means collectively, Harvest Gold Farms Inc. and Novo Inte',\n",
              "    'Highlight the parts (if any) of this contract related to \"Effective Date\" that should be reviewed by a lawyer. Details: The date when the contract is effective\\xa0',\n",
              "    'December 19, 2019',\n",
              "    243,\n",
              "    260),\n",
              "   ('Exhibit 10.1 JOINT VENTURE AGREEMENT BETWEEN NOVO INTEGRATED SCIENCES INC. (\"NVOS\") AND HARVEST GOLD FARMS INC. (\"HGF\") FOR THE DEVELOPMENT, MANAGEMENT AND OPERATION OF HEMP FARMING AND MEDICINAL CROPS\\n\\n\\n\\n\\n\\nJOINT VENTURE AGREEMENT Dated as of December 19, 2019 This Joint Venture Agreement (the \"Agreement\") is entered into between Novo Integrated Sciences Inc., a Nevada Corporation with offices located at 11120 NE 2nd Street, Suite 200, Bellevue, Washington 98004, U.S.A (herein referred to as \"NVOS\") and Harvest Gold Farms Inc., a corporation organized under the laws of New Brunswick, Canada with offices located at 866 E. H. Daigle Blvd, Grand Falls, New Brunswick, E3Z 3E8, Canada (herein referred to as \"HGF\"). NVOS and HGF may be referred to herein collectively as the \"Parties\" and separately as a \"Party.\" RECEITALS WHEREAS, NVOS is willing to assist in development, assist in management and purchase biomass resulting from open field farming for health-related cash crops, in particular medicinal cannabis and industrial hemp; WHEREAS, NVOS is willing to develop and construct processing facilities as well as finished goods manufacturing and packaging facilities; WHEREAS, NVOS is willing to provide the Joint Venture access to its distribution pathways established either directly or indirectly through NVOS or its wholly or partially owned subsidiaries; WHEREAS, NVOS is willing to establish reasonable commercial cost bases to product processing and packaging ensuring a profitable and fully transparent Joint Venture; WHEREAS, NVOS is willing to utilize all applicable HGF tools and offerings for the purposes of developing a fully comprehensive North American business platform; WHEREAS, HGF is willing to work towards a mutually acceptable Joint Venture; WHEREAS, HGF is willing to engage to its fullest potential in the licencing, employment harvesting, legal right consulting, business development within its geographical jurisdiction; WHEREAS, HGF is willing assist in transport and distribution of raw and finished goods in both domestic and international jurisdictions; WHEREAS, HGF is willing to provide certified biomass to the JV on pre-determined, mutually agreed price per acre and participate on a net revenue split of products offered to market directly or indirectly through NVOS channels; NOW THEREFORE, the Parties agree to sign this Agreement for the purposes of developing, managing and arranging medicinal farming projects involving hemp and cannabis cash crops (hereinafter referred to as the \"Primary Project\") under the following terms set out in this Agreement for the noted project (herein, referred to as the \"Primary Contract\").\\n\\n\\n\\n\\n\\nARTICLE 1 - DEFINITIONS AND INTERPRETATION 1.1 For the purposes of this Agreement, unless the context otherwise requires, the following terms shall have the respective meanings set forth below and grammatical variations of such terms shall have corresponding meanings: (a) \"Action\" means any legal action, suit, claim, investigation, hearing or proceeding, including any audit, claim or assessment for Taxes or otherwise. (b) \"Agreement\" means this Joint Venture Agreement, dated December 19, 2019. (c) \"Company\" means the Joint Venture entity which will be registered and incorporated in a Canadian jurisdiction with its operating name as Novo Earth Therapeutics Inc. (d) \"Cost\" means cost of goods sold as defined in the financials of the Primary Project. (e) \"Effective Date\" is the date of the most recent final signature on this Agreement. (f) \"EPC\" means engineering, procurement, construction contracts. (g) \"HFG\" means Harvest Gold Farms Inc. (h) \"Joint Venture\" means a business arrangement where NVOS and HGF have agreed to pool their resources for the purpose of the Primary Project. (i) \"Law\" means any domestic or foreign, federal, state, provincial, municipal or local law, statute, ordinance, code, rule, or regulation having the force of law. (j) \"NHL\" means Novo Healthnet Limited. (k) \"NVOS\" means Novo Integrated Sciences Inc. (l) \"Parties\" means collectively, Harvest Gold Farms Inc. and Novo Inte',\n",
              "    'Highlight the parts (if any) of this contract related to \"Effective Date\" that should be reviewed by a lawyer. Details: The date when the contract is effective\\xa0',\n",
              "    '\"Effective Date\" is the date of the most recent final signature on this Agreement.',\n",
              "    3441,\n",
              "    3523),\n",
              "   ('Exhibit 10(xiv)\\n\\nMASTER SERVICES AGREEMENT Between RadialSpark, LLC and Clear Capital Page 1 of 10\\n\\n\\n\\n\\n\\nTHIS MASTER SERVICES AGREEMENT (\"Agreement\"), dated as of 09/24/2018 (the \"Effective Date\"), is between Clear Capital (the \"Company\") and RadialSpark, LLC (the \"Contractor\"). WHEREAS, Company desires from time to time to retain Contractor to perform certain management consulting services for Company; and WHEREAS, Contractor desires to perform such management consulting services for Company; NOW THEREFORE, in consideration of the foregoing premises, and the mutual covenants and agreements set forth herein, the parties hereto agree as follows: 1. PURPOSE OF ENGAGEMENT. (a) Company agrees to retain Contractor to perform the consulting services for Company, on a task by task basis (the \"Services\"), and Contractor agrees to furnish the Services on the terms and subject to the conditions set forth in this Agreement. During the term of this Agreement, Company and Contractor will develop and agree upon statements of work defining the Services and work product to be provided by Contractor, Contractor\\'s compensation, additional terms and conditions, if any, applicable to a particular engagement and such other details as the parties deem appropriate (each a \"Statement of Work\"). A Statement of Work may provide specifications for deliverables to be provided thereunder (the \"Specifications\"). Statements of Work that are from time to time agreed upon shall reference this Agreement, and shall be executed by the parties and attached hereto and shall form a part hereof. In all instances of a conflict, between the provisions of this Agreement and the specific provisions set forth in a Statement of Work, the provisions of this Agreement shall control. (b) Contractor shall provide sufficient qualified personnel to perform the Services in a professional and workmanlike manner in accordance with industry standards. A Statement of Work may designate certain individuals as \"Key Personnel\" for an engagement, and the parties subsequently may agree in writing that additional individuals are Key Personnel for such engagement. If there are Key Personnel for an engagement, Contractor shall provide the Services through those personnel and such additional personnel of Contractor as Contractor may from time to time determine to be required for the performance of the Services. Company shall have the right to interview and approve such additional personnel at Company\\'s request. If one or more Key Personnel terminate their employment with Contractor or otherwise become\\n\\nPage 2 of 10\\n\\n\\n\\n\\n\\nunavailable to work on an engagement for reasons beyond Contractor\\'s reasonable control, Contractor may provide the Services through other personnel with comparable training and experience. If Company becomes dissatisfied with any of Contractor\\'s personnel providing the Services, Company may notify Contractor of the details of its dissatisfaction, and the parties shall cooperate to remedy the problem as soon as possible. If Company reasonably requests, Contractor shall reassign the individual who is the subject of Company\\'s dissatisfaction and replace that person with other personnel in accordance with this Agreement. (c) Unless otherwise provided in a Statement of Work, Contractor shall provide the Services at Contractor\\'s facility. Contractor shall provide computing equipment consistent with the Services to be provided under the Statement of Work. When services are provided at a Company facility, Company shall provide workspace and other facilities such as computer support consistent with the requirements of the Services to be provided under the Statement of Work. Contractor shall cause its personnel at Company\\'s facility to comply with Company\\'s (i) safety and security rules and other rules applicable to those working in the facility, and (ii) Company\\'s policies concerning access to and security of any Company computer system to which Contractor may have access; provided, that Company has provided Contractor with copies of such rules and policies or has advised Contra',\n",
              "    'Highlight the parts (if any) of this contract related to \"Effective Date\" that should be reviewed by a lawyer. Details: The date when the contract is effective\\xa0',\n",
              "    '9/24/2018',\n",
              "    163,\n",
              "    172)]),\n",
              " (('Exclusivity', 'possible negative'),\n",
              "  [('Exhibit 10.2\\n\\n______________________________________________________________________________\\n\\nCO-PROMOTION AGREEMENT\\n\\nby and between\\n\\nDOVA PHARMACEUTICALS, INC.\\n\\nand\\n\\nVALEANT PHARMACEUTICALS NORTH AMERICA LLC\\n\\nSeptember 26, 2018\\n\\n______________________________________________________________________________\\n\\nCONFIDENTIAL TREATMENT HAS BEEN REQUESTED FOR PORTIONS OF THIS EXHIBIT. THE COPY FILED HEREWITH OMITS THE INFORMATION SUBJECT TO A CONFIDENTIALITY REQUEST. OMISSIONS ARE DESIGNATED [***]. A COMPLETE VERSION OF THIS EXHIBIT HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION.\\n\\nSource: DOVA PHARMACEUTICALS INC., 10-Q, 11/8/2018\\n\\n\\n\\n\\n\\nTABLE OF CONTENTS\\n\\nPage\\n\\nARTICLE 1 DEFINITIONS 1\\n\\nARTICLE 2 RIGHTS AND OBLIGATIONS 8\\n\\n2.1 Engagement; Grant of Rights. 8\\n\\n2.2 Retention of Rights. 9\\n\\n2.3 Non-Competition; Non-Solicitation. 9\\n\\n2.4 Dova Trademarks and Copyrights. 10\\n\\nARTICLE 3 JOINT STEERING COMMITTEE 11\\n\\n3.1 Formation of the JSC. 11\\n\\n3.2 Meetings and Minutes. 11\\n\\n3.3 Purpose of the JSC. 11\\n\\n3.4 Decision Making. 13\\n\\n3.5 Marketing Sub-Committee. 13\\n\\nARTICLE 4 VALEANT ACTIVITIES FOR THE PRODUCT 14\\n\\n4.1 Valeant Activities. 14\\n\\n4.2 Detailing. 15\\n\\n4.3 Compliance with Applicable Law. 17\\n\\n4.4 Field Force Personnel Training; Product Materials. 19\\n\\n4.5 Provisions Related to Field Force Personnel. 21\\n\\n4.6 Responsibility for Valeant Activity Costs and Expenses. 22\\n\\n4.7 Data Sharing. 22\\n\\nARTICLE 5 REGULATORY, SAFETY AND SURVEILLANCE, COMMERCIAL MATTERS 23\\n\\n5.1 Dova Responsibility. 23\\n\\n5.2 Valeant Involvement. 23\\n\\n5.3 Inspections. 23\\n\\n5.4 Pharmacovigilance. 24\\n\\n5.5 Unsolicited Requests for Medical Information. 24\\n\\n5.6 Recalls and Market Withdrawals. 25\\n\\n5.7 Certain Reporting Responsibilities. 25\\n\\n5.8 Booking of Sales Revenues. 25\\n\\n5.9 Returns. 25\\n\\nSource: DOVA PHARMACEUTICALS INC., 10-Q, 11/8/2018\\n\\n\\n\\n\\n\\ni\\n\\nCONFIDENTIAL TREATMENT HAS BEEN REQUESTED FOR PORTIONS OF THIS EXHIBIT. THE COPY FILED HEREWITH OMITS THE INFORMATION SUBJECT TO A CONFIDENTIALITY REQUEST. OMISSIONS ARE DESIGNATED [***]. A COMPLETE VERSION OF THIS EXHIBIT HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION.\\n\\nSource: DOVA PHARMACEUTICALS INC., 10-Q, 11/8/2018\\n\\n\\n\\n\\n\\nTABLE OF CONTENTS (continued)\\n\\n5.10 Manufacturing; Distribution; Marketing. 25\\n\\nARTICLE 6 FINANCIAL PROVISIONS 26\\n\\n6.1 Promotion Fee. 26\\n\\n6.2 Milestone Payment. 27\\n\\n6.3 Reports; Payments. 27\\n\\n6.4 Taxes. 28\\n\\n6.5 Determination of Specialty. 29\\n\\nARTICLE 7 AUDIT RIGHTS 30\\n\\n7.1 Recordkeeping. 30\\n\\n7.2 Valeant Rights. 30\\n\\n7.3 Dova Rights. 31\\n\\nARTICLE 8 INTELLECTUAL PROPERTY 32\\n\\n8.1 Ownership of Intellectual Property. 32\\n\\n8.2 Title to Trademarks and Copyrights. 32\\n\\n8.3 Protection of Trademarks and Copyrights. 32\\n\\n8.4 Disclosure of Know-How. 33\\n\\nARTICLE 9 CONFIDENTIALITY 33\\n\\n9.1 Confidential Information. 33\\n\\n9.2 Public Announcements. 34\\n\\nARTICLE 10 REPRESENTATIONS AND WARRANTIES; ADDITIONAL COVENANTS 35\\n\\n10.1 Representations and Warranties of Dova. 35\\n\\n10.2 Representations and Warranties of Valeant. 37\\n\\n10.3 Disclaimer of Warranty. 38\\n\\n10.4 Additional Covenants. 39\\n\\nARTICLE 11 INDEMNIFICATION; LIMITATIONS ON LIABILITY 39\\n\\n11.1 Indemnification by Dova. 39\\n\\n11.2 Indemnification by Valeant. 39\\n\\n11.3 Indemnification Procedures. 40\\n\\n11.4 Limitation of Liability. 40\\n\\n11.5 Insurance. 40\\n\\nARTICLE 12 TERM AND TERMINATION 41\\n\\n12.1 Term. 41\\n\\n12.2 Early Termination for Cause. 41\\n\\nSource: DOVA PHARMACEUTICALS INC., 10-Q, 11/8/2018\\n\\n\\n\\n\\n\\n12.3 Other Early Termination. 42\\n\\n12.4 Effects of Termination. 42\\n\\n12.5 Tail Period. 42\\n\\nii\\n\\nCONFIDENTIAL TREATMENT HAS BEEN REQUESTED FOR PORTIONS OF THIS EXHIBIT. THE COPY FILED HEREWITH OMITS THE INFORMATION SUBJECT TO A CONFIDENTIALITY REQUEST. OMISSIONS ARE DESIGNATED [***]. A COMPLETE VERSION OF THIS EXHIBIT HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION.\\n\\nSource: DOVA PHARMACEUTICALS INC., 10-Q, 11/8/2018\\n\\n\\n\\n\\n\\nTABLE OF CONTENTS (continued)\\n\\n12.6 Survival. 43\\n\\nARTICLE 13 MISCELLANEOUS 43\\n\\n13.1 Force Majeure. 43\\n\\n13.2 Assignment. 43\\n\\n13.3 Severability. 44\\n\\n13.4 Notices. 44\\n\\n13.5 Governing Law. 45\\n\\n13.6 Dispute Resolution. 45\\n\\n13.7 Waiver ',\n",
              "    'Highlight the parts (if any) of this contract related to \"Exclusivity\" that should be reviewed by a lawyer. Details: Is there an exclusive dealing\\xa0 commitment with the counterparty? This includes a commitment to procure all โrequirementsโ from one party of certain technology, goods, or services or a prohibition on licensing or selling technology, goods or services to third parties, or a prohibition on\\xa0 collaborating or working with other parties), whether during the contract or\\xa0 after the contract ends (or both).',\n",
              "    'During the Term, subject to the terms and conditions of this Agreement, Dova hereby grants to Valeant the right, on a co-exclusive basis (solely with Dova and its Affiliates), to Detail and promote the Product in the Specialty in the Territory in the Field, and to conduct the Valeant Activities and the activities of the institutional account management team (pursuant to and subject to the terms of Section 4.1.5) for the Product in the Territory in the Field in accordance with the terms and conditions of this Agreement.',\n",
              "    0,\n",
              "    0),\n",
              "   ('Exhibit 10.13\\n\\nConfidential Materials omitted and filed separately with the Securities and Exchange Commission. Asterisks denote omissions.\\n\\nDATED: OCTOBER 15, 2009\\n\\nPACIRA PHARMACEUTICALS, INC.\\n\\nand\\n\\nEKR THERAPEUTICS, INC.        AMENDED AND RESTATED   STRATEGIC LICENSING, DISTRIBUTION AND MARKETING AGREEMENT\\n\\n\\n\\n\\n\\nTHIS AMENDED AND RESTATED STRATEGIC LICENSING, DISTRIBUTION AND MARKETING AGREEMENT (the  \"Agreement\") is made on October 15, 2009 (the \"Agreement Date\") and is effective as of the Effective Date (as defined below), between:   PACIRA PHARMACEUTICALS, INC. (F/K/A SKYEPHARMA, INC.) a company incorporated in the state of California whose principal place of business is 10450 Sciences Center Drive, San Diego, California 92121 USA (\"PPI\"); and   EKR THERAPEUTICS, INC., a company incorporated in the state of Delaware whose principal place of business is 1545 Route 206  South, Third Floor, Bedminster, New Jersey 07921 (\"EKR\").\\n\\nRecitals\\n\\nPPI owns and has all right title and interest in or has acquired exclusive rights to the PPI IP (as defined below), the Trademark (as  defined below) and the Product (as defined below).\\n\\nEKR has, among other things, specialized knowledge and expertise in relation to the marketing and sale of pharmaceutical products.\\n\\nPursuant to that certain Strategic Licensing, Distribution and Marketing Agreement between EKR and PPI dated as of August 10, 2007  (the \"Original Agreement\"), PPI granted and EKR acquired the exclusive right and license to sell, offer to sell, distribute and market the Product in  the Territory (as defined below) in the Field (as defined below).\\n\\nEKR and PPI desire to amend and restate the Original Agreement in its entirety as set forth herein in order to provide for: (i) certain  changes to the financial terms set forth in the Original Agreement, (ii) the transfer of Marketing Authorizations (as defined below) from PPI to      -1-\\n\\n\\n\\n\\n\\nEKR, and EKR\\'s assumption of obligations thereunder, (iii) the transfer of title to certain manufacturing equipment from PPI to EKR and the lease  of such equipment back from EKR to PPI and (iv) certain other changes as are set forth herein; all of the foregoing subject to and in accordance  with the terms and conditions of this Agreement.\\n\\nNOW THEREFORE, in consideration of the following mutual agreements and covenants set forth herein and intending to be legally  bound hereby, PPI and EKR (each, a \"Party\"  and collectively, the \"Parties\")  acknowledge and agree that this Agreement shall amend and  supersede in its entirety the Original Agreement and hereby agree as follows:\\n\\nOperative Provisions\\n\\n\\n\\n\\n\\n   -2-\\n\\n1. Definitions   1.1 As used in this Agreement, the following words and expressions have the following meanings:\\n\\n\"Affiliate\"\\n\\n\\n\\nWith respect to any Party to this Agreement shall mean any company, corporation, firm, individual or other  entity which Controls, is Controlled by or is under common Control with such Party to this Agreement for only  so long as such Control exists;\\n\\n\\n\\n\\n\\n   -3-\\n\\n\"Applicable Laws\"\\n\\n\\n\\nShall mean all laws, rules and regulations regarding the manufacture, packaging, labeling, import, export,  storage, distribution, representation, promotion, marketing and sale of the Products including but not limited to  the Federal Food, Drug and Cosmetic Act of 1938, as amended (\"FD&C Act\") and the Controlled Substances  Act, as amended (21 U.S.C. ยง801 et seq.), or as defined in attendant regulations promulgated under authorities  granted by the FD&C Act, together with any equivalent laws, rules, regulations, codes or guidelines having  effect in any jurisdiction in the Territory;\\n\\n\"Calendar Year\"    Shall mean the period of twelve months commencing on 1st January in any year, and each consecutive period  of twelve months thereafter during the Term;\\n\\n\"cGMP\"    Means Current Good Manufacturing Practices pursuant to 21 CFR Parts 210 and 211, as may be amended from  time to time;\\n\\n\"Commercial Launch\"\\n\\n\\n\\nShall mean the date of the first arm\\'s length sale by EKR to an unaffiliated Third Party customer for commercial  use of Pro',\n",
              "    'Highlight the parts (if any) of this contract related to \"Exclusivity\" that should be reviewed by a lawyer. Details: Is there an exclusive dealing\\xa0 commitment with the counterparty? This includes a commitment to procure all โrequirementsโ from one party of certain technology, goods, or services or a prohibition on licensing or selling technology, goods or services to third parties, or a prohibition on\\xa0 collaborating or working with other parties), whether during the contract or\\xa0 after the contract ends (or both).',\n",
              "    'PPI hereby grants EKR the exclusive right and license (with the right to sublicense) to use, market, promote, sell, distribute and warehouse the Products (the \"Distribution Rights\") in the Field in the Territory during the Term, as  well as to make or have made the Products anywhere in the world for import or sale in the Field in the Territory in each case, under the PPI  IP provided that PPI retains all rights necessary to manufacture and supply the Products to EKR in accordance with this Agreement and the  Supply Agreement.',\n",
              "    0,\n",
              "    0),\n",
              "   ('Exhibit 10.13\\n\\nConfidential Materials omitted and filed separately with the Securities and Exchange Commission. Asterisks denote omissions.\\n\\nDATED: OCTOBER 15, 2009\\n\\nPACIRA PHARMACEUTICALS, INC.\\n\\nand\\n\\nEKR THERAPEUTICS, INC.        AMENDED AND RESTATED   STRATEGIC LICENSING, DISTRIBUTION AND MARKETING AGREEMENT\\n\\n\\n\\n\\n\\nTHIS AMENDED AND RESTATED STRATEGIC LICENSING, DISTRIBUTION AND MARKETING AGREEMENT (the  \"Agreement\") is made on October 15, 2009 (the \"Agreement Date\") and is effective as of the Effective Date (as defined below), between:   PACIRA PHARMACEUTICALS, INC. (F/K/A SKYEPHARMA, INC.) a company incorporated in the state of California whose principal place of business is 10450 Sciences Center Drive, San Diego, California 92121 USA (\"PPI\"); and   EKR THERAPEUTICS, INC., a company incorporated in the state of Delaware whose principal place of business is 1545 Route 206  South, Third Floor, Bedminster, New Jersey 07921 (\"EKR\").\\n\\nRecitals\\n\\nPPI owns and has all right title and interest in or has acquired exclusive rights to the PPI IP (as defined below), the Trademark (as  defined below) and the Product (as defined below).\\n\\nEKR has, among other things, specialized knowledge and expertise in relation to the marketing and sale of pharmaceutical products.\\n\\nPursuant to that certain Strategic Licensing, Distribution and Marketing Agreement between EKR and PPI dated as of August 10, 2007  (the \"Original Agreement\"), PPI granted and EKR acquired the exclusive right and license to sell, offer to sell, distribute and market the Product in  the Territory (as defined below) in the Field (as defined below).\\n\\nEKR and PPI desire to amend and restate the Original Agreement in its entirety as set forth herein in order to provide for: (i) certain  changes to the financial terms set forth in the Original Agreement, (ii) the transfer of Marketing Authorizations (as defined below) from PPI to      -1-\\n\\n\\n\\n\\n\\nEKR, and EKR\\'s assumption of obligations thereunder, (iii) the transfer of title to certain manufacturing equipment from PPI to EKR and the lease  of such equipment back from EKR to PPI and (iv) certain other changes as are set forth herein; all of the foregoing subject to and in accordance  with the terms and conditions of this Agreement.\\n\\nNOW THEREFORE, in consideration of the following mutual agreements and covenants set forth herein and intending to be legally  bound hereby, PPI and EKR (each, a \"Party\"  and collectively, the \"Parties\")  acknowledge and agree that this Agreement shall amend and  supersede in its entirety the Original Agreement and hereby agree as follows:\\n\\nOperative Provisions\\n\\n\\n\\n\\n\\n   -2-\\n\\n1. Definitions   1.1 As used in this Agreement, the following words and expressions have the following meanings:\\n\\n\"Affiliate\"\\n\\n\\n\\nWith respect to any Party to this Agreement shall mean any company, corporation, firm, individual or other  entity which Controls, is Controlled by or is under common Control with such Party to this Agreement for only  so long as such Control exists;\\n\\n\\n\\n\\n\\n   -3-\\n\\n\"Applicable Laws\"\\n\\n\\n\\nShall mean all laws, rules and regulations regarding the manufacture, packaging, labeling, import, export,  storage, distribution, representation, promotion, marketing and sale of the Products including but not limited to  the Federal Food, Drug and Cosmetic Act of 1938, as amended (\"FD&C Act\") and the Controlled Substances  Act, as amended (21 U.S.C. ยง801 et seq.), or as defined in attendant regulations promulgated under authorities  granted by the FD&C Act, together with any equivalent laws, rules, regulations, codes or guidelines having  effect in any jurisdiction in the Territory;\\n\\n\"Calendar Year\"    Shall mean the period of twelve months commencing on 1st January in any year, and each consecutive period  of twelve months thereafter during the Term;\\n\\n\"cGMP\"    Means Current Good Manufacturing Practices pursuant to 21 CFR Parts 210 and 211, as may be amended from  time to time;\\n\\n\"Commercial Launch\"\\n\\n\\n\\nShall mean the date of the first arm\\'s length sale by EKR to an unaffiliated Third Party customer for commercial  use of Pro',\n",
              "    'Highlight the parts (if any) of this contract related to \"Exclusivity\" that should be reviewed by a lawyer. Details: Is there an exclusive dealing\\xa0 commitment with the counterparty? This includes a commitment to procure all โrequirementsโ from one party of certain technology, goods, or services or a prohibition on licensing or selling technology, goods or services to third parties, or a prohibition on\\xa0 collaborating or working with other parties), whether during the contract or\\xa0 after the contract ends (or both).',\n",
              "    'Subject to the terms of this Agreement, PPI hereby appoints EKR and EKR agrees to be retained as the exclusive  distributor, and Authorized Distributor of Record, of the Products in the Field in the Territory during the Term to market, distribute,  warehouse and sell the Products.',\n",
              "    0,\n",
              "    0),\n",
              "   ('Exhibit 10.13\\n\\nConfidential Materials omitted and filed separately with the Securities and Exchange Commission. Asterisks denote omissions.\\n\\nDATED: OCTOBER 15, 2009\\n\\nPACIRA PHARMACEUTICALS, INC.\\n\\nand\\n\\nEKR THERAPEUTICS, INC.        AMENDED AND RESTATED   STRATEGIC LICENSING, DISTRIBUTION AND MARKETING AGREEMENT\\n\\n\\n\\n\\n\\nTHIS AMENDED AND RESTATED STRATEGIC LICENSING, DISTRIBUTION AND MARKETING AGREEMENT (the  \"Agreement\") is made on October 15, 2009 (the \"Agreement Date\") and is effective as of the Effective Date (as defined below), between:   PACIRA PHARMACEUTICALS, INC. (F/K/A SKYEPHARMA, INC.) a company incorporated in the state of California whose principal place of business is 10450 Sciences Center Drive, San Diego, California 92121 USA (\"PPI\"); and   EKR THERAPEUTICS, INC., a company incorporated in the state of Delaware whose principal place of business is 1545 Route 206  South, Third Floor, Bedminster, New Jersey 07921 (\"EKR\").\\n\\nRecitals\\n\\nPPI owns and has all right title and interest in or has acquired exclusive rights to the PPI IP (as defined below), the Trademark (as  defined below) and the Product (as defined below).\\n\\nEKR has, among other things, specialized knowledge and expertise in relation to the marketing and sale of pharmaceutical products.\\n\\nPursuant to that certain Strategic Licensing, Distribution and Marketing Agreement between EKR and PPI dated as of August 10, 2007  (the \"Original Agreement\"), PPI granted and EKR acquired the exclusive right and license to sell, offer to sell, distribute and market the Product in  the Territory (as defined below) in the Field (as defined below).\\n\\nEKR and PPI desire to amend and restate the Original Agreement in its entirety as set forth herein in order to provide for: (i) certain  changes to the financial terms set forth in the Original Agreement, (ii) the transfer of Marketing Authorizations (as defined below) from PPI to      -1-\\n\\n\\n\\n\\n\\nEKR, and EKR\\'s assumption of obligations thereunder, (iii) the transfer of title to certain manufacturing equipment from PPI to EKR and the lease  of such equipment back from EKR to PPI and (iv) certain other changes as are set forth herein; all of the foregoing subject to and in accordance  with the terms and conditions of this Agreement.\\n\\nNOW THEREFORE, in consideration of the following mutual agreements and covenants set forth herein and intending to be legally  bound hereby, PPI and EKR (each, a \"Party\"  and collectively, the \"Parties\")  acknowledge and agree that this Agreement shall amend and  supersede in its entirety the Original Agreement and hereby agree as follows:\\n\\nOperative Provisions\\n\\n\\n\\n\\n\\n   -2-\\n\\n1. Definitions   1.1 As used in this Agreement, the following words and expressions have the following meanings:\\n\\n\"Affiliate\"\\n\\n\\n\\nWith respect to any Party to this Agreement shall mean any company, corporation, firm, individual or other  entity which Controls, is Controlled by or is under common Control with such Party to this Agreement for only  so long as such Control exists;\\n\\n\\n\\n\\n\\n   -3-\\n\\n\"Applicable Laws\"\\n\\n\\n\\nShall mean all laws, rules and regulations regarding the manufacture, packaging, labeling, import, export,  storage, distribution, representation, promotion, marketing and sale of the Products including but not limited to  the Federal Food, Drug and Cosmetic Act of 1938, as amended (\"FD&C Act\") and the Controlled Substances  Act, as amended (21 U.S.C. ยง801 et seq.), or as defined in attendant regulations promulgated under authorities  granted by the FD&C Act, together with any equivalent laws, rules, regulations, codes or guidelines having  effect in any jurisdiction in the Territory;\\n\\n\"Calendar Year\"    Shall mean the period of twelve months commencing on 1st January in any year, and each consecutive period  of twelve months thereafter during the Term;\\n\\n\"cGMP\"    Means Current Good Manufacturing Practices pursuant to 21 CFR Parts 210 and 211, as may be amended from  time to time;\\n\\n\"Commercial Launch\"\\n\\n\\n\\nShall mean the date of the first arm\\'s length sale by EKR to an unaffiliated Third Party customer for commercial  use of Pro',\n",
              "    'Highlight the parts (if any) of this contract related to \"Exclusivity\" that should be reviewed by a lawyer. Details: Is there an exclusive dealing\\xa0 commitment with the counterparty? This includes a commitment to procure all โrequirementsโ from one party of certain technology, goods, or services or a prohibition on licensing or selling technology, goods or services to third parties, or a prohibition on\\xa0 collaborating or working with other parties), whether during the contract or\\xa0 after the contract ends (or both).',\n",
              "    'PPI hereby grants to EKR a royalty free and exclusive license (with the right to sublicense) to use the  Trademarks in the Territory solely in connection with the exercise of the Distribution Rights in the Territory during the Term (and thereafter  as set forth in Section 17.4) and EKR shall market and sell the Products under the Trademarks.',\n",
              "    0,\n",
              "    0),\n",
              "   ('1                                                                    Exhibit 10.16\\n\\n                                                                 CONFIDENTIAL Portions of this Exhibit have been omitted pursuant to a request for confidential treatment. The omitted portions, marked by [****], have been separately filed with the Commission.\\n\\n                           SPONSORSHIP AGREEMENT\\n\\nThis agreement (\"Agreement\") is entered into as of the 23rd day of September, 1997 (\"Effective Date\"), by and between Excite, Inc., a California corporation, located at 555 Broadway, Redwood City, California 94063 (\"Excite\"), and N2K Inc., a Pennsylvania corporation, located at 55 Broad Street, 26th Floor, New York, New York, 10004 (\"Sponsor\").\\n\\n                                 RECITALS\\n\\nA.   Excite maintains a site on the Internet at http://www.excite.com (the      \"Excite Site\") and owns and/or manages related Web Sites worldwide      (collectively, the \"Excite Network\") which, among other things, allow users      to search for and access content and other sites on the Internet.\\n\\nB.   Excite also maintains and/or manages certain Web pages which may be      delivered to users via email, desktop \"channels\" or Internet \"push\"      technologies (collectively, \"Broadcast Pages\") which may incorporate      content supplied to Excite by third parties for the purpose of providing      value to Excite users and providing access to the content, products and/or      services of such third parties.\\n\\nC.   Sponsor is in the business of distributing certain online retail music      merchandise and related content and maintains a Web site at      http://www.musicblvd.com (the \"Sponsor Site\") and other Web sites through      which it makes this merchandise and this content available to its users.\\n\\nD.   Sponsor wishes to be the exclusive retail store music sponsor of the Excite      Site and the Excite Broadcast Pages, to distribute its music-related      content through the Excite Site and the Excite Broadcast Pages and to      promote its online retail music merchandise business to Excite.com users.\\n\\nTherefore, the parties agree as follows:\\n\\n1.       EXCLUSIVITY, TERM AND RIGHT OF FIRST REFUSAL\\n\\n      a)       Sponsor will be the exclusive retail music store sponsor of                   the Excite Site and the Excite Broadcast Pages. Excite will                   not permit the display of advertising banners, promotional                   buttons, promotional links or other promotional materials for                   any retail sale of Music Products on the Excite Site, except                   those Music Products offered by Sponsor, nor advertising by                   any other Retail Music Store. \"Retail Music Store\" shall mean                   any entity which is primarily engaged in the sale of Music                   Products at retail to consumers. \"Music Products\"     2                                                                     CONFIDENTIAL\\n\\n              shall mean pre-recorded music hard goods, digitally                  distributed music (except live and/or cybercast events), music                  books (to the extent this Agreement does not conflict with                  Excite\\'s existing agreement with Amazon.com), music-related                  t-shirts and apparel, and music videos (except live and/or                  cybercast events).\\n\\n              Notwithstanding the foregoing, Excite may make available                  opportunities on the Excite Site to purchase Music Products                  from parties other than Sponsor if such Music Products are not                  available from Sponsor so long as, prior to entering into                  arrangements to make available opportunities to purchase Music                  Products from parties other than Sponsor, Excite notifies                  Sponsor of its interest in the Music Products and gives Sponsor                  thirty (30) days to make the desired Music Products available                  through the Sponsor Site. Excite and Sponsor acknowledge that ',\n",
              "    'Highlight the parts (if any) of this contract related to \"Exclusivity\" that should be reviewed by a lawyer. Details: Is there an exclusive dealing\\xa0 commitment with the counterparty? This includes a commitment to procure all โrequirementsโ from one party of certain technology, goods, or services or a prohibition on licensing or selling technology, goods or services to third parties, or a prohibition on\\xa0 collaborating or working with other parties), whether during the contract or\\xa0 after the contract ends (or both).',\n",
              "    'In no event will Excite enter                  into arrangements to make available opportunities to purchase                  Music Products from parties other than Sponsor that would                  prevent Sponsor from being the exclusive source of such Music                  Products on the Excite Site once the Music Products become                  available through Sponsor.',\n",
              "    0,\n",
              "    0),\n",
              "   (\"Exhibit 10.18 Confidential EXECUTION COPY\\n\\nCERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY [***], HAS BEEN OMITTED BECAUSE IT IS BOTH NOT MATERIAL AND WOULD BE COMPETITIVELY HARMFUL IF PUBLICLY DISCLOSED.\\n\\nDEVELOPMENT AND OPTION AGREEMENT\\n\\nbetween\\n\\nHARPOON THERAPEUTICS, INC.\\n\\nand\\n\\nABBVIE BIOTECHNOLOGY LTD\\n\\nDated as of November 20, 2019\\n\\nSource: HARPOON THERAPEUTICS, INC., 10-K, 3/12/2020\\n\\n\\n\\n\\n\\nTABLE OF CONTENTS\\n\\nARTICLE 1 DEFINITIONS 1\\n\\nARTICLE 2 COLLABORATION MANAGEMENT\\n\\n18\\n\\n2.1 Joint Governance Committee. 18 2.2 General Provisions Applicable to the JGC. 19 2.3 Discontinuation of the JGC. 20 2.4 Interactions Between the JGC and Internal Teams. 20 2.5 CMC Working Group. 21 2.6 Working Groups. 21 2.7 Expenses. 21\\n\\nARTICLE 3 DEVELOPMENT AND REGULATORY\\n\\n21\\n\\n3.1 Initial Development Plan and Activities. 21 3.2 AbbVie Option. 24 3.3 [***]. 25 3.4 Post-Exercise Development Activities. 26 3.5 Supply of Technology for Development Purposes. 27 3.6 Expenses and Invoicing. 27 3.7 Subcontracting. 28 3.8 Regulatory Matters. 28\\n\\nARTICLE 4 COMMERCIALIZATION 30\\n\\n4.1 In General. 30 4.2 Commercialization Diligence. 30 4.3 Booking of Sales; Distribution. 31 4.4 Product Trademarks. 31 4.5 Commercial Supply of Licensed Compounds or Licensed Products. 31\\n\\nARTICLE 5 GRANT OF RIGHTS\\n\\n33\\n\\n5.1 Grants to AbbVie. 33 5.2 Grants to Harpoon. 34 5.3 Sublicenses. 34 5.4 Distributorships. 34 5.5 Co-Promotion Rights. 34 5.6 Retention of Rights. 34 5.7 Confirmatory Patent License. 35 5.8 Exclusivity with Respect to the Territory. 35 5.9 In-License Agreements. 35\\n\\nARTICLE 6 PAYMENTS AND RECORDS\\n\\n36\\n\\n6.1 Upfront Payment. 36 6.2 Development and Regulatory Milestones. 36 6.3 First Commercial Sales Milestones. 37 6.4 Sales-Based Milestones. 37 6.5 Royalties. 38 6.6 Royalty Payments and Reports. 39 6.7 Mode of Payment; Offsets. 40 6.8 Withholding Taxes. 40\\n\\nSource: HARPOON THERAPEUTICS, INC., 10-K, 3/12/2020\\n\\n\\n\\n\\n\\n6.9 Indirect Taxes. 40 6.10 Interest on Late Payments. 41 6.11 Audit. 41 6.12 Audit Dispute. 41 6.13 Confidentiality. 41 6.14 [***] 41 6.15 No Other Compensation. 42\\n\\nARTICLE 7 INTELLECTUAL PROPERTY\\n\\n42\\n\\n7.1 Ownership of Intellectual Property. 42 7.2 Maintenance and Prosecution of Patents. 43 7.3 Enforcement of Patents. 45 7.4 Infringement Claims by Third Parties. 48 7.5 Invalidity or Unenforceability Defenses or Actions. 48 7.6 Product Trademarks. 49 7.7 International Nonproprietary Name. 50 7.8 Inventor's Remuneration. 50 7.9 Common Interest. 50\\n\\nARTICLE 8 PHARMACOVIGILANCE AND SAFETY\\n\\n50\\n\\n8.1 Pharmacovigilance. 50 8.2 Global Safety Database. 50\\n\\nARTICLE 9 CONFIDENTIALITY AND NON- DISCLOSURE\\n\\n51\\n\\n9.1 Product Information. 51 9.2 Confidentiality Obligations. 51 9.3 Permitted Disclosures. 52 9.4 Use of Name. 53 9.5 Public Announcements. 53 9.6 Publications. 54 9.7 Return of Confidential Information. 54 9.8 Survival. 54\\n\\nARTICLE 10 REPRESENTATIONS AND WARRANTIES\\n\\n55\\n\\n10.1 Mutual Representations and Warranties. 55 10.2 Additional Representations and Warranties of Harpoon. 55 10.3 Covenants of Harpoon. 58 10.4 Covenants of AbbVie. 58 10.5 DISCLAIMER OF WARRANTIES. 59\\n\\nARTICLE 11 INDEMNITY 60\\n\\n11.1 Indemnification of Harpoon. 60 11.2 Indemnification of AbbVie. 60 11.3 Notice of Claim. 60 11.4 Control of Defense. 61 11.5 Special, Indirect, and Other Losses. 61 11.6 Insurance. 61\\n\\nARTICLE 12 TERM AND TERMINATION\\n\\n62\\n\\n12.1 Term. 62\\n\\n- ii -\\n\\nSource: HARPOON THERAPEUTICS, INC., 10-K, 3/12/2020\\n\\n\\n\\n\\n\\n12.2 Termination for Material Breach. 62 12.3 Additional Termination Rights by AbbVie. 63 12.4 Termination for Insolvency. 63 12.5 Rights in Bankruptcy. 63 12.6 Termination in Entirety. 63 12.7 Reversion of Harpoon Products. 66 12.8 Termination of Terminated Territory. 67 12.9 Remedies. 67 12.10 Accrued Rights; Surviving Obligations. 67\\n\\nARTICLE 13 MISCELLANEOUS 68\\n\\n13.1 Force Majeure. 68 13.2 Change in Control of Harpoon. 68 13.3 Export Control. 69 13.4 Assignment. 69 13.5 Severability. 70 13.6 Governing Law, Jurisdiction and Service. 70 13.7 Dispute Resolution. 70 13.8 Notices. 71 13.9 Entire Agreement; Amendments. 72 13.10 English Language. 72 1\",\n",
              "    'Highlight the parts (if any) of this contract related to \"Exclusivity\" that should be reviewed by a lawyer. Details: Is there an exclusive dealing\\xa0 commitment with the counterparty? This includes a commitment to procure all โrequirementsโ from one party of certain technology, goods, or services or a prohibition on licensing or selling technology, goods or services to third parties, or a prohibition on\\xa0 collaborating or working with other parties), whether during the contract or\\xa0 after the contract ends (or both).',\n",
              "    \"Effective upon the date that AbbVie commences performing Initial Development Activities pursuant to Section 3.1.2, Harpoon (on behalf of itself and its Affiliates) shall grant and hereby grants AbbVie a co- exclusive (with Harpoon), royalty-free license, with the right to grant sublicenses in accordance with Section 5.3, under the Harpoon Patents, the Harpoon Know-How, and Harpoon's interests in the Joint Patents and the Joint Know-How, solely to the extent necessary for AbbVie to conduct Initial Development Activities assumed by AbbVie in accordance with Section 3.1.2 (if any).\",\n",
              "    0,\n",
              "    0),\n",
              "   (\"Exhibit 10.18 Confidential EXECUTION COPY\\n\\nCERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY [***], HAS BEEN OMITTED BECAUSE IT IS BOTH NOT MATERIAL AND WOULD BE COMPETITIVELY HARMFUL IF PUBLICLY DISCLOSED.\\n\\nDEVELOPMENT AND OPTION AGREEMENT\\n\\nbetween\\n\\nHARPOON THERAPEUTICS, INC.\\n\\nand\\n\\nABBVIE BIOTECHNOLOGY LTD\\n\\nDated as of November 20, 2019\\n\\nSource: HARPOON THERAPEUTICS, INC., 10-K, 3/12/2020\\n\\n\\n\\n\\n\\nTABLE OF CONTENTS\\n\\nARTICLE 1 DEFINITIONS 1\\n\\nARTICLE 2 COLLABORATION MANAGEMENT\\n\\n18\\n\\n2.1 Joint Governance Committee. 18 2.2 General Provisions Applicable to the JGC. 19 2.3 Discontinuation of the JGC. 20 2.4 Interactions Between the JGC and Internal Teams. 20 2.5 CMC Working Group. 21 2.6 Working Groups. 21 2.7 Expenses. 21\\n\\nARTICLE 3 DEVELOPMENT AND REGULATORY\\n\\n21\\n\\n3.1 Initial Development Plan and Activities. 21 3.2 AbbVie Option. 24 3.3 [***]. 25 3.4 Post-Exercise Development Activities. 26 3.5 Supply of Technology for Development Purposes. 27 3.6 Expenses and Invoicing. 27 3.7 Subcontracting. 28 3.8 Regulatory Matters. 28\\n\\nARTICLE 4 COMMERCIALIZATION 30\\n\\n4.1 In General. 30 4.2 Commercialization Diligence. 30 4.3 Booking of Sales; Distribution. 31 4.4 Product Trademarks. 31 4.5 Commercial Supply of Licensed Compounds or Licensed Products. 31\\n\\nARTICLE 5 GRANT OF RIGHTS\\n\\n33\\n\\n5.1 Grants to AbbVie. 33 5.2 Grants to Harpoon. 34 5.3 Sublicenses. 34 5.4 Distributorships. 34 5.5 Co-Promotion Rights. 34 5.6 Retention of Rights. 34 5.7 Confirmatory Patent License. 35 5.8 Exclusivity with Respect to the Territory. 35 5.9 In-License Agreements. 35\\n\\nARTICLE 6 PAYMENTS AND RECORDS\\n\\n36\\n\\n6.1 Upfront Payment. 36 6.2 Development and Regulatory Milestones. 36 6.3 First Commercial Sales Milestones. 37 6.4 Sales-Based Milestones. 37 6.5 Royalties. 38 6.6 Royalty Payments and Reports. 39 6.7 Mode of Payment; Offsets. 40 6.8 Withholding Taxes. 40\\n\\nSource: HARPOON THERAPEUTICS, INC., 10-K, 3/12/2020\\n\\n\\n\\n\\n\\n6.9 Indirect Taxes. 40 6.10 Interest on Late Payments. 41 6.11 Audit. 41 6.12 Audit Dispute. 41 6.13 Confidentiality. 41 6.14 [***] 41 6.15 No Other Compensation. 42\\n\\nARTICLE 7 INTELLECTUAL PROPERTY\\n\\n42\\n\\n7.1 Ownership of Intellectual Property. 42 7.2 Maintenance and Prosecution of Patents. 43 7.3 Enforcement of Patents. 45 7.4 Infringement Claims by Third Parties. 48 7.5 Invalidity or Unenforceability Defenses or Actions. 48 7.6 Product Trademarks. 49 7.7 International Nonproprietary Name. 50 7.8 Inventor's Remuneration. 50 7.9 Common Interest. 50\\n\\nARTICLE 8 PHARMACOVIGILANCE AND SAFETY\\n\\n50\\n\\n8.1 Pharmacovigilance. 50 8.2 Global Safety Database. 50\\n\\nARTICLE 9 CONFIDENTIALITY AND NON- DISCLOSURE\\n\\n51\\n\\n9.1 Product Information. 51 9.2 Confidentiality Obligations. 51 9.3 Permitted Disclosures. 52 9.4 Use of Name. 53 9.5 Public Announcements. 53 9.6 Publications. 54 9.7 Return of Confidential Information. 54 9.8 Survival. 54\\n\\nARTICLE 10 REPRESENTATIONS AND WARRANTIES\\n\\n55\\n\\n10.1 Mutual Representations and Warranties. 55 10.2 Additional Representations and Warranties of Harpoon. 55 10.3 Covenants of Harpoon. 58 10.4 Covenants of AbbVie. 58 10.5 DISCLAIMER OF WARRANTIES. 59\\n\\nARTICLE 11 INDEMNITY 60\\n\\n11.1 Indemnification of Harpoon. 60 11.2 Indemnification of AbbVie. 60 11.3 Notice of Claim. 60 11.4 Control of Defense. 61 11.5 Special, Indirect, and Other Losses. 61 11.6 Insurance. 61\\n\\nARTICLE 12 TERM AND TERMINATION\\n\\n62\\n\\n12.1 Term. 62\\n\\n- ii -\\n\\nSource: HARPOON THERAPEUTICS, INC., 10-K, 3/12/2020\\n\\n\\n\\n\\n\\n12.2 Termination for Material Breach. 62 12.3 Additional Termination Rights by AbbVie. 63 12.4 Termination for Insolvency. 63 12.5 Rights in Bankruptcy. 63 12.6 Termination in Entirety. 63 12.7 Reversion of Harpoon Products. 66 12.8 Termination of Terminated Territory. 67 12.9 Remedies. 67 12.10 Accrued Rights; Surviving Obligations. 67\\n\\nARTICLE 13 MISCELLANEOUS 68\\n\\n13.1 Force Majeure. 68 13.2 Change in Control of Harpoon. 68 13.3 Export Control. 69 13.4 Assignment. 69 13.5 Severability. 70 13.6 Governing Law, Jurisdiction and Service. 70 13.7 Dispute Resolution. 70 13.8 Notices. 71 13.9 Entire Agreement; Amendments. 72 13.10 English Language. 72 1\",\n",
              "    'Highlight the parts (if any) of this contract related to \"Exclusivity\" that should be reviewed by a lawyer. Details: Is there an exclusive dealing\\xa0 commitment with the counterparty? This includes a commitment to procure all โrequirementsโ from one party of certain technology, goods, or services or a prohibition on licensing or selling technology, goods or services to third parties, or a prohibition on\\xa0 collaborating or working with other parties), whether during the contract or\\xa0 after the contract ends (or both).',\n",
              "    \"Upon the [***], Harpoon (on behalf of itself and its Affiliates) hereby grants to AbbVie a co-exclusive (with Harpoon), royalty-free (subject to [***] [***]) license, with the right to grant sublicenses in accordance with Section 5.3, under the Harpoon Patents, the Harpoon Know-How, and Harpoon's interests in the Joint Patents and the Joint Know- How, to Develop and Manufacture the Licensed Compounds and Licensed Products solely to the extent necessary for AbbVie to perform [***].\",\n",
              "    0,\n",
              "    0),\n",
              "   (\"Exhibit 10.18 Confidential EXECUTION COPY\\n\\nCERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY [***], HAS BEEN OMITTED BECAUSE IT IS BOTH NOT MATERIAL AND WOULD BE COMPETITIVELY HARMFUL IF PUBLICLY DISCLOSED.\\n\\nDEVELOPMENT AND OPTION AGREEMENT\\n\\nbetween\\n\\nHARPOON THERAPEUTICS, INC.\\n\\nand\\n\\nABBVIE BIOTECHNOLOGY LTD\\n\\nDated as of November 20, 2019\\n\\nSource: HARPOON THERAPEUTICS, INC., 10-K, 3/12/2020\\n\\n\\n\\n\\n\\nTABLE OF CONTENTS\\n\\nARTICLE 1 DEFINITIONS 1\\n\\nARTICLE 2 COLLABORATION MANAGEMENT\\n\\n18\\n\\n2.1 Joint Governance Committee. 18 2.2 General Provisions Applicable to the JGC. 19 2.3 Discontinuation of the JGC. 20 2.4 Interactions Between the JGC and Internal Teams. 20 2.5 CMC Working Group. 21 2.6 Working Groups. 21 2.7 Expenses. 21\\n\\nARTICLE 3 DEVELOPMENT AND REGULATORY\\n\\n21\\n\\n3.1 Initial Development Plan and Activities. 21 3.2 AbbVie Option. 24 3.3 [***]. 25 3.4 Post-Exercise Development Activities. 26 3.5 Supply of Technology for Development Purposes. 27 3.6 Expenses and Invoicing. 27 3.7 Subcontracting. 28 3.8 Regulatory Matters. 28\\n\\nARTICLE 4 COMMERCIALIZATION 30\\n\\n4.1 In General. 30 4.2 Commercialization Diligence. 30 4.3 Booking of Sales; Distribution. 31 4.4 Product Trademarks. 31 4.5 Commercial Supply of Licensed Compounds or Licensed Products. 31\\n\\nARTICLE 5 GRANT OF RIGHTS\\n\\n33\\n\\n5.1 Grants to AbbVie. 33 5.2 Grants to Harpoon. 34 5.3 Sublicenses. 34 5.4 Distributorships. 34 5.5 Co-Promotion Rights. 34 5.6 Retention of Rights. 34 5.7 Confirmatory Patent License. 35 5.8 Exclusivity with Respect to the Territory. 35 5.9 In-License Agreements. 35\\n\\nARTICLE 6 PAYMENTS AND RECORDS\\n\\n36\\n\\n6.1 Upfront Payment. 36 6.2 Development and Regulatory Milestones. 36 6.3 First Commercial Sales Milestones. 37 6.4 Sales-Based Milestones. 37 6.5 Royalties. 38 6.6 Royalty Payments and Reports. 39 6.7 Mode of Payment; Offsets. 40 6.8 Withholding Taxes. 40\\n\\nSource: HARPOON THERAPEUTICS, INC., 10-K, 3/12/2020\\n\\n\\n\\n\\n\\n6.9 Indirect Taxes. 40 6.10 Interest on Late Payments. 41 6.11 Audit. 41 6.12 Audit Dispute. 41 6.13 Confidentiality. 41 6.14 [***] 41 6.15 No Other Compensation. 42\\n\\nARTICLE 7 INTELLECTUAL PROPERTY\\n\\n42\\n\\n7.1 Ownership of Intellectual Property. 42 7.2 Maintenance and Prosecution of Patents. 43 7.3 Enforcement of Patents. 45 7.4 Infringement Claims by Third Parties. 48 7.5 Invalidity or Unenforceability Defenses or Actions. 48 7.6 Product Trademarks. 49 7.7 International Nonproprietary Name. 50 7.8 Inventor's Remuneration. 50 7.9 Common Interest. 50\\n\\nARTICLE 8 PHARMACOVIGILANCE AND SAFETY\\n\\n50\\n\\n8.1 Pharmacovigilance. 50 8.2 Global Safety Database. 50\\n\\nARTICLE 9 CONFIDENTIALITY AND NON- DISCLOSURE\\n\\n51\\n\\n9.1 Product Information. 51 9.2 Confidentiality Obligations. 51 9.3 Permitted Disclosures. 52 9.4 Use of Name. 53 9.5 Public Announcements. 53 9.6 Publications. 54 9.7 Return of Confidential Information. 54 9.8 Survival. 54\\n\\nARTICLE 10 REPRESENTATIONS AND WARRANTIES\\n\\n55\\n\\n10.1 Mutual Representations and Warranties. 55 10.2 Additional Representations and Warranties of Harpoon. 55 10.3 Covenants of Harpoon. 58 10.4 Covenants of AbbVie. 58 10.5 DISCLAIMER OF WARRANTIES. 59\\n\\nARTICLE 11 INDEMNITY 60\\n\\n11.1 Indemnification of Harpoon. 60 11.2 Indemnification of AbbVie. 60 11.3 Notice of Claim. 60 11.4 Control of Defense. 61 11.5 Special, Indirect, and Other Losses. 61 11.6 Insurance. 61\\n\\nARTICLE 12 TERM AND TERMINATION\\n\\n62\\n\\n12.1 Term. 62\\n\\n- ii -\\n\\nSource: HARPOON THERAPEUTICS, INC., 10-K, 3/12/2020\\n\\n\\n\\n\\n\\n12.2 Termination for Material Breach. 62 12.3 Additional Termination Rights by AbbVie. 63 12.4 Termination for Insolvency. 63 12.5 Rights in Bankruptcy. 63 12.6 Termination in Entirety. 63 12.7 Reversion of Harpoon Products. 66 12.8 Termination of Terminated Territory. 67 12.9 Remedies. 67 12.10 Accrued Rights; Surviving Obligations. 67\\n\\nARTICLE 13 MISCELLANEOUS 68\\n\\n13.1 Force Majeure. 68 13.2 Change in Control of Harpoon. 68 13.3 Export Control. 69 13.4 Assignment. 69 13.5 Severability. 70 13.6 Governing Law, Jurisdiction and Service. 70 13.7 Dispute Resolution. 70 13.8 Notices. 71 13.9 Entire Agreement; Amendments. 72 13.10 English Language. 72 1\",\n",
              "    'Highlight the parts (if any) of this contract related to \"Exclusivity\" that should be reviewed by a lawyer. Details: Is there an exclusive dealing\\xa0 commitment with the counterparty? This includes a commitment to procure all โrequirementsโ from one party of certain technology, goods, or services or a prohibition on licensing or selling technology, goods or services to third parties, or a prohibition on\\xa0 collaborating or working with other parties), whether during the contract or\\xa0 after the contract ends (or both).',\n",
              "    'Upon the Effective Date, Harpoon hereby grants to AbbVie the exclusive right, but not the obligation, to obtain the licenses set forth in Section 5.1.3 (the \"License Option\").',\n",
              "    0,\n",
              "    0),\n",
              "   (\"Exhibit 10.18 Confidential EXECUTION COPY\\n\\nCERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY [***], HAS BEEN OMITTED BECAUSE IT IS BOTH NOT MATERIAL AND WOULD BE COMPETITIVELY HARMFUL IF PUBLICLY DISCLOSED.\\n\\nDEVELOPMENT AND OPTION AGREEMENT\\n\\nbetween\\n\\nHARPOON THERAPEUTICS, INC.\\n\\nand\\n\\nABBVIE BIOTECHNOLOGY LTD\\n\\nDated as of November 20, 2019\\n\\nSource: HARPOON THERAPEUTICS, INC., 10-K, 3/12/2020\\n\\n\\n\\n\\n\\nTABLE OF CONTENTS\\n\\nARTICLE 1 DEFINITIONS 1\\n\\nARTICLE 2 COLLABORATION MANAGEMENT\\n\\n18\\n\\n2.1 Joint Governance Committee. 18 2.2 General Provisions Applicable to the JGC. 19 2.3 Discontinuation of the JGC. 20 2.4 Interactions Between the JGC and Internal Teams. 20 2.5 CMC Working Group. 21 2.6 Working Groups. 21 2.7 Expenses. 21\\n\\nARTICLE 3 DEVELOPMENT AND REGULATORY\\n\\n21\\n\\n3.1 Initial Development Plan and Activities. 21 3.2 AbbVie Option. 24 3.3 [***]. 25 3.4 Post-Exercise Development Activities. 26 3.5 Supply of Technology for Development Purposes. 27 3.6 Expenses and Invoicing. 27 3.7 Subcontracting. 28 3.8 Regulatory Matters. 28\\n\\nARTICLE 4 COMMERCIALIZATION 30\\n\\n4.1 In General. 30 4.2 Commercialization Diligence. 30 4.3 Booking of Sales; Distribution. 31 4.4 Product Trademarks. 31 4.5 Commercial Supply of Licensed Compounds or Licensed Products. 31\\n\\nARTICLE 5 GRANT OF RIGHTS\\n\\n33\\n\\n5.1 Grants to AbbVie. 33 5.2 Grants to Harpoon. 34 5.3 Sublicenses. 34 5.4 Distributorships. 34 5.5 Co-Promotion Rights. 34 5.6 Retention of Rights. 34 5.7 Confirmatory Patent License. 35 5.8 Exclusivity with Respect to the Territory. 35 5.9 In-License Agreements. 35\\n\\nARTICLE 6 PAYMENTS AND RECORDS\\n\\n36\\n\\n6.1 Upfront Payment. 36 6.2 Development and Regulatory Milestones. 36 6.3 First Commercial Sales Milestones. 37 6.4 Sales-Based Milestones. 37 6.5 Royalties. 38 6.6 Royalty Payments and Reports. 39 6.7 Mode of Payment; Offsets. 40 6.8 Withholding Taxes. 40\\n\\nSource: HARPOON THERAPEUTICS, INC., 10-K, 3/12/2020\\n\\n\\n\\n\\n\\n6.9 Indirect Taxes. 40 6.10 Interest on Late Payments. 41 6.11 Audit. 41 6.12 Audit Dispute. 41 6.13 Confidentiality. 41 6.14 [***] 41 6.15 No Other Compensation. 42\\n\\nARTICLE 7 INTELLECTUAL PROPERTY\\n\\n42\\n\\n7.1 Ownership of Intellectual Property. 42 7.2 Maintenance and Prosecution of Patents. 43 7.3 Enforcement of Patents. 45 7.4 Infringement Claims by Third Parties. 48 7.5 Invalidity or Unenforceability Defenses or Actions. 48 7.6 Product Trademarks. 49 7.7 International Nonproprietary Name. 50 7.8 Inventor's Remuneration. 50 7.9 Common Interest. 50\\n\\nARTICLE 8 PHARMACOVIGILANCE AND SAFETY\\n\\n50\\n\\n8.1 Pharmacovigilance. 50 8.2 Global Safety Database. 50\\n\\nARTICLE 9 CONFIDENTIALITY AND NON- DISCLOSURE\\n\\n51\\n\\n9.1 Product Information. 51 9.2 Confidentiality Obligations. 51 9.3 Permitted Disclosures. 52 9.4 Use of Name. 53 9.5 Public Announcements. 53 9.6 Publications. 54 9.7 Return of Confidential Information. 54 9.8 Survival. 54\\n\\nARTICLE 10 REPRESENTATIONS AND WARRANTIES\\n\\n55\\n\\n10.1 Mutual Representations and Warranties. 55 10.2 Additional Representations and Warranties of Harpoon. 55 10.3 Covenants of Harpoon. 58 10.4 Covenants of AbbVie. 58 10.5 DISCLAIMER OF WARRANTIES. 59\\n\\nARTICLE 11 INDEMNITY 60\\n\\n11.1 Indemnification of Harpoon. 60 11.2 Indemnification of AbbVie. 60 11.3 Notice of Claim. 60 11.4 Control of Defense. 61 11.5 Special, Indirect, and Other Losses. 61 11.6 Insurance. 61\\n\\nARTICLE 12 TERM AND TERMINATION\\n\\n62\\n\\n12.1 Term. 62\\n\\n- ii -\\n\\nSource: HARPOON THERAPEUTICS, INC., 10-K, 3/12/2020\\n\\n\\n\\n\\n\\n12.2 Termination for Material Breach. 62 12.3 Additional Termination Rights by AbbVie. 63 12.4 Termination for Insolvency. 63 12.5 Rights in Bankruptcy. 63 12.6 Termination in Entirety. 63 12.7 Reversion of Harpoon Products. 66 12.8 Termination of Terminated Territory. 67 12.9 Remedies. 67 12.10 Accrued Rights; Surviving Obligations. 67\\n\\nARTICLE 13 MISCELLANEOUS 68\\n\\n13.1 Force Majeure. 68 13.2 Change in Control of Harpoon. 68 13.3 Export Control. 69 13.4 Assignment. 69 13.5 Severability. 70 13.6 Governing Law, Jurisdiction and Service. 70 13.7 Dispute Resolution. 70 13.8 Notices. 71 13.9 Entire Agreement; Amendments. 72 13.10 English Language. 72 1\",\n",
              "    'Highlight the parts (if any) of this contract related to \"Exclusivity\" that should be reviewed by a lawyer. Details: Is there an exclusive dealing\\xa0 commitment with the counterparty? This includes a commitment to procure all โrequirementsโ from one party of certain technology, goods, or services or a prohibition on licensing or selling technology, goods or services to third parties, or a prohibition on\\xa0 collaborating or working with other parties), whether during the contract or\\xa0 after the contract ends (or both).',\n",
              "    \"Upon the License Option Exercise Closing Date, Harpoon (on behalf of itself and its Affiliates) hereby grants to AbbVie:\\n\\n(a) an exclusive (including with regard to Harpoon and its Affiliates, except as provided in Section 5.6) license (or sublicense), with the right to grant sublicenses in accordance with Section 5.3, under the Harpoon Patents, the Harpoon Know-How, and Harpoon's interests in the Joint Patents and the Joint Know-How, to Exploit the Licensed Compounds and Licensed Products in the Field in the Territory;\\n\\n(b) an exclusive (including with regard to Harpoon and its Affiliates, except as provided in Section 5.6) license and right of reference, with the right to grant sublicenses and further rights of reference in accordance with Section 5.3, under the Regulatory Approvals and any other Regulatory Documentation that Harpoon or its Affiliates may Control with respect to the Licensed Compounds or Licensed Products solely for purposes of Exploiting the Licensed Compounds and Licensed Products in the Field in the Territory.\",\n",
              "    0,\n",
              "    0),\n",
              "   ('Exhibit 10.54 DISTRIBUTION AND DEVELOPMENT AGREEMENT This Distribution and Development Agreement (this \"Agreement\") is made and entered into as of May 1, 2016 by and between Sekisui Diagnostics, LLC and its Affiliates, a Delaware limited liability company with principal offices at 4 Hartwell Place, Lexington, Massachusetts 02421 (\"Sekisui\"), and Qualigen, Inc. and its Affiliates, a Delaware corporation with principal offices at 2042 Corte Del Nogal, Carlsbad, California 92011 (\"Qualigen\" and together with Sekisui, each a \"Party\" and together the \"Parties\"). WHEREAS, Qualigen is engaged in the manufacture, supply and development of certain clinical rapid diagnostic test devices and controls; and WHEREAS, Qualigen wishes to appoint Sekisui as its exclusive distributor for such products in the Territory (as defined below); and WHEREAS, Sekisui wishes to be appointed as the exclusive distributor of such products and to fund the development of certain future products. NOW, THEREFORE, in consideration of the mutual covenants hereinafter contained, the parties hereto agree as follows: 1. Definitions 1.1. Adverse Event shall mean an incident in which the Product was alleged to have caused or contributed to the death or serious injury of a patient or operator and would require submitting a Medical Devices Report to the FDA (as hereinafter defined) as per 21 CFR 803, or a similar report to a Competent Authority (as hereinafter defined) as per Vigilance Guidance MEDDEV 2.12-1. 1.2. Affiliate shall mean, (i) with respect to Qualigen, any corporation or other form of business organization, which directly or indirectly owns, controls, is controlled by, or is under common control with Qualigen, and (ii), with respect to Sekisui, shall mean Sekisui Diagnostics (UK) Ltd., Sekisui Diagnostics PEI, Inc., SEKISUI MEDICAL CO., LTD., and Sekisui Diagnostics GmbH. An entity shall be regarded as being in control of another entity if the former entity has the direct or indirect power to vote more than fifty percent (50%) of the outstanding voting securities (or other ownership interest for a business organization other than a corporation) of that entity, or the direct or indirect ability to direct or cause the direction of the general management and policies of the other entity. 1.3. Applicable Markets shall mean the United States, Canada, the European Union, Japan and other additional geographies that are added from time to time at the request of Sekisui, but only to the extent that it is commercially reasonable for Qualigen to expand to such additional geographies. 1.4. Available Margin is defined on Exhibit A. 1.5. Business Plan shall mean the business plan attached as Exhibit B hereto, which business plan may be amended from time to time by mutual agreement of Qualigen and Sekisui. 1.6. COGS is defined on Exhibit A.\\n\\nSource: RITTER PHARMACEUTICALS INC, S-4/A, 3/13/2020\\n\\n\\n\\n\\n\\n1.7. Competent Authority shall mean the governmental authority in a member state of the European Union which has competence in relation to the Products. 1.8. Development Plan shall mean the development plan attached as Exhibit C hereto, which development plan may be amended from time to time by mutual agreement of Qualigen and Sekisui. 1.9. Effective Date shall mean May 1, 2016. 1.10. European Union shall mean the countries in Europe that are under the CE mark regulatory regime. 1.11. Exclusivity Period shall mean the period from the Effective Date until December 31, 2018. 1.12. FDA shall mean the U.S. Food and Drug Administration or any successor agency. 1.13. Health Canada shall mean the department of the government of Canada with responsibility for national public health. 1.14. Intellectual Property Rights means all intellectual property rights in any jurisdiction worldwide, including, without limitation: (a) Patent Rights; (b) rights associated with works of authorship including copyrights, copyright applications, and copyright registrations; (c) rights relating to the protection of trade secrets, know-how or confidential information; and (d) rights in any trade names',\n",
              "    'Highlight the parts (if any) of this contract related to \"Exclusivity\" that should be reviewed by a lawyer. Details: Is there an exclusive dealing\\xa0 commitment with the counterparty? This includes a commitment to procure all โrequirementsโ from one party of certain technology, goods, or services or a prohibition on licensing or selling technology, goods or services to third parties, or a prohibition on\\xa0 collaborating or working with other parties), whether during the contract or\\xa0 after the contract ends (or both).',\n",
              "    'Qualigen hereby appoints Sekisui, and Sekisui accepts the appointment to act on an exclusive basis pursuant to the terms and conditions of this Agreement, as a distributor for the sale of the Products in the Territory.',\n",
              "    0,\n",
              "    0),\n",
              "   ('Exhibit 10.54 DISTRIBUTION AND DEVELOPMENT AGREEMENT This Distribution and Development Agreement (this \"Agreement\") is made and entered into as of May 1, 2016 by and between Sekisui Diagnostics, LLC and its Affiliates, a Delaware limited liability company with principal offices at 4 Hartwell Place, Lexington, Massachusetts 02421 (\"Sekisui\"), and Qualigen, Inc. and its Affiliates, a Delaware corporation with principal offices at 2042 Corte Del Nogal, Carlsbad, California 92011 (\"Qualigen\" and together with Sekisui, each a \"Party\" and together the \"Parties\"). WHEREAS, Qualigen is engaged in the manufacture, supply and development of certain clinical rapid diagnostic test devices and controls; and WHEREAS, Qualigen wishes to appoint Sekisui as its exclusive distributor for such products in the Territory (as defined below); and WHEREAS, Sekisui wishes to be appointed as the exclusive distributor of such products and to fund the development of certain future products. NOW, THEREFORE, in consideration of the mutual covenants hereinafter contained, the parties hereto agree as follows: 1. Definitions 1.1. Adverse Event shall mean an incident in which the Product was alleged to have caused or contributed to the death or serious injury of a patient or operator and would require submitting a Medical Devices Report to the FDA (as hereinafter defined) as per 21 CFR 803, or a similar report to a Competent Authority (as hereinafter defined) as per Vigilance Guidance MEDDEV 2.12-1. 1.2. Affiliate shall mean, (i) with respect to Qualigen, any corporation or other form of business organization, which directly or indirectly owns, controls, is controlled by, or is under common control with Qualigen, and (ii), with respect to Sekisui, shall mean Sekisui Diagnostics (UK) Ltd., Sekisui Diagnostics PEI, Inc., SEKISUI MEDICAL CO., LTD., and Sekisui Diagnostics GmbH. An entity shall be regarded as being in control of another entity if the former entity has the direct or indirect power to vote more than fifty percent (50%) of the outstanding voting securities (or other ownership interest for a business organization other than a corporation) of that entity, or the direct or indirect ability to direct or cause the direction of the general management and policies of the other entity. 1.3. Applicable Markets shall mean the United States, Canada, the European Union, Japan and other additional geographies that are added from time to time at the request of Sekisui, but only to the extent that it is commercially reasonable for Qualigen to expand to such additional geographies. 1.4. Available Margin is defined on Exhibit A. 1.5. Business Plan shall mean the business plan attached as Exhibit B hereto, which business plan may be amended from time to time by mutual agreement of Qualigen and Sekisui. 1.6. COGS is defined on Exhibit A.\\n\\nSource: RITTER PHARMACEUTICALS INC, S-4/A, 3/13/2020\\n\\n\\n\\n\\n\\n1.7. Competent Authority shall mean the governmental authority in a member state of the European Union which has competence in relation to the Products. 1.8. Development Plan shall mean the development plan attached as Exhibit C hereto, which development plan may be amended from time to time by mutual agreement of Qualigen and Sekisui. 1.9. Effective Date shall mean May 1, 2016. 1.10. European Union shall mean the countries in Europe that are under the CE mark regulatory regime. 1.11. Exclusivity Period shall mean the period from the Effective Date until December 31, 2018. 1.12. FDA shall mean the U.S. Food and Drug Administration or any successor agency. 1.13. Health Canada shall mean the department of the government of Canada with responsibility for national public health. 1.14. Intellectual Property Rights means all intellectual property rights in any jurisdiction worldwide, including, without limitation: (a) Patent Rights; (b) rights associated with works of authorship including copyrights, copyright applications, and copyright registrations; (c) rights relating to the protection of trade secrets, know-how or confidential information; and (d) rights in any trade names',\n",
              "    'Highlight the parts (if any) of this contract related to \"Exclusivity\" that should be reviewed by a lawyer. Details: Is there an exclusive dealing\\xa0 commitment with the counterparty? This includes a commitment to procure all โrequirementsโ from one party of certain technology, goods, or services or a prohibition on licensing or selling technology, goods or services to third parties, or a prohibition on\\xa0 collaborating or working with other parties), whether during the contract or\\xa0 after the contract ends (or both).',\n",
              "    'Sekisui shall purchase the Products exclusively from Qualigen, and Qualigen shall supply the Products exclusively to Sekisui, in each case for the Territory.',\n",
              "    0,\n",
              "    0),\n",
              "   ('Exhibit 10.54 DISTRIBUTION AND DEVELOPMENT AGREEMENT This Distribution and Development Agreement (this \"Agreement\") is made and entered into as of May 1, 2016 by and between Sekisui Diagnostics, LLC and its Affiliates, a Delaware limited liability company with principal offices at 4 Hartwell Place, Lexington, Massachusetts 02421 (\"Sekisui\"), and Qualigen, Inc. and its Affiliates, a Delaware corporation with principal offices at 2042 Corte Del Nogal, Carlsbad, California 92011 (\"Qualigen\" and together with Sekisui, each a \"Party\" and together the \"Parties\"). WHEREAS, Qualigen is engaged in the manufacture, supply and development of certain clinical rapid diagnostic test devices and controls; and WHEREAS, Qualigen wishes to appoint Sekisui as its exclusive distributor for such products in the Territory (as defined below); and WHEREAS, Sekisui wishes to be appointed as the exclusive distributor of such products and to fund the development of certain future products. NOW, THEREFORE, in consideration of the mutual covenants hereinafter contained, the parties hereto agree as follows: 1. Definitions 1.1. Adverse Event shall mean an incident in which the Product was alleged to have caused or contributed to the death or serious injury of a patient or operator and would require submitting a Medical Devices Report to the FDA (as hereinafter defined) as per 21 CFR 803, or a similar report to a Competent Authority (as hereinafter defined) as per Vigilance Guidance MEDDEV 2.12-1. 1.2. Affiliate shall mean, (i) with respect to Qualigen, any corporation or other form of business organization, which directly or indirectly owns, controls, is controlled by, or is under common control with Qualigen, and (ii), with respect to Sekisui, shall mean Sekisui Diagnostics (UK) Ltd., Sekisui Diagnostics PEI, Inc., SEKISUI MEDICAL CO., LTD., and Sekisui Diagnostics GmbH. An entity shall be regarded as being in control of another entity if the former entity has the direct or indirect power to vote more than fifty percent (50%) of the outstanding voting securities (or other ownership interest for a business organization other than a corporation) of that entity, or the direct or indirect ability to direct or cause the direction of the general management and policies of the other entity. 1.3. Applicable Markets shall mean the United States, Canada, the European Union, Japan and other additional geographies that are added from time to time at the request of Sekisui, but only to the extent that it is commercially reasonable for Qualigen to expand to such additional geographies. 1.4. Available Margin is defined on Exhibit A. 1.5. Business Plan shall mean the business plan attached as Exhibit B hereto, which business plan may be amended from time to time by mutual agreement of Qualigen and Sekisui. 1.6. COGS is defined on Exhibit A.\\n\\nSource: RITTER PHARMACEUTICALS INC, S-4/A, 3/13/2020\\n\\n\\n\\n\\n\\n1.7. Competent Authority shall mean the governmental authority in a member state of the European Union which has competence in relation to the Products. 1.8. Development Plan shall mean the development plan attached as Exhibit C hereto, which development plan may be amended from time to time by mutual agreement of Qualigen and Sekisui. 1.9. Effective Date shall mean May 1, 2016. 1.10. European Union shall mean the countries in Europe that are under the CE mark regulatory regime. 1.11. Exclusivity Period shall mean the period from the Effective Date until December 31, 2018. 1.12. FDA shall mean the U.S. Food and Drug Administration or any successor agency. 1.13. Health Canada shall mean the department of the government of Canada with responsibility for national public health. 1.14. Intellectual Property Rights means all intellectual property rights in any jurisdiction worldwide, including, without limitation: (a) Patent Rights; (b) rights associated with works of authorship including copyrights, copyright applications, and copyright registrations; (c) rights relating to the protection of trade secrets, know-how or confidential information; and (d) rights in any trade names',\n",
              "    'Highlight the parts (if any) of this contract related to \"Exclusivity\" that should be reviewed by a lawyer. Details: Is there an exclusive dealing\\xa0 commitment with the counterparty? This includes a commitment to procure all โrequirementsโ from one party of certain technology, goods, or services or a prohibition on licensing or selling technology, goods or services to third parties, or a prohibition on\\xa0 collaborating or working with other parties), whether during the contract or\\xa0 after the contract ends (or both).',\n",
              "    \"Qualigen shall supply Sekisui with all of Sekisui's commercial requirements for the Product in the Applicable Markets.\",\n",
              "    0,\n",
              "    0),\n",
              "   ('Exhibit 10.28\\n\\n                              ENDORSEMENT AGREEMENT\\n\\n            This Endorsement Agreement (\"Agreement\") is made and entered into as of August 24, 1995, by and among the following parties:\\n\\n                  (a) Kathy Ireland, Inc. (\"KI Inc.\"), furnishing the services       of Kathy Ireland (\"KI\"), c/o The Sterling/Winters Co., 1900 Avenue of the       Stars, Suite #1640, Los Angeles, California 90067;\\n\\n                  (b) The Sterling/Winters Co. (\"SW\"), 1900 Avenue of the Stars,       Suite #1640, Los Angeles, California 90067; and\\n\\n                  (c) Diplomat Ambassador Eyewear Group (\"Diplomat\"), 1010 Arch       Street, 3rd Floor, Philadelphia, Pennsylvania 19107.\\n\\n            1. Recitals.\\n\\n                  (a) Whereas Diplomat has created a new product line to be known as \"Kathy Ireland Eyewear\" (\"KI Eyewear\");\\n\\n                  (b) Whereas Diplomat estimates on a non-binding basis that wholesale sales of KI Eyewear will reach $          during the first License Year, $          during the 2nd License Year, $          during the 3rd License Year, and $          during the 4th License Year (as those License Years are defined in subparagraph 3.(b) of this Agreement);\\n\\n                  (c) Whereas Diplomat desires to obtain the right to use the name, likeness and endorsement of KI in connection with the advertisement, promotion and sale of KI Eyewear; and\\n\\n                  (d) Whereas KI, Inc. has the authority to grant the right to use KI\\'s name, likeness and endorsement to Diplomat in connection with the advertisement, promotion and sale of KI Eyewear and desires to do so;\\n\\n                  (e) NOW THEREFORE, for and in consideration of the mutual promises and conditions contained in this Agreement, the parties hereby agree as follows.\\n\\n            2. Grant of License.\\n\\n                  (a) Products. Upon the terms and conditions set forth in this Agreement, KI, Inc. hereby grants to Diplomat and Diplomat hereby accepts the right, license and privilege of utilizing KI\\'s name and likeness solely upon and in connection with the manufacture, sale and distribution of the following products:\\n\\n                        (1) sunglasses, eyeglasses, readers and ophthalmic frames;\\n\\n                                       1\\n\\n                        (2) optical cases, optical eye chains, eye pins, and lens cleaning kits sold only in optical retailers; and\\n\\n                        (3) such other optical accessories as the parties shall agree.\\n\\n                  (b) Territory. The license hereby granted extends worldwide.\\n\\n                  (c) Term. The term of the license hereby granted shall commence August 1, 1995 and continue until January 30, 2000, unless sooner terminated in the manner provided in the immediately succeeding sentence or as otherwise provided in this Agreement. Notwithstanding the foregoing, if the management of Kmart stores elects not to carry KI eyewear prior to the end of the first license year (January 30, 1997), then either party shall have the right to terminate this Agreement as of such date.\\n\\n                  3. Terms of Payment.\\n\\n                  (a) Rate. Diplomat agrees to pay KI, Inc. as royalty a sum equal to  % of the net wholesale volume of the products covered by this Agreement by Diplomat and its affiliated, associated, or subsidiary companies. The term \"net wholesale volume\" shall mean gross sales to all customers; less returns, trade discounts and cash discounts; but no deduction shall be made for other discounts or uncollectible accounts. No costs incurred in the manufacture, sale, distribution, or exploitation of the products covered by this Agreement shall be deducted from any royalty payable by Diplomat.\\n\\n                  (b) Minimum Royalties. Diplomat agrees to pay KI, Inc. the minimum royalties set forth below as a minimum guarantee against royalties to be paid to KI, Inc. under subparagraph 3.(a), above:\\n\\n                  (1) 1st License Year (8/1/95 - 1/30/97):     $                   (2) 2nd License Year (2/1/97 - 1/30/98):     $                   (3) 3',\n",
              "    'Highlight the parts (if any) of this contract related to \"Exclusivity\" that should be reviewed by a lawyer. Details: Is there an exclusive dealing\\xa0 commitment with the counterparty? This includes a commitment to procure all โrequirementsโ from one party of certain technology, goods, or services or a prohibition on licensing or selling technology, goods or services to third parties, or a prohibition on\\xa0 collaborating or working with other parties), whether during the contract or\\xa0 after the contract ends (or both).',\n",
              "    \"Nothing in this Agreement shall be construed to prevent KI, Inc. from granting any other licenses for the use of KI's name or likeness, or from utilizing KI's name and likeness in any manner whatsoever, except that KI, Inc. agrees that except as provided herein it will grant no other licenses for the territory to which this license extends for the use of KI's name and likeness in connection with the sale of the products described in subparagraphs 2.(a)(1) and (2) of this Agreement effective during the term of this Agreement.\",\n",
              "    0,\n",
              "    0),\n",
              "   ('Exhibit 10.28\\n\\n                              ENDORSEMENT AGREEMENT\\n\\n            This Endorsement Agreement (\"Agreement\") is made and entered into as of August 24, 1995, by and among the following parties:\\n\\n                  (a) Kathy Ireland, Inc. (\"KI Inc.\"), furnishing the services       of Kathy Ireland (\"KI\"), c/o The Sterling/Winters Co., 1900 Avenue of the       Stars, Suite #1640, Los Angeles, California 90067;\\n\\n                  (b) The Sterling/Winters Co. (\"SW\"), 1900 Avenue of the Stars,       Suite #1640, Los Angeles, California 90067; and\\n\\n                  (c) Diplomat Ambassador Eyewear Group (\"Diplomat\"), 1010 Arch       Street, 3rd Floor, Philadelphia, Pennsylvania 19107.\\n\\n            1. Recitals.\\n\\n                  (a) Whereas Diplomat has created a new product line to be known as \"Kathy Ireland Eyewear\" (\"KI Eyewear\");\\n\\n                  (b) Whereas Diplomat estimates on a non-binding basis that wholesale sales of KI Eyewear will reach $          during the first License Year, $          during the 2nd License Year, $          during the 3rd License Year, and $          during the 4th License Year (as those License Years are defined in subparagraph 3.(b) of this Agreement);\\n\\n                  (c) Whereas Diplomat desires to obtain the right to use the name, likeness and endorsement of KI in connection with the advertisement, promotion and sale of KI Eyewear; and\\n\\n                  (d) Whereas KI, Inc. has the authority to grant the right to use KI\\'s name, likeness and endorsement to Diplomat in connection with the advertisement, promotion and sale of KI Eyewear and desires to do so;\\n\\n                  (e) NOW THEREFORE, for and in consideration of the mutual promises and conditions contained in this Agreement, the parties hereby agree as follows.\\n\\n            2. Grant of License.\\n\\n                  (a) Products. Upon the terms and conditions set forth in this Agreement, KI, Inc. hereby grants to Diplomat and Diplomat hereby accepts the right, license and privilege of utilizing KI\\'s name and likeness solely upon and in connection with the manufacture, sale and distribution of the following products:\\n\\n                        (1) sunglasses, eyeglasses, readers and ophthalmic frames;\\n\\n                                       1\\n\\n                        (2) optical cases, optical eye chains, eye pins, and lens cleaning kits sold only in optical retailers; and\\n\\n                        (3) such other optical accessories as the parties shall agree.\\n\\n                  (b) Territory. The license hereby granted extends worldwide.\\n\\n                  (c) Term. The term of the license hereby granted shall commence August 1, 1995 and continue until January 30, 2000, unless sooner terminated in the manner provided in the immediately succeeding sentence or as otherwise provided in this Agreement. Notwithstanding the foregoing, if the management of Kmart stores elects not to carry KI eyewear prior to the end of the first license year (January 30, 1997), then either party shall have the right to terminate this Agreement as of such date.\\n\\n                  3. Terms of Payment.\\n\\n                  (a) Rate. Diplomat agrees to pay KI, Inc. as royalty a sum equal to  % of the net wholesale volume of the products covered by this Agreement by Diplomat and its affiliated, associated, or subsidiary companies. The term \"net wholesale volume\" shall mean gross sales to all customers; less returns, trade discounts and cash discounts; but no deduction shall be made for other discounts or uncollectible accounts. No costs incurred in the manufacture, sale, distribution, or exploitation of the products covered by this Agreement shall be deducted from any royalty payable by Diplomat.\\n\\n                  (b) Minimum Royalties. Diplomat agrees to pay KI, Inc. the minimum royalties set forth below as a minimum guarantee against royalties to be paid to KI, Inc. under subparagraph 3.(a), above:\\n\\n                  (1) 1st License Year (8/1/95 - 1/30/97):     $                   (2) 2nd License Year (2/1/97 - 1/30/98):     $                   (3) 3',\n",
              "    'Highlight the parts (if any) of this contract related to \"Exclusivity\" that should be reviewed by a lawyer. Details: Is there an exclusive dealing\\xa0 commitment with the counterparty? This includes a commitment to procure all โrequirementsโ from one party of certain technology, goods, or services or a prohibition on licensing or selling technology, goods or services to third parties, or a prohibition on\\xa0 collaborating or working with other parties), whether during the contract or\\xa0 after the contract ends (or both).',\n",
              "    'The license hereby granted shall be exclusive as to the products described in subparagraphs 2.(a)(1) and (2) of this Agreement, but nonexclusive as to all other products covered by this Agreement.',\n",
              "    0,\n",
              "    0)]),\n",
              " (('Change Of Control', 'possible negative'),\n",
              "  [('Exhibit 10.2\\n\\n______________________________________________________________________________\\n\\nCO-PROMOTION AGREEMENT\\n\\nby and between\\n\\nDOVA PHARMACEUTICALS, INC.\\n\\nand\\n\\nVALEANT PHARMACEUTICALS NORTH AMERICA LLC\\n\\nSeptember 26, 2018\\n\\n______________________________________________________________________________\\n\\nCONFIDENTIAL TREATMENT HAS BEEN REQUESTED FOR PORTIONS OF THIS EXHIBIT. THE COPY FILED HEREWITH OMITS THE INFORMATION SUBJECT TO A CONFIDENTIALITY REQUEST. OMISSIONS ARE DESIGNATED [***]. A COMPLETE VERSION OF THIS EXHIBIT HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION.\\n\\nSource: DOVA PHARMACEUTICALS INC., 10-Q, 11/8/2018\\n\\n\\n\\n\\n\\nTABLE OF CONTENTS\\n\\nPage\\n\\nARTICLE 1 DEFINITIONS 1\\n\\nARTICLE 2 RIGHTS AND OBLIGATIONS 8\\n\\n2.1 Engagement; Grant of Rights. 8\\n\\n2.2 Retention of Rights. 9\\n\\n2.3 Non-Competition; Non-Solicitation. 9\\n\\n2.4 Dova Trademarks and Copyrights. 10\\n\\nARTICLE 3 JOINT STEERING COMMITTEE 11\\n\\n3.1 Formation of the JSC. 11\\n\\n3.2 Meetings and Minutes. 11\\n\\n3.3 Purpose of the JSC. 11\\n\\n3.4 Decision Making. 13\\n\\n3.5 Marketing Sub-Committee. 13\\n\\nARTICLE 4 VALEANT ACTIVITIES FOR THE PRODUCT 14\\n\\n4.1 Valeant Activities. 14\\n\\n4.2 Detailing. 15\\n\\n4.3 Compliance with Applicable Law. 17\\n\\n4.4 Field Force Personnel Training; Product Materials. 19\\n\\n4.5 Provisions Related to Field Force Personnel. 21\\n\\n4.6 Responsibility for Valeant Activity Costs and Expenses. 22\\n\\n4.7 Data Sharing. 22\\n\\nARTICLE 5 REGULATORY, SAFETY AND SURVEILLANCE, COMMERCIAL MATTERS 23\\n\\n5.1 Dova Responsibility. 23\\n\\n5.2 Valeant Involvement. 23\\n\\n5.3 Inspections. 23\\n\\n5.4 Pharmacovigilance. 24\\n\\n5.5 Unsolicited Requests for Medical Information. 24\\n\\n5.6 Recalls and Market Withdrawals. 25\\n\\n5.7 Certain Reporting Responsibilities. 25\\n\\n5.8 Booking of Sales Revenues. 25\\n\\n5.9 Returns. 25\\n\\nSource: DOVA PHARMACEUTICALS INC., 10-Q, 11/8/2018\\n\\n\\n\\n\\n\\ni\\n\\nCONFIDENTIAL TREATMENT HAS BEEN REQUESTED FOR PORTIONS OF THIS EXHIBIT. THE COPY FILED HEREWITH OMITS THE INFORMATION SUBJECT TO A CONFIDENTIALITY REQUEST. OMISSIONS ARE DESIGNATED [***]. A COMPLETE VERSION OF THIS EXHIBIT HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION.\\n\\nSource: DOVA PHARMACEUTICALS INC., 10-Q, 11/8/2018\\n\\n\\n\\n\\n\\nTABLE OF CONTENTS (continued)\\n\\n5.10 Manufacturing; Distribution; Marketing. 25\\n\\nARTICLE 6 FINANCIAL PROVISIONS 26\\n\\n6.1 Promotion Fee. 26\\n\\n6.2 Milestone Payment. 27\\n\\n6.3 Reports; Payments. 27\\n\\n6.4 Taxes. 28\\n\\n6.5 Determination of Specialty. 29\\n\\nARTICLE 7 AUDIT RIGHTS 30\\n\\n7.1 Recordkeeping. 30\\n\\n7.2 Valeant Rights. 30\\n\\n7.3 Dova Rights. 31\\n\\nARTICLE 8 INTELLECTUAL PROPERTY 32\\n\\n8.1 Ownership of Intellectual Property. 32\\n\\n8.2 Title to Trademarks and Copyrights. 32\\n\\n8.3 Protection of Trademarks and Copyrights. 32\\n\\n8.4 Disclosure of Know-How. 33\\n\\nARTICLE 9 CONFIDENTIALITY 33\\n\\n9.1 Confidential Information. 33\\n\\n9.2 Public Announcements. 34\\n\\nARTICLE 10 REPRESENTATIONS AND WARRANTIES; ADDITIONAL COVENANTS 35\\n\\n10.1 Representations and Warranties of Dova. 35\\n\\n10.2 Representations and Warranties of Valeant. 37\\n\\n10.3 Disclaimer of Warranty. 38\\n\\n10.4 Additional Covenants. 39\\n\\nARTICLE 11 INDEMNIFICATION; LIMITATIONS ON LIABILITY 39\\n\\n11.1 Indemnification by Dova. 39\\n\\n11.2 Indemnification by Valeant. 39\\n\\n11.3 Indemnification Procedures. 40\\n\\n11.4 Limitation of Liability. 40\\n\\n11.5 Insurance. 40\\n\\nARTICLE 12 TERM AND TERMINATION 41\\n\\n12.1 Term. 41\\n\\n12.2 Early Termination for Cause. 41\\n\\nSource: DOVA PHARMACEUTICALS INC., 10-Q, 11/8/2018\\n\\n\\n\\n\\n\\n12.3 Other Early Termination. 42\\n\\n12.4 Effects of Termination. 42\\n\\n12.5 Tail Period. 42\\n\\nii\\n\\nCONFIDENTIAL TREATMENT HAS BEEN REQUESTED FOR PORTIONS OF THIS EXHIBIT. THE COPY FILED HEREWITH OMITS THE INFORMATION SUBJECT TO A CONFIDENTIALITY REQUEST. OMISSIONS ARE DESIGNATED [***]. A COMPLETE VERSION OF THIS EXHIBIT HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION.\\n\\nSource: DOVA PHARMACEUTICALS INC., 10-Q, 11/8/2018\\n\\n\\n\\n\\n\\nTABLE OF CONTENTS (continued)\\n\\n12.6 Survival. 43\\n\\nARTICLE 13 MISCELLANEOUS 43\\n\\n13.1 Force Majeure. 43\\n\\n13.2 Assignment. 43\\n\\n13.3 Severability. 44\\n\\n13.4 Notices. 44\\n\\n13.5 Governing Law. 45\\n\\n13.6 Dispute Resolution. 45\\n\\n13.7 Waiver ',\n",
              "    'Highlight the parts (if any) of this contract related to \"Change Of Control\" that should be reviewed by a lawyer. Details: Does one party have the right to terminate or is consent or notice required of the counterparty if such party undergoes a change of control, such as a merger, stock sale, transfer of all or substantially all of its assets or business, or assignment by operation of law?',\n",
              "    \"Notwithstanding the foregoing, (a) either Party may, without the other Party's consent, assign this Agreement and its rights and obligations hereunder in whole or in part to an Affiliate; and (b) Dova may assign this Agreement to a successor in interest in connection with the sale or other transfer of all or substantially all of Dova's assets or rights relating to the Product; provided that such assignee shall remain subject to all of the terms and conditions hereof in all respects and shall assume all obligations of Dova hereunder whether accruing before or after such assignment.\",\n",
              "    0,\n",
              "    0)]),\n",
              " (('Anti-Assignment', 'possible negative'),\n",
              "  [('Exhibit 10.2\\n\\n______________________________________________________________________________\\n\\nCO-PROMOTION AGREEMENT\\n\\nby and between\\n\\nDOVA PHARMACEUTICALS, INC.\\n\\nand\\n\\nVALEANT PHARMACEUTICALS NORTH AMERICA LLC\\n\\nSeptember 26, 2018\\n\\n______________________________________________________________________________\\n\\nCONFIDENTIAL TREATMENT HAS BEEN REQUESTED FOR PORTIONS OF THIS EXHIBIT. THE COPY FILED HEREWITH OMITS THE INFORMATION SUBJECT TO A CONFIDENTIALITY REQUEST. OMISSIONS ARE DESIGNATED [***]. A COMPLETE VERSION OF THIS EXHIBIT HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION.\\n\\nSource: DOVA PHARMACEUTICALS INC., 10-Q, 11/8/2018\\n\\n\\n\\n\\n\\nTABLE OF CONTENTS\\n\\nPage\\n\\nARTICLE 1 DEFINITIONS 1\\n\\nARTICLE 2 RIGHTS AND OBLIGATIONS 8\\n\\n2.1 Engagement; Grant of Rights. 8\\n\\n2.2 Retention of Rights. 9\\n\\n2.3 Non-Competition; Non-Solicitation. 9\\n\\n2.4 Dova Trademarks and Copyrights. 10\\n\\nARTICLE 3 JOINT STEERING COMMITTEE 11\\n\\n3.1 Formation of the JSC. 11\\n\\n3.2 Meetings and Minutes. 11\\n\\n3.3 Purpose of the JSC. 11\\n\\n3.4 Decision Making. 13\\n\\n3.5 Marketing Sub-Committee. 13\\n\\nARTICLE 4 VALEANT ACTIVITIES FOR THE PRODUCT 14\\n\\n4.1 Valeant Activities. 14\\n\\n4.2 Detailing. 15\\n\\n4.3 Compliance with Applicable Law. 17\\n\\n4.4 Field Force Personnel Training; Product Materials. 19\\n\\n4.5 Provisions Related to Field Force Personnel. 21\\n\\n4.6 Responsibility for Valeant Activity Costs and Expenses. 22\\n\\n4.7 Data Sharing. 22\\n\\nARTICLE 5 REGULATORY, SAFETY AND SURVEILLANCE, COMMERCIAL MATTERS 23\\n\\n5.1 Dova Responsibility. 23\\n\\n5.2 Valeant Involvement. 23\\n\\n5.3 Inspections. 23\\n\\n5.4 Pharmacovigilance. 24\\n\\n5.5 Unsolicited Requests for Medical Information. 24\\n\\n5.6 Recalls and Market Withdrawals. 25\\n\\n5.7 Certain Reporting Responsibilities. 25\\n\\n5.8 Booking of Sales Revenues. 25\\n\\n5.9 Returns. 25\\n\\nSource: DOVA PHARMACEUTICALS INC., 10-Q, 11/8/2018\\n\\n\\n\\n\\n\\ni\\n\\nCONFIDENTIAL TREATMENT HAS BEEN REQUESTED FOR PORTIONS OF THIS EXHIBIT. THE COPY FILED HEREWITH OMITS THE INFORMATION SUBJECT TO A CONFIDENTIALITY REQUEST. OMISSIONS ARE DESIGNATED [***]. A COMPLETE VERSION OF THIS EXHIBIT HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION.\\n\\nSource: DOVA PHARMACEUTICALS INC., 10-Q, 11/8/2018\\n\\n\\n\\n\\n\\nTABLE OF CONTENTS (continued)\\n\\n5.10 Manufacturing; Distribution; Marketing. 25\\n\\nARTICLE 6 FINANCIAL PROVISIONS 26\\n\\n6.1 Promotion Fee. 26\\n\\n6.2 Milestone Payment. 27\\n\\n6.3 Reports; Payments. 27\\n\\n6.4 Taxes. 28\\n\\n6.5 Determination of Specialty. 29\\n\\nARTICLE 7 AUDIT RIGHTS 30\\n\\n7.1 Recordkeeping. 30\\n\\n7.2 Valeant Rights. 30\\n\\n7.3 Dova Rights. 31\\n\\nARTICLE 8 INTELLECTUAL PROPERTY 32\\n\\n8.1 Ownership of Intellectual Property. 32\\n\\n8.2 Title to Trademarks and Copyrights. 32\\n\\n8.3 Protection of Trademarks and Copyrights. 32\\n\\n8.4 Disclosure of Know-How. 33\\n\\nARTICLE 9 CONFIDENTIALITY 33\\n\\n9.1 Confidential Information. 33\\n\\n9.2 Public Announcements. 34\\n\\nARTICLE 10 REPRESENTATIONS AND WARRANTIES; ADDITIONAL COVENANTS 35\\n\\n10.1 Representations and Warranties of Dova. 35\\n\\n10.2 Representations and Warranties of Valeant. 37\\n\\n10.3 Disclaimer of Warranty. 38\\n\\n10.4 Additional Covenants. 39\\n\\nARTICLE 11 INDEMNIFICATION; LIMITATIONS ON LIABILITY 39\\n\\n11.1 Indemnification by Dova. 39\\n\\n11.2 Indemnification by Valeant. 39\\n\\n11.3 Indemnification Procedures. 40\\n\\n11.4 Limitation of Liability. 40\\n\\n11.5 Insurance. 40\\n\\nARTICLE 12 TERM AND TERMINATION 41\\n\\n12.1 Term. 41\\n\\n12.2 Early Termination for Cause. 41\\n\\nSource: DOVA PHARMACEUTICALS INC., 10-Q, 11/8/2018\\n\\n\\n\\n\\n\\n12.3 Other Early Termination. 42\\n\\n12.4 Effects of Termination. 42\\n\\n12.5 Tail Period. 42\\n\\nii\\n\\nCONFIDENTIAL TREATMENT HAS BEEN REQUESTED FOR PORTIONS OF THIS EXHIBIT. THE COPY FILED HEREWITH OMITS THE INFORMATION SUBJECT TO A CONFIDENTIALITY REQUEST. OMISSIONS ARE DESIGNATED [***]. A COMPLETE VERSION OF THIS EXHIBIT HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION.\\n\\nSource: DOVA PHARMACEUTICALS INC., 10-Q, 11/8/2018\\n\\n\\n\\n\\n\\nTABLE OF CONTENTS (continued)\\n\\n12.6 Survival. 43\\n\\nARTICLE 13 MISCELLANEOUS 43\\n\\n13.1 Force Majeure. 43\\n\\n13.2 Assignment. 43\\n\\n13.3 Severability. 44\\n\\n13.4 Notices. 44\\n\\n13.5 Governing Law. 45\\n\\n13.6 Dispute Resolution. 45\\n\\n13.7 Waiver ',\n",
              "    'Highlight the parts (if any) of this contract related to \"Anti-Assignment\" that should be reviewed by a lawyer. Details: Is consent or notice required of a party if the contract is assigned to a third party?',\n",
              "    'Any attempted assignment not in accordance with this Section 13.2 shall be void.',\n",
              "    0,\n",
              "    0),\n",
              "   ('Exhibit 10.2\\n\\n______________________________________________________________________________\\n\\nCO-PROMOTION AGREEMENT\\n\\nby and between\\n\\nDOVA PHARMACEUTICALS, INC.\\n\\nand\\n\\nVALEANT PHARMACEUTICALS NORTH AMERICA LLC\\n\\nSeptember 26, 2018\\n\\n______________________________________________________________________________\\n\\nCONFIDENTIAL TREATMENT HAS BEEN REQUESTED FOR PORTIONS OF THIS EXHIBIT. THE COPY FILED HEREWITH OMITS THE INFORMATION SUBJECT TO A CONFIDENTIALITY REQUEST. OMISSIONS ARE DESIGNATED [***]. A COMPLETE VERSION OF THIS EXHIBIT HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION.\\n\\nSource: DOVA PHARMACEUTICALS INC., 10-Q, 11/8/2018\\n\\n\\n\\n\\n\\nTABLE OF CONTENTS\\n\\nPage\\n\\nARTICLE 1 DEFINITIONS 1\\n\\nARTICLE 2 RIGHTS AND OBLIGATIONS 8\\n\\n2.1 Engagement; Grant of Rights. 8\\n\\n2.2 Retention of Rights. 9\\n\\n2.3 Non-Competition; Non-Solicitation. 9\\n\\n2.4 Dova Trademarks and Copyrights. 10\\n\\nARTICLE 3 JOINT STEERING COMMITTEE 11\\n\\n3.1 Formation of the JSC. 11\\n\\n3.2 Meetings and Minutes. 11\\n\\n3.3 Purpose of the JSC. 11\\n\\n3.4 Decision Making. 13\\n\\n3.5 Marketing Sub-Committee. 13\\n\\nARTICLE 4 VALEANT ACTIVITIES FOR THE PRODUCT 14\\n\\n4.1 Valeant Activities. 14\\n\\n4.2 Detailing. 15\\n\\n4.3 Compliance with Applicable Law. 17\\n\\n4.4 Field Force Personnel Training; Product Materials. 19\\n\\n4.5 Provisions Related to Field Force Personnel. 21\\n\\n4.6 Responsibility for Valeant Activity Costs and Expenses. 22\\n\\n4.7 Data Sharing. 22\\n\\nARTICLE 5 REGULATORY, SAFETY AND SURVEILLANCE, COMMERCIAL MATTERS 23\\n\\n5.1 Dova Responsibility. 23\\n\\n5.2 Valeant Involvement. 23\\n\\n5.3 Inspections. 23\\n\\n5.4 Pharmacovigilance. 24\\n\\n5.5 Unsolicited Requests for Medical Information. 24\\n\\n5.6 Recalls and Market Withdrawals. 25\\n\\n5.7 Certain Reporting Responsibilities. 25\\n\\n5.8 Booking of Sales Revenues. 25\\n\\n5.9 Returns. 25\\n\\nSource: DOVA PHARMACEUTICALS INC., 10-Q, 11/8/2018\\n\\n\\n\\n\\n\\ni\\n\\nCONFIDENTIAL TREATMENT HAS BEEN REQUESTED FOR PORTIONS OF THIS EXHIBIT. THE COPY FILED HEREWITH OMITS THE INFORMATION SUBJECT TO A CONFIDENTIALITY REQUEST. OMISSIONS ARE DESIGNATED [***]. A COMPLETE VERSION OF THIS EXHIBIT HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION.\\n\\nSource: DOVA PHARMACEUTICALS INC., 10-Q, 11/8/2018\\n\\n\\n\\n\\n\\nTABLE OF CONTENTS (continued)\\n\\n5.10 Manufacturing; Distribution; Marketing. 25\\n\\nARTICLE 6 FINANCIAL PROVISIONS 26\\n\\n6.1 Promotion Fee. 26\\n\\n6.2 Milestone Payment. 27\\n\\n6.3 Reports; Payments. 27\\n\\n6.4 Taxes. 28\\n\\n6.5 Determination of Specialty. 29\\n\\nARTICLE 7 AUDIT RIGHTS 30\\n\\n7.1 Recordkeeping. 30\\n\\n7.2 Valeant Rights. 30\\n\\n7.3 Dova Rights. 31\\n\\nARTICLE 8 INTELLECTUAL PROPERTY 32\\n\\n8.1 Ownership of Intellectual Property. 32\\n\\n8.2 Title to Trademarks and Copyrights. 32\\n\\n8.3 Protection of Trademarks and Copyrights. 32\\n\\n8.4 Disclosure of Know-How. 33\\n\\nARTICLE 9 CONFIDENTIALITY 33\\n\\n9.1 Confidential Information. 33\\n\\n9.2 Public Announcements. 34\\n\\nARTICLE 10 REPRESENTATIONS AND WARRANTIES; ADDITIONAL COVENANTS 35\\n\\n10.1 Representations and Warranties of Dova. 35\\n\\n10.2 Representations and Warranties of Valeant. 37\\n\\n10.3 Disclaimer of Warranty. 38\\n\\n10.4 Additional Covenants. 39\\n\\nARTICLE 11 INDEMNIFICATION; LIMITATIONS ON LIABILITY 39\\n\\n11.1 Indemnification by Dova. 39\\n\\n11.2 Indemnification by Valeant. 39\\n\\n11.3 Indemnification Procedures. 40\\n\\n11.4 Limitation of Liability. 40\\n\\n11.5 Insurance. 40\\n\\nARTICLE 12 TERM AND TERMINATION 41\\n\\n12.1 Term. 41\\n\\n12.2 Early Termination for Cause. 41\\n\\nSource: DOVA PHARMACEUTICALS INC., 10-Q, 11/8/2018\\n\\n\\n\\n\\n\\n12.3 Other Early Termination. 42\\n\\n12.4 Effects of Termination. 42\\n\\n12.5 Tail Period. 42\\n\\nii\\n\\nCONFIDENTIAL TREATMENT HAS BEEN REQUESTED FOR PORTIONS OF THIS EXHIBIT. THE COPY FILED HEREWITH OMITS THE INFORMATION SUBJECT TO A CONFIDENTIALITY REQUEST. OMISSIONS ARE DESIGNATED [***]. A COMPLETE VERSION OF THIS EXHIBIT HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION.\\n\\nSource: DOVA PHARMACEUTICALS INC., 10-Q, 11/8/2018\\n\\n\\n\\n\\n\\nTABLE OF CONTENTS (continued)\\n\\n12.6 Survival. 43\\n\\nARTICLE 13 MISCELLANEOUS 43\\n\\n13.1 Force Majeure. 43\\n\\n13.2 Assignment. 43\\n\\n13.3 Severability. 44\\n\\n13.4 Notices. 44\\n\\n13.5 Governing Law. 45\\n\\n13.6 Dispute Resolution. 45\\n\\n13.7 Waiver ',\n",
              "    'Highlight the parts (if any) of this contract related to \"Anti-Assignment\" that should be reviewed by a lawyer. Details: Is consent or notice required of a party if the contract is assigned to a third party?',\n",
              "    'Except as provided in this Section 13.2, this Agreement may not be assigned or otherwise transferred, nor may any rights or obligations hereunder be assigned or transferred, by either Party, without the written consent of the other Party (such consent not to be unreasonably withheld); provided that a merger, sale of stock or comparable transaction shall not constitute an assignment.',\n",
              "    0,\n",
              "    0)])]"
            ]
          },
          "metadata": {},
          "execution_count": 119
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "# def getFinal(row):\n",
        "#   for content in row[1]:\n",
        "#     return (content[0],content[1],content[3],content[4])\n",
        "\n",
        "final = group_key_df.flatMap(lambda x : x[1]).map(lambda x:(x[0],x[1],x[3],x[4])).toDF([\"source\", \"question\", \"answer_start\", \"answer_end\"])\n",
        "\n",
        "final.printSchema()\n",
        "final.show()\n",
        "final.write.mode(\"Overwrite\").json(\"output.json\")"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "mKF9z5vZ5B63",
        "outputId": "c7192f9b-cf49-4517-c282-62fb2b89aa7d"
      },
      "execution_count": 128,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "root\n",
            " |-- source: string (nullable = true)\n",
            " |-- question: string (nullable = true)\n",
            " |-- answer_start: long (nullable = true)\n",
            " |-- answer_end: long (nullable = true)\n",
            "\n",
            "+--------------------+--------------------+------------+----------+\n",
            "|              source|            question|answer_start|answer_end|\n",
            "+--------------------+--------------------+------------+----------+\n",
            "|Exhibit 10.16 SUP...|Highlight the par...|          14|        29|\n",
            "|1                ...|Highlight the par...|         225|       251|\n",
            "|Exhibit 10.13\\n\\n...|Highlight the par...|         322|       400|\n",
            "|ENDORSEMENT\\n\\nCo...|Highlight the par...|          30|        41|\n",
            "|Exhibit 10.4   IN...|Highlight the par...|          54|        85|\n",
            "|Exhibit 10.4\\n\\nC...|Highlight the par...|          60|        98|\n",
            "|EXHIBIT 10.13    ...|Highlight the par...|         505|       524|\n",
            "|Exhibit 10.1\\n\\nS...|Highlight the par...|        1911|      1939|\n",
            "|Exhibit 10.2    S...|Highlight the par...|          86|       114|\n",
            "|EXHIBIT 10.2   EN...|Highlight the par...|          15|        47|\n",
            "|EXHIBIT 10.1\\n\\nC...|Highlight the par...|          14|        45|\n",
            "|Exhibit 10.1 CERT...|Highlight the par...|         372|       425|\n",
            "|1                ...|Highlight the par...|         371|       392|\n",
            "|Exhibit 2.7 FORM ...|Highlight the par...|          12|        47|\n",
            "|Exhibit 10.1   CO...|Highlight the par...|          15|        36|\n",
            "|SCHEDULE TO Softw...|Highlight the par...|           0|        69|\n",
            "|Exhibit 10.5\\n\\nN...|Highlight the par...|         395|       416|\n",
            "|EXHIBIT 10.6    T...|Highlight the par...|        3964|      4007|\n",
            "|Exhibit 10.1 NON-...|Highlight the par...|          62|       103|\n",
            "|Exhibit 4.72\\n\\nC...|Highlight the par...|          98|       126|\n",
            "+--------------------+--------------------+------------+----------+\n",
            "only showing top 20 rows\n",
            "\n"
          ]
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        ""
      ],
      "metadata": {
        "id": "JMnieVFHqOE2"
      },
      "execution_count": null,
      "outputs": []
    },
    {
      "cell_type": "code",
      "source": [
        ""
      ],
      "metadata": {
        "id": "CmlXiQ6E3-G8"
      },
      "execution_count": null,
      "outputs": []
    }
  ]
}